
<html lang="en"     class="pb-page"  data-request-id="71c54183-a80a-47e3-ae7b-1e0df6b744cb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.1c00644;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity" /></meta><meta name="dc.Creator" content="Samo  Guzelj" /></meta><meta name="dc.Creator" content="Sanja  Nabergoj" /></meta><meta name="dc.Creator" content="Martina  Gobec" /></meta><meta name="dc.Creator" content="Stane  Pajk" /></meta><meta name="dc.Creator" content="Veronika  Klančič" /></meta><meta name="dc.Creator" content="Bram  Slütter" /></meta><meta name="dc.Creator" content="Ruža  Frkanec" /></meta><meta name="dc.Creator" content="Adela  Štimac" /></meta><meta name="dc.Creator" content="Primož  Šket" /></meta><meta name="dc.Creator" content="Janez  Plavec" /></meta><meta name="dc.Creator" content="Irena  Mlinarič-Raščan" /></meta><meta name="dc.Creator" content="Žiga  Jakopin" /></meta><meta name="dc.Description" content="We report on the design, synthesis, and biological evaluation of a series of nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramylpeptide agonists with improved in vitro ..." /></meta><meta name="Description" content="We report on the design, synthesis, and biological evaluation of a series of nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramylpeptide agonists with improved in vitro ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 27, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00644" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00644" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00644" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00644" /></link>
        
    
    

<title>Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00644" /></meta><meta property="og:title" content="Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0024.jpeg" /></meta><meta property="og:description" content="We report on the design, synthesis, and biological evaluation of a series of nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramylpeptide agonists with improved in vitro and in vivo adjuvant properties. We identified two promising compounds: 68, a potent nanomolar in vitro NOD2 agonist, and the more lipophilic 75, which shows superior adjuvant activity in vivo. Both compounds had immunostimulatory effects on peripheral blood mononuclear cells at the protein and transcriptional levels, and augmented dendritic-cell-mediated activation of T cells, while 75 additionally enhanced the cytotoxic activity of peripheral blood mononuclear cells against malignant cells. The C18 lipophilic tail of 75 is identified as a pivotal structural element that confers in vivo adjuvant activity in conjunction with a liposomal delivery system. Accordingly, liposome-encapsulated 75 showed promising adjuvant activity in mice, surpassing that of muramyl dipeptide, while achieving a more balanced Th1/Th2 immune response, thus highlighting its potential as a vaccine adjuvant." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00644"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00644">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00644&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00644&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00644&amp;href=/doi/10.1021/acs.jmedchem.1c00644" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 7809-7838</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00611" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00649" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their <i>In Vivo</i> Adjuvant Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Samo Guzelj</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samo Guzelj</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samo++Guzelj">Samo Guzelj</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sanja Nabergoj</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sanja Nabergoj</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sanja++Nabergoj">Sanja Nabergoj</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Gobec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Gobec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Gobec">Martina Gobec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stane Pajk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stane Pajk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stane++Pajk">Stane Pajk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Veronika Klančič</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Veronika Klančič</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Veronika++Klan%C4%8Di%C4%8D">Veronika Klančič</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bram Slütter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bram Slütter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Div. BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bram++Sl%C3%BCtter">Bram Slütter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruža Frkanec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruža Frkanec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, 10000 Zagreb, Croatia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ru%C5%BEa++Frkanec">Ruža Frkanec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adela Štimac</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adela Štimac</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, 10000 Zagreb, Croatia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adela++%C5%A0timac">Adela Štimac</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Primož Šket</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Primož Šket</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Slovenian NMR Centre, National Institute of Chemistry, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Primo%C5%BE++%C5%A0ket">Primož Šket</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Janez Plavec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janez Plavec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Slovenian NMR Centre, National Institute of Chemistry, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janez++Plavec">Janez Plavec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Irena Mlinarič-Raščan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Irena Mlinarič-Raščan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Irena++Mlinari%C4%8D-Ra%C5%A1%C4%8Dan">Irena Mlinarič-Raščan</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Žiga Jakopin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Žiga Jakopin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +386 1 4769 646. Fax: + 386 1 4258 031. E-mail: <a href="/cdn-cgi/l/email-protection#4b31222c2a65212a20243b22250b2d2d2a653e2522662721653822"><span class="__cf_email__" data-cfemail="a7ddcec0c689cdc6ccc8d7cec9e7c1c1c689d2c9ce8acbcd89d4ce">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=%C5%BDiga++Jakopin">Žiga Jakopin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9384-0858" title="Orcid link">https://orcid.org/0000-0001-9384-0858</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00644&amp;href=/doi/10.1021%2Facs.jmedchem.1c00644" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 7809–7838</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 27, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 April 2021</li><li><span class="item_label"><b>Published</b> online</span>27 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 June 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00644" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00644</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00644"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">999</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00644" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Samo&quot;,&quot;last_name&quot;:&quot;Guzelj&quot;},{&quot;first_name&quot;:&quot;Sanja&quot;,&quot;last_name&quot;:&quot;Nabergoj&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Gobec&quot;},{&quot;first_name&quot;:&quot;Stane&quot;,&quot;last_name&quot;:&quot;Pajk&quot;},{&quot;first_name&quot;:&quot;Veronika&quot;,&quot;last_name&quot;:&quot;Klančič&quot;},{&quot;first_name&quot;:&quot;Bram&quot;,&quot;last_name&quot;:&quot;Slütter&quot;},{&quot;first_name&quot;:&quot;Ruža&quot;,&quot;last_name&quot;:&quot;Frkanec&quot;},{&quot;first_name&quot;:&quot;Adela&quot;,&quot;last_name&quot;:&quot;Štimac&quot;},{&quot;first_name&quot;:&quot;Primož&quot;,&quot;last_name&quot;:&quot;Šket&quot;},{&quot;first_name&quot;:&quot;Janez&quot;,&quot;last_name&quot;:&quot;Plavec&quot;},{&quot;first_name&quot;:&quot;Irena&quot;,&quot;last_name&quot;:&quot;Mlinarič-Raščan&quot;},{&quot;first_name&quot;:&quot;Žiga&quot;,&quot;last_name&quot;:&quot;Jakopin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;7809-7838&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00644&quot;},&quot;abstract&quot;:&quot;We report on the design, synthesis, and biological evaluation of a series of nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramylpeptide agonists with improved in vitro and in vivo adjuvant properties. We identified two promising compounds: 68, a potent nanomolar in vitro NOD2 agonist, and the more lipophilic 75, which shows superior adjuvant activity in vivo. Both compounds had immunostimulatory effects on peripheral blood mononuclear cells at the protein and transcriptional levels, and augmented dendritic-cell-mediated activation of T cells, while 75 additionally enhanced the cytotoxic activity of peripheral blood mononuclear cells against malignant cells. The C18 lipophilic tail of 75 is identified as a pivotal structural element that confers in vivo adjuvant activity in conjunction with a liposomal delivery system. Accordingly, liposome-encapsulated 75 showed promising adjuvant activity in mice, surpassing that of muramyl dipeptide, while achieving a more balanced Th1/Th2 immun&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00644&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00644" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00644&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00644" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00644&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00644" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00644&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00644&amp;href=/doi/10.1021/acs.jmedchem.1c00644" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00644" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00644" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00644%26sid%3Dliteratum%253Aachs%26pmid%3D34043358%26genre%3Darticle%26aulast%3DGuzelj%26date%3D2021%26atitle%3DStructural%2BFine-Tuning%2Bof%2BDesmuramylpeptide%2BNOD2%2BAgonists%2BDefines%2BTheir%2BIn%2BVivo%2BAdjuvant%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D11%26spage%3D7809%26epage%3D7838%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/jmcmar.2021.64.issue-11/20210610/jmcmar.2021.64.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report on the design, synthesis, and biological evaluation of a series of nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramylpeptide agonists with improved <i>in vitro</i> and <i>in vivo</i> adjuvant properties. We identified two promising compounds: <b>68</b>, a potent nanomolar <i>in vitro</i> NOD2 agonist, and the more lipophilic <b>75</b>, which shows superior adjuvant activity <i>in vivo</i>. Both compounds had immunostimulatory effects on peripheral blood mononuclear cells at the protein and transcriptional levels, and augmented dendritic-cell-mediated activation of T cells, while <b>75</b> additionally enhanced the cytotoxic activity of peripheral blood mononuclear cells against malignant cells. The C<sub>18</sub> lipophilic tail of <b>75</b> is identified as a pivotal structural element that confers <i>in vivo</i> adjuvant activity in conjunction with a liposomal delivery system. Accordingly, liposome-encapsulated <b>75</b> showed promising adjuvant activity in mice, surpassing that of muramyl dipeptide, while achieving a more balanced Th1/Th2 immune response, thus highlighting its potential as a vaccine adjuvant.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Defense against invading pathogens in vertebrates is accomplished through coordinated responses of the nonspecific innate and the antigen-specific adaptive immune systems. The former orchestrates the first line of defense through the action of a superfamily of pattern recognition receptors (PRRs). PRRs are responsible for recognition of “nonself” features, which are conserved microbial components that are also known as pathogen-associated molecular patterns.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> As well as promotion of the immediate innate immune response, PRRs are involved in shaping of the gradually forming adaptive immune responses through engagement of antigen-presenting cells.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, both naturally and synthetically derived modulators of PRRs have been of considerable interest for medicinal chemists for development as vaccine adjuvants.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a></div><div class="NLM_p">Nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) belongs to the intracellular NOD-like receptor family of PRRs, and it is composed of three motifs: (i) two effector N-terminal caspase recruitment domains (CARDs); (ii) a centrally located nucleotide-binding domain that is required for oligomerization; and (iii) a C-terminal leucine-rich repeat domain that is implicated in ligand recognition.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> NOD2 is primarily expressed in leukocytes and intestinal epithelial cells (especially Paneth cells), where it is required to sense bacterial cell wall peptidoglycan fragments that enter the cytosol.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> The minimal essential peptidoglycan substructure that can still activate NOD2 is muramyl dipeptide (MDP), a glycopeptide in the cell wall of both Gram-positive and Gram-negative bacteria.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> MDP comprises <i>N</i>-acetylmuramic acid (MurNAc) and an <span class="smallcaps smallerCapital">l</span>-alanine-<span class="smallcaps smallerCapital">d</span>-isoglutamine dipeptide, which is attached to the MurNAc via a lactic acid spacer. Recognition of MDP is followed by self-oligomerization, through which NOD2 recruits the adaptor protein receptor-interacting serine/threonine kinase 2, RIP2, via CARD–CARD interactions. This triggers the downstream signaling cascades that include the mitogen-activated protein kinase and nuclear factor κB (NF-κB) pathways, which results in a wide array of immune responses.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> These are characterized by release of pro-inflammatory cytokines, chemokines, and antimicrobial factors (including defensins), generation of reactive nitrogen species, and recruitment and priming of neutrophils, inflammatory monocytes, and dendritic cells (DCs).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Of note, NOD2 activation also facilitates autophagy, an essential process for efficient antigen processing and activation of the adaptive immune system.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a></div><div class="NLM_p">Due to their broad immunomodulatory effects, NOD2 agonists are of significant clinical relevance. They have been highlighted for providing nonspecific protective effects against bacterial and viral infections.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Furthermore, NOD2 is an enticing target for expansion of the currently limited selection of vaccine adjuvants.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> As well as generating robust and sustainable systemic immune responses, recent reports have additionally extended the potential of NOD2-activating adjuvants to mucosal vaccines.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> These represent an attractive alternative to conventional vaccines, as they generate mucosal immune responses, which are essential for protection against pathogens transmitted through mucosal surfaces. Finally, the developing field of cancer immunotherapy has highlighted NOD2 agonists as potential immunotherapeutics, either as adjuvants in cancer vaccines, or by directly enhancing immune cell antitumor activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">MDP was first recognized as the minimal effective component of Freund’s complete adjuvant.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> While MDP promotes both innate and adaptive immune responses, its use in the clinic is hindered by its strong pyrogenicity,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> rapid elimination,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and metabolic instability.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> To circumvent these issues and to improve its clinical utility, structural modifications of MDP have been studied extensively, with several reviews available that have comprehensively described their structure–activity relationships.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29−31)</a> Notably, two lipophilic derivatives of MDP, known as romurtide<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and mifamurtide,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> are currently in use for the treatment of leukopenia and osteosarcoma, respectively, while a hydrophilic MDP derivative, murabutide, has been investigated in several clinical trials as a vaccine adjuvant (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. MDP and its representative derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The discovery that the full glycopeptide scaffold is not mandatory for NOD2 agonism led to the concept of desmuramylpeptides, a class of compounds that lack the MurNAc moiety. Replacement of this carbohydrate fragment with suitable surrogates can simplify their synthesis and allow for easier manipulation of their lipophilicity. Most desmuramylpeptides comprise the preserved or slightly varied MDP dipeptide motif plus various lipophilic groups, which have included carbocycles,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> adamantane,<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> and diverse aromatic moieties.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45 ref46">(40−46)</a> Here, we describe the design, synthesis, and biological evaluation of a series of novel acylated desmuramyltripeptides that are based on the structure of <b>1</b>, which is a potent NOD2 agonist that was previously reported by our group and contains a <i>trans</i>-feruloyl-glycine MurNAc mimetic.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Our current study identified the structural requirements for <i>in vitro</i> and <i>in vivo</i> immunostimulatory activity of <b>1</b>, which led to the surprising observation that NOD2 activation <i>in vitro</i> does not necessarily coincide with its adjuvant activity <i>in vivo</i>. We identified <b>68</b> as a potent <i>in vitro</i> NOD2 agonist with more than 2-fold improved potency over <b>1</b> and <b>75</b> with superior adjuvant activity <i>in vivo</i>. Compounds <b>68</b> and <b>75</b> induced proinflammatory transcriptional changes and cytokine production in peripheral blood mononuclear cells (PBMCs), both alone and in combination with lipopolysaccharide (LPS), and enhanced antigen presentation of DCs. Furthermore, <b>75</b> stimulated the cytotoxic activity of PBMCs against malignant cells and, importantly, had promising <i>in vivo</i> adjuvant activity with a balanced Th1/Th2 immune response in a mouse model of adjuvanticity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Design</h3><div class="NLM_p">Compound <b>1</b> comprises a <i>trans</i>-feruloyl-glycine MurNAc mimetic attached to the <span class="smallcaps smallerCapital">l</span>-valine-<span class="smallcaps smallerCapital">d</span>-glutamate dipeptide, and it showed good NOD2 agonistic activity with twice the potency of MDP in a HEK293 cell assay with overexpressed NOD2. It also enhanced the LPS-induced release of proinflammatory cytokines and was devoid of pyrogenicity, although it showed weak adjuvant activity in a mouse model of adjuvanticity.</div><div class="NLM_p">Recent biophysical data have suggested that MDP interacts with NOD2 through the leucine-rich repeat domain.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Maekawa et al. (2016) solved the crystal structure of NOD2 apoprotein in its ADP-bound inactive form.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> To date, however, no crystal structure of NOD2 with a bound ligand has been reported, and thus the exact binding mechanisms of MDP and its related compounds (including <b>1</b>) remain to be defined. Previous studies of <b>1</b> have suggested that the aromatic ring of the <i>trans</i>-feruloyl moiety contributes to NOD2 binding with π–π stacking and cation−π interactions, while both the 4-hydroxy and 3-methoxy groups form H-bonds with residues in the putative binding site.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> To determine whether these interactions can be optimized, we designed several derivatives with modified substitutions of the aromatic ring (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Furthermore, we evaluated both increased flexibility of (i.e., reduction of the feruloyl alkene bond) and conformational restrictions to (i.e., introduction of the cyclopropyl ring) the <i>trans</i> geometry. Notably, cyclopropyl fragments have an established track record in drug design, in part due to their “locking” of <i>E</i>/<i>Z</i> isomerizable alkene bonds in favorable conformations.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Exploration of the chemical space around the MurNAc surrogate moiety thus yielded compounds <b>18</b>–<b>21</b> and <b>24</b>–<b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of novel desmuramylpeptides based on <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. NOD2 Agonistic Activities of Compounds with Structural Modifications of the MurNAc Mimetic, the Central Amino Acid, and the Effect of Chain Elongation by <span class="smallcaps smallerCapital">l</span>-Lysine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0018.gif" alt="" id="GRAPHIC-d7e588-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0019.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">SEAP activities were measured in NOD2-specific HEK-Blue cell supernatants after incubation for 18 h with MDP (2 μM) or the compounds of interest (2 μM). The data are shown as fold increases of NF-κB transcriptional activity relative to the negative control (0.1% DMSO) and are expressed as mean ± SEM of at least two independent experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are expressed as mean ± SEM of at least two independent experiments with 7 or 8 concentrations used (from 1 nM to 20 μM).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Mixture of two diastereomers (<i>R</i>,<i>R</i> and <i>S</i>,<i>S</i> configurations of substituents on the cyclopropyl ring).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">It was not possible to conclusively determine the absolute stereochemical configurations of <b>29a</b> and <b>29b</b>; however, both contained a <i>trans-</i>configured cyclopropyl ring (<i>R</i>,<i>R</i> and <i>S</i>,<i>S</i> configurations).</p></div></div><div></div></div><div class="NLM_p">Recognition of MDP by NOD2 is highly stereospecific. While deviations from the <span class="smallcaps smallerCapital">l</span>–<span class="smallcaps smallerCapital">d</span> conformation of the <span class="smallcaps smallerCapital">l</span>-alanine-<span class="smallcaps smallerCapital">d</span>-isoglutamine pharmacophore can result in reduced or lack of activity, slight variations of the amino acids are permissible. For example, replacement of <span class="smallcaps smallerCapital">l</span>-alanine with <span class="smallcaps smallerCapital">l</span>-valine or <span class="smallcaps smallerCapital">l</span>-serine showed comparable activity.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50−52)</a> Additionally, the <span class="smallcaps smallerCapital">l</span>-threonine derivative decoupled the pyrogenic activity of MDP from its adjuvanticity.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Likewise, chain elongation with <span class="smallcaps smallerCapital">l</span>-lysine at the C-terminus, which mimics the structure of peptidoglycan from Gram-positive bacteria, achieved a similar immunostimulatory effect compared to that of MDP.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> By applying both principles to <b>1</b> (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), derivatives were designed where <span class="smallcaps smallerCapital">l</span>-valine was replaced by <span class="smallcaps smallerCapital">l</span>-serine and by its more lipophilic congeners <i>O</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-serine and <span class="smallcaps smallerCapital">l</span>-threonine (compounds <b>30</b>–<b>32</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), as well as by compounds where the peptide was elongated at the ω-carboxyl group of <span class="smallcaps smallerCapital">d</span>-glutamic acid with a methyl ester of either <span class="smallcaps smallerCapital">l</span>-lysine or <i>N</i><sup>6</sup>-stearoyl-<span class="smallcaps smallerCapital">l</span>-lysine; this latter closely resembles the structure of romurtide (compounds <b>41</b> and <b>82</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">While <b>1</b> had potent activity in <i>in vitro</i> assays, it induced less pronounced increases in mouse serum titers of antigen-specific IgG upon ovalbumin immunization. We hypothesized that the disparity between the <i>in vitro</i> and <i>in vivo</i> data was a consequence of poor pharmacokinetic properties, including the metabolic instability of the ester groups. Compound <b>1</b> was suggested to be a prodrug by <i>in vitro</i> experiments, which was supported by <i>in silico</i> experiments, with the need for hydrolysis of the ethyl esters for its activation. However, if this occurs prior to <b>1</b> reaching its effector cells, this will be detrimental to its effects. We also demonstrated that the hydrolyzed free acid was less able to cross the cell membrane compared to its parent diester compound.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Additionally, while MDP enters cells through the SLC15 peptide transporters and endocytosis,<a onclick="showRef(event, 'ref57 ref58 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59 ref60">(57−60)</a> desmuramylpeptides cross the cell membrane by passive absorption to reach their target receptor NOD2 in the cytoplasm.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">Taking these aspects into account, we set out to modify the pharmacokinetic properties of the parent molecule, according to two different approaches. First, the introduction of lipophilic acyl groups to the carbohydrate<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and <span class="smallcaps smallerCapital">d</span>-isoglutamine<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> moieties of MDP was previously shown not only to improve the adjuvant and immunoprotective properties but also to decrease the pyrogenicity of these derivatives. Analogous transformations were applied to <b>1</b> by acylation of the phenolic hydroxyl group on the <i>trans</i>-feruloyl moiety, as well as by replacing the ethyl esters with bulkier groups, to yield a library of prodrug derivatives (<b>56</b>, <b>68</b>, <b>72</b>–<b>81</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Among these, the cyclopentyl derivatives might serve a dual role. In addition to increasing the lipophilicity, chemical motifs that incorporate cyclopentyl esters have been reported to be selectively cleaved by human carboxylesterase-1, an enzyme that is restricted in expression to hepatocytes and cells of monocyte–macrophage lineage.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> As these latter cells express high levels of NOD2, implementation of these esterase-sensitive chemical motifs might lead to beneficial buildup of the hydrolyzed active compound only in these cells, given that charged acids would have little possibility to leave the cells.</div><div class="NLM_p">Second, we explored the chemical space of the <span class="smallcaps smallerCapital">d</span>-glutamic acid moiety with various mimetics of the carboxylic acid functionality. Namely, we introduced bioisosteric replacements of ester moieties with amides and esters of hydroxamic acid (compounds <b>57</b>–<b>64</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Hydroxamates have previously been used as successful bioisosteric replacements of carboxylic acid groups.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Amides, on the other hand, are well established for their potential as prodrugs of carboxylic acids.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. NOD2 Agonistic Activities of the Desmuramylpeptides with a Modified <span class="smallcaps smallerCapital">d</span>-Glutamic Acid Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0020.gif" alt="" id="GRAPHIC-d7e851-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0021.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">SEAP activities were measured in NOD2-specific HEK-Blue cell supernatants after incubation for 18 h with MDP (2 μM) or the compounds of interest (2 μM). The data are shown as fold increases of NF-κB transcriptional activity relative to the negative control (0.1% DMSO) and are expressed as mean ± SEM of at least two independent experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Mixture of two diastereomers with <span class="smallcaps smallerCapital">l</span> and <span class="smallcaps smallerCapital">d</span> configurations of valine.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  Chemistry</h3><div class="NLM_p">To prepare compounds with modifications of the <i>trans</i>-ferulic acid moiety, we designed a scalable divergent synthetic route that comprised the sequential deprotection and amide bond formation steps shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <span class="smallcaps smallerCapital">d</span>-Glutamic acid was first esterified with thionyl chloride in ethanol, to produce the diester <b>2</b>. Coupling of <b>2</b> to commercially available Boc-protected <span class="smallcaps smallerCapital">l</span>-valine with dicyclohexylcarbodiimide (DCC)/1-hydroxybenzotriazole (HOBt) produced the dipeptide <b>3</b>. Boc deprotection of <b>3</b> with trifluoroacetic acid (TFA) in dichloromethane (DCM) produced the deprotected TFA salt, which was immediately coupled to Boc-glycine using DCC/HOBt. Treatment of the resulting <b>6</b> with TFA produced the deprotected salt, which allowed diversification via coupling to various carboxylic acids using the 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC)/HOBt coupling strategy, to produce acyl tripeptides of <b>1</b>, <b>19</b>–<b>23</b>, and <b>25</b>–<b>29</b>. Compound <b>1</b> was additionally reduced by catalytic hydrogenation to produce the more flexible congener <b>18</b>, while <b>23</b> was deprotected with TFA to produce the free amine <b>24</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Boc-<span class="smallcaps smallerCapital">l</span>-Val or Boc-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-Ser or Boc-<span class="smallcaps smallerCapital">l</span>-Thr, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (ii) TFA/DCM (1:5), rt; (iii) Boc-Gly, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (iv) RCOOH, EDC, HOBt, DIPEA, DMAP, DMF, rt; (v) H<sub>2</sub>, Pd/C, CH<sub>3</sub>COOH, rt.</p></p></figure><div class="NLM_p">Analogously, desmuramylpeptides with a modified central amino acid were synthesized by coupling <b>2</b> to commercially available Boc-protected <span class="smallcaps smallerCapital">l</span>-serine (<i>O</i>-benzyl protected) and <span class="smallcaps smallerCapital">l</span>-threonine, to produce dipeptides <b>4</b> and <b>5</b>. Following deprotection with TFA, DCC/HOBt coupling to Boc-glycine produced the tripeptides <b>7</b> and <b>9</b>. Catalytic hydrogenation of <b>7</b> produced the deprotected <b>8</b>, after which compounds <b>7</b>, <b>8</b>, and <b>9</b> were deprotected with TFA and coupled with <i>trans</i>-ferulic acid using the EDC/HOBt coupling strategy, to produce, in turn, the desmuramylpeptides <b>30</b>, <b>31</b>, and <b>32</b>.</div><div class="NLM_p">Cyclopropane mimetics of <i>trans</i>-ferulic acid were synthesized as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <i>trans</i>-Ferulic acid was protected in sequential steps, first with thionyl chloride in ethanol to produce the ethyl ester <b>10</b>, which was reacted with acetyl chloride to produce the doubly protected compound <b>11</b>. Cyclopropanation of the double bond of <b>11</b> using the Johnson–Corey–Chaykovsky reaction resulted in cleavage of the acetyl group, along with subsequent methylation of the <i>in situ</i> liberated 4-phenol group, to produce <b>12</b>, which then underwent alkaline hydrolysis, to produce the 3,4-dimethoxy derivative <b>13</b>. To avoid deprotection of the hydroxyl group, the less labile double benzyl protection was used, with <i>trans</i>-ferulic acid reacted with benzyl chloride, to produce <b>14</b>. Cyclopropanation of <b>14</b> produced <b>15</b>. Removal of the benzyl groups from <b>15</b> by catalytic hydrogenation over palladium/carbon unexpectedly resulted in the opening of the cyclopropyl ring (<b>16</b>), while a milder debenzylation method using palladium acetate, triethylsilane, and triethylamine was used to produce the desired compound, <b>17</b>.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Cyclopropane Carrying <i>trans-</i>Ferulic Acid Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) SOCl<sub>2</sub>, EtOH, reflux; (ii) CH<sub>3</sub>COCl, Et<sub>3</sub>N, THF, rt; (iii) NaH, trimethylsulfoxonium iodide, DMSO, 50 °C; (iv) 1 M NaOH, EtOH, rt; (v) BnCl, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (vi) H<sub>2</sub>, Pd/C, rt; (vii) Pd(OAc)<sub>2</sub>, Et<sub>3</sub>SiH, Et<sub>3</sub>N, DCM, rt.</p></p></figure><div class="NLM_p">The synthesis of compounds with an additional <span class="smallcaps smallerCapital">l</span>-lysine residue incorporated is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. First, the 5-benzyl ester of Boc-<span class="smallcaps smallerCapital">d</span>-glutamic acid was subjected to DCC/HOBt-mediated coupling with ethanol, to produce compound <b>33</b>. TFA-mediated cleavage of the Boc protecting group and subsequent DCC/HOBt coupling was performed twice, first with Boc-<span class="smallcaps smallerCapital">l</span>-valine, and then with Boc-glycine, to produce the tripeptide <b>35</b>. Following cleavage of the benzyl ester of <b>35</b> with catalytic hydrogenation, the free acid <b>36</b> was coupled to Fmoc-protected <span class="smallcaps smallerCapital">l</span>-lysine (<b>37</b>; Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Scheme S1">Scheme S1</a>) using (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate (COMU) as the coupling reagent, to produce <b>38</b>. Then <b>38</b> was converted to <b>40</b> via a two-step sequence that involved cleavage of the Boc protecting group with TFA, and subsequent coupling to the <i>N</i>-hydroxysuccinimide-activated <i>trans</i>-ferulic acid <b>39</b> (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Scheme S2">Scheme S2</a>). Finally, Fmoc deprotection of the tetrapeptide <b>40</b> under alkaline conditions generated by 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in tetrahydrofuran (THF), with 1-octanethiol acting as the dibenzofulvene scavenger,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> produced the desired desmuramylpeptide <b>41</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) EtOH, DCC, DMAP, DCM, rt; (ii) TFA/DCM (1:5), rt; (iii) Boc-<span class="smallcaps smallerCapital">l</span>-Val, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (iv) Boc-Gly, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (v) H<sub>2</sub>, Pd/C, EtOH, rt; (vi) <b>37</b>, COMU, DIPEA, DMF, rt; (vii) <b>39</b>, NaHCO<sub>3</sub>, THF/H<sub>2</sub>O, rt; (viii) DBU, 1-octanethiol, THF, rt.</p></p></figure><div class="NLM_p">Assembly of the desmuramylpeptides with modifications of the <span class="smallcaps smallerCapital">d</span>-glutamic acid moiety was carried out as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Glycine was first esterified with thionyl chloride in ethanol to produce the ethyl ester <b>42</b>, which was then coupled to <i>trans</i>-ferulic acid using the EDC/HOBt coupling strategy. Next, the <i>N</i>-feruloyl-glycine <b>43</b> produced was deprotected with alkaline hydrolysis, and subsequently coupled with the ethyl ester of <span class="smallcaps smallerCapital">l</span>-valine (<b>44</b>) using EDC/HOBt, to produce the acyl dipeptide <b>45</b>. Alkaline hydrolysis of <b>45</b> produced the free acid <b>46</b>. Diversification by EDC/HOBt-mediated coupling to various <span class="smallcaps smallerCapital">d</span>-glutamic acid derivatives (<b>47</b>–<b>55</b>; Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Scheme S3">Scheme S3</a>) produced the desmuramylpeptides <b>56</b>–<b>64</b>, with incorporated carboxylic acid bioisosteres.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>56</b>–<b>64</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF, rt; (ii) 1 M NaOH, EtOH, rt; (iii) <b>44</b>, EDC, HOBt, DIPEA, DMAP, DMF, rt; (v) <b>47</b>–<b>55</b>, EDC, HOBt, DIPEA, DMAP, DMF, rt.</p></p></figure><div class="NLM_p">A synthetic procedure similar to that described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was used for the synthesis of lipophilic esters <b>68</b> and <b>72</b> (shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Boc-<span class="smallcaps smallerCapital">d</span>-glutamic acid was first esterified with cyclopentanol using EDC to produce the corresponding diester <b>65</b>. Following Boc deprotection with TFA, the ensuing coupling to Boc-protected <span class="smallcaps smallerCapital">l</span>-valine produced the dipeptide <b>66</b>. Similarly, acid-catalyzed esterification of <span class="smallcaps smallerCapital">d</span>-glutamic acid with 1-octadecanol produced the diester <b>69</b>, which was coupled to Boc-<span class="smallcaps smallerCapital">l</span>-valine to produce the dipeptide <b>70</b>. Compounds <b>66</b> and <b>70</b> were then subjected to two iterative cycles of TFA-mediated Boc deprotection with consecutive coupling, first to Boc-glycine, to produce <b>67</b> and <b>71</b>, and ultimately to <i>trans</i>-ferulic acid, to produce the ester congeners of <b>1</b>, <b>68</b> and <b>72</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>68</b> and <b>72</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) cyclopentanol, EDC, DMAP, DCM, rt; (ii) 1-octadecanol, pTsOH, toluene, reflux; (iii) TFA/DCM (1:5), rt; (iv) Boc-<span class="smallcaps smallerCapital">l</span>-Val, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (v) Boc-<span class="smallcaps smallerCapital">l</span>-Val, EDC, HOBt, DIPEA, DMAP, DCM, rt; (vi) Boc-Gly, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt, or Boc-Gly, EDC, HOBt, DIPEA, DMAP, DCM, rt; (vii) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF or DCM, rt.</p></p></figure><div class="NLM_p">Compounds <b>1</b>, <b>30</b>, <b>31</b>, <b>32</b>, <b>41</b>, and <b>68</b> were further acylated with acyl chlorides of varying chain lengths in the presence of triethylamine to produce the lipophilic ester derivatives <b>73</b>–<b>82</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>73</b>–<b>82</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) RCOCl, Et<sub>3</sub>N, THF, rt; (ii) C<sub>17</sub>H<sub>35</sub>COCl, Et<sub>3</sub>N, DMF, rt.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.3.  Biological Studies</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">2.3.1.  NOD2 Agonistic Activity of Synthesized Desmuramylpeptides</h4><div class="NLM_p">To determine the NOD2 agonistic potential of the synthesized desmuramylpeptides at the cellular level, we used the validated and commercially available HEK-Blue NOD2 cell line reporter assay. HEK-Blue NOD2 cells were first treated for 18 h with MDP, <b>1</b>, or the novel desmuramylpeptides at 2 μM. The NF-κB transcriptional activity measured was normalized to that of the vehicle treated (0.1% DMSO) control HEK-Blue NOD2 cells. The compounds that showed significant activity at 2 μM were further assayed for their dose-dependent activities, for determination of their EC<sub>50</sub> values. None of the tested compounds were cytotoxic toward the HEK-Blue NOD2 cells at the highest tested concentration (20 μM), as determined by the (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium) (i.e., MTS) cell viability assay (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a>).</div><div class="NLM_p">Exploration around the chemical space of the cinnamoyl moiety of the parent compound <b>1</b> (EC<sub>50</sub> = 89 nM) produced compounds <b>18</b>–<b>21</b> and <b>24</b>–<b>28</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Increased flexibility through the reduction of the double bond (<b>18</b>; EC<sub>50</sub> = 6.16 μM) resulted in decreased NOD2 agonistic activity by a factor of 70. Similarly, the NOD2 agonistic activity was decreased by a factor of 156 with the spacer prolonged to a propylene group (<b>19</b>; EC<sub>50</sub> = 13.9 μM), which indicated that <b>1</b> provides the optimal positioning of the aromatic ring. The 4-hydroxy-3-methoxy substitution pattern of the aromatic ring in <b>1</b> was also seen to be advantageous; namely, the 3,4-dimethoxy (<b>20</b>; EC<sub>50</sub> = 763 nM), 3,4-dihydroxy (<b>21</b>; EC<sub>50</sub> = 1.73 μM), and 4-amino (<b>24</b>; EC<sub>50</sub> = 542 nM) derivatives all showed lower activities. Interestingly, the 4-isopropyl (<b>25</b>; EC<sub>50</sub> = 71 nM) and the 4-nitro (<b>26</b>; EC<sub>50</sub> = 49 nM) derivatives showed similar NOD2 agonistic activity to <b>1</b>, despite their contrasting electronic properties, which indicated that the interactions with the protein of the group in the 4-position are primarily of a hydrophobic nature and are related to the size of the substituent. A nitro-substituted cinnamic acid was previously used in the design of MDP-C, which is a potent <i>in vivo</i> NOD2 agonist; however, in contrast to <b>26</b>, the nitro group was attached to the <span class="smallcaps smallerCapital">d</span>-glutamic acid moiety.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Cyclopropanation of the alkene moiety in the structure of the 3,4-dimethoxy derivative <b>20</b> produced <b>27</b> (EC<sub>50</sub> = 322 nM) with a 2.4-fold improved potency over <b>20</b>, which suggests that the cyclopropane ring assists in directing the aromatic ring to a more favorable position. Surprisingly, by applying the same concept to <b>1</b>, which thus produced <b>28</b> (EC<sub>50</sub> = 369 nM), the potency was reduced by a factor of 4. The <sup>1</sup>H–<sup>1</sup>H NOESY spectra revealed that both <b>27</b> and <b>28</b> retained the <i>trans</i> orientation of the substituents on the cyclopropane ring (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Figures S7 and S8">Figures S7 and S8</a>). This analysis, however, did not differentiate between the two <i>trans</i>-configured diastereomers (i.e., carrying the <i>R</i>,<i>R</i> and <i>S</i>,<i>S</i> configurations on the cyclopropyl ring), and the relative levels of those two species in the mixture could not be determined. Considering that it is likely that only one of them binds ideally to NOD2, changes in their proportions would influence the EC<sub>50</sub> determined, which provides a possible explanation of the disparate data obtained after cyclopropanation of <b>1</b> and <b>20</b>. Our previous study also identified <b>29</b>, a cyclopropyl derivative with a 3,4-difluoro substituted aromatic ring.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> With an EC<sub>50</sub> of 49 nM, <b>29</b> was the most potent derivative in the cyclopropyl series. With the aim to ascertain the potencies of individual diastereomers, we subjected <b>29</b> to chiral HPLC resolution (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Figures S4, S5, and S6">Figures S4, S5, and S6</a>), which yielded very low quantities of its pure diastereomers <b>29a</b> (EC<sub>50</sub> = 66 nM) and <b>29b</b> (EC<sub>50</sub> = 39 nM), with a relatively small difference between their NOD2 activities. <sup>1</sup>H–<sup>1</sup>H NOESY analysis revealed that both <b>29a</b> and <b>29b</b> contained a <i>trans</i>-configured cyclopropyl ring (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Figure S9">Figure S9</a>); however, as for <b>27</b> and <b>28</b>, it was not possible to determine their absolute stereochemical configurations here. Nonetheless, as this approach provided only marginal improvements in the NOD2 activity, we posited that their chiral resolution would serve no direct purpose here and that the diastereomeric mixtures of cyclopropane featuring derivatives do not need to be separated.</div><div class="NLM_p">Next, we examined the effects of modifications to the amino-acid structure (<b>30</b>–<b>32</b>, <b>41</b>, <b>82</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The MDP analogs with <span class="smallcaps smallerCapital">l</span>-threonine and <span class="smallcaps smallerCapital">l</span>-serine were previously shown to be suitable substitutes for the <span class="smallcaps smallerCapital">l</span>-alanine, as demonstrated by their retained <i>in vivo</i> adjuvant activities;<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> however, these substitutions have yet to be evaluated in the context of desmuramylpeptides. Interestingly, desmuramylpeptides with both <span class="smallcaps smallerCapital">l</span>-threonine (<b>32</b>; EC<sub>50</sub> = 12.5 μM) and <span class="smallcaps smallerCapital">l</span>-serine (<b>31</b>; EC<sub>50</sub> > 20 μM) showed relatively poor activities. <i>O</i>-Benzylation of <span class="smallcaps smallerCapital">l</span>-serine (<b>30</b>; EC<sub>50</sub> = 5.56 μM) slightly improved the activity, perhaps indicating the importance of the bulky nature of this amino-acid side chain. Lower activity was also seen when the peptide chain was extended by <span class="smallcaps smallerCapital">l</span>-lysine (<b>41</b>; EC<sub>50</sub> = 10.2 μM). This might be attributable to decreased membrane permeability at physiological pH, due to the presence of an ionized amine group; however, amidation of this group with a lipophilic stearoyl chain (<b>82</b>; EC<sub>50</sub> = 11.5 μM) did little to improve the activity. Similar data were obtained in a study by Effenberg et al. (2017), where norAbuMDP-Lys-L18 (a derivative of MDP with stearoyl-<span class="smallcaps smallerCapital">l</span>-lysine) showed reduced potency compared to MDP, despite the resemblance of both compounds to romurtide.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a><named-content content-type="anchor" rid="tbl1" type="simple"></named-content></div><div class="NLM_p">Exploration of the chemical space around the <span class="smallcaps smallerCapital">d</span>-glutamic acid moiety produced desmuramylpeptides <b>57</b>–<b>64</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Both functionalized carboxamates and amides were evaluated as potential bioisosteric replacements of the carboxylic acid functionality. When compared to the 2.83-fold and 3.06-fold NOD2 activations of MDP and <b>1</b> in a single point assay, with respect to untreated control cells, these compounds showed considerably diminished NOD2 agonistic activity at 2 μM (1.30-fold to 1.45-fold NOD2 activation). These data are in agreement with the previously reported impaired activities of MDP derivatives that have either a diamidated <span class="smallcaps smallerCapital">d</span>-isoglutamine moiety<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> or a lipophilic amide attached to the α position of <span class="smallcaps smallerCapital">d</span>-isoglutamine.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Slightly better activities were expected for the derivatives with hydroxamate, given that hydroxamic acids are readily hydrolyzed to their corresponding carboxylic acids.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> However, it is worth noting that HEK293 cells have low hydrolytic activity due to low expression of carboxylesterases, the enzymes involved in the hydrolysis of both hydroxamic acids and amides.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> Higher susceptibility of ester groups to both enzymatic and spontaneous hydrolytic processes might explain the superior effects of <b>1</b> and other ester derivatives in the HEK-Blue NOD2 cell assays. Nonetheless, given that direct bioisosteric replacement of both ethyl ester groups with their ethyl amide counterparts resulted in substantially diminished activity of <b>57</b>, these data provide confirmation of our previous <i>in vitro</i> and docking studies that suggested that the <b>1</b> ester moieties predominantly assist in compound internalization and do not contribute to the NOD2 binding.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><named-content content-type="anchor" rid="tbl2" type="simple"></named-content></div><div class="NLM_p">These data encouraged us to introduce the last group of modifications, in which we retained the original pharmacophore of <b>1</b> and increase its lipophilicity by introducing cleavable ester groups of varying sizes to the cinnamoyl and <span class="smallcaps smallerCapital">d</span>-glutamic acid moieties. As the cellular assays are defined by both the crossing of the membrane by the compounds and their activation of NOD2, the lipophilicity of these compounds will have a major role in their cellular NOD2 activities. The phenolic hydroxy group served as a useful attachment point for the introduction of acetyl (C<sub>2</sub>), lauroyl (C<sub>12</sub>), and stearoyl (C<sub>18</sub>) groups through esterification. Likewise, the two ethyl ester functional groups were readily replaced with bulkier cyclopentyl, <i>tert</i>-butyl, and stearyl groups. The NOD2 agonistic activities of the resulting prodrug derivatives are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. NOD2 Agonistic Activities of the Lipophilic Desmuramylpeptides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0022.gif" alt="" id="GRAPHIC-d7e1902-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0023.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">SEAP activities were measured in NOD2-specific HEK-Blue cell supernatants after incubation for 18 h with MDP (2 μM) or the compounds of interest (2 μM). The data are shown as fold increases of NF-κB transcriptional activity relative to the negative control (0.1% DMSO) and are expressed as mean ± SEM of at least two independent experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are expressed as mean ± SEM of at least two independent experiments with 7 or 8 concentrations used (from 1 nM to 20 μM). ND, not determined.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">ClogP values as calculated by the ChemDraw software.</p></div></div><div></div></div><div class="NLM_p">Of note, there was an inverted U-shape correlation between the compound NOD2 activities and their lipophilicities (as calculated logP [ClogP] values; <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Namely, the desmuramylpeptides with ClogP in the 1.7 to 3.8 range showed increasing NOD2 activation, where compound <b>68</b> had an EC<sub>50</sub> of 40 nM, an over 2-fold improvement over <b>1</b> (EC<sub>50</sub> = 89 nM). Compound <b>74</b>, a derivative with a lauroyl tail on the aromatic ring, was the most active NOD2 agonist of this series (EC<sub>50</sub> = 30 nM), despite a significantly increased ClogP of 7.08. Interestingly, lauric acid (C<sub>12</sub>) was previously shown to activate NOD2 and induce IL-8 secretion from HCT116 colon epithelial cells.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> To determine whether the increased activity of <b>74</b> here is a result of the release of lauric acid after hydrolysis, the HEK-Blue NOD2 cells were also treated with lauric acid, both alone and in combination with <b>1</b>. In contrast to previous indications, lauric acid did not show any NOD2 activation alone, and it did not enhance the NOD2 agonistic activity of <b>1</b> (data not shown). Further increases in the lipophilicity resulted in a sharp drop in the <i>in vitro</i> NOD2 agonistic activity. Extending the C<sub>12</sub> chain of <b>74</b> to a longer C<sub>18</sub> chain, which produced <b>75</b> (EC<sub>50</sub> = 2.83 μM), resulted in markedly diminished activity, by a factor of 90, although the stearoyl group is a structural motif that has been used repeatedly in the preparation of potent MDP derivatives.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ClogP–EC<sub>50</sub> relationship of the compound <b>1</b> prodrug derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We postulated that the differences in NOD2 activation here can be attributed to more facile cleavage of the shorter acetyl and lauroyl esters, compared to the longer stearoyl esters, by the intracellular enzymes in the HEK293 cell line used. We thus expected that the introduction of the acetyl, lauroyl, and stearoyl groups to the structure of the dicyclopentyl congener <b>68</b> would follow the same activity trend, with the lauroyl derivative additionally improving the activity of <b>68</b>. Unexpectedly, the resulting C<sub>12</sub> counterpart <b>77</b> (EC<sub>50</sub> = 243 nM) showed a sixth of the activity of <b>68</b>. As exemplified by <b>78</b> (EC<sub>50</sub> = 6.16 μM), extending the lipophilic tail to C<sub>18</sub> further abrogated the NOD2 activation. These data demonstrate that NOD2 activation by these compounds is most likely linked directly to their lipophilicity. This is further supported by the NOD2 agonistic activities of the two acetylated derivatives, the diethyl ester <b>73</b> (EC<sub>50</sub> = 62 nM), and its dicyclopentyl surrogate <b>76</b> (EC<sub>50</sub> = 63 nM). These two maintained similar ClogP values and consequently retained the EC<sub>50</sub> values of their congeners with a free phenolic hydroxy group. Finally, replacing both of the ethyl groups of <b>1</b> with stearyl esters (i.e., <b>72</b>) almost completely abrogated the NOD2 agonistic activity. Similar structure–activity relationships were identified previously and attributed to the different interactions of the lipophilic MDP analogs with the biomembranes. While higher lipophilicity facilitated membrane permeability, it also increased the association of the compounds with the membrane.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The retention of the lipophilic derivatives in the membrane might explain their reduced effects in the cell assays here, as they will then not be available to bind to NOD2, which is located in the cytoplasm. Conversely, these same effects might be beneficial and lead to enhanced activities of such derivatives in <i>in vivo</i> assays, especially when liposomes are used as the lipophilic delivery system.</div><div class="NLM_p">As expected, similarly reduced NOD2 activation was shown when a stearoyl chain was introduced into the structure of <b>30</b> (2.04-fold activation at 2 μM) to produce <b>79</b> (1.68-fold), a derivative with <i>O</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-serine replacement of the <span class="smallcaps smallerCapital">l</span>-valine. However, when a stearoyl chain was introduced into <b>31</b> (1.21-fold) to produce <b>80</b> (the <span class="smallcaps smallerCapital">l</span>-serine based analog; 1.21-fold) there was almost no change to the NOD2 activation, while when a stearoyl chain was introduced into <b>32</b> (the <span class="smallcaps smallerCapital">l</span>-threonine based analog; EC<sub>50</sub> = 12.5 μM) to produce <b>81</b> (EC<sub>50</sub> = 1.45 μM), this showed a 10-fold improvement in potency.</div><div class="NLM_p">Compound <b>56</b> provided a notable deviation from the ClogP–EC<sub>50</sub> relationship, where there were two <i>tert</i>-butyl ester groups on the <span class="smallcaps smallerCapital">d</span>-glutamic acid. <i>tert</i>-Butyl esters are considerably less hydrolyzable by intracellular esterases, and especially by human carboxylesterase-1. On the other hand, cyclopentyl esters were previously shown to be excellent substrates for hydrolysis by human carboxylesterase-1.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Given the low carboxylesterase activity of HEK293 cells, it is no surprise that <b>56</b> resulted in markedly reduced NOD2 activation, despite its favorable ClogP (3.30).</div><div class="NLM_p">As NOD2 and NOD1 agonists share certain structural characteristics, we wanted to determine whether these compounds selectively target NOD2. Selectivity against NOD1 of MDP and all of these synthesized desmuramylpeptides was analyzed in an analogous assay with the HEK-Blue NOD1 cell line. None of the compounds tested showed any significant activity at 2 μM, which thus confirmed their selectivity for NOD2 (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Figure S2">Figure S2</a>).</div><div class="NLM_p">Furthermore, the specificities were determined by pretreating HEK-Blue NOD2 cells with a previously reported NOD2 antagonist<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> prior to stimulation with MDP (2 μM) or the desmuramylpeptides (2 μM). The resulting NF-κB-induced SEAP activities were compared to those of the controls without the NOD2 antagonist pretreatment. The comparative reduction in NF-κB transcriptional activities indicated that the effects of these desmuramylpeptides are due to their NOD2 activation (Supporting Information, <a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a>).</div><div class="NLM_p last">We note here that the readouts from the HEK-Blue cell assay system might not accurately represent the behaviors of these synthesized desmuramylpeptides under <i>in vivo</i> conditions. Thus, further biological evaluations were carried out for the most potent <i>in vitro</i> NOD2 agonists, <b>68</b>, <b>73</b>, and <b>74</b>, also with the inclusion of two derivatives with a stearoyl group, <b>75</b> and <b>81</b>. The C<sub>18</sub> lipophilic tail was shown to be beneficial for development of MDP derivatives with activities <i>in vivo</i>, in part due to its anchoring in the membrane of the liposomes<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> used as the delivery system of choice for the <i>in vivo</i> applications of NOD2 agonists. As the experimental design included the investigation of <i>in vivo</i> adjuvant activities of NOD2 agonists encapsulated in a liposomal formulation, inclusion of <b>75</b> and <b>81</b> in further testing was thus warranted, despite their lower NOD2 activation in the HEK-Blue NOD2 cell assays.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">2.3.2.  Immunostimulatory Effect of Desmuramylpeptides on PBMCs</h4><div class="NLM_p">The immunostimulatory effects of the selected desmuramylpeptides were evaluated using human primary peripheral blood mononuclear cells (PBMCs). This heterogeneous mixture of immune cells allowed the study of the effects of these NOD2 agonists in a physiologically relevant system, where other NOD2-interacting and downstream signaling proteins were present. The effects of desmuramylpeptides were first determined for the secreted cytokine profile using a cytometric bead array cytokine kit. Moreover, considering that activation of NOD2 is also an important amplification signal for Toll-like receptor (TLR)-induced inflammatory responses,<a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79−81)</a> we also examined the effects on cytokine secretion of the combination of desmuramylpeptides with LPS, a well-known TLR4 agonist.</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows the effects of the desmuramylpeptides (2 μM) on induction of the cytokines IL-1β, IL-6, IL-8, and TNF-α, both alone and in combination with LPS (10 ng/mL). These data show similar structure–activity relationships to the data obtained in the SEAP reporter gene assays. Compounds <b>68</b>, <b>73</b>, and <b>74</b> by themselves induced small increases in the levels of all four of these cytokines, with similar effects to MDP, while <b>75</b> and <b>81</b> induced lower responses. In line with previous studies, the effects of MDP and the desmuramylpeptides were most pronounced for the induction of the chemokine IL-8.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of the MDP and desmuramylpeptide treatments on the release of cytokines from human PBMCs. Cytokine concentrations were measured after 18 h stimulation with MDP (2 μM) or the desmuramylpeptides (2 μM) in the absence or presence of LPS (10 ng/mL). Data are expressed as mean ± SEM of 4 independent experiments. <sup>#</sup><i>p</i> < 0.05, <sup>###</sup><i>p</i> < 0.001 versus untreated controls; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus LPS-treated PBMCs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Stimulation with LPS resulted in large increases in cytokine production in general, which were further enhanced by MDP and the desmuramylpeptides. When compared to stimulation by LPS alone, all of the tested compounds significantly increased the levels of IL-1β, IL-6, and TNF-α. These effects were synergistic; i.e., the IL-1β, IL-6, and TNF-α produced upon combined desmuramylpeptide and LPS stimulation were higher than the sum of the effects from these individual immunostimulants. This is in agreement with the previously described synergistic signal amplification between NOD2 and TLR4.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> On the other hand, the IL-8 produced appeared to plateau following the combined stimulation with LPS and the NOD2 agonists, which thus indicated the saturation of IL-8 production in these PBMCs.</div><div class="NLM_p">Among the diverse PBMC subpopulations, natural killer (NK) cells express high levels of functional NOD2.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> As innate immune cells, NK cells have a central role in immunosurveillance, by their detection and destruction of virus-infected and cancer cells, through both direct cytolytic activity and release of cytokines, which can further facilitate the recruitment and activation of other innate and adaptive immune cell types. Stimulation of NK cells with MDP activates the NF-κB signaling pathway, which results in expression and release of TNF-α and interferon (IFN)-γ, as the key regulators of the Th1 cellular immune response.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> This is further enhanced synergistically by IL-12 and IFN-α, which suggests a role for accessory-cell-derived cytokines in the formation of an optimal NK cell response.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> MDP-stimulated NK cells also show enhanced cytotoxicity toward the Tu167 squamous cell carcinoma of the head and neck cell line.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Furthermore, monocytes represent ∼10% of PBMCs, and they have a similar nonspecific cytolytic activity against cancer cells, which is potentiated after MDP stimulation, both alone and in combination with IFN-γ.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87,88)</a></div><div class="NLM_p">In the present study, we examined these desmuramylpeptides in terms of potentiation of the cytotoxic activity of the PBMCs against cancer cells. To this end, we used a previously described flow-cytometry-based cytotoxicity assay where PBMCs are co-incubated with fluorescently labeled cancer cells.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> As indicated above, the NOD2-mediated NK cell activity originates from both the direct effects of NOD2 agonists on NK cells and the indirect activation through cytokine release by other NOD2-responsive cells, including monocytes. Thus, we used the whole PBMC population as the effector cells, rather than isolated NK cells, to provide conditions that would be closer to the <i>in vivo</i> environment, wherein the immune responses can be reinforced by interactions between the distinct immune cell subpopulations. Two malignant cell lines were used as the target cells in a 40:1 effector to target cell ratio: MEC1 B-chronic lymphocytic leukemia cells, and K562 chronic myelogenous leukemia cells. The K562 cells are considered a “classic” NK cell target, as they lack the expression of major histocompatibility complex (MHC) class I that is required for NK cell inhibition.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p">Interestingly, apart from LPS as the positive control,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> only <b>75</b> showed any significant boost to the cytotoxicity of the PBMCs against both of these cancer cell lines at 10 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). At 1 μM, this augmented cytotoxicity was still significant against the K562 cells, but not against the MEC1 cells, while at 100 nM, no effects were seen against either cell line (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). These data are markedly in contrast with the data obtained in the HEK-Blue NOD2 cell line, where <b>75</b> had one-hundredth the NOD2 agonistic activity compared to MDP, <b>1</b>, <b>68</b>, <b>73</b>, and <b>74</b>. As the desmuramylpeptides <b>73</b>, <b>74</b>, and <b>75</b> belong to a series of <b>1</b> prodrug derivatives that contain increasing lengths of lipophilic acids on the aromatic ring (i.e., acetic, lauric, stearic acids), these data indicated that the long lipophilic tail might be a contributing factor for PBMC cytotoxicity. Conversely, <b>81</b> also has a stearoyl tail but was devoid of activity; however, the generally weaker NOD2 agonism of <span class="smallcaps smallerCapital">l</span>-threonine based desmuramylpeptides compared to <span class="smallcaps smallerCapital">l</span>-valine derivatives has to be borne in mind. In parallel, the PBMCs and cancer cells were also treated with the desmuramylpeptides alone, to define any direct cytotoxicity they might have toward the PBMCs or cancer cells. None of these resulted in increased proportions of dead cells, thereby confirming that the enhanced activity of <b>75</b> can be attributed to the stimulation of PBMC cytotoxic activity (data not shown).</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of MDP and desmuramylpeptides on the cytotoxic activities of PBMCs against K562 and MEC1 cells. (A) PBMCs were treated for 18 h with MDP (10 μM), desmuramylpeptides (10 μM), or LPS (1 μg/mL) before the addition of the K562 or MEC1 cells. Cytotoxicity was determined after 4 h co-incubation. (B) Concentration-dependent effect of <b>75</b> on the induction of PBMC cytotoxicity. Data are shown as activities relative to the negative control (NT, 0.1% DMSO) and are expressed as mean ± SEM of three (MEC1) or four (K562) independent experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus relevant negative controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar lipophilicity-dependent effects on immune cell stimulation were described by Kalyuzhin et al. (1996).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> An MDP derivative with a C<sub>7</sub> lipophilic tail was shown to be a potent stimulator of T cells, macrophages, and NK cells, with the NK cell activity seen as increased cytotoxicity against YAC-1 lymphoma cells. On the other hand, a C<sub>16</sub> MDP derivative showed suppressive effects on the function of lymphocytes, except for the release of IL-1 and TNF-α, which was comparable after stimulation for both of these MDP derivatives. Based on these data, where the tested desmuramylpeptides induced similar levels of cytokines in PBMCs, the large differences in their cytotoxicity activation suggest that there is no linear dependence between lipophilicity and immunostimulatory effects in the various PBMC cell subpopulations. As for the HEK-Blue NOD2 cell assay, these effects might be ascribed to the hydrolipophilic balance and its effects on the interactions of these compounds with biomembranes.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Further studies are required to determine the physicochemical properties that are optimal for the induction of NK cell activity. Nonetheless, given the previously reported link between NOD2-dependent NK cell activation and <i>in vivo</i> antitumor activity,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> the data from the present study demonstrate the potential of these desmuramylpeptides in NK cell-dependent cancer immunotherapeutic approaches.</div><div class="NLM_p">Furthermore, we carried out an analogous cytotoxicity assay on macrophages that were produced by differentiation of THP-1 cells using phorbol 12-myristate 13-acetate, for 3 days.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Interestingly, the desmuramylpeptide treatments did not enhance the tumoricidal activities of the resulting M0 macrophages against the MEC1 cancer cell line (data not shown). THP-1-derived macrophages have been reported to express functional NOD2; however, in line with our findings, MDP treatment of these cells did not result in their activation, as shown by the unchanged levels of their secreted cytokines.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">Based on the potent <i>in vitro</i> NOD2 activation by <b>68</b> and the PBMC cytotoxicity activation by <b>75</b>, we explored the effects of <b>68</b> and <b>75</b> in terms of induction at the transcriptional level. Next-generation sequencing of RNA isolated from PBMCs was carried out following their stimulation for 18 h with <b>68</b> or <b>75</b> (2 μM). After applying a low expression filter, the remaining 19046 genes from the desmuramylpeptide-treated samples were compared to the vehicle-treated controls (0.1% DMSO). As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, <b>68</b> significantly modulated the expression of 445 genes (230 up-regulated, 215 down-regulated, compared to the control), while <b>75</b> modulated the expression of 270 genes (127 up-regulated, 143 down-regulated, compared to the control). Differential expression analysis between the <b>68</b>- and <b>75</b>-treated samples, however, did not show any significant differentially expressed genes (data not shown). This thus indicates that <b>68</b> and <b>75</b> induced similar transcriptional changes, where those of <b>75</b> were of lower magnitude, which is consistent with the weaker <i>in vitro</i> potency of <b>75</b> compared to <b>68</b>.</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Significantly up-regulated and down-regulated genes in PBMCs from three independent donors after 18 h of treatment with <b>68</b> and <b>75</b> (2 μM) treatment. A false discovery rate cutoff of <0.05 and a gene expression fold-change >1.5 or <0.667 compared to the untreated control (0.1% DMSO) was applied.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To explore the functional implications of the observed transcriptional changes, gene enrichment analysis was performed for the differentially expressed genes after the <b>68</b> and <b>75</b> treatments. This was based on the Gene Ontology (GO) biological processes database and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. The analysis was performed using Metascape, which is a web-based annotation tool that is distinguished from other similar tools by hierarchical clustering of the overlapping enrichment terms.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Each cluster is then represented only by its most significant term, thus removing other redundant terms within each specific cluster. The analysis of the <b>68</b> and <b>75</b> induced transcriptomes revealed significant enrichment of several pathways involved in immune responses (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The pathway that was most significantly overexpressed by both compounds was the KEGG pathway “Cytokine-cytokine receptor interaction” (hsa04060), within which there was up-regulation of IL1B, IL6, and CXCL8 (IL-8), which confirms the observations made at the protein level (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compounds <b>68</b> and <b>75</b> also induced the transcription of proinflammatory IL-1 cytokines and their antagonists (IL1A, IL36B, IL1RN, IL36RN), IL-17 cytokines (IL17A, IL17F), oncostatin M (member of the IL-6 cytokine family), and IL12B (p40 subunit of IL-12) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Furthermore, there was marked up-regulation of several CC (CCL1, 3, 7, 20, 22, 3L3, 4L2) and CXC (CXCL1, 2, 3, 5, 6, 7, 8) chemokines. Indeed, a study on the transcriptional signatures of 23 different TLR/NOD-like receptor agonists (including murabutide as a representative NOD2 agonist) by Salyer and David (2018) identified strong up-regulation of CC and CXC chemokines as a shared characteristic of the majority of the innate immune stimulants they tested.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> CXCL1, 2, 3, 5, 6, 7, and 8 are primarily responsible for neutrophil trafficking, as these bind to the cognate receptor CXCR2, and thus contribute to neutrophil-mediated inflammation.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Interestingly, while the up-regulation of IL12B, IL17A, and IL17F indicated a Th1/Th17 type response, <b>68</b> and <b>75</b> both induced the down-regulation of Th1-associated chemokines CXCL9, CXCL10, and CXCL11. These three chemokines share the same CXCR3 receptor that is mainly expressed on Th1 and NK cells, and they are predominantly involved in IFN-γ-driven Th1 immune responses. Conversely, the up-regulated CCL1 and CCL22 are generally considered to be indicative of Th2 responses.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The shift toward Th2-type responses was further substantiated by up-regulation of the co-stimulatory molecule TNFSF4 (also known as OX40 ligand [OX40L]). Notably, the activation of the OX40L–OX40 axis has previously been linked to NOD2 ligand-driven Th2 polarization.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Top 20 most-enriched Gene Ontology (GO) biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms. The differentially expressed genes after <b>68</b> and <b>75</b> treatments (2 μM) were used as input in pathway enrichment analysis using Metascape.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Heat maps of the (A) log<sub>2</sub>(fold change) of the differentially expressed genes in the “Cytokine-cytokine receptor interaction” KEGG pathway and (B) log<sub>2</sub>(fold change) of significantly modulated interferon-stimulated genes (ISGs) by <b>68</b> and <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">While <b>68</b> and <b>75</b> induced similar transcriptional changes in regards to cytokines and chemokines, there were pronounced differences in the induction of genes related to the defense response against viral pathogens. Specifically, there was a <b>68</b>-mediated up-regulation of several interferon-stimulated genes (ISGs), which, conversely, were modulated by <b>75</b> to a lesser degree (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). Their transcription is triggered through the JAK-STAT pathway following recognition of IFNs by their cognate receptors. Several of the upregulated ISGs, such as EIF2AK2 (protein kinase R), IFITM1, ISG20, MX1, OAS1, and RSAD2 (viperin) were previously featured for their antiviral effector functions.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Importantly, the activity of endogenously induced type I IFNs and their respective ISGs was also found to be a key step in the development of adaptive immune responses induced by a wide range of currently used vaccine adjuvants. Their effects are especially essential in the formation of Th1-type responses by promoting the differentiation of Th1 cells and the induction of cytotoxic T lymphocytes, thus generating antiviral and antitumor protective immunity.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> A meta-analysis of the transcriptional profiles induced by several different vaccines linked LY6E, MX1, OAS3, IFI44L, IFI6, and IFITM3 to the early phases after vaccination.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> With the exception of IFITM3, all of these genes were significantly up-regulated by <b>68</b>. It is worth noting that while we did observe the up-regulation of IFN downstream signaling proteins, such as the transcription factors STAT2, IRF7, and IRF9, we did not detect the transcription of type I IFN mRNA. However, it is known that the expression of IFNs is both induced and shut off rapidly, to ensure swift immunoprotective effects prior to the onset of detrimental effects to the host.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.3.3.  <i>In Vitro</i> Adjuvant Properties of Desmuramylpeptides <b>68</b> and <b>75</b></h4><div class="NLM_p">Dendritic cells have an instrumental role in bridging the innate and adaptive arms of immunity by processing and presenting antigens to naive T cells, to thus generate antigen-specific T-cell and B-cell immune responses.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> As DCs express a wide range of PRRs, including NOD2, they serve as critical target cells for adjuvant functions. NOD2 activation in DCs was previously shown to increase expression of co-stimulatory molecules (e.g., CD80, CD86, CD40) and production of inflammatory cytokines (e.g., TNF-α, IL-6, IL-8, IL-12), indicators of DC maturation and activation.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104,105)</a> NOD2 engagement by MDP in DCs also induces autophagy, a vital process in the delivery of cytosolic proteins for MHC class II antigen presentation, which ultimately leads to induction of CD4<sup>+</sup> T helper cell responses.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Depending on the nature of the stimuli involved in DC activation, these cells respond with the production of different cytokines, which leads to the polarization of T helper cells toward distinct effector functions.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Among these, the Th2 and Th1 subtypes are known to promote antigen-specific humoral and cellular immunity, respectively. Cellular immune responses are further characterized by induction of cytotoxic CD8<sup>+</sup> T cells, which are instrumental in protective immunity against intracellular pathogens and tumors. Notably, NOD2 activation functions as an effective signal for DC-mediated cross-priming of cytotoxic CD8<sup>+</sup> T cells, through up-regulation of MHC class I-dependent antigen cross-presentation pathways.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a></div><div class="NLM_p">To evaluate the adjuvant potential of the two most-promising desmuramylpeptides, <b>68</b> and <b>75</b>, in terms of their effects on DC-mediated activation of CD4<sup>+</sup> and CD8<sup>+</sup> T cells, we used an <i>in vitro</i> antigen-presentation assay with C57BL/6 mouse bone-marrow-derived DCs (BMDCs). Following stimulation with <b>68</b> and <b>75</b> (1 or 10 μM) in the presence of ovalbumin soluble protein (50 μg/mL), BMDCs were cocultured with carboxyfluorescein succinimidyl ester (CFSE)-labeled naive ovalbumin-specific CD4<sup>+</sup> or CD8<sup>+</sup> T cells, which were isolated from splenocytes of OT II and OT I transgenic mice, respectively. After 3 days of coculture, CD25 (α subunit of IL-2 receptor)<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> expression was determined, along with the CFSE dilution, as markers of T-cell activation and proliferation, respectively. Furthermore, we also examined how this desmuramylpeptide-induced priming of T cells affected the secreted cytokine profiles in BMDC/T-cell cocultures.</div><div class="NLM_p">As illustrated in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,B, with <b>68</b> and <b>75</b> at 10 μM, both significantly enhanced BMDC-mediated CD4<sup>+</sup> T-cell activation and proliferation. In line with its superior <i>in vitro</i> NOD2 activation, <b>68</b> also showed this effect at 1 μM. Enhanced T-cell activation by <b>68</b>, and to a lesser degree by <b>75</b>, was additionally characterized by elevated levels of IL-2, IL-6, IFN-γ, TNF-α, and IL-17A (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C). The effects of <b>68</b> were most pronounced for the production of IL-2, a pleiotropic cytokine that in addition to driving CD4<sup>+</sup> T-cell growth also augments the activity of CD8<sup>+</sup> and NK cells. Activated CD4<sup>+</sup> T cells produce large amounts of IL-2, although Th1 cells are generally considered to be the major source of IL-2.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> IFN-γ is characterized by its inductive effects on CD8<sup>+</sup> T cells, macrophages, and NK cells, and its up-regulation of MHC I and MHC II antigen presentation pathways in DCs, and it is similarly associated with a switch toward a Th1-like immune response. Taken together with the unaffected levels of Th2-associated IL-4 and IL-10, these data indicate that <b>68</b> induced a primarily Th1 polarized response. Interestingly, NOD2 activation by MDP was previously identified as a driving force toward Th2 polarization, with reduced levels of IFN-γ and increased production of IL-4.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> This previous study, however, used human-monocyte-derived DCs, while the present study used BMDCs from C57BL/6 mice, a strain that is generally considered as Th1 dominant.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Further studies on other mice strains and human DCs would thus be required to accurately determine the Th1/Th2 polarization promoted by the desmuramylpeptides.</div><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. CD4<sup>+</sup> and CD8<sup>+</sup> T cell activation, proliferation, and cytokine secretion in response to ovalbumin presentation by bone-marrow-derived dendritic cells (BMDCs) pretreated with desmuramylpeptides <b>68</b> and <b>75</b>. BMDCs from C57BL/6 mice were treated with <b>68</b> and <b>75</b> (1 and 10 μM) and ovalbumin (50 μg/mL). After 18 h, they were washed and cocultured for 72 h with carboxyfluorescein succinimidyl ester (CFSE)-labeled ovalbumin-specific CD4<sup>+</sup> or CD8<sup>+</sup> T cells, isolated from OT II or OT I mouse splenocytes, respectively. (A) Representative dot plots of live Thy1.2<sup>+</sup>/CD4<sup>+</sup> or Thy1.2<sup>+</sup>/CD8<sup>+</sup> T cells, showing CD25 expression and CFSE dilution. (B) Quantification of the proportions of CD25<sup>+</sup>, CFSE<sup>low</sup> T cells. The analysis regions are shown in panel A. (C) Cytokine concentrations in coculture supernatants following co-incubation with BMDCs as described in panel A. Data are expressed as mean ± SEM of duplicates of two independent experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>68</b> also significantly increased the BMDC processing and cross-presentation of ovalbumin to CD8<sup>+</sup> T cells, which resulted in their enhanced activation, proliferation, and cytokine secretion. It has been shown that activation of NOD1 and NOD2 in a similar <i>in vitro</i> cross-priming assay described by Asano et al. (2010) translated into enhanced proliferation of IFN-γ-secreting CD8<sup>+</sup> T cells <i>in vivo</i>, which resulted in increased antigen-specific antitumor and antibacterial cytotoxic activities.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Complementary data in intranasally immunized mice were also reported for adamantylamide dipeptide, another representative of the desmuramylpeptide class of adjuvants.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> As most of the currently licensed adjuvants almost exclusively induce antibody responses, there is a pressing need for adjuvants that can induce cellular immunity, especially in the cancer immunotherapy field. Based on the data described above, <b>68</b> holds great potential in this respect.</div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.3.4.  <i>In Vivo</i> Adjuvant Properties of Desmuramylpeptides <b>68</b> and <b>75</b> in Ovalbumin-Induced Antibody Responses</h4><div class="NLM_p">There is clear evidence that NOD2 activation translates into adjuvant activities <i>in vivo</i>.<a onclick="showRef(event, 'ref31 ref52 ref113'); return false;" href="javascript:void(0);" class="ref ref31 ref52 ref113">(31,52,113)</a> Due to the unfavorable pharmacokinetic and toxicologic properties of MDP, significant effort has been devoted to the development of more tolerable MDP derivatives. During this research, <i>in vivo</i> experimental data have revealed that both lipophilicity of the derivative and context of application influence the intensity and type of the provoked immune response. For example, MDP applied in saline induces a predominantly Th2-biased humoral immune response.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> On the other hand, lipophilic MDP derivatives promote a Th1-biased cellular immune response, especially when used in conjunction with lipophilic carrier systems such as liposomes.<a onclick="showRef(event, 'ref70 ref114'); return false;" href="javascript:void(0);" class="ref ref70 ref114">(70,114)</a> Notably, liposomes have repeatedly been featured in the development of vaccines, due to their versatility, biocompatibility, and enhancing effects on the generation of immune responses.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">To determine whether enhanced antigen presentation <i>in vitro</i> is correlated to <i>in vivo</i> adjuvant activities, an immunization study was performed in a murine model of adjuvanticity. Specifically, the selected desmuramylpeptides were investigated for induction of systemic immune responses against the model antigen ovalbumin. Seven groups of NIH/OlaHsd mice were immunized with ovalbumin-containing neutral liposomes, either alone or with additional adjuvants of MDP or the desmuramylpeptides <b>1</b>, <b>68</b>, <b>74</b>, <b>75</b>, or <b>81</b>. After immunization and one booster dose, the mice sera were collected and assayed for ovalbumin-specific IgG antibodies (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).</div><figure id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Ovalbumin-specific IgG (left), IgG1 (middle), and IgG2a (right) responses in NIH/OlaHsd mice after immunization with ovalbumin-loaded neutral liposomes (10 μg of ovalbumin per dose), with adjuvants MDP or the desmuramylpeptides (0.30 μmol of adjuvant per dose). The concentrations were measured 1 week after the booster dose. Data are expressed as mean ± SEM of 5 mice per group. *<i>p</i> < 0.05; ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As expected, due to the low immunogenicity of ovalbumin, the ovalbumin-loaded liposomes without added adjuvants induced weak systemic responses and thus served as the negative controls. In agreement with our previous experiments, MDP moderately enhanced the production of anti-ovalbumin IgG antibodies, while <b>1</b> showed only marginal adjuvant activity.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> On the other hand, there was a significant 5-fold boost in the elicited IgG responses in the group immunized with the addition of <b>75</b>, followed by a 3-fold boost by <b>81</b>, where both of these derivatives had a C<sub>18</sub> lipophilic tail on the aromatic ring. The C<sub>12</sub>-carrying derivative <b>74</b> showed similar activity to <b>1</b>, while <b>68</b>, although it was the most potent <i>in vitro</i> NOD2 agonist, was devoid of adjuvant activity under these conditions.</div><div class="NLM_p">To understand the nature of these induced immune responses in terms of Th1/Th2 polarization, the levels of the Th1-associated IgG1 and Th2-associated IgG2a antibody isotypes were also measured (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> In all of the experimental groups, the levels of induced anti-ovalbumin IgG1 closely resembled the total IgG levels; however, there were notable differences in the desmuramylpeptide enhancement of production of IgG2a. Consistent with previous reports, MDP induced a predominantly Th2-biased response,<a onclick="showRef(event, 'ref15 ref117'); return false;" href="javascript:void(0);" class="ref ref15 ref117">(15,117)</a> with significant increases in IgG1 generation and only marginal increases in IgG2a, compared to the control without adjuvant. Likewise, a largely IgG1-based response was elicited by <b>1</b> and <b>81</b>, while in the groups immunized by <b>68</b> and <b>74</b>, there was slight suppression of the IgG2a response. Finally, immunization with the liposomes containing the <b>75</b> adjuvant significantly enhanced ovalbumin-specific IgG1 responses and, importantly, also induced the highest levels of IgG2a antibodies, which indicated a shift toward a more balanced Th1/Th2 response.</div><div class="NLM_p">It is clear that the <i>in vivo</i> activities of the desmuramylpeptides do not follow the same structure–activity relationship rules as the <i>in vitro</i> activities. Given that <b>1</b>, <b>68</b>, <b>74</b>, and <b>75</b> act as prodrugs of the same active compound, their differential effects on the induction of humoral immune responses appear to originate from their distinctive physicochemical properties. Indeed, an evident increase in the adjuvant activities correlated with the addition of a lipophilic C<sub>18</sub> tail on the aromatic ring, as for <b>75</b> and <b>81</b>.</div><div class="NLM_p">Entrapment and subsequent retention of both antigens and adjuvants are important considerations in the design of liposomal vaccines. The entrapment of soluble MDP in liposomes was previously shown to be problematic, due to the diffusive escape with a short half-life of retention of 5 h.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Many lipophilic MDP derivatives have been designed to allow their loading into liposomes to be increased, to provide increased adjuvant activity and reduced side effects. For example, addition of lipophilic adamantane groups to peptidoglycan fragments was shown to assist in the anchoring of these derivatives into the liposomal lipid bilayer, using NMR spectroscopy.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Likewise, straight-chain lipophilic anchors can be used for the same purpose, due to the extensive network of van der Waals interactions that they can form in the lipophilic bilayer of liposomes. Surprisingly, a reduction in chain length from C<sub>18</sub> to C<sub>16</sub> was shown to significantly increase the propensity for the undesired escape of lipids from liposomal membranes.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Analogously, the enhanced <i>in vivo</i> activities of <b>75</b>, and to a lesser extent of <b>81</b>, compared to their C<sub>12</sub> congener <b>74</b> and the compounds that lacked a lipophilic anchor appeared to be due to their more efficient liposome encapsulation and subsequent retention, thus facilitating their uptake by antigen-presenting cells. Stable incorporation into liposomes additionally protects adjuvants from the actions of hydrolytic enzymes. Given that desmuramylpeptides rely on passive absorption to cross the cell membrane,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> extracellular hydrolysis would severely hamper their activation of the cytosolic NOD2.</div><div class="NLM_p">One of the key advantages of liposomes is their versatility. The chemical properties of the lipid components and the preparation procedures can be chosen to modulate charge, size, size distribution, entrapment, and location of antigens and adjuvants, all of which can potentially influence the intensity and form of the immune response against the antigen of interest.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> The net surface charge of liposomes, in particular, was shown to significantly influence the entrapment efficiency of the antigen<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> and the interactions of the liposomes with antigen-presenting cells and other endogenous tissue components.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Moreover, surface modifications of liposomes can be exploited for targeted delivery of antigens and adjuvants to specific immune-cell populations, to thus promote the desired immune responses while avoiding adverse effects due to targeting of irrelevant cell types. Among the potential targets, mannose receptors are highly expressed on the surface of DCs and macrophages. Liposomes decorated with mannose receptor ligands (i.e., mannosylated liposomes) enhance the uptake and activation of DCs, to result in amplified immune responses against the encapsulated antigen.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Additionally, MDP-containing mannosylated liposomes have been shown to be effective for inhibition of liver metastasis through their targeted delivery to tumoricidal macrophages. This thus expands the potential of these formulations to cancer immunotherapies.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><div class="NLM_p">To determine whether the adjuvanticity of <b>75</b> can be modulated through changes to the liposomal formulation, a second <i>in vivo</i> experiment was designed in which the adjuvant activities of three different liposomal compositions were compared. Neutral liposomes were prepared from egg phosphatidylcholine and cholesterol. Addition of the anionic dicetylphosphate resulted in liposomes with a negative net surface charge, while monomannosyl–poly(ethylene glycol)–palmitic acid derivative (Man-PEG-Pam) was added to assemble mannosylated liposomes.</div><div class="NLM_p">The measured ovalbumin-specific IgG, IgG1, and IgG2a antibody levels after immunization with MDP or <b>75</b> adjuvants in neutral, negatively charged, and mannosylated liposomes (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) led to several observations: (i) Contrary to previous reports,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> negatively charged liposomes without adjuvant elicited a substantially weaker ovalbumin-specific humoral response compared to both neutral and mannosylated liposomes, both of which exhibited similar adjuvant activities. It is worth noting that the entrapment efficiency of ovalbumin was not evaluated in our study and might contribute to the reduced adjuvanticity of negatively charged liposomes. (ii) The composition of liposomes with MDP-adjuvant significantly influenced the intensity of the immune response. Neutral liposomes had the weakest adjuvant activities, and interestingly, this was even weaker than the neutral liposomes without adjuvant. A stronger IgG response was observed with negatively charged liposomes, while mannosylated liposomes showed the strongest immunogenicity. The levels of Th2-associated IgG1 antibodies followed the same trend. The Th1-associated IgG2a response, however, remained unchanged, compared to liposomes without adjuvant, which is consistent with the predominantly Th2-biased adjuvant activity of MDP.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (iii) The liposomal composition had little influence on the intensity of the <b>75</b>-elicited IgG response, although it did alter the Th1/Th2 bias of the provoked immune response. Namely, the negatively charged liposomes showed diminished IgG1 activity. Mannosylated liposomes, on the other hand, enhanced the production of IgG2a antibodies, which is in agreement with previous reports of Th1-biased immune responses upon immunization with mannosylated liposomes with NOD2 agonist adjuvant.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> (iv) Finally, regardless of the liposomal composition, <b>75</b> increased the levels of IgG antibodies compared to the controls without adjuvant, with comparable or stronger adjuvant activities than MDP. Additionally, while MDP elicited a predominantly Th2-biased IgG1 response, <b>75</b> also augmented the production of ovalbumin-specific IgG2a antibodies, resulting in a mixed Th1/Th2 response.</div><figure id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Ovalbumin-specific IgG (top), IgG1 (middle), and IgG2a (bottom) responses in NIH/OlaHsd mice after immunization with neutral (phosphatidylcholine–cholesterol, 7:5), anionic (phosphatidylcholine–cholesterol–dicetylphosphate, 7:5:1), and mannosylated (phosphatidylcholine–cholesterol–mannose-PEG-PA, 7:5:0.5) ovalbumin-loaded liposomes (10 μg of ovalbumin per dose), with adjuvants MDP or <b>75</b> (0.15 μmol of adjuvant per dose). The concentrations were measured 1 week after the second booster dose. Data are expressed as mean ± SEM of 5 mice per group. *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The combined data from both of the <i>in vivo</i> experiments showed that introduction of a C<sub>18</sub> lipophilic anchor into the structure of <b>1</b>, to produce <b>75</b>, substantially improved the <b>1</b><i>in vivo</i> adjuvant activity, which appears to be due to the stronger incorporation and retention of <b>75</b> in the liposomal lipid bilayer. Similar transformations were applied previously to MDP and its derivatives, which resulted in higher immunoadjuvant activities and, importantly, reduced pyrogenicity, one of the main factors that has hindered the use of MDP in the clinic.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> In line with previous reports, the increased lipophilicity additionally augmented the production of IgG2a antibodies, which indicated a shift toward a balanced Th1/Th2 immune response, especially when <b>75</b> was administered in the form of mannosylated liposomes. Given that the majority of the currently used adjuvants induce predominantly Th2-biased responses, the eliciting of a Th1-biased or balanced response remains a highly sought after trait for adjuvants; for example, induction of Th1 responses is highly desirable for vaccines that target intracellular pathogens or cancers. Furthermore, when another representative MDP derivative was used in an intranasal mucosal vaccine (i.e., murabutide), this induced robust systemic and mucosal immunity that was characterized by IgG and IgA levels higher than those after parenteral vaccination with alum-adjuvant.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We thus postulate that <b>75</b> shows similar potential, and propose <b>75</b>-adjuvanted mucosal vaccination as the next potential direction for further research.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the present study, we performed a focused structure–activity relationship optimization of <b>1</b>, which resulted in a library of novel desmuramylpeptide NOD2 agonists. In particular, we have identified two promising compounds: <b>68</b>, as a potent <i>in vitro</i> NOD2 agonist with a more than 2-fold improved potency over <b>1</b>, and <b>75</b>, which shows superior adjuvant activity <i>in vivo</i>. Both <b>68</b> and <b>75</b> induced cytokine production in PBMCs, both alone and in combination with LPS, and enhanced antigen presentation of DCs. Furthermore, <b>75</b> stimulated the cytotoxic activity of PBMCs against malignant cells. Interestingly, the <i>in vitro</i> NOD2 activation and <i>in vivo</i> adjuvant activities do not necessarily correlate in a linear fashion and are highly dependent on the lipophilicity of the compounds. Specifically, we identified a C<sub>18</sub> lipophilic chain as a pivotal moiety, which conferred <i>in vivo</i> adjuvant activity if administered with a liposomal delivery system. As a C<sub>18</sub>-lipidated derivative of <b>1</b>, <b>75</b> showed promising adjuvant activity <i>in vivo</i> in a mouse model of adjuvanticity, surpassing that of MDP and achieving a more balanced Th1/Th2 immune response. The <b>75</b><i>bona fide</i> induction of an immune response to a model antigen in mice thus highlights its potential as a vaccine adjuvant. Taken together, these data provide deeper understanding of the desmuramylpeptide structural features required to achieve <i>in vitro</i> and <i>in vivo</i> immunostimulatory activities.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">4.1.  Materials</h3><div class="NLM_p">Chemicals were obtained from Sigma-Aldrich (St. Louis, MO, U.S.A.), Tokyo Chemical Industry (Tokyo, Japan), Acros Organics (Geel, Belgium), Enamine (Monmouth Junction, NJ, U.S.A.), and Apollo (Stockport, U.K.) and were used without further purification. MDP, C12-iE-DAP, and LPS (from <i>E. coli</i> O55:B5) were obtained from InvivoGen, Inc. (San Diego, CA, U.S.A.). Analytical TLC was performed on Merck 60 F254 silica gel plates (0.25 mm), with visualization using ultraviolet light, ninhydrin, and potassium permanganate. Column chromatography was carried out on silica gel 60 (particle size 240–400 mesh). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 400 and 100 MHz, respectively, on an Avance III spectrometer (Bruker Corporation, Billerica, MA, U.S.A.) in CDCl<sub>3</sub>, DMSO-<i>d</i><sub>6,</sub> or deuterated methanol (MeOD) with tetramethylsilane as the internal standard. NOESY spectra were recorded at 800 MHz on an Agilent Technologies NMR spectrometer (Santa Clara, CA, U.S.A.). Mass spectra were obtained using an Exactive Plus orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, U.S.A.) or on Expression CMS mass spectrometer (Advion Inc., Ithaca, NY, U.S.A.). Analytical UHPLC analyses were performed on a Dionex UltiMate 3000 Rapid Separation Binary System (Thermo Fisher Scientific, Waltham, MA, U.S.A.) equipped with an autosampler, a binary pump system, a photodiode array detector, a thermostatted column compartment, and the Chromeleon Chromatography data system. The columns used were Waters Acquity UPLC BEH C18 (1.7 μm, 2.1 mm × 50 mm) or Waters Acquity UPLC CSH C18 (1.7 μm, 2.1 mm × 50 mm) with a flow rate of 0.3 mL/min. The eluent was a mixture of 0.1% TFA in water (A) and acetonitrile (B) with a gradient (%B) as follows: 0–10 min, 5–95%; 10–12 min, 95%; 12–12.5 min, 95–5%. The columns were thermostatted at 40 °C. All of the compounds tested were established to be ≥95% pure.</div><div class="NLM_p last">Compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>6</b>, <b>29</b>, <b>42</b>, <b>43</b>, <b>44</b>, <b>45</b>, and <b>46</b> were prepared as previously described by our group.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The NOD2 antagonist was synthesized as described.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The analytical data here were identical to those reported previously. The assembly of the final compounds was as described below, while the preparation of other precursors is given in the <a class="ref internalNav" href="#notes1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.2.  General Synthetic Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.2.1.  General Procedure A: TFA-Mediated Acidolysis</h4><div class="NLM_p last">The Boc-protected compound was added to an ice-chilled stirred mixture of TFA and DCM (1:5), and the mixture was allowed to warm to room temperature. After 3 h, the solvent was evaporated <i>in vacuo</i>. The residue was washed three times with diethyl ether.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">4.2.2.  General Procedure B: EDC-Mediated Coupling</h4><div class="NLM_p last">To an ice-chilled stirred solution of the requisite amine (1 equiv) and carboxylic acid (1.0–1.2 equiv) in dry dimethylformamide (DMF), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA; 3 equiv) was added. After stirring for 15 min, HOBt (1.0–1.2 equiv), EDC (1.0–1.2 equiv), and a catalytic amount of 4-dimethylaminopyridine (DMAP) were added, and the mixture was allowed to warm to room temperature. The stirring was continued overnight, after which the mixture was diluted with ethyl acetate (EtOAc; 40 mL) and washed with 1 M HCl (2 × 20 mL), saturated NaHCO<sub>3</sub> solution (2 × 20 mL), and brine (20 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i>. If necessary, the residues were further purified using column chromatography to produce sufficiently pure compounds.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.2.3.  General Procedure C: HCl-Mediated Acidolysis</h4><div class="NLM_p last">To an ice-chilled stirring solution of the Boc-protected compound in EtOAc (3 mL), 1 M HCl solution in acetic acid (2 mL) was added dropwise. The mixture was allowed to warm to room temperature. The stirring was continued for 2 h, after which the mixture was diluted with EtOAc (30 mL) and washed with a 1 M NaOH solution (3 × 10 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i> to produce the deprotected amine.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.2.4.  General Procedure D: Acylation with Acyl Chlorides</h4><div class="NLM_p last">To an ice-chilled stirring solution of the alcohol or amine (1 equiv) in THF, Et<sub>3</sub>N (1.2 equiv) and the requisite acyl chloride (1.2 equiv) were added dropwise, and the resulting mixture was allowed to warm to room temperature. The stirring was continued for 1 h, after which the mixture was diluted with EtOAc (25 mL) and washed with 1 M HCl (2 × 10 mL), saturated NaHCO<sub>3</sub> solution (2 × 10 mL), and brine (10 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i>. If necessary, the residues were further purified using column chromatography, to produce sufficiently pure compounds.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.3.  Synthesis and Characterization of Compounds</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">4.3.1.  Diethyl (3-(4-Hydroxy-3-methoxyphenyl)propanoyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>18</b>)</h4><div class="NLM_p last">A solution of compound <b>1</b> (64 mg, 0.120 mmol) in acetic acid (10 mL) was hydrogenated over 10% palladium-on-carbon for 2 h at room temperature and under atmospheric pressure. The catalyst was removed by filtration, and the filtrate was concentrated <i>in vacuo</i> to produce the title compound <b>18</b> as a white solid (65 mg, 100%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71 (br, 1H), 8.38 (d, <i>J</i> = 7.6 Hz, 1H), 8.19–8.10 (m, 1H), 7.84 (d, <i>J</i> = 8.9 Hz, 1H), 6.76 (d, <i>J</i> = 2.0 Hz, 1H), 6.65 (d, <i>J</i> = 7.9 Hz, 1H), 6.57 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 4.30–4.19 (m, 2H), 4.12–3.99 (m, 4H), 3.90 (d, <i>J</i> = 4.8 Hz, 1H), 3.78–3.70 (m, 4H), 2.74–2.64 (m, 2H), 2.43–2.31 (m, 4H), 2.06–1.92 (m, 2H), 1.90–1.76 (m, 1H), 1.22–1.12 (m, 6H), 0.90–0.76 (m, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.57, 172.04, 171.54, 171.42, 169.50, 147.82, 145.03, 132.54, 120.63, 115.70, 112.76, 61.07, 60.42, 57.78, 55.90, 51.52, 42.49, 37.70, 31.23, 31.14, 30.17, 26.35, 19.56, 18.17, 14.52, 14.45. HRMS calcd for C<sub>26</sub>H<sub>40</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 538.2759 (M + H)<sup>+</sup>, found 538.2756.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.3.2.  Diethyl (4-(4-Hydroxy-3-methoxyphenyl)butanoyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>19</b>)</h4><div class="NLM_p last">Compound <b>6</b> (83 mg, 0.179 mmol) was deprotected using general procedure A and coupled to <b>16</b> (42 mg, 0.200 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce the title compound <b>19</b> as an off-white solid (46 mg, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.63 (s, 1H), 8.35 (d, <i>J</i> = 7.6 Hz, 1H), 8.07 (t, <i>J</i> = 5.9 Hz, 1H), 7.73 (d, <i>J</i> = 9.0 Hz, 1H), 6.73 (s, 1H), 6.65 (d, <i>J</i> = 7.9 Hz, 1H), 6.55 (d, <i>J</i> = 7.8 Hz, 1H), 4.27–4.21 (m, 2H), 4.11–4.01 (m, 4H), 3.77–3.69 (m, 5H), 2.45 (t, <i>J</i> = 7.8 Hz, 2H), 2.34 (t, <i>J</i> = 7.6 Hz, 2H), 2.12 (t, <i>J</i> = 7.5 Hz, 2H), 2.02–1.93 (m, 2H), 1.86–1.79 (m, 1H), 1.75 (p, <i>J</i> = 7.5 Hz, 2H), 1.19–1.14 (m, 6H), 0.85–0.80 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.92, 172.86, 171.68, 171.35, 169.60, 146.54, 143.80, 133.38, 120.96, 114.30, 111.15, 61.64, 60.80, 58.44, 55.86, 51.86, 43.32, 35.33, 34.88, 31.01, 30.37, 27.31, 26.82, 19.26, 17.83, 14.14, 14.08. HRMS calcd for C<sub>27</sub>H<sub>42</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 552.2916 (M + H)<sup>+</sup>, found 552.2907.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">4.3.3.  Diethyl ((<i>E</i>)-3-(3,4-Dimethoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>20</b>)</h4><div class="NLM_p last">Compound <b>6</b> (138 mg, 0.300 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-3,4-dimethoxycinnamic acid (68 mg, 0.330 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce the title compound <b>20</b> as an off-white solid (102 mg, 64%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.51 (d, <i>J</i> = 15.6 Hz, 1H), 7.22–7.13 (m, 2H), 6.99 (d, <i>J</i> = 8.4 Hz, 1H), 6.57 (d, <i>J</i> = 15.7 Hz, 1H), 4.49–4.41 (m, 1H), 4.34–4.28 (m, 1H), 4.26–4.04 (m, 6H), 3.89 (s, 3H), 3.88 (s, 3H), 2.40 (t, <i>J</i> = 7.1 Hz, 2H), 2.27–2.13 (m, 2H), 2.09–1.97 (m, 1H), 1.32–1.18 (m, 6H), 1.00 (t, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 172.94, 172.35, 171.55, 170.61, 168.07, 150.97, 149.31, 141.05, 127.82, 121.99, 117.56, 111.25, 110.02, 61.06, 60.28, 58.62, 55.02, 51.79, 42.58, 30.43, 29.85, 25.86, 18.35, 16.65, 13.07. HRMS calcd for C<sub>27</sub>H<sub>40</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 550.2759 (M + H)<sup>+</sup>, found 550.2756.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">4.3.4.  Diethyl ((<i>E</i>)-3-(3,4-Dihydroxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>21</b>)</h4><div class="NLM_p last">Compound <b>6</b> (78 mg, 0.170 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-caffeic acid (34 mg, 0.187 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce the title compound <b>21</b> as a cream-colored solid (43 mg, 49%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 15.7 Hz, 1H), 7.04 (d, <i>J</i> = 2.1 Hz, 1H), 6.94 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 6.78 (d, <i>J</i> = 8.2 Hz, 1H), 6.45 (d, <i>J</i> = 15.7 Hz, 1H), 4.49–4.41 (m, 1H), 4.31 (d, <i>J</i> = 6.1 Hz, 1H), 4.24–4.15 (m, 2H), 4.15–3.93 (m, 4H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 2.30–2.11 (m, 2H), 2.08–1.93 (m, 1H), 1.32–1.15 (m, 6H), 1.00 (t, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 172.95, 172.36, 171.54, 170.69, 168.37, 147.57, 145.36, 141.60, 126.75, 120.93, 116.29, 115.04, 113.69, 61.07, 60.30, 58.63, 51.78, 42.58, 30.43, 29.85, 25.85, 18.34, 16.65, 13.06. HRMS calcd for C<sub>25</sub>H<sub>36</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 522.2446 (M + H)<sup>+</sup>, found 522.2445.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.3.5.  Diethyl ((<i>E</i>)-3-(4-Aminophenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>24</b>)</h4><div class="NLM_p last">Compound <b>6</b> (276 mg, 0.600 mmol) was deprotected using general procedure A and coupled to <b>22</b> (174 mg, 0.660 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce compound <b>23</b> as a yellow solid (179 mg, 49%). This compound was deprotected using general procedure A. The residue was dissolved in EtOAc (50 mL) and washed with a saturated NaHCO<sub>3</sub> solution (3 × 30 mL) and brine (30 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i> to produce the title compound <b>24</b> as an orange solid (135 mg, 91%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.46 (d, <i>J</i> = 15.7 Hz, 1H), 7.34 (d, <i>J</i> = 8.6 Hz, 2H), 6.70 (d, <i>J</i> = 8.6 Hz, 2H), 6.42 (d, <i>J</i> = 15.7 Hz, 1H), 4.48–4.42 (m, 1H), 4.31 (d, <i>J</i> = 6.0 Hz, 1H), 4.23–4.14 (m, 2H), 4.14–3.92 (m, 4H), 2.43 (t, <i>J</i> = 7.3 Hz, 2H), 2.27–2.13 (m, 2H), 2.08–1.95 (m, 1H), 1.28 (t, <i>J</i> = 7.2 Hz, 3H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 0.99 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 172.95, 172.34, 171.54, 170.77, 168.77, 150.25, 141.92, 129.24, 123.70, 114.39, 114.16, 61.06, 60.29, 58.62, 51.80, 42.63, 30.43, 29.86, 25.87, 18.34, 16.65, 13.06. HRMS calcd for C<sub>25</sub>H<sub>37</sub>N<sub>4</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 505.2657 (M + H)<sup>+</sup>, found 505.2641.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.3.6.  Diethyl ((<i>E</i>)-3-(4-Isopropylphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>25</b>)</h4><div class="NLM_p last">Compound <b>6</b> (92 mg, 0.200 mmol) was deprotected using general procedure A and coupled to <i>trans-</i>4-isopropylcinnamic acid (42 mg, 0.220 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce the title compound <b>25</b> as a white solid (44 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42–8.31 (m, 2H), 7.94 (d, <i>J</i> = 9.0 Hz, 1H), 7.49 (d, <i>J</i> = 7.9 Hz, 2H), 7.40 (d, <i>J</i> = 15.7 Hz, 1H), 7.29 (d, <i>J</i> = 7.9 Hz, 2H), 6.69 (d, <i>J</i> = 15.8 Hz, 1H), 4.31–4.21 (m, 2H), 4.14–3.97 (m, 4H), 3.90 (d, <i>J</i> = 5.8 Hz, 2H), 2.96–2.84 (m, 1H), 2.35 (t, <i>J</i> = 7.5 Hz, 2H), 2.05–1.93 (m, 2H), 1.89–1.76 (m, 1H), 1.25–1.10 (m, 12H), 0.85 (t, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.95, 171.44, 170.92, 168.82, 165.34, 149.99, 138.84, 132.40, 127.54, 126.79, 120.75, 60.48, 59.81, 57.27, 50.97, 42.10, 33.20, 30.66, 29.60, 25.81, 23.57, 19.02, 17.64, 13.95, 13.90. HRMS calcd for C<sub>28</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 532.3017 (M + H)<sup>+</sup>, found 532.3012.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.3.7.  Diethyl ((<i>E</i>)-3-(4-Nitrophenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>26</b>)</h4><div class="NLM_p last">Compound <b>6</b> (92 mg, 0.200 mmol) was deprotected using general procedure A and coupled to <i>trans-</i>4-nitrocinnamic acid (42 mg, 0.220 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce the title compound <b>26</b> as a yellow solid (69 mg, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.51 (t, <i>J</i> = 5.8 Hz, 1H), 8.40 (d, <i>J</i> = 7.5 Hz, 1H), 8.27 (d, <i>J</i> = 8.7 Hz, 2H), 8.00 (d, <i>J</i> = 9.0 Hz, 1H), 7.85 (d, <i>J</i> = 8.8 Hz, 2H), 7.55 (d, <i>J</i> = 15.9 Hz, 1H), 6.95 (d, <i>J</i> = 15.9 Hz, 1H), 4.31–4.21 (m, 2H), 4.15–3.97 (m, 4H), 3.94 (d, <i>J</i> = 5.7 Hz, 2H), 2.35 (t, <i>J</i> = 7.5 Hz, 2H), 2.07–1.93 (m, 2H), 1.91–1.76 (m, 1H), 1.22–1.11 (m, 6H), 0.85 (t, <i>J</i> = 6.3 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.53, 172.01, 171.47, 169.12, 165.04, 148.00, 141.94, 137.14, 129.09, 126.59, 124.59, 61.05, 60.39, 57.87, 51.53, 42.69, 31.26, 30.18, 26.40, 19.58, 18.25, 14.52, 14.47. HRMS calcd for C<sub>25</sub>H<sub>35</sub>N<sub>4</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 535.2399 (M + H)<sup>+</sup>, found 535.2393.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.3.8.  Diethyl (2-(3,4-Dimethoxyphenyl)cyclopropane-1-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>27</b>)</h4><div class="NLM_p last">Compound <b>6</b> (92 mg, 0.200 mmol) was deprotected using general procedure A and coupled to <b>13</b> (49 mg, 0.220 mmol) using general procedure B. Purification by flash chromatography (5% MeOH in DCM) produced the title compound <b>27</b> as a yellow solid (36 mg, 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43–8.36 (m, 2H), 7.85–7.77 (m, 1H), 6.84 (d, <i>J</i> = 8.3 Hz, 1H), 6.75–6.69 (m, 1H), 6.62 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 4.29–4.20 (m, 2H), 4.14–3.98 (m, 4H), 3.84–3.76 (m, 2H), 3.73 (s, 3H), 3.70 (s, 3H), 2.35 (t, <i>J</i> = 7.6 Hz, 2H), 2.22–2.14 (m, 1H), 2.06–1.88 (m, 3H), 1.88–1.77 (m, 1H), 1.32–1.24 (m, 1H), 1.21–1.11 (m, 7H), 0.89–0.79 (m, 6H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 174.23, 172.92, 172.27, 171.56, 170.55, 149.07, 147.75, 133.45, 117.96, 111.70, 110.29, 61.06, 60.31, 58.40, 55.13, 55.05, 51.78, 42.65, 30.57, 29.84, 25.88, 24.96, 24.58, 18.35, 16.64, 14.62, 13.10, 13.06. HRMS calcd for C<sub>28</sub>H<sub>40</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 562.2770 (M – H)<sup>−</sup>, found 562.2769.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.3.9.  Diethyl (2-(4-Hydroxy-3-methoxyphenyl)cyclopropane-1-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>28</b>)</h4><div class="NLM_p last">Compound <b>6</b> (111 mg, 0.242 mmol) was deprotected using general procedure A and coupled to <b>17</b> (42 mg, 0.202 mmol) using general procedure B. White solid (98 mg, 88%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75 (s, 1H), 8.41–8.35 (m, 2H), 7.84–7.76 (m, 1H), 6.70–6.67 (m, 1H), 6.66 (d, <i>J</i> = 8.1 Hz, 1H), 6.49 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 4.31–4.20 (m, 2H), 4.14–3.99 (m, 4H), 3.83–3.77 (m, 2H), 3.74 (s, 3H), 2.35 (t, <i>J</i> = 7.5 Hz, 2H), 2.19–2.09 (m, 1H), 2.03–1.93 (m, 2H), 1.92–1.86 (m, 1H), 1.85–1.77 (m, 1H), 1.31–1.22 (m, 1H), 1.22–1.12 (m, 7H), 0.83 (t, <i>J</i> = 7.5 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.52, 172.17, 172.14, 172.00, 171.48, 169.41, 147.94, 145.27, 132.10, 118.35, 115.81, 110.99, 61.05, 60.41, 57.65, 57.62, 56.03, 51.52, 42.68, 42.63, 31.34, 31.31, 30.17, 26.41, 25.50, 24.45, 19.56, 18.14, 15.38, 14.53, 14.46. HRMS calcd for C<sub>27</sub>H<sub>40</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 550.2759 (M + H)<sup>+</sup>, found 550.2748.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.3.10.  Diethyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-threonyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>32</b>)</h4><div class="NLM_p last">Compound <b>9</b> (388 mg, 0.841 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-ferulic acid (180 mg, 0.925 mmol) using general procedure B. Purification by flash chromatography (6% MeOH in DCM) produced the title compound <b>32</b> as a yellow solid (263 mg, 58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.74 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (d, <i>J</i> = 8.1 Hz, 1H), 7.51 (d, <i>J</i> = 15.5 Hz, 1H), 7.14 (t, <i>J</i> = 5.3 Hz, 1H), 7.04–6.95 (m, 2H), 6.85 (d, <i>J</i> = 8.0 Hz, 1H), 6.43–6.31 (m, 2H), 4.58–4.47 (m, 2H), 4.45–4.35 (m, 1H), 4.23–4.01 (m, 6H), 3.86 (s, 3H), 3.79 (d, <i>J</i> = 6.4 Hz, 1H), 2.43 (t, <i>J</i> = 7.4 Hz, 2H), 2.29–2.14 (m, 1H), 2.13–1.97 (m, 1H), 1.28–1.14 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.08, 172.23, 171.25, 170.31, 167.36, 147.69, 146.86, 142.03, 127.09, 122.31, 117.15, 114.84, 110.06, 67.30, 61.91, 60.84, 58.35, 55.92, 52.35, 43.70, 30.54, 26.26, 18.82, 14.12, 14.07. HRMS calcd for C<sub>25</sub>H<sub>36</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 538.2395 (M + H)<sup>+</sup>, found 538.2396.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.3.11.  Diethyl <i>O</i>-Benzyl-<i>N</i>-(((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)glycyl)-<span class="smallcaps smallerCapital">l</span>-seryl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>30</b>)</h4><div class="NLM_p last">Compound <b>7</b> (227 mg, 0.420 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-ferulic acid (82 mg, 0.420 mmol) using general procedure B. Yellow solid (177 mg, 69%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (d, <i>J</i> = 7.9 Hz, 1H), 7.60 (d, <i>J</i> = 7.9 Hz, 1H), 7.52 (d, <i>J</i> = 15.6 Hz, 1H), 7.33–7.17 (m, 6H), 7.02–6.94 (m, 2H), 6.84 (d, <i>J</i> = 8.0 Hz, 1H), 6.36 (d, <i>J</i> = 15.5 Hz, 1H), 4.85–4.71 (m, 1H), 4.62–4.43 (m, 3H), 4.21–3.97 (m, 6H), 3.91–3.83 (m, 1H), 3.81 (s, 3H), 3.69–3.57 (m, 1H), 2.35 (t, <i>J</i> = 7.7 Hz, 2H), 2.26–2.11 (m, 1H), 2.07–1.94 (m, 1H), 1.26–1.11 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.85, 171.70, 170.05, 169.86, 167.25, 147.78, 147.04, 141.84, 137.40, 128.43, 127.81, 127.73, 127.11, 122.20, 117.30, 115.01, 110.29, 73.40, 73.30, 69.54, 61.59, 60.64, 55.88, 53.03, 51.99, 43.60, 30.22, 26.93, 26.88. HRMS calcd for C<sub>31</sub>H<sub>40</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 614.2708 (M + H)<sup>+</sup>, found 614.2695.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.3.12.  Diethyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-seryl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>31</b>)</h4><div class="NLM_p last">Compound <b>8</b> (277 mg, 0.620 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-ferulic acid (120 mg, 0.620 mmol) using general procedure B. Orange solid (150 mg, 46%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.52 (d, <i>J</i> = 15.7 Hz, 1H), 7.18 (d, <i>J</i> = 1.9 Hz, 1H), 7.08 (d, <i>J</i> = 8.5 Hz, 1H), 6.83 (d, <i>J</i> = 8.2 Hz, 1H), 6.54 (d, <i>J</i> = 15.7 Hz, 1H), 4.54–4.45 (m, 2H), 4.25–4.01 (m, 6H), 3.92 (s, 3H), 3.89–3.79 (m, 2H), 2.49–2.40 (m, 2H), 2.29–2.17 (m, 1H), 2.10–2.03 (m, 1H), 1.35–1.18 (m, 6H). <sup>13</sup>C NMR (101 MHz, MeOD) δ 173.06, 171.69, 171.02, 170.72, 168.48, 148.68, 147.91, 141.59, 126.73, 122.00, 116.56, 115.08, 110.33, 61.46, 61.15, 60.26, 55.44, 55.00, 51.93, 42.91, 29.82, 29.37, 26.01, 13.04. HRMS calcd for C<sub>24</sub>H<sub>34</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 524.2239 (M + H)<sup>+</sup>, found 524.2231.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.3.13.  Methyl ((<i>R</i>)-5-Ethoxy-4-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)-5-oxopentanoyl)-<span class="smallcaps smallerCapital">l</span>-lysinate (<b>41</b>)</h4><div class="NLM_p last">To a stirring solution of compound <b>40</b> (104 mg, 0.119 mmol) in THF (15 mL), 1-octanethiol (210 μL, 1.19 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU; 9 μL, 0.060 mmol) were added. The resulting mixture was stirred overnight at room temperature. The solvent was evaporated <i>in vacuo</i>, and the residue was washed twice with diethyl ether then recrystallized from ethanol/diethyl ether to produce the title compound <b>41</b> as a yellow solid (40 mg, 52%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.47 (d, <i>J</i> = 15.7 Hz, 1H), 7.13 (d, <i>J</i> = 2.0 Hz, 1H), 7.05 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.2 Hz, 1H), 6.48 (d, <i>J</i> = 15.6 Hz, 1H), 4.43–4.35 (m, 1H), 4.33–4.07 (m, 4H), 3.90 (s, 3H), 3.71 (s, 3H), 3.66–3.59 (m, 1H), 3.61–3.51 (m, 1H), 2.62 (t, <i>J</i> = 7.1 Hz, 2H), 2.40–2.18 (m, 4H), 2.11–2.01 (m, 2H), 1.84–1.70 (m, 2H), 1.67–1.50 (m, 1H), 1.49–1.38 (m, 2H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H), 1.02 (t, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.24, 172.22, 171.97, 171.59, 169.51, 166.35, 165.79, 148.35, 140.00, 126.67, 122.12, 118.80, 116.16, 111.37, 60.93, 55.96, 53.76, 52.43, 52.28, 52.19, 48.32, 42.76, 38.08, 32.00, 28.74, 26.45, 23.88, 19.65, 19.41, 18.26, 14.50. HRMS calcd for C<sub>31</sub>H<sub>48</sub>N<sub>5</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 650.3396 (M + H)<sup>+</sup>, found 650.3387.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.3.14.  Di-<i>tert</i>-butyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>56</b>)</h4><div class="NLM_p last">Compound <b>47</b> (55 mg, 0.153 mmol) was deprotected using general procedure C and coupled to <b>46</b> (64 mg, 0.184 mmol) using general procedure B. Purification by flash chromatography (5% MeOH in DCM) produced the title compound <b>56</b> as an orange solid (27 mg, 30%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 15.6, 1H), 7.11 (d, <i>J</i> = 1.6 Hz, 1H), 7.01 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 2.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.46 (d, <i>J</i> = 16.0 Hz, 1H), 4.29–4.25 (m, 2H), 4.02–3.91 (m, 2H), 3.85 (s, 3H), 2.26 (t, <i>J</i> = 7.6 Hz, 2H), 2.15–2.00 (m, 2H), 1.94–1.81 (m, 1H), 1.42 (s, 9H), 1.38 (s, 9H), 0.93 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.12, 172.28, 171.23, 170.71, 166.75, 165.00, 147.17, 146.93, 144.83, 144.20, 138.75, 127.17, 122.49, 117.24, 114.70, 110.20, 80.92, 58.47, 52.43, 38.61, 28.10, 28.01, 27.96, 27.32. HRMS calcd for C<sub>30</sub>H<sub>44</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 590.3078 (M – H)<sup>−</sup>, found 590.3062.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.3.15.  (<i>R</i>)-<i>N</i><sup>1</sup>,<i>N</i><sup>5</sup>-Diethyl-2-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)pentanediamide (<b>57</b>)</h4><div class="NLM_p last">Compound <b>48</b> (108 mg, 0.326 mmol) was deprotected using general procedure C and coupled to <b>46</b> (139 mg, 0.391 mmol) using general procedure B to produce the title compound <b>57</b> as an orange solid (99 mg, 57%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.45 (s, 1H), 8.40–8.13 (m, 2H), 8.03–8.00 (m, 1H), 7.90–7.75 (m, 2H), 7.33 (d, <i>J</i> = 16.0, 1H), 7.14 (d, <i>J</i> = 1.6 Hz, 1H), 7.00 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 6.79 (d, <i>J</i> = 8.0 Hz, 1H), 6.57 (d, <i>J</i> = 15.6 Hz, 1H), 4.28–4.05 (m, 2H), 3.92–3.82 (m, 2H), 3.80 (s, 3H), 3.07–3.02 (m, 4H), 2.18–1.86 (m, 3H), 1.83–1.60 (m, 2H), 1.19–1.00 (m, 6H), 0.98–0.96 (m, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.05, 169.51, 169.48, 169.41, 166.32, 160.85, 160.10, 159.44, 148.30, 147.77, 126.67, 125.45, 118.57, 115.61, 110.81, 107.63, 107.07, 84.11, 55.47, 46.64, 33.28, 31.40, 29.96, 27.69, 27.60, 26.69, 24.43, 21.90, 14.69. HRMS calcd for C<sub>26</sub>H<sub>40</sub>N<sub>5</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 534.2990 (M + H)<sup>+</sup>, found 534.2986.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.3.16.  (<i>R</i>)-<i>N</i><sup>1</sup>,<i>N</i><sup>5</sup>-Dibutyl-2-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)pentanediamide (<b>58</b>)</h4><div class="NLM_p last">Compound <b>49</b> (120 mg, 0.336 mmol) was deprotected using general procedure A and coupled to <b>46</b> (130 mg, 0.370 mmol) using general procedure B to produce the title compound <b>58</b> as an orange solid (115 mg, 58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.45 (s, 1H), 8.25 (d, <i>J</i> = 8.0 Hz, 1H), 8.16 (t, <i>J</i> = 5.6 Hz, 1H), 8.05–7.94 (m, 1H), 7.85–7.71 (m, 2H), 7.33 (d, <i>J</i> = 15.6, 1H), 7.14 (d, <i>J</i> = 2.0 Hz, 1H), 7.00 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.2 Hz, 1H), 6.79 (d, <i>J</i> = 8.0 Hz, 1H), 6.55 (d, <i>J</i> = 16.0 Hz, 1H), 4.18–4.11 (m, 2H), 3.92–3.86 (m, 2H), 3.80 (s, 3H), 3.06–3.00 (m, 4H), 2.10–1.99 (m, 2H), 1.98–1.81 (m, 2H), 1.78–1.63 (m, 1H), 1.36–1.22 (m, 8H), 0.87–0.80 (m, 12H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.18, 171.17, 171.13, 169.45, 147.76, 139.38, 138.21, 121.54, 115.60, 110.81, 55.46, 52.37, 38.09, 31.87, 31.21, 31.13, 19.53, 19.45, 19.08, 18.26, 13.65. HRMS calcd for C<sub>30</sub>H<sub>48</sub>N<sub>5</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 590.3554 (M + H)<sup>+</sup>, found 590.3542.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.3.17.  <i>tert</i>-Butyl <i>N</i><sup>5</sup>-Butyl-<i>N</i><sup>2</sup>-((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutaminate (<b>59</b>)</h4><div class="NLM_p last">Compound <b>50</b> (45 mg, 0.126 mmol) was deprotected using general procedure A and coupled to <b>46</b> (53 mg, 0.151 mmol) using general procedure B to produce the title compound <b>59</b> as a yellow solid (35 mg, 47%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.42 (d, <i>J</i> = 15.6 Hz, 1H), 7.10 (s, 1H), 7.00 (d, <i>J</i> = 8.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.46 (d, <i>J</i> = 15.6 Hz, 1H), 4.24–4.14 (m, 2H), 4.09–3.89 (m, 2H), 3.85 (s, 3H), 3.15–3.00 (m, 2H), 2.22–2.03 (m, 4H), 1.94–1.79 (m, 2H), 1.41 (s, 9H), 1.33–1.20 (m, 3H), 0.97–0.82 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.46, 172.41, 171.41, 171.03, 169.98, 167.32, 167.11, 147.79, 146.92, 142.02, 141.72, 127.02, 122.29, 117.25, 114.91, 110.02, 82.22, 58.95, 55.93, 52.65, 43.81, 39.49, 32.63, 31.58, 31.52, 30.43, 27.96, 19.43, 17.64, 13.77. HRMS calcd for C<sub>30</sub>H<sub>47</sub>N<sub>4</sub>O<sub>8</sub><i>m</i>/<i>z</i>: 591.3394 (M + H)<sup>+</sup>, found 591.3403.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">4.3.18.  <i>tert</i>-Butyl <i>N</i><sup>2</sup>-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<i>N</i><sup>5</sup>-methoxy-<span class="smallcaps smallerCapital">d</span>-glutaminate (<b>60</b>)</h4><div class="NLM_p last">Compound <b>51</b> (62 mg, 0.187 mmol) was deprotected using general procedure C and coupled to <b>46</b> (79 mg, 0.224 mmol) using general procedure B. Purification by flash chromatography (3% MeOH in DCM) produced the title compound <b>60</b> as an orange waxy solid (12 mg, 11%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 15.6 Hz, 1H), 7.11 (d, <i>J</i> = 2.0 Hz, 1H), 7.01 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.47 (d, <i>J</i> = 15.6 Hz, 1H), 4.34–4.33 (m, 1H), 4.13–4.09 (m, 1H), 4.05–3.93 (m, 2H), 3.85 (s, 3H), 3.68 (s, 3H), 2.45–2.20 (m, 2H), 2.15–2.02 (m, 2H), 1.88–1.76 (m, 1H), 1.44 (s, 9H), 0.92–0.90 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.20, 169.08, 167.42, 166.65, 161.17, 146.74, 141.98, 127.12, 124.23, 122.54, 117.21, 114.74, 114.18, 109.51, 82.51, 57.32, 55.96, 52.30, 43.49, 31.19, 29.32, 28.29, 27.98, 24.88, 19.00, 17.75. HRMS calcd for C<sub>27</sub>H<sub>39</sub>N<sub>4</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 563.2717 (M – H)<sup>−</sup>, found 563.2722.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.3.19.  <i>tert</i>-Butyl <i>N</i><sup>2</sup>-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<i>N</i><sup>5</sup>-methoxy-<i>N</i><sup>5</sup>-methyl-<span class="smallcaps smallerCapital">d</span>-glutaminate (<b>61</b>)</h4><div class="NLM_p last">Compound <b>52</b> (78 mg, 0.225 mmol) was deprotected using general procedure C and coupled to <b>46</b> (95 mg, 0.270 mmol) using general procedure B to produce the title compound <b>61</b> as an orange solid (57 mg, 44%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 15.6 Hz, 1H), 7.10 (d, <i>J</i> = 1.6 Hz, 1H), 7.01 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.46 (d, <i>J</i> = 15.6 Hz, 1H), 4.34–4.20 (m, 2H), 4.05–3.90 (m, 2H), 3.85 (s, 3H), 3.70–3.57 (m, 3H), 3.13–3.07 (m, 3H), 2.58–2.42 (m, 2H), 2.18–2.01 (m, 2H), 1.98–1.84 (m, 1H), 1.42–1.41 (m, 9H), 0.97–0.90 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.63, 173.44, 171.20, 170.65, 169.65, 169.40, 166.94, 147.62, 146.88, 141.82, 141.63, 127.22, 122.25, 122.22, 117.55, 114.86, 110.01, 82.03, 65.88, 61.22, 58.43, 58.37, 55.91, 53.06, 52.99, 43.57, 43.37, 32.19, 31.26, 31.14, 28.32, 26.16, 19.35, 19.16, 18.07, 15.28. *Some signals in the <sup>13</sup>C spectrum are doubled due to the presence of both <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-configured valine. HRMS calcd for C<sub>28</sub>H<sub>41</sub>N<sub>4</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 577.2874 (M – H)<sup>−</sup>, found 577.2858.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.3.20.  <i>tert</i>-Butyl (<i>R</i>)-2-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)-5-oxo-5-(pyrrolidin-1-yl)pentanoate (<b>62</b>)</h4><div class="NLM_p last">Compound <b>53</b> (70 mg, 0.196 mmol) was deprotected using general procedure C and coupled to <b>46</b> (82 mg, 0.235 mmol) using general procedure B to produce the title compound <b>62</b> as a yellow solid (65 mg, 57%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 16.0 Hz, 1H), 7.10 (s, 1H), 7.00 (d, <i>J</i> = 8.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.46 (d, <i>J</i> = 15.6 Hz, 1H), 4.42–4.16 (m, 2H), 4.09–3.90 (m, 2H), 3.84 (s, 3H), 3.83–3.65 (m, 2H), 3.43–3.31 (m, 2H), 2.43–2.25 (m, 2H), 2.21–1.68 (m, 7H), 1.44–1.37 (m, 9H), 0.97–0.89 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.27, 171.17, 171.08, 169.80, 167.08, 167.03, 147.81, 147.07, 146.98, 141.70, 127.28, 127.19, 122.29, 122.22, 117.66, 117.60, 115.10, 115.04, 114.94, 110.21, 110.12, 82.00, 80.92, 58.47, 58.44, 56.02, 56.00, 53.52, 53.39, 46.84, 46.77, 46.74, 46.12, 46.01, 43.49, 31.22, 28.08, 26.09, 24.37, 19.37, 19.33, 18.02. *Some signals in the <sup>13</sup>C spectrum are doubled due to the presence of both <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-configured valine. HRMS calcd for C<sub>30</sub>H<sub>43</sub>N<sub>4</sub>O<sub>8</sub><i>m</i>/<i>z</i>: 587.3081 (M – H)<sup>−</sup>, found 587.3088.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.3.21.  <i>tert</i>-Butyl (<i>R</i>)-4-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)-5-(methoxy(methyl)amino)-5-oxopentanoate (<b>63</b>)</h4><div class="NLM_p last">Compound <b>54</b> (70 mg, 0.201 mmol) was deprotected using general procedure C and coupled to <b>46</b> (84 mg, 0.241 mmol) using general procedure B to produce the title compound <b>63</b> as an orange solid (40 mg, 34%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 16.0 Hz, 1H), 7.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.01 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.47 (d, <i>J</i> = 15.6 Hz, 1H), 4.34–4.22 (m, 2H), 4.06–3.91 (m, 2H), 3.85 (s, 3H), 3.77 (s, 3H), 3.15 (s, 3H), 2.36–2.22 (m, 2H), 2.16–1.92 (m, 2H), 1.89–1.78 (m, 1H), 1.41–1.38 (m, 9H), 0.95–0.90 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.29, 172.08, 171.22, 171.12, 169.46, 169.38, 166.85, 147.54, 146.82, 141.61, 127.29, 122.25, 122.19, 117.62, 114.81, 109.98, 109.91, 80.77, 65.88, 61.64, 58.39, 58.28, 55.92, 48.82, 48.73, 43.46, 43.41, 32.14, 31.23, 28.05, 26.95, 19.35, 19.20, 18.13, 17.87, 15.28. *Some signals in the <sup>13</sup>C spectrum are doubled due to the presence of both <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-configured valine. HRMS calcd for C<sub>28</sub>H<sub>43</sub>N<sub>4</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 579.3030 (M + H)<sup>+</sup>, found 579.3036.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">4.3.22.  <i>tert</i>-Butyl (<i>R</i>)-4-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)-5-oxo-5-(pyrrolidin-1-yl)pentanoate (<b>64</b>)</h4><div class="NLM_p last">Compound <b>55</b> (65 mg, 0.182 mmol) was deprotected using general procedure C and coupled to <b>46</b> (76 mg, 0.218 mmol) using general procedure B to produce the title compound <b>64</b> as a yellow solid (30 mg, 28%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.44 (d, <i>J</i> = 15.6 Hz, 1H), 7.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.01 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 1H), 6.47 (d, <i>J</i> = 15.6 Hz, 1H), 4.65–4.60 (m, 1H), 4.34–4.19 (m, 1H), 4.06–3.91 (m, 2H), 3.84 (s, 3H), 3.70–3.59 (m, 2H), 3.44–3.31 (m, 2H), 2.34–2.22 (m, 2H), 2.14–2.04 (m, 1H), 2.02–1.91 (m, 3H), 1.86–1.79 (m, 3H), 1.41–1.38 (m, 9H), 0.94–0.89 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.20, 172.09, 171.01, 169.94, 169.57, 169.42, 166.85, 147.49, 146.81, 141.58, 141.40, 127.35, 122.16, 117.80, 114.79, 109.91, 80.79, 58.13, 55.92, 50.02, 46.60, 46.21, 43.41, 31.35, 30.97, 30.92, 30.88, 28.06, 27.24, 26.01, 24.12, 19.30, 17.99, 17.88. *Some signals in the <sup>13</sup>C spectrum are doubled due to the presence of both <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-configured valine. HRMS calcd for C<sub>30</sub>H<sub>43</sub>N<sub>4</sub>O<sub>8</sub><i>m</i>/<i>z</i>: 587.3081 (M – H)<sup>−</sup>, found 587.3078.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">4.3.23.  Dicyclopentyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>68</b>)</h4><div class="NLM_p last">Compound <b>67</b> (108 mg, 0.200 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-ferulic acid (43 mg, 0.220 mmol) using general procedure B. The residue was washed twice with diethyl ether to produce the title compound <b>68</b> as an off-white solid (93 mg, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 15.6 Hz, 1H), 7.24 (d, <i>J</i> = 7.6 Hz, 1H), 7.09–6.97 (m, 3H), 6.92–6.81 (m, 2H), 6.37 (d, <i>J</i> = 15.6 Hz, 1H), 6.00 (s, 1H), 5.21–5.07 (m, 2H), 4.55–4.47 (m, 1H), 4.46–4.40 (m, 1H), 4.23–4.06 (m, 2H), 3.91 (s, 3H), 2.41–2.29 (m, 2H), 2.26–2.08 (m, 2H), 2.06–1.93 (m, 1H), 1.87–1.76 (m, 4H), 1.74–1.51 (m, 12H), 1.00–0.88 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.72, 171.46, 171.10, 169.47, 166.86, 147.57, 146.75, 141.86, 127.23, 122.31, 117.40, 114.73, 109.87, 78.65, 77.57, 58.50, 55.96, 52.03, 43.69, 32.70, 32.65, 32.60, 32.51, 30.80, 30.69, 26.93, 23.70, 23.64, 19.34, 17.74. HRMS calcd for C<sub>32</sub>H<sub>46</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 616.3229 (M + H)<sup>+</sup>, found 616.3221.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">4.3.24.  Dioctadecyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>72</b>)</h4><div class="NLM_p last">Compound <b>71</b> (489 mg, 0.538 mmol) was deprotected using general procedure A and coupled to <i>trans</i>-ferulic acid (125 mg, 0.646 mmol) using general procedure B, using DCM instead of DMF as the reaction solvent. Purification by flash chromatography (5% MeOH in DCM) produced the title compound <b>72</b> as a yellow solid (376 mg, 71%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 15.6 Hz, 1H), 7.22 (d, <i>J</i> = 7.5 Hz, 1H), 7.06 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 7.03–6.94 (m, 2H), 6.89 (d, <i>J</i> = 8.2 Hz, 1H), 6.77 (t, <i>J</i> = 5.2 Hz, 1H), 6.35 (d, <i>J</i> = 15.6 Hz, 1H), 5.95 (d, <i>J</i> = 7.8 Hz, 1H), 4.60–4.52 (m, 1H), 4.47–4.38 (m, 1H), 4.17–4.06 (m, 4H), 4.02 (t, <i>J</i> = 6.8 Hz, 2H), 3.91 (s, 3H), 2.48–2.32 (m, 2H), 2.30–2.13 (m, 2H), 2.10–1.97 (m, 1H), 1.64–1.52 (m, 4H), 1.25 (s, 60H), 1.00–0.91 (m, 6H), 0.88 (t, <i>J</i> = 6.8 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.08, 171.78, 171.11, 169.50, 166.89, 147.59, 146.72, 141.97, 127.19, 122.36, 117.29, 114.73, 109.77, 65.88, 65.09, 58.48, 55.93, 51.99, 43.74, 31.94, 30.70, 30.40, 29.73, 29.68, 29.64, 29.57, 29.54, 29.38, 29.31, 29.26, 29.21, 28.56, 28.49, 26.84, 25.90, 25.81, 22.71, 19.37, 17.65, 14.14. HRMS calcd for C<sub>58</sub>H<sub>102</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 984.7611 (M + H)<sup>+</sup>, found 984.7609.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">4.3.25.  Diethyl ((<i>E</i>)-3-(4-Acetoxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>73</b>)</h4><div class="NLM_p last">Synthesized from <b>1</b> (64 mg, 0.120 mmol) and acetyl chloride (10 μL, 0.144 mmol) using general procedure D. Purification by flash chromatography (EtOAc) produced the title compound <b>73</b> as a white solid (27 mg, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 7.6 Hz, 1H), 8.32 (t, <i>J</i> = 5.8 Hz, 1H), 7.95 (d, <i>J</i> = 9.0 Hz, 1H), 7.43 (d, <i>J</i> = 15.8 Hz, 1H), 7.34 (d, <i>J</i> = 1.9 Hz, 1H), 7.17 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.12 (d, <i>J</i> = 8.1 Hz, 1H), 6.76 (d, <i>J</i> = 15.8 Hz, 1H), 4.31–4.21 (m, 2H), 4.14–3.98 (m, 4H), 3.91 (d, <i>J</i> = 5.7 Hz, 2H), 3.82 (s, 3H), 2.35 (t, <i>J</i> = 7.5 Hz, 2H), 2.26 (s, 3H), 2.05–1.91 (m, 2H), 1.91–1.77 (m, 1H), 1.21–1.11 (m, 6H), 0.85 (t, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.55, 172.05, 171.50, 169.31, 168.94, 165.70, 151.53, 140.65, 138.89, 134.34, 123.75, 122.60, 120.58, 112.06, 61.06, 60.40, 57.82, 56.23, 51.52, 42.68, 31.26, 30.17, 26.37, 20.88, 19.58, 18.23, 14.52, 14.47. HRMS calcd for C<sub>28</sub>H<sub>40</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 578.2708 (M + H)<sup>+</sup>, found 578.2704.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">4.3.26.  Diethyl ((<i>E</i>)-3-(4-(Dodecanoyloxy)-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>74</b>)</h4><div class="NLM_p last">Synthesized from <b>1</b> (64 mg, 0.120 mmol) and lauroyl chloride (34 μL, 0.144 mmol) using general procedure D. Purification by flash chromatography (20% hexanes in EtOAc) produced the title compound <b>74</b> as a white solid (45 mg, 52%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60 (d, <i>J</i> = 15.6 Hz, 1H), 7.29 (d, <i>J</i> = 7.8 Hz, 1H), 7.13–7.04 (m, 3H), 7.01 (d, <i>J</i> = 7.9 Hz, 1H), 6.97–6.90 (m, 1H), 6.48 (d, <i>J</i> = 15.6 Hz, 1H), 4.60–4.50 (m, 1H), 4.49–4.41 (m, 1H), 4.21–4.05 (m, 6H), 3.84 (s, 3H), 2.57 (t, <i>J</i> = 7.5 Hz, 2H), 2.47–2.32 (m, 2H), 2.26–2.15 (m, 2H), 2.10–1.96 (m, 1H), 1.75 (p, <i>J</i> = 7.5 Hz, 2H), 1.47–1.18 (m, 22H), 1.01–0.91 (m, 6H), 0.89 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.97, 171.74, 171.66, 171.14, 169.35, 166.41, 151.38, 141.22, 141.19, 133.54, 123.21, 120.65, 120.03, 111.60, 61.67, 60.82, 58.52, 55.89, 51.97, 43.69, 34.04, 31.92, 30.83, 30.41, 29.63, 29.52, 29.36, 29.30, 29.06, 26.77, 25.01, 22.70, 19.35, 17.72, 14.14, 14.11. HRMS calcd for C<sub>38</sub>H<sub>60</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 718.4273 (M + H)<sup>+</sup>, found 718.4260.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">4.3.27.  Diethyl ((<i>E</i>)-3-(3-Methoxy-4-(stearoyloxy)phenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>75</b>)</h4><div class="NLM_p last">Synthesized from <b>1</b> (64 mg, 0.120 mmol) and stearoyl chloride (49 μL, 0.144 mmol) using general procedure D. The residue was washed twice with diethyl ether to produce the title compound <b>75</b> (38 mg, 40%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60 (d, <i>J</i> = 15.6 Hz, 1H), 7.30 (d, <i>J</i> = 7.6 Hz, 1H), 7.14–7.05 (m, 3H), 7.01 (d, <i>J</i> = 7.9 Hz, 1H), 6.95 (t, <i>J</i> = 5.2 Hz, 1H), 6.48 (d, <i>J</i> = 15.6 Hz, 1H), 4.60–4.50 (m, 1H), 4.49–4.40 (m, 1H), 4.22–4.05 (m, 6H), 3.84 (s, 3H), 2.57 (t, <i>J</i> = 7.5 Hz, 2H), 2.45–2.35 (m, 2H), 2.29–2.13 (m, 2H), 2.10–1.98 (m, 1H), 1.79–1.69 (m, 2H), 1.47–1.17 (m, 34H), 1.00–0.92 (m, 6H), 0.88 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.98, 171.74, 171.69, 171.16, 169.37, 166.43, 151.38, 141.22, 141.19, 133.54, 123.21, 120.65, 120.03, 111.61, 61.68, 60.83, 58.52, 55.89, 51.97, 43.70, 34.04, 31.94, 30.81, 30.41, 29.71, 29.68, 29.65, 29.54, 29.38, 29.31, 29.08, 26.77, 25.01, 22.71, 19.35, 17.71, 14.14, 14.11. HRMS calcd for C<sub>44</sub>H<sub>72</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 802.5212 (M + H)<sup>+</sup>, found 802.5204.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">4.3.28.  Dicyclopentyl ((<i>E</i>)-3-(4-Acetoxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>76</b>)</h4><div class="NLM_p last">Synthesized from <b>68</b> (69 mg, 0.112 mmol) and acetyl chloride (10 μL, 0.134 mmol) using general procedure D. Purification by flash chromatography (3% MeOH in DCM) produced the title compound <b>76</b> as an off-white solid (59 mg, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.59 (d, <i>J</i> = 15.6 Hz, 1H), 7.40 (d, <i>J</i> = 7.6 Hz, 1H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 7.15–7.06 (m, 3H), 7.01 (d, <i>J</i> = 8.7 Hz, 1H), 6.51 (d, <i>J</i> = 15.6 Hz, 1H), 5.20–5.08 (m, 2H), 4.56–4.42 (m, 2H), 4.20–4.10 (m, 2H), 3.85 (s, 3H), 2.41–2.29 (m, 5H), 2.26–2.08 (m, 2H), 2.03–1.92 (m, 1H), 1.85–1.77 (m, 4H), 1.74–1.60 (m, 8H), 1.59–1.51 (m, 4H), 1.01–0.88 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.66, 171.54, 171.21, 169.40, 168.86, 166.40, 151.32, 140.99, 133.77, 123.15, 120.58, 120.32, 111.73, 78.66, 77.55, 58.54, 55.93, 52.01, 43.61, 32.69, 32.64, 32.60, 32.50, 30.93, 30.69, 26.94, 23.69, 23.63, 20.66, 19.33, 17.84. HRMS calcd for C<sub>34</sub>H<sub>48</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 658.3334 (M + H)<sup>+</sup>, found 658.3311.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.3.29.  Dicyclopentyl ((<i>E</i>)-3-(4-(Dodecanoyloxy)-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>77</b>)</h4><div class="NLM_p last">Synthesized from <b>68</b> (60 mg, 0.097 mmol) and lauroyl chloride (28 μL, 0.117 mmol) using general procedure D. The residue was washed twice with hexane to produce the title compound <b>77</b> as a white solid (77 mg, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60 (d, <i>J</i> = 15.6 Hz, 1H), 7.17–7.08 (m, 3H), 7.01 (d, <i>J</i> = 7.9 Hz, 1H), 6.90 (d, <i>J</i> = 8.7 Hz, 1H), 6.78 (t, <i>J</i> = 5.1 Hz, 1H), 6.46 (d, <i>J</i> = 15.6 Hz, 1H), 5.21–5.09 (m, 2H), 4.56–4.46 (m, 1H), 4.46–4.38 (m, 1H), 4.23–4.06 (m, 2H), 3.85 (s, 3H), 2.57 (t, <i>J</i> = 7.5 Hz, 2H), 2.44–2.29 (m, 2H), 2.27–2.08 (m, 2H), 2.05–1.92 (m, 1H), 1.88–1.51 (m, 18H), 1.48–1.38 (m, 2H), 1.36–1.25 (m, 14H), 1.00–0.91 (m, 6H), 0.88 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.79, 171.70, 171.41, 170.96, 169.22, 166.32, 151.40, 141.29, 141.24, 133.52, 123.21, 120.71, 119.97, 111.57, 78.69, 77.61, 58.48, 55.90, 52.06, 43.67, 34.04, 32.70, 32.65, 32.61, 32.52, 31.91, 30.78, 30.68, 29.62, 29.51, 29.34, 29.28, 29.06, 26.91, 25.01, 23.69, 23.64, 22.69, 19.33, 17.69, 14.12. HRMS calcd for C<sub>44</sub>H<sub>68</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 798.4899 (M + H)<sup>+</sup>, found 798.4876.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">4.3.30.  Dicyclopentyl ((<i>E</i>)-3-(3-Methoxy-4-(stearoyloxy)phenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>78</b>)</h4><div class="NLM_p last">Synthesized from <b>68</b> (62 mg, 0.101 mmol) and stearoyl chloride (41 μL, 0.121 mmol) using general procedure D. The residue was washed twice with hexane to produce the title compound <b>78</b> as a white solid (83 mg, 93%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60 (d, <i>J</i> = 15.6 Hz, 1H), 7.25 (d, <i>J</i> = 9.5 Hz, 1H), 7.14–7.04 (m, 3H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H), 6.94 (t, <i>J</i> = 5.2 Hz, 1H), 6.48 (d, <i>J</i> = 15.7 Hz, 1H), 5.22–5.09 (m, 2H), 4.56–4.40 (m, 2H), 4.19–4.13 (m, 2H), 3.84 (s, 3H), 2.57 (t, <i>J</i> = 7.5 Hz, 2H), 2.48–2.27 (m, 2H), 2.25–2.09 (m, 2H), 2.06–1.94 (m, 1H), 1.88–1.51 (m, 18H), 1.47–1.37 (m, 2H), 1.37–1.18 (m, 26H), 1.00–0.92 (m, 6H), 0.88 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.71, 171.70, 171.44, 171.07, 169.30, 166.36, 151.39, 141.20, 141.16, 133.58, 123.19, 120.64, 120.10, 111.66, 78.66, 77.57, 58.51, 55.90, 52.03, 43.64, 35.31, 34.05, 32.69, 32.65, 32.60, 32.52, 31.93, 30.91, 30.68, 29.70, 29.67, 29.64, 29.53, 29.37, 29.30, 29.20, 29.08, 28.88, 26.95, 25.01, 24.24, 23.69, 23.64, 22.70, 19.32, 17.79, 14.13. HRMS calcd for C<sub>50</sub>H<sub>80</sub>N<sub>3</sub>O<sub>10</sub><i>m</i>/<i>z</i>: 882.5838 (M + H)<sup>+</sup>, found 882.5810.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">4.3.31.  Diethyl <i>O</i>-Benzyl-<i>N</i>-(((<i>E</i>)-3-(3-methoxy-4-(stearoyloxy)phenyl)acryloyl)glycyl)-<span class="smallcaps smallerCapital">l</span>-seryl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>79</b>)</h4><div class="NLM_p last">Synthesized from <b>30</b> (68 mg, 0.110 mmol) and stearoyl chloride (41 μL, 0.120 mmol) using general procedure D as a white solid (93 mg, 96%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.59 (d, <i>J</i> = 15.5 Hz, 1H), 7.39–7.22 (m, 6H), 7.13–6.98 (m, 4H), 6.62 (t, <i>J</i> = 5.2 Hz, 1H), 6.41 (d, <i>J</i> = 15.6 Hz, 1H), 4.67 (td, <i>J</i> = 6.4, 3.8 Hz, 1H), 4.62–4.47 (m, 3H), 4.21–3.98 (m, 6H), 3.97–3.89 (m, 1H), 3.84 (s, 3H), 3.65–3.58 (m, 1H), 2.58 (t, <i>J</i> = 7.5 Hz, 2H), 2.43–2.26 (m, 2H), 2.26–2.13 (m, 1H), 2.07–1.94 (m, 1H), 1.76 (p, <i>J</i> = 7.5 Hz, 2H), 1.46–1.16 (m, 34H), 0.88 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.97, 171.70, 171.46, 169.59, 169.07, 166.33, 151.39, 141.44, 141.26, 137.28, 133.47, 128.51, 127.97, 127.84, 123.21, 120.77, 119.80, 111.52, 73.51, 69.18, 61.63, 60.74, 55.90, 52.89, 52.08, 43.60, 34.05, 31.93, 30.24, 29.71, 29.67, 29.64, 29.53, 29.37, 29.30, 29.08, 26.87, 25.02, 22.70, 14.13. HRMS calcd for C<sub>49</sub>H<sub>74</sub>N<sub>3</sub>O<sub>11</sub><i>m</i>/<i>z</i>: 880.5318 (M + H)<sup>+</sup>, found 880.5302.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">4.3.32.  Diethyl ((<i>E</i>)-3-(3-Methoxy-4-(stearoyloxy)phenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-seryl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>80</b>)</h4><div class="NLM_p last">Synthesized from <b>31</b> (75 mg, 0.140 mmol) and stearoyl chloride (53 μL, 0.160 mmol) using general procedure D. Purification by flash chromatography (6% MeOH in DCM) produced the title compound <b>80</b> as a white solid (23 mg, 21%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.57 (d, <i>J</i> = 15.6 Hz, 1H), 7.30 (d, <i>J</i> = 1.8 Hz, 1H), 7.21 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 7.06 (d, <i>J</i> = 8.2 Hz, 1H), 6.69 (d, <i>J</i> = 16.0 Hz, 1H), 4.55–4.44 (m, 2H), 4.23–4.03 (m, 6H), 3.88 (s, 3H), 3.87–3.84 (m, 2H), 2.60 (t, <i>J</i> = 7.3 Hz, 2H), 2.51–2.40 (m, 2H), 2.33–2.16 (m, 1H), 2.13–1.98 (m, 1H), 1.81–1.69 (m, 2H), 1.51–1.18 (m, 34H), 0.92 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.27, 172.12, 171.72, 170.89, 169.57, 166.69, 151.40, 141.53, 141.29, 133.41, 123.22, 120.75, 119.75, 111.61, 61.95, 60.91, 55.90, 54.87, 52.50, 43.75, 34.05, 31.93, 30.53, 29.71, 29.67, 29.53, 29.37, 29.30, 29.08, 25.01, 22.70, 14.13, 14.10. HRMS calcd for C<sub>42</sub>H<sub>68</sub>N<sub>3</sub>O<sub>11</sub><i>m</i>/<i>z</i>: 790.4848 (M + H)<sup>+</sup>, found 790.4835.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">4.3.33.  Diethyl ((<i>E</i>)-3-(3-Methoxy-4-(stearoyloxy)phenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-threonyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>81</b>)</h4><div class="NLM_p last">Synthesized from <b>32</b> (65 mg, 0.120 mmol) and stearoyl chloride (49 μL, 0.144 mmol) using general procedure D. Purification by flash chromatography (5% MeOH in DCM) produced the title compound <b>81</b> as an off-white solid (35 mg, 36%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.69 (d, <i>J</i> = 7.5 Hz, 1H), 7.57 (d, <i>J</i> = 15.5 Hz, 1H), 7.53–7.47 (m, 1H), 7.15–7.06 (m, 3H), 7.00 (d, <i>J</i> = 8.5 Hz, 1H), 6.47 (d, <i>J</i> = 15.5 Hz, 1H), 4.58–4.44 (m, 2H), 4.41 (d, <i>J</i> = 6.5 Hz, 1H), 4.21–4.02 (m, 6H), 3.84 (s, 3H), 2.57 (t, <i>J</i> = 7.5 Hz, 2H), 2.43 (t, <i>J</i> = 7.4 Hz, 2H), 2.29–2.16 (m, 1H), 2.13–1.99 (m, 1H), 1.75 (p, <i>J</i> = 7.5 Hz, 2H), 1.49–1.06 (m, 37H), 0.88 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.16, 172.22, 171.79, 171.29, 170.13, 166.79, 151.38, 141.41, 141.23, 133.46, 123.20, 120.73, 119.83, 111.62, 67.28, 61.97, 60.89, 58.29, 55.88, 52.41, 34.04, 31.94, 30.55, 29.71, 29.68, 29.65, 29.54, 29.38, 29.31, 29.08, 26.16, 25.01, 24.95, 22.71, 18.78, 14.14, 14.08. HRMS calcd for C<sub>43</sub>H<sub>70</sub>N<sub>3</sub>O<sub>11</sub><i>m</i>/<i>z</i>: 804.5005 (M + H)<sup>+</sup>, found 804.4999.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.3.34.  Methyl <i>N</i><sup>2</sup>-((<i>R</i>)-5-Ethoxy-4-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)-5-oxopentanoyl)-<i>N</i><sup>6</sup>-stearoyl-<span class="smallcaps smallerCapital">l</span>-lysinate (<b>82</b>)</h4><div class="NLM_p last">Synthesized from <b>41</b> (30 mg, 0.0462 mmol) and stearoyl chloride (14 μL, 0.0462 mmol) using general procedure D. Purification by flash chromatography (7% MeOH in DCM) produced the title compound <b>82</b> as an off-white solid (11 mg, 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.65–7.54 (m, 2H), 7.37 (d, <i>J</i> = 7.3 Hz, 1H), 7.25–7.21 (m, 1H), 7.12–7.06 (m, 1H), 7.04 (d, <i>J</i> = 1.9 Hz, 1H), 6.94–6.84 (m, 2H), 6.41 (d, <i>J</i> = 15.6 Hz, 1H), 5.84 (s, 1H), 5.75 (d, <i>J</i> = 5.4 Hz, 1H), 4.41–4.34 (m, 2H), 4.29–4.12 (m, 3H), 4.03–3.93 (m, 2H), 3.93 (s, 3H), 3.72 (s, 3H), 3.34–3.18 (m, 2H), 2.34 (t, <i>J</i> = 6.5 Hz, 2H), 2.22–2.13 (m, 4H), 1.78 (s, 2H), 1.69–1.36 (m, 5H), 1.34–1.16 (m, 33H), 1.01 (d, <i>J</i> = 6.8 Hz, 3H), 0.96 (d, <i>J</i> = 6.9 Hz, 3H), 0.92–0.84 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.19, 172.41, 172.20, 171.92, 171.50, 169.42, 166.27, 148.83, 148.28, 139.95, 126.79, 122.05, 118.95, 116.10, 111.36, 60.94, 57.77, 55.98, 52.38, 52.25, 52.17, 38.49, 35.89, 31.75, 31.56, 31.29, 30.98, 29.49, 29.47, 29.40, 29.23, 29.16, 29.12, 27.15, 25.78, 23.23, 22.56, 19.64, 18.23, 14.50, 14.42. HRMS calcd for C<sub>49</sub>H<sub>82</sub>N<sub>5</sub>O<sub>11</sub><i>m</i>/<i>z</i>: 916.6005 (M + H)<sup>+</sup>, found 916.6002.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63">4.4.  Mice</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">4.4.1.  Experiments with Bone-Marrow-Derived Dendritic Cells and T Cells</h4><div class="NLM_p last">C57BL/6, OT I (C57BL/6-Tg(TcraTcrb)1100Mjb/J), and OT II (C57BL/6-Tg(TcraTcrb)425Cbn/Crl) mice were purchased from Jackson Laboratory (Bar Harbor, ME, U.S.A.) and bred at the University of Leiden (The Netherlands). The mice were kept under standard laboratory conditions, with food and water provided <i>ad libitum</i>. The mice were euthanized while sedated by cervical dislocation. All animal work was performed according to the guidelines of the European Parliament Directive 2010/63EU, and the experimental work was approved by the Animal Ethics Committee of Leiden University. For culture conditions of BMDCs, see below.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">4.4.2.  <i>In Vivo</i> Experiments</h4><div class="NLM_p last">NIH/OlaHsd inbred mice were raised at the Institute of Immunology, Croatia. All mice used were females from 2.0 to 2.5 months old. During the experimental period, the mice were housed in the Animal Facility of the Institute of Immunology, with food and water provided <i>ad libitum</i>. All animal work was performed according to the Croatian Law on Animal Welfare (2017), which complies strictly with the EC Directive (2010/63/EU).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66">4.5.  Cell Cultures</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">4.5.1.  HEK-Blue NOD1 and NOD2 Cells</h4><div class="NLM_p last">HEK-Blue NOD1 and NOD2 cells (InvivoGen, San Diego, CA, U.S.A.) were cultured according to the manufacturer instructions in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich, St. Louis, MO, U.S.A.) supplemented with 10% heat-inactivated fetal bovine serum (Gibco), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma-Aldrich), 100 U/mL penicillin (Sigma-Aldrich), 100 μg/mL streptomycin (Sigma-Aldrich), and 100 μg/mL normocin (InvivoGen) for two passages. All subsequent passages were cultured in medium additionally supplemented with 30 μg/mL blasticidin (InvivoGen) and 100 μg/mL Zeocin (InvivoGen). The cells were incubated in a humidified atmosphere at 37 °C and 5% CO<sub>2</sub>.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">4.5.2.  Peripheral Blood Mononuclear Cells</h4><div class="NLM_p last">Human PBMCs from healthy and consenting donors were isolated from heparinized blood by density gradient centrifugation with Ficoll-Paque (Pharmacia, Sweden). The isolated cells were resuspended in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, U.S.A.) supplemented with 10% heat-inactivated fetal bovine serum (Gibco), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma-Aldrich), 100 U/mL penicillin (Sigma-Aldrich), and 100 μg/mL streptomycin (Sigma-Aldrich) and used in the assays.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">4.5.3.  Cancer Cell Lines</h4><div class="NLM_p last">K562 cells are a chronic myelogenous leukemia cell line (ATCC, Manassas, VA, U.S.A.),<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and MEC1 cells are a B-chronic lymphocytic leukemia cell line (DSMZ GmbH, Braunschweig, Germany).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The K562 cells were cultured in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, U.S.A.) supplemented with 10% heat-inactivated fetal bovine serum (Gibco), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma-Aldrich), 100 U/mL penicillin (Sigma-Aldrich), and 100 μg/mL streptomycin (Sigma-Aldrich). The MEC1 cells were cultured in Iscove’s modified Dulbecco’s medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma-Aldrich), 100 U/mL penicillin (Sigma-Aldrich), and 100 μg/mL streptomycin (Sigma-Aldrich).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">4.5.4.  Bone-Marrow-Derived Dendritic Cells</h4><div class="NLM_p last">Bone marrow cells were isolated from the tibia of C57BL/6 mice and cultured in Dulbecco’s modified Eagle’s medium (Lonza, Basel, Switzerland) supplemented with 10% heat-inactivated fetal bovine serum (Lonza), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Lonza), 100 U/mL penicillin (Lonza), 100 μg/mL streptomycin (Lonza), and 20 ng/mL granulocyte-macrophage colony-stimulating factor (ImmunoTools, Friesoythe, Germany) for 7 days at 37 °C and 5% CO<sub>2</sub>. The purity of the BMDCs was evaluated with PE-labeled anti-mouse CD11c (Biolegend, San Diego, CA, U.S.A.) by flow cytometry with >90% shown to be CD11c positive.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71">4.6.  Cytotoxicity</h3><div class="NLM_p last">The tested compounds were dissolved in DMSO and further diluted in culture medium to the desired final concentrations, such that the final DMSO concentration did not exceed 0.1%. HEK-Blue NOD2 cells were seeded (40 000 cells/well) in 96-well plates in 100 μL of culture medium and treated with 20 μM of each compound or with the corresponding vehicle (0.1% DMSO; control cells). After 18 h of incubation (37 °C, 5% CO<sub>2</sub>), the metabolic activity was assessed using the CellTiter 96 Aqueous One Solution cell proliferation assay (Promega, Madison, WI, U.S.A.), according to the manufacturer instructions. The experiments were run in duplicate and repeated as two independent biological replicates.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72">4.7.  Measurement of NF-kB Transcriptional Activity (HEK-Blue Detection)</h3><div class="NLM_p last">HEK-Blue NOD2 and NOD1 cell line reporter assays are derived from HEK293 cells by cotransfection of the hNOD2 or hNOD1 genes, respectively, and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene. Following activation of NOD2 or NOD1, the resulting NF-κB induces production of SEAP, the levels of which can be quantified colorimetrically. HEK-Blue NOD2 or NOD1 cells were seeded (2.5 × 10<sup>5</sup> cells/mL) in 96-well plates in 200 μL of HEK-Blue detection medium (InvivoGen, San Diego, CA, U.S.A.) and treated with the compounds (2 μM for fixed concentration assay; 7–8 different concentrations from 1 nM to 20 μM for EC<sub>50</sub> determination) or with the corresponding vehicle (0.1% DMSO). After 18 h of incubation (37 °C, 5% CO<sub>2</sub>), secreted embryonic alkaline phosphatase (SEAP) activity was determined spectrophotometrically as absorbance at 630 nm (BioTek Synergy microplate reader; Winooski, VT, U.S.A.). EC<sub>50</sub> values were calculated using Prism software (version 9; GraphPad Software, CA, U.S.A.). For determination of specificity, HEK-Blue NOD2 cells (2.5 × 10<sup>5</sup> cells/mL) were first pretreated for 1 h with a 10 μM NOD2 antagonist, before the addition of the compounds (2 μM), with incubation for 18 h. SEAP activity in the supernatants was determined as above. The experiments were run in duplicate and repeated as at least two independent biological replicates.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73">4.8.  Cytokine Release from Peripheral Blood Mononuclear Cells</h3><div class="NLM_p last">Peripheral blood mononuclear cells were seeded (1 × 10<sup>6</sup> cells/mL) in 48-well plates in 500 μL of growth medium and treated with the compounds (2 μM) or with the corresponding vehicle (0.1% DMSO) in the absence and presence of LPS (10 ng/mL). Cell-free supernatants were collected after 18 h of incubation (37 °C, 5% CO<sub>2</sub>) and stored at −80 °C until tested. Cytokine production was determined with the BD Cytometric Bead Array Human Inflammatory Cytokines Kit (contents: IL-8, IL-1β, IL-6, IL-10, TNF, IL-12p70; BD Bioscience) on an Attune NxT flow cytometer (Thermo Fisher Scientific, Waltham, MA, U.S.A.). Standard curves were generated using recombinant cytokines contained in the kit. The data were analyzed using the FlowJo (Tree Star, Inc., Ashland, OR, U.S.A.) and Prism (GraphPad, San Diego, CA, U.S.A.) software. The experiments were repeated as four independent biological replicates. Statistical significance was determined by repeated measures one-way ANOVA followed with Dunnett’s multiple comparisons test.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74">4.9.  Peripheral Blood Mononuclear Cell Cytotoxicity</h3><div class="NLM_p last">The PBMC cytotoxicity assays using K562 and MEC1 cells were performed as described previously, with some modifications.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> PBMCs were seeded (4 × 10<sup>5</sup> cells/well) in 96-well plates and treated with compounds (0.1–10 μM) or vehicle (0.1% DMSO) for 18 h. The K562 or MEC1 cells were stained with CFSE (Invitrogen, Carlsbad, CA, U.S.A.), washed twice with complete medium, and added (1 × 10<sup>4</sup> cells/well) to pretreated PBMCs for a final effector cell to target tumor cell ratio of 40:1. After a 4 h co-incubation (37 °C, 5% CO<sub>2</sub>), cells were stained with Sytox blue dead cell stain (Invitrogen) and analyzed using an Attune NxT flow cytometer (Thermo Fisher Scientific, Waltham, MA, U.S.A.) and the FlowJo software (Tree Star, Inc., Ashland, OR, U.S.A.). Cells that were positive for both CFSE and Sytox blue were defined as dead K562 and MEC1 cells. PBMCs alone and the CFSE-labeled cancer cells alone were also treated with the compounds at the same concentrations and stained with Sytox blue to determine any direct cytotoxicity of the compounds toward the PBMCs and cancer cells. The experiments were run in duplicate and repeated as three independent biological replicates. Statistical significance was determined by one-way ANOVA followed with Dunnett’s multiple comparisons test.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75">4.10.  RNA Sequencing</h3><div class="NLM_p">Peripheral blood mononuclear cells from three independent donors were seeded (2 × 10<sup>6</sup> cells/mL) in 24-well plates in 1 mL of growth medium and treated with the compounds (2 μM) or vehicle (0.1% DMSO) for 18 h at 37 °C in 5% CO<sub>2</sub>. The cells were washed with phosphate-buffered saline, resuspended in RNAlater RNA stabilization solution (Sigma-Aldrich, St. Louis, MO, U.S.A.), and stored at −80 °C. RNA extraction, library construction, and sequencing were conducted by Genewiz (Leipzig, Germany).</div><div class="NLM_p">Briefly, total RNA was extracted using the RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer protocol. RNA samples were quantified using Qubit 4.0 Fluorometer (Life Technologies, Carlsbad, CA, U.S.A.), and RNA integrity was checked with RNA Kit on a 5600 Fragment Analyzer (Agilent Technologies, Palo Alto, CA, U.S.A.). All RNA samples were of high quality with an RNA quality number of ≥9.4. RNA sequencing libraries were prepared using NEBNext Ultra II RNA library prep kit for Illumina according to the manufacturer instructions (New England Biolabs, Ipswich, MA, U.S.A.). Libraries were loaded on the Illumina NovaSeq 6000 instrument, and clustering was performed directly on the NovaSeq before sequencing according to the manufacturer instructions. The samples were sequenced using a 2 × 150 paired end configuration. Image analysis and base calling were conducted by the NovaSeq Control Software. Raw sequence data (.bcl files) generated from the Illumina NovaSeq were converted into <i>fastq</i> files and demultiplexed using Illumina’s bcl2fastq 2.19 software. One mismatch was allowed for index sequence identification. After investigating the quality of the raw data, sequence reads were trimmed to remove possible adapter sequences and nucleotides with poor quality using Trimmomatic v.0.36. The trimmed reads were mapped to the <i>Homo sapiens</i> reference genome as available on ENSEMBL, using STAR aligner v.2.5.2b, thus generating BAM files. Unique gene hit counts were calculated using feature counts from the Subread package v.1.5.2. Only unique reads that fell within exon regions were counted. After extraction of gene hit counts, the gene hit counts table was used for downstream differential expression analysis.</div><div class="NLM_p last">Differential expression analysis was performed with iDEP.91.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> First, a low expression filter was applied (0.5 counts per million in at least 1 library). The remaining gene counts were normalized by counts per million in the EdgeR package, with a pseudocount of 4. Differential gene expression analysis was performed with the DESeq2 method, using a false discovery rate <0.05 and a gene expression fold change >1.5 or <0.667 as the cutoff values. The list of differentially expressed genes was then used as input for gene annotation and pathway enrichment analysis with Metascape.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76">4.11.  Bone-Marrow-Derived Dendritic Cell Antigen Presentation</h3><div class="NLM_p last">CD4<sup>+</sup> and CD8<sup>+</sup> T cells were purified from splenocytes of OT II and OT I transgenic mice using CD4<sup>+</sup> and CD8<sup>+</sup> T cell isolation kits (Miltenyi Biotec, Germany), according to manufacturer instructions. Purified T cells were stained with CFSE (Invitrogen, Carlsbad, CA, U.S.A.) and washed. Then, 5 × 10<sup>4</sup> T cells were mixed with 1 × 10<sup>4</sup> BMDCs per well (pretreated with desmuramylpeptides [1 or 10 μM] and 50 μg/mL ovalbumin [InvivoGen, San Diego, CA, U.S.A.] for 18 h, and then washed). After 72 h of co-incubation (37 °C, 5% CO<sub>2</sub>), the supernatants were collected and stored at −80 °C for subsequent cytokine measurements. The cells were stained with Fixable viability dye eFluor 780 (eBioscience, Thermo Fisher Scientific, MA, U.S.A.), anti-Thy1.2-PE-Cy7 antibodies (Biolegend, San Diego, CA, U.S.A.), anti-CD8-eFluor450 antibodies (eBioscience), anti-CD4-eFluor450 antibodies (eBioscience), and anti-CD25-APC antibodies (Biolegend) and analyzed using a Beckman Coulter Cytoflex S flow cytometer (CA, U.S.A.) and FlowJo software (Tree Star, Inc., Ashland, OR, U.S.A.). Live Thy1.2<sup>+</sup>/CD4<sup>+</sup> and Thy1.2<sup>+</sup>/CD8<sup>+</sup> were evaluated for CFSE dilution and CD25 expression. The experiments were run in duplicate and repeated as two independent biological replicates. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple comparisons test.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77">4.12.  T Cell Cytokine Release</h3><div class="NLM_p last">Supernatants from CD4<sup>+</sup> and CD8<sup>+</sup> T cells after 72 h of co-incubation with BMDCs (pretreated with desmuramylpeptides [10 μM] and washed) were collected as described above. The cytokine concentrations were determined with the Cytometric Bead Array Mouse Th1/Th2/Th17 Cytokine Kit (contents: IL-2, IL-4, IL-6, IFN-γ, TNF, IL-17A, IL-10; BD Bioscience) on an Attune NxT flow cytometer (Thermo Fisher Scientific, Waltham, MA, U.S.A.). Standard curves were generated using recombinant cytokines contained in the kit. The data were analyzed using the FlowJo (Tree Star, Inc., Ashland, OR, U.S.A.) and Prism (GraphPad, San Diego, CA, U.S.A.) software. The experiments were run in duplicate and repeated as two independent biological replicates.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78">4.13.  <i>In Vivo</i> Induction of Ovalbumin-Specific Immune Response</h3><div id="sec4_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">4.13.1.  Materials, Antigens, and Antibodies</h4><div class="NLM_p last">Bovine serum albumin, Tween 20, monoclonal anti-chicken egg albumin (clone OVA-14 mouse IgG1 isotype), <i>o</i>-phenylenediaminedihydrochloride, and MDP were from Sigma (U.S.A.). Horseradish-peroxidase-conjugated goat anti-mouse IgG (HRP-anti-mouse IgG) was from Bio-Rad Laboratories (U.S.A.). Biotin-conjugated rat anti-mouse IgG1 and anti-mouse IgG2a monoclonal antibodies and streptavidin–peroxidase were from PharMingen, Becton Dickinson (U.S.A.). Chemicals for buffers and solutions were from Kemika (Croatia). Ovalbumin was from Serva (Germany). <span class="smallcaps smallerCapital">l</span>-α-Phosphatidylcholine, type XI-E, from fresh egg yolk (egg-phosphatidylcholine) was from Avanti Polar Lipids. Cholesterol from porcine liver and dicetylphosphate were from Sigma (U.S.A.). Monomannosyl-PEG-palmitic acid derivative (Man-PEG-Pam) was synthesized as previously described.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div></div><div id="sec4_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">4.13.2.  Preparation of Liposomes</h4><div class="NLM_p last">Multilamellar liposomes were prepared by the modified thin lipid film method as described previously.<a onclick="showRef(event, 'ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref130 ref131">(130,131)</a> For the preparation of neutral liposomes, a 7:5 molar ratio of egg-phosphatidylcholine and cholesterol was used. For the preparation of negatively charged liposomes, a 7:5:1 molar ratio of egg-phosphatidylcholine, cholesterol, and dicetylphosphate was used, while a 7:5:0.5 molar ratio of egg-phosphatidylcholine, cholesterol, and Man-PEG-Pam was used in the preparation of mannosylated liposomes. Lipids (total lipid concentration, 4 mg/mL) were dissolved in chloroform/methanol (2:1). A methanol or chloroform/methanol solution of MDP or the desmuramylpeptides was added to the lipid solution for a final concentration of 2 mM and 1.5 mM for the first (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) and second (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) experiments, respectively. After rotary evaporation of the solvent, the remaining lipid film was dried in vacuum for 1 h and then dispersed by gentle handshaking in an ovalbumin solution in saline (0.0667 and 0.1 mg/mL for the first and second experiments, respectively). This was then left overnight at 4 °C to swell and stabilize. Liposome size was reduced by sonification. Nonentrapped material was not separated from liposomes, and the complete liposome suspension was used for immunizations.</div></div><div id="sec4_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">4.13.3.  Immunizations</h4><div class="NLM_p last">For the first experiment (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), sex-matched NIH/OlaHsd mice (five per group) were immunized subcutaneously in the tail base and boosted one time after 21 days. The injection volume in all experimental groups was 0.15 mL per mouse, which corresponds to 10 μg of OVA, 400 μg of lipids, and 0.30 μmol of MDP and desmuramylpeptides. For the second experiment (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), sex-matched NIH/OlaHsd mice (five per group) were immunized and boosted two times subcutaneously into the tail base at 21-day intervals. The injection volume in all experimental groups was 0.1 mL per mouse, which corresponds to 10 μg of OVA, 400 μg of lipids, and 0.15 μmol of MDP and <b>75</b>. The mice were anesthetized with ip application of ketamine/xylazine (25 mg/kg each) prior to blood collection from the axillary plexus on the seventh day after the last booster dose. Individual serum from each animal was decomplemented at 56 °C for 30 min and then stored at −20 °C until tested.</div></div><div id="sec4_13_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">4.13.4.  Ovalbumin-Specific Serum Antibody Concentration Determination by ELISA</h4><div class="NLM_p last">ELISA assays were performed as detailed previously.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Briefly, high-binding ELISA plates (Costar, U.S.A.) were coated with a 15 μg/mL solution of ovalbumin in carbonate buffer, pH 9.6, and incubated overnight at room temperature. Nonspecific antibody binding was blocked with 0.5% w/v bovine serum albumin in PBS-T (0.05% (v/v) Tween 20 in phosphate-buffered saline) for 2 h at 37 °C. After washing, five serial dilutions of mice sera and standard preparations were added in duplicate. Plates were incubated overnight at room temperature, washed, and analyzed for ovalbumin-specific IgG levels by incubation with HRP-conjugated goat anti-mouse IgG (2 h at 37 °C) and then, after washing, with 0.6 mg/mL <i>o</i>-phenylenediaminedihydrochloride solution in citrate-phosphate buffer, pH 5.0, with 0.5 μL of 30% H<sub>2</sub>O<sub>2</sub> per milliliter for 30 min at room temperature in the dark. The enzymatic reaction was stopped with 12.5% H<sub>2</sub>SO<sub>4</sub>, and absorbance at 492 nm was measured using a microplate reader (Thermo Fisher Scientific, Waltham, MA, U.S.A.). For the determination of ovalbumin-specific IgG1 and IgG2a, the plates were incubated with biotin-conjugated rat anti-mouse IgG1 or IgG2a (2 h at 37 °C) and subsequently with streptavidin–peroxidase for another 2 h at 37 °C. After washing, the substrate solution was added and incubated for 30 min at room temperature in the dark, as described above. The enzymatic reaction was stopped with 12.5% H<sub>2</sub>SO<sub>4</sub>, and absorbance at 492 nm was measured using a microplate reader. The relative quantities of antibodies were determined by parallel line assays using appropriate standard preparations of anti-ovalbumin IgG, anti-ovalbumin IgG1, and anti-ovalbumin IgG2a. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple comparisons test.</div></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83">4.14.  Screening against PAINS</h3><div class="NLM_p last">All tested compounds were screened against the PAINS filter<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> as implemented in CANVAS (Schrödinger software, Release 2020-2, New York, U.S.A.). Compound <b>21</b> was identified as an interfering compound due to the presence of a catechol structure. Given that <b>21</b> was tested in two independent analogous assays with HEK-Blue NOD1 and NOD2 cells and it showed no activity in the NOD1 assay, the activity measured in the NOD2 assay did not arise from nonspecific activation. Furthermore, the reduced NOD2 activation of <b>21</b> after NOD2 antagonist pretreatment in the specificity assay provided an additional argument for the absence of interference of the catechol structure in <b>21</b>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84">4.15.  Statistics</h3><div class="NLM_p last">Data analysis was performed using Prism software (version 9; GraphPad Software, CA, U.S.A.). Statistical differences were determined as specified under individual experimental procedures. A <i>p</i> value < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00644" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00644?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00644</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">(Molecular formula strings <a href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Synthesis and analytical data of intermediate compounds <b>4</b>, <b>5</b>, <b>7</b>–<b>17</b>, <b>22</b>, <b>33</b>–<b>40</b>, <b>47</b>–<b>55</b>, <b>65</b>–<b>67</b>, and <b>69</b>–<b>71</b>, supporting schemes and figures, experimental procedure for chiral HPLC resolution of compound <b>29</b>, <sup>1</sup>H–<sup>1</sup>H NOESY determination of cyclopropane stereoconfiguration in compounds <b>27</b>, <b>28</b>, <b>29a</b>, and <b>29b</b>, and <sup>1</sup>H and <sup>13</sup>C NMR spectra of representative tested compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_001.csv">jm1c00644_si_001.csv (3.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_002.pdf">jm1c00644_si_002.pdf (2.84 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00644" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Žiga Jakopin</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9384-0858" title="Orcid link">https://orcid.org/0000-0001-9384-0858</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cdb7a4aaace3a7aca6a2bda4a38dababace3b8a3a4e0a1a7e3bea4"><span class="__cf_email__" data-cfemail="ed97848a8cc3878c86829d8483ad8b8b8cc3988384c08187c39e84">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samo Guzelj</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanja Nabergoj</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Gobec</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stane Pajk</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronika Klančič</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bram Slütter</span> - <span class="hlFld-Affiliation affiliation">Div.
BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruža Frkanec</span> - <span class="hlFld-Affiliation affiliation">Centre
for Research and Knowledge Transfer in Biotechnology, University of Zagreb, 10000 Zagreb, Croatia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adela Štimac</span> - <span class="hlFld-Affiliation affiliation">Centre
for Research and Knowledge Transfer in Biotechnology, University of Zagreb, 10000 Zagreb, Croatia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Primož Šket</span> - <span class="hlFld-Affiliation affiliation">Slovenian
NMR Centre, National Institute of Chemistry, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janez Plavec</span> - <span class="hlFld-Affiliation affiliation">Slovenian
NMR Centre, National Institute of Chemistry, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irena Mlinarič-Raščan</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The study was designed by Ž.J. and S.G. The synthetic work and characterization of compounds was conducted by Ž.J., S.G., and V.K. Chiral HPLC resolution was performed by S.P. NOESY experiments were conducted by S.G., P.Š., and J.P. In vitro assays of cytotoxicity, NOD1 and NOD2 stimulation, PBMC isolation, and stimulation and determination of cytotoxicity versus cancer cells were conducted by S.G., M. G., and S.N. In vitro assays with BMDCs and T cells were conducted by S.G. and B.S. Preparation of experimental liposomal formulations and in vivo experiments (immunization experiments, analysis of sera) were conducted by A.Š. and R.F. Ž.J. and S.G. wrote the manuscript. Ž.J., S.G., S.N., M.G., S.P., V.K., B.S., A.Š., R.F., and I.M.R. analyzed the data, read the manuscript, and gave approval to the final version.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30838" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30838" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was funded by the Slovenian Research Agency (Grants P1-0208 and J3-9256), the Croatian Science Foundation (HrZZ) (Project No. IP-2018-01-6910), their mutual bilateral contract (BI-HR/18-19-001), and the COST action CA16231 “European Network of Vaccine Adjuvants (ENOVA)” (Grant ID STSM-CA16231- 130120-114265). The authors thank Dr. Chris Berrie for proofreading the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BMDC</td><td class="NLM_def"><p class="first last">bone-marrow-derived dendritic cell</p></td></tr><tr><td class="NLM_term">CARD</td><td class="NLM_def"><p class="first last">caspase recruitment domain</p></td></tr><tr><td class="NLM_term">CFSE</td><td class="NLM_def"><p class="first last">carboxyfluorescein succinimidyl ester</p></td></tr><tr><td class="NLM_term">COMU</td><td class="NLM_def"><p class="first last">(1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cell</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">GO</td><td class="NLM_def"><p class="first last">Gene Ontology</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">ISG</td><td class="NLM_def"><p class="first last">interferon-stimulated gene</p></td></tr><tr><td class="NLM_term">KEGG</td><td class="NLM_def"><p class="first last">Kyoto Encyclopedia of Genes and Genomes</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">Man-PEG-Pam</td><td class="NLM_def"><p class="first last">monomannosyl–poly(ethylene glycol)–palmitic acid</p></td></tr><tr><td class="NLM_term">MDP</td><td class="NLM_def"><p class="first last">muramyl dipeptide</p></td></tr><tr><td class="NLM_term">MHC</td><td class="NLM_def"><p class="first last">major histocompatibility complex</p></td></tr><tr><td class="NLM_term">MurNAc</td><td class="NLM_def"><p class="first last"><i>N</i>-acetylmuramic acid</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">NK</td><td class="NLM_def"><p class="first last">natural killer</p></td></tr><tr><td class="NLM_term">NOD</td><td class="NLM_def"><p class="first last">nucleotide-binding oligomerization domain</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">pattern recognition receptor</p></td></tr><tr><td class="NLM_term">SEAP</td><td class="NLM_def"><p class="first last">secreted embryonic alkaline phosphatase</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 132 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janeway, C. A.</span></span> <span> </span><span class="NLM_article-title">Approaching the Asymptote? Evolution and Revolution in Immunology</span>. <i>Cold Spring Harbor Symp. Quant. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1101/SQB.1989.054.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1101%2FSQB.1989.054.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=2700931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3cXkslGqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=1-13&author=C.+A.+Janeway&title=Approaching+the+Asymptote%3F+Evolution+and+Revolution+in+Immunology&doi=10.1101%2FSQB.1989.054.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Approaching the asymptote?  Evolution and revolution in immunology</span></div><div class="casAuthors">Janeway, C. A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review with 51 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow291fgYVUsbVg90H21EOLACvtfcHk0lhHd6VcQUCLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslGqtrY%253D&md5=db5e51a8f8f6fc9b2dbac1f8cec043e5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2FSQB.1989.054.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252FSQB.1989.054.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26atitle%3DApproaching%2520the%2520Asymptote%253F%2520Evolution%2520and%2520Revolution%2520in%2520Immunology%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1989%26volume%3D54%26spage%3D1%26epage%3D13%26doi%3D10.1101%2FSQB.1989.054.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janeway, C. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Innate Immune Recognition</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.20.083001.084359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev.immunol.20.083001.084359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11861602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=197-216&author=C.+A.+Janewayauthor=R.+Medzhitov&title=Innate+Immune+Recognition&doi=10.1146%2Fannurev.immunol.20.083001.084359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immune recognition</span></div><div class="casAuthors">Janeway, Charles A., Jr.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-216</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The innate immune system is a universal and ancient form of host defense against infection.  Innate immune recognition relies on a limited no. of germline-encoded receptors.  These receptors evolved to recognize conserved products of microbial metab. produced by microbial pathogens, but not by the host.  Recognition of these mol. structures allows the immune system to distinguish infectious nonself from noninfectious self.  Toll-like receptors play a major role in pathogen recognition and initiation of inflammatory and immune responses.  Stimulation of Toll-like receptors by microbial products leads to the activation of signaling pathways that result in the induction of antimicrobial genes and inflammatory cytokines.  In addn., stimulation of Toll-like receptors triggers dendritic cell maturation and results in the induction of costimulatory mols. and increased antigen-presenting capacity.  Thus, microbial recognition by Toll-like receptors helps to direct adaptive immune responses to antigens derived from microbial pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Ee-TeDKpobVg90H21EOLACvtfcHk0lgPDP9JuhSLUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D&md5=0c4bd7dbf690ad61e6b81324be227d8e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.20.083001.084359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.20.083001.084359%26sid%3Dliteratum%253Aachs%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DInnate%2520Immune%2520Recognition%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D20%26spage%3D197%26epage%3D216%26doi%3D10.1146%2Fannurev.immunol.20.083001.084359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasare, C.</span></span> <span> </span><span class="NLM_article-title">Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">3791</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1602000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.1602000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=28483987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Sku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=3791-3800&author=A.+Jainauthor=C.+Pasare&title=Innate+Control+of+Adaptive+Immunity%3A+Beyond+the+Three-Signal+Paradigm&doi=10.4049%2Fjimmunol.1602000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm</span></div><div class="casAuthors">Jain, Aakanksha; Pasare, Chandrashekhar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3791-3800</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  Activation of cells in the adaptive immune system is a highly orchestrated process dictated by multiples cues from the innate immune system.  Although the fundamental principles of innate control of adaptive immunity are well established, it is not fully understood how innate cells integrate qual. pathogenic information to generate tailored protective adaptive immune responses.  In this review, we discuss complexities involved in the innate control of adaptive immunity that extend beyond TCR engagement, costimulation, and priming cytokine prodn. but are crit. for the generation of protective T cell immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eo8hBrZjsrVg90H21EOLACvtfcHk0lgPDP9JuhSLUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Sku70%253D&md5=24160f03414111378a91b90cdd5b8f10</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1602000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1602000%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%26aulast%3DPasare%26aufirst%3DC.%26atitle%3DInnate%2520Control%2520of%2520Adaptive%2520Immunity%253A%2520Beyond%2520the%2520Three-Signal%2520Paradigm%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26spage%3D3791%26epage%3D3800%26doi%3D10.4049%2Fjimmunol.1602000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaji, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, M. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raw, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span> <span> </span><span class="NLM_article-title">Trends in Adjuvant Development for Vaccines: DAMPs and PAMPs as Potential New Adjuvants</span>. <i>Braz. J. Med. Biol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1590/S0100-879X2011000600003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1590%2FS0100-879X2011000600003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21584443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1yltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=500-513&author=E.+N.+Miyajiauthor=E.+Carvalhoauthor=M.+L.+S.+Oliveiraauthor=I.+Rawauthor=P.+L.+Ho&title=Trends+in+Adjuvant+Development+for+Vaccines%3A+DAMPs+and+PAMPs+as+Potential+New+Adjuvants&doi=10.1590%2FS0100-879X2011000600003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants</span></div><div class="casAuthors">Miyaji, E. N.; Carvalho, E.; Oliveira, M. L. S.; Raw, I.; Ho, P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Brazilian Journal of Medical and Biological Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">500-513</span>CODEN:
                <span class="NLM_cas:coden">BJMRDK</span>;
        ISSN:<span class="NLM_cas:issn">0100-879X</span>.
    
            (<span class="NLM_cas:orgname">Associacao Brasileira de Divulgacao Cientifica</span>)
        </div><div class="casAbstract">A review.  Aluminum salts have been widely used in vaccine formulations and, after their introduction more than 80 years ago, only few vaccine formulations using new adjuvants were developed in the last two decades.  Recent advances in the understanding of how innate mechanisms influence the adaptive immunity opened up the possibility for the development of new adjuvants in a more rational design.  The purpose of this review is to discuss the recent advances in this field regarding the attempts to det. the mol. basis and the general mechanisms underlying the development of new adjuvants, with particular emphasis on the activation of receptors of innate immune recognition.  One can anticipate that the use of these novel adjuvants will also provide a window of opportunities for the development of new vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdhSXlHEaX8LVg90H21EOLACvtfcHk0lgPDP9JuhSLUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1yltrc%253D&md5=989ef52a4bd3cc7c3a80a9ea3d2a6d59</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1590%2FS0100-879X2011000600003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0100-879X2011000600003%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaji%26aufirst%3DE.%2BN.%26aulast%3DCarvalho%26aufirst%3DE.%26aulast%3DOliveira%26aufirst%3DM.%2BL.%2BS.%26aulast%3DRaw%26aufirst%3DI.%26aulast%3DHo%26aufirst%3DP.%2BL.%26atitle%3DTrends%2520in%2520Adjuvant%2520Development%2520for%2520Vaccines%253A%2520DAMPs%2520and%2520PAMPs%2520as%2520Potential%2520New%2520Adjuvants%26jtitle%3DBraz.%2520J.%2520Med.%2520Biol.%2520Res.%26date%3D2011%26volume%3D44%26spage%3D500%26epage%3D513%26doi%3D10.1590%2FS0100-879X2011000600003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandakumar, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span> <span> </span><span class="NLM_article-title">Targeting Pattern-Recognition Receptors to Discover New Small Molecule Immune Modulators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2017.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29268133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2ntr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=82-92&author=G.+Zhuauthor=Y.+Xuauthor=X.+Cenauthor=K.+S.+Nandakumarauthor=S.+Liuauthor=K.+Cheng&title=Targeting+Pattern-Recognition+Receptors+to+Discover+New+Small+Molecule+Immune+Modulators&doi=10.1016%2Fj.ejmech.2017.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting pattern-recognition receptors to discover new small molecule immune modulators</span></div><div class="casAuthors">Zhu, Gengzheng; Xu, Yao; Cen, Xiaohong; Nandakumar, Kutty Selva; Liu, Shuwen; Cheng, Kui</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-92</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Pattern recognition receptors (PRRs) are key immune receptors of the innate immune system, which recognize the conserved pathogen-assocd. mol. patterns (PAMPs) of the invading pathogens.  Compared to the adaptive immune receptors, PRRs have three distinguishing features, viz., universal expression, fast response and recognizing many kinds of microbes.  Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), C-type lectin receptors (CLRs) and NOD-like receptors (NLRs) recognize viral nucleic acid/bacterial fragments and trigger anti-microbial innate immune responses.  Upon recognition of their ligand species, PRRs recruit specific intracellular adaptor proteins to initiate signaling pathways culminating in the activation of nuclear factor-κB (NF-κB), mitogen-activated protein (MAP) kinases and interferon regulatory factors (IRFs) that control the transcription of genes encoding pro-inflammatory factors including type I interferon and other inflammatory cytokines, which are crit. for eliminating the potential threat to the host.  Here, we summarize the effects of small mol. regulators acting on signaling pathways initiated by TLR, RLR and NLR as well as their influence on innate and adaptive immune responses leading to therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJYT3GE2sDCLVg90H21EOLACvtfcHk0lh7UT5EUOkKoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2ntr7L&md5=dd71c03c5334ac994cbd0d987df28a9f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCen%26aufirst%3DX.%26aulast%3DNandakumar%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DK.%26atitle%3DTargeting%2520Pattern-Recognition%2520Receptors%2520to%2520Discover%2520New%2520Small%2520Molecule%2520Immune%2520Modulators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D82%26epage%3D92%26doi%3D10.1016%2Fj.ejmech.2017.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pashenkov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagil, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinegin, B. V.</span></span> <span> </span><span class="NLM_article-title">NOD1 and NOD2: Molecular Targets in Prevention and Treatment of Infectious Diseases</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2017.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.intimp.2017.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29207344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=385-400&author=M.+V.+Pashenkovauthor=Y.+A.+Dagilauthor=B.+V.+Pinegin&title=NOD1+and+NOD2%3A+Molecular+Targets+in+Prevention+and+Treatment+of+Infectious+Diseases&doi=10.1016%2Fj.intimp.2017.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases</span></div><div class="casAuthors">Pashenkov, Mikhail V.; Dagil, Yulia A.; Pinegin, Boris V.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain (NOD) 1 and NOD2 are pattern-recognition receptors responsible for sensing fragments of bacterial peptidoglycan known as muropeptides.  Stimulation of innate immunity by systemic or local administration of NOD1 and NOD2 agonists is an attractive means to prevent and treat infectious diseases.  In this review, we discuss novel data concerning structural features of selective and non-selective (dual) NOD1 and NOD2 agonists, main signaling pathways and biol. effects induced by NOD1 and NOD2 stimulation, including induction of pro-inflammatory cytokines, type I interferons and antimicrobial peptides, induction of autophagy, alterations of metab.  We also discuss interactions between NOD1/NOD2 and Toll-like receptor agonists in terms of synergy and cross-tolerance.  Finally, we review available animal data on the role of NOD1 and NOD2 in protection against infections, and discuss how these data could be applied in human infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolmFF5asrsnLVg90H21EOLACvtfcHk0lh7UT5EUOkKoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsb3N&md5=c471cd90f05c8e417f28ff932c290ce4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2017.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2017.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DPashenkov%26aufirst%3DM.%2BV.%26aulast%3DDagil%26aufirst%3DY.%2BA.%26aulast%3DPinegin%26aufirst%3DB.%2BV.%26atitle%3DNOD1%2520and%2520NOD2%253A%2520Molecular%2520Targets%2520in%2520Prevention%2520and%2520Treatment%2520of%2520Infectious%2520Diseases%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2018%26volume%3D54%26spage%3D385%26epage%3D400%26doi%3D10.1016%2Fj.intimp.2017.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabergoj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Harnessing the Untapped Potential of Nucleotide-Binding Oligomerization Domain Ligands for Cancer Immunotherapy</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1484</span>, <span class="refDoi"> DOI: 10.1002/med.21557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fmed.21557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30548868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1447-1484&author=S.+Nabergojauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=%C5%BD.+Jakopin&title=Harnessing+the+Untapped+Potential+of+Nucleotide-Binding+Oligomerization+Domain+Ligands+for+Cancer+Immunotherapy&doi=10.1002%2Fmed.21557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy</span></div><div class="casAuthors">Nabergoj, Sanja; Mlinaric-Rascan, Irena; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1447-1484</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  In the last decade, cancer immunotherapy has emerged as an effective alternative to traditional therapies such as chemotherapy and radiation.  In contrast to the latter, cancer immunotherapy has the potential to distinguish between cancer and healthy cells, and thus to avoid severe and intolerable side-effects, since the cancer cells are effectively eliminated by stimulated immune cells.  The cytosolic nucleotide-binding oligomerization domains 1 and 2 receptors (NOD1 and NOD2) are important components of the innate immune system and constitute interesting targets in terms of strengthening the immune response against cancer cells.  Many NOD ligands have been synthesized, in particular NOD2 agonists that exhibit favorable immunostimulatory and anticancer activity.  Among them, mifamurtide has already been approved in Europe by the European Medicine Agency for treating patients with osteosarcoma in combination with chemotherapy after complete surgical removal of the primary tumor.  This review is focused on NOD receptors as promising targets in cancer immunotherapy as well as summarizing current knowledge of the various NOD ligands exhibiting antitumor and even antimetastatic activity in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0sCUjlJS-ObVg90H21EOLACvtfcHk0lh7UT5EUOkKoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnK&md5=544097b21f38c2b1fb10d92e7f731a1d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmed.21557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21557%26sid%3Dliteratum%253Aachs%26aulast%3DNabergoj%26aufirst%3DS.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DHarnessing%2520the%2520Untapped%2520Potential%2520of%2520Nucleotide-Binding%2520Oligomerization%2520Domain%2520Ligands%2520for%2520Cancer%2520Immunotherapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1447%26epage%3D1484%26doi%3D10.1002%2Fmed.21557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbara, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croitoru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">NOD Proteins: Regulators of Inflammation in Health and Disease</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1038/nri3565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnri3565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=24336102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=9-23&author=D.+J.+Philpottauthor=M.+T.+Sorbaraauthor=S.+J.+Robertsonauthor=K.+Croitoruauthor=S.+E.+Girardin&title=NOD+Proteins%3A+Regulators+of+Inflammation+in+Health+and+Disease&doi=10.1038%2Fnri3565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">NOD proteins: regulators of inflammation in health and disease</span></div><div class="casAuthors">Philpott, Dana J.; Sorbara, Matthew T.; Robertson, Susan J.; Croitoru, Kenneth; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-23</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Entry of bacteria into host cells is an important virulence mechanism.  Through peptidoglycan recognition, the nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2 enable detection of intracellular bacteria and promote their clearance through initiation of a pro-inflammatory transcriptional program and other host defense pathways, including autophagy.  Recent findings have expanded the scope of the cellular compartments monitored by NOD1 and NOD2 and have elucidated the signalling pathways that are triggered downstream of NOD activation.  In vivo, NOD1 and NOD2 have complex roles, both during bacterial infection and at homeostasis.  The assocn. of alleles that encode constitutively active or constitutively inactive forms of NOD2 with different diseases highlights this complexity and indicates that a balanced level of NOD signalling is crucial for the maintenance of immune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHe0P1JHOtJ7Vg90H21EOLACvtfcHk0lj5iKzk_mwZ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO&md5=4de699679859f47003bceeea35012b34</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnri3565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3565%26sid%3Dliteratum%253Aachs%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSorbara%26aufirst%3DM.%2BT.%26aulast%3DRobertson%26aufirst%3DS.%2BJ.%26aulast%3DCroitoru%26aufirst%3DK.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DNOD%2520Proteins%253A%2520Regulators%2520of%2520Inflammation%2520in%2520Health%2520and%2520Disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D9%26epage%3D23%26doi%3D10.1038%2Fnri3565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al
Nabhani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreau, F.</span></span> <span> </span><span class="NLM_article-title">Nod2: The Intestinal Gate Keeper</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e1006177</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1006177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1371%2Fjournal.ppat.1006177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=28253332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1SlurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=e1006177&author=Z.+Al%0ANabhaniauthor=G.+Dietrichauthor=J.+P.+Hugotauthor=F.+Barreau&title=Nod2%3A+The+Intestinal+Gate+Keeper&doi=10.1371%2Fjournal.ppat.1006177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2: the intestinal gate keeper</span></div><div class="casAuthors">Al Nabhani, Ziad; Dietrich, Gilles; Hugot, Jean-Pierre; Barreau, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1006177/1-e1006177/19</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain 2 (NOD2) is an intracellular pattern recognition receptor that senses bacterial peptidoglycan (PGN)-conserved motifs in cytosol and stimulates host immune response.  The assocn. of NOD2 mutations with a no. of inflammatory pathologies, including Crohn disease (CD), Graft-vs.-host disease (GVHD), and Blau syndrome, highlights its pivotal role in host-pathogen interactions and inflammatory response.  Stimulation of NOD2 by its ligand (muramyl dipeptide) activates pro-inflammatory pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinases (MAPKs), and Caspase-1.  A loss of NOD2 function may result in a failure in the control of microbial infection, thereby initiating systemic responses and aberrant inflammation.  Because the ligand of Nod2 is conserved in both gram-pos. and gram-neg. bacteria, NOD2 detects a wide variety of microorganisms.  Furthermore, current literature evidences that NOD2 is also able to control viruses' and parasites' infections.  In this review, we present and discuss recent developments about the role of NOD2 in shaping the gut commensal microbiota and pathogens, including bacteria, viruses, and parasites, and the mechanisms by which Nod2 mutations participate in disease occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm0ESWuIVBirVg90H21EOLACvtfcHk0lj5iKzk_mwZ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1SlurrF&md5=33c9d8885b44457f8db918c755249de8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006177%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BNabhani%26aufirst%3DZ.%26aulast%3DDietrich%26aufirst%3DG.%26aulast%3DHugot%26aufirst%3DJ.%2BP.%26aulast%3DBarreau%26aufirst%3DF.%26atitle%3DNod2%253A%2520The%2520Intestinal%2520Gate%2520Keeper%26jtitle%3DPLoS%2520Pathog.%26date%3D2017%26volume%3D13%26spage%3De1006177%26doi%3D10.1371%2Fjournal.ppat.1006177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamaillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labigne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansonetti, P. J.</span></span> <span> </span><span class="NLM_article-title">Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">8869</span>– <span class="NLM_lpage">8872</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200651200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.C200651200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12527755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=8869-8872&author=S.+E.+Girardinauthor=I.+G.+Bonecaauthor=J.+Vialaauthor=M.+Chamaillardauthor=A.+Labigneauthor=G.+Thomasauthor=D.+J.+Philpottauthor=P.+J.+Sansonetti&title=Nod2+Is+a+General+Sensor+of+Peptidoglycan+through+Muramyl+Dipeptide+%28MDP%29+Detection&doi=10.1074%2Fjbc.C200651200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection</span></div><div class="casAuthors">Girardin, Stephen E.; Boneca, Ivo G.; Viala, Jerome; Chamaillard, Mathias; Labigne, Agnes; Thomas, Gilles; Philpott, Dana J.; Sansonetti, Philippe J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8869-8872</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod2 activates the NF-κB pathway following intracellular stimulation by bacterial products.  Recently, mutations in Nod2 have been shown to be assocd. with Crohn's disease, suggesting a role for bacteria-host interactions in the etiol. of this disorder.  The authors show here that Nod2 is a general sensor of peptidoglycan through the recognition of muramyl dipeptide (MDP), the minimal bioactive peptidoglycan motif common to all bacteria.  Moreover, the 3020insC frameshift mutation, the most frequent Nod2 variant assocd. with Crohn's disease patients, fully abrogates Nod2-dependent detection of peptidoglycan and MDP.  Together, these results impact on the understanding of Crohn's disease development.  Addnl., the characterization of Nod2 as the first pathogen-recognition mol. that detects MDP will help to unravel the well known biol. activities of this immunomodulatory compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOYkWjlEqR7Vg90H21EOLACvtfcHk0ljXORiwAbo4_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D&md5=220b5b27786d90179dca20566d643bf6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200651200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200651200%26sid%3Dliteratum%253Aachs%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DViala%26aufirst%3DJ.%26aulast%3DChamaillard%26aufirst%3DM.%26aulast%3DLabigne%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSansonetti%26aufirst%3DP.%2BJ.%26atitle%3DNod2%2520Is%2520a%2520General%2520Sensor%2520of%2520Peptidoglycan%2520through%2520Muramyl%2520Dipeptide%2520%2528MDP%2529%2520Detection%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D8869%26epage%3D8872%26doi%3D10.1074%2Fjbc.C200651200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontalba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Luna, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2: Implications for Crohn’s Disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">5509</span>– <span class="NLM_lpage">5512</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200673200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.C200673200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12514169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1aqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=5509-5512&author=N.+Inoharaauthor=Y.+Oguraauthor=A.+Fontalbaauthor=O.+Gutierrezauthor=F.+Ponsauthor=J.+Crespoauthor=K.+Fukaseauthor=S.+Inamuraauthor=S.+Kusumotoauthor=M.+Hashimotoauthor=S.+J.+Fosterauthor=A.+P.+Moranauthor=J.+L.+Fernandez-Lunaauthor=G.+Nu%C3%B1ez&title=Host+Recognition+of+Bacterial+Muramyl+Dipeptide+Mediated+through+NOD2%3A+Implications+for+Crohn%E2%80%99s+Disease&doi=10.1074%2Fjbc.C200673200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2</span></div><div class="casAuthors">Inohara, Naohiro; Ogura, Yasunori; Fontalba, Ana; Gutierrez, Olga; Pons, Fernando; Crespo, Javier; Fukase, Koichi; Inamura, Seiichi; Kusumoto, Shoichi; Hashimoto, Masahito; Foster, Simon J.; Moran, Anthony P.; Fernandez-Luna, Jose L.; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5509-5512</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NOD2, a protein assocd. with susceptibility to Crohn's disease, confers responsiveness to bacterial prepns. of lipopolysaccharide and peptidoglycan, but the precise moiety recognized remains elusive.  Biochem. and functional analyses identified muramyl dipeptide (MurNAc-L-Ala-D-isoGln) derived from peptidoglycan as the essential structure in bacteria recognized by NOD2.  Replacement of L-Ala for D-Ala or D-isoGln for L-isoGln eliminated the ability of muramyl dipeptide to stimulate NOD2, indicating stereoselective recognition.  Muramyl dipeptide was recognized by NOD2 but not by TLR2 or co-expression of TLR2 with TLR1 or TLR6.  NOD2 mutants assocd. with susceptibility to Crohn's disease were deficient in their recognition of muramyl dipeptide.  Notably, peripheral blood mononuclear cells from individuals homozygous for the major disease-assocd. L1007fsinsC NOD2 mutation responded to lipopolysaccharide but not to synthetic muramyl dipeptide.  Thus, NOD2 mediates the host response to bacterial muropeptides derived from peptidoglycan, an activity that is important for protection against Crohn's disease.  Because muramyl dipeptide is the essential structure of peptidoglycan required for adjuvant activity, these results also have implications for understanding adjuvant function and effective vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL3tQ2w4Cw4bVg90H21EOLACvtfcHk0ljXORiwAbo4_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1aqsro%253D&md5=85e6c71168111b190abc37013fcfbaee</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200673200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200673200%26sid%3Dliteratum%253Aachs%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DFontalba%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DO.%26aulast%3DPons%26aufirst%3DF.%26aulast%3DCrespo%26aufirst%3DJ.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInamura%26aufirst%3DS.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DS.%2BJ.%26aulast%3DMoran%26aufirst%3DA.%2BP.%26aulast%3DFernandez-Luna%26aufirst%3DJ.%2BL.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DHost%2520Recognition%2520of%2520Bacterial%2520Muramyl%2520Dipeptide%2520Mediated%2520through%2520NOD2%253A%2520Implications%2520for%2520Crohn%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D5509%26epage%3D5512%26doi%3D10.1074%2Fjbc.C200673200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyananda, L. D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, E. K.</span></span> <span> </span><span class="NLM_article-title">The Innate Immune Protein Nod2 Binds Directly to MDP, a Bacterial Cell Wall Fragment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">13535</span>– <span class="NLM_lpage">13537</span>, <span class="refDoi"> DOI: 10.1021/ja303883c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303883c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=13535-13537&author=C.+L.+Grimesauthor=L.+D.+Z.+Ariyanandaauthor=J.+E.+Melnykauthor=E.+K.+O%E2%80%99Shea&title=The+Innate+Immune+Protein+Nod2+Binds+Directly+to+MDP%2C+a+Bacterial+Cell+Wall+Fragment&doi=10.1021%2Fja303883c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment</span></div><div class="casAuthors">Grimes, Catherine Leimkuhler; Ariyananda, Lushanti De Zoysa; Melnyk, James E.; O'Shea, Erin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13535-13537</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mammalian Nod2 is an intracellular protein that is implicated in the innate immune response to the bacterial cell wall and is assocd. with the development of Crohn's disease, Blau syndrome, and gastrointestinal cancers.  Nod2 is required for an immune response to muramyl dipeptide (MDP), an immunostimulatory fragment of bacterial cell wall, but it is not known whether MDP binds directly to Nod2.  We report the expression and purifn. of human Nod2 from insect cells.  Using novel MDP self-assembled monolayers (SAMs), we provide the first biochem. evidence for a direct, high-affinity interaction between Nod2 and MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_35GPZTPtLVg90H21EOLACvtfcHk0ljSlpDR9MJZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F&md5=9bb26db0105a836a5130c961622f4e34</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja303883c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303883c%26sid%3Dliteratum%253Aachs%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26aulast%3DAriyananda%26aufirst%3DL.%2BD.%2BZ.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DE.%2BK.%26atitle%3DThe%2520Innate%2520Immune%2520Protein%2520Nod2%2520Binds%2520Directly%2520to%2520MDP%252C%2520a%2520Bacterial%2520Cell%2520Wall%2520Fragment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D13535%26epage%3D13537%26doi%3D10.1021%2Fja303883c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monie, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, J. A.</span></span> <span> </span><span class="NLM_article-title">Pathogen Sensing by Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Is Mediated by Direct Binding to Muramyl Dipeptide and ATP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23057</span>– <span class="NLM_lpage">23067</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.344283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M112.344283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22549783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23057-23067&author=J.+Moauthor=J.+P.+Boyleauthor=C.+B.+Howardauthor=T.+P.+Monieauthor=B.+K.+Davisauthor=J.+A.+Duncan&title=Pathogen+Sensing+by+Nucleotide-Binding+Oligomerization+Domain-Containing+Protein+2+%28NOD2%29+Is+Mediated+by+Direct+Binding+to+Muramyl+Dipeptide+and+ATP&doi=10.1074%2Fjbc.M112.344283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP</span></div><div class="casAuthors">Mo, Jinyao; Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.; Davis, Beckley K.; Duncan, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">23057-23067</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide binding and oligomerization domain-contg. protein 2 (NOD2/Card15) is an intracellular protein that is involved in the recognition of bacterial cell wall-derived muramyl dipeptide.  Mutations in the gene encoding NOD2 are assocd. with inherited inflammatory disorders, including Crohn disease and Blau syndrome.  NOD2 is a member of the nucleotide-binding domain and leucine-rich repeat-contg. protein gene (NLR) family.  Nucleotide binding is thought to play a crit. role in signaling by NLR family members.  However, the mol. mechanisms underlying signal transduction by these proteins remain largely unknown.  Mutations in the nucleotide-binding domain of NOD2 have been shown to alter its signal transduction properties in response to muramyl dipeptide in cellular assays.  Using purified recombinant protein, we now demonstrate that NOD2 binds and hydrolyzes ATP.  Addnl., we have found that the purified recombinant protein is able to bind directly to muramyl dipeptide and can assoc. with known NOD2-interacting proteins in vitro.  Binding of NOD2 to muramyl dipeptide and homo-oligomerization of NOD2 are enhanced by ATP binding, suggesting a model of the mol. mechanism for signal transduction that involves binding of nucleotide followed by binding of muramyl dipeptide and oligomerization of NOD2 into a signaling complex.  These findings set the stage for further studies into the mol. mechanisms that underlie detection of muramyl dipeptide and assembly of NOD2-contg. signaling complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHB17K-Mn8MrVg90H21EOLACvtfcHk0ljSlpDR9MJZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D&md5=79080d42bc5db467360658170bde4caf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.344283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.344283%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DHoward%26aufirst%3DC.%2BB.%26aulast%3DMonie%26aufirst%3DT.%2BP.%26aulast%3DDavis%26aufirst%3DB.%2BK.%26aulast%3DDuncan%26aufirst%3DJ.%2BA.%26atitle%3DPathogen%2520Sensing%2520by%2520Nucleotide-Binding%2520Oligomerization%2520Domain-Containing%2520Protein%25202%2520%2528NOD2%2529%2520Is%2520Mediated%2520by%2520Direct%2520Binding%2520to%2520Muramyl%2520Dipeptide%2520and%2520ATP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23057%26epage%3D23067%26doi%3D10.1074%2Fjbc.M112.344283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monie, T. P.</span></span> <span> </span><span class="NLM_article-title">Insights into the Molecular Basis of the Nod2 Signalling Pathway</span>. <i>Open Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">140178</span>, <span class="refDoi"> DOI: 10.1098/rsob.140178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1098%2Frsob.140178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25520185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=140178&author=J.+P.+Boyleauthor=R.+Parkhouseauthor=T.+P.+Monie&title=Insights+into+the+Molecular+Basis+of+the+Nod2+Signalling+Pathway&doi=10.1098%2Frsob.140178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the molecular basis of the NOD2 signalling pathway</span></div><div class="casAuthors">Boyle, Joseph P.; Parkhouse, Rhiannon; Monie, Tom P.</div><div class="citationInfo"><span class="NLM_cas:title">Open Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">140178/1-140178/12</span>CODEN:
                <span class="NLM_cas:coden">OBPICQ</span>;
        ISSN:<span class="NLM_cas:issn">2046-2441</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The cytosolic pattern recognition receptor NOD2 is activated by the peptidoglycan fragment muramyl dipeptide to generate a proinflammatory immune response.  Downstream effects include the secretion of cytokines such as interleukin 8, the upregulation of pro-interleukin 1b, the induction of autophagy, the prodn. of antimicrobial peptides and defensins, and contributions to the maintenance of the compn. of the intestinal microbiota.  Polymorphisms in NOD2 are the cause of the inflammatory disorder Blau syndrome and act as susceptibility factors for the inflammatory bowel condition Crohn's disease.  The complexity of NOD2 signalling is highlighted by the observation that over 30 cellular proteins interact with NOD2 directly and influence or regulate its functional activity.  Previously, the majority of reviews on NOD2 function have focused upon the role of NOD2 in inflammatory disease or in its interaction with and response to microbes.  However, the functionality of NOD2 is underpinned by its biochem. interactions.  Consequently, in this review, we have taken the opportunity to address the more 'basic' elements of NOD2 signalling.  In particular, we have focused upon the core interactions of NOD2 with protein factors that influence and modulate the signal transduction pathways involved in NOD2 signalling.  Further, where information exists, such as in relation to the role of RIP2,we have drawn comparison with the closely related, but functionally discrete, pattern recognition receptor NOD1.  Overall, we provide a comprehensive resource targeted at understanding the complexities of NOD2 signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLYhRouK6rObVg90H21EOLACvtfcHk0ljSlpDR9MJZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7g%253D&md5=b236838c3cf7c96bc67f12036285eea9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1098%2Frsob.140178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsob.140178%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DParkhouse%26aufirst%3DR.%26aulast%3DMonie%26aufirst%3DT.%2BP.%26atitle%3DInsights%2520into%2520the%2520Molecular%2520Basis%2520of%2520the%2520Nod2%2520Signalling%2520Pathway%26jtitle%3DOpen%2520Biol.%26date%3D2014%26volume%3D4%26spage%3D140178%26doi%3D10.1098%2Frsob.140178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvanantham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommerman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">7925</span>– <span class="NLM_lpage">7935</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.181.11.7925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.181.11.7925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19017983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=7925-7935&author=J.+G.+Magalhaesauthor=J.+H.+Fritzauthor=L.+Le+Bourhisauthor=G.+Sellgeauthor=L.+H.+Travassosauthor=T.+Selvananthamauthor=S.+E.+Girardinauthor=J.+L.+Gommermanauthor=D.+J.+Philpott&title=Nod2-Dependent+Th2+Polarization+of+Antigen-Specific+Immunity&doi=10.4049%2Fjimmunol.181.11.7925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity</span></div><div class="casAuthors">Magalhaes, Joao Gamelas; Fritz, Joerg H.; Le Bourhis, Lionel; Sellge, Gernot; Travassos, Leonardo H.; Selvanantham, Thirumahal; Girardin, Stephen E.; Gommerman, Jennifer L.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7925-7935</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">While a no. of microbial-assocd. mol. patterns have been known for decades to act as adjuvants, the mechanisms and the signaling pathways underlying their action have remained elusive.  Here, the authors examd. the unfolding of the adaptive immune response induced by Nod2 in vivo upon activation by its specific ligand, muramyl dipeptide, a component of peptidoglycan.  The authors' findings demonstrate that this bacterial sensor triggers a potent Ag-specific immune response with a Th2-type polarization profile, characterized by the induction of IL-4 and IL-5 by T cells and IgG1 Ab responses.  Nod2 was also crit. for the induction of both Th1- and Th2-type responses following costimulation with TLR agonists.  Importantly, the synergistic responses to Nod2 and TLR agonists seen in vivo were recapitulated by dendritic cells in vitro, suggesting that these cells likely play a central role in the integration of Nod2- and TLR-dependent signals for driving the adaptive immune response.  Taken together, the authors' results identify Nod2 as a crit. mediator of microbial-induced potentiation and polarization of Ag-dependent immunity.  Moreover, these findings affect the authors' understanding of Crohn's diseases pathogenesis, where lack of Nod2-dependent Th2 signaling in a subset of these patients might explain heightened Th1-mediated inflammation at the level of the intestinal mucosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJlqhZbkvAl7Vg90H21EOLACvtfcHk0lhXBFqTZjuDGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM&md5=d57612e894994da00c2cd14d5d578f54</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.11.7925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.11.7925%26sid%3Dliteratum%253Aachs%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DSellge%26aufirst%3DG.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DSelvanantham%26aufirst%3DT.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DGommerman%26aufirst%3DJ.%2BL.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNod2-Dependent%2520Th2%2520Polarization%2520of%2520Antigen-Specific%2520Immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26spage%3D7925%26epage%3D7935%26doi%3D10.4049%2Fjimmunol.181.11.7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">NOD-Like Receptors: Role in Innate Immunity and Inflammatory Disease</span>. <i>Annu. Rev. Pathol.: Mech. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1146/annurev.pathol.4.110807.092239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev.pathol.4.110807.092239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18928408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1ahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=365-398&author=G.+Chenauthor=M.+H.+Shawauthor=Y.-G.+Kimauthor=G.+Nu%C3%B1ez&title=NOD-Like+Receptors%3A+Role+in+Innate+Immunity+and+Inflammatory+Disease&doi=10.1146%2Fannurev.pathol.4.110807.092239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NOD-like receptors: role in innate immunity and inflammatory disease</span></div><div class="casAuthors">Chen, Grace; Shaw, Michael H.; Kim, Yun-Gi; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">365-398</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The NOD-like receptors (NLRs) are a specialized group of intracellular receptors that represent a key component of the host innate immune system.  Since the discovery of the first NLR almost 10 years ago, the study of this special class of microbial sensors has burgeoned; consequently, a better understanding of the mechanism by which these receptors recognize microbes and other danger signals and of how they activate inflammatory signaling pathways has emerged.  Moreover, in addn. to their primary role in host defense against invading pathogens, their ability to regulate nuclear factor-kappa B (NF-κB) signaling, interleukin-1-beta (IL-1β) prodn., and cell death indicates that they are crucial to the pathogenesis of a variety of inflammatory human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1aZBb_POhVrVg90H21EOLACvtfcHk0lhXBFqTZjuDGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1ahsr4%253D&md5=339eb7ae462311c4c679437e0321b0ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pathol.4.110807.092239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pathol.4.110807.092239%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DShaw%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DY.-G.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DNOD-Like%2520Receptors%253A%2520Role%2520in%2520Innate%2520Immunity%2520and%2520Inflammatory%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2009%26volume%3D4%26spage%3D365%26epage%3D398%26doi%3D10.1146%2Fannurev.pathol.4.110807.092239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negroni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierdomenico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchiara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stronati, L.</span></span> <span> </span><span class="NLM_article-title">NOD2 and Inflammation: Current Insights</span>. <i>J. Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.2147/JIR.S137606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2147%2FJIR.S137606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29483781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVymurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=49-60&author=A.+Negroniauthor=M.+Pierdomenicoauthor=S.+Cucchiaraauthor=L.+Stronati&title=NOD2+and+Inflammation%3A+Current+Insights&doi=10.2147%2FJIR.S137606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 and inflammation: current insights</span></div><div class="casAuthors">Negroni, Anna; Pierdomenico, Maria; Cucchiara, Salvatore; Stronati, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inflammation Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">JIROAC</span>;
        ISSN:<span class="NLM_cas:issn">1178-7031</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">The nucleotide-binding oligomerization domain (NOD) protein, NOD2, belonging to the intracellular NOD-like receptor family, detects conserved motifs in bacterial peptidoglycan and promotes their clearance through activation of a proinflammatory transcriptional program and other innate immune pathways, including autophagy and endoplasmic reticulum stress.  An inactive form due to mutations or a constitutive high expression of NOD2 is assocd. with several inflammatory diseases, suggesting that balanced NOD2 signaling is crit. for the maintenance of immune homeostasis.  In this review, we discuss recent developments about the pathway and mechanisms of regulation of NOD2 and illustrate the principal functions of the gene, with particular emphasis on its central role in maintaining the equil. between intestinal microbiota and host immune responses to control inflammation.  Furthermore, we survey recent studies illustrating the role of NOD2 in several inflammatory diseases, in particular, inflammatory bowel disease, of which it is the main susceptibility gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoGElZ7bfMbrVg90H21EOLACvtfcHk0lhXBFqTZjuDGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVymurrE&md5=a4cf9346296eefe7b420964c2a5c0cbd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2147%2FJIR.S137606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJIR.S137606%26sid%3Dliteratum%253Aachs%26aulast%3DNegroni%26aufirst%3DA.%26aulast%3DPierdomenico%26aufirst%3DM.%26aulast%3DCucchiara%26aufirst%3DS.%26aulast%3DStronati%26aufirst%3DL.%26atitle%3DNOD2%2520and%2520Inflammation%253A%2520Current%2520Insights%26jtitle%3DJ.%2520Inflammation%2520Res.%26date%3D2018%26volume%3D11%26spage%3D49%26epage%3D60%26doi%3D10.2147%2FJIR.S137606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichulik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, A.</span></span> <span> </span><span class="NLM_article-title">NOD2 Stimulation Induces Autophagy in Dendritic Cells Influencing Bacterial Handling and Antigen Presentation</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1038/nm.2069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnm.2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19966812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=90-97&author=R.+Cooneyauthor=J.+Bakerauthor=O.+Brainauthor=B.+Danisauthor=T.+Pichulikauthor=P.+Allanauthor=D.+J.+P.+Fergusonauthor=B.+J.+Campbellauthor=D.+Jewellauthor=A.+Simmons&title=NOD2+Stimulation+Induces+Autophagy+in+Dendritic+Cells+Influencing+Bacterial+Handling+and+Antigen+Presentation&doi=10.1038%2Fnm.2069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation</span></div><div class="casAuthors">Cooney, Rachel; Baker, John; Brain, Oliver; Danis, Benedicte; Pichulik, Tica; Allan, Philip; Ferguson, David J. P.; Campbell, Barry J.; Jewell, Derek; Simmons, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-97</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg.-2 (NOD2) acts as a bacterial sensor in dendritic cells (DCs), but it is not clear how bacterial recognition links with antigen presentation after NOD2 stimulation.  NOD2 variants are assocd. with Crohn's disease, where breakdown in self-recognition of commensal bacteria leads to gastrointestinal inflammation.  Here the authors show NOD2 triggering by muramyldipeptide induces autophagy in DCs.  This effect requires receptor-interacting serine-threonine kinase-2 (RIPK-2), autophagy-related protein-5 (ATG5), ATG7 and ATG16L1 but not NLR family, pyrin domain contg.-3 (NALP3).  The authors show that NOD2-mediated autophagy is required for both bacterial handling and generation of major histocompatibility complex (MHC) class II antigen-specific CD4+ T cell responses in DCs.  DCs from individuals with Crohn's disease expressing Crohn's disease-assocd. NOD2 or ATG16L1 risk variants are defective in autophagy induction, bacterial trafficking and antigen presentation.  The authors' findings link two Crohn's disease-assocd. susceptibility genes in a single functional pathway and reveal defects in this pathway in Crohn's disease DCs that could lead to bacterial persistence via impaired lysosomal destruction and immune mediated clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1-DHs4aTb0bVg90H21EOLACvtfcHk0lg0ADWtIxw3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3L&md5=9ecc98f28c3465da94237fa729ebc345</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnm.2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2069%26sid%3Dliteratum%253Aachs%26aulast%3DCooney%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DJ.%26aulast%3DBrain%26aufirst%3DO.%26aulast%3DDanis%26aufirst%3DB.%26aulast%3DPichulik%26aufirst%3DT.%26aulast%3DAllan%26aufirst%3DP.%26aulast%3DFerguson%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DCampbell%26aufirst%3DB.%2BJ.%26aulast%3DJewell%26aufirst%3DD.%26aulast%3DSimmons%26aufirst%3DA.%26atitle%3DNOD2%2520Stimulation%2520Induces%2520Autophagy%2520in%2520Dendritic%2520Cells%2520Influencing%2520Bacterial%2520Handling%2520and%2520Antigen%2520Presentation%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D90%26epage%3D97%26doi%3D10.1038%2Fnm.2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, L. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramjeet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chea, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allaoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nod1 and Nod2 Direct Autophagy by Recruiting ATG16L1 to the Plasma Membrane at the Site of Bacterial Entry</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/ni.1823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fni.1823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19898471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOrur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=55-62&author=L.+H.+Travassosauthor=L.+A.+M.+Carneiroauthor=M.+Ramjeetauthor=S.+Husseyauthor=Y.+G.+Kimauthor=J.+G.+Magalhaesauthor=L.+Yuanauthor=F.+Soaresauthor=E.+Cheaauthor=L.+Le+Bourhisauthor=I.+G.+Bonecaauthor=A.+Allaouiauthor=N.+L.+Jonesauthor=G.+Nunezauthor=S.+E.+Girardinauthor=D.+J.+Philpott&title=Nod1+and+Nod2+Direct+Autophagy+by+Recruiting+ATG16L1+to+the+Plasma+Membrane+at+the+Site+of+Bacterial+Entry&doi=10.1038%2Fni.1823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry</span></div><div class="casAuthors">Travassos, Leonardo H.; Carneiro, Leticia A. M.; Ramjeet, Mahendrasingh; Hussey, Seamus; Kim, Yun-Gi; Magalhaes, Joao G.; Yuan, Linda; Soares, Fraser; Chea, Evelyn; Le Bourhis, Lionel; Boneca, Ivo G.; Allaoui, Abdelmounaaim; Jones, Nicola L.; Nunez, Gabriel; Girardin, Stephen E.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-62</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is emerging as a crucial defense mechanism against bacteria, but the host intracellular sensors responsible for inducing autophagy in response to bacterial infection remain unknown.  Here the authors demonstrated that the intracellular sensors Nod1 and Nod2 are crit. for the autophagic response to invasive bacteria.  By a mechanism independent of the adaptor RIP2 and transcription factor NF-κB, Nod1 and Nod2 recruited the autophagy protein ATG16L1 to the plasma membrane at the bacterial entry site.  In cells homozygous for the Crohn's disease-assocd. NOD2 frameshift mutation, mutant Nod2 failed to recruit ATG16L1 to the plasma membrane and wrapping of invading bacteria by autophagosomes was impaired.  The authors' results link bacterial sensing by Nod proteins to the induction of autophagy and provide a functional link between Nod2 and ATG16L1, which are encoded by two of the most important genes assocd. with Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpod7yaAQxL4rVg90H21EOLACvtfcHk0lg0ADWtIxw3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOrur3L&md5=55a50958d13cf60bae196c547fa2cd13</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fni.1823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1823%26sid%3Dliteratum%253Aachs%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DCarneiro%26aufirst%3DL.%2BA.%2BM.%26aulast%3DRamjeet%26aufirst%3DM.%26aulast%3DHussey%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DSoares%26aufirst%3DF.%26aulast%3DChea%26aufirst%3DE.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DAllaoui%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DN.%2BL.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNod1%2520and%2520Nod2%2520Direct%2520Autophagy%2520by%2520Recruiting%2520ATG16L1%2520to%2520the%2520Plasma%2520Membrane%2520at%2520the%2520Site%2520of%2520Bacterial%2520Entry%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D55%26epage%3D62%26doi%3D10.1038%2Fni.1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhães, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the Therapeutic Potential of NOD-like Receptors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1038/nrd2783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnrd2783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19483708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=465-479&author=K.+Geddesauthor=J.+G.+Magalh%C3%A3esauthor=S.+E.+Girardin&title=Unleashing+the+Therapeutic+Potential+of+NOD-like+Receptors&doi=10.1038%2Fnrd2783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the therapeutic potential of NOD-like receptors</span></div><div class="casAuthors">Geddes, Kaoru; Magalhaes, Joao G.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">465-479</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation.  Whereas some NLRs, including NOD1, NOD2, NAIP (NLR family, apoptosis inhibitory protein) and NLRC4, detect conserved bacterial mol. signatures within the host cytosol, other members of this family sense 'danger signals', i.e., xenocompounds or mols. that when recognized alert the immune system of hazardous environments, perhaps independently of a microbial trigger.  In the past few years, remarkable progress has been made towards deciphering the role and the biol. of NLRs, which has shown that these innate immune sensors have pivotal roles in providing immunity to infection, adjuvanticity and inflammation.  Furthermore, several inflammatory disorders have been assocd. with mutations in human NLR genes.  Here, the authors discuss the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCvglqYhhnV7Vg90H21EOLACvtfcHk0lg0ADWtIxw3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D&md5=06a9045f6206702396cd920edf38649b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd2783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2783%26sid%3Dliteratum%253Aachs%26aulast%3DGeddes%26aufirst%3DK.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DJ.%2BG.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DUnleashing%2520the%2520Therapeutic%2520Potential%2520of%2520NOD-like%2520Receptors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D465%26epage%3D479%26doi%3D10.1038%2Fnrd2783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maisonneuve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertholet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gregorio, E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the Potential of NOD- and Toll-like Agonists as Vaccine Adjuvants</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12294</span>– <span class="NLM_lpage">12299</span>, <span class="refDoi"> DOI: 10.1073/pnas.1400478111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.1400478111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25136133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12294-12299&author=C.+Maisonneuveauthor=S.+Bertholetauthor=D.+J.+Philpottauthor=E.+De+Gregorio&title=Unleashing+the+Potential+of+NOD-+and+Toll-like+Agonists+as+Vaccine+Adjuvants&doi=10.1073%2Fpnas.1400478111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants</span></div><div class="casAuthors">Maisonneuve, Charles; Bertholet, Sylvie; Philpott, Dana J.; De Gregorio, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12294-12299</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Innate immunity confers an immediate nonspecific mechanism of microbial recognition through germ line-encoded pattern recognition receptors (PRRs).  Of these, Toll-like receptors (TLRs) and nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) have shaped the authors' current understanding of innate regulation of adaptive immunity.  It is now recognized that PRRs are paramount in instructing an appropriate adaptive immune response.  Their ligands have been the focus of adjuvant research with the goal of generating modern vaccine combinations tailored to specific pathogens.  In this review the authors will highlight the recent findings in the field of adjuvant research with a particular focus on the potential of TLR and NLR ligands as adjuvants and their influence on adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Pm03irVncrVg90H21EOLACvtfcHk0lgyLYRMjNnJGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM&md5=de6088e853b57a9f4d2d622e0a27a2c8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1400478111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1400478111%26sid%3Dliteratum%253Aachs%26aulast%3DMaisonneuve%26aufirst%3DC.%26aulast%3DBertholet%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DDe%2BGregorio%26aufirst%3DE.%26atitle%3DUnleashing%2520the%2520Potential%2520of%2520NOD-%2520and%2520Toll-like%2520Agonists%2520as%2520Vaccine%2520Adjuvants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12294%26epage%3D12299%26doi%3D10.1073%2Fpnas.1400478111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst-Kralovetz, M. M.</span></span> <span> </span><span class="NLM_article-title">Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-like Particle Vaccine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e41529</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0041529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1371%2Fjournal.pone.0041529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22855691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFanu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=E.+M.+Jacksonauthor=M.+M.+Herbst-Kralovetz&title=Intranasal+Vaccination+with+Murabutide+Enhances+Humoral+and+Mucosal+Immune+Responses+to+a+Virus-like+Particle+Vaccine&doi=10.1371%2Fjournal.pone.0041529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine</span></div><div class="casAuthors">Jackson, Erin M.; Herbst-Kralovetz, Melissa M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e41529</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2) receptor on mammalian cells.  MB has previously been approved for testing in multiple human clin. trials to det. its value as an antiviral therapeutic, and as an adjuvant for injected vaccines.  We have found a new use for this immunomodulator; it functions as a mucosal adjuvant that enhances immunogenicity of virus-like particles (VLP) administered intranasally.  MB enhanced Norwalk virus (NV) VLP-specific IgG systemically and IgA prodn. at distal mucosal sites following intranasal (IN) vaccination.  A dose escalation study identified 100 μg as the optimal MB dosage in mice, based on the magnitude of VLP-specific IgG, IgG1, IgG2a and IgA prodn. in serum and VLP-specific IgA prodn. at distal mucosal sites.  IN vaccination using VLP with MB was compared to IN delivery VLP with cholera toxin (CT) or gardiquimod (GARD) and to parenteral VLP delivery with alum; the MB groups were equiv. to CT and GARD and superior to alum in inducing mucosal immune responses and stimulated equiv. systemic VLP-specific antibodies.  These data support the further testing of MB as a potent mucosal adjuvant for inducing robust and durable antibody responses to non-replicating subunit vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJryNC_4ZINLVg90H21EOLACvtfcHk0lgyLYRMjNnJGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFanu7fM&md5=68b4b677cc8faac2720d5ed72d390761</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0041529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0041529%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BM.%26aulast%3DHerbst-Kralovetz%26aufirst%3DM.%2BM.%26atitle%3DIntranasal%2520Vaccination%2520with%2520Murabutide%2520Enhances%2520Humoral%2520and%2520Mucosal%2520Immune%2520Responses%2520to%2520a%2520Virus-like%2520Particle%2520Vaccine%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0041529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumgardner, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoy, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajikawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaenhammer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, G. A.</span></span> <span> </span><span class="NLM_article-title">Nod2 Is Required for Antigen-Specific Humoral Responses against Antigens Orally Delivered Using a Recombinant Lactobacillus Vaccine Platform</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e0196950</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0196950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1371%2Fjournal.pone.0196950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29734365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSgsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0196950&author=S.+A.+Bumgardnerauthor=L.+Zhangauthor=A.+S.+LaVoyauthor=B.+Andreauthor=C.+B.+Frankauthor=A.+Kajikawaauthor=T.+R.+Klaenhammerauthor=G.+A.+Dean&title=Nod2+Is+Required+for+Antigen-Specific+Humoral+Responses+against+Antigens+Orally+Delivered+Using+a+Recombinant+Lactobacillus+Vaccine+Platform&doi=10.1371%2Fjournal.pone.0196950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform</span></div><div class="casAuthors">Bumgardner, Sara A.; Zhang, Lin; Lavoy, Alora S.; Andre, Barbara; Frank, Chad B.; Kajikawa, Akinobu; Klaenhammer, Todd R.; Dean, Gregg A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0196950/1-e0196950/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Safe and efficacious orally-delivered mucosal vaccine platforms are desperately needed to combat the plethora of mucosally transmitted pathogens.  Lactobacillus spp. have emerged as attractive candidates to meet this need and are known to activate the host innate immune response in a species- and strain-specific manner.  For selected bacterial isolates and mutants, we investigated the role of key innate immune pathways required for induction of innate and subsequent adaptive immune responses.  Co-culture of murine macrophages with L. gasseri (strain NCK1785), L. acidophilus (strain NCFM), or NCFM-derived mutants-NCK2025 and NCK2031-elicited an M2b-like phenotype assocd. with TH2 skewing and immune regulatory function.  For NCFM, this M2b phenotype was dependent on expression of lipoteichoic acid and S layer proteins.  Through the use of macrophage genetic knockouts, we identified Toll-like receptor 2 (TLR2), the cytosolic nucleotide-binding oligomerization domain contg. 2 (NOD2) receptor, and the inflammasome-assocd. caspase-1 as contributors to macrophage activation, with NOD2 cooperating with caspase-1 to induce inflammasome derived interleukin (IL)-1β in a pyroptosis-independent fashion.  Finally, utilizing an NCFM-based mucosal vaccine platform with surface expression of human immunodeficiency virus type 1 Gag or membrane proximal external region (MPER), we demonstrated that NOD2 signaling is required for antigen-specific mucosal and systemic humoral responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopw3fGdvbxjbVg90H21EOLACvtfcHk0lgyLYRMjNnJGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSgsLvO&md5=949778cf216d503f24b51482f3bd7fae</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0196950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0196950%26sid%3Dliteratum%253Aachs%26aulast%3DBumgardner%26aufirst%3DS.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLaVoy%26aufirst%3DA.%2BS.%26aulast%3DAndre%26aufirst%3DB.%26aulast%3DFrank%26aufirst%3DC.%2BB.%26aulast%3DKajikawa%26aufirst%3DA.%26aulast%3DKlaenhammer%26aufirst%3DT.%2BR.%26aulast%3DDean%26aufirst%3DG.%2BA.%26atitle%3DNod2%2520Is%2520Required%2520for%2520Antigen-Specific%2520Humoral%2520Responses%2520against%2520Antigens%2520Orally%2520Delivered%2520Using%2520a%2520Recombinant%2520Lactobacillus%2520Vaccine%2520Platform%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26spage%3De0196950%26doi%3D10.1371%2Fjournal.pone.0196950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciorbaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Minimal Structural Requirements for Adjuvant Activity of Bacterial Peptidoglycan Derivatives</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(74)90458-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0006-291X%2874%2990458-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=4606813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE2MXivFKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1974&pages=1317-1325&author=F.+Ellouzauthor=A.+Adamauthor=R.+Ciorbaruauthor=E.+Lederer&title=Minimal+Structural+Requirements+for+Adjuvant+Activity+of+Bacterial+Peptidoglycan+Derivatives&doi=10.1016%2F0006-291X%2874%2990458-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives</span></div><div class="casAuthors">Ellouz, Farielle; Adam, Arlette; Ciorbaru, Rita; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1317-25</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The monomeric subunit of mesodiaminopimelic acid contg. bacterial peptidoglycans, i.e. the disaccharide tetrapeptide N-acetyl glucosaminyl-N-acetyl muramyl-L-alanyl-D-isoglutaminyl-meso-diamino-pimelyl-D-alanine could replace whole killed mycobacteria in Freund's adjuvant.  Further structural simplifications of the disaccharide-tetrapeptide were possible without loss of adjuvant activity.  Natural N-acetyl-muramyl-tripeptides were active.  The smallest adjuvant mol. was a synthetic N-acetyl muramyl-dipeptide prepd. by Sinay, et al.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox10QSAEGsQrVg90H21EOLACvtfcHk0lgyLYRMjNnJGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXivFKjtw%253D%253D&md5=d9b9a0ec8b4783c564aabdc2be222a15</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2874%2990458-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252874%252990458-6%26sid%3Dliteratum%253Aachs%26aulast%3DEllouz%26aufirst%3DF.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DCiorbaru%26aufirst%3DR.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMinimal%2520Structural%2520Requirements%2520for%2520Adjuvant%2520Activity%2520of%2520Bacterial%2520Peptidoglycan%2520Derivatives%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1974%26volume%3D59%26spage%3D1317%26epage%3D1325%26doi%3D10.1016%2F0006-291X%2874%2990458-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, S. M.</span></span> <span> </span><span class="NLM_article-title">The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1093/infdis/138.6.760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1093%2Finfdis%2F138.6.760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=368262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE1MXhtlKisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1978&pages=760-767&author=C.+A.+Dinarelloauthor=R.+J.+Elinauthor=L.+Chedidauthor=S.+M.+Wolff&title=The+Pyrogenicity+of+the+Synthetic+Adjuvant+Muramyl+Dipeptide+and+Two+Structural+Analogues&doi=10.1093%2Finfdis%2F138.6.760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogs</span></div><div class="casAuthors">Dinarello, Charles A.; Elin, Ronald J.; Chedid, Louis; Wolff, Sheldon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">760-7</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">Muramyl dipeptide (N-acetylmuramyl-L-alanine-D-isoglutamine, MDP) induced biphasic fevers in rabbits, but 2 structural analogs, N-acetylmuramyl-L-alanine-D-glutamic acid (MDPA) and the dimethylester of MDPA, were 10-fold less pyrogenic.  MDP and its analogs released leukocytic pyrogen (LP) from rabbit phagocytic cells in vitro.  In addn., MDP released LP from human phagocytes.  Human phagocytes, however, required a 10-fold greater concn. of MDP than did rabbit cells.  The structural analogs were similarly less effective than the parent mol. in releasing LP from human cells.  All prepns. of MDP were neg. in the limulus amebocyte lysate test and failed to show pyrogenic cross-tolerance with bacterial endotoxin.  Thus MDP, which is a pyrogenic mol., is also able to release LP from rabbit phagocytes and to a lesser degree from human phagocytes, but does not cause gelation of limulus amebocyte lysate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojcA2TceMfpbVg90H21EOLACvtfcHk0lgKntLNRQSCxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhtlKisrs%253D&md5=66cd96e1e634325797795757184c4c67</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F138.6.760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F138.6.760%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DElin%26aufirst%3DR.%2BJ.%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DWolff%26aufirst%3DS.%2BM.%26atitle%3DThe%2520Pyrogenicity%2520of%2520the%2520Synthetic%2520Adjuvant%2520Muramyl%2520Dipeptide%2520and%2520Two%2520Structural%2520Analogues%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1978%26volume%3D138%26spage%3D760%26epage%3D767%26doi%3D10.1093%2Finfdis%2F138.6.760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riveau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span> <span> </span><span class="NLM_article-title">Central Pyrogenic Activity of Muramyl Dipeptide</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1084/jem.152.4.869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1084%2Fjem.152.4.869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=7420023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL3cXmtF2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1980&pages=869-877&author=G.+Riveauauthor=K.+Masekauthor=M.+Parantauthor=L.+Chedid&title=Central+Pyrogenic+Activity+of+Muramyl+Dipeptide&doi=10.1084%2Fjem.152.4.869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Central pyrogenic activity of muramyl dipeptide</span></div><div class="casAuthors">Riveau, Gilles; Masek, Karel; Parant, Monique; Chedid, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">869-77</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">Fever can be elicited in the rabbit by the i.v. administration of relatively large doses of a synthetic immunoadjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine, or muramyl dipeptide (MDP).  This response could be mediated by endogenous pyrogen because MDP has been shown to induce their prodn. both in vivo and in vitro.  In rabbits, intracisternal injection of small amts. of MDP could elevate fever without activating the release of endogenous pyrogen in the plasma or in the cerebrospinal fluid.  Moreover, indomethacin inhibited hyperthermia produced by intracerebroventricular administration of MDP.  Therefore, a direct effect of the glycopeptide on the thermoregulatory centers is suggested besides its indirect effect through the prodn. of leukocytic pyrogen.  This mol. apparently represents the minimal requirement for the pyrogenicity of bacterial peptidoglycan because administration, even by the intracerebral route, of a mixt. of muramic acid and of its dipeptide moiety did not elicit fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSo26lu7L0rVg90H21EOLACvtfcHk0lgKntLNRQSCxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmtF2ht70%253D&md5=8002fe8aabe5c1684365e75a6e28a7fc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1084%2Fjem.152.4.869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.152.4.869%26sid%3Dliteratum%253Aachs%26aulast%3DRiveau%26aufirst%3DG.%26aulast%3DMasek%26aufirst%3DK.%26aulast%3DParant%26aufirst%3DM.%26aulast%3DChedid%26aufirst%3DL.%26atitle%3DCentral%2520Pyrogenic%2520Activity%2520of%2520Muramyl%2520Dipeptide%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1980%26volume%3D152%26spage%3D869%26epage%3D877%26doi%3D10.1084%2Fjem.152.4.869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Fate of the Synthetic Immunoadjuvant, Muramyl Dipeptide (14C-Labelled) in the Mouse</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/0192-0561(79)90028-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0192-0561%2879%2990028-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=551094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE1MXktVeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1979&pages=35-41&author=M.+Parantauthor=F.+Parantauthor=L.+Chedidauthor=A.+Yapoauthor=J.+F.+Petitauthor=E.+Lederer&title=Fate+of+the+Synthetic+Immunoadjuvant%2C+Muramyl+Dipeptide+%2814C-Labelled%29+in+the+Mouse&doi=10.1016%2F0192-0561%2879%2990028-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fate of the synthetic immunoadjuvant, muramyl dipeptide (carbon-14-labeled) in the mouse</span></div><div class="casAuthors">Parant, M.; Parant, F.; Chedid, L.; Yapo, A.; Petit, J. F.; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-41</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">Following i.v. or s.c. injection into mice, more than 50% of muramyl dipeptide (MDP)-14C was recovered unchanged in the urine after 30 min; more than 90% was recovered after 2 h.  MDP was sequestered for a longer time at the site of injection when administered as a water-in-oil emulsion.  Considering the relatively rapid elimination obsd., it is suggested that the biol. effects of MDP and related compds., when administered in an aq. medium, may be due to their activity at minute concns. and (or) an immediate action at the cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9goIH9UIFUbVg90H21EOLACvtfcHk0lgKntLNRQSCxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktVeku78%253D&md5=8e211dd6ebb2350ee60378e3a6f56d33</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2879%2990028-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252879%252990028-6%26sid%3Dliteratum%253Aachs%26aulast%3DParant%26aufirst%3DM.%26aulast%3DParant%26aufirst%3DF.%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DYapo%26aufirst%3DA.%26aulast%3DPetit%26aufirst%3DJ.%2BF.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DFate%2520of%2520the%2520Synthetic%2520Immunoadjuvant%252C%2520Muramyl%2520Dipeptide%2520%252814C-Labelled%2529%2520in%2520the%2520Mouse%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1979%26volume%3D1%26spage%3D35%26epage%3D41%26doi%3D10.1016%2F0192-0561%2879%2990028-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A.</span></span> <span> </span><span class="NLM_article-title">Degradation of Muramyl Dipeptide by Mammalian Serum</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1128/IAI.50.1.320-321.1985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FIAI.50.1.320-321.1985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3876287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL2MXlslKrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=320-321&author=J.+Harrisonauthor=A.+Fox&title=Degradation+of+Muramyl+Dipeptide+by+Mammalian+Serum&doi=10.1128%2FIAI.50.1.320-321.1985"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of muramyl dipeptide by mammalian serum</span></div><div class="casAuthors">Harrison, J.; Fox, A.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">320-1</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Muramyl dipeptide, N-acetylmuramyl-L-alanine-D-isoglutamine (MDP), which elicits an acute inflammation in vivo is degraded by normal rat serum into its constituents, N-acetylmuramic acid and L-alanine-D-isoglutamine.  The dipeptide is further degraded into its components L-alanine and D-isoglutamine.  These results may help to explain how inflammation elicited by MDP is terminated in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnN4jhCqu0rVg90H21EOLACvtfcHk0lisHhDF7709Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlslKrur0%253D&md5=c3a40b9fdbddda69c90cdcede218440e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FIAI.50.1.320-321.1985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.50.1.320-321.1985%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DA.%26atitle%3DDegradation%2520of%2520Muramyl%2520Dipeptide%2520by%2520Mammalian%2520Serum%26jtitle%3DInfect.%2520Immun.%26date%3D1985%26volume%3D50%26spage%3D320%26epage%3D321%26doi%3D10.1128%2FIAI.50.1.320-321.1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K. S.</span></span> <span> </span><span class="NLM_article-title">Muramyl Dipeptide and Its Derivatives: Peptide Adjuvant in Immuno- Logical Disorders and Cancer Therapy</span>. <i>Curr. Bioact. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.2174/157340711796817913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2174%2F157340711796817913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22180736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ansLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=180-197&author=C.+Ogawaauthor=Y.+J.+Liuauthor=K.+S.+Kobayashi&title=Muramyl+Dipeptide+and+Its+Derivatives%3A+Peptide+Adjuvant+in+Immuno-+Logical+Disorders+and+Cancer+Therapy&doi=10.2174%2F157340711796817913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy</span></div><div class="casAuthors">Ogawa, Chikako; Liu, Yuen-Joyce; Kobayashi, Koichi S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Bioactive Compounds</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">180-197</span>CODEN:
                <span class="NLM_cas:coden">CBCUBY</span>;
        ISSN:<span class="NLM_cas:issn">1573-4072</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln.  It was first identified in bacterial cell wall peptidoglycan as an active component in Freund's complete adjuvant.  In the cell, MDP is detected by NOD2, a cytoplasmic receptor belonging to the human innate immune system.  NOD2 mutations are frequently obsd. in patients with Crohn's disease, an autoimmune disorder, suggesting the significance of the MDP-NOD2 pathway in activating immunity.  For this reason, structural modifications of MDP and its derivs. have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clin. use in the treatment of cancer and other diseases.  This review summarizes the synthetic chem. of MDP and its derivs. and discusses their pharmacol. action and stereoselective synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1jEHwObGRy7Vg90H21EOLACvtfcHk0lisHhDF7709Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ansLrK&md5=c906fb7dd2d2d9353c3f4be202672d49</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F157340711796817913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340711796817913%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26aulast%3DKobayashi%26aufirst%3DK.%2BS.%26atitle%3DMuramyl%2520Dipeptide%2520and%2520Its%2520Derivatives%253A%2520Peptide%2520Adjuvant%2520in%2520Immuno-%2520Logical%2520Disorders%2520and%2520Cancer%2520Therapy%26jtitle%3DCurr.%2520Bioact.%2520Compd.%26date%3D2011%26volume%3D7%26spage%3D180%26epage%3D197%26doi%3D10.2174%2F157340711796817913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzonkowski, P.</span></span> <span> </span><span class="NLM_article-title">Recent Developments in the Synthesis and Biological Activity of Muramylpeptides</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2438</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.2174/092986711795843173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2174%2F092986711795843173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21568914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFOrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2438-2451&author=K.+Dzierzbickaauthor=A.+Wardowskaauthor=P.+Trzonkowski&title=Recent+Developments+in+the+Synthesis+and+Biological+Activity+of+Muramylpeptides&doi=10.2174%2F092986711795843173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the synthesis and biological activity of muramylpeptides</span></div><div class="casAuthors">Dzierzbicka, K.; Wardowska, A.; Trzonkowski, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2438-2451</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Derivs. of muramyl dipeptide (MDP) are considered as immunostimulants and adjuvants in the immunotherapy of cancer and infections.  The interest in these compds. is mainly related to a high variety of their structure and biol. properties.  Here, the authors describe the synthesis and biol. activity of several recently developed classes of MDP analogs.  The authors also report potential of these analogs in the treatment of cancer and infectious diseases in exptl. systems and cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquy7mDG-GTibVg90H21EOLACvtfcHk0lisHhDF7709Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFOrsbc%253D&md5=1a019b3429b4b4acca08c2dbf6d4e1c5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F092986711795843173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795843173%26sid%3Dliteratum%253Aachs%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DWardowska%26aufirst%3DA.%26aulast%3DTrzonkowski%26aufirst%3DP.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Synthesis%2520and%2520Biological%2520Activity%2520of%2520Muramylpeptides%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2438%26epage%3D2451%26doi%3D10.2174%2F092986711795843173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hespen, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, H. C.</span></span> <span> </span><span class="NLM_article-title">Translation of Peptidoglycan Metabolites into Immunotherapeutics</span>. <i>Clin. Transl. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1095</span> <span class="refDoi"> DOI: 10.1002/cti2.1095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fcti2.1095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=31798878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=M.+E.+Griffinauthor=C.+W.+Hespenauthor=Y.+C.+Wangauthor=H.+C.+Hang&title=Translation+of+Peptidoglycan+Metabolites+into+Immunotherapeutics&doi=10.1002%2Fcti2.1095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcti2.1095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcti2.1095%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DM.%2BE.%26aulast%3DHespen%26aufirst%3DC.%2BW.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DHang%26aufirst%3DH.%2BC.%26atitle%3DTranslation%2520of%2520Peptidoglycan%2520Metabolites%2520into%2520Immunotherapeutics%26jtitle%3DClin.%2520Transl.%2520Immunol.%26date%3D2019%26volume%3D8%26doi%3D10.1002%2Fcti2.1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, I.</span></span> <span> </span><span class="NLM_article-title">Review: Inducer of Cytokines in Vivo: Overview of Field and Romurtide Experience</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/0192-0561(92)90180-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0192-0561%2892%2990180-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1618600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK38XktVSis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1992&pages=487-496&author=I.+Azuma&title=Review%3A+Inducer+of+Cytokines+in+Vivo%3A+Overview+of+Field+and+Romurtide+Experience&doi=10.1016%2F0192-0561%2892%2990180-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inducer of cytokines in vivo:  overview of field and romurtide experience</span></div><div class="casAuthors">Azuma, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">487-96</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">A review with 48 refs.  Cell-wall skeletons of bacteria such as mycobacteria, nocardia, corynebacteria, propionibacteria and listeria, have potent adjuvant activity on immune responses.  It was reported that N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) was the min. structural requirement of adjuvant activity of the bacterial cell-wall skeleton and a variety of MDP derivs. and related compds. were synthesized.  Among the synthetic MDP derivs., MDP-Lys(L18)(romurtide) was selected as the immunostimulant, by using exptl. models for non-specific host resistance against Escherichia coli in mice.  Romurtide was shown to have host-stimulating activity against bacterial, fungal and viral infections, cytokine-producing activity and the capacity to increase the no. of leukocytes and platelets in exptl. models.  It was also shown that the clin. effectiveness of romurtide depends on the restoration of the no. of leukocytes and platelets of cancer patients treated with chemotherapy or radiation therapy.  The mechanism of action of romurtide is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qHvvJRbOH7Vg90H21EOLACvtfcHk0lhaxRgOSA7h_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVSis7c%253D&md5=2b0b20fef4134d4e3ef445364cdc85af</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2892%2990180-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252892%252990180-S%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DI.%26atitle%3DReview%253A%2520Inducer%2520of%2520Cytokines%2520in%2520Vivo%253A%2520Overview%2520of%2520Field%2520and%2520Romurtide%2520Experience%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1992%26volume%3D14%26spage%3D487%26epage%3D496%26doi%3D10.1016%2F0192-0561%2892%2990180-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, P. A.</span></span> <span> </span><span class="NLM_article-title">Muramyl Tripeptide (Mifamurtide) for the Treatment of Osteosarcoma</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1586/era.09.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1586%2Fera.09.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19671023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvF2qurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1035-1049&author=P.+A.+Meyers&title=Muramyl+Tripeptide+%28Mifamurtide%29+for+the+Treatment+of+Osteosarcoma&doi=10.1586%2Fera.09.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma</span></div><div class="casAuthors">Meyers, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1035-1049</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Osteosarcoma is an ultraorphan disease.  There are approx. 1000 new patients diagnosed with osteosarcoma each year in the USA and Europe.  Current treatment for osteosarcoma utilizes multiagent chemotherapy and surgical resection of all clin. detectable disease.  Current treatments for osteosarcoma achieve 60-70% event-free survival (EFS) for patients with localized disease and approx. 20% EFS for patients who present with metastasis.  These results have been stable for two decades.  The addn. of muramyl tripeptide (mifamurtide) to chemotherapy resulted in a trend towards improved EFS and a one-third redn. in the risk of death from osteosarcoma.  Mifamurtide has been approved in Europe for the treatment of newly diagnosed osteosarcoma in combination with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGratgeyBKw14bVg90H21EOLACvtfcHk0lhaxRgOSA7h_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvF2qurg%253D&md5=69289d5929805bd03fe48a0f0726b408</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1586%2Fera.09.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.09.69%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DP.%2BA.%26atitle%3DMuramyl%2520Tripeptide%2520%2528Mifamurtide%2529%2520for%2520the%2520Treatment%2520of%2520Osteosarcoma%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D1035%26epage%3D1049%26doi%3D10.1586%2Fera.09.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riveau, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F. J.</span></span> <span> </span><span class="NLM_article-title">Biological Activity of a New Synthetic Muramyl Peptide Adjuvant Devoid of Pyrogenicity</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1128/IAI.35.2.417-424.1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FIAI.35.2.417-424.1982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=7035362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL38Xht1Smt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1982&pages=417-424&author=L.+A.+Chedidauthor=M.+A.+Parantauthor=F.+M.+Audibertauthor=G.+J.+Riveauauthor=E.+Ledererauthor=J.+P.+Choayauthor=P.+L.+Lefrancierauthor=F.+J.+Parant&title=Biological+Activity+of+a+New+Synthetic+Muramyl+Peptide+Adjuvant+Devoid+of+Pyrogenicity&doi=10.1128%2FIAI.35.2.417-424.1982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity</span></div><div class="casAuthors">Chedid, Louis A.; Parant, Monique A.; Audibert, Francoise M.; Riveau, Gilles J.; Parant, Francine J.; Lederer, Edgar; Choay, Jean P.; Lefrancier, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-24</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The immunostimulant activities of muramyl dipeptide (enhancement of specific immune responses and of nonspecific resistance to infection) were retained by its N-acetylmuramyl-L-alanyl-D-glutaminyl-n-Bu ester deriv., although very large amts. administered i.v., or intracerebroventricularly did not elicit fever in the rabbit.  This analog also appeared to be devoid of other secondary effects which have been obsd. after administration of muramyl dipeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuqHm58o6PtrVg90H21EOLACvtfcHk0lhaxRgOSA7h_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xht1Smt7g%253D&md5=9a7e6ee981d0376e9ca6ad3007bf3c38</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FIAI.35.2.417-424.1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.35.2.417-424.1982%26sid%3Dliteratum%253Aachs%26aulast%3DChedid%26aufirst%3DL.%2BA.%26aulast%3DParant%26aufirst%3DM.%2BA.%26aulast%3DAudibert%26aufirst%3DF.%2BM.%26aulast%3DRiveau%26aufirst%3DG.%2BJ.%26aulast%3DLederer%26aufirst%3DE.%26aulast%3DChoay%26aufirst%3DJ.%2BP.%26aulast%3DLefrancier%26aufirst%3DP.%2BL.%26aulast%3DParant%26aufirst%3DF.%2BJ.%26atitle%3DBiological%2520Activity%2520of%2520a%2520New%2520Synthetic%2520Muramyl%2520Peptide%2520Adjuvant%2520Devoid%2520of%2520Pyrogenicity%26jtitle%3DInfect.%2520Immun.%26date%3D1982%26volume%3D35%26spage%3D417%26epage%3D424%26doi%3D10.1128%2FIAI.35.2.417-424.1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Z.</span></span> <span> </span><span class="NLM_article-title">Murabutide Revisited: A Review of Its Pleiotropic Biological Effects</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.2174/0929867311320160002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2174%2F0929867311320160002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23531213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=2068-2079&author=Z.+Jakopin&title=Murabutide+Revisited%3A+A+Review+of+Its+Pleiotropic+Biological+Effects&doi=10.2174%2F0929867311320160002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Murabutide revisited: a review of its pleiotropic biological effects</span></div><div class="casAuthors">Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2068-2079</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the great efforts put into their development, the list of clin. approved immunol. adjuvants is still very short.  Evolution of the knowledge of the immune system has enabled for rational design of novel adjuvants and has led to the conclusion that more than one type of adjuvant will be required.  Derivs. of muramyl dipeptide (MDP), the minimal immunomodulatory structure of bacterial cell wall peptidoglycan, have gained considerable attention in the past decades, because of their potent adjuvant effects.  Murabutide is a safe deriv. of MDP, which interacts with cells of the immune system, both innate and adaptive, and exerts its effect through activation of Nod2.  The transcriptional response of murabutide-stimulated macrophages revealed enhanced expression of genes coding for various proteins such as immune mediators and their receptors, transcription factors and kinases, ion channels/transporters and proteins involved in cell metabolic activity, thus reflecting a broad spectrum of biol. effects.  In addn. to its well recognized adjuvant effect, murabutide has also been shown to enhance the host's resistance against microbial infections, nonspecific resistance against tumors and the induction of cytokines and chemokines implicated in enhancing the immune response and hematopoesis.  This article provides an insight into the mechanism of action of murabutide and its interactions with the cells of the immune system in vitro and in vivo.  On account of its numerous biol. effects, murabutide has been the subject of several clin. studies.  Many of these have confirmed its potential to synergize with cytokines of therapeutic interest in potentiating the tumoricidal activity of macrophages or targeting chronic viral diseases, as well as reducing the cytokine dosage needed to achieve a therapeutic effect.  This review covers the findings of all relevant studies and focuses on the role of murabutide and its potential in the treatment of several microbial diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRI0UmLi-DrVg90H21EOLACvtfcHk0lj3-TY8VD3KQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D&md5=519fd1fb58ae28d9da85019cfc765e61</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F0929867311320160002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320160002%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3DZ.%26atitle%3DMurabutide%2520Revisited%253A%2520A%2520Review%2520of%2520Its%2520Pleiotropic%2520Biological%2520Effects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D2068%26epage%3D2079%26doi%3D10.2174%2F0929867311320160002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pečar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štalc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraber-Herzog, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povšič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhadolc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hočevar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hönig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogi-Kohlenprath, R.</span></span> <span> </span><span class="NLM_article-title">N-{trans-2-[[2′-(Acetylamino)Cyclohexyl]Oxy]Acetyl}-L-Alanyl-D-Glutamic Acid: A Novel Immunologically Active Carbocyclic Muramyl Dipeptide Analogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1021/jm970509d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970509d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Kgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=530-539&author=D.+Kikeljauthor=S.+Pe%C4%8Darauthor=V.+Kotnikauthor=A.+%C5%A0talcauthor=B.+Wraber-Herzogauthor=S.+Sim%C4%8Di%C4%8Dauthor=A.+Ihanauthor=L.+Klamferauthor=L.+Pov%C5%A1i%C4%8Dauthor=R.+Grahekauthor=E.+Suhadolcauthor=M.+Ho%C4%8Devarauthor=H.+H%C3%B6nigauthor=R.+Rogi-Kohlenprath&title=N-%7Btrans-2-%5B%5B2%E2%80%B2-%28Acetylamino%29Cyclohexyl%5DOxy%5DAcetyl%7D-L-Alanyl-D-Glutamic+Acid%3A+A+Novel+Immunologically+Active+Carbocyclic+Muramyl+Dipeptide+Analogue&doi=10.1021%2Fjm970509d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-{trans-2-[[2'-(Acetylamino)cyclohexyl]oxy]acetyl}-L-alanyl-D-glutamic Acid: A Novel Immunologically Active Carbocyclic Muramyl Dipeptide Analog</span></div><div class="casAuthors">Kikelj, Danijel; Pecar, Slavko; Kotnik, Vladimir; Stalc, Anton; Wraber-Herzog, Branka; Simci, Sasa; Ihan, Alojz; Klamfer, Lidija; Povsic, Lucka; Grahek, Rok; Suhadolc, Elizabeta; Hocevar, Mirjam; Hoenig, Helmut; Rogi-Kohlenprath, Renate</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">530-539</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel non-pyrogenic carbocyclic muramyl dipeptide (MDP) analog I was obtained by replacement of the N-acetylmuramic acid part and the D-isoglutamine residue of the MDP mol. by a trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl moiety and D-glutamic acid, resp.  The title compd. was selected as a promising candidate for further evaluation among several related analogs on the basis of am immunorestoration test in mice.  This novel nor-MDP analog protects mice against the immunosuppressive effect of cyclophosphamide and increases the nonspecific resistance of mice against the fungal infection.  It is an immunomodulator which enhances the maturation of lymphocytes B to plasma cells and increases the activity of lymphocytes B and lymphocytes T as well as that of macrophages but does not alter the no. of these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz-kMFxRmzXbVg90H21EOLACvtfcHk0lj3-TY8VD3KQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Kgtw%253D%253D&md5=16636862090e41b383e9b0cef9e5a1b3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm970509d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970509d%26sid%3Dliteratum%253Aachs%26aulast%3DKikelj%26aufirst%3DD.%26aulast%3DPe%25C4%258Dar%26aufirst%3DS.%26aulast%3DKotnik%26aufirst%3DV.%26aulast%3D%25C5%25A0talc%26aufirst%3DA.%26aulast%3DWraber-Herzog%26aufirst%3DB.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DIhan%26aufirst%3DA.%26aulast%3DKlamfer%26aufirst%3DL.%26aulast%3DPov%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DGrahek%26aufirst%3DR.%26aulast%3DSuhadolc%26aufirst%3DE.%26aulast%3DHo%25C4%258Devar%26aufirst%3DM.%26aulast%3DH%25C3%25B6nig%26aufirst%3DH.%26aulast%3DRogi-Kohlenprath%26aufirst%3DR.%26atitle%3DN-%257Btrans-2-%255B%255B2%25E2%2580%25B2-%2528Acetylamino%2529Cyclohexyl%255DOxy%255DAcetyl%257D-L-Alanyl-D-Glutamic%2520Acid%253A%2520A%2520Novel%2520Immunologically%2520Active%2520Carbocyclic%2520Muramyl%2520Dipeptide%2520Analogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D530%26epage%3D539%26doi%3D10.1021%2Fjm970509d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribić, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranesǐc, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomic, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Immunostimulating Properties of Novel Adamant-1-Yl Tripeptides</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201100232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fcbdv.201100232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22492495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFSgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=777-788&author=R.+Ribi%C4%87author=L.+Habjanecauthor=B.+Vranes%C7%90cauthor=R.+Frkanecauthor=S.+Tomic&title=Synthesis+and+Immunostimulating+Properties+of+Novel+Adamant-1-Yl+Tripeptides&doi=10.1002%2Fcbdv.201100232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and immunostimulating properties of novel adamant-1-yl tripeptides</span></div><div class="casAuthors">Ribic, Rosana; Habjanec, Lidija; Vranesic, Branka; Frkanec, Ruza; Tomic, Srdanka</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">777-788</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">The aim of this work was to prep. L- and D-(adamant-1-yl)-Gly-L-Ala-D-isoGln peptides in order to study their adjuvant (immunostimulating) activities.  Adjuvant activity of adamant-1-yl tripeptides was tested in the mouse model using ovalbumin as an antigen and in comparison to the peptidoglycan monomer (PGM; β-D-GlcNAc-(1→4)-D-MurNAc-L-Ala-D-isoGln-mesoDAP(εNH2)-D-Ala-D-Ala) and structurally related adamant-2-yl tripeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-C76l1s5A47Vg90H21EOLACvtfcHk0lj3-TY8VD3KQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFSgs7g%253D&md5=585e59ff5388599f56e97c33ffa09e80</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201100232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201100232%26sid%3Dliteratum%253Aachs%26aulast%3DRibi%25C4%2587%26aufirst%3DR.%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DVranes%25C7%2590c%26aufirst%3DB.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTomic%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Immunostimulating%2520Properties%2520of%2520Novel%2520Adamant-1-Yl%2520Tripeptides%26jtitle%3DChem.%2520Biodiversity%26date%3D2012%26volume%3D9%26spage%3D777%26epage%3D788%26doi%3D10.1002%2Fcbdv.201100232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masihi, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwenke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gast, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huchshorn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palache, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, K.</span></span> <span> </span><span class="NLM_article-title">Effect of Immunomodulator Adamantylamide Dipeptide on Antibody Response to Influenza Subunit Vaccines and Protection against Aerosol Influenza Infection</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/0264-410X(90)90140-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0264-410X%2890%2990140-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=2336875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3cXkvVCltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=159-163&author=K.+N.+Masihiauthor=W.+Langeauthor=S.+Schwenkeauthor=G.+Gastauthor=P.+Huchshornauthor=A.+Palacheauthor=K.+Ma%C5%A1ek&title=Effect+of+Immunomodulator+Adamantylamide+Dipeptide+on+Antibody+Response+to+Influenza+Subunit+Vaccines+and+Protection+against+Aerosol+Influenza+Infection&doi=10.1016%2F0264-410X%2890%2990140-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection</span></div><div class="casAuthors">Masihi, K. N.; Lange, W.; Schwenke, S.; Gast, G.; Huchshorn, P.; Palache, A.; Masek, K.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-63</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    </div><div class="casAbstract">Adamantylamide dipeptide (AdDP) is a novel synthetic compd. combining the antiviral properties of amantadine and the essential adjuvant activity of immunomodulator muramyl dipeptide.  Mice were immunized with influenza A/Taiwan/1/86 (H1N1), A/Sichuan/2/87 (H3N2) and influenza B/Beijing/1/87 subunit vaccines contg. AdDP or aluminum hydroxide (Al(OH)3).  Induction of homologous hemagglutination-inhibition (HI) antibodies and correlation to protection against lethal aerosol influenza A/PR/8/34 (H1N1) infection were investigated.  Subunit vaccine contg. A/Sichuan (H3N2) and Al(OH)3 stimulated high HI antibody titers but failed to provide protection against heterologous influenza A (H1N1) challenge infection following either the primary or the secondary immunization.  In contrast, similar treatment with A/Sichuan subunit vaccine contg. AdDP conferred significant protection against heterologous challenge despite low levels of circulating antibody.  Primary immunization with even influenza B/Beijing subunit vaccine contg. AdDP, but not Al(OH), provided partial protection against influenza A challenge.  These results suggest that appropriate immunomodulators like AdDP can convert restricted homotypic immunity induced by inactivated influenza subunit vaccines to advantageous cross-reacting type of heterologous response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWA94Pk_A7rrVg90H21EOLACvtfcHk0lh90EyZMSwS5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvVCltbo%253D&md5=94d489e4926f72d34c0b89a6a21a8a79</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0264-410X%2890%2990140-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0264-410X%252890%252990140-H%26sid%3Dliteratum%253Aachs%26aulast%3DMasihi%26aufirst%3DK.%2BN.%26aulast%3DLange%26aufirst%3DW.%26aulast%3DSchwenke%26aufirst%3DS.%26aulast%3DGast%26aufirst%3DG.%26aulast%3DHuchshorn%26aufirst%3DP.%26aulast%3DPalache%26aufirst%3DA.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DK.%26atitle%3DEffect%2520of%2520Immunomodulator%2520Adamantylamide%2520Dipeptide%2520on%2520Antibody%2520Response%2520to%2520Influenza%2520Subunit%2520Vaccines%2520and%2520Protection%2520against%2520Aerosol%2520Influenza%2520Infection%26jtitle%3DVaccine%26date%3D1990%26volume%3D8%26spage%3D159%26epage%3D163%26doi%3D10.1016%2F0264-410X%2890%2990140-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corral, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinstein, S.</span></span> <span> </span><span class="NLM_article-title">Adamantylamide Dipeptide as Effective Immunoadjuvant in Rabbits and Mice</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4603</span>– <span class="NLM_lpage">4609</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(01)00259-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0264-410X%2801%2900259-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11535307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFWrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=4603-4609&author=P.+D.+Beckerauthor=R.+S.+Corralauthor=C.+A.+Guzm%C3%A1nauthor=S.+Grinstein&title=Adamantylamide+Dipeptide+as+Effective+Immunoadjuvant+in+Rabbits+and+Mice&doi=10.1016%2FS0264-410X%2801%2900259-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice</span></div><div class="casAuthors">Becker, P. D.; Corral, R. S.; Guzman, C. A.; Grinstein, S.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4603-4609</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In the search for more potent and less toxic immunomodulators, adamantylamide dipeptide (AdDP) was synthesized by the covalent union of amantadine with the L-alanyl-D-isoglutamine residue of muramyldipeptide (MDP).  The present expts. demonstrate the ability of AdDP, co-administered with a protein immunogen, to raise or enhance a humoral response in immunized animals.  BALB/c mice were immunized either by the i.p. or oral route with ovalbumin (Ova) alone or combined with either AdDP or CpG oligonucleotide (ODN-CpG), a proved adjuvant.  A clear adjuvant dose-response relationship was obsd. on the increment of Ova-specific serum antibody titers when AdDP was used as adjuvant, irresp. of the administration route.  The IgG isotype anal. showed that AdDP promotes a consistent increment in IgG1 antibodies assocd. with a dominant Th2 response pattern.  When administered by the oral route, AdDP was at least as efficient as ODN-CpG as adjuvant.  Similar results were obtained in rabbits immunized by the oral route, suggesting that the adjuvanticity of AdDP is not restricted to the murine system.  In conclusion, AdDP was shown to be a powerful and non-toxic adjuvant at both systemic and mucosal levels, which makes it a promising tool for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr9D8vBjNJ_bVg90H21EOLACvtfcHk0lh90EyZMSwS5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFWrtrY%253D&md5=1c7e370a52a8a6617dbaae2992a96a4b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2801%2900259-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252801%252900259-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DP.%2BD.%26aulast%3DCorral%26aufirst%3DR.%2BS.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DC.%2BA.%26aulast%3DGrinstein%26aufirst%3DS.%26atitle%3DAdamantylamide%2520Dipeptide%2520as%2520Effective%2520Immunoadjuvant%2520in%2520Rabbits%2520and%2520Mice%26jtitle%3DVaccine%26date%3D2001%26volume%3D19%26spage%3D4603%26epage%3D4609%26doi%3D10.1016%2FS0264-410X%2801%2900259-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urleb, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Modulation of Tumour Necrosis Factor Production with Desmuramyldipeptide Analogues</span>. <i>Pfluegers Arch.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>440</i></span>,  <span class="NLM_fpage">R064</span>– <span class="NLM_lpage">R066</span>, <span class="refDoi"> DOI: 10.1007/s004240000008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1007%2Fs004240000008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=28008484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVyhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2000&pages=R064-R066&author=S.+Sim%C4%8Di%C4%8Dauthor=B.+Wraberauthor=M.+Sollnerauthor=U.+Urlebauthor=S.+Gobec&title=Modulation+of+Tumour+Necrosis+Factor+Production+with+Desmuramyldipeptide+Analogues&doi=10.1007%2Fs004240000008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of tumor necrosis factor production with desmuramyldipeptide analogs</span></div><div class="casAuthors">Simcic, Sasa; Wraber, Branka; Sollner, Marija; Urleb, Uros; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">5, Suppl.</span>),
    <span class="NLM_cas:pages">R64-R66</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Some synthetic analogs of the immunomodulatory agent muramyl dipeptide (MDP), i.e. phthalimido- (LK-511, LK-413, LK-512, LK-423, LK-508), adamantyl- (LK-415, LK-517), 7-oxoalkyl-(LK-409) desmuramylpeptides were assessed for the tumor necrosis factor (TNF) inducing activity and the ability to modulate TNF prodn. in in vitro phorbol 12-myristate 13-acetate (PMA) & ionomycin stimulated cultures of human peripheral blood mononuclear cells.  A kinetic study over a 40-h period indicated that desmuramyldipeptides were weak TNF inducers compared to romurtide, PMA & ionomycin or lipopolysaccharide.  By contrast, they showed the potential to up- or down-regulate the prodn. of TNF evoked by PMA & ionomycin, which was strongly dependent on the time of the stimulation.  After 4h of stimulation, the TNF secretion was augmented by LK-508, LK-409 and LK-511, after 18 h by LK-409 and LK-423, and after 40 h by LK-423, LK-511, LK-415 and LK-512.  However, LK-517 and LK-512 inhibited the secretion of TNF after the 18-h period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsTNqXhRzCX7Vg90H21EOLACvtfcHk0lh90EyZMSwS5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVyhsL8%253D&md5=9bc8d3346ce9276a5e7fd9b976ca3b22</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs004240000008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004240000008%26sid%3Dliteratum%253Aachs%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DWraber%26aufirst%3DB.%26aulast%3DSollner%26aufirst%3DM.%26aulast%3DUrleb%26aufirst%3DU.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DModulation%2520of%2520Tumour%2520Necrosis%2520Factor%2520Production%2520with%2520Desmuramyldipeptide%2520Analogues%26jtitle%3DPfluegers%2520Arch.%26date%3D2000%26volume%3D440%26spage%3DR064%26epage%3DR066%26doi%3D10.1007%2Fs004240000008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolenc, M. S.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Novel Desmuramyldipeptide Analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3762</span>– <span class="NLM_lpage">3777</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2011.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21669478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3762-3777&author=%C5%BD.+Jakopinauthor=E.+Corsiniauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+S.+Dolenc&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Novel+Desmuramyldipeptide+Analogs&doi=10.1016%2Fj.ejmech.2011.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel desmuramyldipeptide analogs</span></div><div class="casAuthors">Jakopin, Ziga; Corsini, Emanuela; Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3762-3777</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel desmuramyldipeptides have been designed and synthesized as part of the search for therapeutically useful muramyldipeptide (MDP) analogs.  Their immunomodulatory properties were initially assessed in vitro, evaluating their effect on lipopolysaccharide (LPS)-induced cytokine release in THP-1 cells.  Following the initial screening, selected compds. were further investigated for immunomodulatory properties using LPS and phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells.  The results confirmed the immunomodulatory properties of some of the synthesized desmuramyldipeptide analogs.  Taken together, the data confirmed the immunostimulatory effect of pyrido-fused [1,2]-benzisothiazole-contg. MDP deriv. I, while for indole-contg. MDP derivs. II and III, an immunosuppressive effect was obsd.  Further studies will be necessary to address their potential therapeutic use as immunomodulatory drugs, both as immunostimulants or antiinflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdf0ICGmE7rrVg90H21EOLACvtfcHk0lgbdzJx969xHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI&md5=0e658d046b6551ad97d9e5887bb960c8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DCorsini%26aufirst%3DE.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DDolenc%26aufirst%3DM.%2BS.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Desmuramyldipeptide%2520Analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3762%26epage%3D3777%26doi%3D10.1016%2Fj.ejmech.2011.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">New Muramyl Dipeptide (MDP) Mimics without the Carbohydrate Moiety as Potential Adjuvant Candidates for a Therapeutic Hepatitis B Vaccine (HBV)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4292</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.bmcl.2011.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21683593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4292-4295&author=N.+Zhaoauthor=Y.+Maauthor=S.+Zhangauthor=X.+Fangauthor=Z.+Liangauthor=G.+Liu&title=New+Muramyl+Dipeptide+%28MDP%29+Mimics+without+the+Carbohydrate+Moiety+as+Potential+Adjuvant+Candidates+for+a+Therapeutic+Hepatitis+B+Vaccine+%28HBV%29&doi=10.1016%2Fj.bmcl.2011.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)</span></div><div class="casAuthors">Zhao, Nan; Ma, Yao; Zhang, Shengmei; Fang, Xin; Liang, Zhenglun; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4292-4295</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new muramyl dipeptide (MDP) mimics were designed and synthesized via a solid-phase synthetic route.  Their adjuvant activities were evaluated ex vivo for investigation of the synergism of the S28-39 peptide, which is an MHC class I binding epitope of recombinant hepatitis B surface antigen (HBsAg) for both humans and mice.  Several compds. without the carbohydrate moiety exerted better adjuvanticity than the MDP-C that has been reported by the authors previously.  A primary screening test revealed that compds. 6, 14 and 16 exhibited stronger adjuvanticity compared with other MDP mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0n6Vaul0AJ7Vg90H21EOLACvtfcHk0lgbdzJx969xHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D&md5=110f9bdbbcd8c37da8dfc295e4128dfe</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DNew%2520Muramyl%2520Dipeptide%2520%2528MDP%2529%2520Mimics%2520without%2520the%2520Carbohydrate%2520Moiety%2520as%2520Potential%2520Adjuvant%2520Candidates%2520for%2520a%2520Therapeutic%2520Hepatitis%2520B%2520Vaccine%2520%2528HBV%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4292%26epage%3D4295%26doi%3D10.1016%2Fj.bmcl.2011.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Immunomodulatory Properties of Novel Nucleotide Oligomerization Domain 2 (Nod2) Agonistic Desmuramyldipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6478</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.1021/jm300503b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300503b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6478-6488&author=%C5%BD.+Jakopinauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Immunomodulatory+Properties+of+Novel+Nucleotide+Oligomerization+Domain+2+%28Nod2%29+Agonistic+Desmuramyldipeptides&doi=10.1021%2Fjm300503b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory Properties of Novel Nucleotide Oligomerization Domain 2 (Nod2) Agonistic Desmuramyldipeptides</span></div><div class="casAuthors">Jakopin, Ziga; Gobec, Martina; Mlinaric-Rascan, Irena; Sollner Dolenc, Marija</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6478-6488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a pressing need for the development of novel adjuvants for human use.  The minimal bioactive structure of bacterial peptidoglycan (PGN), muramyldipeptide (MDP), and its deriv. murabutide (MB) have long been known for their adjuvant activities.  For this reason, a series of novel desmuramyldipeptides have been designed and synthesized as part of our search for therapeutically useful MDP analogs.  Since nucleotide oligomerization domain 2 (Nod2) is a putative receptor for MDP, we used engineered HEK293 cells overexpressing Nod2 to screen and validate our compds. for their Nod2-agonist activity.  Their immunomodulatory properties were subsequently assessed in vitro by evaluating their effect on proinflammatory cytokine prodn. of phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells (PBMCs).  Herein, we present novel desmuramyldipeptides, the most active of them possessing immunoenhancing properties as a result of their potent Nod2-agonistic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwj-B62knTQ7Vg90H21EOLACvtfcHk0lgbdzJx969xHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D&md5=7da25625df463ffa238394773501767e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm300503b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300503b%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DImmunomodulatory%2520Properties%2520of%2520Novel%2520Nucleotide%2520Oligomerization%2520Domain%25202%2520%2528Nod2%2529%2520Agonistic%2520Desmuramyldipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6478%26epage%3D6488%26doi%3D10.1021%2Fjm300503b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolenc, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Z.</span></span> <span> </span><span class="NLM_article-title">Structural Requirements of Acylated Gly-l-Ala-d-Glu Analogs for Activation of the Innate Immune Receptor NOD2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2016.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=27039337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=1-12&author=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+S.+Dolencauthor=Z.+Jakopin&title=Structural+Requirements+of+Acylated+Gly-l-Ala-d-Glu+Analogs+for+Activation+of+the+Innate+Immune+Receptor+NOD2&doi=10.1016%2Fj.ejmech.2016.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements of acylated Gly-L-Ala-D-Glu analogs for activation of the innate immune receptor NOD2</span></div><div class="casAuthors">Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The fragment of bacterial peptidoglycan muramyl dipeptide (MDP) has long been known for its adjuvant activity, however the underlying mechanism of this action has only recently been elucidated.  It is ascribed to its agonist action on the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2).  In spite of the pressing need for novel adjuvants for human use, this discovery is hampered, by not knowing the structural requirements underlying the immunostimulatory activity.  The authors have investigated how minor modifications of hit compd. acyl Gly-L-Ala-D-Glu deriv. I modulate the mol. recognition by NOD2.  A series of novel desmuramyldipeptides has been designed and synthesized leading to the identification of compd. 16, in which the sugar moiety is replaced by a 6-phenylindole moiety, that exhibits the strongest NOD2 activation to date sans the carbohydrate moiety.  The results have enabled a deeper understanding of the structural requirements of desmuramylpeptides for NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0x5MPpjFx7Vg90H21EOLACvtfcHk0lilJDaRwEKbqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D&md5=7a990ab9f29e7802bd24bcb051c60bd4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DDolenc%26aufirst%3DM.%2BS.%26aulast%3DJakopin%26aufirst%3DZ.%26atitle%3DStructural%2520Requirements%2520of%2520Acylated%2520Gly-l-Ala-d-Glu%2520Analogs%2520for%2520Activation%2520of%2520the%2520Innate%2520Immune%2520Receptor%2520NOD2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalamati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. H.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Immunological Evaluation of Novel Amphiphilic Desmuramyl Peptides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2017.09.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29028529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=26-36&author=F.+A.+Khanauthor=M.+Ulanovaauthor=B.+Baiauthor=D.+Yalamatiauthor=Z.+H.+Jiang&title=Design%2C+Synthesis+and+Immunological+Evaluation+of+Novel+Amphiphilic+Desmuramyl+Peptides&doi=10.1016%2Fj.ejmech.2017.09.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides</span></div><div class="casAuthors">Khan, Farooq-Ahmad; Ulanova, Marina; Bai, Bing; Yalamati, Damayanthi; Jiang, Zi-Hua</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) - an essential bacterial cell wall component - is recognized by our immune system as pathogen-assocd. mol. pattern (PAMP) which results in immune responses with adverse toxic effects.  In order to harness the beneficial properties from the pro-inflammatory characteristics of the bacterial cell wall motif, MDP was strategically re-designed while conserving the L-D configurations of the dipeptide moiety.  The muramic acid was replaced with a hydrophilic arene and lipophilic chain was introduced at peptide end to give the amphiphilic desmuramyl peptides (DMPs).  The novel DMPs were found to modulate the immune response by amplifying the LPS-induced surface glycoprotein (ICAM-1) expression in THP-1 cells without showing significant toxicity.  Furthermore, these compds. were able to trigger the secretion of higher levels of pro-inflammatory cytokine (TNF-α) than the well-studied NOD2 agonist, Murabutide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobuKf0Rtg3pbVg90H21EOLACvtfcHk0lilJDaRwEKbqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvP&md5=9f65538e0a5fe8c232102c253356e68a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.070%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DF.%2BA.%26aulast%3DUlanova%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DB.%26aulast%3DYalamati%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DZ.%2BH.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Immunological%2520Evaluation%2520of%2520Novel%2520Amphiphilic%2520Desmuramyl%2520Peptides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D26%26epage%3D36%26doi%3D10.1016%2Fj.ejmech.2017.09.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašič, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štimac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trontelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderluh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2707</span>– <span class="NLM_lpage">2724</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslWmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2707-2724&author=M.+Gobecauthor=T.+Toma%C5%A1i%C4%8Dauthor=A.+%C5%A0timacauthor=R.+Frkanecauthor=J.+Tronteljauthor=M.+Anderluhauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=%C5%BD.+Jakopin&title=Discovery+of+Nanomolar+Desmuramylpeptide+Agonists+of+the+Innate+Immune+Receptor+Nucleotide-Binding+Oligomerization+Domain-Containing+Protein+2+%28NOD2%29+Possessing+Immunostimulatory+Properties&doi=10.1021%2Facs.jmedchem.7b01052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of nanomolar desmuramylpeptide agonists of the innate immune receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) possessing immunostimulatory properties</span></div><div class="casAuthors">Gobec, Martina; Tomasic, Tihomir; Stimac, Adela; Frkanec, Ruza; Trontelj, Jurij; Anderluh, Marko; Mlinaric-Rascan, Irena; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2707-2724</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2).  There is a pressing need for novel adjuvants, and NOD2 agonists provide an untapped source of potential candidates.  Here, we report the design, synthesis, and characterization of a series of novel acyl tripeptides.  A pivotal structural element for mol. recognition by NOD2 has been identified, culminating in the discovery of compd. 9, the most potent desmuramylpeptide NOD2 agonist to date.  Compd. 9 augmented pro-inflammatory cytokine release from human peripheral blood mononuclear cells in synergy with lipopolysaccharide.  Furthermore, it was able to induce ovalbumin-specific IgG titers in a mouse model of adjuvancy.  These findings provide deeper insights into the structural requirements of desmuramylpeptides for NOD2-activation and highlight the potential use of NOD2 agonists as adjuvants for vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOxF_6cWHX7Vg90H21EOLACvtfcHk0lilJDaRwEKbqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslWmsLY%253D&md5=6d449dadd56e82616ebfea6243d80f8e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01052%26sid%3Dliteratum%253Aachs%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DToma%25C5%25A1i%25C4%258D%26aufirst%3DT.%26aulast%3D%25C5%25A0timac%26aufirst%3DA.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTrontelj%26aufirst%3DJ.%26aulast%3DAnderluh%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DDiscovery%2520of%2520Nanomolar%2520Desmuramylpeptide%2520Agonists%2520of%2520the%2520Innate%2520Immune%2520Receptor%2520Nucleotide-Binding%2520Oligomerization%2520Domain-Containing%2520Protein%25202%2520%2528NOD2%2529%2520Possessing%2520Immunostimulatory%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2707%26epage%3D2724%26doi%3D10.1021%2Facs.jmedchem.7b01052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauro, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahnson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-Rich Repeat Domain of Nod2</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=264-270&author=M.+L.+Lauroauthor=E.+A.+D%E2%80%99Ambrosioauthor=B.+J.+Bahnsonauthor=C.+L.+Grimes&title=Molecular+Recognition+of+Muramyl+Dipeptide+Occurs+in+the+Leucine-Rich+Repeat+Domain+of+Nod2&doi=10.1021%2Facsinfecdis.6b00154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2</span></div><div class="casAuthors">Lauro, Mackenzie L.; D'Ambrosio, Elizabeth A.; Bahnson, Brian J.; Grimes, Catherine Leimkuhler</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">264-270</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic mutations in the innate immune receptor nucleotide-binding oligomerization domain-contg. 2 (Nod2) have demonstrated increased susceptibility to Crohn's disease, an inflammatory bowel disease that is hypothesized to be accompanied by changes in the gut microbiota.  Nod2 responds to the presence of bacteria, specifically a fragment of the bacterial cell wall, muramyl dipeptide (MDP).  The proposed site of this interaction is the leucine-rich repeat (LRR) domain.  Surface plasmon resonance and mol. modeling were used to investigate the interaction of the LRR domain with MDP.  A functional and pure LRR domain was obtained from Escherichia coli expression in high yield.  The LRR domain binds to MDP with high affinity, with a KD of 212 ± 24 nM.  Crit. portions of the receptor were detd. by mutagenesis of putative binding residues.  Fragment anal. of MDP revealed that both the peptide and carbohydrate portion contribute to the binding interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUCvojsr_fLVg90H21EOLACvtfcHk0lg3XBfsRwWpiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN&md5=75ab3d912d40a9e0f1ab611d57cae68e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00154%26sid%3Dliteratum%253Aachs%26aulast%3DLauro%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DE.%2BA.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26atitle%3DMolecular%2520Recognition%2520of%2520Muramyl%2520Dipeptide%2520Occurs%2520in%2520the%2520Leucine-Rich%2520Repeat%2520Domain%2520of%2520Nod2%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D264%26epage%3D270%26doi%3D10.1021%2Facsinfecdis.6b00154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maekawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of NOD2 and Its Implications in Human Disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11813</span>, <span class="refDoi"> DOI: 10.1038/ncomms11813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fncomms11813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=27283905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11813&author=S.+Maekawaauthor=U.+Ohtoauthor=T.+Shibataauthor=K.+Miyakeauthor=T.+Shimizu&title=Crystal+Structure+of+NOD2+and+Its+Implications+in+Human+Disease&doi=10.1038%2Fncomms11813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of NOD2 and its implications in human disease</span></div><div class="casAuthors">Maekawa, Sakiko; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11813</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg. protein 2 (NOD2), a member of the NOD-like receptors family, are crucial for innate immune responses.  Mutations of NOD2 have been assocd. with chronic inflammatory disorders such as Crohn's disease (CD), Blau syndrome (BS) and early-onset sarcoidosis (EOS), but little is known about its signalling mechanism and the role it plays in these diseases.  Here, we report the crystal structure of rabbit NOD2 in an ADP-bound state.  The structure reveals an inactive closed conformation in which the subdomains in the NOD domain are closely packed by ADP-mediated and inter-domain interactions.  Mapping of the BS- or EOS-assocd. gain-of-function mutations reveals that most of these mutations are located in the NOD subdomain interfaces, and are likely to disrupt the inner domain interactions, facilitating a conformational change to the active form.  Conversely, mutations assocd. with CD are distributed throughout the protein, some of which may affect oligomer formation and ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJqTm2zQOG7Vg90H21EOLACvtfcHk0lg3XBfsRwWpiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D&md5=ff4a78caf8d9e744e473b6767c9d8154</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms11813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11813%26sid%3Dliteratum%253Aachs%26aulast%3DMaekawa%26aufirst%3DS.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DCrystal%2520Structure%2520of%2520NOD2%2520and%2520Its%2520Implications%2520in%2520Human%2520Disease%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11813%26doi%3D10.1038%2Fncomms11813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The “Cyclopropyl Fragment” Is a Versatile Player That Frequently Appears in Preclinical/Clinical Drug Molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%80%9CCyclopropyl+Fragment%E2%80%9D+Is+a+Versatile+Player+That+Frequently+Appears+in+Preclinical%2FClinical+Drug+Molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0lg3XBfsRwWpiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%259CCyclopropyl%2520Fragment%25E2%2580%259D%2520Is%2520a%2520Versatile%2520Player%2520That%2520Frequently%2520Appears%2520in%2520Preclinical%252FClinical%2520Drug%2520Molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Modulation of the Immune Response by a Synthetic Adjuvant and Analogs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2472</span>– <span class="NLM_lpage">2475</span>, <span class="refDoi"> DOI: 10.1073/pnas.73.7.2472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.73.7.2472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1065901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE28XltVOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1976&pages=2472-2475&author=L.+Chedidauthor=F.+Audibertauthor=P.+Lefrancierauthor=J.+Choayauthor=E.+Lederer&title=Modulation+of+the+Immune+Response+by+a+Synthetic+Adjuvant+and+Analogs&doi=10.1073%2Fpnas.73.7.2472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the immune response by a synthetic adjuvant and analogs</span></div><div class="casAuthors">Chedid, L.; Audibert, F.; Lafrancier, P.; Choay, J.; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2472-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">N-Acetylmuramyl-L-alanyl-D-isoglutamine increases the humoral immune response of mice when given in aq. media instead of the usual water-in-oil emulsions.  Moreover, this compd. is adjuvant active even by the oral route.  In view of studying the relation between chem. structure and biol. activity, several synthetic analogs were tested.  The immune response could be modulated according to chem. modifications, and the synthetic analog with D- in place of L-alanine was shown to inhibit the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87LLelnt9aLVg90H21EOLACvtfcHk0ljOZhr9MvCJjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltVOgur4%253D&md5=fb68de365b38d84c8a3f06b1a29773b6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.73.7.2472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.73.7.2472%26sid%3Dliteratum%253Aachs%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DAudibert%26aufirst%3DF.%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DChoay%26aufirst%3DJ.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DModulation%2520of%2520the%2520Immune%2520Response%2520by%2520a%2520Synthetic%2520Adjuvant%2520and%2520Analogs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1976%26volume%3D73%26spage%3D2472%26epage%3D2475%26doi%3D10.1073%2Fpnas.73.7.2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byars, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, A. C.</span></span> <span> </span><span class="NLM_article-title">Adjuvant Formulation for Use in Vaccines to Elicit Both Cell-Mediated and Humoral Immunity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/0264-410X(87)90105-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0264-410X%2887%2990105-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3499713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL2sXmtVCqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1987&pages=223-228&author=N.+E.+Byarsauthor=A.+C.+Allison&title=Adjuvant+Formulation+for+Use+in+Vaccines+to+Elicit+Both+Cell-Mediated+and+Humoral+Immunity&doi=10.1016%2F0264-410X%2887%2990105-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity</span></div><div class="casAuthors">Byars, Noelene E.; Allison, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-8</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    </div><div class="casAbstract">Adjuvant formulations which elicit both humoral and cell-mediated immunity will be required for vaccines based on peptides, viral and bacterial subunits and genetically engineered antigens.  An adjuvant formulation which increases both cell-mediated and humoral immunity and is free of significant side effects encountered with other adjuvants or vehicles is described.  The components include the threonyl analog of muramyl dipeptide, Tween 80, Pluronic L121 and squalane.  This formulation was effective with several antigens, in several species, including rodents, cats and monkeys.  The formulation will be useful for both human and veterinary vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bIfnd8zh4bVg90H21EOLACvtfcHk0ljOZhr9MvCJjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtVCqu7s%253D&md5=1af249ccb54e3948b2de0daefca172e3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0264-410X%2887%2990105-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0264-410X%252887%252990105-8%26sid%3Dliteratum%253Aachs%26aulast%3DByars%26aufirst%3DN.%2BE.%26aulast%3DAllison%26aufirst%3DA.%2BC.%26atitle%3DAdjuvant%2520Formulation%2520for%2520Use%2520in%2520Vaccines%2520to%2520Elicit%2520Both%2520Cell-Mediated%2520and%2520Humoral%2520Immunity%26jtitle%3DVaccine%26date%3D1987%26volume%3D5%26spage%3D223%26epage%3D228%26doi%3D10.1016%2F0264-410X%2887%2990105-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Identification of a Synthetic Muramyl Peptide Derivative with Enhanced Nod2 Stimulatory Capacity</span>. <i>Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1177/1753425912471691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1177%2F1753425912471691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23339926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=493-503&author=S.+J.+Rubinoauthor=J.+G.+Magalhaesauthor=D.+Philpottauthor=G.+M.+Bahrauthor=D.+Blanotauthor=S.+E.+Girardin&title=Identification+of+a+Synthetic+Muramyl+Peptide+Derivative+with+Enhanced+Nod2+Stimulatory+Capacity&doi=10.1177%2F1753425912471691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity</span></div><div class="casAuthors">Rubino, Stephen J.; Magalhaes, Joao G.; Philpott, Dana; Bahr, George M.; Blanot, Didier; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">493-503, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Muramyl peptides (MPs) represent the building blocks of bacterial peptidoglycan, a crit. component of bacterial cell walls.  MPs are well characterized for their immunomodulatory properties, and numerous studies have delineated the role of MPs or synthetic MP analogs in host defense, adjuvanticity and inflammation.  More recently, Nod1 and Nod2 have been identified as the host sensors for specific MPs and in particular, Nod2 was shown to detect muramyl dipeptide (MDP), a MP found in both Gram-pos. and Gram-neg. bacterial cell walls.  Because mutations in Nod2 are assocd. with the etiol. of Crohn's disease, there is a need to identify synthetic MP analogs that could potentiate Nod2-dependent immunity.  Here, we analyzed the Nod2-activating property of 36 MP analogs that had been tested previously for their adjuvanticity and anti-infectious activity.  Using a luciferase-based screen, we demonstrate that addn. of a Me group to the second amino acid of MDP generates a MDP deriv. with enhanced Nod2-activating capacity.  We further validated these results in murine macrophages, human dendritic cells and in vivo.  These results offer a basis for the rational development of synthetic MPs that could be used in the treatment of inflammatory disorders that have been assocd. with Nod2 dysfunction, such as Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2n3YBmuCU7Vg90H21EOLACvtfcHk0ljOZhr9MvCJjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M&md5=5238da0a9a6bbf359078c44f9c84ae09</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1177%2F1753425912471691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912471691%26sid%3Dliteratum%253Aachs%26aulast%3DRubino%26aufirst%3DS.%2BJ.%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DPhilpott%26aufirst%3DD.%26aulast%3DBahr%26aufirst%3DG.%2BM.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DIdentification%2520of%2520a%2520Synthetic%2520Muramyl%2520Peptide%2520Derivative%2520with%2520Enhanced%2520Nod2%2520Stimulatory%2520Capacity%26jtitle%3DInnate%2520Immun.%26date%3D2013%26volume%3D19%26spage%3D493%26epage%3D503%26doi%3D10.1177%2F1753425912471691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waters, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrell, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. H.</span></span> <span> </span><span class="NLM_article-title">Uveitis Induction in the Rabbit by Muramyl Dipeptides</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1128/IAI.51.3.816-825.1986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FIAI.51.3.816-825.1986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3949381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL28XhvF2murk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1986&pages=816-825&author=R.+V.+Watersauthor=T.+G.+Terrellauthor=G.+H.+Jones&title=Uveitis+Induction+in+the+Rabbit+by+Muramyl+Dipeptides&doi=10.1128%2FIAI.51.3.816-825.1986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Uveitis induction in the rabbit by muramyl dipeptides</span></div><div class="casAuthors">Waters, Ruth V.; Terrell, Timothy G.; Jones, Gordon H.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">816-25</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Intraocular inflammation (uveitis) was produced in rabbits by i.v. or s.c. treatment with N-acetylmuramyl-L-alanyl-D-isoglutamine  [53678-77-6] and several of its synthetic analogs at doses of ≤0.2 mg/kg in saline.  A dose-dependent increase in permeability of the ocular blood-aq. barrier as measured by leakage of protein or fluoresceinated dextran from the serum into the eye was obsd. 2-14 h after glycopeptide treatment.  Peak response occurred at ∼3 h postdose.  The lowest dose found to produce maximal vascular leakage for the most active glycopeptide analogs was 1 mg/kg.  The adjuvant-inactive L-L-stereoisomer  [59331-38-3] of N-acetylmurmuramyl-L-alanyl-D-isoglutamine was inactive, even at doses as high as 10 mg/kg.  Analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine which were homologous in the lactyl side chain caused less uveitis.  Chronic biweekly i.v. treatment of rabbits for 1 mo with either N-acetyl-L-α-aminobutyryl-D-isoglutamine  [101910-88-7] or its lipophilic 6-O-stearoyl deriv.  [92627-93-5] at 1 mg/kg, but not with murabutide  [74817-61-1], resulted in leukocytic inflammatory lesions unique to the uveal tract of the eye.  The uveitis was potentially reversible and occurred with decreased severity as long as 2 mo after cessation of chronic treatment.  Pyrogenicity but not adjuvanticity correlated with ability of glycopeptides to induce vascular leakage.  Thus, several adjuvant-active muramyl dipeptide analogs with minimal ability to cause acute vascular leakage or chronic inflammation in the rabbit eye have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4_idkYeCqbVg90H21EOLACvtfcHk0lh4Ju3qCLP-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvF2murk%253D&md5=fa32cb76fe077c195a4279436f51307d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FIAI.51.3.816-825.1986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.51.3.816-825.1986%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DR.%2BV.%26aulast%3DTerrell%26aufirst%3DT.%2BG.%26aulast%3DJones%26aufirst%3DG.%2BH.%26atitle%3DUveitis%2520Induction%2520in%2520the%2520Rabbit%2520by%2520Muramyl%2520Dipeptides%26jtitle%3DInfect.%2520Immun.%26date%3D1986%26volume%3D51%26spage%3D816%26epage%3D825%26doi%3D10.1128%2FIAI.51.3.816-825.1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Enhancement of Nonspecific Immunity to Klebsiella Pneumoniae Infection by a Synthetic Immunoadjuvant (N-Acetylmuramyl-L-Alanyl-D-Isoglutamine) and Several Analogs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2089</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1073/pnas.74.5.2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.74.5.2089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=325566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE2sXksFWms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1977&pages=2089-2093&author=L.+Chedidauthor=M.+Parantauthor=F.+Parantauthor=P.+Lefrancherauthor=J.+Choayauthor=E.+Lederer&title=Enhancement+of+Nonspecific+Immunity+to+Klebsiella+Pneumoniae+Infection+by+a+Synthetic+Immunoadjuvant+%28N-Acetylmuramyl-L-Alanyl-D-Isoglutamine%29+and+Several+Analogs&doi=10.1073%2Fpnas.74.5.2089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs</span></div><div class="casAuthors">Chedid, L.; Parant, M.; Parant, F.; Lefrancier, P.; Choay, J.; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2089-93</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">N-acetylmuramyl-L-alanyl-D-isoglutamine and 4 other synthetic adjuvants that are structural analogs of part of the mycobacterial peptidoglycan monomer are shown to enhance the nonspecific immunity of mice infected by K. pneumoniae.  These compds. are active by various routes, including oral administration; they are also effective when administered after challenge.  Of the 17 other analogs tested, none is able to increase significantly resistance to infection, although 7 of these mols. are adjuvant-active in saline.  Previously it was shown that in contrast to lipopolysaccharides, these synthetic adjuvants are devoid of immunogenicity, mitogenicity, and toxicity in normal or adrenalectomized mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2X-kzpASLF7Vg90H21EOLACvtfcHk0lh4Ju3qCLP-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXksFWms7c%253D&md5=cc35ec34c4e56f9fd0ab5d8c8a68bb64</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1073%2Fpnas.74.5.2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.74.5.2089%26sid%3Dliteratum%253Aachs%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DParant%26aufirst%3DM.%26aulast%3DParant%26aufirst%3DF.%26aulast%3DLefrancher%26aufirst%3DP.%26aulast%3DChoay%26aufirst%3DJ.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DEnhancement%2520of%2520Nonspecific%2520Immunity%2520to%2520Klebsiella%2520Pneumoniae%2520Infection%2520by%2520a%2520Synthetic%2520Immunoadjuvant%2520%2528N-Acetylmuramyl-L-Alanyl-D-Isoglutamine%2529%2520and%2520Several%2520Analogs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1977%26volume%3D74%26spage%3D2089%26epage%3D2093%26doi%3D10.1073%2Fpnas.74.5.2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roychowdhury, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Proinflammatory Properties of Muramyl Tripeptides Containing Lysine and Diaminopimelic Acid Moieties</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2088</span>– <span class="NLM_lpage">2097</span>, <span class="refDoi"> DOI: 10.1002/cbic.200500181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fcbic.200500181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=16222728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ehtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=2088-2097&author=A.+Roychowdhuryauthor=M.+A.+Wolfertauthor=G.+J.+Boons&title=Synthesis+and+Proinflammatory+Properties+of+Muramyl+Tripeptides+Containing+Lysine+and+Diaminopimelic+Acid+Moieties&doi=10.1002%2Fcbic.200500181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and proinflammatory properties of muramyl tripeptides containing lysine and diaminopimelic acid moieties</span></div><div class="casAuthors">Roychowdhury, Abhijit; Wolfert, Margreet A.; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2088-2097</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The unusual amino acid diaminopimelic acid (DAP) was prepd. by cross metathesis of appropriately protected vinyl glycine and allyl glycine derivs.  Catalytic hydrogenation of the cross-coupling product resulted in redn. of the double bond and the removal of protecting groups.  The resulting compds. were appropriately protected for the polymer-supported and soln.-phase synthesis of muramyl tripeptides I [R1 = R2 = NH2 (2) or OH (3)], which differ in the amidation of the α-carboxylic acids of the isoglutamine and DAP moieties.  Muramyl dipeptide (MDP), the DAP-contg. muramyl tripeptide 3, and the lysine-contg. muramyl tripeptides induced TNF-α gene expression without TNF-α protein prodn. in a human monocytic cell line.  The obsd. block in translation could be removed by co-incubation with LPS, resulting in an apparent synergistic effect.  Compd. 2 did not induce TNF-α gene expression, neither did it exhibit a synergistic effect with LPS; this indicates that amidation of the α-carboxylic acids of the isoglutamine and DAP moieties results in a loss of biol. activity.  It is proposed that amidation of α-carboxylic acids is a strategy that may be used by pathogens to avoid detection by the innate immune system.  Furthermore, the pattern recognition receptors Nod1 and Nod2 have been implicated in the possible induction of a synergistic effect of muramoyl peptides with LPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp28ne2N6kjEbVg90H21EOLACvtfcHk0lh4Ju3qCLP-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ehtLvL&md5=d27c8075907ab22788a1c51a46b8ae69</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200500181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200500181%26sid%3Dliteratum%253Aachs%26aulast%3DRoychowdhury%26aufirst%3DA.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DBoons%26aufirst%3DG.%2BJ.%26atitle%3DSynthesis%2520and%2520Proinflammatory%2520Properties%2520of%2520Muramyl%2520Tripeptides%2520Containing%2520Lysine%2520and%2520Diaminopimelic%2520Acid%2520Moieties%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D2088%26epage%3D2097%26doi%3D10.1002%2Fcbic.200500181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervé, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansonetti, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengin-Lecreulx, D.</span></span> <span> </span><span class="NLM_article-title">Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">41702</span>– <span class="NLM_lpage">41708</span>, <span class="refDoi"> DOI: 10.1074/jbc.M307198200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M307198200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12871942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1ams7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=41702-41708&author=S.+E.+Girardinauthor=L.+H.+Travassosauthor=M.+Herv%C3%A9author=D.+Blanotauthor=I.+G.+Bonecaauthor=D.+J.+Philpottauthor=P.+J.+Sansonettiauthor=D.+Mengin-Lecreulx&title=Peptidoglycan+Molecular+Requirements+Allowing+Detection+by+Nod1+and+Nod2&doi=10.1074%2Fjbc.M307198200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2</span></div><div class="casAuthors">Girardin, Stephen E.; Travassos, Leonardo H.; Herve, Mireille; Blanot, Didier; Boneca, Ivo G.; Philpott, Dana J.; Sansonetti, Philippe J.; Mengin-Lecreulx, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">41702-41708</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod1 and Nod2 are mammalian proteins implicated in the intracellular detection of pathogen-assocd. mol. patterns.  Recently, naturally occurring peptidoglycan (PG) fragments were identified as the microbial motifs sensed by Nod1 and Nod2.  Whereas Nod2 detects GlcNAc-MurNAc dipeptide (GM-Di), Nod1 senses a unique diaminopimelate-contg. GlcNAc-MurNAc tripeptide muropeptide (GM-TriDAP) found mostly in Gram-neg. bacterial PGs.  Because Nod1 and Nod2 detect similar yet distinct muropeptides, we further analyzed the mol. sensing specificity of Nod1 and Nod2 toward PG fragments.  Using a wide array of natural or modified muramyl peptides, we show here that Nod1 and Nod2 have evolved divergent strategies to achieve PG sensing.  By defining the PG structural requirements for Nod1 and Nod2 sensing, this study reveals how PG processing and modifications, either by host or bacterial enzymes, may affect innate immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZk7F7GiPHp7Vg90H21EOLACvtfcHk0liUMaoZpP0Zyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1ams7g%253D&md5=0a8a693bc5e596e860206a92a2705d72</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307198200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307198200%26sid%3Dliteratum%253Aachs%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DHerv%25C3%25A9%26aufirst%3DM.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSansonetti%26aufirst%3DP.%2BJ.%26aulast%3DMengin-Lecreulx%26aufirst%3DD.%26atitle%3DPeptidoglycan%2520Molecular%2520Requirements%2520Allowing%2520Detection%2520by%2520Nod1%2520and%2520Nod2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D41702%26epage%3D41708%26doi%3D10.1074%2Fjbc.M307198200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakalarski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mazière, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumperman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delamarre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span> <span> </span><span class="NLM_article-title">Endosomes Are Specialized Platforms for Bacterial Sensing and NOD2 Signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1038/nature13133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnature13133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=24695226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=240-244&author=N.+Nakamuraauthor=J.+R.+Lillauthor=Q.+Phungauthor=Z.+Jiangauthor=C.+Bakalarskiauthor=A.+De+Mazi%C3%A8reauthor=J.+Klumpermanauthor=M.+Schlatterauthor=L.+Delamarreauthor=I.+Mellman&title=Endosomes+Are+Specialized+Platforms+for+Bacterial+Sensing+and+NOD2+Signalling&doi=10.1038%2Fnature13133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomes are specialized platforms for bacterial sensing and NOD2 signalling</span></div><div class="casAuthors">Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; de Maziere, Ann; Klumperman, Judith; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7499</span>),
    <span class="NLM_cas:pages">240-244</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The detection of microbial pathogens involves the recognition of conserved microbial components by host cell sensors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs).  TLRs are membrane receptors that survey the extracellular environment for microbial infections, whereas NLRs are cytosolic complexes that detect microbial products that reach the cytosol.  Upon detection, both sensor classes trigger innate inflammatory responses and allow the engagement of adaptive immunity.  Endo-lysosomes are the entry sites for a variety of pathogens, and therefore the sites at which the immune system first senses their presence.  Pathogens internalized by endocytosis are well known to activate TLRs 3 and 7-9 that are localized to endocytic compartments and detect ligands present in the endosomal lumen.  Internalized pathogens also activate sensors in the cytosol such as NOD1 and NOD2 (ref. 2), indicating that endosomes also provide for the translocation of bacterial components across the endosomal membrane.  Despite the fact that NOD2 is well understood to have a key role in regulating innate immune responses and that mutations at the NOD2 locus are a common risk factor in inflammatory bowel disease and possibly other chronic inflammatory states, little is known about how its ligands escape from endosomes.  Here we show that two endo-lysosomal peptide transporters, SLC15A3 and SLC15A4, are preferentially expressed by dendritic cells, esp. after TLR stimulation.  The transporters mediate the egress of bacterially derived components, such as the NOD2 cognate ligand muramyl dipeptide (MDP), and are selectively required for NOD2 responses to endosomally derived MDP.  Enhanced expression of the transporters also generates endosomal membrane tubules characteristic of dendritic cells, which further enhanced the NOD2-dependent response to MDP.  Finally, sensing required the recruitment of NOD2 and its effector kinase RIPK2 to the endosomal membrane, possibly by forming a complex with SLC15A3 or SLC15A4.  Thus, dendritic cell endosomes are specialized platforms for both the lumenal and cytosolic sensing of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoppdcGuBL0_bVg90H21EOLACvtfcHk0liUMaoZpP0Zyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D&md5=dd38ce753d9529651acea52f83a753b1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnature13133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13133%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DPhung%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DBakalarski%26aufirst%3DC.%26aulast%3DDe%2BMazi%25C3%25A8re%26aufirst%3DA.%26aulast%3DKlumperman%26aufirst%3DJ.%26aulast%3DSchlatter%26aufirst%3DM.%26aulast%3DDelamarre%26aufirst%3DL.%26aulast%3DMellman%26aufirst%3DI.%26atitle%3DEndosomes%2520Are%2520Specialized%2520Platforms%2520for%2520Bacterial%2520Sensing%2520and%2520NOD2%2520Signalling%26jtitle%3DNature%26date%3D2014%26volume%3D509%26spage%3D240%26epage%3D244%26doi%3D10.1038%2Fnature13133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marina-García, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, G.</span></span> <span> </span><span class="NLM_article-title">Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">4321</span>– <span class="NLM_lpage">4327</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.0802197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19299732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=4321-4327&author=N.+Marina-Garc%C3%ADaauthor=L.+Franchiauthor=Y.-G.+Kimauthor=Y.+Huauthor=D.+E.+Smithauthor=G.-J.+Boonsauthor=G.+N%C3%BA%C3%B1ez&title=Clathrin-+and+Dynamin-Dependent+Endocytic+Pathway+Regulates+Muramyl+Dipeptide+Internalization+and+NOD2+Activation&doi=10.4049%2Fjimmunol.0802197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation</span></div><div class="casAuthors">Marina-Garcia, Noemi; Franchi, Luigi; Kim, Yun-Gi; Hu, Yonjun; Smith, David E.; Boons, Geert-Jan; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4321-4327</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP), the NOD2 agonist, induces NF-κB and MAPK activation leading to the prodn. of antimicrobial and proinflammatory mols.  MDP is internalized into acidified vesicles in macrophages.  However, the endocytic mechanism of MDP uptake that induces NOD2 signaling is unknown.  We now report the identification of an endocytosis pathway dependent on clathrin and dynamin that mediates MDP internalization and NOD2 activation.  Intracellular MDP uptake was inhibited by chlorpromazine, a drug that disrupts clathrin-dependent endocytosis, but not by compds. that block pinocytosis or cellular entry via scavenger or mannose receptors.  In contrast, MDP uptake and NOD2-dependent signaling were unimpaired in macrophages deficient in PepT1, a peptide transporter previously implicated in MDP internalization.  Both chlorpromazine and knockdown of clathrin expression by RNA interference attenuated MDP-induced NF-κB and MAPK activation.  Furthermore, MDP uptake and NOD2-dependent signaling were impaired by inhibition of dynamin, a GTPase required for budding of clathrin-coated vesicles from the plasma membrane.  Finally, bafilomycin A, a specific inhibitor of the vacuolar proton pump, blocked MDP accumulation in acidified vesicles and cytokine responses, suggesting that vacuolar maturation is important for MDP-induced NOD2 signaling.  These studies provide evidence for a clathrin- and dynamin-dependent endocytosis pathway that mediates MDP uptake and NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8_dCzxcnmtrVg90H21EOLACvtfcHk0liUMaoZpP0Zyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D&md5=7df403b628d10949d61a470550e7ae02</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802197%26sid%3Dliteratum%253Aachs%26aulast%3DMarina-Garc%25C3%25ADa%26aufirst%3DN.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DY.-G.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DBoons%26aufirst%3DG.-J.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26atitle%3DClathrin-%2520and%2520Dynamin-Dependent%2520Endocytic%2520Pathway%2520Regulates%2520Muramyl%2520Dipeptide%2520Internalization%2520and%2520NOD2%2520Activation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D4321%26epage%3D4327%26doi%3D10.4049%2Fjimmunol.0802197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattoli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtal, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavricka, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">PH-Dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">23818</span>– <span class="NLM_lpage">23829</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.033670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M109.033670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19570976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=23818-23829&author=J.+Leeauthor=I.+Tattoliauthor=K.+A.+Wojtalauthor=S.+R.+Vavrickaauthor=D.+J.+Philpottauthor=S.+E.+Girardin&title=PH-Dependent+Internalization+of+Muramyl+Peptides+from+Early+Endosomes+Enables+Nod1+and+Nod2+Signaling&doi=10.1074%2Fjbc.M109.033670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling</span></div><div class="casAuthors">Lee, Jooeun; Tattoli, Ivan; Wojtal, Kacper A.; Vavricka, Stephan R.; Philpott, Dana J.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">23818-23829</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides.  The biol. effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear.  Using the human epithelial cell line HEK293T as a model system, the authors demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-β-cyclodextrin.  In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6.  Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5.  Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands.  In support for this, the authors identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-κB signaling.  Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder assocd. with mutations in Nod1 and Nod2.  Together, the authors' results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyr2dvGF25XrVg90H21EOLACvtfcHk0lhNV03PDK5guQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J&md5=ce9181846219003ee56b3c0e487d591c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033670%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTattoli%26aufirst%3DI.%26aulast%3DWojtal%26aufirst%3DK.%2BA.%26aulast%3DVavricka%26aufirst%3DS.%2BR.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DPH-Dependent%2520Internalization%2520of%2520Muramyl%2520Peptides%2520from%2520Early%2520Endosomes%2520Enables%2520Nod1%2520and%2520Nod2%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D23818%26epage%3D23829%26doi%3D10.1074%2Fjbc.M109.033670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vavricka, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musch, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phanvijhitsiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waypa, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneewind, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. B.</span></span> <span> </span><span class="NLM_article-title">HPepT1 Transports Muramyl Dipeptide, Activating NF-κB and Stimulating IL-8 Secretion in Human Colonic Caco2/Bbe Cells</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">1401</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2004.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1053%2Fj.gastro.2004.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15521010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1401-1409&author=S.+R.+Vavrickaauthor=M.+W.+Muschauthor=J.+E.+Changauthor=Y.+Nakagawaauthor=K.+Phanvijhitsiriauthor=T.+S.+Waypaauthor=D.+Merlinauthor=O.+Schneewindauthor=E.+B.+Chang&title=HPepT1+Transports+Muramyl+Dipeptide%2C+Activating+NF-%CE%BAB+and+Stimulating+IL-8+Secretion+in+Human+Colonic+Caco2%2FBbe+Cells&doi=10.1053%2Fj.gastro.2004.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">HPepT1 transports muramyl dipeptide, activating NF-.vkappa.1B and stimulating IL-8 secretion in human colonic Caco2/bbe cells</span></div><div class="casAuthors">Vavricka, Stephan R.; Musch, Mark W.; Chang, Jonathan E.; Nakagawa, Yasushi; Phanvijhitsiri, Kittiporn; Waypa, Tonya S.; Merlin, Didier; Schneewind, Olaf; Chang, Eugene B.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1401-1409</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Bacterial proteoglycan-derived muramyl dipeptide (MDP) activates the intracellular NOD2/CARD15 gene product.  How intestinal epithelial cells take up MDP is poorly understood.  We hypothesized that the intestinal apical di-/tripeptide transporter, hPepT1, transports MDP, thereby activating downstream pathways similar to nuclear factor κ B (NF-κB).  Time- and concn.-dependent 3H-MDP uptakes were studied in Caco2/bbe (C2) cell monolayers where hPepT1 expression was either over- or underexpressed, using an inducible adenovirus system or silencing RNA (siRNA), resp.  NF-κB activation and interleukin (IL)-8 and monocyte chemoattractant protein-1 (MCP-1) release were detd. by ELISA.  NOD2/CARD15 expression was inhibited by siRNA.  MDP in human duodenal, cecal, and stool samples was measured.  MDP, but not its isoforms, inhibited uptake of glycosylsarcosine in C2 cells, indicating stereoselective and competitive inhibition.  Approx. 90% of the MDP was cytosolic, showing uptake rather than binding.  The Km for MDP uptake was 4.3 mmol/L.  Cells overexpressing hPepT1 showed increased Gly-Sar and MDP uptake, whereas decreased uptake was obsd. after hPepT1 siRNA-inhibition.  MDP treatment activated NF-κB, resulting in IL-8 release, an effect blocked by siRNA-inhibited expression of NOD2/CARD15.  MDP content in cecal and stool samples (in normal subjects) was 20-87 μmol/L, but undetectable in duodenal fluid.  In colonic epithelial cells, MDP is taken up by hPepT1 and activates NF-κB and chemokine prodn.  Because hPepT1 expression in chronic colonic inflammation is increased, this may play an important role in promoting colonocyte participation in host defense and pathogen clearance through increased uptake of MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbKSWLRST-IrVg90H21EOLACvtfcHk0lhNV03PDK5guQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKisrzE&md5=76223a95416d7f9f866c828da4cbfdfd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2004.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2004.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DVavricka%26aufirst%3DS.%2BR.%26aulast%3DMusch%26aufirst%3DM.%2BW.%26aulast%3DChang%26aufirst%3DJ.%2BE.%26aulast%3DNakagawa%26aufirst%3DY.%26aulast%3DPhanvijhitsiri%26aufirst%3DK.%26aulast%3DWaypa%26aufirst%3DT.%2BS.%26aulast%3DMerlin%26aufirst%3DD.%26aulast%3DSchneewind%26aufirst%3DO.%26aulast%3DChang%26aufirst%3DE.%2BB.%26atitle%3DHPepT1%2520Transports%2520Muramyl%2520Dipeptide%252C%2520Activating%2520NF-%25CE%25BAB%2520and%2520Stimulating%2520IL-8%2520Secretion%2520in%2520Human%2520Colonic%2520Caco2%252FBbe%2520Cells%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1401%26epage%3D1409%26doi%3D10.1053%2Fj.gastro.2004.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smrdel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabnar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Černe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrenšek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovačič, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogataj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urleb, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrhar, A.</span></span> <span> </span><span class="NLM_article-title">Physicochemical and Preclinical Pharmacokinetic and Toxicological Evaluation of LK-423—a New Phthalimido-Desmuramyl-Dipeptide Derivative with Immunomodulating Activity</span>. <i>Drug Dev. Ind. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.3109/03639040902889814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3109%2F03639040902889814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19832629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1293-1304&author=P.+Smrdelauthor=I.+Grabnarauthor=I.+Locatelliauthor=M.+%C4%8Cerneauthor=S.+Andren%C5%A1ekauthor=N.+Kova%C4%8Di%C4%8Dauthor=A.+Kristlauthor=M.+Bogatajauthor=U.+Urlebauthor=A.+Mrhar&title=Physicochemical+and+Preclinical+Pharmacokinetic+and+Toxicological+Evaluation+of+LK-423%E2%80%94a+New+Phthalimido-Desmuramyl-Dipeptide+Derivative+with+Immunomodulating+Activity&doi=10.3109%2F03639040902889814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423 phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity</span></div><div class="casAuthors">Smrdel, Polona; Grabnar, Iztok; Locatelli, Igor; Cerne, Manica; Andrensek, Samo; Kovacic, Natasa; Kristl, Albin; Bogataj, Marija; Urleb, Uros; Mrhar, Ales</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1293-1304</span>CODEN:
                <span class="NLM_cas:coden">DDIPD8</span>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">LK-423 is a new phthalimido-desmuramyl-dipeptide deriv. with immunomodulating activity.  As optimized delivery to the site of action appears crucial for further preclin. development of LK-423, the aim of this study was to perform a physicochem. and preclin. pharmacokinetic and toxicol. evaluation.  The soly., partition coeff., permeability, and stability profile were detd.  Pharmacokinetics were evaluated in rats following i.v. and oral application of LK-423, and in dogs after i.v. administration and oral administration of microcapsules, designed for colon-specific delivery of LK-423 based on pH-, time-, and enzyme-controlled release mechanisms.  Addnl., the acute and subchronic toxicity was examd.  LK-423 is hydrophilic, sparingly to slightly sol., and poorly permeable.  Stability profile in aq. soln. is pH dependent.  A pharmacokinetic study following i.v. application to rats and dogs revealed that LK-423 is rapidly eliminated with a short terminal phase half-life, and high plasma clearance, as well as a limited distribution to the peripheral tissue.  Oral bioavailability of LK-423 is low, presumably due to low permeability.  Debris of insol. microcapsule coating in feces and obtained plasma concn. profiles confirm that LK-423 microcapsules are a promising approach for local treatment of inflammatory diseases of the large intestine.  Acute and a subchronic toxicity results indicate that LK-423 is a safe and nontoxic drug under the applied exptl. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLWRgVEBDtmbVg90H21EOLACvtfcHk0ljeRMMiTIETGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrnL&md5=c73a505d4c1f75ae9ab8d51da65a14c4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3109%2F03639040902889814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03639040902889814%26sid%3Dliteratum%253Aachs%26aulast%3DSmrdel%26aufirst%3DP.%26aulast%3DGrabnar%26aufirst%3DI.%26aulast%3DLocatelli%26aufirst%3DI.%26aulast%3D%25C4%258Cerne%26aufirst%3DM.%26aulast%3DAndren%25C5%25A1ek%26aufirst%3DS.%26aulast%3DKova%25C4%258Di%25C4%258D%26aufirst%3DN.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DBogataj%26aufirst%3DM.%26aulast%3DUrleb%26aufirst%3DU.%26aulast%3DMrhar%26aufirst%3DA.%26atitle%3DPhysicochemical%2520and%2520Preclinical%2520Pharmacokinetic%2520and%2520Toxicological%2520Evaluation%2520of%2520LK-423%25E2%2580%2594a%2520New%2520Phthalimido-Desmuramyl-Dipeptide%2520Derivative%2520with%2520Immunomodulating%2520Activity%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2009%26volume%3D35%26spage%3D1293%26epage%3D1304%26doi%3D10.3109%2F03639040902889814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamawaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, Y.</span></span> <span> </span><span class="NLM_article-title">Adjuvant Activity of Synthetic 6-O-’mycoloyl’-N-Acetylmuramyl-L-Alanyl-D-Isoglutamine and Related Compounds</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1128/IAI.20.3.600-607.1978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2Fiai.20.3.600-607.1978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=97234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE1cXltVGlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1978&pages=600-607&author=I.+Azumaauthor=K.+Sugimuraauthor=M.+Yamawakiauthor=M.+Uemiyaauthor=S.+Kusumotoauthor=S.+Okadaauthor=T.+Shibaauthor=Y.+Yamamura&title=Adjuvant+Activity+of+Synthetic+6-O-%E2%80%99mycoloyl%E2%80%99-N-Acetylmuramyl-L-Alanyl-D-Isoglutamine+and+Related+Compounds&doi=10.1128%2FIAI.20.3.600-607.1978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds</span></div><div class="casAuthors">Azuma, Ichiro; Sugimura, Kazuhisa; Yamawaki, Mikio; Uemiya, Masanao; Kusumoto, Shoichi; Okada, Satoshi; Shiba, Tetsuo; Yamamura, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">600-7</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Adjuvant and antitumor activities of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine were examd.  All the synthetic 6-O-corynomycoloyl-, 6-O-nocardomycoloyl-, and 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine were active as adjuvants for cell-mediated immune responses.  However, 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine was less active as an adjuvant on circulating antibody formation.  It was shown that pyrogenic activity of N-acetylmuramyldipeptide was reduced by 6-O-acylation with mycolic acid, but not with nocardomycolic or corynomycolic acids.  Tumor-suppression activity was obsd. by the synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine by using transplantable tumor in syngenic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY1SYthz4YMrVg90H21EOLACvtfcHk0ljeRMMiTIETGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXltVGlt7w%253D&md5=818773f59eabe3932fccdc1bab99b05e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1128%2Fiai.20.3.600-607.1978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fiai.20.3.600-607.1978%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DI.%26aulast%3DSugimura%26aufirst%3DK.%26aulast%3DYamawaki%26aufirst%3DM.%26aulast%3DUemiya%26aufirst%3DM.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DShiba%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DY.%26atitle%3DAdjuvant%2520Activity%2520of%2520Synthetic%25206-O-%25E2%2580%2599mycoloyl%25E2%2580%2599-N-Acetylmuramyl-L-Alanyl-D-Isoglutamine%2520and%2520Related%2520Compounds%26jtitle%3DInfect.%2520Immun.%26date%3D1978%26volume%3D20%26spage%3D600%26epage%3D607%26doi%3D10.1128%2FIAI.20.3.600-607.1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamet, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span> <span> </span><span class="NLM_article-title">Apyrogenic, Adjuvant-Active N-Acetylmuramyl-Dipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1021/jm00343a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00343a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL38XkslU%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=87-90&author=P.+Lefrancierauthor=M.+Derrienauthor=X.+Jametauthor=J.+Choayauthor=E.+Ledererauthor=F.+Audibertauthor=M.+Parantauthor=F.+Parantauthor=L.+Chedid&title=Apyrogenic%2C+Adjuvant-Active+N-Acetylmuramyl-Dipeptides&doi=10.1021%2Fjm00343a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides</span></div><div class="casAuthors">Lefrancier, Pierre; Derrien, Marcel; Jamet, Xavier; Choay, Jean; Lederer, Edgar; Audibert, Francoise; Parant, Monique; Parant, Francine; Chedid, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-90</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Seven analogs I (R = alkyl) of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) were synthesized in which the D-isoglutaminyl residue was replaced by D-glutamine alkyl esters.  They are all adjuvant active; however, their i.v. injection does not induce a febrile response in rabbits at a dose of 10 mg/kg, in contrast to MDP in which the minimal pyrogenic dose is 25 μg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9wAiNEhILbVg90H21EOLACvtfcHk0ljeRMMiTIETGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslU%253D&md5=6813ca9606d5a0e0e7822292aa305207</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm00343a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00343a018%26sid%3Dliteratum%253Aachs%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DDerrien%26aufirst%3DM.%26aulast%3DJamet%26aufirst%3DX.%26aulast%3DChoay%26aufirst%3DJ.%26aulast%3DLederer%26aufirst%3DE.%26aulast%3DAudibert%26aufirst%3DF.%26aulast%3DParant%26aufirst%3DM.%26aulast%3DParant%26aufirst%3DF.%26aulast%3DChedid%26aufirst%3DL.%26atitle%3DApyrogenic%252C%2520Adjuvant-Active%2520N-Acetylmuramyl-Dipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D87%26epage%3D90%26doi%3D10.1021%2Fjm00343a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Needham, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawden, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfield, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bone, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotherton, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krige, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legris, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testar, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, A. H.</span></span> <span> </span><span class="NLM_article-title">Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1124/jpet.111.183640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1124%2Fjpet.111.183640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21778281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=132-142&author=L.+A.+Needhamauthor=A.+H.+Davidsonauthor=L.+J.+Bawdenauthor=A.+Belfieldauthor=E.+A.+Boneauthor=D.+H.+Brothertonauthor=S.+Bryantauthor=M.+H.+Charltonauthor=V.+L.+Clarkauthor=S.+J.+Daviesauthor=A.+Donaldauthor=F.+A.+Dayauthor=D.+Krigeauthor=V.+Legrisauthor=J.+McDermottauthor=Y.+McGovernauthor=J.+Owenauthor=S.+R.+Patelauthor=S.+Pintatauthor=R.+J.+Testarauthor=G.+M.+A.+Wellsauthor=D.+Moffatauthor=A.+H.+Drummond&title=Drug+Targeting+to+Monocytes+and+Macrophages+Using+Esterase-Sensitive+Chemical+Motifs&doi=10.1124%2Fjpet.111.183640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs</span></div><div class="casAuthors">Needham, Lindsey A.; Davidson, Alan H.; Bawden, Lindsay J.; Belfield, Andrew; Bone, Elisabeth A.; Brotherton, Deborah H.; Bryant, Sam; Charlton, Michael H.; Clark, Vanessa L.; Davies, Stephen J.; Donald, Alastair; Day, Francesca A.; Krige, David; Legris, Valerie; McDermott, Joanne; McGovern, Yvonne; Owen, Jo; Patel, Sanjay R.; Pintat, Stephane; Testar, Richard J.; Wells, Graham M. A.; Moffat, David; Drummond, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The therapeutic and toxic effects of drugs are often generated through effects on distinct cell types in the body.  Selective delivery of drugs to specific cells or cell lineages would, therefore, have major advantages, in particular, the potential to significantly improve the therapeutic window of an agent.  Cells of the monocyte-macrophage lineage represent an important target for many therapeutic agents because of their central involvement in a wide range of diseases including inflammation, cancer, atherosclerosis, and diabetes.  We have developed a versatile chem. platform that is designed to enhance the potency and delivery of small-mol. drugs to intracellular mol. targets.  One facet of the technol. involves the selective delivery of drugs to cells of the monocyte-macrophage lineage, using the intracellular carboxylesterase, human carboxylesterase-1 (hCE-1), which is expressed predominantly in these cells.  Here, we demonstrate selective delivery of many types of intracellularly targeted small mols. to monocytes and macrophages by attaching a small esterase-sensitive chem. motif (ESM) that is selectively hydrolyzed within these cells to a charged, pharmacol. active drug.  ESM versions of histone deacetylase (HDAC) inhibitors, for example, are extremely potent anticytokine and antiarthritic agents with a wider therapeutic window than conventional HDAC inhibitors.  In human blood, effects on monocytes (hCE-1-pos.) are seen at concns. 1000-fold lower than those that affect other cell types (hCE-1-neg.).  Chem. conjugates of this type, by limiting effects on other cells, could find widespread applicability in the treatment of human diseases where monocyte-macrophages play a key role in disease pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5B4-j7rP0LVg90H21EOLACvtfcHk0lhP7-G7Y8TTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnL&md5=c71ecc27d0f43ef10c0ee8778a36d4d3</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.183640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.183640%26sid%3Dliteratum%253Aachs%26aulast%3DNeedham%26aufirst%3DL.%2BA.%26aulast%3DDavidson%26aufirst%3DA.%2BH.%26aulast%3DBawden%26aufirst%3DL.%2BJ.%26aulast%3DBelfield%26aufirst%3DA.%26aulast%3DBone%26aufirst%3DE.%2BA.%26aulast%3DBrotherton%26aufirst%3DD.%2BH.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCharlton%26aufirst%3DM.%2BH.%26aulast%3DClark%26aufirst%3DV.%2BL.%26aulast%3DDavies%26aufirst%3DS.%2BJ.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DDay%26aufirst%3DF.%2BA.%26aulast%3DKrige%26aufirst%3DD.%26aulast%3DLegris%26aufirst%3DV.%26aulast%3DMcDermott%26aufirst%3DJ.%26aulast%3DMcGovern%26aufirst%3DY.%26aulast%3DOwen%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DPintat%26aufirst%3DS.%26aulast%3DTestar%26aufirst%3DR.%2BJ.%26aulast%3DWells%26aufirst%3DG.%2BM.%2BA.%26aulast%3DMoffat%26aufirst%3DD.%26aulast%3DDrummond%26aufirst%3DA.%2BH.%26atitle%3DDrug%2520Targeting%2520to%2520Monocytes%2520and%2520Macrophages%2520Using%2520Esterase-Sensitive%2520Chemical%2520Motifs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D132%26epage%3D142%26doi%3D10.1124%2Fjpet.111.183640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltiel, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fergus, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt-Leopold, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marston, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tecle, H.</span></span> <span> </span><span class="NLM_article-title">The Discovery of the Benzhydroxamate MEK Inhibitors CI-1040 and PD 0325901</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6501</span>– <span class="NLM_lpage">6504</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.bmcl.2008.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18952427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6501-6504&author=S.+D.+Barrettauthor=A.+J.+Bridgesauthor=D.+T.+Dudleyauthor=A.+R.+Saltielauthor=J.+H.+Fergusauthor=C.+M.+Flammeauthor=A.+M.+Delaneyauthor=M.+Kaufmanauthor=S.+Lepageauthor=W.+R.+Leopoldauthor=S.+A.+Przybranowskiauthor=J.+Sebolt-Leopoldauthor=K.+Van+Becelaereauthor=A.+M.+Dohertyauthor=R.+M.+Kennedyauthor=D.+Marstonauthor=W.+A.+Howardauthor=Y.+Smithauthor=J.+S.+Warmusauthor=H.+Tecle&title=The+Discovery+of+the+Benzhydroxamate+MEK+Inhibitors+CI-1040+and+PD+0325901&doi=10.1016%2Fj.bmcl.2008.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901</span></div><div class="casAuthors">Barrett, Stephen D.; Bridges, Alexander J.; Dudley, David T.; Saltiel, Alan R.; Fergus, James H.; Flamme, Cathlin M.; Delaney, Amy M.; Kaufman, Michael; LePage, Sophie; Leopold, Wilbur R.; Przybranowski, Sally A.; Sebolt-Leopold, Judith; Van Becelaere, Keri; Doherty, Annette M.; Kennedy, Robert M.; Marston, Dan; Howard, W. Allen, Jr.; Smith, Yvonne; Warmus, Joseph S.; Tecle, Haile</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6501-6504</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of benzhydroxamate esters derived from their precursor anthranilic acids have been prepd. and have been identified as potent MEK inhibitors.  CI-1040 (I) was the first MEK inhibitor to demonstrate in vivo activity in preclin. animal models and subsequently became the first MEK inhibitor to enter clin. trial.  CI-1040 suffered however from poor exposure due to its poor soly. and rapid clearance, and as a result, development of the compd. was terminated.  Optimization of the diphenylamine core and modification of the hydroxamate side chain for cell potency, soly., and exposure with oral delivery resulted in the discovery of the clin. candidate PD 0325901 (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpam9NxZxX93rVg90H21EOLACvtfcHk0lhP7-G7Y8TTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI&md5=e64f7ae6a446c504528621e7d14d67ce</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DS.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26aulast%3DFergus%26aufirst%3DJ.%2BH.%26aulast%3DFlamme%26aufirst%3DC.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DLepage%26aufirst%3DS.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DPrzybranowski%26aufirst%3DS.%2BA.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DKennedy%26aufirst%3DR.%2BM.%26aulast%3DMarston%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DTecle%26aufirst%3DH.%26atitle%3DThe%2520Discovery%2520of%2520the%2520Benzhydroxamate%2520MEK%2520Inhibitors%2520CI-1040%2520and%2520PD%25200325901%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6501%26epage%3D6504%26doi%3D10.1016%2Fj.bmcl.2008.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, R.</span></span> <span> </span><span class="NLM_article-title">Prodrugs Design Based on Inter- and Intramolecular Chemical Processes</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fcbdd.12224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23998799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVajurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=643-668&author=R.+Karaman&title=Prodrugs+Design+Based+on+Inter-+and+Intramolecular+Chemical+Processes&doi=10.1111%2Fcbdd.12224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs Design Based on Inter- and Intramolecular Chemical Processes</span></div><div class="casAuthors">Karaman, Rafik</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">643-668</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This review provides the reader a concise overview of the majority of prodrug approaches with the emphasis on the modern approaches to prodrug design.  The chem. approach catalyzed by metabolic enzymes which is considered as widely used among all other approaches to minimize the undesirable drug physicochem. properties is discussed.  Part of this review will shed light on the use of MO methods such as DFT, semiempirical and ab initio for the design of novel prodrugs.  This novel prodrug approach implies prodrug design based on enzyme models that were utilized for mimicking enzyme catalysis.  The computational approach exploited for the prodrug design involves MO and mol. mechanics (DFT,ab initio, and MM2) calcns. and correlations between exptl. and calcd. values of intramol. processes that were exptl. studied to assign the factors detg. the reaction rates in certain processes for better understanding on how enzymes might exert their extraordinary catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWvKE8uQzlT7Vg90H21EOLACvtfcHk0ljvWQj67MBzbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVajurfL&md5=5d94c6ea1d0e7e71c646cd70dfccc2d0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12224%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DR.%26atitle%3DProdrugs%2520Design%2520Based%2520on%2520Inter-%2520and%2520Intramolecular%2520Chemical%2520Processes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D82%26spage%3D643%26epage%3D668%26doi%3D10.1111%2Fcbdd.12224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J. A.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Cleavage of Benzyl Ethers, Esters, and Carbamates in the Presence of Other Easily Reducible Groups</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1999</i></span> (<span class="NLM_issue">S1</span>),  <span class="NLM_fpage">1399</span>– <span class="NLM_lpage">1400</span>, <span class="refDoi"> DOI: 10.1055/s-1999-3664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1055%2Fs-1999-3664" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1999&publication_year=1999&pages=1399-1400&issue=S1&author=R.+S.+Colemanauthor=J.+A.+Shah&title=Chemoselective+Cleavage+of+Benzyl+Ethers%2C+Esters%2C+and+Carbamates+in+the+Presence+of+Other+Easily+Reducible+Groups&doi=10.1055%2Fs-1999-3664"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1055%2Fs-1999-3664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1999-3664%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BS.%26aulast%3DShah%26aufirst%3DJ.%2BA.%26atitle%3DChemoselective%2520Cleavage%2520of%2520Benzyl%2520Ethers%252C%2520Esters%252C%2520and%2520Carbamates%2520in%2520the%2520Presence%2520of%2520Other%2520Easily%2520Reducible%2520Groups%26jtitle%3DSynthesis%26date%3D1999%26volume%3D1999%26issue%3DS1%26spage%3D1399%26epage%3D1400%26doi%3D10.1055%2Fs-1999-3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppeck, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span> <span> </span><span class="NLM_article-title">A Convenient and Scaleable Procedure for Removing the Fmoc Group in Solution</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">5329</span>– <span class="NLM_lpage">5333</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)00853-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0040-4039%2800%2900853-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslWmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=5329-5333&author=J.+E.+Sheppeckauthor=H.+Karauthor=H.+Hong&title=A+Convenient+and+Scaleable+Procedure+for+Removing+the+Fmoc+Group+in+Solution&doi=10.1016%2FS0040-4039%2800%2900853-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient and scaleable procedure for removing the Fmoc group in solution</span></div><div class="casAuthors">Sheppeck, J. E.; Kar, H.; Hong, H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">5329-5333</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An improved and simple reagent system was developed to facilitate soln.-phase deprotection of Fmoc-protected amino acids.  Catalytic DBU in the presence of an aliph. or polymer-supported thiol rapidly removed the Fmoc group to provide the amine free base in excellent yields and purity on multi-gram scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRwEh4RdXYILVg90H21EOLACvtfcHk0ljvWQj67MBzbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslWmurc%253D&md5=7eda49e1d4c0b550b73bb3783dcae388</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2900853-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252900853-4%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DKar%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DH.%26atitle%3DA%2520Convenient%2520and%2520Scaleable%2520Procedure%2520for%2520Removing%2520the%2520Fmoc%2520Group%2520in%2520Solution%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D5329%26epage%3D5333%26doi%3D10.1016%2FS0040-4039%2800%2900853-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">A Novel Immunostimulator, N2-[α-O-Benzyl-N-(Acetylmuramyl) -L-Alanyl-D-Isoglutaminyl]-N6-Trans-(m-Nitrocinnamoyl)-L-Lysine, and Its Adjuvancy on the Hepatitis B Surface Antigen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5112</span>– <span class="NLM_lpage">5122</span>, <span class="refDoi"> DOI: 10.1021/jm0493313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0493313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVCltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5112-5122&author=H.-Z.+Yangauthor=S.+Xuauthor=X.-Y.+Liaoauthor=S.-D.+Zhangauthor=Z.-L.+Liangauthor=B.-H.+Liuauthor=J.-Y.+Baiauthor=C.+Jiangauthor=J.+Dingauthor=G.-F.+Chengauthor=G.+Liu&title=A+Novel+Immunostimulator%2C+N2-%5B%CE%B1-O-Benzyl-N-%28Acetylmuramyl%29+-L-Alanyl-D-Isoglutaminyl%5D-N6-Trans-%28m-Nitrocinnamoyl%29-L-Lysine%2C+and+Its+Adjuvancy+on+the+Hepatitis+B+Surface+Antigen&doi=10.1021%2Fjm0493313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Immunostimulator, N2-[α-O-Benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and Its Adjuvancy on the Hepatitis B Surface Antigen</span></div><div class="casAuthors">Yang, Hong-Zhen; Xu, Song; Liao, Xue-Yan; Zhang, Suo-De; Liang, Zheng-Lun; Liu, Bai-He; Bai, Jin-Ye; Jiang, Chao; Ding, Jian; Cheng, Gui-Fang; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5112-5122</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Muramyl dipeptide C (MDP-C), N2-[α-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, has been synthesized as a novel, nonspecific immunomodulator.  This study shows that MDP-C induces strong cytolytic activity by macrophages on P388 leukemia cells and cytotoxic activity by cytotoxic T lymphocytes (CTLs) on P815 mastocytoma cells.  The results also indicate that MDP-C is an effective stimulator for prodn. of interleukin-2 and interleukin-12 by murine bone morrow derived dendritic cells (BMDCs) and prodn. of interferon-γ by CTLs.  Addnl., MDP-C increases the expression levels of several surface mols., including CD11c, MHC class I, and intercellular adhesion mol.-1 in BMDCs.  Moreover, MDP-C remarkably enhances the immune system's responsiveness to hepatitis B surface antigen (HBsAg) in hepatitis B virus transgenic mice for both antibody prodn. and specific HBsAg T-cell responses ex vivo.  Thus, MDP-C is an apyrogenic, nonallergenic, and low-toxicity immunostimulator with great potential for diagnostic, immunotherapeutic, and prophylactic applications in diseases such as hepatitis B and cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQgp5am5lbGLVg90H21EOLACvtfcHk0ljvWQj67MBzbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVCltrg%253D&md5=664055ca9ac2df91e0ef0f2067801bb1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm0493313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493313%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.-Z.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DX.-Y.%26aulast%3DZhang%26aufirst%3DS.-D.%26aulast%3DLiang%26aufirst%3DZ.-L.%26aulast%3DLiu%26aufirst%3DB.-H.%26aulast%3DBai%26aufirst%3DJ.-Y.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.-F.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DA%2520Novel%2520Immunostimulator%252C%2520N2-%255B%25CE%25B1-O-Benzyl-N-%2528Acetylmuramyl%2529%2520-L-Alanyl-D-Isoglutaminyl%255D-N6-Trans-%2528m-Nitrocinnamoyl%2529-L-Lysine%252C%2520and%2520Its%2520Adjuvancy%2520on%2520the%2520Hepatitis%2520B%2520Surface%2520Antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5112%26epage%3D5122%26doi%3D10.1021%2Fjm0493313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Effenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek Knötigová, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zyka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čelechovská, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartheldyová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubatka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudelka, Š.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukáč, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalová, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šaman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Křupka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkocziova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosztyu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šebela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drož, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hučko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanásová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledvina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span> <span> </span><span class="NLM_article-title">Nonpyrogenic Molecular Adjuvants Based on NorAbu-Muramyldipeptide and NorAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7745</span>– <span class="NLM_lpage">7763</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00593</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00593" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7745-7763&author=R.+Effenbergauthor=P.+Tur%C3%A1nek+Kn%C3%B6tigov%C3%A1author=D.+Zykaauthor=H.+%C4%8Celechovsk%C3%A1author=J.+Ma%C5%A1ekauthor=E.+Bartheldyov%C3%A1author=F.+Hubatkaauthor=%C5%A0.+Koudelkaauthor=R.+Luk%C3%A1%C4%8Dauthor=A.+Kovalov%C3%A1author=D.+%C5%A0amanauthor=M.+K%C5%99upkaauthor=L.+Barkocziovaauthor=P.+Kosztyuauthor=M.+%C5%A0ebelaauthor=L.+Dro%C5%BEauthor=M.+Hu%C4%8Dkoauthor=M.+Kan%C3%A1sov%C3%A1author=A.+D.+Millerauthor=M.+Ra%C5%A1kaauthor=M.+Ledvinaauthor=J.+Tur%C3%A1nek&title=Nonpyrogenic+Molecular+Adjuvants+Based+on+NorAbu-Muramyldipeptide+and+NorAbu-Glucosaminyl+Muramyldipeptide%3A+Synthesis%2C+Molecular+Mechanisms+of+Action%2C+and+Biological+Activities+in+Vitro+and+in+Vivo&doi=10.1021%2Facs.jmedchem.7b00593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpyrogenic Molecular Adjuvants Based on norAbu-Muramyldipeptide and norAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo</span></div><div class="casAuthors">Effenberg, Roman; Turanek Knotigova, Pavlina; Zyka, Daniel; Celechovska, Hana; Masek, Josef; Bartheldyova, Eliska; Hubatka, Frantisek; Koudelka, Stepan; Lukac, Robert; Kovalova, Anna; Saman, David; Krupka, Michal; Barkocziova, Lucia; Kosztyu, Petr; Sebela, Marek; Droz, Ladislav; Hucko, Michal; Kanasova, Maria; Miller, Andrew D.; Raska, Milan; Ledvina, Miroslav; Turanek, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7745-7763</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acyl analogs of muramyldipeptide (MDP) (abbreviated N-L18 norAbuGMDP, N-B30 norAbuGMDP, norAbuMDP-Lys(L18), norAbuMDP-Lys(B30), norAbuGMDP-Lys(L18), norAbuGMDP-Lys(B30), B30 norAbuMDP, L18 norAbuMDP) are designed and synthesized comprising the normuramyl-L-α-aminobutanoyl (norAbu) structural moiety.  All new analogs show depressed pyrogenicity in both free (micellar) state and in liposomal formulations when tested in rabbits in vivo (s.c. and iv application).  New analogs are also shown to be selective activators of NOD2 and NLRP3 (inflammasome) in vitro but not NOD1.  Potencies of NOD2 and NLRP3 stimulation are found comparable with free MDP and other pos. controls.  Analogs are also demonstrated to be effective in stimulating cellular proliferation when the sera from mice are injected s.c. with individual liposome-loaded analogs, causing proliferation of bone marrow-derived GM-progenitors cells.  Importantly, vaccination nanoparticles prepd. from metallochelation liposomes, His-tagged antigen rOspA from Borrelia burgdorferi, and lipophilic analog norAbuMDP-Lys(B30) as adjuvant, are shown to provoke OspA-specific antibody responses with a strong Th1-bias (dominance of IgG2a response).  In contrast, the adjuvant effects of Alum or parent MDP show a strong Th2-bias (dominance of IgG1 response).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUp8pDHzdC7Vg90H21EOLACvtfcHk0lgoveJJz5pMgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF&md5=ca10207e03938dc2e1dd1400b79d38d8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00593%26sid%3Dliteratum%253Aachs%26aulast%3DEffenberg%26aufirst%3DR.%26aulast%3DTur%25C3%25A1nek%2BKn%25C3%25B6tigov%25C3%25A1%26aufirst%3DP.%26aulast%3DZyka%26aufirst%3DD.%26aulast%3D%25C4%258Celechovsk%25C3%25A1%26aufirst%3DH.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DBartheldyov%25C3%25A1%26aufirst%3DE.%26aulast%3DHubatka%26aufirst%3DF.%26aulast%3DKoudelka%26aufirst%3D%25C5%25A0.%26aulast%3DLuk%25C3%25A1%25C4%258D%26aufirst%3DR.%26aulast%3DKovalov%25C3%25A1%26aufirst%3DA.%26aulast%3D%25C5%25A0aman%26aufirst%3DD.%26aulast%3DK%25C5%2599upka%26aufirst%3DM.%26aulast%3DBarkocziova%26aufirst%3DL.%26aulast%3DKosztyu%26aufirst%3DP.%26aulast%3D%25C5%25A0ebela%26aufirst%3DM.%26aulast%3DDro%25C5%25BE%26aufirst%3DL.%26aulast%3DHu%25C4%258Dko%26aufirst%3DM.%26aulast%3DKan%25C3%25A1sov%25C3%25A1%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DRa%25C5%25A1ka%26aufirst%3DM.%26aulast%3DLedvina%26aufirst%3DM.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DNonpyrogenic%2520Molecular%2520Adjuvants%2520Based%2520on%2520NorAbu-Muramyldipeptide%2520and%2520NorAbu-Glucosaminyl%2520Muramyldipeptide%253A%2520Synthesis%252C%2520Molecular%2520Mechanisms%2520of%2520Action%252C%2520and%2520Biological%2520Activities%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7745%26epage%3D7763%26doi%3D10.1021%2Facs.jmedchem.7b00593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayyad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F. C.</span></span> <span> </span><span class="NLM_article-title">Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3836</span>– <span class="NLM_lpage">3844</span>, <span class="refDoi"> DOI: 10.1002/asia.202001003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fasia.202001003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=32975372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFahtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=3836-3844&author=W.+C.+Chengauthor=T.+Y.+Youauthor=Z.+Z.+Teoauthor=A.+A.+Sayyadauthor=J.+Maharanaauthor=C.+W.+Guoauthor=P.+H.+Liangauthor=C.+S.+Linauthor=F.+C.+Meng&title=Further+Insights+on+Structural+Modifications+of+Muramyl+Dipeptides+to+Study+the+Human+NOD2+Stimulating+Activity&doi=10.1002%2Fasia.202001003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Further insights on structural modifications of muramyl dipeptides to study the human NOPD2 stimulating activity</span></div><div class="casAuthors">Cheng, Wei-Chieh; You, Ting-Yun; Teo, Zhen-Zhuo; Sayyad, Ashik A.; Maharana, Jitendra; Guo, Chih-Wei; Liang, Pi-Hui; Lin, Chung-Shun; Meng, Fan-Chun</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3836-3844</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of muramyl dipeptide (MDP) analogs with structural modifications at the C4 position of MurNAc and on the D-iso-glutamine (isoGln) residue of the peptide part were synthesized.  The C4-diversification of MurNAc was conveniently achieved by using CuAAC click strategy to conjugate an azido muramyl dipeptide precursor with structurally diverse alkynes.  D-Glutamic acid (Glu), replaced with isoGln, was applied for the structural diversity through esterification or amidation of the carboxylic acid.  In total, 26 MDP analogs were synthesized and bio-evaluated for the study of human NOD2 stimulation activity in the innate immune response.  Interestingly, MDP derivs. with an ester moiety are found to be more potent than ref. compd. MDP itself or MDP analogs contg. an amide moiety.  Among the varied lengths of the alkyl chain in ester derivs., the MDP analog bearing the D-glutamate dodecyl (C12) ester moiety showed the best NOD2 stimulation potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUmChGuw6K9bVg90H21EOLACvtfcHk0lgoveJJz5pMgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFahtrzI&md5=71f50964c0946a0b5a1f2d81ba0a480b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fasia.202001003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.202001003%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DW.%2BC.%26aulast%3DYou%26aufirst%3DT.%2BY.%26aulast%3DTeo%26aufirst%3DZ.%2BZ.%26aulast%3DSayyad%26aufirst%3DA.%2BA.%26aulast%3DMaharana%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DC.%2BW.%26aulast%3DLiang%26aufirst%3DP.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BS.%26aulast%3DMeng%26aufirst%3DF.%2BC.%26atitle%3DFurther%2520Insights%2520on%2520Structural%2520Modifications%2520of%2520Muramyl%2520Dipeptides%2520to%2520Study%2520the%2520Human%2520NOD2%2520Stimulating%2520Activity%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2020%26volume%3D15%26spage%3D3836%26epage%3D3844%26doi%3D10.1002%2Fasia.202001003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piveteau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gealageas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roignant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolojanahary, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemdani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herledan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biela, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez-Poulain, R.</span></span> <span> </span><span class="NLM_article-title">Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9067</span>– <span class="NLM_lpage">9089</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01444</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1amurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9067-9089&author=P.+Hermantauthor=D.+Boscauthor=C.+Piveteauauthor=R.+Gealageasauthor=B.+Lamauthor=C.+Roncoauthor=M.+Roignantauthor=H.+Tolojanaharyauthor=L.+Jeanauthor=P.+Y.+Renardauthor=M.+Lemdaniauthor=M.+Bourotteauthor=A.+Herledanauthor=C.+Bedartauthor=A.+Bielaauthor=F.+Lerouxauthor=B.+Deprezauthor=R.+Deprez-Poulain&title=Controlling+Plasma+Stability+of+Hydroxamic+Acids%3A+A+MedChem+Toolbox&doi=10.1021%2Facs.jmedchem.7b01444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox</span></div><div class="casAuthors">Hermant, Paul; Bosc, Damien; Piveteau, Catherine; Gealageas, Ronan; Lam, BaoVy; Ronco, Cyril; Roignant, Matthieu; Tolojanahary, Hasina; Jean, Ludovic; Renard, Pierre-Yves; Lemdani, Mohamed; Bourotte, Marilyne; Herledan, Adrien; Bedart, Corentin; Biela, Alexandre; Leroux, Florence; Deprez, Benoit; Deprez-Poulain, Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9067-9089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas.  Some hydroxamic acids display a high plasma clearance resulting in poor in vivo activity, though they may be very potent compds. in vitro.  The authors designed a 57-member library of hydroxamic acids to explore the structure-plasma stability relationships in these series and to identify which enzyme(s) and which pharmacophores are crit. for plasma stability.  Arylesterases and carboxylesterases were identified as the main metabolic enzymes for hydroxamic acids.  Finally, the authors suggest structural features to be introduced or removed to improve stability.  This work thus provides the first medicinal chem. toolbox (exptl. procedures and structural guidance) to assess and control the plasma stability of hydroxamic acids and realize their full potential as in vivo pharmacol. probes and therapeutic agents.  This study is particularly relevant to preclin. development as it allows obtaining compds. equally stable in human and rodent models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp13iDBW5DnrVg90H21EOLACvtfcHk0liFZu0ePQh3tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1amurbE&md5=a7314d840db2c12c7fb769d0b8d52236</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01444%26sid%3Dliteratum%253Aachs%26aulast%3DHermant%26aufirst%3DP.%26aulast%3DBosc%26aufirst%3DD.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DGealageas%26aufirst%3DR.%26aulast%3DLam%26aufirst%3DB.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DRoignant%26aufirst%3DM.%26aulast%3DTolojanahary%26aufirst%3DH.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.%2BY.%26aulast%3DLemdani%26aufirst%3DM.%26aulast%3DBourotte%26aufirst%3DM.%26aulast%3DHerledan%26aufirst%3DA.%26aulast%3DBedart%26aufirst%3DC.%26aulast%3DBiela%26aufirst%3DA.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DControlling%2520Plasma%2520Stability%2520of%2520Hydroxamic%2520Acids%253A%2520A%2520MedChem%2520Toolbox%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9067%26epage%3D9089%26doi%3D10.1021%2Facs.jmedchem.7b01444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durland-Busbice, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinz-Taheny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantzig, A. H.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1158%2F1078-0432.CCR-12-1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23325581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1159-1168&author=S.+E.+Prattauthor=S.+Durland-Busbiceauthor=R.+L.+Shepardauthor=K.+Heinz-Tahenyauthor=P.+W.+Iversenauthor=A.+H.+Dantzig&title=Human+Carboxylesterase-2+Hydrolyzes+the+Prodrug+of+Gemcitabine+%28LY2334737%29+and+Confers+Prodrug+Sensitivity+to+Cancer+Cells&doi=10.1158%2F1078-0432.CCR-12-1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells</span></div><div class="casAuthors">Pratt, Susan E.; Durland-Busbice, Sara; Shepard, Robert L.; Heinz-Taheny, Kathleen; Iversen, Philip W.; Dantzig, Anne H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1159-1168</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The oral prodrug of gemcitabine LY2334737 is cleaved systemically to gemcitabine; the mechanism responsible for hydrolysis is unknown.  LY2334737 cytotoxicity was tested in the NCI-60 panel; mining of microarray expression data identified carboxylesterase (CES) as a top hydrolase candidate.  Studies examd. whether CES is responsible for hydrolysis and whether cellular CES expression confers prodrug sensitivity.  Exptl. Design: Human recombinant CES isoenzymes were assayed for LY2334737 hydrolysis.  Stable CES-overexpressing HCT-116 transfectants and a SK-OV-3 knockdown were prepd.  Cell lines were tested for drug sensitivity and CES expression by quant. real time-PCR (qRT-PCR), Western blotting, and immunohistochem. staining.  Bystander cytotoxicity studies were conducted with GFP-tagged PC-3 cells as the reporter cell line.  Therapeutic response of the HCT-116 transfectants was evaluated in xenografts.  Results: Of 3 human CES isoenzymes tested, only CES2 hydrolyzed LY2334737.  Five cell lines that express CES2 responded to LY2334737 treatment.  LY2334737 was less cytotoxic to a SK-OV-3 CES2 knockdown than parental cells.  The drug response of CES2-transfected HCT-116 cells correlated with CES2 expression level.  Bystander studies showed statistically greater PC-3-GFP growth inhibition by LY2334737 when cells were cocultured with CES2 and not mock transfectants.  Oral treatment of xenograft models with 3.2 mg/kg LY2334737 once a day for 21 days showed greater tumor growth inhibition of CES2 transfectant than the mock transfectant (P ≤ 0.001).  Conclusions: CES2 is responsible for the slow hydrolysis of LY2334737.  Because intact prodrug circulates at high plasma levels after oral LY2334737 administration, improved response rates may be obsd. by tailoring LY2334737 treatment to patients with CES2 tumor expression.  Clin Cancer Res; 19(5); 1159-68. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM5cExv8fNIbVg90H21EOLACvtfcHk0liFZu0ePQh3tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D&md5=37b16874ce4de70dea8a5e57f8aa8a0b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1184%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DS.%2BE.%26aulast%3DDurland-Busbice%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DR.%2BL.%26aulast%3DHeinz-Taheny%26aufirst%3DK.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DDantzig%26aufirst%3DA.%2BH.%26atitle%3DHuman%2520Carboxylesterase-2%2520Hydrolyzes%2520the%2520Prodrug%2520of%2520Gemcitabine%2520%2528LY2334737%2529%2520and%2520Confers%2520Prodrug%2520Sensitivity%2520to%2520Cancer%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D1159%26epage%3D1168%26doi%3D10.1158%2F1078-0432.CCR-12-1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterases: A Comprehensive Review</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.apsb.2018.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30245959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=699-712&author=D.+Wangauthor=L.+Zouauthor=Q.+Jinauthor=J.+Houauthor=G.+Geauthor=L.+Yang&title=Human+Carboxylesterases%3A+A+Comprehensive+Review&doi=10.1016%2Fj.apsb.2018.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Human carboxylesterases: a comprehensive review</span></div><div class="casAuthors">Wang Dandan; Zou Liwei; Jin Qiang; Ge Guangbo; Yang Ling; Hou Jie</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">699-712</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase superfamily.  In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade.  These two enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants.  The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs.  This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators.  The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism.  It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdULHHuJhbyicZfW6udTcc2eaWvgl0eCV8Zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D&md5=4c0b70b0208577496c8e0270af5eda8e</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DHuman%2520Carboxylesterases%253A%2520A%2520Comprehensive%2520Review%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26spage%3D699%26epage%3D712%26doi%3D10.1016%2Fj.apsb.2018.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. H.</span></span> <span> </span><span class="NLM_article-title">Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">11618</span>– <span class="NLM_lpage">11628</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608644200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M608644200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17303577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFemtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=11618-11628&author=L.+Zhaoauthor=M.+J.+Kwonauthor=S.+Huangauthor=J.+Y.+Leeauthor=K.+Fukaseauthor=N.+Inoharaauthor=D.+H.+Hwang&title=Differential+Modulation+of+Nods+Signaling+Pathways+by+Fatty+Acids+in+Human+Colonic+Epithelial+HCT116+Cells&doi=10.1074%2Fjbc.M608644200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells</span></div><div class="casAuthors">Zhao, Ling; Kwon, Myung-Ja; Huang, Shurong; Lee, Joo Y.; Fukase, Koichi; Inohara, Naohiro; Hwang, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11618-11628</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg. proteins (Nods) are intracellular pattern recognition receptors recognizing conserved moieties of bacterial peptidoglycan through their leucine-rich repeats domain.  The agonists for Nods activate proinflammatory signaling pathways, including NF-κB pathways.  The results from our previous studies showed that the activation of TLR4 and TLR2, leucine-rich repeat-contg. pattern recognition receptors, were differentially modulated by satd. and n-3 polyunsatd. fatty acids in macrophages and dendritic cells.  Here, we show the differential modulation of NF-κB activation and interleukin-8 (IL-8) expression in colonic epithelial cells HCT116 by satd. and unsatd. fatty acids mediated through Nods proteins.  Lauric acid (C12:0) dose dependently activated NF-κB and induced IL-8 expression in HCT116 cells, which express both Nod1 and Nod2, but not detectable amts. of TLR2 and TLR4.  These effects of lauric acid were inhibited by dominant neg. forms of Nod1 or Nod2, but not by dominant neg. forms of TLR2, TLR4, and TLR5.  The effects of lauric acid were also attenuated by small RNA interference targeting Nod1 or Nod2.  In contrast, polyunsatd. fatty acids, esp. n-3 polyunsatd. fatty acids, inhibited the activation of NF-κB and IL-8 expression induced by lauric acid or known Nods ligands in HCT116.  Furthermore, lauric acid induced, but docosahexaenoic acid inhibited lauric acid- or Nod2 ligand MDP-induced, Nod2 oligomerization in HEK293T cells transfected with Nod2.  Together, these results provide new insights into the role of dietary fatty acids in modulating inflammation in colon epithelial cells.  The results suggest that Nods may be involved in inducing sterile inflammation, one of the key etiol. conditions in the development of many chronic inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgi02SieBwb7Vg90H21EOLACvtfcHk0lg9PjCI0KFLQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFemtbg%253D&md5=72fc6f77dab89a364060e6d48488399a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608644200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608644200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DKwon%26aufirst%3DM.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DHwang%26aufirst%3DD.%2BH.%26atitle%3DDifferential%2520Modulation%2520of%2520Nods%2520Signaling%2520Pathways%2520by%2520Fatty%2520Acids%2520in%2520Human%2520Colonic%2520Epithelial%2520HCT116%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D11618%26epage%3D11628%26doi%3D10.1074%2Fjbc.M608644200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalyuzhin, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemlyakov, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, B. B.</span></span> <span> </span><span class="NLM_article-title">Distinctive Immunomodulating Properties and Interactivity with Model Membranes and Cells of Two Homologous Muramyl Dipeptide Derivatives Differing by Their Lipophilicity</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1016/S0192-0561(96)00061-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0192-0561%2896%2900061-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=9089008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADyaK2s3ksVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1996&pages=651-659&author=O.+V.+Kalyuzhinauthor=A.+E.+Zemlyakovauthor=B.+B.+Fuchs&title=Distinctive+Immunomodulating+Properties+and+Interactivity+with+Model+Membranes+and+Cells+of+Two+Homologous+Muramyl+Dipeptide+Derivatives+Differing+by+Their+Lipophilicity&doi=10.1016%2FS0192-0561%2896%2900061-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Distinctive immunomodulating properties and interactivity with model membranes and cells of two homologous muramyl dipeptide derivatives differing by their lipophilicity</span></div><div class="casAuthors">Kalyuzhin O V; Zemlyakov A E; Fuchs B B</div><div class="citationInfo"><span class="NLM_cas:title">International journal of immunopharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">651-9</span>
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">We have studied and compared the immunomodulating activities of two muramyl dipeptide (MDP) derivatives: beta-heptylglycoside-MDP (C7H15MDP) and beta-hexadecylglycoside-MDP (C16H33MDP).  The amphiphilic derivative C7H15MDP has been found to be a more effective stimulator of T lymphocyte proliferation and allospecific cytotoxic T cell generation in a mixed lymphocyte culture, and a more effective activator of interleukin-1 (IL-1) and tumour necrosis factor (TNF) production by murine peritoneal macrophages, in comparison with MDP and C16H33MDP used in equimolar concentrations.  C7H15MDP also stimulated cytotoxicity of natural killer (NK) cells: On the contrary, its lipophilic homologue C16H33MDP did not show such activities in vitro except for its influence on IL-1 and TNF production.  We have found significant differences in the interaction of these two 14C-labelled MDP derivatives with model membranes and in the uptake of these preparations by erythroleukemia K562 cells.  We consider the hydrolipophilic balance of the above preparations to be the main cause of their different interactions with membranes and their uptake by cells and, as a result, their opposite immunomodulating activities in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU4x9c7LCMHYxhnOQkIHOxfW6udTcc2eYsoR9p0enPGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3ksVWquw%253D%253D&md5=53f39651259c0defb1cbc358fe59ebc8</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0192-0561%2896%2900061-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0192-0561%252896%252900061-6%26sid%3Dliteratum%253Aachs%26aulast%3DKalyuzhin%26aufirst%3DO.%2BV.%26aulast%3DZemlyakov%26aufirst%3DA.%2BE.%26aulast%3DFuchs%26aufirst%3DB.%2BB.%26atitle%3DDistinctive%2520Immunomodulating%2520Properties%2520and%2520Interactivity%2520with%2520Model%2520Membranes%2520and%2520Cells%2520of%2520Two%2520Homologous%2520Muramyl%2520Dipeptide%2520Derivatives%2520Differing%2520by%2520Their%2520Lipophilicity%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1996%26volume%3D18%26spage%3D651%26epage%3D659%26doi%3D10.1016%2FS0192-0561%2896%2900061-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzelj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbančič, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Structural Features and Functional Activities of Benzimidazoles as NOD2 Antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">112089</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2020.112089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=32014680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2020&pages=112089&author=S.+Guzeljauthor=M.+Gobecauthor=D.+Urban%C4%8Di%C4%8Dauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=E.+Corsiniauthor=%C5%BD.+Jakopin&title=Structural+Features+and+Functional+Activities+of+Benzimidazoles+as+NOD2+Antagonists&doi=10.1016%2Fj.ejmech.2020.112089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features and functional activities of benzimidazoles as NOD2 antagonists</span></div><div class="casAuthors">Guzelj, Samo; Gobec, Martina; Urbancic, Dunja; Mlinaric-Rascan, Irena; Corsini, Emanuela; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112089pp.</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To gain insight into the structure-activity relationships of NOD2 antagonists, a series of novel analogs was designed and synthesized, and then screened for antagonist activity vs. NOD2, and counter-screened vs. NOD1.  N-(2,3-Dihydro-1H-indene-5-yl)-2-(2-(2-(phenylsulfonamido)ethyl)-1H-benzo [d]imidazole-l-yl)acetamide and N-(2,3-dihydro-1H-indene-5-yl)-2-(2-(2-(phenylsulfonamido)ethyl)-1H-benzo [d]imidazole-l-yl)acetamide were identified as potent and moderately selective NOD2 antagonists, and N-(2,3-dihydro-1H-indene-5-yl)-2-(2-(2-((5-(dimethylamino)naphthalene)-1-sulfonamido)ethyl)-1H-benzo[d]imidazole-1-yl)acetamide and N-(2,3-dihydro-1H-inden-5-yl)-2-(2-(3-(Nmethylphenylsulfonamido)propyl)-1H-benzo[d]imidazol-1-yl)acetamide as dual NOD1/NOD2 antagonists, with balanced activities against both targets in the low micromolar range.  These data enable in-depth exploration of their structure-activity relationships and provide deeper understanding of the structural features required for NOD2 antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPLN9pOAgrF7Vg90H21EOLACvtfcHk0lg9PjCI0KFLQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFOgt74%253D&md5=d7ede6be50594c89517e68ba503023fe</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112089%26sid%3Dliteratum%253Aachs%26aulast%3DGuzelj%26aufirst%3DS.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DUrban%25C4%258Di%25C4%258D%26aufirst%3DD.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DCorsini%26aufirst%3DE.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DStructural%2520Features%2520and%2520Functional%2520Activities%2520of%2520Benzimidazoles%2520as%2520NOD2%2520Antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D190%26spage%3D112089%26doi%3D10.1016%2Fj.ejmech.2020.112089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schupp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuettenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, M.</span></span> <span> </span><span class="NLM_article-title">Stability of Alkyl Chain-Mediated Lipid Anchoring in Liposomal Membranes</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2213</span>, <span class="refDoi"> DOI: 10.3390/cells9102213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3390%2Fcells9102213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitFOhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=2213&author=L.+Gleueauthor=J.+Schuppauthor=N.+Zimmerauthor=E.+Beckerauthor=H.+Freyauthor=A.+Tuettenbergauthor=M.+Helm&title=Stability+of+Alkyl+Chain-Mediated+Lipid+Anchoring+in+Liposomal+Membranes&doi=10.3390%2Fcells9102213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Stability of alkyl chain-mediated lipid anchoring in liposomal membranes</span></div><div class="casAuthors">Gleue, Lukas; Schupp, Jonathan; Zimmer, Niklas; Becker, Eyleen; Frey, Holger; Tuettenberg, Andrea; Helm, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2213</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Lipid exchange among biol. membranes, lipoprotein particles, micelles, and liposomes is an important yet underrated phenomenon with repercussions throughout the life sciences.  The premature loss of lipid mols. from liposomal formulations severely impacts therapeutic applications of the latter and thus limits the type of lipids and lipid conjugates available for fine-tuning liposomal properties.  While cholesterol derivs., with their irregular lipophilic surface shape, are known to readily undergo lipid exchange and interconvert, e.g., with serum, the situation is unclear for lipids with regular, linear-shaped alkyl chains.  This study compares the propensity of fluorescence-labeled lipid conjugates of systematically varied lengths to migrate from liposomal particles consisting mainly of egg phosphatidyl choline 3 (EPC3) and cholesterol into biomembranes.  We show that dialkyl glyceryl lipids with chains of 18-20 methylene units are inherently stable in liposomal membranes.  In contrast, C16 lipids show some lipid exchange, albeit significantly less than comparable cholesterol conjugates.  Remarkably, the C18 chain length, which confers noticeable anchor stability, corresponds to the typical chain length in biol. membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol5WwGGG770bVg90H21EOLACvtfcHk0ljZ_lN9-itIKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitFOhsbw%253D&md5=f30d4d45a2a25efedfd8a8a0226522c3</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3390%2Fcells9102213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells9102213%26sid%3Dliteratum%253Aachs%26aulast%3DGleue%26aufirst%3DL.%26aulast%3DSchupp%26aufirst%3DJ.%26aulast%3DZimmer%26aufirst%3DN.%26aulast%3DBecker%26aufirst%3DE.%26aulast%3DFrey%26aufirst%3DH.%26aulast%3DTuettenberg%26aufirst%3DA.%26aulast%3DHelm%26aufirst%3DM.%26atitle%3DStability%2520of%2520Alkyl%2520Chain-Mediated%2520Lipid%2520Anchoring%2520in%2520Liposomal%2520Membranes%26jtitle%3DCells%26date%3D2020%26volume%3D9%26spage%3D2213%26doi%3D10.3390%2Fcells9102213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Der Meer, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of Muramyl Dipeptide Stimulation of Cytokine Production by Blood Components</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2249.2009.03926.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fj.1365-2249.2009.03926.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19438594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=428-433&author=J.+H.+M.+Van%0ADer+Meerauthor=M.+G.+Neteaauthor=C.+A.+Dinarello&title=Modulation+of+Muramyl+Dipeptide+Stimulation+of+Cytokine+Production+by+Blood+Components&doi=10.1111%2Fj.1365-2249.2009.03926.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of muramyl dipeptide stimulation of cytokine production by blood components</span></div><div class="casAuthors">van der Meer, J. H. M.; Netea, M. G.; Dinarello, C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-433</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is the minimal active fragment of peptidoglycan of the cell wall of Gram-pos. bacteria, with potential beneficial effects as a vaccine adjuvant.  Peptidoglycans and MDP are recognized by the intracellular receptor NOD2 (nucleotide-binding oligomerization domain 2), leading to prodn. of proinflammatory cytokines.  In the present study, it is shown that, despite stimulatory effects on isolated human mononuclear cells, MDP does not stimulate prodn. of tumor necrosis factor-α, interleukin-1β or interleukin-6 in a whole-blood assay.  However, MDP retains synergistic effects on lipopolysaccharide-induced cytokines in whole blood.  Screening tests of NOD2 function based on whole-blood stimulation should therefore employ strategies based on the synergistic effects of MDP on Toll-like receptor-induced cytokine prodn.  Plasma was not responsible for the inhibition of MDP in whole blood.  The inhibition of MDP stimulation was dependent upon cellular components, with erythrocyte-derived Hb and neutrophils collaborating in the inhibition of MDP effects in whole blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUdpMc135fu7Vg90H21EOLACvtfcHk0ljZ_lN9-itIKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D&md5=a6310bc3893e2094498393e42d080279</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2009.03926.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2009.03926.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BMeer%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DModulation%2520of%2520Muramyl%2520Dipeptide%2520Stimulation%2520of%2520Cytokine%2520Production%2520by%2520Blood%2520Components%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2009%26volume%3D156%26spage%3D428%26epage%3D433%26doi%3D10.1111%2Fj.1365-2249.2009.03926.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferwerda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naber, T. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan Kullberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adema, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Meer, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">6518</span>– <span class="NLM_lpage">6523</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.174.10.6518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.174.10.6518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15879155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvV2lsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=6518-6523&author=M.+G.+Neteaauthor=G.+Ferwerdaauthor=D.+J.+de+Jongauthor=T.+Jansenauthor=L.+Jacobsauthor=M.+Kramerauthor=T.+H.+J.+Naberauthor=J.+P.+H.+Drenthauthor=S.+E.+Girardinauthor=B.+Jan+Kullbergauthor=G.+J.+Ademaauthor=J.+W.+M.+Van+der+Meer&title=Nucleotide-Binding+Oligomerization+Domain-2+Modulates+Specific+TLR+Pathways+for+the+Induction+of+Cytokine+Release&doi=10.4049%2Fjimmunol.174.10.6518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release</span></div><div class="casAuthors">Netea, Mihai G.; Ferwerda, Gerben; De Jong, Dirk J.; Jansen, Trees; Jacobs, Liesbeth; Kramer, Matthijs; Naber, Ton H. J.; Drenth, Joost P. H.; Girardin, Stephen E.; Kullberg, Bart Jan; Adema, Gosse J.; Van der Meer, Jos W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6518-6523</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The recognition of peptidoglycan by cells of the innate immune system has been controversial; both TLR2 and nucleotide-binding oligomerization domain-2 (NOD2) have been implicated in this process.  In the present study we demonstrate that although NOD2 is required for recognition of peptidoglycan, this leads to strong synergistic effects on TLR2-mediated prodn. of both pro- and anti-inflammatory cytokines.  Defective IL-10 prodn. in patients with Crohn's disease bearing loss of function mutations of NOD2 may lead to overwhelming inflammation due to a subsequent Th1 bias.  In addn. to the potentiation of TLR2 effects, NOD2 is a modulator of signals transmitted through TLR4 and TLR3, but not through TLR5, TLR9, or TLR7.  Thus, interaction between NOD2 and specific TLR pathways may represent an important modulatory mechanism of innate immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkVzWqYuBjtLVg90H21EOLACvtfcHk0ljZ_lN9-itIKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvV2lsr8%253D&md5=bde0c40f99924444f5583d08273ed2ab</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.174.10.6518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.174.10.6518%26sid%3Dliteratum%253Aachs%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DFerwerda%26aufirst%3DG.%26aulast%3Dde%2BJong%26aufirst%3DD.%2BJ.%26aulast%3DJansen%26aufirst%3DT.%26aulast%3DJacobs%26aufirst%3DL.%26aulast%3DKramer%26aufirst%3DM.%26aulast%3DNaber%26aufirst%3DT.%2BH.%2BJ.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%2BH.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DJan%2BKullberg%26aufirst%3DB.%26aulast%3DAdema%26aufirst%3DG.%2BJ.%26aulast%3DVan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DNucleotide-Binding%2520Oligomerization%2520Domain-2%2520Modulates%2520Specific%2520TLR%2520Pathways%2520for%2520the%2520Induction%2520of%2520Cytokine%2520Release%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D6518%26epage%3D6523%26doi%3D10.4049%2Fjimmunol.174.10.6518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Aulock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, C.</span></span> <span> </span><span class="NLM_article-title">MDP and Other Muropeptides - Direct and Synergistic Effects on the Immune System</span>. <i>J. Endotoxin Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1179/096805106X89044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1179%2F096805106X89044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=16690010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=69-85&author=S.+Traubauthor=S.+von+Aulockauthor=T.+Hartungauthor=C.+Hermann&title=MDP+and+Other+Muropeptides+-+Direct+and+Synergistic+Effects+on+the+Immune+System&doi=10.1179%2F096805106X89044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">MDP and other muropeptides - direct and synergistic effects on the immune system</span></div><div class="casAuthors">Traub, Stephanie; von Aulock, Sonja; Hartung, Thomas; Hermann, Corinna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endotoxin Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-85</span>CODEN:
                <span class="NLM_cas:coden">JENREB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0519</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  Muropeptides are breakdown products of peptidoglycan (PGN) of Gram-neg. and Gram-pos. bacteria.  They are released during bacterial growth and division, as part of the host response by lysozyme and amidases, or upon antibiotic treatment.  After phagocytosis of bacteria or bacterial breakdown products by host immune cells, the muropeptides trigger intracellular signaling cascades, leading to altered gene expression and activation of the immune response.  Numerous muropeptides and derivs. have been synthesized chem. to characterize their immunostimulatory effects and adjuvant activity.  Muramyl dipeptide, a natural partial structure of PGN, is the minimal structure with adjuvant activity.  This review discusses the structure and occurrence of muropeptides and gives a broad overview of their inflammatory and adjuvant activity and the possible involvement of receptors in these responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEKqY15UjK3LVg90H21EOLACvtfcHk0lhjEk9sAdRuEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D&md5=b10e36602d50c3022a76e7bf47b3d3e6</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1179%2F096805106X89044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F096805106X89044%26sid%3Dliteratum%253Aachs%26aulast%3DTraub%26aufirst%3DS.%26aulast%3Dvon%2BAulock%26aufirst%3DS.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHermann%26aufirst%3DC.%26atitle%3DMDP%2520and%2520Other%2520Muropeptides%2520-%2520Direct%2520and%2520Synergistic%2520Effects%2520on%2520the%2520Immune%2520System%26jtitle%3DJ.%2520Endotoxin%2520Res.%26date%3D2006%26volume%3D12%26spage%3D69%26epage%3D85%26doi%3D10.1179%2F096805106X89044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, H.</span></span> <span> </span><span class="NLM_article-title">Muramyldipeptide and Diaminopimelic Acid-Containing Desmuramylpeptides in Combination with Chemically Synthesized Toll-like Receptor Agonists Synergistically Induced Production of Interleukin-8 in a NOD2- and NOD1-Dependent Manner, Respectively, in Human</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2004.00433.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fj.1462-5822.2004.00433.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15617523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotlWrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=53-61&author=A.+Ueharaauthor=S.+Yangauthor=Y.+Fujimotoauthor=K.+Fukaseauthor=S.+Kusumotoauthor=K.+Shibataauthor=S.+Sugawaraauthor=H.+Takada&title=Muramyldipeptide+and+Diaminopimelic+Acid-Containing+Desmuramylpeptides+in+Combination+with+Chemically+Synthesized+Toll-like+Receptor+Agonists+Synergistically+Induced+Production+of+Interleukin-8+in+a+NOD2-+and+NOD1-Dependent+Manner%2C+Respectively%2C+in+Human&doi=10.1111%2Fj.1462-5822.2004.00433.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture</span></div><div class="casAuthors">Uehara, A.; Yang, S.; Fujimoto, Y.; Fukase, K.; Kusumoto, S.; Shibata, K.; Sugawara, S.; Takada, H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Two types of synthetic peptidoglycan fragments, diaminopimelic acid (DAP)-contg. desmuramylpeptides (DMP) and muramyldipeptide (MDP), induced secretion of interleukin (IL)-8 in a dose-dependent manner in human monocytic THP-1 cells, although high concns. of compds. are required as compared with chem. synthesized Toll-like receptor (TLR) agonists mimicking bacterial components: TLR2 agonistic lipopeptide (Pam3CSSNA), TLR4 agonistic lipid A (LA-15-PP) and TLR9 agonistic bacterial CpG DNA.  The authors found marked synergistic IL-8 secretion induced by MDP or DAP-contg. DMP in combination with synthetic TLR agonists in THP-1 cells.  Suppression of the mRNA expression of nucleotide-binding oligomerization domain (NOD)1 and NOD2 by RNA interference specifically inhibited the synergistic IL-8 secretion induced by DMP and MDP with these TLR agonists resp.  In accordance with the above results, enhanced IL-8 mRNA expression and the activation of nuclear factor (NF)-κB induced by MDP or DMP in combination with synthetic TLR agonists were markedly suppressed in NOD2- and NOD1-silenced cells resp.  These findings indicated that NOD2 and NOD1 are specifically responsible for the synergistic effects of MDP and DMP with TLR agonists, and suggested that in host innate immune responses to invading bacteria, combinatory dual signaling through extracellular TLRs and intracellular NODs might lead to the synergistic activation of host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUbud42ZGZvrVg90H21EOLACvtfcHk0lhjEk9sAdRuEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotlWrsA%253D%253D&md5=c89bceb1dc9f08b145d9e8d8f5fe879a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2004.00433.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2004.00433.x%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DFujimoto%26aufirst%3DY.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26atitle%3DMuramyldipeptide%2520and%2520Diaminopimelic%2520Acid-Containing%2520Desmuramylpeptides%2520in%2520Combination%2520with%2520Chemically%2520Synthesized%2520Toll-like%2520Receptor%2520Agonists%2520Synergistically%2520Induced%2520Production%2520of%2520Interleukin-8%2520in%2520a%2520NOD2-%2520and%2520NOD1-Dependent%2520Manner%252C%2520Respectively%252C%2520in%2520Human%26jtitle%3DCell.%2520Microbiol.%26date%3D2005%26volume%3D7%26spage%3D53%26epage%3D61%26doi%3D10.1111%2Fj.1462-5822.2004.00433.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitting, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengin-Lecreulx, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caroff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaillon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adib-Conquy, M.</span></span> <span> </span><span class="NLM_article-title">Synergistic Stimulation of Human Monocytes and Dendritic Cells by Toll-like Receptor 4 and NOD1- and NOD2- Activating Agonists</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2459</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1002/eji.200526286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Feji.200526286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=16021602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Gmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=2459-2470&author=J.+H.+Fritzauthor=S.+E.+Girardinauthor=C.+Fittingauthor=C.+Wertsauthor=D.+Mengin-Lecreulxauthor=M.+Caroffauthor=J.+M.+Cavaillonauthor=D.+J.+Philpottauthor=M.+Adib-Conquy&title=Synergistic+Stimulation+of+Human+Monocytes+and+Dendritic+Cells+by+Toll-like+Receptor+4+and+NOD1-+and+NOD2-+Activating+Agonists&doi=10.1002%2Feji.200526286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists</span></div><div class="casAuthors">Fritz, Jorg H.; Girardin, Stephen E.; Fitting, Catherine; Werts, Catherine; Mengin-Lecreulx, Dominique; Caroff, Martine; Cavaillon, Jean-Marc; Philpott, Dana J.; Adib-Conquy, Minou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2459-2470</span>CODEN:
                <span class="NLM_cas:coden">EJIMAF</span>;
        ISSN:<span class="NLM_cas:issn">0014-2980</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Muropeptides are degrdn. products of bacterial peptidoglycan (PG) sensed by nucleotide-binding oligomerization domain 1 (NOD1) and NOD2, members of a recently discovered family of pattern recognition mols. (PRM).  One of these muropeptides, muramyl dipeptide (MDP) mediates cell signaling by NOD2, exerts adjuvant activity and synergizes with lipopolysaccharide (LPS) to induce pro-inflammatory responses in vitro and in vivo.  In contrast, few and contradictory results exist about the stimulatory capacity of NOD1 agonists.  Thus, the ability of NOD1 (MurNAc-L-Ala-γ-D-Glu-meso-diaminopimelic acid, MtriDAP) and NOD2 (MurNAc-L-Ala-D-isoGln, MDP; MurNAc-L-Ala-γ-D-Glu-L-Lys, MtriLYS) agonists to activate primary human myeloid cells was examd.  The authors show that both CD14+ monocytes and CD1a+ immature dendritic cells (DC) express NOD1 and NOD2 mRNA.  Stimulation of primary human monocytes and DC with highly purified muropeptides (MtriDAP, MDP and MtriLYS) induces release of pro-inflammatory cytokines.  The authors reveal here that NOD1 as well as NOD2 agonists act cooperatively with LPS to stimulate the release of both pro- and anti-inflammatory cytokines in these myeloid cell subsets.  Finally, the authors report that NOD1 as well as NOD2 agonists synergize with sub-active doses of LPS to induce DC maturation, demonstrating that NOD agonists act cooperatively with mols. sensed by Toll-like receptor 4 to instruct the onset of adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3O1mLZxSadrVg90H21EOLACvtfcHk0ljTHNmuPEMllw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Gmur4%253D&md5=b32a674d49e8c4ae127b2f3bb3cf82cc</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Feji.200526286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200526286%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DFitting%26aufirst%3DC.%26aulast%3DWerts%26aufirst%3DC.%26aulast%3DMengin-Lecreulx%26aufirst%3DD.%26aulast%3DCaroff%26aufirst%3DM.%26aulast%3DCavaillon%26aufirst%3DJ.%2BM.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DAdib-Conquy%26aufirst%3DM.%26atitle%3DSynergistic%2520Stimulation%2520of%2520Human%2520Monocytes%2520and%2520Dendritic%2520Cells%2520by%2520Toll-like%2520Receptor%25204%2520and%2520NOD1-%2520and%2520NOD2-%2520Activating%2520Agonists%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2005%26volume%3D35%26spage%3D2459%26epage%3D2470%26doi%3D10.1002%2Feji.200526286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. W.</span></span> <span> </span><span class="NLM_article-title">Dual Roles of NOD2 in TLR4-Mediated Signal Transduction and -Induced Inflammatory Gene Expression in Macrophages</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2010.01567.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fj.1462-5822.2010.01567.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21199260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Gisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=717-730&author=W.+H.+Tsaiauthor=D.+Y.+Huangauthor=Y.+H.+Yuauthor=C.+Y.+Chenauthor=W.+W.+Lin&title=Dual+Roles+of+NOD2+in+TLR4-Mediated+Signal+Transduction+and+-Induced+Inflammatory+Gene+Expression+in+Macrophages&doi=10.1111%2Fj.1462-5822.2010.01567.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages</span></div><div class="casAuthors">Tsai, Wen-Hsiang; Huang, Duen-Yi; Yu, Yang-Hao; Chen, Chih-Yi; Lin, Wan-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">717-730</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NOD2 of the NLRs and TLR4 of the TLRs are major pattern-recognition receptors, which sense different microbial pathogens and have important roles in innate immunity.  Herein, we investigated the roles of NOD2 in TLR4-mediated signalling and gene regulation in RAW264.7 macrophages.  We found that MDP (a NOD2 ligand) increased LPS-induced expressions of TNF-α, IL-1β, IL-6, INOS and COX-2.  MDP did not affect LPS-induced activation of MAPKs or IKK, while it potentiated LPS-induced NF-κB activation.  Meanwhile TLR4 activation increased NOD2 mRNA expression, and upregulated NOD2 upon MDP treatment is a pos. regulator of TLR4-mediated signalling.  Intriguingly we found that NOD2 silencing led to increases in LPS-induced signal transduction and inflammatory responses, and a decrease in LPS-elicited homologous tolerance.  We thus propose that NOD2 in the absence of MDP treatment might also play a neg. regulatory role in the action of TLR4.  Further, we demonstrated that both CARD and LRR domains of the NOD2 protein were responsible for the neg. regulatory action on TLR4.  In summary, it is the first time to demonstrate that NOD2 have dual effects on TLR4 signalling and exert a novel ligand-independent action.  Elucidating mol. mechanisms by which NOD2 exerts its ligand-independent action on TLR4 requires further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2DLBiJ6PHMLVg90H21EOLACvtfcHk0ljTHNmuPEMllw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Gisrk%253D&md5=0100e88602d0dd9510f1fa58944a7ea7</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2010.01567.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2010.01567.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DW.%2BH.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DYu%26aufirst%3DY.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DW.%2BW.%26atitle%3DDual%2520Roles%2520of%2520NOD2%2520in%2520TLR4-Mediated%2520Signal%2520Transduction%2520and%2520-Induced%2520Inflammatory%2520Gene%2520Expression%2520in%2520Macrophages%26jtitle%3DCell.%2520Microbiol.%26date%3D2011%26volume%3D13%26spage%3D717%26epage%3D730%26doi%3D10.1111%2Fj.1462-5822.2010.01567.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo
Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapoval, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medvedev, A. E.</span></span> <span> </span><span class="NLM_article-title">Activation of Cytokine-Producing and Antitumor Activities of Natural Killer Cells and Macrophages by Engagement of Toll-like and NOD-like Receptors</span>. <i>Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1177/1753425910372000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1177%2F1753425910372000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=20682587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGisrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=375-387&author=F.+Qiuauthor=A.+Maniarauthor=M.+Quevedo%0ADiazauthor=A.+I.+Chapovalauthor=A.+E.+Medvedev&title=Activation+of+Cytokine-Producing+and+Antitumor+Activities+of+Natural+Killer+Cells+and+Macrophages+by+Engagement+of+Toll-like+and+NOD-like+Receptors&doi=10.1177%2F1753425910372000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors</span></div><div class="casAuthors">Qiu, Fu; Maniar, Amudhan; Diaz, Marco Quevedo; Chapoval, Andrei I.; Medvedev, Andrei E.</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Macrophages and natural killer (NK) cells are important antitumor effectors by virtue of their ability to produce cytokines, chemokines and interferons (IFNs) and to mediate tumor cytotoxicity.  Little is known about the impact of Toll-like receptor (TLR) and nucleotide binding and oligomerization domain (NOD)-like receptor (NLR) pathways on NK cell functions, and the role of TLRs and NLRs in macrophage activation is incompletely understood.  In this study, we examd. the capacities of expressed TLRs and NLRs to elicit cytokine prodn. in human NK cells and THP1 macrophages, and to activate NK cytotoxicity against the squamous cell carcinoma of head and neck cell line Tu167 and erythroleukemia K562 cells.  We found that NK cells express high levels of NOD2, NLRP3, TLR3, TLR7, and TLR9, while NOD1 was expressed at low levels.  All tested NLR and TLR agonists potentiated NK cytotoxicity against Tu167 cells, whereas only poly (I:C) increased NK cytotoxicity against K562 cells.  Poly (I:C) and Escherichia coli RNA markedly up-regulated TNF-α and IFN-γ expression in the NK92 cell line and human CD56+CD3- primary NK cells.  High levels of NOD2, TLR7 and TLR9 proteins were obsd. in human THP1 cells, followed by TLR3, NOD1, and NLRP3.  Stimulation of NLRP3 with E. coli RNA led to the highest induction of TNF-α, IL-6, IL-12p40, RANTES and IFN-β, whereas TLR7, TLR3, TLR9, NOD1 and NOD2 agonists had lower effects.  Our data reveal involvement of TLRs and NLRs in potentiation of antitumor cytotoxicity and cytokine-producing activities of human NK cells and macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnYmtQp05Z_rVg90H21EOLACvtfcHk0ljTHNmuPEMllw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGisrvE&md5=27c3fc7a79e0261bc1140f9eebb92bc4</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1177%2F1753425910372000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425910372000%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DManiar%26aufirst%3DA.%26aulast%3DQuevedo%2BDiaz%26aufirst%3DM.%26aulast%3DChapoval%26aufirst%3DA.%2BI.%26aulast%3DMedvedev%26aufirst%3DA.%2BE.%26atitle%3DActivation%2520of%2520Cytokine-Producing%2520and%2520Antitumor%2520Activities%2520of%2520Natural%2520Killer%2520Cells%2520and%2520Macrophages%2520by%2520Engagement%2520of%2520Toll-like%2520and%2520NOD-like%2520Receptors%26jtitle%3DInnate%2520Immun.%26date%3D2011%26volume%3D17%26spage%3D375%26epage%3D387%26doi%3D10.1177%2F1753425910372000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Athié-Morales, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, C. M.</span></span> <span> </span><span class="NLM_article-title">Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">4082</span>– <span class="NLM_lpage">4089</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.180.6.4082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.180.6.4082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18322218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisl2jtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=4082-4089&author=V.+Athi%C3%A9-Moralesauthor=G.+M.+O%E2%80%99Connorauthor=C.+M.+Gardiner&title=Activation+of+Human+NK+Cells+by+the+Bacterial+Pathogen-Associated+Molecular+Pattern+Muramyl+Dipeptide&doi=10.4049%2Fjimmunol.180.6.4082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide</span></div><div class="casAuthors">Athie-Morales, Veronica; O'Connor, Geraldine M.; Gardiner, Clair M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4082-4089</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is a bacterial pathogen assocd. mol. pattern derived from both Gram-pos. and -neg. bacteria.  It is a specific ligand for nuclear oligomerization domain 2, a pattern recognition receptor best characterized for its role in immunosurveillance in the gut.  In this study, the authors demonstrate that human peripheral blood NK cells express nuclear oligomerization domain 2 and respond to MDP.  NK cells naturally internalize MDP leading to direct cell activation, including signaling through NF-κB: characterized by p50/p65 heterodimers at early stimulations times and sustained activation of p50 homodimers.  Moreover, MDP synergizes with IFN-α and IL-12 to activate NK cells and stimulate IFN-γ secretion, suggesting a role for accessory cells in induction of an optimal NK cell response.  Although IL-12 costimulation leads to a greater IFN-γ response by NK cells, higher levels of CD69 in response to MDP are induced in the presence of IFN-α, suggesting that different pathogen-induced cytokine profiles will affect down-stream NK cell responses.  In contrast, MDP alone or in combination with either IFN-α or IL-12 only poorly increases NK cell cytotoxicity.  In summary, this report identifies MDP as a bacterial pathogen assocd. mol. pattern that activates human NK cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLgbPkn2nW2bVg90H21EOLACvtfcHk0lgkM-LLspQ_xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisl2jtro%253D&md5=1d0902a4786820232d37b70b608469fb</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.180.6.4082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.180.6.4082%26sid%3Dliteratum%253Aachs%26aulast%3DAthi%25C3%25A9-Morales%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DG.%2BM.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26atitle%3DActivation%2520of%2520Human%2520NK%2520Cells%2520by%2520the%2520Bacterial%2520Pathogen-Associated%2520Molecular%2520Pattern%2520Muramyl%2520Dipeptide%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D4082%26epage%3D4089%26doi%3D10.4049%2Fjimmunol.180.6.4082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, S. W.</span></span> <span> </span><span class="NLM_article-title">Interactions between Human Monocytes and Tumour Cells. Monocytes Can Either Enhance or Inhibit the Growth and Survival of K562 Cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1038/bjc.1992.296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fbjc.1992.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1520583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADyaK38zpt1OjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1992&pages=463-469&author=B.+Daviesauthor=S.+W.+Edwards&title=Interactions+between+Human+Monocytes+and+Tumour+Cells.+Monocytes+Can+Either+Enhance+or+Inhibit+the+Growth+and+Survival+of+K562+Cells&doi=10.1038%2Fbjc.1992.296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells</span></div><div class="casAuthors">Davies B; Edwards S W</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-9</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Human bloodstream monocytes can kill cultured tumour cells (K562), as assessed by specific release of 51Cr from the targets and by inhibition of 3H-thymidine incorporation.  Confluent monolayers of monocytes were required for maximal cytotoxicity, and the density of the K562 cells was also an important factor.  For example, when K562 cells were seeded at high cell densities, they were killed during incubation with monocytes, but when seeded at low cell densities their growth and survival was enhanced during culture with monocytes.  The factor(s) which promoted the survival and division of low density K562 cultures was endogenously secreted from monocytes as it was present in monocyte-conditioned medium, whereas the cytotoxic factor(s) were only expressed during co-culture of monocytes with K562 cells.  Conditioned medium from HL 60, U-937, HeLa and K562 could also enhance the growth and survival of low density K562 cultures, and a similar effect was also observed upon the addition of catalase and superoxide dismutase to such cultures.  Thus, the monocyte:target ratio is important in determining whether monocytes exhibit cytotoxic or growth-promoting effects and hence tumour-derived or monocyte-derived reactive oxidant species may play a role in tumour cell cycle regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ438yWUhto_v_I8Jvzw4xCfW6udTcc2eZq1lXtk-ARGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zpt1OjsA%253D%253D&md5=749c7906e26fdb2366b10e50e9b49aec</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1992.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1992.296%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DEdwards%26aufirst%3DS.%2BW.%26atitle%3DInteractions%2520between%2520Human%2520Monocytes%2520and%2520Tumour%2520Cells.%2520Monocytes%2520Can%2520Either%2520Enhance%2520or%2520Inhibit%2520the%2520Growth%2520and%2520Survival%2520of%2520K562%2520Cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1992%26volume%3D66%26spage%3D463%26epage%3D469%26doi%3D10.1038%2Fbjc.1992.296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Berestein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidler, I. J.</span></span> <span> </span><span class="NLM_article-title">Potentiation of Direct Antitumor Cytotoxicity and Production of Tumor Cytolytic Factors in Human Blood Monocytes by Human Recombinant Interferon-Gamma and Muramyl Dipeptide Derivatives</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1007/BF00199855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1007%2FBF00199855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3081250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL28XhvVClsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1986&pages=93-99&author=S.+Soneauthor=G.+Lopez-Beresteinauthor=I.+J.+Fidler&title=Potentiation+of+Direct+Antitumor+Cytotoxicity+and+Production+of+Tumor+Cytolytic+Factors+in+Human+Blood+Monocytes+by+Human+Recombinant+Interferon-Gamma+and+Muramyl+Dipeptide+Derivatives&doi=10.1007%2FBF00199855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives</span></div><div class="casAuthors">Sone, Saburo; Lopez-Berestein, Gabriel; Fidler, Isaiah J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-9</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    </div><div class="casAbstract">The authors investigated whether human peripheral blood monocytes isolated by centrifugal elutriation from healthy donors could be activated to become tumoricidal and release tumor cytolytic factor (TCF) subsequent to incubation with recombinant human interferon-γ (r-IFN-γ) or a deriv. of muramyl dipeptide (nor-MDP), or both.  Blood monocytes incubated in endotoxin-free medium contg. up to 1000 units/mL of r-IFN-γ or in medium contg. <1 μg/mL of nor-MDP were not activated to lyse radiolabeled allogeneic human tumor cells.  In contrast, the incubation of monocytes with various dose combinations of r-IFN-γ and nor-MDP generated significant direct cytotoxic activity as well as prodn. of TCF.  Preincubation of the r-IFN-γ and nor-MDP mixt. with polymyxin B did not inhibit the synergism, thus ruling out the possibility that the process was due to endotoxin contamination.  TCF harvested from monocyte culture supernatants was cytolytic against 5 allogeneic tumor targets, but not against a nontumorigenic cell line.  Thus, r-IFN-γ can prime human blood monocytes to allow their activation by synthetic nor-MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqy0FUWvb3sbVg90H21EOLACvtfcHk0lgkM-LLspQ_xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVClsr8%253D&md5=477d315b64583fe8fc89596a5e48fddf</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2FBF00199855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00199855%26sid%3Dliteratum%253Aachs%26aulast%3DSone%26aufirst%3DS.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DFidler%26aufirst%3DI.%2BJ.%26atitle%3DPotentiation%2520of%2520Direct%2520Antitumor%2520Cytotoxicity%2520and%2520Production%2520of%2520Tumor%2520Cytolytic%2520Factors%2520in%2520Human%2520Blood%2520Monocytes%2520by%2520Human%2520Recombinant%2520Interferon-Gamma%2520and%2520Muramyl%2520Dipeptide%2520Derivatives%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D1986%26volume%3D21%26spage%3D93%26epage%3D99%26doi%3D10.1007%2FBF00199855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandarian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunga, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Saenz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetti, M.</span></span> <span> </span><span class="NLM_article-title">A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>, <span class="NLM_elocation-id">e56191</span> <span class="refDoi"> DOI: 10.3791/56191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3791%2F56191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&author=F.+Kandarianauthor=G.+M.+Sungaauthor=D.+Arango-Saenzauthor=M.+Rossetti&title=A+Flow+Cytometry-Based+Cytotoxicity+Assay+for+the+Assessment+of+Human+NK+Cell+Activity&doi=10.3791%2F56191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.3791%2F56191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F56191%26sid%3Dliteratum%253Aachs%26aulast%3DKandarian%26aufirst%3DF.%26aulast%3DSunga%26aufirst%3DG.%2BM.%26aulast%3DArango-Saenz%26aufirst%3DD.%26aulast%3DRossetti%26aufirst%3DM.%26atitle%3DA%2520Flow%2520Cytometry-Based%2520Cytotoxicity%2520Assay%2520for%2520the%2520Assessment%2520of%2520Human%2520NK%2520Cell%2520Activity%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2017%26volume%3D126%26doi%3D10.3791%2F56191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay-McLean, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coenraads, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuy, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, N. F.</span></span> <span> </span><span class="NLM_article-title">Expression of Ligands for Activating Natural Killer Cell Receptors on Cell Lines Commonly Used to Assess Natural Killer Cell Function</span>. <i>BMC Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">8</span>, <span class="refDoi"> DOI: 10.1186/s12865-018-0272-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1186%2Fs12865-018-0272-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30696399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=8&author=A.+Tremblay-McLeanauthor=S.+Coenraadsauthor=Z.+Kianiauthor=F.+P.+Dupuyauthor=N.+F.+Bernard&title=Expression+of+Ligands+for+Activating+Natural+Killer+Cell+Receptors+on+Cell+Lines+Commonly+Used+to+Assess+Natural+Killer+Cell+Function&doi=10.1186%2Fs12865-018-0272-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function</span></div><div class="casAuthors">Tremblay-McLean Alexandra; Coenraads Sita; Kiani Zahra; Dupuy Franck P; Bernard Nicole F; Tremblay-McLean Alexandra; Kiani Zahra; Bernard Nicole F; Bernard Nicole F; Bernard Nicole F</div><div class="citationInfo"><span class="NLM_cas:title">BMC immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Natural killer cell responses to virally-infected or transformed cells depend on the integration of signals received through inhibitory and activating natural killer cell receptors.  Human Leukocyte Antigen null cells are used in vitro to stimulate natural killer cell activation through missing-self mechanisms.  On the other hand, CEM.NKr.CCR5 cells are used to stimulate natural killer cells in an antibody dependent manner since they are resistant to direct killing by natural killer cells.  Both K562 and 721.221 cell lines lack surface major histocompatibility compatibility complex class Ia ligands for inhibitory natural killer cell receptors.  Previous work comparing natural killer cell stimulation by K562 and 721.221 found that they stimulated different frequencies of natural killer cell functional subsets.  We hypothesized that natural killer cell function following K562, 721.221 or CEM.NKr.CCR5 stimulation reflected differences in the expression of ligands for activating natural killer cell receptors.  RESULTS:  K562 expressed a higher intensity of ligands for Natural Killer G2D and the Natural Cytotoxicity Receptors, which are implicated in triggering natural killer cell cytotoxicity. 721.221 cells expressed a greater number of ligands for activating natural killer cell receptors. 721.221 expressed cluster of differentiation 48, 80 and 86 with a higher mean fluorescence intensity than did K562.  The only ligands for activating receptor that were detected on CEM.NKr.CCR5 cells at a high intensity were cluster of differentiation 48, and intercellular adhesion molecule-2.  CONCLUSIONS:  The ligands expressed by K562 engage natural killer cell receptors that induce cytolysis.  This is consistent with the elevated contribution that the cluster of differentiation 107a function makes to total K562 induced natural killer cell functionality compared to 721.221 cells.  The ligands expressed on 721.221 cells can engage a larger number of activating natural killer cell receptors, which may explain their ability to activate a larger frequency of these cells to become functional and secrete cytokines.  The few ligands for activating natural killer cell receptors expressed by CEM.NKr.CCR5 may reduce their ability to activate natural killer cells in an antibody independent manner explaining their relative resistance to direct natural killer cell cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ87iNUlz2Cuxe4jJGKT5N0fW6udTcc2eaB715Q31FvZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmslahsQ%253D%253D&md5=b33a908f8db06ab0efe73b3a320b78f5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1186%2Fs12865-018-0272-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12865-018-0272-x%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay-McLean%26aufirst%3DA.%26aulast%3DCoenraads%26aufirst%3DS.%26aulast%3DKiani%26aufirst%3DZ.%26aulast%3DDupuy%26aufirst%3DF.%2BP.%26aulast%3DBernard%26aufirst%3DN.%2BF.%26atitle%3DExpression%2520of%2520Ligands%2520for%2520Activating%2520Natural%2520Killer%2520Cell%2520Receptors%2520on%2520Cell%2520Lines%2520Commonly%2520Used%2520to%2520Assess%2520Natural%2520Killer%2520Cell%2520Function%26jtitle%3DBMC%2520Immunol.%26date%3D2019%26volume%3D20%26spage%3D8%26doi%3D10.1186%2Fs12865-018-0272-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempsey, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacane, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panara, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bongrazio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, J. W.</span></span> <span> </span><span class="NLM_article-title">Activation of Human Natural Killer Cells by Lipopolysaccharide and Generation of Interleukin-1alpha, Beta, Tumour Necrosis Factor and Interleukin-6. Effect of IL-1 Receptor Antagonist</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1833315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3MXmtlSisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1991&pages=450-456&author=P.+Contiauthor=R.+A.+Dempseyauthor=M.+Realeauthor=R.+C.+Barbacaneauthor=M.+R.+Panaraauthor=M.+Bongrazioauthor=J.+W.+Mier&title=Activation+of+Human+Natural+Killer+Cells+by+Lipopolysaccharide+and+Generation+of+Interleukin-1alpha%2C+Beta%2C+Tumour+Necrosis+Factor+and+Interleukin-6.+Effect+of+IL-1+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1alpha, beta, tumor necrosis factor and interleukin-6.  Effect of IL-1 receptor antagonist</span></div><div class="casAuthors">Conti, P.; Dempsey, R. A.; Reale, M.; Barbacane, R. C.; Panara, M. R.; Bongrazio, M.; Mier, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-6</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    </div><div class="casAbstract">The presence in the body of an antigen species of a bacterial lipopolysaccharide (LPS) has a pleiotropic effect on the immune system activating macrophages, lymphocytes, and natural killer (NK) cells.  Recently it was reported that human macrophages not only secrete interleukin-1 (IL-1) but also its inhibitor, called IL-1 receptor antagonist (IL-1ra), structurally similar to IL-1β, but with no IL-1-like activity and which binds to the IL-1 receptor.  The authors show that LPS stimulates NK cell activity and IL-1ra potentiates the stimulatory effect of human recombinant interleukin-2 (hrIL-2) on NK cell activity.  In addn., hrIL-1ra inhibits DNA synthesis in lymphocyte cultures stimulated with phytohemagglutinin (PHA) (20 μg/mL), presumably via IL-1 inhibition.  LPS is a potent stimulator of monokines: IL-6, tumor necrosis factor-α (TNF-α), and IL-1β, as detd. by RIA method, and interferon-γ (IFN-γ), IL-2, TNF-α, and IL-1α, as detd. by ELISA method, in peripheral blood mononuclear cells (PBMC).  PBMC were used as effector cells since LPS requires the presence of accessory cells to activate lymphocytes and bind to the HLA-DR mol. on accessory cells.  The effect of LPS on PBMC cytotoxicity was compared with an endotoxin-free ext. of Escherichia coli, OM-8990, which did not provoke cytokine prodn. nor did it cause enhancement of NK cell activity.  Human recombinant IL-1ra potentiates the stimulatory effect of IL-2 on NK cell activity, similar to hrIL-1β.  Since IL-1ra is a part of the IL-1 family, it may work in a similar fashion to IL-1, which also potentiates IL-2 to enhance NK cell activity but has been shown not to be directly important in tumor cell killing.  In addn., hrIL-1ra can amplify the effect of IL-2 on NK activity, possibly by inhibiting the cyclooxygenase products, which are immunosuppressive and are generated in antigen-stimulated PBMC cultures.  The generation of IFN-γ by PBMC after treatment with LPS strongly suggests that the enhancement of NK cell activity may be indirectly due to IFN prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra0QyCYWopEbVg90H21EOLACvtfcHk0lirxwcUub3ewQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtlSisLg%253D&md5=b4ebcae4f8e3be5438ce098ee31061fd</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DP.%26aulast%3DDempsey%26aufirst%3DR.%2BA.%26aulast%3DReale%26aufirst%3DM.%26aulast%3DBarbacane%26aufirst%3DR.%2BC.%26aulast%3DPanara%26aufirst%3DM.%2BR.%26aulast%3DBongrazio%26aufirst%3DM.%26aulast%3DMier%26aufirst%3DJ.%2BW.%26atitle%3DActivation%2520of%2520Human%2520Natural%2520Killer%2520Cells%2520by%2520Lipopolysaccharide%2520and%2520Generation%2520of%2520Interleukin-1alpha%252C%2520Beta%252C%2520Tumour%2520Necrosis%2520Factor%2520and%2520Interleukin-6.%2520Effect%2520of%2520IL-1%2520Receptor%2520Antagonist%26jtitle%3DImmunology%26date%3D1991%26volume%3D73%26spage%3D450%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodziejczyk, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wysocka-Skrzela, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myśliwski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosnowska, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antitumor Activity of Conjugates of Muramyldipeptide, Normuramyldipeptide, and Desmuramylpeptides with Acridine/Acridone Derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3606</span>– <span class="NLM_lpage">3615</span>, <span class="refDoi"> DOI: 10.1021/jm001115g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001115g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntF2hsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3606-3615&author=K.+Dzierzbickaauthor=A.+M.+Kolodziejczykauthor=B.+Wysocka-Skrzelaauthor=A.+My%C5%9Bliwskiauthor=D.+Sosnowska&title=Synthesis+and+Antitumor+Activity+of+Conjugates+of+Muramyldipeptide%2C+Normuramyldipeptide%2C+and+Desmuramylpeptides+with+Acridine%2FAcridone+Derivatives&doi=10.1021%2Fjm001115g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antitumor Activity of Conjugates of Muramyldipeptide, Normuramyldipeptide, and Desmuramylpeptides with Acridine/Acridone Derivatives</span></div><div class="casAuthors">Dzierzbicka, Krystyna; Kolodziejczyk, Aleksander M.; Wysocka-Skrzela, Barbara; Mysliwski, Andrzej; Sosnowska, Danuta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3606-3615</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of muramyldipeptides I (R = acridine or acridone derivs.; Xaa = L-Ala, L-Val; Y = CH2Ph, Me), normuramyldipeptides II (R1 = H, Me; Xaa = L-Ala, L-Val, L-Pro; R2 = acridine or acridone derivs.) and desmuramyldipeptides analogs III·2HCl (R3 = acridine or acridone derivs.) and IV·2HCl contg. acridine derivs. V (Alk = alkylene) or acridone derivs. VI are described.  In I, the hydroxyl group at C6 of the sugar moiety formed esters with acridine/acridone N-substituted ω-aminoalkanocarboxylic acids, whereas II, III and IV have an amide bond formed between the carboxylic group of isoglutamine and the amine function of the resp. acridine/acridone derivs.  The preliminary screening data indicate that I, III and IV exhibit small cytotoxic activity; several compds. of type II exhibit potent in vitro cytotoxic activity against a panel of human cell lines and have been selected by the National Cancer Institute (NCI) Evaluation Committee for further testing.  I (R = V, Alk = CH2CH2; Xaa = L-Ala, Y = CH2Ph) shows an immunostimulating effect on the cytotoxic activity of the NK cells obtained from the spleen of healthy and Ab melanoma bearing animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRe-Ggxl4FYLVg90H21EOLACvtfcHk0lirxwcUub3ewQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntF2hsr8%253D&md5=5879c5469a8bf2a58bc70f871cf49eb9</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm001115g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001115g%26sid%3Dliteratum%253Aachs%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DKolodziejczyk%26aufirst%3DA.%2BM.%26aulast%3DWysocka-Skrzela%26aufirst%3DB.%26aulast%3DMy%25C5%259Bliwski%26aufirst%3DA.%26aulast%3DSosnowska%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Antitumor%2520Activity%2520of%2520Conjugates%2520of%2520Muramyldipeptide%252C%2520Normuramyldipeptide%252C%2520and%2520Desmuramylpeptides%2520with%2520Acridine%252FAcridone%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3606%26epage%3D3615%26doi%3D10.1021%2Fjm001115g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span> <span> </span><span class="NLM_article-title">Induction of Maturation in Cultured Human Monocytic Leukemia Cells by a Phorbol Diester</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1530</span>– <span class="NLM_lpage">1536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=6949641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL38Xks1OmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1982&pages=1530-1536&author=S.+Tsuchiyaauthor=Y.+Gotaauthor=H.+Okumuraauthor=S.+Nakaeauthor=T.+Konnoauthor=K.+Tadaauthor=Y.+Kobayashi&title=Induction+of+Maturation+in+Cultured+Human+Monocytic+Leukemia+Cells+by+a+Phorbol+Diester"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester</span></div><div class="casAuthors">Tsuchiya, Shigeru; Kobayashi, Yasuko; Goto, Yoichi; Okumura, Hidesada; Nakae, Shingi; Konno, Tasuke; Tada, Keiya</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1530-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Suspension cultures of a human monocytic leukemia cell line, THP-1, were treated with 0.16-160 nM 12-O-tetradecanoylphorbol 13-acetate (TPA)(I)  [16561-29-8].  In an original cell line, THP-1-O, cultured again from -80° cryopreservation, >80% of the cells adhered to the glass substrate with marked morphol. change within 3 h of TPA treatment.  Adherent cells became flat and ameboid in shape, and many microvilli and flaps of the cell surface disappeared.  Well-developed Golgi app., rough endoplasmic reticula, and a large amt. of free ribosomes were seen in the cytoplasm.  On the other hand, in THP-1-R cells cultured continuously without cryopreservation for 26 mo, ∼80% of the cells adhered to the substrate 48 h after TPA treatment.  Round and ovoid shapes were kept in THP-1-R cells treated with TPA.  Surface Fc receptors for IgG were present on >90% of THP-1-O and THP-1-R cells and were little affected by treatment with TPA.  Sixty to 70% of the TPA-treated THP-1-O and THP-1-R cells were able to phagocytize yeasts and IgG-coated sheep erythrocytes.  Less than 20% of the untreated THP-1 cells were able to phagocytize yeasts and IgG-coated sheep erythrocytes.  In histochem. staining, α-naphthyl butyrate esterase  [9013-79-0] was enhanced after treatment with TPA.  lysozyme  [16561-29-8] Activity in culture supernatants was not affected by TPA treatment.  When exposed to latex beads and TPA, increased 14CO2 prodn. from 1-14C-glucose in THP-1-O cells was obsd.  Thus, after treatment with TPA, human monocytic leukemia cells may be converted into mature cells with functions of macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokMwBQGw8vorVg90H21EOLACvtfcHk0liIzYbvUCFaHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xks1OmsLw%253D&md5=32acb53dd3d1f64484e00a6d2ec5c29c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DGota%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DH.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DTada%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26atitle%3DInduction%2520of%2520Maturation%2520in%2520Cultured%2520Human%2520Monocytic%2520Leukemia%2520Cells%2520by%2520a%2520Phorbol%2520Diester%26jtitle%3DCancer%2520Res.%26date%3D1982%26volume%3D42%26spage%3D1530%26epage%3D1536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pache, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodabakhshi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaseichuk, O.</span></span> <span> </span><span class="NLM_article-title">Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1523</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-09234-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fs41467-019-09234-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30944313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252Fhtl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1523&author=Y.+Zhouauthor=B.+Zhouauthor=L.+Pacheauthor=M.+Changauthor=C.+Bennerauthor=S.+K.+Chandaauthor=A.+H.+Khodabakhshiauthor=O.+Tanaseichuk&title=Metascape+Provides+a+Biologist-Oriented+Resource+for+the+Analysis+of+Systems-Level+Datasets&doi=10.1038%2Fs41467-019-09234-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</span></div><div class="casAuthors">Zhou Yingyao; Zhou Bin; Khodabakhshi Alireza Hadj; Tanaseichuk Olga; Pache Lars; Chanda Sumit K; Chang Max; Benner Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1523</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A critical component in the interpretation of systems-level studies is the inference of enriched biological pathways and protein complexes contained within OMICs datasets.  Successful analysis requires the integration of a broad set of current biological databases and the application of a robust analytical pipeline to produce readily interpretable results.  Metascape is a web-based portal designed to provide a comprehensive gene list annotation and analysis resource for experimental biologists.  In terms of design features, Metascape combines functional enrichment, interactome analysis, gene annotation, and membership search to leverage over 40 independent knowledgebases within one integrated portal.  Additionally, it facilitates comparative analyses of datasets across multiple independent and orthogonal experiments.  Metascape provides a significantly simplified user experience through a one-click Express Analysis interface to generate interpretable outputs.  Taken together, Metascape is an effective and efficient tool for experimental biologists to comprehensively analyze and interpret OMICs-based studies in the big data era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUXgctuHZqc4HWj6b1v8uTfW6udTcc2ebJyS1aMB99jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252Fhtl2rtg%253D%253D&md5=cb130c08668f9c8221f464a84039164d</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-09234-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-09234-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DPache%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DBenner%26aufirst%3DC.%26aulast%3DChanda%26aufirst%3DS.%2BK.%26aulast%3DKhodabakhshi%26aufirst%3DA.%2BH.%26aulast%3DTanaseichuk%26aufirst%3DO.%26atitle%3DMetascape%2520Provides%2520a%2520Biologist-Oriented%2520Resource%2520for%2520the%2520Analysis%2520of%2520Systems-Level%2520Datasets%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D1523%26doi%3D10.1038%2Fs41467-019-09234-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salyer, A. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S. A.</span></span> <span> </span><span class="NLM_article-title">Transcriptomal Signatures of Vaccine Adjuvants and Accessory Immunostimulation of Sentinel Cells by Toll-like Receptor 2/6 Agonists</span>. <i>Hum. Vaccines Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1686</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.1080/21645515.2018.1480284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F21645515.2018.1480284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29852079" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1686-1696&author=A.+C.+D.+Salyerauthor=S.+A.+David&title=Transcriptomal+Signatures+of+Vaccine+Adjuvants+and+Accessory+Immunostimulation+of+Sentinel+Cells+by+Toll-like+Receptor+2%2F6+Agonists&doi=10.1080%2F21645515.2018.1480284"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1080%2F21645515.2018.1480284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21645515.2018.1480284%26sid%3Dliteratum%253Aachs%26aulast%3DSalyer%26aufirst%3DA.%2BC.%2BD.%26aulast%3DDavid%26aufirst%3DS.%2BA.%26atitle%3DTranscriptomal%2520Signatures%2520of%2520Vaccine%2520Adjuvants%2520and%2520Accessory%2520Immunostimulation%2520of%2520Sentinel%2520Cells%2520by%2520Toll-like%2520Receptor%25202%252F6%2520Agonists%26jtitle%3DHum.%2520Vaccines%2520Immunother.%26date%3D2018%26volume%3D14%26spage%3D1686%26epage%3D1696%26doi%3D10.1080%2F21645515.2018.1480284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokol, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-032713-120145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev-immunol-032713-120145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=24655300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVemtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=659-702&author=J.+W.+Griffithauthor=C.+L.+Sokolauthor=A.+D.+Luster&title=Chemokines+and+Chemokine+Receptors%3A+Positioning+Cells+for+Host+Defense+and+Immunity&doi=10.1146%2Fannurev-immunol-032713-120145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines and chemokine receptors: positioning cells for host defense and immunity</span></div><div class="casAuthors">Griffith, Jason W.; Sokol, Caroline L.; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">659-702</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Chemokines are chemotactic cytokines that control the migratory patterns and positioning of all immune cells.  Although chemokines were initially appreciated as important mediators of acute inflammation, we now know that this complex system of approx. 50 endogenous chemokine ligands and 20 G protein-coupled seven-transmembrane signaling receptors is also crit. for the generation of primary and secondary adaptive cellular and humoral immune responses.  Recent studies demonstrate important roles for the chemokine system in the priming of naive T cells, in cell fate decisions such as effector and memory cell differentiation, and in regulatory T cell function.  In this review, we focus on recent advances in understanding how the chemokine system orchestrates immune cell migration and positioning at the organismic level in homeostasis, in acute inflammation, and during the generation and regulation of adoptive primary and secondary immune responses in the lymphoid system and peripheral nonlymphoid tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-1gG2fqwlE7Vg90H21EOLACvtfcHk0liIzYbvUCFaHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVemtLo%253D&md5=ef858cb14d464ca55622f931fac475f9</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032713-120145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032713-120145%26sid%3Dliteratum%253Aachs%26aulast%3DGriffith%26aufirst%3DJ.%2BW.%26aulast%3DSokol%26aufirst%3DC.%2BL.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DChemokines%2520and%2520Chemokine%2520Receptors%253A%2520Positioning%2520Cells%2520for%2520Host%2520Defense%2520and%2520Immunity%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D32%26spage%3D659%26epage%3D702%26doi%3D10.1146%2Fannurev-immunol-032713-120145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvanantham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comeau, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croft, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nucleotide Oligomerization Domain-Containing Proteins Instruct T Cell Helper Type 2 Immunity through Stromal Activation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">14896</span>– <span class="NLM_lpage">14901</span>, <span class="refDoi"> DOI: 10.1073/pnas.1015063108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.1015063108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21856952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFyktb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=14896-14901&author=J.+G.+Magalhaesauthor=S.+J.+Rubinoauthor=L.+H.+Travassosauthor=L.+Le+Bourhisauthor=W.+Duanauthor=G.+Sellgeauthor=K.+Geddesauthor=C.+Reardonauthor=M.+Lechmannauthor=L.+A.+Carneiroauthor=T.+Selvananthamauthor=J.+H.+Fritzauthor=B.+C.+Taylorauthor=D.+Artisauthor=T.+W.+Makauthor=M.+R.+Comeauauthor=M.+Croftauthor=S.+E.+Girardinauthor=D.+J.+Philpott&title=Nucleotide+Oligomerization+Domain-Containing+Proteins+Instruct+T+Cell+Helper+Type+2+Immunity+through+Stromal+Activation&doi=10.1073%2Fpnas.1015063108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation</span></div><div class="casAuthors">Magalhaes, Joao G.; Rubino, Stephen J.; Travassos, Leonardo H.; Le Bourhis, Lionel; Duan, Wei; Sellge, Gernot; Geddes, Kaoru; Reardon, Colin; Lechmann, Matthias; Carneiro, Leticia A.; Selvanantham, Thirumahal; Fritz, Jorg H.; Taylor, Betsy C.; Artis, David; Mak, Tak Wah; Comeau, Michael R.; Croft, Michael; Girardin, Stephen E.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">14896-14901, S14896/1-S14896/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although a no. of studies have examd. the development of T-helper cell type 2 (Th2) immunity in different settings, the mechanisms underlying the initiation of this arm of adaptive immunity are not well understood.  We exploited the fact that immunization with antigen plus either nucleotide-binding oligomerization domain-contg. proteins 1 (Nod1) or 2 (Nod2) agonists drives Th2 induction to understand how these pattern-recognition receptors mediate the development of systemic Th2 immune responses.  Here, we show in bone-marrow chimeric mice that Nod1 and Nod2 expression within the stromal compartment is necessary for priming of effector CD4+ Th2 responses and specific IgG1 antibodies.  In contrast, sensing of these ligands by dendritic cells was not sufficient to induce Th2 immunity, although these cells contribute to the response.  Moreover, we detd. that CD11c+ cells were the crit. antigen-presenting cells, whereas basophils and B cells did not affect the capacity of Nod ligands to induce CD4+ Th2 effector function.  Finally, we found that full Th2 induction upon Nod1 and Nod2 activation was dependent on both thymic stromal lymphopoietin prodn. by the stromal cells and the up-regulation of the costimulatory mol., OX40 ligand, on dendritic cells.  This study provides in vivo evidence of how systemic Th2 immunity is induced in the context of Nod stimulation.  Such understanding will influence the rational design of therapeutics that could reprogram the immune system during an active Th1-mediated disease, such as Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5oZUZGqE2mrVg90H21EOLACvtfcHk0lh6KsvtJluwPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFyktb7P&md5=36f71771b5f06951de0f3f9938db70c3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015063108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015063108%26sid%3Dliteratum%253Aachs%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DRubino%26aufirst%3DS.%2BJ.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DSellge%26aufirst%3DG.%26aulast%3DGeddes%26aufirst%3DK.%26aulast%3DReardon%26aufirst%3DC.%26aulast%3DLechmann%26aufirst%3DM.%26aulast%3DCarneiro%26aufirst%3DL.%2BA.%26aulast%3DSelvanantham%26aufirst%3DT.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DTaylor%26aufirst%3DB.%2BC.%26aulast%3DArtis%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DComeau%26aufirst%3DM.%2BR.%26aulast%3DCroft%26aufirst%3DM.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNucleotide%2520Oligomerization%2520Domain-Containing%2520Proteins%2520Instruct%2520T%2520Cell%2520Helper%2520Type%25202%2520Immunity%2520through%2520Stromal%2520Activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D14896%26epage%3D14901%26doi%3D10.1073%2Fpnas.1015063108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoggins, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, C. M.</span></span> <span> </span><span class="NLM_article-title">Interferon-Stimulated Genes and Their Antiviral Effector Functions</span>. <i>Curr. Opin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1016/j.coviro.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.coviro.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22328912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=519-525&author=J.+W.+Schogginsauthor=C.+M.+Rice&title=Interferon-Stimulated+Genes+and+Their+Antiviral+Effector+Functions&doi=10.1016%2Fj.coviro.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-stimulated genes and their antiviral effector functions</span></div><div class="casAuthors">Schoggins, John W.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">519-525</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Many viruses trigger the type I interferon (IFN) system, leading to the transcription of hundreds of interferon-stimulated genes (ISGs).  The products of these ISGs exert numerous antiviral effector functions, many of which are still not fully described.  Recent efforts have been aimed at identifying which ISGs are antiviral and further characterizing their mechanisms of action.  IFN effectors vary widely in their magnitude of inhibitory activity and display combinatorial antiviral properties.  Collectively, ISGs can target almost any step in a virus life cycle.  Some of the most potent antiviral effectors reinforce the system by further inducing IFN or ISGs.  Other genes enhance or facilitate viral replication, suggesting that some viruses may have evolved to co-opt IFN effectors for a survival advantage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfASL1CEkHzrVg90H21EOLACvtfcHk0lh6KsvtJluwPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htrfP&md5=da3904fc16d3d47401de41246d7aaf8d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSchoggins%26aufirst%3DJ.%2BW.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DInterferon-Stimulated%2520Genes%2520and%2520Their%2520Antiviral%2520Effector%2520Functions%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2011%26volume%3D1%26spage%3D519%26epage%3D525%26doi%3D10.1016%2Fj.coviro.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proietti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pucchio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sestili, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vincenzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venditti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capone, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seif, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maeyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tough, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardelli, F.</span></span> <span> </span><span class="NLM_article-title">Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.169.1.375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.169.1.375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12077267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=375-383&author=E.+Proiettiauthor=L.+Bracciauthor=S.+Puzelliauthor=T.+Di+Pucchioauthor=P.+Sestiliauthor=E.+De+Vincenziauthor=M.+Vendittiauthor=I.+Caponeauthor=I.+Seifauthor=E.+De+Maeyerauthor=D.+Toughauthor=I.+Donatelliauthor=F.+Belardelli&title=Type+I+IFN+as+a+Natural+Adjuvant+for+a+Protective+Immune+Response%3A+Lessons+from+the+Influenza+Vaccine+Model&doi=10.4049%2Fjimmunol.169.1.375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model</span></div><div class="casAuthors">Proietti, Enrico; Bracci, Laura; Puzelli, Simona; Di Pucchio, Tiziana; Sestili, Paola; De Vincenzi, Enrico; Venditti, Massimo; Capone, Imerio; Seif, Isabelle; De Maeyer, Edward; Tough, David; Donatelli, Isabella; Belardelli, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">375-383</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The identification of natural adjuvants capable of selectively promoting an efficient immune response against infectious agents would represent an important advance in immunol., with direct implications for vaccine development, whose progress is generally hampered by the difficulties in defining powerful synthetic adjuvants suitable for clin. use.  Here, we demonstrate that endogenous type I IFN is necessary for the Th1 type of immune response induced by typical adjuvants in mice and that IFN itself is an unexpectedly powerful adjuvant when administered with the human influenza vaccine, for inducing IgG2a and IgA prodn. and conferring protection from virus challenge.  The finding that these cytokines, currently used in patients, are necessary for full expression of adjuvant activity and are sufficient for the generation of a protective immune response opens new perspectives in understanding the basis of immunity and in vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv70AN_-b_5LVg90H21EOLACvtfcHk0lh6KsvtJluwPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKisL4%253D&md5=a7d590f7cf763f874f0ba8c1848884f8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.169.1.375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.169.1.375%26sid%3Dliteratum%253Aachs%26aulast%3DProietti%26aufirst%3DE.%26aulast%3DBracci%26aufirst%3DL.%26aulast%3DPuzelli%26aufirst%3DS.%26aulast%3DDi%2BPucchio%26aufirst%3DT.%26aulast%3DSestili%26aufirst%3DP.%26aulast%3DDe%2BVincenzi%26aufirst%3DE.%26aulast%3DVenditti%26aufirst%3DM.%26aulast%3DCapone%26aufirst%3DI.%26aulast%3DSeif%26aufirst%3DI.%26aulast%3DDe%2BMaeyer%26aufirst%3DE.%26aulast%3DTough%26aufirst%3DD.%26aulast%3DDonatelli%26aufirst%3DI.%26aulast%3DBelardelli%26aufirst%3DF.%26atitle%3DType%2520I%2520IFN%2520as%2520a%2520Natural%2520Adjuvant%2520for%2520a%2520Protective%2520Immune%2520Response%253A%2520Lessons%2520from%2520the%2520Influenza%2520Vaccine%2520Model%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D375%26epage%3D383%26doi%3D10.4049%2Fjimmunol.169.1.375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Sorsa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proietti, E.</span></span> <span> </span><span class="NLM_article-title">Type I Interferons as Vaccine Adjuvants against Infectious Diseases and Cancer</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1586/14760584.7.3.373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1586%2F14760584.7.3.373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18393607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlahtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=373-381&author=L.+Bracciauthor=V.+La+Sorsaauthor=F.+Belardelliauthor=E.+Proietti&title=Type+I+Interferons+as+Vaccine+Adjuvants+against+Infectious+Diseases+and+Cancer&doi=10.1586%2F14760584.7.3.373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Type I interferons as vaccine adjuvants against infectious diseases and cancer</span></div><div class="casAuthors">Bracci, Laura; La Sorsa, Valentina; Belardelli, Filippo; Proietti, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Presently, new attention is given to type I interferons (IFNs) as essential factors linking innate and adaptive immunity.  Several studies provided evidence about the importance of IFN-α in the differentiation of the Th1 subset, in the generation and activity of cytotoxic T lymphocytes, in the enhancement of a primary antibody response and in the activation of dendritic cells.  Owing to their immunomodulatory properties, type I IFNs can represent good candidates to be used as adjuvants for vaccination.  In the present review, we summarize recent studies in humans and in animal models, suggesting a possible application of type I IFNs as adjuvants for the development of more effective vaccines against infectious diseases and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Pb5qN0fE6bVg90H21EOLACvtfcHk0lj_rrKnwraajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlahtbw%253D&md5=efb274ef8c40a7a0a5e30ec0c75f3f86</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1586%2F14760584.7.3.373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14760584.7.3.373%26sid%3Dliteratum%253Aachs%26aulast%3DBracci%26aufirst%3DL.%26aulast%3DLa%2BSorsa%26aufirst%3DV.%26aulast%3DBelardelli%26aufirst%3DF.%26aulast%3DProietti%26aufirst%3DE.%26atitle%3DType%2520I%2520Interferons%2520as%2520Vaccine%2520Adjuvants%2520against%2520Infectious%2520Diseases%2520and%2520Cancer%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2008%26volume%3D7%26spage%3D373%26epage%3D381%26doi%3D10.1586%2F14760584.7.3.373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span> <span> </span><span class="NLM_article-title">Type I Interferon Related Genes Are Common Genes on the Early Stage after Vaccination by Meta-Analysis of Microarray Data</span>. <i>Hum. Vaccines Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1080/21645515.2015.1008884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F21645515.2015.1008884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25839220" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=739-745&author=J.+Zhangauthor=J.+Shaoauthor=X.+Wuauthor=Q.+Maoauthor=Y.+Wangauthor=F.+Gaoauthor=W.+Kongauthor=Z.+Liang&title=Type+I+Interferon+Related+Genes+Are+Common+Genes+on+the+Early+Stage+after+Vaccination+by+Meta-Analysis+of+Microarray+Data&doi=10.1080%2F21645515.2015.1008884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1080%2F21645515.2015.1008884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21645515.2015.1008884%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DZ.%26atitle%3DType%2520I%2520Interferon%2520Related%2520Genes%2520Are%2520Common%2520Genes%2520on%2520the%2520Early%2520Stage%2520after%2520Vaccination%2520by%2520Meta-Analysis%2520of%2520Microarray%2520Data%26jtitle%3DHum.%2520Vaccines%2520Immunother.%26date%3D2015%26volume%3D11%26spage%3D739%26epage%3D745%26doi%3D10.1080%2F21645515.2015.1008884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khabar, K. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, H. A.</span></span> <span> </span><span class="NLM_article-title">Post-Transcriptional Control of the Interferon System</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">769</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2007.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.biochi.2007.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17408842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFKrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2007&pages=761-769&author=K.+S.+A.+Khabarauthor=H.+A.+Young&title=Post-Transcriptional+Control+of+the+Interferon+System&doi=10.1016%2Fj.biochi.2007.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Post-transcriptional control of the interferon system</span></div><div class="casAuthors">Khabar, Khalid S. A.; Young, Howard A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">761-769</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The interferon (IFN) system is a well-controlled network of signaling, transcriptional, and post-transcriptional processes that orchestrate host defense against microbes.  The IFN response comprises a multi-array of IFN-stimulated gene products that mediate a variety of biol. processes designed to control infection and regulate specific immune responses.  In this review, the authors focus on post-transcriptional mechanisms of gene regulation that occur during the course of IFN induction and during the response of cells to IFN.  Post-transcriptional mechanisms involve different levels of regulation such as mRNA stability, alternative splicing, and translation.  Such controls offer a fine tuning mechanism for efficient and rapid response and as a neg. feedback control in IFN biosynthesis and response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgIlYEt4emhLVg90H21EOLACvtfcHk0lj_rrKnwraajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFKrtbs%253D&md5=49acb0a7279de3ba235829ec7f582327</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2007.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2007.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DKhabar%26aufirst%3DK.%2BS.%2BA.%26aulast%3DYoung%26aufirst%3DH.%2BA.%26atitle%3DPost-Transcriptional%2520Control%2520of%2520the%2520Interferon%2520System%26jtitle%3DBiochimie%26date%3D2007%26volume%3D89%26spage%3D761%26epage%3D769%26doi%3D10.1016%2Fj.biochi.2007.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span> <span> </span><span class="NLM_article-title">Dendritic Cells and the Control of Immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>392</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/32588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2F32588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=9521319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1998&pages=245-252&author=J.+Banchereauauthor=R.+M.+Steinman&title=Dendritic+Cells+and+the+Control+of+Immunity&doi=10.1038%2F32588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells and the control of immunity</span></div><div class="casAuthors">Banchereau, Jacques; Steinman, Ralph M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">392</span>
        (<span class="NLM_cas:issue">6673</span>),
    <span class="NLM_cas:pages">245-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 103 refs.  B and T lymphocytes are the mediators of immunity, but their function is under the control of dendritic cells.  Dendritic cells in the periphery capture and process antigens, express lymphocyte co-stimulatory mols., migrate to lymphoid organs, and secrete cytokines to initiate immune responses.  They not only activate lymphocytes, they also tolerize T cells to antigens that are innate to the body (self-antigens), thereby minimizing autoimmune reactions.  Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow mol. and cell biol. anal.  With knowledge comes the realization that these cells are a powerful tool for manipulating the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cFu9pwhnSrVg90H21EOLACvtfcHk0liNROcGxMyjpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D&md5=af17ace619fc543c7260cb04146d4c30</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2F32588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F32588%26sid%3Dliteratum%253Aachs%26aulast%3DBanchereau%26aufirst%3DJ.%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26atitle%3DDendritic%2520Cells%2520and%2520the%2520Control%2520of%2520Immunity%26jtitle%3DNature%26date%3D1998%26volume%3D392%26spage%3D245%26epage%3D252%26doi%3D10.1038%2F32588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Todate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Muramyl Dipeptide-Lys Stimulates the Function of Human Dendritic Cells</span>. <i>J. Leukoc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1189/jlb.70.5.723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1189%2Fjlb.70.5.723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11698491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=723-729&author=A.+Todateauthor=T.+Sudaauthor=H.+Kuwataauthor=K.+Chidaauthor=H.+Nakamura&title=Muramyl+Dipeptide-Lys+Stimulates+the+Function+of+Human+Dendritic+Cells&doi=10.1189%2Fjlb.70.5.723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl dipeptide-Lys stimulates the function of human dendritic cells</span></div><div class="casAuthors">Todate, Akihito; Suda, Takafumi; Kuwata, Hiroshi; Chida, Kingo; Nakamura, Hirotoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">723-729</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP)-Lys (L18), a synthetic MDP analog derived from bacterial cell walls, has been reported to be a potent immunoadjuvant that enhances protective immunity against pathogens and tumors by stimulating immune-competent cells, such as monocytes and macrophages.  However, it is not known whether MDP-Lys modulates the function of dendritic cells (DCs), which are the most potent antigen-presenting cells and play a crucial role in initiating T cell-mediated immunity.  Therefore, we examd. the effects of MDP-Lys on the expression of surface mols., cytokine prodn., and antigen-presenting function of human DCs generated from peripheral blood cells in the presence of interleukin (IL)-4 and granulocyte-macrophage colony-stimulating factor.  We found that MDP-Lys markedly up-regulated the expression of CD80, CD83, CD86, and CD40, but not human leukocyte antigen-DR, and stimulated the prodn. of tumor necrosis factor-α, IL-6, IL-8, IL-10, and IL-12 (p40) by human DCs in a dose-dependent manner.  Furthermore, MDP-Lys-treated DCs showed enhanced antigen-presenting function compared with untreated DCs, as assessed by an allogeneic mixed lymphocyte reaction.  These results suggested that the immunoadjuvant activity of MDP-Lys in vivo is mediated, in part, by its stimulation of DC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVi5NO0qPVQLVg90H21EOLACvtfcHk0liNROcGxMyjpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D&md5=0123eaf8d8f353ed56e2dd604b90afc4</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1189%2Fjlb.70.5.723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.70.5.723%26sid%3Dliteratum%253Aachs%26aulast%3DTodate%26aufirst%3DA.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DH.%26aulast%3DChida%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DMuramyl%2520Dipeptide-Lys%2520Stimulates%2520the%2520Function%2520of%2520Human%2520Dendritic%2520Cells%26jtitle%3DJ.%2520Leukoc.%2520Biol.%26date%3D2001%26volume%3D70%26spage%3D723%26epage%3D729%26doi%3D10.1189%2Fjlb.70.5.723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewulf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr, G. M.</span></span> <span> </span><span class="NLM_article-title">Enhanced Maturation and Functional Capacity of Monocyte-Derived Immature Dendritic Cells by the Synthetic Immunomodulator Murabutide</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2567.2001.01269.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1046%2Fj.1365-2567.2001.01269.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11529939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1els78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2001&pages=479-487&author=V.+Vidalauthor=J.+Dewulfauthor=G.+M.+Bahr&title=Enhanced+Maturation+and+Functional+Capacity+of+Monocyte-Derived+Immature+Dendritic+Cells+by+the+Synthetic+Immunomodulator+Murabutide&doi=10.1046%2Fj.1365-2567.2001.01269.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide</span></div><div class="casAuthors">Vidal, Vincent; Dewulf, Joelle; Bahr, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">479-487</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Murabutide is a safe synthetic immunomodulator derived from muramyl dipeptide, the smallest bioactive unit of bacterial peptidoglycan.  Although it is well known that muramyl peptides modulate the functions of monocytes/macrophages, their activity on dendritic cells is poorly documented.  We thus investigated the effects of Murabutide on immunophenotype, endocytosis, T-cell stimulatory capacity, and cytokine secretion of human monocyte-derived immature dendritic cells (iDCs).  We found that Murabutide triggers immunophenotypic changes as upon treatment, iDCs up-regulate the surface expression of the major histocompatibility complex type II mol. human leukocyte antigen-DR, the co-stimulatory mols. CD80, CD86 and CD40 and the differentiation marker CD83, and down-regulate the expression of the mannose receptor.  These phenotypic changes are also mirrored by changes in their biol. activity.  Subsequent to treatment with the synthetic immunomodulator, DC have a decreased endocytic capacity but exhibit enhanced stimulatory capacity for both allogeneic and autologous T cells.  In addn., Murabutide-stimulated iDCs have a greater cytostatic activity toward the tumor cell line THP-1.  Furthermore, in the presence of Murabutide, DCs transiently increased the release of macrophage inhibitory protein-1β, tumor necrosis factor-α and interleukin-10, whereas the enhanced prodn. of macrophage-colony stimulating factor was sustained over the 3-day period analyzed.  In addn., Murabutide triggers the phosphorylation of the three classes of mitogen-activated protein kinases in iDCs.  Our results demonstrate that Murabutide triggers the maturation and activation of monocyte-derived iDCs.  As this immunomodulator is approved for administration in humans, it could be a useful adjunct to boost the efficacy of DC-based vaccines designed against tumors or virus-infected cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRYQqkI-ucAbVg90H21EOLACvtfcHk0liNROcGxMyjpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1els78%253D&md5=4af31647b9cfee735ada109fca7cd27a</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2567.2001.01269.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2567.2001.01269.x%26sid%3Dliteratum%253Aachs%26aulast%3DVidal%26aufirst%3DV.%26aulast%3DDewulf%26aufirst%3DJ.%26aulast%3DBahr%26aufirst%3DG.%2BM.%26atitle%3DEnhanced%2520Maturation%2520and%2520Functional%2520Capacity%2520of%2520Monocyte-Derived%2520Immature%2520Dendritic%2520Cells%2520by%2520the%2520Synthetic%2520Immunomodulator%2520Murabutide%26jtitle%3DImmunology%26date%3D2001%26volume%3D103%26spage%3D479%26epage%3D487%26doi%3D10.1046%2Fj.1365-2567.2001.01269.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohteki, T.</span></span> <span> </span><span class="NLM_article-title">Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.0900726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=20008287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=736-745&author=J.+Asanoauthor=H.+Tadaauthor=N.+Onaiauthor=T.+Satoauthor=Y.+Horieauthor=Y.+Fujimotoauthor=K.+Fukaseauthor=A.+Suzukiauthor=T.+W.+Makauthor=T.+Ohteki&title=Nucleotide+Oligomerization+Binding+Domain-Like+Receptor+Signaling+Enhances+Dendritic+Cell-Mediated+Cross-Priming+In+Vivo&doi=10.4049%2Fjimmunol.0900726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo</span></div><div class="casAuthors">Asano, Jumpei; Tada, Hiroyuki; Onai, Nobuyuki; Sato, Taku; Horie, Yasuo; Fujimoto, Yukari; Fukase, Koichi; Suzuki, Akira; Mak, Tak W.; Ohteki, Toshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">736-745</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Nucleotide oligomerization binding domain (Nod)-like receptors are crit. cytosolic sensors for the recognition of bacterial peptidoglycan.  However, their role in the induction of dendritic cell (DC)-mediated cross-priming remains unclear.  In this study, the authors demonstrate that injecting ligands for Nod1 and Nod2 along with Ag into wild-type mice significantly enhanced the cross-priming of Ag-specific CD8+ T cells by CD8α+ DCs, as assessed from the expansion of IFN-γ+ CD8+ T cells, CTL activity against Ag-pulsed targets, and the rejection of transplanted tumors expressing the cognate Ag.  The enhancement of CD8α+ DC-mediated cross-priming was likely due to the upregulation of Ag cross-presentation and of costimulatory mols.  The authors' findings collectively indicate that Nod1/2 signaling is crit. for the optimal induction of DC cross-priming in vivo, which may offer an alternative therapeutic pathway in cancer and hosts refractory to TLR signals or paralyzed by viral evasion strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6nN-YGjYJ3bVg90H21EOLACvtfcHk0liNROcGxMyjpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslCmtg%253D%253D&md5=ca81c1e78255fd64b892f89963e8029b</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900726%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DJ.%26aulast%3DTada%26aufirst%3DH.%26aulast%3DOnai%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DHorie%26aufirst%3DY.%26aulast%3DFujimoto%26aufirst%3DY.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DOhteki%26aufirst%3DT.%26atitle%3DNucleotide%2520Oligomerization%2520Binding%2520Domain-Like%2520Receptor%2520Signaling%2520Enhances%2520Dendritic%2520Cell-Mediated%2520Cross-Priming%2520In%2520Vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26spage%3D736%26epage%3D745%26doi%3D10.4049%2Fjimmunol.0900726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corridoni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steevels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thézénas, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prota, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gileadi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ternette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerundolo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, A.</span></span> <span> </span><span class="NLM_article-title">NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">958</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2019.00958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3389%2Ffimmu.2019.00958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=31114588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsl2nsb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=958&author=D.+Corridoniauthor=S.+Shiraishiauthor=T.+Chapmanauthor=T.+Steevelsauthor=D.+Muraroauthor=M.-L.+Th%C3%A9z%C3%A9nasauthor=G.+Protaauthor=J.-L.+Chenauthor=U.+Gileadiauthor=N.+Ternetteauthor=V.+Cerundoloauthor=A.+Simmons&title=NOD2+and+TLR2+Signal+via+TBK1+and+PI31+to+Direct+Cross-Presentation+and+CD8+T+Cell+Responses&doi=10.3389%2Ffimmu.2019.00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 and TLR2 signal via TBK1 and PI31 to direct cross-presentation and CD8 T cell responses</span></div><div class="casAuthors">Corridoni, Daniele; Shiraishi, Seiji; Chapman, Thomas; Steevels, Tessa; Muraro, Daniele; Thezenas, Marie-Laetitia; Prota, Gennaro; Chen, Ji-Li; Gileadi, Uzi; Ternette, Nicola; Cerundolo, Vincenzo; Simmons, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">958</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">NOD2 and TLR2 recognize components of bacterial cell wall peptidoglycan and direct defense against enteric pathogens.  CD8+ T cells are important for immunity to such pathogens but how NOD2 and TLR2 induce antigen specific CD8+ T cell responses is unknown.  Here, we define how these pattern recognition receptors (PRRs) signal in primary dendritic cells (DCs) to influence MHC class I antigen presentation.  We show NOD2 and TLR2 phosphorylate PI31 via TBK1 following activation in DCs.  PI31 interacts with TBK1 and Sec16A at endoplasmic reticulum exit sites (ERES), which pos. regulates MHC class I peptide loading and immunoproteasome stability.  Following NOD2 and TLR2 stimulation, depletion of PI31 or inhibition of TBK1 activity in vivo impairs DC cross-presentation and CD8+ T cell activation.  DCs from Crohn's patients expressing NOD2 polymorphisms show dysregulated cross-presentation and CD8+ T cell responses.  Our findings reveal unidentified mechanisms that underlie CD8+ T cell responses to bacteria in health and in Crohn's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob81TlNX1Fc7Vg90H21EOLACvtfcHk0lhJ4Mql24iZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsl2nsb3L&md5=56d42d96d773d59be298874d62d6017f</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2019.00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2019.00958%26sid%3Dliteratum%253Aachs%26aulast%3DCorridoni%26aufirst%3DD.%26aulast%3DShiraishi%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%26aulast%3DSteevels%26aufirst%3DT.%26aulast%3DMuraro%26aufirst%3DD.%26aulast%3DTh%25C3%25A9z%25C3%25A9nas%26aufirst%3DM.-L.%26aulast%3DProta%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.-L.%26aulast%3DGileadi%26aufirst%3DU.%26aulast%3DTernette%26aufirst%3DN.%26aulast%3DCerundolo%26aufirst%3DV.%26aulast%3DSimmons%26aufirst%3DA.%26atitle%3DNOD2%2520and%2520TLR2%2520Signal%2520via%2520TBK1%2520and%2520PI31%2520to%2520Direct%2520Cross-Presentation%2520and%2520CD8%2520T%2520Cell%2520Responses%26jtitle%3DFront.%2520Immunol.%26date%3D2019%26volume%3D10%26spage%3D958%26doi%3D10.3389%2Ffimmu.2019.00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eirikis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, U.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of Lymphocyte Activation Marker Expression and Cytokine Secretion Profile in Stimulated Human Peripheral Blood Mononuclear Cell Cultures: An in Vitro Model to Monitor Cellular Immune Function</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/j.jim.2004.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.jim.2004.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15541283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFCisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2004&pages=127-142&author=M.+Reddyauthor=E.+Eirikisauthor=C.+Davisauthor=H.+M.+Davisauthor=U.+Prabhakar&title=Comparative+Analysis+of+Lymphocyte+Activation+Marker+Expression+and+Cytokine+Secretion+Profile+in+Stimulated+Human+Peripheral+Blood+Mononuclear+Cell+Cultures%3A+An+in+Vitro+Model+to+Monitor+Cellular+Immune+Function&doi=10.1016%2Fj.jim.2004.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function</span></div><div class="casAuthors">Reddy, Manjula; Eirikis, Edward; Davis, Cuc; Davis, Hugh M.; Prabhakar, Uma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-142</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of lymphocytes is a complex, yet finely regulated cascade of events that results in the expression of cytokine receptors, prodn. and secretion of cytokines and expression of several cell surface mols. that eventually lead to divergent immune responses.  Assessing the qual. and quant. nature of lymphocyte function following immunotherapy provides valuable information about the immune responses mediated by a therapeutic agent.  To facilitate evaluation of the immunomodulatory activity of therapeutic agents, we have established a platform of in vitro immunoassays with normal human peripheral blood mononuclear cells (PBMCs) treated with several polyclonal activators that are known to exhibit different modes of action.  We evaluated the kinetics of cell surface marker expression and cytokine release from PBMCs stimulated in parallel with various activating agents over a time course.  These stimulating agents induced early (CD69 and CD71) and late (CD25 and HLA-DR) activation markers to varying antigen densities, indicated different cytokine profiles, and showed differential inhibition with dexamethasone (DEX), an inhibitor of early signaling events.  Based on the assocn. or correlation of the kinetics of activation marker expression and secreted cytokines, the results of our study indicate the appropriate time points for the simultaneous measurement of both these activation products.  This study defines the kinetics for both measures of T cell activation and provides a comprehensive review with various polyclonal activators that can serve as a ref. for monitoring lymphocyte function in clin. study samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV9WHA6sVSG7Vg90H21EOLACvtfcHk0lhJ4Mql24iZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFCisbw%253D&md5=b9dcc72e6e7252c29f69fad606d8f039</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.jim.2004.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jim.2004.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%26aulast%3DEirikis%26aufirst%3DE.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DH.%2BM.%26aulast%3DPrabhakar%26aufirst%3DU.%26atitle%3DComparative%2520Analysis%2520of%2520Lymphocyte%2520Activation%2520Marker%2520Expression%2520and%2520Cytokine%2520Secretion%2520Profile%2520in%2520Stimulated%2520Human%2520Peripheral%2520Blood%2520Mononuclear%2520Cell%2520Cultures%253A%2520An%2520in%2520Vitro%2520Model%2520to%2520Monitor%2520Cellular%2520Immune%2520Function%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D2004%26volume%3D293%26spage%3D127%26epage%3D142%26doi%3D10.1016%2Fj.jim.2004.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Létourneau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantaleo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyman, O.</span></span> <span> </span><span class="NLM_article-title">IL-2- and CD25-Dependent Immunoregulatory Mechanisms in the Homeostasis of T-Cell Subsets</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">758</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2009.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.jaci.2009.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19348914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2isLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=758-762&author=S.+L%C3%A9tourneauauthor=C.+Kriegauthor=G.+Pantaleoauthor=O.+Boyman&title=IL-2-+and+CD25-Dependent+Immunoregulatory+Mechanisms+in+the+Homeostasis+of+T-Cell+Subsets&doi=10.1016%2Fj.jaci.2009.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets</span></div><div class="casAuthors">Letourneau, Sven; Krieg, Carsten; Pantaleo, Giuseppe; Boyman, Onur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">758-762</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  IL-2 plays a pivotal role in regulating the adaptive immune system by controlling the survival and proliferation of regulatory T (Treg) cells, which are required for the maintenance of immune tolerance.  Moreover, IL-2 is implicated in the differentiation and homeostasis of effector T-cell subsets, including TH1, TH2, TH17, and memory CD8+ T cells.  The IL-2 receptor is composed of 3 distinct subunits, namely the α (CD25), β (CD122), and γ (γc) chains.  Of crucial importance for the delivery of IL-2 signals to Treg cells is the expression of CD25, which, along with CD122 and γc, confers high affinity binding to IL-2.  Notably, recent findings suggest a novel role for CD25, whereby CD25 mols. on Treg cells and possibly other cells are capable of influencing T-cell homeostasis by means of IL-2 deprivation.  This review explores these findings and integrates them into our current understanding of T-cell homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8izAMuuIItrVg90H21EOLACvtfcHk0lhJ4Mql24iZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2isLk%253D&md5=1db3f85daa51c87a3bde459c949b8e0f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2009.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2009.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A9tourneau%26aufirst%3DS.%26aulast%3DKrieg%26aufirst%3DC.%26aulast%3DPantaleo%26aufirst%3DG.%26aulast%3DBoyman%26aufirst%3DO.%26atitle%3DIL-2-%2520and%2520CD25-Dependent%2520Immunoregulatory%2520Mechanisms%2520in%2520the%2520Homeostasis%2520of%2520T-Cell%2520Subsets%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2009%26volume%3D123%26spage%3D758%26epage%3D762%26doi%3D10.1016%2Fj.jaci.2009.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Heel, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Playford, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span> <span> </span><span class="NLM_article-title">NOD2 Activity Modulates the Phenotype of LPS-Stimulated Dendritic Cells to Promote the Development of T-Helper Type 2-like Lymphocytes - Possible Implications for NOD2-Associated Crohn’s Disease</span>. <i>J. Crohn’s Colitis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.crohns.2007.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.crohns.2007.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21172192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fls1yrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=106-115&author=M.+Butlerauthor=R.+Chaudharyauthor=D.+A.+van+Heelauthor=R.+J.+Playfordauthor=S.+Ghosh&title=NOD2+Activity+Modulates+the+Phenotype+of+LPS-Stimulated+Dendritic+Cells+to+Promote+the+Development+of+T-Helper+Type+2-like+Lymphocytes+-+Possible+Implications+for+NOD2-Associated+Crohn%E2%80%99s+Disease&doi=10.1016%2Fj.crohns.2007.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease</span></div><div class="casAuthors">Butler Matt; Chaudhary Rakesh; van Heel David A; Playford Raymond J; Ghosh Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Crohn's & colitis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-15</span>
        ISSN:<span class="NLM_cas:issn">1873-9946</span>.
    </div><div class="casAbstract">Sensing of commensal microorganisms via Toll-like receptors (TLR) in the gut is essential for maintaining intestinal homeostasis in healthy individuals.  Conversely, Crohn's disease is characterised by an inappropriate T helper-type 1 (Th1)-mediated immune response towards these same microorganisms.  NOD2 is expressed by dendritic cells (DC) and mediates responses to bacterial muramyl-dipeptides (MDP).  Mutations in NOD2 (CARD15) have recently been associated with susceptibility to Crohn's disease although the underlying mechanisms have yet to be established.  We investigated the functional outcome of NOD2 and TLR4-mediated activation in monocyte-derived DC from wild-type NOD2 healthy controls and NOD2 frame-shift mutation-carrying Crohn's disease patients.  In wild-type DC, MDP acted synergistically with LPS to amplify inflammatory cytokine production, enhance co-stimulatory molecule expression, and produce DC that promoted the proliferation of naive, allogeneic, CD4(+) T lymphocytes with a Th2-like cytokine profile.  By contrast, DC carrying homozygous NOD2 mutations were unable to react to MDP, responded to LPS only, and promoted the development of Th1 cells.  These results suggest activation of the NOD2 pathway in DC modulates their response to TLR agonists and regulates their ability to induce polarised Th1 responses.  As a consequence, Crohn's disease patients with defective NOD2 may be predisposed to the generation of strongly polarised Th1 responses against common commensal microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ35j2NBeL_ZNK0qsdY6Nc1fW6udTcc2eaHbDoZRlW9Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fls1yrug%253D%253D&md5=7d02fcf2b45699c6e3e68e10da11a12c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.crohns.2007.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.crohns.2007.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%26aulast%3DChaudhary%26aufirst%3DR.%26aulast%3Dvan%2BHeel%26aufirst%3DD.%2BA.%26aulast%3DPlayford%26aufirst%3DR.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26atitle%3DNOD2%2520Activity%2520Modulates%2520the%2520Phenotype%2520of%2520LPS-Stimulated%2520Dendritic%2520Cells%2520to%2520Promote%2520the%2520Development%2520of%2520T-Helper%2520Type%25202-like%2520Lymphocytes%2520-%2520Possible%2520Implications%2520for%2520NOD2-Associated%2520Crohn%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Crohn%25E2%2580%2599s%2520Colitis%26date%3D2007%26volume%3D1%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.crohns.2007.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Numata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsukawa, A.</span></span> <span> </span><span class="NLM_article-title">Innate Immune Response in Th1- and Th2-Dominant Mouse Strains</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1097/01.shk.0000142249.08135.e9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1097%2F01.shk.0000142249.08135.e9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15489639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSlurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=460-466&author=H.+Watanabeauthor=K.+Numataauthor=T.+Itoauthor=K.+Takagiauthor=A.+Matsukawa&title=Innate+Immune+Response+in+Th1-+and+Th2-Dominant+Mouse+Strains&doi=10.1097%2F01.shk.0000142249.08135.e9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immune response in Th1- and Th2-dominant mouse strains</span></div><div class="casAuthors">Watanabe, Hiroyuki; Numata, Kousuke; Ito, Takaaki; Takagi, Katsumasa; Matsukawa, Akihiro</div><div class="citationInfo"><span class="NLM_cas:title">Shock</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-466</span>CODEN:
                <span class="NLM_cas:coden">SAGUAI</span>;
        ISSN:<span class="NLM_cas:issn">1073-2322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">C57BL/6 and BALB/c mice are prototypical Th1- and Th2-type mouse strains, resp.  In the present study, we attempted to characterize the innate immune response of macrophages from these mouse strains.  Macrophages from C57BL/6 mice produced higher levels of tumor necrosis factor-α (TNF-α) and interleukin (IL)-12 than those from BALB/c mice after stimulation with macrophage-activating lipopeptide-2 (MALP-2, a synthetic TLR-2 ligand) or lipopolysaccharide (LPS, a TLR-4 ligand).  The augmented IL-12 prodn. by C57BL/6 macrophages increased interferon-γ and, in contrast, decreased IL-13 prodn. by CD4+ T cells.  On stimulation with MALP-2 or LPS, C57BL/6 macrophages produced lysosomal enzyme and nitric oxide, effector mols. for bacterial killing, whereas BALB/c macrophages did not.  Bactericidal activity of BALB/c macrophages was impaired relative to C57BL/6 macrophages when cells were infected with live bacteria in vitro.  In a murine model of septic peritonitis induced by cecal ligation and puncture (CLP), BALB/c mice failed to facilitate bacterial clearance relative to C57BL/6 mice despite an augmented peritoneal leukocyte infiltration that was assocd. with increased peritoneal levels of cytokines/chemokines.  BALB/c mice exhibited increased plasma and hepatic levels of cytokines/chemokines, resulting in an exaggerated systemic inflammation as detd. by acute-phase proteins.  Finally, BALB/c mice were vulnerable to CLP-induced lethality relative to C57BL/6 mice.  Altogether, innate immune response of macrophages is different between these mouse strains, which may affect the development of Th1 and Th2 adaptive immunity in these strains.  Reduced systemic inflammatory response in C57BL/6 mice that may result from an eminent local response appears to be beneficial during sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJulbLeviK4LVg90H21EOLACvtfcHk0lgQWkPPJtxqQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSlurbN&md5=92e0bd6db93ab6c03549cbc1a52f92d8</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1097%2F01.shk.0000142249.08135.e9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.shk.0000142249.08135.e9%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DNumata%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DMatsukawa%26aufirst%3DA.%26atitle%3DInnate%2520Immune%2520Response%2520in%2520Th1-%2520and%2520Th2-Dominant%2520Mouse%2520Strains%26jtitle%3DShock%26date%3D2004%26volume%3D22%26spage%3D460%26epage%3D466%26doi%3D10.1097%2F01.shk.0000142249.08135.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nörder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinstein, S.</span></span> <span> </span><span class="NLM_article-title">Immune Modulator Adamantylamide Dipeptide Stimulates Efficient Major Histocompatibility Complex Class I-Restricted Responses in Mice</span>. <i>Clin. Vaccine Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1128/CVI.00316-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FCVI.00316-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17344349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=538-543&author=P.+D.+Beckerauthor=M.+N%C3%B6rderauthor=C.+A.+Guzm%C3%A1nauthor=S.+Grinstein&title=Immune+Modulator+Adamantylamide+Dipeptide+Stimulates+Efficient+Major+Histocompatibility+Complex+Class+I-Restricted+Responses+in+Mice&doi=10.1128%2FCVI.00316-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice</span></div><div class="casAuthors">Becker, Pablo D.; Noerder, Miriam; Guzman, Carlos A.; Grinstein, Saul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Vaccine Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">CVILA6</span>;
        ISSN:<span class="NLM_cas:issn">1556-6811</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Adamantylamide L-alanyl-D-isoglutamine (AdDP) is a synthetic adjuvant which belongs to the family of the desmuramyl peptides.  AdDP exerts its adjuvant properties when it is administered either by the parenteral or by the mucosal route, leading to the elicitation of strong humoral responses at both the systemic and the mucosal levels.  However, very little is known about the effect of AdDP on cellular immunity.  Here we demonstrate that AdDP is able to stimulate cellular responses, which are characterized by the release of gamma interferon by CD8+ T cells when they are restimulted with a major histocompatibilty complex class I-restricted peptide and strong in vivo lymphocyte-mediated cytotoxic activity.  The capacity of AdDP to stimulate the elicitation of both cellular and humoral adaptive responses makes this adjuvant a promising tool for the development of mucosal vaccine formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRNVT7JnXhLbVg90H21EOLACvtfcHk0lgQWkPPJtxqQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslSmsL8%253D&md5=2865e0b5d5185c8f0e69e7d2620a463b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1128%2FCVI.00316-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCVI.00316-06%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DP.%2BD.%26aulast%3DN%25C3%25B6rder%26aufirst%3DM.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DC.%2BA.%26aulast%3DGrinstein%26aufirst%3DS.%26atitle%3DImmune%2520Modulator%2520Adamantylamide%2520Dipeptide%2520Stimulates%2520Efficient%2520Major%2520Histocompatibility%2520Complex%2520Class%2520I-Restricted%2520Responses%2520in%2520Mice%26jtitle%3DClin.%2520Vaccine%2520Immunol.%26date%3D2007%26volume%3D14%26spage%3D538%26epage%3D543%26doi%3D10.1128%2FCVI.00316-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meshcheryakova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andronova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, V.</span></span> <span> </span><span class="NLM_article-title">Evidence for Correlation between the Intensities of Adjuvant Effects and NOD2 Activation by Monomeric, Dimeric and Lipophylic Derivatives of N-Acetylglucosaminyl-N-Acetylmuramyl Peptides</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4515</span>– <span class="NLM_lpage">4520</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2007.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.vaccine.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17481783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2mu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=4515-4520&author=E.+Meshcheryakovaauthor=E.+Makarovauthor=D.+Philpottauthor=T.+Andronovaauthor=V.+Ivanov&title=Evidence+for+Correlation+between+the+Intensities+of+Adjuvant+Effects+and+NOD2+Activation+by+Monomeric%2C+Dimeric+and+Lipophylic+Derivatives+of+N-Acetylglucosaminyl-N-Acetylmuramyl+Peptides&doi=10.1016%2Fj.vaccine.2007.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for correlation between the intensities of adjuvant effects and NOD2 activation by monomeric, dimeric and lipophylic derivatives of N-acetylglucosaminyl-N-acetylmuramyl peptides</span></div><div class="casAuthors">Meshcheryakova, Elena; Makarov, Evgenii; Philpott, Dana; Andronova, Tat'yana; Ivanov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4515-4520</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Adjuvanticity of a series of peptidoglycan fragments-known as muramyl peptides-and their lipophylic derivs. was examd. and compared with the ability of these compds. to activate NF-kB pathway through NOD2.  The adjuvant activity of di, tetrasaccharide peptides and stearoyl contg. derivs. has at least two peaks in dose-response curves and the greater of them correlates with resp. dose-response data for NF-kB stimulation through NOD2.  Introduction of stearoyl moiety, with the aim of improving muramyl peptide interaction with the cell membrane and subsequent intracellular delivery, influenced the corresponding activities in vitro, but did not correlate with improved effects in vivo expts.  IgG subtypes tests indicate that muramyl peptides preferentially stimulate IgG1 prodn., whereas the tetrasaccharide contg. muramyl peptide addnl. induces prodn. of IgG2b subclasses.  On the whole, comparison of the adjuvanticity in vivo and the NOD2 activation in vitro revealed a clear correlation between the two responses.  These findings confirm the view that NOD2 pathway activation should account, at least in part, for the adjuvant effects of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdvS1EOgNnmbVg90H21EOLACvtfcHk0lisof8UUt0KfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2mu7c%253D&md5=78576c3948d6f0d5fe529afdcc99c96d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMeshcheryakova%26aufirst%3DE.%26aulast%3DMakarov%26aufirst%3DE.%26aulast%3DPhilpott%26aufirst%3DD.%26aulast%3DAndronova%26aufirst%3DT.%26aulast%3DIvanov%26aufirst%3DV.%26atitle%3DEvidence%2520for%2520Correlation%2520between%2520the%2520Intensities%2520of%2520Adjuvant%2520Effects%2520and%2520NOD2%2520Activation%2520by%2520Monomeric%252C%2520Dimeric%2520and%2520Lipophylic%2520Derivatives%2520of%2520N-Acetylglucosaminyl-N-Acetylmuramyl%2520Peptides%26jtitle%3DVaccine%26date%3D2007%26volume%3D25%26spage%3D4515%26epage%3D4520%26doi%3D10.1016%2Fj.vaccine.2007.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, D. V.</span></span> <span> </span><span class="NLM_article-title">Well-Defined and Potent Liposomal Hepatitis B Vaccines Adjuvanted with Lipophilic MDP Derivatives</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2008.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.nano.2008.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19523433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1eqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=334-344&author=V.+Jainauthor=S.+P.+Vyasauthor=D.+V.+Kohli&title=Well-Defined+and+Potent+Liposomal+Hepatitis+B+Vaccines+Adjuvanted+with+Lipophilic+MDP+Derivatives&doi=10.1016%2Fj.nano.2008.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives</span></div><div class="casAuthors">Jain, Vikas; Vyas, Suresh P.; Kohli, Dharmveer V.</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-344</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The characterization of immunol. cascades of the innate immune system activated by invariant mol. structures termed as pathogen-assocd. mol. patterns recognized by pattern recognition receptors of macrophages and dendritic cells, have allowed the elucidation of the mechanisms underlying the immunomodulatory properties of adjuvants.  Thus, adjuvant-active lipophilic analogs of N-acetyl muramyl dipeptide (MDP) were incorporated in liposomal hepatitis B surface antigen (HBsAg) formulations.  The immunoreactivity of the formulations was evaluated by measuring anti-HBs, IgG, and isotype antibody titer and compared with alumadsorbed HBsAg formulation.  The formulations were also evaluated for cell-mediated immune response by HBsAg-specific proliferation of splenocytes and simultaneous estn. of cytokines (interleukin-4 [IL-4], interferon-γ [IFN-γ]).  Results indicate that the serum IgG and anti-HBs titer obtained after i.m. administration of liposomal muramyl tripeptide-phosphatidylethanolamine (MTP-PE) and liposomal N-acetylmuramyl-L-alanyl-D-isoglutamine-glycerol dipalmitate (MDP-GDP) antigenic formulations were significantly higher.  The incorporation of MTP-PE on the liposomal HBsAg increased the stimulation index (SI) four to five times as compared to plain HBsAg soln., and it also induced significantly higher Th1 cellular immune response with a predominant IFN-γ level.  So it is the novel effective and potentially safe approach in which liposomes act as delivery vehicles for hepatitis B viral antigen to antigen-presenting cells and is ornamented with a biol. response modifier that could activate these target cells to enhance the antigen presentation to T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKF7cV_b7UYLVg90H21EOLACvtfcHk0lisof8UUt0KfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1eqsQ%253D%253D&md5=ece8c37c546f9fb3279fa4ef57d0f40a</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2008.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2008.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DV.%26aulast%3DVyas%26aufirst%3DS.%2BP.%26aulast%3DKohli%26aufirst%3DD.%2BV.%26atitle%3DWell-Defined%2520and%2520Potent%2520Liposomal%2520Hepatitis%2520B%2520Vaccines%2520Adjuvanted%2520with%2520Lipophilic%2520MDP%2520Derivatives%26jtitle%3DNanomedicine%26date%3D2009%26volume%3D5%26spage%3D334%26epage%3D344%26doi%3D10.1016%2Fj.nano.2008.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwendener, R. A.</span></span> <span> </span><span class="NLM_article-title">Liposomes as Vaccine Delivery Systems: A Review of the Recent Advances</span>. <i>Ther. Adv. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1177/2051013614541440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1177%2F2051013614541440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25364509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFWitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=159-182&author=R.+A.+Schwendener&title=Liposomes+as+Vaccine+Delivery+Systems%3A+A+Review+of+the+Recent+Advances&doi=10.1177%2F2051013614541440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Liposomes as vaccine delivery systems: a review of the recent advances</span></div><div class="casAuthors">Schwendener, Reto A.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Vaccines</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">159-182</span>CODEN:
                <span class="NLM_cas:coden">TAVHAV</span>;
        ISSN:<span class="NLM_cas:issn">2051-0144</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Liposomes and liposome-derived nanovesicles such as archaeosomes and virosomes have become important carrier systems in vaccine development and the interest for liposome-based vaccines has markedly increased.  A key advantage of liposomes, archaeosomes and virosomes in general, and liposome-based vaccine delivery systems in particular, is their versatility and plasticity.  Liposome compn. and prepn. can be chosen to achieve desired features such as selection of lipid, charge, size, size distribution, entrapment and location of antigens or adjuvants.  Depending on the chem. properties, water-sol. antigens (proteins, peptides, nucleic acids, carbohydrates, haptens) are entrapped within the aq. inner space of liposomes, whereas lipophilic compds. (lipopeptides, antigens, adjuvants, linker mols.) are intercalated into the lipid bilayer and antigens or adjuvants can be attached to the liposome surface either by adsorption or stable chem. linking.  Coformulations contg. different types of antigens or adjuvants can be combined with the parameters mentioned to tailor liposomal vaccines for individual applications.  Special emphasis is given in this review to cationic adjuvant liposome vaccine formulations.  Examples of vaccines made with CAF01, an adjuvant composed of the synthetic immune-stimulating mycobacterial cordfactor glycolipid trehalose dibehenate as immunomodulator and the cationic membrane forming mol. di-Me dioctadecylammonium are presented.  Other vaccines such as cationic liposome-DNA complexes (CLDCs) and other adjuvants like muramyl dipeptide, monophosphoryl lipid A and listeriolysin O are mentioned as well.  The field of liposomes and liposome-based vaccines is vast.  Therefore, this review concs. on recent and relevant studies emphasizing current reports dealing with the most studied antigens and adjuvants, and pertinent examples of vaccines.  Studies on liposome-based veterinary vaccines and exptl. therapeutic cancer vaccines are also summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWNgLJ_ogUJLVg90H21EOLACvtfcHk0lisof8UUt0KfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFWitrw%253D&md5=a80234bd900bbeacdaa20a44f24c38fd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1177%2F2051013614541440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2051013614541440%26sid%3Dliteratum%253Aachs%26aulast%3DSchwendener%26aufirst%3DR.%2BA.%26atitle%3DLiposomes%2520as%2520Vaccine%2520Delivery%2520Systems%253A%2520A%2520Review%2520of%2520the%2520Recent%2520Advances%26jtitle%3DTher.%2520Adv.%2520Vaccines%26date%3D2014%26volume%3D2%26spage%3D159%26epage%3D182%26doi%3D10.1177%2F2051013614541440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finkelman, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katona, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schooley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosmann, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, W. E.</span></span> <span> </span><span class="NLM_article-title">Lymphokine Control of in Vivo Immunoglobulin Isotype Selection</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1146/annurev.iy.08.040190.001511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev.iy.08.040190.001511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1693082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFGksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=303-330&author=F.+D.+Finkelmanauthor=J.+Holmesauthor=I.+M.+Katonaauthor=J.+F.+Urbanauthor=M.+P.+Beckmannauthor=L.+S.+Parkauthor=K.+A.+Schooleyauthor=R.+L.+Coffmanauthor=T.+R.+Mosmannauthor=W.+E.+Paul&title=Lymphokine+Control+of+in+Vivo+Immunoglobulin+Isotype+Selection&doi=10.1146%2Fannurev.iy.08.040190.001511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphokine control of in vivo immunoglobulin isotype selection</span></div><div class="casAuthors">Finkelman, Fred D.; Holmes, Joanne; Katona, Ildy M.; Urban, Joseph F., Jr.; Beckmann, M. Patricia; Park, Linda S.; Schooley, Kenneth A.; Coffman, Robert L.; Mosmann, Timothy R.; Paul, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">303-33</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    </div><div class="casAbstract">A review with 76 refs. of the role of interleukins and interferons in the regulation of Ig isotype selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGootFYwwR1SYbVg90H21EOLACvtfcHk0lhwKt70QZMgVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFGksLs%253D&md5=8b650c349b802f9f3720d529669b7f78</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1146%2Fannurev.iy.08.040190.001511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.iy.08.040190.001511%26sid%3Dliteratum%253Aachs%26aulast%3DFinkelman%26aufirst%3DF.%2BD.%26aulast%3DHolmes%26aufirst%3DJ.%26aulast%3DKatona%26aufirst%3DI.%2BM.%26aulast%3DUrban%26aufirst%3DJ.%2BF.%26aulast%3DBeckmann%26aufirst%3DM.%2BP.%26aulast%3DPark%26aufirst%3DL.%2BS.%26aulast%3DSchooley%26aufirst%3DK.%2BA.%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26aulast%3DMosmann%26aufirst%3DT.%2BR.%26aulast%3DPaul%26aufirst%3DW.%2BE.%26atitle%3DLymphokine%2520Control%2520of%2520in%2520Vivo%2520Immunoglobulin%2520Isotype%2520Selection%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1990%26volume%3D8%26spage%3D303%26epage%3D330%26doi%3D10.1146%2Fannurev.iy.08.040190.001511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Comparative Study of Structurally Related Peptidoglycan Monomer and Muramyl Dipeptide on Humoral IgG Immune Response to Ovalbumin in Mouse</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2010.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.intimp.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=20403461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=751-759&author=L.+Habjanecauthor=B.+Halassyauthor=J.+Toma%C5%A1i%C4%87&title=Comparative+Study+of+Structurally+Related+Peptidoglycan+Monomer+and+Muramyl+Dipeptide+on+Humoral+IgG+Immune+Response+to+Ovalbumin+in+Mouse&doi=10.1016%2Fj.intimp.2010.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse</span></div><div class="casAuthors">Habjanec, Lidija; Halassy, Beata; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">751-759</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structurally related peptidoglycan monomer (PGM) and muramyl dipeptide (MDP) differ in several aspects of biol. activity but have in common immunostimulating properties.  Comparative study of the effects of these adjuvants on humoral IgG immune response specific for protein antigen ovalbumin (OVA) was carried out in two inbred mouse strains, CBA and NIH/OlaHsd, and their ability to modulate the bias of immune response towards Th1/Th2 was evaluated.  MDP had better adjuvant activity at some points than PGM, whereas both adjuvants stimulated Th2-biased immune response specific for OVA.  In comparison to Complete Freund's adjuvant (CFA), as a golden std. of adjuvant action, both PGM and MDP exhibited considerably lower activity.  Addn. of PGM to Incomplete Freund's adjuvant (IFA) on humoral immune response was studied also, and the effect of such adjuvant formulation was compared to the effect of CFA.  While CFA induced the switch towards Th1-biased immune response, the addn. of PGM into IFA did have no impact on modulating the immune response towards more pronounced Th2-type of immune response, defined by IFA itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEa9MV5PnV7bVg90H21EOLACvtfcHk0lhwKt70QZMgVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D&md5=0279f7b455963f0048e0d182805bd5f1</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DComparative%2520Study%2520of%2520Structurally%2520Related%2520Peptidoglycan%2520Monomer%2520and%2520Muramyl%2520Dipeptide%2520on%2520Humoral%2520IgG%2520Immune%2520Response%2520to%2520Ovalbumin%2520in%2520Mouse%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2010%26volume%3D10%26spage%3D751%26epage%3D759%26doi%3D10.1016%2Fj.intimp.2010.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, J. M.</span></span> <span> </span><span class="NLM_article-title">Activation of Alveolar Macrophage Tumoricidal Activity and Eradication of Experimental Metastases by Freeze-Dried Liposomes Containing a New Lipophilic Muramyl Dipeptide Derivative</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3838084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL2MXhtF2mtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=128-134&author=N.+C.+Phillipsauthor=M.+L.+Morasauthor=L.+Chedidauthor=P.+Lefrancierauthor=J.+M.+Bernard&title=Activation+of+Alveolar+Macrophage+Tumoricidal+Activity+and+Eradication+of+Experimental+Metastases+by+Freeze-Dried+Liposomes+Containing+a+New+Lipophilic+Muramyl+Dipeptide+Derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative</span></div><div class="casAuthors">Phillips, Nigel C.; Moras, Maria L.; Chedid, Louis; Lefrancier, Pierre; Bernard, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-34</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The ability of a member of a new class of lipophilic muramyl dipeptide (MDP)  [53678-77-6] deriv., muramyl dipeptide-glyceryldipalmitate (MDP-GDP)  [95238-29-2], to induce alveolar macrophage cytotoxic activity in vitro towards B16 melanoma cells when incorporated into 2 types of liposome was studied.  MDP-GDP incorporated into conventionally prepd. liposomes formulated from distearoylphosphatidylcholine  [4539-70-2] and phosphatidylserine (7:3 molar ratio) was 10-fold more effective than liposomes contg. MDP, and 7000-fold more effective than free MDP in inducing macrophage cytotoxic activity.  MDP-GDP incorporated into freeze-dried liposomes was 50,000- to 100,000-fold more effective than free MDP in inducing such activity.  Freeze-dried liposomes contg. MDP-GDP were efficiently localized in the lungs of normal mice, and induced cytotoxic activity in the alveolar macrophages.  Such liposomes were able to significantly reduce the pulmonary metastatic burden of mice carrying the B16 melanoma.  These data provide evidence that this class of lipophilic MDP deriv., when incorporated into freeze-dried liposomes, is a potent inducer of macrophage cytotoxic activity in vitro and in situ, and has antitumor activity in vivo.  In addn., the use of a freeze-drying procedure allows the prepn. and long-term storage of reproducible liposome formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTM_-uSCzLwLVg90H21EOLACvtfcHk0lhwKt70QZMgVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtF2mtL8%253D&md5=dfbc7f2f99c9e06635cbc3a23cdc858a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DN.%2BC.%26aulast%3DMoras%26aufirst%3DM.%2BL.%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DBernard%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520Alveolar%2520Macrophage%2520Tumoricidal%2520Activity%2520and%2520Eradication%2520of%2520Experimental%2520Metastases%2520by%2520Freeze-Dried%2520Liposomes%2520Containing%2520a%2520New%2520Lipophilic%2520Muramyl%2520Dipeptide%2520Derivative%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribić, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manček-Keber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinnaeve, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehér, K.</span></span> <span> </span><span class="NLM_article-title">Targeted Delivery of Adamantylated Peptidoglycan Immunomodulators in Lipid Nanocarriers: NMR Shows That Cargo Fragments Are Available on the Surface</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">4132</span>– <span class="NLM_lpage">4145</span>, <span class="refDoi"> DOI: 10.1021/acs.jpcb.0c00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jpcb.0c00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntVKksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2020&pages=4132-4145&author=R.+Ribi%C4%87author=M.+Man%C4%8Dek-Keberauthor=F.+Chainauthor=D.+Sinnaeveauthor=J.+C.+Martinsauthor=R.+Jeralaauthor=S.+Tomi%C4%87author=K.+Feh%C3%A9r&title=Targeted+Delivery+of+Adamantylated+Peptidoglycan+Immunomodulators+in+Lipid+Nanocarriers%3A+NMR+Shows+That+Cargo+Fragments+Are+Available+on+the+Surface&doi=10.1021%2Facs.jpcb.0c00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Delivery of Adamantylated Peptidoglycan Immunomodulators in Lipid Nanocarriers: NMR Shows That Cargo Fragments Are Available on the Surface</span></div><div class="casAuthors">Ribic, Rosana; Mancek-Keber, Mateja; Chain, Fernando; Sinnaeve, Davy; Martins, Jose C.; Jerala, Roman; Tomic, Srdjanka; Feher, Krisztina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4132-4145</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an in-depth investigation of the membrane interactions of peptidoglycan (PGN)-based immune adjuvants designed for lipid-based delivery systems using NMR spectroscopy.  The derivs. contain a cargo peptidoglycan (PGN) dipeptide fragment and an adamantyl group, which serves as an anchor to the lipid bilayer.  Furthermore, derivs. with a mannose group that can actively target cell surface receptors on immune cells are also studied.  We showed that the targeting mannose group and the cargo PGN fragment are both available on the lipid bilayer surface, thereby enabling interactions with cognate receptors.  We found that the nonmannosylated compds. are incorporated stronger into the lipid assemblies than the mannosylated ones, but the latter compds. penetrate deeper in the bilayer.  This might be explained by stronger electrostatic interactions available for zwitterionic nonmannosylated derivs. as opposed to the compds. in which the charged N-terminus is capped by mannose groups.  The higher incorporation efficiency of the nonmannosylated compds. correlated with a larger relative enhancement in immune stimulation activities upon lipid incorporation compared to that of the derivs. with the mannose group.  The chirality of the adamantyl group also influenced the incorporation efficiency, which in turn correlated with membrane-assocd. conformations that affect possible intermol. interactions with lipid mols.  These findings will help in improving the development of PGN-based immune adjuvants suitable for delivery in lipid nanoparticles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDrKFb-vglLVg90H21EOLACvtfcHk0lhh5tHLugQ1pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntVKksrg%253D&md5=f136e4dd03eb00ee5d0c9d57dc70ec08</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jpcb.0c00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jpcb.0c00029%26sid%3Dliteratum%253Aachs%26aulast%3DRibi%25C4%2587%26aufirst%3DR.%26aulast%3DMan%25C4%258Dek-Keber%26aufirst%3DM.%26aulast%3DChain%26aufirst%3DF.%26aulast%3DSinnaeve%26aufirst%3DD.%26aulast%3DMartins%26aufirst%3DJ.%2BC.%26aulast%3DJerala%26aufirst%3DR.%26aulast%3DTomi%25C4%2587%26aufirst%3DS.%26aulast%3DFeh%25C3%25A9r%26aufirst%3DK.%26atitle%3DTargeted%2520Delivery%2520of%2520Adamantylated%2520Peptidoglycan%2520Immunomodulators%2520in%2520Lipid%2520Nanocarriers%253A%2520NMR%2520Shows%2520That%2520Cargo%2520Fragments%2520Are%2520Available%2520on%2520the%2520Surface%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2020%26volume%3D124%26spage%3D4132%26epage%3D4145%26doi%3D10.1021%2Facs.jpcb.0c00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brgles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurašin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikirić, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Entrapment of Ovalbumin into Liposomes - Factors Affecting Entrapment Efficiency, Liposome Size, and Zeta Potential</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1080/08982100802312762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F08982100802312762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18770073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOrurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=235-248&author=M.+Brglesauthor=D.+Jura%C5%A1inauthor=M.+D.+Sikiri%C4%87author=R.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Entrapment+of+Ovalbumin+into+Liposomes+-+Factors+Affecting+Entrapment+Efficiency%2C+Liposome+Size%2C+and+Zeta+Potential&doi=10.1080%2F08982100802312762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Entrapment of Ovalbumin into Liposomes-Factors Affecting Entrapment Efficiency, Liposome Size, and Zeta Potential</span></div><div class="casAuthors">Brgles, Marija; Jurasin, Darija; Sikiric, Maja Dutour; Frkanec, Ruza; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Various amts. of Ovalbumin (OVA) were encapsulated into pos. and neg. charged multilamellar liposomes, with the aim to investigate the entrapment efficiency in different buffers and to study their effects on the liposome size and zeta potential.  Results showed that the entrapment efficiency of OVA in anionic liposomes was the same in 10 mM Phosphate Buffer (PB) as in Phosphate-Buffered Saline (PBS; PB + 0.15 M NaCl).  Also, liposome size was approx. 1200 nm for all anionic liposomes incorporating OVA.  The entrapment efficiency of OVA in cationic liposomes was highly dependent on ionic strength.  The size of cationic liposomes was approx. 1200 nm in PBS, regardless of protein content, but increased with the amt. of the incorporated protein in PB.  Aggregation of cationic liposomes in PB was obsd. when the mass of the protein was 2.5 mg or greater.  The zeta potential of anionic liposomes was neg. and of cationic liposomes pos. in the whole range of protein mass tested.  These results show how different compns. of lipid and aq. phases can be used to vary the entrapment efficiency, liposome size, and zeta potential-the factors that are of great importance for the use of liposomes as drug carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhYnJ-NAzl77Vg90H21EOLACvtfcHk0lhh5tHLugQ1pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOrurjN&md5=2ccc236c578fa6060330541e518501a3</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1080%2F08982100802312762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08982100802312762%26sid%3Dliteratum%253Aachs%26aulast%3DBrgles%26aufirst%3DM.%26aulast%3DJura%25C5%25A1in%26aufirst%3DD.%26aulast%3DSikiri%25C4%2587%26aufirst%3DM.%2BD.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEntrapment%2520of%2520Ovalbumin%2520into%2520Liposomes%2520-%2520Factors%2520Affecting%2520Entrapment%2520Efficiency%252C%2520Liposome%2520Size%252C%2520and%2520Zeta%2520Potential%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2008%26volume%3D18%26spage%3D235%26epage%3D248%26doi%3D10.1080%2F08982100802312762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tandrup Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foged, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith Korsholm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rades, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, D.</span></span> <span> </span><span class="NLM_article-title">Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics8010007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3390%2Fpharmaceutics8010007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=7&author=S.+Tandrup+Schmidtauthor=C.+Fogedauthor=K.+Smith+Korsholmauthor=T.+Radesauthor=D.+Christensen&title=Liposome-Based+Adjuvants+for+Subunit+Vaccines%3A+Formulation+Strategies+for+Subunit+Antigens+and+Immunostimulators&doi=10.3390%2Fpharmaceutics8010007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics8010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics8010007%26sid%3Dliteratum%253Aachs%26aulast%3DTandrup%2BSchmidt%26aufirst%3DS.%26aulast%3DFoged%26aufirst%3DC.%26aulast%3DSmith%2BKorsholm%26aufirst%3DK.%26aulast%3DRades%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DD.%26atitle%3DLiposome-Based%2520Adjuvants%2520for%2520Subunit%2520Vaccines%253A%2520Formulation%2520Strategies%2520for%2520Subunit%2520Antigens%2520and%2520Immunostimulators%26jtitle%3DPharmaceutics%26date%3D2016%26volume%3D8%26spage%3D7%26doi%3D10.3390%2Fpharmaceutics8010007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Targeting Strategies of Liposomal Subunit Vaccine Delivery Systems to Improve Vaccine Efficacy</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1080/1061186X.2018.1547734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F1061186X.2018.1547734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30589361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1WhurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=780-789&author=R.+Yuauthor=Y.+Maiauthor=Y.+Zhaoauthor=Y.+Houauthor=Y.+Liuauthor=J.+Yang&title=Targeting+Strategies+of+Liposomal+Subunit+Vaccine+Delivery+Systems+to+Improve+Vaccine+Efficacy&doi=10.1080%2F1061186X.2018.1547734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy</span></div><div class="casAuthors">Yu, Rui; Mai, Yaping; Zhao, Yue; Hou, Yanhui; Liu, Yanhua; Yang, Jianhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Liposomes are versatile delivery systems and immunol. adjuvants that not only can load various antigens, such as proteins, peptides, nucleic acids and carbohydrates, but also can combine them with immunostimulators.  Liposomes have great potential in the development of new types of vaccines, and much effort has been devoted to enhancing vaccine efficacy in recent years.  Different types of immune cells such as macrophages and dendritic cells play an important role in the immune response and in preventing or treating cancer, allergy or many other infectious diseases.  Targeting liposome-based delivery systems to certain immune cells and organs is one of the most effective measures in such treatments.  Extensive research has shown that liposomes combined with immunostimulators or modified with pattern recognition receptor ligands can target various immune cells and the lymphatic system, thus not only inducing and promoting the desired immune response but also decreasing adverse effects throughout the body and avoiding targeting irrelevant cell types or tissues.  Therefore, in this review, we outline some targeting strategies that can be adopted in the design of liposomal vaccines to improve vaccine efficacy, and we summarise the related liposome-based vaccine applications in several diseases.  These applications have great potential to treat or prevent some infectious and intractable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdOLUHq18--bVg90H21EOLACvtfcHk0lhh5tHLugQ1pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1WhurzL&md5=7f95c644c04cde3803d105dfb3b360e5</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1080%2F1061186X.2018.1547734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1061186X.2018.1547734%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DR.%26aulast%3DMai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DTargeting%2520Strategies%2520of%2520Liposomal%2520Subunit%2520Vaccine%2520Delivery%2520Systems%2520to%2520Improve%2520Vaccine%2520Efficacy%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2019%26volume%3D27%26spage%3D780%26epage%3D789%26doi%3D10.1080%2F1061186X.2018.1547734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Opanasopit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashida, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Liver Metastasis by Targeting of Immunomodulators Using Mannosylated Liposome Carriers</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1016/S0168-3659(02)00006-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0168-3659%2802%2900006-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11943405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=283-294&author=P.+Opanasopitauthor=M.+Sakaiauthor=M.+Nishikawaauthor=S.+Kawakamiauthor=F.+Yamashitaauthor=M.+Hashida&title=Inhibition+of+Liver+Metastasis+by+Targeting+of+Immunomodulators+Using+Mannosylated+Liposome+Carriers&doi=10.1016%2FS0168-3659%2802%2900006-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers</span></div><div class="casAuthors">Opanasopit, Praneet; Sakai, Megumi; Nishikawa, Makiya; Kawakami, Shigeru; Yamashita, Fumiyoshi; Hashida, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Mannosylated liposomes were prepd. by incorporating cholesten-5-yloxy-N-(4-((1-imino-2-β-d-thiomannosylethyl)amino)butyl)formamide (Man-C4-Chol) into small unilamellar liposomes consisting of cholesterol and distearoyl phosphatidylcholine (DSPC).  The biodistribution of liposomes labeled with [3H]cholesteryl hexadecyl ether was examd. in mice.  The rate and extent of the hepatic uptake of those [3H]liposomes increased proportionally on increasing the mixing ratio of Man-C4-Chol.  Their hepatic uptake was reduced by increasing the administered dose due to the limited no. of mannose receptors.  The liver uptake of [3H]Man-liposomes was preferentially mediated by liver non-parenchymal cells (NPC) and significantly inhibited by co-injection with an excess of Man-BSA, indicating the involvement of a mannose receptor-mediated mechanism in the hepatic uptake of Man-liposomes.  Muramyl dipeptide (MDP), an immunomodulator, was also incorporated into the liposomes and its inhibitory effect in an exptl. liver metastasis model was examd.  In contrast to free MDP treatment, which showed little effect on the inhibition of metastasis, liposomal MDP significantly reduced the no. of metastatic colonies in the liver.  Active targeting of MDP to liver NPC by Man-liposomes resulted in more effective inhibition than delivery of MDP by liposomes without mannose.  Treatment with MDP/Man-liposomes further increased the survival of the tumor-bearing mice.  These results suggest that Man-liposomes are effective carriers for targeted delivery of bioactive compds. to liver NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkOYKO9WhFo7Vg90H21EOLACvtfcHk0ljzobhHpFrA3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFyrsbg%253D&md5=3255950f255754266c2a5fc1d749b34d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2802%2900006-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252802%252900006-8%26sid%3Dliteratum%253Aachs%26aulast%3DOpanasopit%26aufirst%3DP.%26aulast%3DSakai%26aufirst%3DM.%26aulast%3DNishikawa%26aufirst%3DM.%26aulast%3DKawakami%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DF.%26aulast%3DHashida%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520Liver%2520Metastasis%2520by%2520Targeting%2520of%2520Immunomodulators%2520Using%2520Mannosylated%2520Liposome%2520Carriers%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2002%26volume%3D80%26spage%3D283%26epage%3D294%26doi%3D10.1016%2FS0168-3659%2802%2900006-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanasarn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloat, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span> <span> </span><span class="NLM_article-title">Negatively Charged Liposomes Show Potent Adjuvant Activity When Simply Admixed with Protein Antigens</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1021/mp200016d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200016d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1174-1185&author=N.+Yanasarnauthor=B.+R.+Sloatauthor=Z.+Cui&title=Negatively+Charged+Liposomes+Show+Potent+Adjuvant+Activity+When+Simply+Admixed+with+Protein+Antigens&doi=10.1021%2Fmp200016d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Negatively Charged Liposomes Show Potent Adjuvant Activity When Simply Admixed with Protein Antigens</span></div><div class="casAuthors">Yanasarn, Nijaporn; Sloat, Brian R.; Cui, Zhengrong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1174-1185</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liposomes have been investigated extensively as a vaccine delivery system.  Herein the adjuvant activities of liposomes with different net surface charges (neutral, pos., or neg.) were evaluated when admixed with protein antigens, ovalbumin (OVA, pI = 4.7), Bacillus anthracis protective antigen protein (PA, pI = 5.6), or cationized OVA (cOVA).  Mice immunized s.c. with OVA admixed with different liposomes generated different antibody responses.  Interestingly, OVA admixed with net neg. charged liposomes prepd. with DOPA was as immunogenic as OVA admixed with pos. charged liposomes prepd. with DOTAP.  Immunization of mice with the anthrax PA protein admixed with the net neg. charged DOPA liposomes also induced a strong and functional anti-PA antibody response.  When the cationized OVA was used as a model antigen, liposomes with net neutral, neg., or pos. charges showed comparable adjuvant activities.  Immunization of mice with the OVA admixed with DOPA liposomes also induced OVA-specific CD8+ cytotoxic T lymphocyte responses and significantly delayed the growth of OVA-expressing B16-OVA tumors in mice.  However, not all net neg. charged liposomes showed a strong adjuvant activity.  The adjuvant activity of the neg. charged liposomes may be related to the liposome's ability (i) to up-regulate the expression of mols. related to the activation and maturation of antigen-presenting cells and (ii) to slightly facilitate the uptake of the antigens by antigen-presenting cells.  Simply admixing certain neg. charged liposomes with certain protein antigens of interest may represent a novel platform for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolppNDqLIroLVg90H21EOLACvtfcHk0ljzobhHpFrA3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGis7s%253D&md5=b61d68897a849b3c9784b058abdb2284</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fmp200016d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200016d%26sid%3Dliteratum%253Aachs%26aulast%3DYanasarn%26aufirst%3DN.%26aulast%3DSloat%26aufirst%3DB.%2BR.%26aulast%3DCui%26aufirst%3DZ.%26atitle%3DNegatively%2520Charged%2520Liposomes%2520Show%2520Potent%2520Adjuvant%2520Activity%2520When%2520Simply%2520Admixed%2520with%2520Protein%2520Antigens%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2011%26volume%3D8%26spage%3D1174%26epage%3D1185%26doi%3D10.1021%2Fmp200016d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Štimac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendelja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikirić, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span> <span> </span><span class="NLM_article-title">Mannosylated Liposomes with Built-in Peptidoglycan Based Immunomodulators for Subunit Vaccine Formulations</span>. <i>Croat. Chem. Acta</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.5562/cca3309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.5562%2Fcca3309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=645-656&author=A.+%C5%A0timacauthor=K.+Bendeljaauthor=M.+D.+Sikiri%C4%87author=L.+Frkanecauthor=R.+Frkanec&title=Mannosylated+Liposomes+with+Built-in+Peptidoglycan+Based+Immunomodulators+for+Subunit+Vaccine+Formulations&doi=10.5562%2Fcca3309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.5562%2Fcca3309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5562%252Fcca3309%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0timac%26aufirst%3DA.%26aulast%3DBendelja%26aufirst%3DK.%26aulast%3DSikiri%25C4%2587%26aufirst%3DM.%2BD.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DFrkanec%26aufirst%3DR.%26atitle%3DMannosylated%2520Liposomes%2520with%2520Built-in%2520Peptidoglycan%2520Based%2520Immunomodulators%2520for%2520Subunit%2520Vaccine%2520Formulations%26jtitle%3DCroat.%2520Chem.%2520Acta%26date%3D2017%26volume%3D90%26spage%3D645%26epage%3D656%26doi%3D10.5562%2Fcca3309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lozzio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozzio, B.</span></span> <span> </span><span class="NLM_article-title">Human Chronic Myelogenous Leukemia Cell-Line with Positive Philadelphia Chromosome</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1182/blood.V45.3.321.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1182%2Fblood.V45.3.321.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=163658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADyaE2M7gvFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1975&pages=321-334&author=C.+Lozzioauthor=B.+Lozzio&title=Human+Chronic+Myelogenous+Leukemia+Cell-Line+with+Positive+Philadelphia+Chromosome&doi=10.1182%2Fblood.V45.3.321.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome</span></div><div class="casAuthors">Lozzio C B; Lozzio B B</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-34</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">A cell-line derived from a patient with chronic myelogenous leukemia (CML) is described.  The new cell-line, which has over 175 serial passanges in a 3 1/2-yr period, has the following characteristics: (1) CML cells started to proliferate actively since they were first incubated in culture media.  A threefold increase in the total number of cells was observed during the first seven passages; the cell population increased by a factor of 10 to 20 every 7 days from passage 8 through 85; from 20 to 40 times from passage 86 through 150, and more than 40 times after 150 passages. (2) The majority of the nononucleated cells are undifferentiated blasts. (3) The karyotype of all the cells examined show the Philadelphia (Ph1) chromosome and a long acrocentric marker plus aneuploidy.  The Giemsa-banding studies identified the Ph1 chromosome as a terminal deletion of the long arm of chromosome 22:del(22)(q12) and the long acrocentric marker as an unbalanced reciprocal translocation of one chromosome 17 and the long arm of one chromosome 15. (4) The CML cells do not produce immunoglobulins, are free of mycoplasma, Epstein-Barr virus, and herpes-like virus particles. (5) CML cells have no alkaline phosphatase and myeloperoxidase activities and did not engulf inert particles. (6) Cultured CML cells provide a constant source of a specific antigen.  This CML cell-line represents a unique source of CML cells with meaningful indicators of malignancy for clinical and experimental studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSn4RF_5flkqEg6wdEZmT2rfW6udTcc2ebSX8MjcN7Kxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2M7gvFyjug%253D%253D&md5=d396e38802cebb103ab1c7b9adbe35af</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1182%2Fblood.V45.3.321.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V45.3.321.321%26sid%3Dliteratum%253Aachs%26aulast%3DLozzio%26aufirst%3DC.%26aulast%3DLozzio%26aufirst%3DB.%26atitle%3DHuman%2520Chronic%2520Myelogenous%2520Leukemia%2520Cell-Line%2520with%2520Positive%2520Philadelphia%2520Chromosome%26jtitle%3DBlood%26date%3D1975%26volume%3D45%26spage%3D321%26epage%3D334%26doi%3D10.1182%2Fblood.V45.3.321.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacchini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfarano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Circosta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottardi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faldella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rege-Cambrin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thunberg, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligaris-Cappio, F.</span></span> <span> </span><span class="NLM_article-title">MEC1 and MEC2: Two New Cell Lines Derived from B-Chronic Lymphocytic Leukaemia in Prolymphocytoid Transformation</span>. <i>Leuk. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/S0145-2126(98)00154-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0145-2126%2898%2900154-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10071128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK1MXhslSls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=127-136&author=A.+Stacchiniauthor=M.+Aragnoauthor=A.+Vallarioauthor=A.+Alfaranoauthor=P.+Circostaauthor=D.+Gottardiauthor=A.+Faldellaauthor=G.+Rege-Cambrinauthor=U.+Thunbergauthor=K.+Nilssonauthor=F.+Caligaris-Cappio&title=MEC1+and+MEC2%3A+Two+New+Cell+Lines+Derived+from+B-Chronic+Lymphocytic+Leukaemia+in+Prolymphocytoid+Transformation&doi=10.1016%2FS0145-2126%2898%2900154-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukemia in prolymphocytoid transformation</span></div><div class="casAuthors">Stacchini, Alessandra; Aragno, Michela; Vallario, Antonella; Alfarano, Alda; Circosta, Paola; Gottardi, Daniela; Faldella, Alessandra; Rege-Cambrin, Giovanna; Thunberg, Ulf; Nilsson, Kenneth; Caligaris-Cappio, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The authors report the establishment and characterization of two cell lines, MEC1 and MEC2, that grew spontaneously on two subsequent occasions from the peripheral blood (PB) of a patient with B-chronic lymphocytic leukemia (B-CLL) in prolymphocytoid transformation.  The patient was EBV-seropos., his leukemic cells were EBNA neg., but the spontaneously grown cell lines are EBNA-2 pos.  In liq. culture MEC1 cells grow adherent to the vessel wall and as tiny clumps; MEC2 cells do not adhere and form large clumps.  The doubling time of MEC1 is 40h and of MEC2 is 31h.  Both cell lines express the same light (κ) and heavy chains (μ, δ) as the fresh parental B-CLL cells at the same high intensity, share the expression of mature B cell markers (CD19, CD20, CD21, CD22), differ in the expression of CD23 and FMC7, are CD11a +, CD18 +, CD44 +, CD49d +, CD54 + and express at high levels both CD80 and CD86.  CD5 is neg. on MEC1 cells (as on the vast majority of parental cells) and it has been lost by MEC2 cells after several months of culture.  The cells have a complex karyotype.  The tumor origin of MEC1 and MEC2 has been demonstrated by Southern blot anal. of the IgH loci and by Ig gene DNA sequencing.  They use the VH4 Ig family and have not undergone somatic mutations (94.8% homol. with germline Ig gene 4-59).  Cytofluorog. anal. and RT-PCR reveal that MEC1 and MEC2 overexpress Bcl-2 together with Bax, express large amts. of Bcl-xL and trace amts. of Bcl-xS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhWMnYUms6JrVg90H21EOLACvtfcHk0lgcXfK3D7IFlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslSls78%253D&md5=d35e4d9891598ad2d609c93b2a9965cd</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2FS0145-2126%2898%2900154-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0145-2126%252898%252900154-4%26sid%3Dliteratum%253Aachs%26aulast%3DStacchini%26aufirst%3DA.%26aulast%3DAragno%26aufirst%3DM.%26aulast%3DVallario%26aufirst%3DA.%26aulast%3DAlfarano%26aufirst%3DA.%26aulast%3DCircosta%26aufirst%3DP.%26aulast%3DGottardi%26aufirst%3DD.%26aulast%3DFaldella%26aufirst%3DA.%26aulast%3DRege-Cambrin%26aufirst%3DG.%26aulast%3DThunberg%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DK.%26aulast%3DCaligaris-Cappio%26aufirst%3DF.%26atitle%3DMEC1%2520and%2520MEC2%253A%2520Two%2520New%2520Cell%2520Lines%2520Derived%2520from%2520B-Chronic%2520Lymphocytic%2520Leukaemia%2520in%2520Prolymphocytoid%2520Transformation%26jtitle%3DLeuk.%2520Res.%26date%3D1999%26volume%3D23%26spage%3D127%26epage%3D136%26doi%3D10.1016%2FS0145-2126%2898%2900154-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span> <span> </span><span class="NLM_article-title">IDEP: An Integrated Web Application for Differential Expression and Pathway Analysis of RNA-Seq Data</span>. <i>BMC Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">534</span>, <span class="refDoi"> DOI: 10.1186/s12859-018-2486-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1186%2Fs12859-018-2486-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30567491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1Sks73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=534&author=S.+X.+Geauthor=E.+W.+Sonauthor=R.+Yao&title=IDEP%3A+An+Integrated+Web+Application+for+Differential+Expression+and+Pathway+Analysis+of+RNA-Seq+Data&doi=10.1186%2Fs12859-018-2486-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">IDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data</span></div><div class="casAuthors">Ge, Steven Xijin; Son, Eun Wo; Yao, Runan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Bioinformatics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">534</span>CODEN:
                <span class="NLM_cas:coden">BBMIC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2105</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">RNA-seq is widely used for transcriptomic profiling, but the bioinformatics anal. of resultant data can be time-consuming and challenging, esp. for biologists.  We aim to streamline the bioinformatic analyses of gene-level data by developing a user-friendly, interactive web application for exploratory data anal., differential expression, and pathway anal.  IDEP (integrated Differential Expression and Pathway anal.) seamlessly connects 63 R/Bioconductor packages, 2 web services, and comprehensive annotation and pathway databases for 220 plant and animal species.  The workflow can be reproduced by downloading customized R code and related pathway files.  As an example, we analyzed an RNA-Seq dataset of lung fibroblasts with Hoxa1 knockdown and revealed the possible roles of SP1 and E2F1 and their target genes, including microRNAs, in blocking G1/S transition.  In another example, our anal. shows that in mouse B cells without functional p53, ionizing radiation activates the MYC pathway and its downstream genes involved in cell proliferation, ribosome biogenesis, and non-coding RNA metab.  In wildtype B cells, radiation induces p53-mediated apoptosis and DNA repair while suppressing the target genes of MYC and E2F1, and leads to growth and cell cycle arrest. iDEP helps unveil the multifaceted functions of p53 and the possible involvement of several microRNAs such as miR-92a, miR-504, and miR-30a.  In both examples, we validated known mol. pathways and generated novel, testable hypotheses.  Combining comprehensive analytic functionalities with massive annotation databases, iDEP enables biologists to easily translate transcriptomic and proteomic data into actionable insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMv97MM-Va7Vg90H21EOLACvtfcHk0lgcXfK3D7IFlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1Sks73P&md5=6b592701c5c3a4896d2ecebb91854df8</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1186%2Fs12859-018-2486-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12859-018-2486-6%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DS.%2BX.%26aulast%3DSon%26aufirst%3DE.%2BW.%26aulast%3DYao%26aufirst%3DR.%26atitle%3DIDEP%253A%2520An%2520Integrated%2520Web%2520Application%2520for%2520Differential%2520Expression%2520and%2520Pathway%2520Analysis%2520of%2520RNA-Seq%2520Data%26jtitle%3DBMC%2520Bioinf.%26date%3D2018%26volume%3D19%26spage%3D534%26doi%3D10.1186%2Fs12859-018-2486-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Štimac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvitaš, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vugrek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span> <span> </span><span class="NLM_article-title">Design and Syntheses of Mono and Multivalent Mannosyl-Lipoconjugates for Targeted Liposomal Drug Delivery</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2016.06.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ijpharm.2016.06.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=27363934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOitLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2016&pages=44-56&author=A.+%C5%A0timacauthor=J.+T.+Cvita%C5%A1author=L.+Frkanecauthor=O.+Vugrekauthor=R.+Frkanec&title=Design+and+Syntheses+of+Mono+and+Multivalent+Mannosyl-Lipoconjugates+for+Targeted+Liposomal+Drug+Delivery&doi=10.1016%2Fj.ijpharm.2016.06.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design and syntheses of mono and multivalent mannosyl-lipoconjugates for targeted liposomal drug delivery</span></div><div class="casAuthors">Stimac, Adela; Cvitas, Jelena Trmcic; Frkanec, Leo; Vugrek, Oliver; Frkanec, Ruza</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-56</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multivalent mannosyl-lipoconjugates may be of interest for glycosylation of liposomes and targeted drug delivery because the mannose specifically binds to C-type lectin receptors on the particular cells.  In this paper syntheses of two types of novel O-mannosides are presented.  Conjugates 1 and 2 with a COOH- and NH2-functionalized spacer and the connection to a lysine and FmocNH-PEG-COOH, are described.  The coupling reactions of prepd. intermediates 6 and 4 with a PEGylated-DSPE or palmitic acid, resp., are presented.  Compds. 5, mono-, 8, di- and 12, tetravalent mannosyl-lipoconjugates, were synthesized.  The synthesized compds. were incorporated into liposomes and liposomal prepns. featuring exposed mannose units were characterized.  Carbohydrate liposomal quartz crystal microbalance based assay has been established for studying carbohydrate-lectin binding.  It was demonstrated that liposomes with incorporated mannosyl-lipoconjugates were effectively recognized by Con A and have great potential to be used for targeted liposomal drug delivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbWSukjX7-LVg90H21EOLACvtfcHk0lgcXfK3D7IFlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOitLbL&md5=a4ad7918ca70761b6fc7cb0b6dc76407</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2016.06.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2016.06.123%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0timac%26aufirst%3DA.%26aulast%3DCvita%25C5%25A1%26aufirst%3DJ.%2BT.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DVugrek%26aufirst%3DO.%26aulast%3DFrkanec%26aufirst%3DR.%26atitle%3DDesign%2520and%2520Syntheses%2520of%2520Mono%2520and%2520Multivalent%2520Mannosyl-Lipoconjugates%2520for%2520Targeted%2520Liposomal%2520Drug%2520Delivery%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2016%26volume%3D511%26spage%3D44%26epage%3D56%26doi%3D10.1016%2Fj.ijpharm.2016.06.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travaš, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstanović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Špoljar, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljevaković, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Entrapment of Peptidoglycans and Adamantyltripeptides into Liposomes: An HPLC Assay for Determination of Encapsulation Efficiency</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1081/LPR-120026452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1081%2FLPR-120026452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=14670233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=279-294&author=R.+Frkanecauthor=D.+Trava%C5%A1author=M.+Krstanovi%C4%87author=B.+H.+%C5%A0poljarauthor=D.+Ljevakovi%C4%87author=B.+Vrane%C5%A1i%C4%87author=L.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Entrapment+of+Peptidoglycans+and+Adamantyltripeptides+into+Liposomes%3A+An+HPLC+Assay+for+Determination+of+Encapsulation+Efficiency&doi=10.1081%2FLPR-120026452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency</span></div><div class="casAuthors">Frkanec, Ruza; Travas, Dijana; Krstanovic, Marina; Spoljar, Beata Halassy; Ljevakovic, Durdica; Vranesic, Branka; Frkanec, Leo; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">279-294</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The encapsulation of different immunomodulating peptides, the peptidoglycan monomer, its semisynthetic derivs. (Adamant-1-yl)-acetyl-peptidoglycan monomer and Boc-Tyr-peptidoglycan monomer, resp., and of 2 diastereoisomers of adamantyltripeptides into the large neg. charged multilamellar liposomes was investigated.  The reproducible quant. method using HPLC was established for the detn. of the entrapped compds.  It was shown that the tested compds. could be efficiently incorporated into liposomes using either the film or modified film method.  The results confirmed that the peptidoglycans with lipophilic substituents and particularly the adamantyltripeptides were incorporated into liposomes with higher efficiency than the peptidoglycan monomer using either of the described methods.  Liposome prepns. were stable at 4°C up to 7 days as shown by minimal leaking of the entrapped material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1hI__p75OorVg90H21EOLACvtfcHk0ljP7nqRsrwD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D&md5=d7c820181996614dad55faa819effe09</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1081%2FLPR-120026452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FLPR-120026452%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTrava%25C5%25A1%26aufirst%3DD.%26aulast%3DKrstanovi%25C4%2587%26aufirst%3DM.%26aulast%3D%25C5%25A0poljar%26aufirst%3DB.%2BH.%26aulast%3DLjevakovi%25C4%2587%26aufirst%3DD.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEntrapment%2520of%2520Peptidoglycans%2520and%2520Adamantyltripeptides%2520into%2520Liposomes%253A%2520An%2520HPLC%2520Assay%2520for%2520Determination%2520of%2520Encapsulation%2520Efficiency%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2003%26volume%3D13%26spage%3D279%26epage%3D294%26doi%3D10.1081%2FLPR-120026452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noethig-Laslo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirosavljević, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">A Spin Labelling Study of Immunomodulating Peptidoglycan Monomer and Adamantyltripeptides Entrapped into Liposomes</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1611</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/S0005-2736(03)00054-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0005-2736%2803%2900054-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12659960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1611&publication_year=2003&pages=187-196&author=R.+Frkanecauthor=V.+Noethig-Lasloauthor=B.+Vrane%C5%A1i%C4%87author=K.+Mirosavljevi%C4%87author=J.+Toma%C5%A1i%C4%87&title=A+Spin+Labelling+Study+of+Immunomodulating+Peptidoglycan+Monomer+and+Adamantyltripeptides+Entrapped+into+Liposomes&doi=10.1016%2FS0005-2736%2803%2900054-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes</span></div><div class="casAuthors">Frkanec, Ruza; Noethig-Laslo, Vesna; Vranesic, Branka; Mirosavljevic, Krunoslav; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1611</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">187-196</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The interaction of immunostimulating compds., the peptidoglycan monomer (PGM) and structurally related adamantyltripeptides (AdTP1 and AdTP2), resp., with phospholipids in liposomal bilayers were investigated by ESR spectroscopy.  The fatty acids bearing the nitroxide spin label at different positions along the acyl chain were used to investigate the interaction of tested compds. with neg. charged multilamellar liposomes.  ESR spectra were studied at 290 and 310 K.  The entrapment of the adamantyltripeptides affected the motional properties of all spin labeled lipids, while the entrapment of PGM had no effect.  Spin labeled PGM was prepd. and the novel compd. bearing the spin label attached via the amino group of diaminopimelic acid was chromatog. purified and chem. characterized.  The rotational correlation time of the spin labeled mol. dissolved in buffer at pH 7.4 was studied as a function of temp.  The conformational change was obsd. above 300 K.  The same effect was obsd. with the spin labeled PGM incorporated into liposomes.  Such effect was not obsd. when the spin labeled PGM was studied at alk. pH, probably due to the hydrolysis of PGM mol.  The study of possible interaction with liposomal membrane is relevant to the use of tested compds. incorporated into liposomes, as adjuvants in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKdV2HeMqDUbVg90H21EOLACvtfcHk0ljP7nqRsrwD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D&md5=d85964e73e290fbc42df57e31045d890</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2FS0005-2736%2803%2900054-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2736%252803%252900054-3%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DNoethig-Laslo%26aufirst%3DV.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DMirosavljevi%25C4%2587%26aufirst%3DK.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DA%2520Spin%2520Labelling%2520Study%2520of%2520Immunomodulating%2520Peptidoglycan%2520Monomer%2520and%2520Adamantyltripeptides%2520Entrapped%2520into%2520Liposomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2003%26volume%3D1611%26spage%3D187%26epage%3D196%26doi%3D10.1016%2FS0005-2736%2803%2900054-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljP7nqRsrwD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. MDP and its representative derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of novel desmuramylpeptides based on <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Boc-<span class="smallcaps smallerCapital">l</span>-Val or Boc-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">l</span>-Ser or Boc-<span class="smallcaps smallerCapital">l</span>-Thr, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (ii) TFA/DCM (1:5), rt; (iii) Boc-Gly, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (iv) RCOOH, EDC, HOBt, DIPEA, DMAP, DMF, rt; (v) H<sub>2</sub>, Pd/C, CH<sub>3</sub>COOH, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Cyclopropane Carrying <i>trans-</i>Ferulic Acid Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) SOCl<sub>2</sub>, EtOH, reflux; (ii) CH<sub>3</sub>COCl, Et<sub>3</sub>N, THF, rt; (iii) NaH, trimethylsulfoxonium iodide, DMSO, 50 °C; (iv) 1 M NaOH, EtOH, rt; (v) BnCl, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (vi) H<sub>2</sub>, Pd/C, rt; (vii) Pd(OAc)<sub>2</sub>, Et<sub>3</sub>SiH, Et<sub>3</sub>N, DCM, rt.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) EtOH, DCC, DMAP, DCM, rt; (ii) TFA/DCM (1:5), rt; (iii) Boc-<span class="smallcaps smallerCapital">l</span>-Val, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (iv) Boc-Gly, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (v) H<sub>2</sub>, Pd/C, EtOH, rt; (vi) <b>37</b>, COMU, DIPEA, DMF, rt; (vii) <b>39</b>, NaHCO<sub>3</sub>, THF/H<sub>2</sub>O, rt; (viii) DBU, 1-octanethiol, THF, rt.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>56</b>–<b>64</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF, rt; (ii) 1 M NaOH, EtOH, rt; (iii) <b>44</b>, EDC, HOBt, DIPEA, DMAP, DMF, rt; (v) <b>47</b>–<b>55</b>, EDC, HOBt, DIPEA, DMAP, DMF, rt.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>68</b> and <b>72</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) cyclopentanol, EDC, DMAP, DCM, rt; (ii) 1-octadecanol, pTsOH, toluene, reflux; (iii) TFA/DCM (1:5), rt; (iv) Boc-<span class="smallcaps smallerCapital">l</span>-Val, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt; (v) Boc-<span class="smallcaps smallerCapital">l</span>-Val, EDC, HOBt, DIPEA, DMAP, DCM, rt; (vi) Boc-Gly, DCC, HOBt, Et<sub>3</sub>N, DMAP, EtOAc, rt, or Boc-Gly, EDC, HOBt, DIPEA, DMAP, DCM, rt; (vii) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF or DCM, rt.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>73</b>–<b>82</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) RCOCl, Et<sub>3</sub>N, THF, rt; (ii) C<sub>17</sub>H<sub>35</sub>COCl, Et<sub>3</sub>N, DMF, rt.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ClogP–EC<sub>50</sub> relationship of the compound <b>1</b> prodrug derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of the MDP and desmuramylpeptide treatments on the release of cytokines from human PBMCs. Cytokine concentrations were measured after 18 h stimulation with MDP (2 μM) or the desmuramylpeptides (2 μM) in the absence or presence of LPS (10 ng/mL). Data are expressed as mean ± SEM of 4 independent experiments. <sup>#</sup><i>p</i> < 0.05, <sup>###</sup><i>p</i> < 0.001 versus untreated controls; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus LPS-treated PBMCs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of MDP and desmuramylpeptides on the cytotoxic activities of PBMCs against K562 and MEC1 cells. (A) PBMCs were treated for 18 h with MDP (10 μM), desmuramylpeptides (10 μM), or LPS (1 μg/mL) before the addition of the K562 or MEC1 cells. Cytotoxicity was determined after 4 h co-incubation. (B) Concentration-dependent effect of <b>75</b> on the induction of PBMC cytotoxicity. Data are shown as activities relative to the negative control (NT, 0.1% DMSO) and are expressed as mean ± SEM of three (MEC1) or four (K562) independent experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus relevant negative controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Significantly up-regulated and down-regulated genes in PBMCs from three independent donors after 18 h of treatment with <b>68</b> and <b>75</b> (2 μM) treatment. A false discovery rate cutoff of <0.05 and a gene expression fold-change >1.5 or <0.667 compared to the untreated control (0.1% DMSO) was applied.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Top 20 most-enriched Gene Ontology (GO) biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms. The differentially expressed genes after <b>68</b> and <b>75</b> treatments (2 μM) were used as input in pathway enrichment analysis using Metascape.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Heat maps of the (A) log<sub>2</sub>(fold change) of the differentially expressed genes in the “Cytokine-cytokine receptor interaction” KEGG pathway and (B) log<sub>2</sub>(fold change) of significantly modulated interferon-stimulated genes (ISGs) by <b>68</b> and <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. CD4<sup>+</sup> and CD8<sup>+</sup> T cell activation, proliferation, and cytokine secretion in response to ovalbumin presentation by bone-marrow-derived dendritic cells (BMDCs) pretreated with desmuramylpeptides <b>68</b> and <b>75</b>. BMDCs from C57BL/6 mice were treated with <b>68</b> and <b>75</b> (1 and 10 μM) and ovalbumin (50 μg/mL). After 18 h, they were washed and cocultured for 72 h with carboxyfluorescein succinimidyl ester (CFSE)-labeled ovalbumin-specific CD4<sup>+</sup> or CD8<sup>+</sup> T cells, isolated from OT II or OT I mouse splenocytes, respectively. (A) Representative dot plots of live Thy1.2<sup>+</sup>/CD4<sup>+</sup> or Thy1.2<sup>+</sup>/CD8<sup>+</sup> T cells, showing CD25 expression and CFSE dilution. (B) Quantification of the proportions of CD25<sup>+</sup>, CFSE<sup>low</sup> T cells. The analysis regions are shown in panel A. (C) Cytokine concentrations in coculture supernatants following co-incubation with BMDCs as described in panel A. Data are expressed as mean ± SEM of duplicates of two independent experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Ovalbumin-specific IgG (left), IgG1 (middle), and IgG2a (right) responses in NIH/OlaHsd mice after immunization with ovalbumin-loaded neutral liposomes (10 μg of ovalbumin per dose), with adjuvants MDP or the desmuramylpeptides (0.30 μmol of adjuvant per dose). The concentrations were measured 1 week after the booster dose. Data are expressed as mean ± SEM of 5 mice per group. *<i>p</i> < 0.05; ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/medium/jm1c00644_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Ovalbumin-specific IgG (top), IgG1 (middle), and IgG2a (bottom) responses in NIH/OlaHsd mice after immunization with neutral (phosphatidylcholine–cholesterol, 7:5), anionic (phosphatidylcholine–cholesterol–dicetylphosphate, 7:5:1), and mannosylated (phosphatidylcholine–cholesterol–mannose-PEG-PA, 7:5:0.5) ovalbumin-loaded liposomes (10 μg of ovalbumin per dose), with adjuvants MDP or <b>75</b> (0.15 μmol of adjuvant per dose). The concentrations were measured 1 week after the second booster dose. Data are expressed as mean ± SEM of 5 mice per group. *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00644/20210602/images/large/jm1c00644_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00644&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 132 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janeway, C. A.</span></span> <span> </span><span class="NLM_article-title">Approaching the Asymptote? Evolution and Revolution in Immunology</span>. <i>Cold Spring Harbor Symp. Quant. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1101/SQB.1989.054.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1101%2FSQB.1989.054.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=2700931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3cXkslGqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=1-13&author=C.+A.+Janeway&title=Approaching+the+Asymptote%3F+Evolution+and+Revolution+in+Immunology&doi=10.1101%2FSQB.1989.054.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Approaching the asymptote?  Evolution and revolution in immunology</span></div><div class="casAuthors">Janeway, C. A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review with 51 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow291fgYVUsbVg90H21EOLACvtfcHk0lisrE7KmF7z5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslGqtrY%253D&md5=db5e51a8f8f6fc9b2dbac1f8cec043e5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2FSQB.1989.054.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252FSQB.1989.054.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26atitle%3DApproaching%2520the%2520Asymptote%253F%2520Evolution%2520and%2520Revolution%2520in%2520Immunology%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1989%26volume%3D54%26spage%3D1%26epage%3D13%26doi%3D10.1101%2FSQB.1989.054.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janeway, C. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Innate Immune Recognition</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.20.083001.084359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev.immunol.20.083001.084359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11861602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=197-216&author=C.+A.+Janewayauthor=R.+Medzhitov&title=Innate+Immune+Recognition&doi=10.1146%2Fannurev.immunol.20.083001.084359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immune recognition</span></div><div class="casAuthors">Janeway, Charles A., Jr.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-216</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The innate immune system is a universal and ancient form of host defense against infection.  Innate immune recognition relies on a limited no. of germline-encoded receptors.  These receptors evolved to recognize conserved products of microbial metab. produced by microbial pathogens, but not by the host.  Recognition of these mol. structures allows the immune system to distinguish infectious nonself from noninfectious self.  Toll-like receptors play a major role in pathogen recognition and initiation of inflammatory and immune responses.  Stimulation of Toll-like receptors by microbial products leads to the activation of signaling pathways that result in the induction of antimicrobial genes and inflammatory cytokines.  In addn., stimulation of Toll-like receptors triggers dendritic cell maturation and results in the induction of costimulatory mols. and increased antigen-presenting capacity.  Thus, microbial recognition by Toll-like receptors helps to direct adaptive immune responses to antigens derived from microbial pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Ee-TeDKpobVg90H21EOLACvtfcHk0lihwskQs0np2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D&md5=0c4bd7dbf690ad61e6b81324be227d8e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.20.083001.084359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.20.083001.084359%26sid%3Dliteratum%253Aachs%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DInnate%2520Immune%2520Recognition%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D20%26spage%3D197%26epage%3D216%26doi%3D10.1146%2Fannurev.immunol.20.083001.084359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasare, C.</span></span> <span> </span><span class="NLM_article-title">Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">3791</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1602000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.1602000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=28483987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Sku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=3791-3800&author=A.+Jainauthor=C.+Pasare&title=Innate+Control+of+Adaptive+Immunity%3A+Beyond+the+Three-Signal+Paradigm&doi=10.4049%2Fjimmunol.1602000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm</span></div><div class="casAuthors">Jain, Aakanksha; Pasare, Chandrashekhar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3791-3800</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  Activation of cells in the adaptive immune system is a highly orchestrated process dictated by multiples cues from the innate immune system.  Although the fundamental principles of innate control of adaptive immunity are well established, it is not fully understood how innate cells integrate qual. pathogenic information to generate tailored protective adaptive immune responses.  In this review, we discuss complexities involved in the innate control of adaptive immunity that extend beyond TCR engagement, costimulation, and priming cytokine prodn. but are crit. for the generation of protective T cell immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eo8hBrZjsrVg90H21EOLACvtfcHk0lgXjj-SJCV8ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Sku70%253D&md5=24160f03414111378a91b90cdd5b8f10</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1602000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1602000%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%26aulast%3DPasare%26aufirst%3DC.%26atitle%3DInnate%2520Control%2520of%2520Adaptive%2520Immunity%253A%2520Beyond%2520the%2520Three-Signal%2520Paradigm%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26spage%3D3791%26epage%3D3800%26doi%3D10.4049%2Fjimmunol.1602000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaji, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, M. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raw, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span> <span> </span><span class="NLM_article-title">Trends in Adjuvant Development for Vaccines: DAMPs and PAMPs as Potential New Adjuvants</span>. <i>Braz. J. Med. Biol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1590/S0100-879X2011000600003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1590%2FS0100-879X2011000600003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21584443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1yltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=500-513&author=E.+N.+Miyajiauthor=E.+Carvalhoauthor=M.+L.+S.+Oliveiraauthor=I.+Rawauthor=P.+L.+Ho&title=Trends+in+Adjuvant+Development+for+Vaccines%3A+DAMPs+and+PAMPs+as+Potential+New+Adjuvants&doi=10.1590%2FS0100-879X2011000600003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants</span></div><div class="casAuthors">Miyaji, E. N.; Carvalho, E.; Oliveira, M. L. S.; Raw, I.; Ho, P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Brazilian Journal of Medical and Biological Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">500-513</span>CODEN:
                <span class="NLM_cas:coden">BJMRDK</span>;
        ISSN:<span class="NLM_cas:issn">0100-879X</span>.
    
            (<span class="NLM_cas:orgname">Associacao Brasileira de Divulgacao Cientifica</span>)
        </div><div class="casAbstract">A review.  Aluminum salts have been widely used in vaccine formulations and, after their introduction more than 80 years ago, only few vaccine formulations using new adjuvants were developed in the last two decades.  Recent advances in the understanding of how innate mechanisms influence the adaptive immunity opened up the possibility for the development of new adjuvants in a more rational design.  The purpose of this review is to discuss the recent advances in this field regarding the attempts to det. the mol. basis and the general mechanisms underlying the development of new adjuvants, with particular emphasis on the activation of receptors of innate immune recognition.  One can anticipate that the use of these novel adjuvants will also provide a window of opportunities for the development of new vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdhSXlHEaX8LVg90H21EOLACvtfcHk0lgSGrcw4E8zIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1yltrc%253D&md5=989ef52a4bd3cc7c3a80a9ea3d2a6d59</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1590%2FS0100-879X2011000600003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0100-879X2011000600003%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaji%26aufirst%3DE.%2BN.%26aulast%3DCarvalho%26aufirst%3DE.%26aulast%3DOliveira%26aufirst%3DM.%2BL.%2BS.%26aulast%3DRaw%26aufirst%3DI.%26aulast%3DHo%26aufirst%3DP.%2BL.%26atitle%3DTrends%2520in%2520Adjuvant%2520Development%2520for%2520Vaccines%253A%2520DAMPs%2520and%2520PAMPs%2520as%2520Potential%2520New%2520Adjuvants%26jtitle%3DBraz.%2520J.%2520Med.%2520Biol.%2520Res.%26date%3D2011%26volume%3D44%26spage%3D500%26epage%3D513%26doi%3D10.1590%2FS0100-879X2011000600003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandakumar, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span> <span> </span><span class="NLM_article-title">Targeting Pattern-Recognition Receptors to Discover New Small Molecule Immune Modulators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2017.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29268133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2ntr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=82-92&author=G.+Zhuauthor=Y.+Xuauthor=X.+Cenauthor=K.+S.+Nandakumarauthor=S.+Liuauthor=K.+Cheng&title=Targeting+Pattern-Recognition+Receptors+to+Discover+New+Small+Molecule+Immune+Modulators&doi=10.1016%2Fj.ejmech.2017.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting pattern-recognition receptors to discover new small molecule immune modulators</span></div><div class="casAuthors">Zhu, Gengzheng; Xu, Yao; Cen, Xiaohong; Nandakumar, Kutty Selva; Liu, Shuwen; Cheng, Kui</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-92</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Pattern recognition receptors (PRRs) are key immune receptors of the innate immune system, which recognize the conserved pathogen-assocd. mol. patterns (PAMPs) of the invading pathogens.  Compared to the adaptive immune receptors, PRRs have three distinguishing features, viz., universal expression, fast response and recognizing many kinds of microbes.  Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), C-type lectin receptors (CLRs) and NOD-like receptors (NLRs) recognize viral nucleic acid/bacterial fragments and trigger anti-microbial innate immune responses.  Upon recognition of their ligand species, PRRs recruit specific intracellular adaptor proteins to initiate signaling pathways culminating in the activation of nuclear factor-κB (NF-κB), mitogen-activated protein (MAP) kinases and interferon regulatory factors (IRFs) that control the transcription of genes encoding pro-inflammatory factors including type I interferon and other inflammatory cytokines, which are crit. for eliminating the potential threat to the host.  Here, we summarize the effects of small mol. regulators acting on signaling pathways initiated by TLR, RLR and NLR as well as their influence on innate and adaptive immune responses leading to therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJYT3GE2sDCLVg90H21EOLACvtfcHk0lgSGrcw4E8zIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2ntr7L&md5=dd71c03c5334ac994cbd0d987df28a9f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCen%26aufirst%3DX.%26aulast%3DNandakumar%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DK.%26atitle%3DTargeting%2520Pattern-Recognition%2520Receptors%2520to%2520Discover%2520New%2520Small%2520Molecule%2520Immune%2520Modulators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D82%26epage%3D92%26doi%3D10.1016%2Fj.ejmech.2017.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pashenkov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagil, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinegin, B. V.</span></span> <span> </span><span class="NLM_article-title">NOD1 and NOD2: Molecular Targets in Prevention and Treatment of Infectious Diseases</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2017.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.intimp.2017.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29207344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=385-400&author=M.+V.+Pashenkovauthor=Y.+A.+Dagilauthor=B.+V.+Pinegin&title=NOD1+and+NOD2%3A+Molecular+Targets+in+Prevention+and+Treatment+of+Infectious+Diseases&doi=10.1016%2Fj.intimp.2017.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases</span></div><div class="casAuthors">Pashenkov, Mikhail V.; Dagil, Yulia A.; Pinegin, Boris V.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain (NOD) 1 and NOD2 are pattern-recognition receptors responsible for sensing fragments of bacterial peptidoglycan known as muropeptides.  Stimulation of innate immunity by systemic or local administration of NOD1 and NOD2 agonists is an attractive means to prevent and treat infectious diseases.  In this review, we discuss novel data concerning structural features of selective and non-selective (dual) NOD1 and NOD2 agonists, main signaling pathways and biol. effects induced by NOD1 and NOD2 stimulation, including induction of pro-inflammatory cytokines, type I interferons and antimicrobial peptides, induction of autophagy, alterations of metab.  We also discuss interactions between NOD1/NOD2 and Toll-like receptor agonists in terms of synergy and cross-tolerance.  Finally, we review available animal data on the role of NOD1 and NOD2 in protection against infections, and discuss how these data could be applied in human infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolmFF5asrsnLVg90H21EOLACvtfcHk0ljt5NQXA4K3cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsb3N&md5=c471cd90f05c8e417f28ff932c290ce4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2017.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2017.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DPashenkov%26aufirst%3DM.%2BV.%26aulast%3DDagil%26aufirst%3DY.%2BA.%26aulast%3DPinegin%26aufirst%3DB.%2BV.%26atitle%3DNOD1%2520and%2520NOD2%253A%2520Molecular%2520Targets%2520in%2520Prevention%2520and%2520Treatment%2520of%2520Infectious%2520Diseases%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2018%26volume%3D54%26spage%3D385%26epage%3D400%26doi%3D10.1016%2Fj.intimp.2017.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabergoj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Harnessing the Untapped Potential of Nucleotide-Binding Oligomerization Domain Ligands for Cancer Immunotherapy</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1484</span>, <span class="refDoi"> DOI: 10.1002/med.21557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fmed.21557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30548868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1447-1484&author=S.+Nabergojauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=%C5%BD.+Jakopin&title=Harnessing+the+Untapped+Potential+of+Nucleotide-Binding+Oligomerization+Domain+Ligands+for+Cancer+Immunotherapy&doi=10.1002%2Fmed.21557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy</span></div><div class="casAuthors">Nabergoj, Sanja; Mlinaric-Rascan, Irena; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1447-1484</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  In the last decade, cancer immunotherapy has emerged as an effective alternative to traditional therapies such as chemotherapy and radiation.  In contrast to the latter, cancer immunotherapy has the potential to distinguish between cancer and healthy cells, and thus to avoid severe and intolerable side-effects, since the cancer cells are effectively eliminated by stimulated immune cells.  The cytosolic nucleotide-binding oligomerization domains 1 and 2 receptors (NOD1 and NOD2) are important components of the innate immune system and constitute interesting targets in terms of strengthening the immune response against cancer cells.  Many NOD ligands have been synthesized, in particular NOD2 agonists that exhibit favorable immunostimulatory and anticancer activity.  Among them, mifamurtide has already been approved in Europe by the European Medicine Agency for treating patients with osteosarcoma in combination with chemotherapy after complete surgical removal of the primary tumor.  This review is focused on NOD receptors as promising targets in cancer immunotherapy as well as summarizing current knowledge of the various NOD ligands exhibiting antitumor and even antimetastatic activity in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0sCUjlJS-ObVg90H21EOLACvtfcHk0ljt5NQXA4K3cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnK&md5=544097b21f38c2b1fb10d92e7f731a1d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmed.21557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21557%26sid%3Dliteratum%253Aachs%26aulast%3DNabergoj%26aufirst%3DS.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DHarnessing%2520the%2520Untapped%2520Potential%2520of%2520Nucleotide-Binding%2520Oligomerization%2520Domain%2520Ligands%2520for%2520Cancer%2520Immunotherapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1447%26epage%3D1484%26doi%3D10.1002%2Fmed.21557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbara, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croitoru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">NOD Proteins: Regulators of Inflammation in Health and Disease</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1038/nri3565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnri3565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=24336102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=9-23&author=D.+J.+Philpottauthor=M.+T.+Sorbaraauthor=S.+J.+Robertsonauthor=K.+Croitoruauthor=S.+E.+Girardin&title=NOD+Proteins%3A+Regulators+of+Inflammation+in+Health+and+Disease&doi=10.1038%2Fnri3565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">NOD proteins: regulators of inflammation in health and disease</span></div><div class="casAuthors">Philpott, Dana J.; Sorbara, Matthew T.; Robertson, Susan J.; Croitoru, Kenneth; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-23</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Entry of bacteria into host cells is an important virulence mechanism.  Through peptidoglycan recognition, the nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2 enable detection of intracellular bacteria and promote their clearance through initiation of a pro-inflammatory transcriptional program and other host defense pathways, including autophagy.  Recent findings have expanded the scope of the cellular compartments monitored by NOD1 and NOD2 and have elucidated the signalling pathways that are triggered downstream of NOD activation.  In vivo, NOD1 and NOD2 have complex roles, both during bacterial infection and at homeostasis.  The assocn. of alleles that encode constitutively active or constitutively inactive forms of NOD2 with different diseases highlights this complexity and indicates that a balanced level of NOD signalling is crucial for the maintenance of immune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHe0P1JHOtJ7Vg90H21EOLACvtfcHk0ljt5NQXA4K3cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO&md5=4de699679859f47003bceeea35012b34</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnri3565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3565%26sid%3Dliteratum%253Aachs%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSorbara%26aufirst%3DM.%2BT.%26aulast%3DRobertson%26aufirst%3DS.%2BJ.%26aulast%3DCroitoru%26aufirst%3DK.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DNOD%2520Proteins%253A%2520Regulators%2520of%2520Inflammation%2520in%2520Health%2520and%2520Disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D9%26epage%3D23%26doi%3D10.1038%2Fnri3565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al
Nabhani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreau, F.</span></span> <span> </span><span class="NLM_article-title">Nod2: The Intestinal Gate Keeper</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e1006177</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1006177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1371%2Fjournal.ppat.1006177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=28253332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1SlurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=e1006177&author=Z.+Al%0ANabhaniauthor=G.+Dietrichauthor=J.+P.+Hugotauthor=F.+Barreau&title=Nod2%3A+The+Intestinal+Gate+Keeper&doi=10.1371%2Fjournal.ppat.1006177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2: the intestinal gate keeper</span></div><div class="casAuthors">Al Nabhani, Ziad; Dietrich, Gilles; Hugot, Jean-Pierre; Barreau, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1006177/1-e1006177/19</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain 2 (NOD2) is an intracellular pattern recognition receptor that senses bacterial peptidoglycan (PGN)-conserved motifs in cytosol and stimulates host immune response.  The assocn. of NOD2 mutations with a no. of inflammatory pathologies, including Crohn disease (CD), Graft-vs.-host disease (GVHD), and Blau syndrome, highlights its pivotal role in host-pathogen interactions and inflammatory response.  Stimulation of NOD2 by its ligand (muramyl dipeptide) activates pro-inflammatory pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinases (MAPKs), and Caspase-1.  A loss of NOD2 function may result in a failure in the control of microbial infection, thereby initiating systemic responses and aberrant inflammation.  Because the ligand of Nod2 is conserved in both gram-pos. and gram-neg. bacteria, NOD2 detects a wide variety of microorganisms.  Furthermore, current literature evidences that NOD2 is also able to control viruses' and parasites' infections.  In this review, we present and discuss recent developments about the role of NOD2 in shaping the gut commensal microbiota and pathogens, including bacteria, viruses, and parasites, and the mechanisms by which Nod2 mutations participate in disease occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm0ESWuIVBirVg90H21EOLACvtfcHk0li-_K_WCw89ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1SlurrF&md5=33c9d8885b44457f8db918c755249de8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006177%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BNabhani%26aufirst%3DZ.%26aulast%3DDietrich%26aufirst%3DG.%26aulast%3DHugot%26aufirst%3DJ.%2BP.%26aulast%3DBarreau%26aufirst%3DF.%26atitle%3DNod2%253A%2520The%2520Intestinal%2520Gate%2520Keeper%26jtitle%3DPLoS%2520Pathog.%26date%3D2017%26volume%3D13%26spage%3De1006177%26doi%3D10.1371%2Fjournal.ppat.1006177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamaillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labigne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansonetti, P. J.</span></span> <span> </span><span class="NLM_article-title">Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">8869</span>– <span class="NLM_lpage">8872</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200651200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.C200651200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12527755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=8869-8872&author=S.+E.+Girardinauthor=I.+G.+Bonecaauthor=J.+Vialaauthor=M.+Chamaillardauthor=A.+Labigneauthor=G.+Thomasauthor=D.+J.+Philpottauthor=P.+J.+Sansonetti&title=Nod2+Is+a+General+Sensor+of+Peptidoglycan+through+Muramyl+Dipeptide+%28MDP%29+Detection&doi=10.1074%2Fjbc.C200651200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection</span></div><div class="casAuthors">Girardin, Stephen E.; Boneca, Ivo G.; Viala, Jerome; Chamaillard, Mathias; Labigne, Agnes; Thomas, Gilles; Philpott, Dana J.; Sansonetti, Philippe J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8869-8872</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod2 activates the NF-κB pathway following intracellular stimulation by bacterial products.  Recently, mutations in Nod2 have been shown to be assocd. with Crohn's disease, suggesting a role for bacteria-host interactions in the etiol. of this disorder.  The authors show here that Nod2 is a general sensor of peptidoglycan through the recognition of muramyl dipeptide (MDP), the minimal bioactive peptidoglycan motif common to all bacteria.  Moreover, the 3020insC frameshift mutation, the most frequent Nod2 variant assocd. with Crohn's disease patients, fully abrogates Nod2-dependent detection of peptidoglycan and MDP.  Together, these results impact on the understanding of Crohn's disease development.  Addnl., the characterization of Nod2 as the first pathogen-recognition mol. that detects MDP will help to unravel the well known biol. activities of this immunomodulatory compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOYkWjlEqR7Vg90H21EOLACvtfcHk0li-_K_WCw89ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D&md5=220b5b27786d90179dca20566d643bf6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200651200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200651200%26sid%3Dliteratum%253Aachs%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DViala%26aufirst%3DJ.%26aulast%3DChamaillard%26aufirst%3DM.%26aulast%3DLabigne%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSansonetti%26aufirst%3DP.%2BJ.%26atitle%3DNod2%2520Is%2520a%2520General%2520Sensor%2520of%2520Peptidoglycan%2520through%2520Muramyl%2520Dipeptide%2520%2528MDP%2529%2520Detection%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D8869%26epage%3D8872%26doi%3D10.1074%2Fjbc.C200651200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontalba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Luna, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2: Implications for Crohn’s Disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">5509</span>– <span class="NLM_lpage">5512</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200673200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.C200673200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12514169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1aqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=5509-5512&author=N.+Inoharaauthor=Y.+Oguraauthor=A.+Fontalbaauthor=O.+Gutierrezauthor=F.+Ponsauthor=J.+Crespoauthor=K.+Fukaseauthor=S.+Inamuraauthor=S.+Kusumotoauthor=M.+Hashimotoauthor=S.+J.+Fosterauthor=A.+P.+Moranauthor=J.+L.+Fernandez-Lunaauthor=G.+Nu%C3%B1ez&title=Host+Recognition+of+Bacterial+Muramyl+Dipeptide+Mediated+through+NOD2%3A+Implications+for+Crohn%E2%80%99s+Disease&doi=10.1074%2Fjbc.C200673200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2</span></div><div class="casAuthors">Inohara, Naohiro; Ogura, Yasunori; Fontalba, Ana; Gutierrez, Olga; Pons, Fernando; Crespo, Javier; Fukase, Koichi; Inamura, Seiichi; Kusumoto, Shoichi; Hashimoto, Masahito; Foster, Simon J.; Moran, Anthony P.; Fernandez-Luna, Jose L.; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5509-5512</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NOD2, a protein assocd. with susceptibility to Crohn's disease, confers responsiveness to bacterial prepns. of lipopolysaccharide and peptidoglycan, but the precise moiety recognized remains elusive.  Biochem. and functional analyses identified muramyl dipeptide (MurNAc-L-Ala-D-isoGln) derived from peptidoglycan as the essential structure in bacteria recognized by NOD2.  Replacement of L-Ala for D-Ala or D-isoGln for L-isoGln eliminated the ability of muramyl dipeptide to stimulate NOD2, indicating stereoselective recognition.  Muramyl dipeptide was recognized by NOD2 but not by TLR2 or co-expression of TLR2 with TLR1 or TLR6.  NOD2 mutants assocd. with susceptibility to Crohn's disease were deficient in their recognition of muramyl dipeptide.  Notably, peripheral blood mononuclear cells from individuals homozygous for the major disease-assocd. L1007fsinsC NOD2 mutation responded to lipopolysaccharide but not to synthetic muramyl dipeptide.  Thus, NOD2 mediates the host response to bacterial muropeptides derived from peptidoglycan, an activity that is important for protection against Crohn's disease.  Because muramyl dipeptide is the essential structure of peptidoglycan required for adjuvant activity, these results also have implications for understanding adjuvant function and effective vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL3tQ2w4Cw4bVg90H21EOLACvtfcHk0li-_K_WCw89ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1aqsro%253D&md5=85e6c71168111b190abc37013fcfbaee</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200673200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200673200%26sid%3Dliteratum%253Aachs%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DFontalba%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DO.%26aulast%3DPons%26aufirst%3DF.%26aulast%3DCrespo%26aufirst%3DJ.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInamura%26aufirst%3DS.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DS.%2BJ.%26aulast%3DMoran%26aufirst%3DA.%2BP.%26aulast%3DFernandez-Luna%26aufirst%3DJ.%2BL.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DHost%2520Recognition%2520of%2520Bacterial%2520Muramyl%2520Dipeptide%2520Mediated%2520through%2520NOD2%253A%2520Implications%2520for%2520Crohn%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D5509%26epage%3D5512%26doi%3D10.1074%2Fjbc.C200673200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyananda, L. D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, E. K.</span></span> <span> </span><span class="NLM_article-title">The Innate Immune Protein Nod2 Binds Directly to MDP, a Bacterial Cell Wall Fragment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">13535</span>– <span class="NLM_lpage">13537</span>, <span class="refDoi"> DOI: 10.1021/ja303883c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303883c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=13535-13537&author=C.+L.+Grimesauthor=L.+D.+Z.+Ariyanandaauthor=J.+E.+Melnykauthor=E.+K.+O%E2%80%99Shea&title=The+Innate+Immune+Protein+Nod2+Binds+Directly+to+MDP%2C+a+Bacterial+Cell+Wall+Fragment&doi=10.1021%2Fja303883c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment</span></div><div class="casAuthors">Grimes, Catherine Leimkuhler; Ariyananda, Lushanti De Zoysa; Melnyk, James E.; O'Shea, Erin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13535-13537</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mammalian Nod2 is an intracellular protein that is implicated in the innate immune response to the bacterial cell wall and is assocd. with the development of Crohn's disease, Blau syndrome, and gastrointestinal cancers.  Nod2 is required for an immune response to muramyl dipeptide (MDP), an immunostimulatory fragment of bacterial cell wall, but it is not known whether MDP binds directly to Nod2.  We report the expression and purifn. of human Nod2 from insect cells.  Using novel MDP self-assembled monolayers (SAMs), we provide the first biochem. evidence for a direct, high-affinity interaction between Nod2 and MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_35GPZTPtLVg90H21EOLACvtfcHk0lj-ouzcBEaC8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F&md5=9bb26db0105a836a5130c961622f4e34</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja303883c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303883c%26sid%3Dliteratum%253Aachs%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26aulast%3DAriyananda%26aufirst%3DL.%2BD.%2BZ.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DE.%2BK.%26atitle%3DThe%2520Innate%2520Immune%2520Protein%2520Nod2%2520Binds%2520Directly%2520to%2520MDP%252C%2520a%2520Bacterial%2520Cell%2520Wall%2520Fragment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D13535%26epage%3D13537%26doi%3D10.1021%2Fja303883c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monie, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, J. A.</span></span> <span> </span><span class="NLM_article-title">Pathogen Sensing by Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Is Mediated by Direct Binding to Muramyl Dipeptide and ATP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23057</span>– <span class="NLM_lpage">23067</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.344283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M112.344283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22549783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23057-23067&author=J.+Moauthor=J.+P.+Boyleauthor=C.+B.+Howardauthor=T.+P.+Monieauthor=B.+K.+Davisauthor=J.+A.+Duncan&title=Pathogen+Sensing+by+Nucleotide-Binding+Oligomerization+Domain-Containing+Protein+2+%28NOD2%29+Is+Mediated+by+Direct+Binding+to+Muramyl+Dipeptide+and+ATP&doi=10.1074%2Fjbc.M112.344283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP</span></div><div class="casAuthors">Mo, Jinyao; Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.; Davis, Beckley K.; Duncan, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">23057-23067</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide binding and oligomerization domain-contg. protein 2 (NOD2/Card15) is an intracellular protein that is involved in the recognition of bacterial cell wall-derived muramyl dipeptide.  Mutations in the gene encoding NOD2 are assocd. with inherited inflammatory disorders, including Crohn disease and Blau syndrome.  NOD2 is a member of the nucleotide-binding domain and leucine-rich repeat-contg. protein gene (NLR) family.  Nucleotide binding is thought to play a crit. role in signaling by NLR family members.  However, the mol. mechanisms underlying signal transduction by these proteins remain largely unknown.  Mutations in the nucleotide-binding domain of NOD2 have been shown to alter its signal transduction properties in response to muramyl dipeptide in cellular assays.  Using purified recombinant protein, we now demonstrate that NOD2 binds and hydrolyzes ATP.  Addnl., we have found that the purified recombinant protein is able to bind directly to muramyl dipeptide and can assoc. with known NOD2-interacting proteins in vitro.  Binding of NOD2 to muramyl dipeptide and homo-oligomerization of NOD2 are enhanced by ATP binding, suggesting a model of the mol. mechanism for signal transduction that involves binding of nucleotide followed by binding of muramyl dipeptide and oligomerization of NOD2 into a signaling complex.  These findings set the stage for further studies into the mol. mechanisms that underlie detection of muramyl dipeptide and assembly of NOD2-contg. signaling complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHB17K-Mn8MrVg90H21EOLACvtfcHk0lj-ouzcBEaC8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D&md5=79080d42bc5db467360658170bde4caf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.344283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.344283%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DHoward%26aufirst%3DC.%2BB.%26aulast%3DMonie%26aufirst%3DT.%2BP.%26aulast%3DDavis%26aufirst%3DB.%2BK.%26aulast%3DDuncan%26aufirst%3DJ.%2BA.%26atitle%3DPathogen%2520Sensing%2520by%2520Nucleotide-Binding%2520Oligomerization%2520Domain-Containing%2520Protein%25202%2520%2528NOD2%2529%2520Is%2520Mediated%2520by%2520Direct%2520Binding%2520to%2520Muramyl%2520Dipeptide%2520and%2520ATP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23057%26epage%3D23067%26doi%3D10.1074%2Fjbc.M112.344283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monie, T. P.</span></span> <span> </span><span class="NLM_article-title">Insights into the Molecular Basis of the Nod2 Signalling Pathway</span>. <i>Open Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">140178</span>, <span class="refDoi"> DOI: 10.1098/rsob.140178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1098%2Frsob.140178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25520185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=140178&author=J.+P.+Boyleauthor=R.+Parkhouseauthor=T.+P.+Monie&title=Insights+into+the+Molecular+Basis+of+the+Nod2+Signalling+Pathway&doi=10.1098%2Frsob.140178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the molecular basis of the NOD2 signalling pathway</span></div><div class="casAuthors">Boyle, Joseph P.; Parkhouse, Rhiannon; Monie, Tom P.</div><div class="citationInfo"><span class="NLM_cas:title">Open Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">140178/1-140178/12</span>CODEN:
                <span class="NLM_cas:coden">OBPICQ</span>;
        ISSN:<span class="NLM_cas:issn">2046-2441</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The cytosolic pattern recognition receptor NOD2 is activated by the peptidoglycan fragment muramyl dipeptide to generate a proinflammatory immune response.  Downstream effects include the secretion of cytokines such as interleukin 8, the upregulation of pro-interleukin 1b, the induction of autophagy, the prodn. of antimicrobial peptides and defensins, and contributions to the maintenance of the compn. of the intestinal microbiota.  Polymorphisms in NOD2 are the cause of the inflammatory disorder Blau syndrome and act as susceptibility factors for the inflammatory bowel condition Crohn's disease.  The complexity of NOD2 signalling is highlighted by the observation that over 30 cellular proteins interact with NOD2 directly and influence or regulate its functional activity.  Previously, the majority of reviews on NOD2 function have focused upon the role of NOD2 in inflammatory disease or in its interaction with and response to microbes.  However, the functionality of NOD2 is underpinned by its biochem. interactions.  Consequently, in this review, we have taken the opportunity to address the more 'basic' elements of NOD2 signalling.  In particular, we have focused upon the core interactions of NOD2 with protein factors that influence and modulate the signal transduction pathways involved in NOD2 signalling.  Further, where information exists, such as in relation to the role of RIP2,we have drawn comparison with the closely related, but functionally discrete, pattern recognition receptor NOD1.  Overall, we provide a comprehensive resource targeted at understanding the complexities of NOD2 signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLYhRouK6rObVg90H21EOLACvtfcHk0ljeiAIJY0Q0cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7g%253D&md5=b236838c3cf7c96bc67f12036285eea9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1098%2Frsob.140178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsob.140178%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DParkhouse%26aufirst%3DR.%26aulast%3DMonie%26aufirst%3DT.%2BP.%26atitle%3DInsights%2520into%2520the%2520Molecular%2520Basis%2520of%2520the%2520Nod2%2520Signalling%2520Pathway%26jtitle%3DOpen%2520Biol.%26date%3D2014%26volume%3D4%26spage%3D140178%26doi%3D10.1098%2Frsob.140178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvanantham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommerman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">7925</span>– <span class="NLM_lpage">7935</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.181.11.7925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.181.11.7925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19017983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=7925-7935&author=J.+G.+Magalhaesauthor=J.+H.+Fritzauthor=L.+Le+Bourhisauthor=G.+Sellgeauthor=L.+H.+Travassosauthor=T.+Selvananthamauthor=S.+E.+Girardinauthor=J.+L.+Gommermanauthor=D.+J.+Philpott&title=Nod2-Dependent+Th2+Polarization+of+Antigen-Specific+Immunity&doi=10.4049%2Fjimmunol.181.11.7925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity</span></div><div class="casAuthors">Magalhaes, Joao Gamelas; Fritz, Joerg H.; Le Bourhis, Lionel; Sellge, Gernot; Travassos, Leonardo H.; Selvanantham, Thirumahal; Girardin, Stephen E.; Gommerman, Jennifer L.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7925-7935</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">While a no. of microbial-assocd. mol. patterns have been known for decades to act as adjuvants, the mechanisms and the signaling pathways underlying their action have remained elusive.  Here, the authors examd. the unfolding of the adaptive immune response induced by Nod2 in vivo upon activation by its specific ligand, muramyl dipeptide, a component of peptidoglycan.  The authors' findings demonstrate that this bacterial sensor triggers a potent Ag-specific immune response with a Th2-type polarization profile, characterized by the induction of IL-4 and IL-5 by T cells and IgG1 Ab responses.  Nod2 was also crit. for the induction of both Th1- and Th2-type responses following costimulation with TLR agonists.  Importantly, the synergistic responses to Nod2 and TLR agonists seen in vivo were recapitulated by dendritic cells in vitro, suggesting that these cells likely play a central role in the integration of Nod2- and TLR-dependent signals for driving the adaptive immune response.  Taken together, the authors' results identify Nod2 as a crit. mediator of microbial-induced potentiation and polarization of Ag-dependent immunity.  Moreover, these findings affect the authors' understanding of Crohn's diseases pathogenesis, where lack of Nod2-dependent Th2 signaling in a subset of these patients might explain heightened Th1-mediated inflammation at the level of the intestinal mucosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJlqhZbkvAl7Vg90H21EOLACvtfcHk0ljeiAIJY0Q0cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM&md5=d57612e894994da00c2cd14d5d578f54</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.11.7925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.11.7925%26sid%3Dliteratum%253Aachs%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DSellge%26aufirst%3DG.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DSelvanantham%26aufirst%3DT.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DGommerman%26aufirst%3DJ.%2BL.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNod2-Dependent%2520Th2%2520Polarization%2520of%2520Antigen-Specific%2520Immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26spage%3D7925%26epage%3D7935%26doi%3D10.4049%2Fjimmunol.181.11.7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">NOD-Like Receptors: Role in Innate Immunity and Inflammatory Disease</span>. <i>Annu. Rev. Pathol.: Mech. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1146/annurev.pathol.4.110807.092239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev.pathol.4.110807.092239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18928408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1ahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=365-398&author=G.+Chenauthor=M.+H.+Shawauthor=Y.-G.+Kimauthor=G.+Nu%C3%B1ez&title=NOD-Like+Receptors%3A+Role+in+Innate+Immunity+and+Inflammatory+Disease&doi=10.1146%2Fannurev.pathol.4.110807.092239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NOD-like receptors: role in innate immunity and inflammatory disease</span></div><div class="casAuthors">Chen, Grace; Shaw, Michael H.; Kim, Yun-Gi; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">365-398</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The NOD-like receptors (NLRs) are a specialized group of intracellular receptors that represent a key component of the host innate immune system.  Since the discovery of the first NLR almost 10 years ago, the study of this special class of microbial sensors has burgeoned; consequently, a better understanding of the mechanism by which these receptors recognize microbes and other danger signals and of how they activate inflammatory signaling pathways has emerged.  Moreover, in addn. to their primary role in host defense against invading pathogens, their ability to regulate nuclear factor-kappa B (NF-κB) signaling, interleukin-1-beta (IL-1β) prodn., and cell death indicates that they are crucial to the pathogenesis of a variety of inflammatory human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1aZBb_POhVrVg90H21EOLACvtfcHk0ljeiAIJY0Q0cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1ahsr4%253D&md5=339eb7ae462311c4c679437e0321b0ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pathol.4.110807.092239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pathol.4.110807.092239%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DShaw%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DY.-G.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DNOD-Like%2520Receptors%253A%2520Role%2520in%2520Innate%2520Immunity%2520and%2520Inflammatory%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2009%26volume%3D4%26spage%3D365%26epage%3D398%26doi%3D10.1146%2Fannurev.pathol.4.110807.092239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negroni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierdomenico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchiara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stronati, L.</span></span> <span> </span><span class="NLM_article-title">NOD2 and Inflammation: Current Insights</span>. <i>J. Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.2147/JIR.S137606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2147%2FJIR.S137606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29483781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVymurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=49-60&author=A.+Negroniauthor=M.+Pierdomenicoauthor=S.+Cucchiaraauthor=L.+Stronati&title=NOD2+and+Inflammation%3A+Current+Insights&doi=10.2147%2FJIR.S137606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 and inflammation: current insights</span></div><div class="casAuthors">Negroni, Anna; Pierdomenico, Maria; Cucchiara, Salvatore; Stronati, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inflammation Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">JIROAC</span>;
        ISSN:<span class="NLM_cas:issn">1178-7031</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">The nucleotide-binding oligomerization domain (NOD) protein, NOD2, belonging to the intracellular NOD-like receptor family, detects conserved motifs in bacterial peptidoglycan and promotes their clearance through activation of a proinflammatory transcriptional program and other innate immune pathways, including autophagy and endoplasmic reticulum stress.  An inactive form due to mutations or a constitutive high expression of NOD2 is assocd. with several inflammatory diseases, suggesting that balanced NOD2 signaling is crit. for the maintenance of immune homeostasis.  In this review, we discuss recent developments about the pathway and mechanisms of regulation of NOD2 and illustrate the principal functions of the gene, with particular emphasis on its central role in maintaining the equil. between intestinal microbiota and host immune responses to control inflammation.  Furthermore, we survey recent studies illustrating the role of NOD2 in several inflammatory diseases, in particular, inflammatory bowel disease, of which it is the main susceptibility gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoGElZ7bfMbrVg90H21EOLACvtfcHk0ljeiAIJY0Q0cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVymurrE&md5=a4cf9346296eefe7b420964c2a5c0cbd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2147%2FJIR.S137606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJIR.S137606%26sid%3Dliteratum%253Aachs%26aulast%3DNegroni%26aufirst%3DA.%26aulast%3DPierdomenico%26aufirst%3DM.%26aulast%3DCucchiara%26aufirst%3DS.%26aulast%3DStronati%26aufirst%3DL.%26atitle%3DNOD2%2520and%2520Inflammation%253A%2520Current%2520Insights%26jtitle%3DJ.%2520Inflammation%2520Res.%26date%3D2018%26volume%3D11%26spage%3D49%26epage%3D60%26doi%3D10.2147%2FJIR.S137606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichulik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, A.</span></span> <span> </span><span class="NLM_article-title">NOD2 Stimulation Induces Autophagy in Dendritic Cells Influencing Bacterial Handling and Antigen Presentation</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1038/nm.2069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnm.2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19966812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=90-97&author=R.+Cooneyauthor=J.+Bakerauthor=O.+Brainauthor=B.+Danisauthor=T.+Pichulikauthor=P.+Allanauthor=D.+J.+P.+Fergusonauthor=B.+J.+Campbellauthor=D.+Jewellauthor=A.+Simmons&title=NOD2+Stimulation+Induces+Autophagy+in+Dendritic+Cells+Influencing+Bacterial+Handling+and+Antigen+Presentation&doi=10.1038%2Fnm.2069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation</span></div><div class="casAuthors">Cooney, Rachel; Baker, John; Brain, Oliver; Danis, Benedicte; Pichulik, Tica; Allan, Philip; Ferguson, David J. P.; Campbell, Barry J.; Jewell, Derek; Simmons, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-97</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg.-2 (NOD2) acts as a bacterial sensor in dendritic cells (DCs), but it is not clear how bacterial recognition links with antigen presentation after NOD2 stimulation.  NOD2 variants are assocd. with Crohn's disease, where breakdown in self-recognition of commensal bacteria leads to gastrointestinal inflammation.  Here the authors show NOD2 triggering by muramyldipeptide induces autophagy in DCs.  This effect requires receptor-interacting serine-threonine kinase-2 (RIPK-2), autophagy-related protein-5 (ATG5), ATG7 and ATG16L1 but not NLR family, pyrin domain contg.-3 (NALP3).  The authors show that NOD2-mediated autophagy is required for both bacterial handling and generation of major histocompatibility complex (MHC) class II antigen-specific CD4+ T cell responses in DCs.  DCs from individuals with Crohn's disease expressing Crohn's disease-assocd. NOD2 or ATG16L1 risk variants are defective in autophagy induction, bacterial trafficking and antigen presentation.  The authors' findings link two Crohn's disease-assocd. susceptibility genes in a single functional pathway and reveal defects in this pathway in Crohn's disease DCs that could lead to bacterial persistence via impaired lysosomal destruction and immune mediated clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1-DHs4aTb0bVg90H21EOLACvtfcHk0lhVuf0A5grTwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3L&md5=9ecc98f28c3465da94237fa729ebc345</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnm.2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2069%26sid%3Dliteratum%253Aachs%26aulast%3DCooney%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DJ.%26aulast%3DBrain%26aufirst%3DO.%26aulast%3DDanis%26aufirst%3DB.%26aulast%3DPichulik%26aufirst%3DT.%26aulast%3DAllan%26aufirst%3DP.%26aulast%3DFerguson%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DCampbell%26aufirst%3DB.%2BJ.%26aulast%3DJewell%26aufirst%3DD.%26aulast%3DSimmons%26aufirst%3DA.%26atitle%3DNOD2%2520Stimulation%2520Induces%2520Autophagy%2520in%2520Dendritic%2520Cells%2520Influencing%2520Bacterial%2520Handling%2520and%2520Antigen%2520Presentation%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D90%26epage%3D97%26doi%3D10.1038%2Fnm.2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, L. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramjeet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chea, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allaoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nod1 and Nod2 Direct Autophagy by Recruiting ATG16L1 to the Plasma Membrane at the Site of Bacterial Entry</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/ni.1823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fni.1823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19898471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOrur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=55-62&author=L.+H.+Travassosauthor=L.+A.+M.+Carneiroauthor=M.+Ramjeetauthor=S.+Husseyauthor=Y.+G.+Kimauthor=J.+G.+Magalhaesauthor=L.+Yuanauthor=F.+Soaresauthor=E.+Cheaauthor=L.+Le+Bourhisauthor=I.+G.+Bonecaauthor=A.+Allaouiauthor=N.+L.+Jonesauthor=G.+Nunezauthor=S.+E.+Girardinauthor=D.+J.+Philpott&title=Nod1+and+Nod2+Direct+Autophagy+by+Recruiting+ATG16L1+to+the+Plasma+Membrane+at+the+Site+of+Bacterial+Entry&doi=10.1038%2Fni.1823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry</span></div><div class="casAuthors">Travassos, Leonardo H.; Carneiro, Leticia A. M.; Ramjeet, Mahendrasingh; Hussey, Seamus; Kim, Yun-Gi; Magalhaes, Joao G.; Yuan, Linda; Soares, Fraser; Chea, Evelyn; Le Bourhis, Lionel; Boneca, Ivo G.; Allaoui, Abdelmounaaim; Jones, Nicola L.; Nunez, Gabriel; Girardin, Stephen E.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-62</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is emerging as a crucial defense mechanism against bacteria, but the host intracellular sensors responsible for inducing autophagy in response to bacterial infection remain unknown.  Here the authors demonstrated that the intracellular sensors Nod1 and Nod2 are crit. for the autophagic response to invasive bacteria.  By a mechanism independent of the adaptor RIP2 and transcription factor NF-κB, Nod1 and Nod2 recruited the autophagy protein ATG16L1 to the plasma membrane at the bacterial entry site.  In cells homozygous for the Crohn's disease-assocd. NOD2 frameshift mutation, mutant Nod2 failed to recruit ATG16L1 to the plasma membrane and wrapping of invading bacteria by autophagosomes was impaired.  The authors' results link bacterial sensing by Nod proteins to the induction of autophagy and provide a functional link between Nod2 and ATG16L1, which are encoded by two of the most important genes assocd. with Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpod7yaAQxL4rVg90H21EOLACvtfcHk0lhVuf0A5grTwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOrur3L&md5=55a50958d13cf60bae196c547fa2cd13</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fni.1823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1823%26sid%3Dliteratum%253Aachs%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DCarneiro%26aufirst%3DL.%2BA.%2BM.%26aulast%3DRamjeet%26aufirst%3DM.%26aulast%3DHussey%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DSoares%26aufirst%3DF.%26aulast%3DChea%26aufirst%3DE.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DAllaoui%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DN.%2BL.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNod1%2520and%2520Nod2%2520Direct%2520Autophagy%2520by%2520Recruiting%2520ATG16L1%2520to%2520the%2520Plasma%2520Membrane%2520at%2520the%2520Site%2520of%2520Bacterial%2520Entry%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D55%26epage%3D62%26doi%3D10.1038%2Fni.1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhães, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the Therapeutic Potential of NOD-like Receptors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1038/nrd2783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnrd2783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19483708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=465-479&author=K.+Geddesauthor=J.+G.+Magalh%C3%A3esauthor=S.+E.+Girardin&title=Unleashing+the+Therapeutic+Potential+of+NOD-like+Receptors&doi=10.1038%2Fnrd2783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the therapeutic potential of NOD-like receptors</span></div><div class="casAuthors">Geddes, Kaoru; Magalhaes, Joao G.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">465-479</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation.  Whereas some NLRs, including NOD1, NOD2, NAIP (NLR family, apoptosis inhibitory protein) and NLRC4, detect conserved bacterial mol. signatures within the host cytosol, other members of this family sense 'danger signals', i.e., xenocompounds or mols. that when recognized alert the immune system of hazardous environments, perhaps independently of a microbial trigger.  In the past few years, remarkable progress has been made towards deciphering the role and the biol. of NLRs, which has shown that these innate immune sensors have pivotal roles in providing immunity to infection, adjuvanticity and inflammation.  Furthermore, several inflammatory disorders have been assocd. with mutations in human NLR genes.  Here, the authors discuss the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCvglqYhhnV7Vg90H21EOLACvtfcHk0lgxuSnCesEVPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D&md5=06a9045f6206702396cd920edf38649b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd2783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2783%26sid%3Dliteratum%253Aachs%26aulast%3DGeddes%26aufirst%3DK.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DJ.%2BG.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DUnleashing%2520the%2520Therapeutic%2520Potential%2520of%2520NOD-like%2520Receptors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D465%26epage%3D479%26doi%3D10.1038%2Fnrd2783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maisonneuve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertholet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gregorio, E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the Potential of NOD- and Toll-like Agonists as Vaccine Adjuvants</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12294</span>– <span class="NLM_lpage">12299</span>, <span class="refDoi"> DOI: 10.1073/pnas.1400478111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.1400478111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25136133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12294-12299&author=C.+Maisonneuveauthor=S.+Bertholetauthor=D.+J.+Philpottauthor=E.+De+Gregorio&title=Unleashing+the+Potential+of+NOD-+and+Toll-like+Agonists+as+Vaccine+Adjuvants&doi=10.1073%2Fpnas.1400478111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants</span></div><div class="casAuthors">Maisonneuve, Charles; Bertholet, Sylvie; Philpott, Dana J.; De Gregorio, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12294-12299</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Innate immunity confers an immediate nonspecific mechanism of microbial recognition through germ line-encoded pattern recognition receptors (PRRs).  Of these, Toll-like receptors (TLRs) and nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) have shaped the authors' current understanding of innate regulation of adaptive immunity.  It is now recognized that PRRs are paramount in instructing an appropriate adaptive immune response.  Their ligands have been the focus of adjuvant research with the goal of generating modern vaccine combinations tailored to specific pathogens.  In this review the authors will highlight the recent findings in the field of adjuvant research with a particular focus on the potential of TLR and NLR ligands as adjuvants and their influence on adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Pm03irVncrVg90H21EOLACvtfcHk0liDQGwIZ3zT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM&md5=de6088e853b57a9f4d2d622e0a27a2c8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1400478111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1400478111%26sid%3Dliteratum%253Aachs%26aulast%3DMaisonneuve%26aufirst%3DC.%26aulast%3DBertholet%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DDe%2BGregorio%26aufirst%3DE.%26atitle%3DUnleashing%2520the%2520Potential%2520of%2520NOD-%2520and%2520Toll-like%2520Agonists%2520as%2520Vaccine%2520Adjuvants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12294%26epage%3D12299%26doi%3D10.1073%2Fpnas.1400478111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst-Kralovetz, M. M.</span></span> <span> </span><span class="NLM_article-title">Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-like Particle Vaccine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e41529</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0041529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1371%2Fjournal.pone.0041529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22855691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFanu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=E.+M.+Jacksonauthor=M.+M.+Herbst-Kralovetz&title=Intranasal+Vaccination+with+Murabutide+Enhances+Humoral+and+Mucosal+Immune+Responses+to+a+Virus-like+Particle+Vaccine&doi=10.1371%2Fjournal.pone.0041529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine</span></div><div class="casAuthors">Jackson, Erin M.; Herbst-Kralovetz, Melissa M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e41529</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2) receptor on mammalian cells.  MB has previously been approved for testing in multiple human clin. trials to det. its value as an antiviral therapeutic, and as an adjuvant for injected vaccines.  We have found a new use for this immunomodulator; it functions as a mucosal adjuvant that enhances immunogenicity of virus-like particles (VLP) administered intranasally.  MB enhanced Norwalk virus (NV) VLP-specific IgG systemically and IgA prodn. at distal mucosal sites following intranasal (IN) vaccination.  A dose escalation study identified 100 μg as the optimal MB dosage in mice, based on the magnitude of VLP-specific IgG, IgG1, IgG2a and IgA prodn. in serum and VLP-specific IgA prodn. at distal mucosal sites.  IN vaccination using VLP with MB was compared to IN delivery VLP with cholera toxin (CT) or gardiquimod (GARD) and to parenteral VLP delivery with alum; the MB groups were equiv. to CT and GARD and superior to alum in inducing mucosal immune responses and stimulated equiv. systemic VLP-specific antibodies.  These data support the further testing of MB as a potent mucosal adjuvant for inducing robust and durable antibody responses to non-replicating subunit vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJryNC_4ZINLVg90H21EOLACvtfcHk0liDQGwIZ3zT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFanu7fM&md5=68b4b677cc8faac2720d5ed72d390761</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0041529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0041529%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BM.%26aulast%3DHerbst-Kralovetz%26aufirst%3DM.%2BM.%26atitle%3DIntranasal%2520Vaccination%2520with%2520Murabutide%2520Enhances%2520Humoral%2520and%2520Mucosal%2520Immune%2520Responses%2520to%2520a%2520Virus-like%2520Particle%2520Vaccine%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0041529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumgardner, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoy, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajikawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaenhammer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, G. A.</span></span> <span> </span><span class="NLM_article-title">Nod2 Is Required for Antigen-Specific Humoral Responses against Antigens Orally Delivered Using a Recombinant Lactobacillus Vaccine Platform</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e0196950</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0196950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1371%2Fjournal.pone.0196950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29734365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSgsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0196950&author=S.+A.+Bumgardnerauthor=L.+Zhangauthor=A.+S.+LaVoyauthor=B.+Andreauthor=C.+B.+Frankauthor=A.+Kajikawaauthor=T.+R.+Klaenhammerauthor=G.+A.+Dean&title=Nod2+Is+Required+for+Antigen-Specific+Humoral+Responses+against+Antigens+Orally+Delivered+Using+a+Recombinant+Lactobacillus+Vaccine+Platform&doi=10.1371%2Fjournal.pone.0196950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform</span></div><div class="casAuthors">Bumgardner, Sara A.; Zhang, Lin; Lavoy, Alora S.; Andre, Barbara; Frank, Chad B.; Kajikawa, Akinobu; Klaenhammer, Todd R.; Dean, Gregg A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0196950/1-e0196950/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Safe and efficacious orally-delivered mucosal vaccine platforms are desperately needed to combat the plethora of mucosally transmitted pathogens.  Lactobacillus spp. have emerged as attractive candidates to meet this need and are known to activate the host innate immune response in a species- and strain-specific manner.  For selected bacterial isolates and mutants, we investigated the role of key innate immune pathways required for induction of innate and subsequent adaptive immune responses.  Co-culture of murine macrophages with L. gasseri (strain NCK1785), L. acidophilus (strain NCFM), or NCFM-derived mutants-NCK2025 and NCK2031-elicited an M2b-like phenotype assocd. with TH2 skewing and immune regulatory function.  For NCFM, this M2b phenotype was dependent on expression of lipoteichoic acid and S layer proteins.  Through the use of macrophage genetic knockouts, we identified Toll-like receptor 2 (TLR2), the cytosolic nucleotide-binding oligomerization domain contg. 2 (NOD2) receptor, and the inflammasome-assocd. caspase-1 as contributors to macrophage activation, with NOD2 cooperating with caspase-1 to induce inflammasome derived interleukin (IL)-1β in a pyroptosis-independent fashion.  Finally, utilizing an NCFM-based mucosal vaccine platform with surface expression of human immunodeficiency virus type 1 Gag or membrane proximal external region (MPER), we demonstrated that NOD2 signaling is required for antigen-specific mucosal and systemic humoral responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopw3fGdvbxjbVg90H21EOLACvtfcHk0liDQGwIZ3zT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSgsLvO&md5=949778cf216d503f24b51482f3bd7fae</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0196950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0196950%26sid%3Dliteratum%253Aachs%26aulast%3DBumgardner%26aufirst%3DS.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLaVoy%26aufirst%3DA.%2BS.%26aulast%3DAndre%26aufirst%3DB.%26aulast%3DFrank%26aufirst%3DC.%2BB.%26aulast%3DKajikawa%26aufirst%3DA.%26aulast%3DKlaenhammer%26aufirst%3DT.%2BR.%26aulast%3DDean%26aufirst%3DG.%2BA.%26atitle%3DNod2%2520Is%2520Required%2520for%2520Antigen-Specific%2520Humoral%2520Responses%2520against%2520Antigens%2520Orally%2520Delivered%2520Using%2520a%2520Recombinant%2520Lactobacillus%2520Vaccine%2520Platform%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26spage%3De0196950%26doi%3D10.1371%2Fjournal.pone.0196950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciorbaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Minimal Structural Requirements for Adjuvant Activity of Bacterial Peptidoglycan Derivatives</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(74)90458-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0006-291X%2874%2990458-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=4606813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE2MXivFKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1974&pages=1317-1325&author=F.+Ellouzauthor=A.+Adamauthor=R.+Ciorbaruauthor=E.+Lederer&title=Minimal+Structural+Requirements+for+Adjuvant+Activity+of+Bacterial+Peptidoglycan+Derivatives&doi=10.1016%2F0006-291X%2874%2990458-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives</span></div><div class="casAuthors">Ellouz, Farielle; Adam, Arlette; Ciorbaru, Rita; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1317-25</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The monomeric subunit of mesodiaminopimelic acid contg. bacterial peptidoglycans, i.e. the disaccharide tetrapeptide N-acetyl glucosaminyl-N-acetyl muramyl-L-alanyl-D-isoglutaminyl-meso-diamino-pimelyl-D-alanine could replace whole killed mycobacteria in Freund's adjuvant.  Further structural simplifications of the disaccharide-tetrapeptide were possible without loss of adjuvant activity.  Natural N-acetyl-muramyl-tripeptides were active.  The smallest adjuvant mol. was a synthetic N-acetyl muramyl-dipeptide prepd. by Sinay, et al.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox10QSAEGsQrVg90H21EOLACvtfcHk0lh1h7e7TJiCSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXivFKjtw%253D%253D&md5=d9b9a0ec8b4783c564aabdc2be222a15</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2874%2990458-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252874%252990458-6%26sid%3Dliteratum%253Aachs%26aulast%3DEllouz%26aufirst%3DF.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DCiorbaru%26aufirst%3DR.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMinimal%2520Structural%2520Requirements%2520for%2520Adjuvant%2520Activity%2520of%2520Bacterial%2520Peptidoglycan%2520Derivatives%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1974%26volume%3D59%26spage%3D1317%26epage%3D1325%26doi%3D10.1016%2F0006-291X%2874%2990458-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, S. M.</span></span> <span> </span><span class="NLM_article-title">The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1093/infdis/138.6.760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1093%2Finfdis%2F138.6.760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=368262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE1MXhtlKisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1978&pages=760-767&author=C.+A.+Dinarelloauthor=R.+J.+Elinauthor=L.+Chedidauthor=S.+M.+Wolff&title=The+Pyrogenicity+of+the+Synthetic+Adjuvant+Muramyl+Dipeptide+and+Two+Structural+Analogues&doi=10.1093%2Finfdis%2F138.6.760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogs</span></div><div class="casAuthors">Dinarello, Charles A.; Elin, Ronald J.; Chedid, Louis; Wolff, Sheldon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">760-7</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">Muramyl dipeptide (N-acetylmuramyl-L-alanine-D-isoglutamine, MDP) induced biphasic fevers in rabbits, but 2 structural analogs, N-acetylmuramyl-L-alanine-D-glutamic acid (MDPA) and the dimethylester of MDPA, were 10-fold less pyrogenic.  MDP and its analogs released leukocytic pyrogen (LP) from rabbit phagocytic cells in vitro.  In addn., MDP released LP from human phagocytes.  Human phagocytes, however, required a 10-fold greater concn. of MDP than did rabbit cells.  The structural analogs were similarly less effective than the parent mol. in releasing LP from human cells.  All prepns. of MDP were neg. in the limulus amebocyte lysate test and failed to show pyrogenic cross-tolerance with bacterial endotoxin.  Thus MDP, which is a pyrogenic mol., is also able to release LP from rabbit phagocytes and to a lesser degree from human phagocytes, but does not cause gelation of limulus amebocyte lysate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojcA2TceMfpbVg90H21EOLACvtfcHk0lh1h7e7TJiCSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhtlKisrs%253D&md5=66cd96e1e634325797795757184c4c67</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F138.6.760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F138.6.760%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DElin%26aufirst%3DR.%2BJ.%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DWolff%26aufirst%3DS.%2BM.%26atitle%3DThe%2520Pyrogenicity%2520of%2520the%2520Synthetic%2520Adjuvant%2520Muramyl%2520Dipeptide%2520and%2520Two%2520Structural%2520Analogues%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1978%26volume%3D138%26spage%3D760%26epage%3D767%26doi%3D10.1093%2Finfdis%2F138.6.760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riveau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span> <span> </span><span class="NLM_article-title">Central Pyrogenic Activity of Muramyl Dipeptide</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1084/jem.152.4.869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1084%2Fjem.152.4.869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=7420023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL3cXmtF2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1980&pages=869-877&author=G.+Riveauauthor=K.+Masekauthor=M.+Parantauthor=L.+Chedid&title=Central+Pyrogenic+Activity+of+Muramyl+Dipeptide&doi=10.1084%2Fjem.152.4.869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Central pyrogenic activity of muramyl dipeptide</span></div><div class="casAuthors">Riveau, Gilles; Masek, Karel; Parant, Monique; Chedid, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">869-77</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">Fever can be elicited in the rabbit by the i.v. administration of relatively large doses of a synthetic immunoadjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine, or muramyl dipeptide (MDP).  This response could be mediated by endogenous pyrogen because MDP has been shown to induce their prodn. both in vivo and in vitro.  In rabbits, intracisternal injection of small amts. of MDP could elevate fever without activating the release of endogenous pyrogen in the plasma or in the cerebrospinal fluid.  Moreover, indomethacin inhibited hyperthermia produced by intracerebroventricular administration of MDP.  Therefore, a direct effect of the glycopeptide on the thermoregulatory centers is suggested besides its indirect effect through the prodn. of leukocytic pyrogen.  This mol. apparently represents the minimal requirement for the pyrogenicity of bacterial peptidoglycan because administration, even by the intracerebral route, of a mixt. of muramic acid and of its dipeptide moiety did not elicit fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSo26lu7L0rVg90H21EOLACvtfcHk0lh1h7e7TJiCSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmtF2ht70%253D&md5=8002fe8aabe5c1684365e75a6e28a7fc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1084%2Fjem.152.4.869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.152.4.869%26sid%3Dliteratum%253Aachs%26aulast%3DRiveau%26aufirst%3DG.%26aulast%3DMasek%26aufirst%3DK.%26aulast%3DParant%26aufirst%3DM.%26aulast%3DChedid%26aufirst%3DL.%26atitle%3DCentral%2520Pyrogenic%2520Activity%2520of%2520Muramyl%2520Dipeptide%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1980%26volume%3D152%26spage%3D869%26epage%3D877%26doi%3D10.1084%2Fjem.152.4.869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Fate of the Synthetic Immunoadjuvant, Muramyl Dipeptide (14C-Labelled) in the Mouse</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/0192-0561(79)90028-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0192-0561%2879%2990028-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=551094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE1MXktVeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1979&pages=35-41&author=M.+Parantauthor=F.+Parantauthor=L.+Chedidauthor=A.+Yapoauthor=J.+F.+Petitauthor=E.+Lederer&title=Fate+of+the+Synthetic+Immunoadjuvant%2C+Muramyl+Dipeptide+%2814C-Labelled%29+in+the+Mouse&doi=10.1016%2F0192-0561%2879%2990028-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fate of the synthetic immunoadjuvant, muramyl dipeptide (carbon-14-labeled) in the mouse</span></div><div class="casAuthors">Parant, M.; Parant, F.; Chedid, L.; Yapo, A.; Petit, J. F.; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-41</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">Following i.v. or s.c. injection into mice, more than 50% of muramyl dipeptide (MDP)-14C was recovered unchanged in the urine after 30 min; more than 90% was recovered after 2 h.  MDP was sequestered for a longer time at the site of injection when administered as a water-in-oil emulsion.  Considering the relatively rapid elimination obsd., it is suggested that the biol. effects of MDP and related compds., when administered in an aq. medium, may be due to their activity at minute concns. and (or) an immediate action at the cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9goIH9UIFUbVg90H21EOLACvtfcHk0ljIFiAPVnSsHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktVeku78%253D&md5=8e211dd6ebb2350ee60378e3a6f56d33</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2879%2990028-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252879%252990028-6%26sid%3Dliteratum%253Aachs%26aulast%3DParant%26aufirst%3DM.%26aulast%3DParant%26aufirst%3DF.%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DYapo%26aufirst%3DA.%26aulast%3DPetit%26aufirst%3DJ.%2BF.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DFate%2520of%2520the%2520Synthetic%2520Immunoadjuvant%252C%2520Muramyl%2520Dipeptide%2520%252814C-Labelled%2529%2520in%2520the%2520Mouse%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1979%26volume%3D1%26spage%3D35%26epage%3D41%26doi%3D10.1016%2F0192-0561%2879%2990028-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A.</span></span> <span> </span><span class="NLM_article-title">Degradation of Muramyl Dipeptide by Mammalian Serum</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1128/IAI.50.1.320-321.1985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FIAI.50.1.320-321.1985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3876287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL2MXlslKrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=320-321&author=J.+Harrisonauthor=A.+Fox&title=Degradation+of+Muramyl+Dipeptide+by+Mammalian+Serum&doi=10.1128%2FIAI.50.1.320-321.1985"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of muramyl dipeptide by mammalian serum</span></div><div class="casAuthors">Harrison, J.; Fox, A.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">320-1</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Muramyl dipeptide, N-acetylmuramyl-L-alanine-D-isoglutamine (MDP), which elicits an acute inflammation in vivo is degraded by normal rat serum into its constituents, N-acetylmuramic acid and L-alanine-D-isoglutamine.  The dipeptide is further degraded into its components L-alanine and D-isoglutamine.  These results may help to explain how inflammation elicited by MDP is terminated in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnN4jhCqu0rVg90H21EOLACvtfcHk0ljIFiAPVnSsHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlslKrur0%253D&md5=c3a40b9fdbddda69c90cdcede218440e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FIAI.50.1.320-321.1985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.50.1.320-321.1985%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DA.%26atitle%3DDegradation%2520of%2520Muramyl%2520Dipeptide%2520by%2520Mammalian%2520Serum%26jtitle%3DInfect.%2520Immun.%26date%3D1985%26volume%3D50%26spage%3D320%26epage%3D321%26doi%3D10.1128%2FIAI.50.1.320-321.1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K. S.</span></span> <span> </span><span class="NLM_article-title">Muramyl Dipeptide and Its Derivatives: Peptide Adjuvant in Immuno- Logical Disorders and Cancer Therapy</span>. <i>Curr. Bioact. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.2174/157340711796817913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2174%2F157340711796817913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22180736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ansLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=180-197&author=C.+Ogawaauthor=Y.+J.+Liuauthor=K.+S.+Kobayashi&title=Muramyl+Dipeptide+and+Its+Derivatives%3A+Peptide+Adjuvant+in+Immuno-+Logical+Disorders+and+Cancer+Therapy&doi=10.2174%2F157340711796817913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy</span></div><div class="casAuthors">Ogawa, Chikako; Liu, Yuen-Joyce; Kobayashi, Koichi S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Bioactive Compounds</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">180-197</span>CODEN:
                <span class="NLM_cas:coden">CBCUBY</span>;
        ISSN:<span class="NLM_cas:issn">1573-4072</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln.  It was first identified in bacterial cell wall peptidoglycan as an active component in Freund's complete adjuvant.  In the cell, MDP is detected by NOD2, a cytoplasmic receptor belonging to the human innate immune system.  NOD2 mutations are frequently obsd. in patients with Crohn's disease, an autoimmune disorder, suggesting the significance of the MDP-NOD2 pathway in activating immunity.  For this reason, structural modifications of MDP and its derivs. have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clin. use in the treatment of cancer and other diseases.  This review summarizes the synthetic chem. of MDP and its derivs. and discusses their pharmacol. action and stereoselective synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1jEHwObGRy7Vg90H21EOLACvtfcHk0ljIFiAPVnSsHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ansLrK&md5=c906fb7dd2d2d9353c3f4be202672d49</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F157340711796817913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340711796817913%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26aulast%3DKobayashi%26aufirst%3DK.%2BS.%26atitle%3DMuramyl%2520Dipeptide%2520and%2520Its%2520Derivatives%253A%2520Peptide%2520Adjuvant%2520in%2520Immuno-%2520Logical%2520Disorders%2520and%2520Cancer%2520Therapy%26jtitle%3DCurr.%2520Bioact.%2520Compd.%26date%3D2011%26volume%3D7%26spage%3D180%26epage%3D197%26doi%3D10.2174%2F157340711796817913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzonkowski, P.</span></span> <span> </span><span class="NLM_article-title">Recent Developments in the Synthesis and Biological Activity of Muramylpeptides</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2438</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.2174/092986711795843173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2174%2F092986711795843173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21568914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFOrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2438-2451&author=K.+Dzierzbickaauthor=A.+Wardowskaauthor=P.+Trzonkowski&title=Recent+Developments+in+the+Synthesis+and+Biological+Activity+of+Muramylpeptides&doi=10.2174%2F092986711795843173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the synthesis and biological activity of muramylpeptides</span></div><div class="casAuthors">Dzierzbicka, K.; Wardowska, A.; Trzonkowski, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2438-2451</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Derivs. of muramyl dipeptide (MDP) are considered as immunostimulants and adjuvants in the immunotherapy of cancer and infections.  The interest in these compds. is mainly related to a high variety of their structure and biol. properties.  Here, the authors describe the synthesis and biol. activity of several recently developed classes of MDP analogs.  The authors also report potential of these analogs in the treatment of cancer and infectious diseases in exptl. systems and cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquy7mDG-GTibVg90H21EOLACvtfcHk0ljnlM9UNfy7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFOrsbc%253D&md5=1a019b3429b4b4acca08c2dbf6d4e1c5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F092986711795843173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795843173%26sid%3Dliteratum%253Aachs%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DWardowska%26aufirst%3DA.%26aulast%3DTrzonkowski%26aufirst%3DP.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Synthesis%2520and%2520Biological%2520Activity%2520of%2520Muramylpeptides%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2438%26epage%3D2451%26doi%3D10.2174%2F092986711795843173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hespen, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, H. C.</span></span> <span> </span><span class="NLM_article-title">Translation of Peptidoglycan Metabolites into Immunotherapeutics</span>. <i>Clin. Transl. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1095</span> <span class="refDoi"> DOI: 10.1002/cti2.1095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fcti2.1095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=31798878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=M.+E.+Griffinauthor=C.+W.+Hespenauthor=Y.+C.+Wangauthor=H.+C.+Hang&title=Translation+of+Peptidoglycan+Metabolites+into+Immunotherapeutics&doi=10.1002%2Fcti2.1095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcti2.1095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcti2.1095%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DM.%2BE.%26aulast%3DHespen%26aufirst%3DC.%2BW.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DHang%26aufirst%3DH.%2BC.%26atitle%3DTranslation%2520of%2520Peptidoglycan%2520Metabolites%2520into%2520Immunotherapeutics%26jtitle%3DClin.%2520Transl.%2520Immunol.%26date%3D2019%26volume%3D8%26doi%3D10.1002%2Fcti2.1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, I.</span></span> <span> </span><span class="NLM_article-title">Review: Inducer of Cytokines in Vivo: Overview of Field and Romurtide Experience</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/0192-0561(92)90180-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0192-0561%2892%2990180-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1618600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK38XktVSis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1992&pages=487-496&author=I.+Azuma&title=Review%3A+Inducer+of+Cytokines+in+Vivo%3A+Overview+of+Field+and+Romurtide+Experience&doi=10.1016%2F0192-0561%2892%2990180-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inducer of cytokines in vivo:  overview of field and romurtide experience</span></div><div class="casAuthors">Azuma, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">487-96</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">A review with 48 refs.  Cell-wall skeletons of bacteria such as mycobacteria, nocardia, corynebacteria, propionibacteria and listeria, have potent adjuvant activity on immune responses.  It was reported that N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) was the min. structural requirement of adjuvant activity of the bacterial cell-wall skeleton and a variety of MDP derivs. and related compds. were synthesized.  Among the synthetic MDP derivs., MDP-Lys(L18)(romurtide) was selected as the immunostimulant, by using exptl. models for non-specific host resistance against Escherichia coli in mice.  Romurtide was shown to have host-stimulating activity against bacterial, fungal and viral infections, cytokine-producing activity and the capacity to increase the no. of leukocytes and platelets in exptl. models.  It was also shown that the clin. effectiveness of romurtide depends on the restoration of the no. of leukocytes and platelets of cancer patients treated with chemotherapy or radiation therapy.  The mechanism of action of romurtide is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qHvvJRbOH7Vg90H21EOLACvtfcHk0ljnlM9UNfy7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVSis7c%253D&md5=2b0b20fef4134d4e3ef445364cdc85af</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2892%2990180-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252892%252990180-S%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DI.%26atitle%3DReview%253A%2520Inducer%2520of%2520Cytokines%2520in%2520Vivo%253A%2520Overview%2520of%2520Field%2520and%2520Romurtide%2520Experience%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1992%26volume%3D14%26spage%3D487%26epage%3D496%26doi%3D10.1016%2F0192-0561%2892%2990180-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, P. A.</span></span> <span> </span><span class="NLM_article-title">Muramyl Tripeptide (Mifamurtide) for the Treatment of Osteosarcoma</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1586/era.09.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1586%2Fera.09.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19671023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvF2qurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1035-1049&author=P.+A.+Meyers&title=Muramyl+Tripeptide+%28Mifamurtide%29+for+the+Treatment+of+Osteosarcoma&doi=10.1586%2Fera.09.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma</span></div><div class="casAuthors">Meyers, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1035-1049</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Osteosarcoma is an ultraorphan disease.  There are approx. 1000 new patients diagnosed with osteosarcoma each year in the USA and Europe.  Current treatment for osteosarcoma utilizes multiagent chemotherapy and surgical resection of all clin. detectable disease.  Current treatments for osteosarcoma achieve 60-70% event-free survival (EFS) for patients with localized disease and approx. 20% EFS for patients who present with metastasis.  These results have been stable for two decades.  The addn. of muramyl tripeptide (mifamurtide) to chemotherapy resulted in a trend towards improved EFS and a one-third redn. in the risk of death from osteosarcoma.  Mifamurtide has been approved in Europe for the treatment of newly diagnosed osteosarcoma in combination with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGratgeyBKw14bVg90H21EOLACvtfcHk0ljnlM9UNfy7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvF2qurg%253D&md5=69289d5929805bd03fe48a0f0726b408</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1586%2Fera.09.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.09.69%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DP.%2BA.%26atitle%3DMuramyl%2520Tripeptide%2520%2528Mifamurtide%2529%2520for%2520the%2520Treatment%2520of%2520Osteosarcoma%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D1035%26epage%3D1049%26doi%3D10.1586%2Fera.09.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riveau, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F. J.</span></span> <span> </span><span class="NLM_article-title">Biological Activity of a New Synthetic Muramyl Peptide Adjuvant Devoid of Pyrogenicity</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1128/IAI.35.2.417-424.1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FIAI.35.2.417-424.1982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=7035362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL38Xht1Smt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1982&pages=417-424&author=L.+A.+Chedidauthor=M.+A.+Parantauthor=F.+M.+Audibertauthor=G.+J.+Riveauauthor=E.+Ledererauthor=J.+P.+Choayauthor=P.+L.+Lefrancierauthor=F.+J.+Parant&title=Biological+Activity+of+a+New+Synthetic+Muramyl+Peptide+Adjuvant+Devoid+of+Pyrogenicity&doi=10.1128%2FIAI.35.2.417-424.1982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity</span></div><div class="casAuthors">Chedid, Louis A.; Parant, Monique A.; Audibert, Francoise M.; Riveau, Gilles J.; Parant, Francine J.; Lederer, Edgar; Choay, Jean P.; Lefrancier, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-24</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The immunostimulant activities of muramyl dipeptide (enhancement of specific immune responses and of nonspecific resistance to infection) were retained by its N-acetylmuramyl-L-alanyl-D-glutaminyl-n-Bu ester deriv., although very large amts. administered i.v., or intracerebroventricularly did not elicit fever in the rabbit.  This analog also appeared to be devoid of other secondary effects which have been obsd. after administration of muramyl dipeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuqHm58o6PtrVg90H21EOLACvtfcHk0lj1X2ipw1uQAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xht1Smt7g%253D&md5=9a7e6ee981d0376e9ca6ad3007bf3c38</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FIAI.35.2.417-424.1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.35.2.417-424.1982%26sid%3Dliteratum%253Aachs%26aulast%3DChedid%26aufirst%3DL.%2BA.%26aulast%3DParant%26aufirst%3DM.%2BA.%26aulast%3DAudibert%26aufirst%3DF.%2BM.%26aulast%3DRiveau%26aufirst%3DG.%2BJ.%26aulast%3DLederer%26aufirst%3DE.%26aulast%3DChoay%26aufirst%3DJ.%2BP.%26aulast%3DLefrancier%26aufirst%3DP.%2BL.%26aulast%3DParant%26aufirst%3DF.%2BJ.%26atitle%3DBiological%2520Activity%2520of%2520a%2520New%2520Synthetic%2520Muramyl%2520Peptide%2520Adjuvant%2520Devoid%2520of%2520Pyrogenicity%26jtitle%3DInfect.%2520Immun.%26date%3D1982%26volume%3D35%26spage%3D417%26epage%3D424%26doi%3D10.1128%2FIAI.35.2.417-424.1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Z.</span></span> <span> </span><span class="NLM_article-title">Murabutide Revisited: A Review of Its Pleiotropic Biological Effects</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.2174/0929867311320160002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.2174%2F0929867311320160002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23531213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=2068-2079&author=Z.+Jakopin&title=Murabutide+Revisited%3A+A+Review+of+Its+Pleiotropic+Biological+Effects&doi=10.2174%2F0929867311320160002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Murabutide revisited: a review of its pleiotropic biological effects</span></div><div class="casAuthors">Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2068-2079</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the great efforts put into their development, the list of clin. approved immunol. adjuvants is still very short.  Evolution of the knowledge of the immune system has enabled for rational design of novel adjuvants and has led to the conclusion that more than one type of adjuvant will be required.  Derivs. of muramyl dipeptide (MDP), the minimal immunomodulatory structure of bacterial cell wall peptidoglycan, have gained considerable attention in the past decades, because of their potent adjuvant effects.  Murabutide is a safe deriv. of MDP, which interacts with cells of the immune system, both innate and adaptive, and exerts its effect through activation of Nod2.  The transcriptional response of murabutide-stimulated macrophages revealed enhanced expression of genes coding for various proteins such as immune mediators and their receptors, transcription factors and kinases, ion channels/transporters and proteins involved in cell metabolic activity, thus reflecting a broad spectrum of biol. effects.  In addn. to its well recognized adjuvant effect, murabutide has also been shown to enhance the host's resistance against microbial infections, nonspecific resistance against tumors and the induction of cytokines and chemokines implicated in enhancing the immune response and hematopoesis.  This article provides an insight into the mechanism of action of murabutide and its interactions with the cells of the immune system in vitro and in vivo.  On account of its numerous biol. effects, murabutide has been the subject of several clin. studies.  Many of these have confirmed its potential to synergize with cytokines of therapeutic interest in potentiating the tumoricidal activity of macrophages or targeting chronic viral diseases, as well as reducing the cytokine dosage needed to achieve a therapeutic effect.  This review covers the findings of all relevant studies and focuses on the role of murabutide and its potential in the treatment of several microbial diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRI0UmLi-DrVg90H21EOLACvtfcHk0lj1X2ipw1uQAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D&md5=519fd1fb58ae28d9da85019cfc765e61</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F0929867311320160002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320160002%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3DZ.%26atitle%3DMurabutide%2520Revisited%253A%2520A%2520Review%2520of%2520Its%2520Pleiotropic%2520Biological%2520Effects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D2068%26epage%3D2079%26doi%3D10.2174%2F0929867311320160002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pečar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štalc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraber-Herzog, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povšič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhadolc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hočevar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hönig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogi-Kohlenprath, R.</span></span> <span> </span><span class="NLM_article-title">N-{trans-2-[[2′-(Acetylamino)Cyclohexyl]Oxy]Acetyl}-L-Alanyl-D-Glutamic Acid: A Novel Immunologically Active Carbocyclic Muramyl Dipeptide Analogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1021/jm970509d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970509d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Kgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=530-539&author=D.+Kikeljauthor=S.+Pe%C4%8Darauthor=V.+Kotnikauthor=A.+%C5%A0talcauthor=B.+Wraber-Herzogauthor=S.+Sim%C4%8Di%C4%8Dauthor=A.+Ihanauthor=L.+Klamferauthor=L.+Pov%C5%A1i%C4%8Dauthor=R.+Grahekauthor=E.+Suhadolcauthor=M.+Ho%C4%8Devarauthor=H.+H%C3%B6nigauthor=R.+Rogi-Kohlenprath&title=N-%7Btrans-2-%5B%5B2%E2%80%B2-%28Acetylamino%29Cyclohexyl%5DOxy%5DAcetyl%7D-L-Alanyl-D-Glutamic+Acid%3A+A+Novel+Immunologically+Active+Carbocyclic+Muramyl+Dipeptide+Analogue&doi=10.1021%2Fjm970509d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-{trans-2-[[2'-(Acetylamino)cyclohexyl]oxy]acetyl}-L-alanyl-D-glutamic Acid: A Novel Immunologically Active Carbocyclic Muramyl Dipeptide Analog</span></div><div class="casAuthors">Kikelj, Danijel; Pecar, Slavko; Kotnik, Vladimir; Stalc, Anton; Wraber-Herzog, Branka; Simci, Sasa; Ihan, Alojz; Klamfer, Lidija; Povsic, Lucka; Grahek, Rok; Suhadolc, Elizabeta; Hocevar, Mirjam; Hoenig, Helmut; Rogi-Kohlenprath, Renate</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">530-539</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel non-pyrogenic carbocyclic muramyl dipeptide (MDP) analog I was obtained by replacement of the N-acetylmuramic acid part and the D-isoglutamine residue of the MDP mol. by a trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl moiety and D-glutamic acid, resp.  The title compd. was selected as a promising candidate for further evaluation among several related analogs on the basis of am immunorestoration test in mice.  This novel nor-MDP analog protects mice against the immunosuppressive effect of cyclophosphamide and increases the nonspecific resistance of mice against the fungal infection.  It is an immunomodulator which enhances the maturation of lymphocytes B to plasma cells and increases the activity of lymphocytes B and lymphocytes T as well as that of macrophages but does not alter the no. of these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz-kMFxRmzXbVg90H21EOLACvtfcHk0lilFpp_UJzWRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Kgtw%253D%253D&md5=16636862090e41b383e9b0cef9e5a1b3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm970509d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970509d%26sid%3Dliteratum%253Aachs%26aulast%3DKikelj%26aufirst%3DD.%26aulast%3DPe%25C4%258Dar%26aufirst%3DS.%26aulast%3DKotnik%26aufirst%3DV.%26aulast%3D%25C5%25A0talc%26aufirst%3DA.%26aulast%3DWraber-Herzog%26aufirst%3DB.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DIhan%26aufirst%3DA.%26aulast%3DKlamfer%26aufirst%3DL.%26aulast%3DPov%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DGrahek%26aufirst%3DR.%26aulast%3DSuhadolc%26aufirst%3DE.%26aulast%3DHo%25C4%258Devar%26aufirst%3DM.%26aulast%3DH%25C3%25B6nig%26aufirst%3DH.%26aulast%3DRogi-Kohlenprath%26aufirst%3DR.%26atitle%3DN-%257Btrans-2-%255B%255B2%25E2%2580%25B2-%2528Acetylamino%2529Cyclohexyl%255DOxy%255DAcetyl%257D-L-Alanyl-D-Glutamic%2520Acid%253A%2520A%2520Novel%2520Immunologically%2520Active%2520Carbocyclic%2520Muramyl%2520Dipeptide%2520Analogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D530%26epage%3D539%26doi%3D10.1021%2Fjm970509d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribić, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranesǐc, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomic, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Immunostimulating Properties of Novel Adamant-1-Yl Tripeptides</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201100232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fcbdv.201100232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22492495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFSgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=777-788&author=R.+Ribi%C4%87author=L.+Habjanecauthor=B.+Vranes%C7%90cauthor=R.+Frkanecauthor=S.+Tomic&title=Synthesis+and+Immunostimulating+Properties+of+Novel+Adamant-1-Yl+Tripeptides&doi=10.1002%2Fcbdv.201100232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and immunostimulating properties of novel adamant-1-yl tripeptides</span></div><div class="casAuthors">Ribic, Rosana; Habjanec, Lidija; Vranesic, Branka; Frkanec, Ruza; Tomic, Srdanka</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">777-788</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">The aim of this work was to prep. L- and D-(adamant-1-yl)-Gly-L-Ala-D-isoGln peptides in order to study their adjuvant (immunostimulating) activities.  Adjuvant activity of adamant-1-yl tripeptides was tested in the mouse model using ovalbumin as an antigen and in comparison to the peptidoglycan monomer (PGM; β-D-GlcNAc-(1→4)-D-MurNAc-L-Ala-D-isoGln-mesoDAP(εNH2)-D-Ala-D-Ala) and structurally related adamant-2-yl tripeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-C76l1s5A47Vg90H21EOLACvtfcHk0lilFpp_UJzWRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFSgs7g%253D&md5=585e59ff5388599f56e97c33ffa09e80</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201100232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201100232%26sid%3Dliteratum%253Aachs%26aulast%3DRibi%25C4%2587%26aufirst%3DR.%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DVranes%25C7%2590c%26aufirst%3DB.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTomic%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Immunostimulating%2520Properties%2520of%2520Novel%2520Adamant-1-Yl%2520Tripeptides%26jtitle%3DChem.%2520Biodiversity%26date%3D2012%26volume%3D9%26spage%3D777%26epage%3D788%26doi%3D10.1002%2Fcbdv.201100232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masihi, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwenke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gast, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huchshorn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palache, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, K.</span></span> <span> </span><span class="NLM_article-title">Effect of Immunomodulator Adamantylamide Dipeptide on Antibody Response to Influenza Subunit Vaccines and Protection against Aerosol Influenza Infection</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/0264-410X(90)90140-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0264-410X%2890%2990140-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=2336875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3cXkvVCltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=159-163&author=K.+N.+Masihiauthor=W.+Langeauthor=S.+Schwenkeauthor=G.+Gastauthor=P.+Huchshornauthor=A.+Palacheauthor=K.+Ma%C5%A1ek&title=Effect+of+Immunomodulator+Adamantylamide+Dipeptide+on+Antibody+Response+to+Influenza+Subunit+Vaccines+and+Protection+against+Aerosol+Influenza+Infection&doi=10.1016%2F0264-410X%2890%2990140-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection</span></div><div class="casAuthors">Masihi, K. N.; Lange, W.; Schwenke, S.; Gast, G.; Huchshorn, P.; Palache, A.; Masek, K.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-63</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    </div><div class="casAbstract">Adamantylamide dipeptide (AdDP) is a novel synthetic compd. combining the antiviral properties of amantadine and the essential adjuvant activity of immunomodulator muramyl dipeptide.  Mice were immunized with influenza A/Taiwan/1/86 (H1N1), A/Sichuan/2/87 (H3N2) and influenza B/Beijing/1/87 subunit vaccines contg. AdDP or aluminum hydroxide (Al(OH)3).  Induction of homologous hemagglutination-inhibition (HI) antibodies and correlation to protection against lethal aerosol influenza A/PR/8/34 (H1N1) infection were investigated.  Subunit vaccine contg. A/Sichuan (H3N2) and Al(OH)3 stimulated high HI antibody titers but failed to provide protection against heterologous influenza A (H1N1) challenge infection following either the primary or the secondary immunization.  In contrast, similar treatment with A/Sichuan subunit vaccine contg. AdDP conferred significant protection against heterologous challenge despite low levels of circulating antibody.  Primary immunization with even influenza B/Beijing subunit vaccine contg. AdDP, but not Al(OH), provided partial protection against influenza A challenge.  These results suggest that appropriate immunomodulators like AdDP can convert restricted homotypic immunity induced by inactivated influenza subunit vaccines to advantageous cross-reacting type of heterologous response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWA94Pk_A7rrVg90H21EOLACvtfcHk0lilFpp_UJzWRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvVCltbo%253D&md5=94d489e4926f72d34c0b89a6a21a8a79</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0264-410X%2890%2990140-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0264-410X%252890%252990140-H%26sid%3Dliteratum%253Aachs%26aulast%3DMasihi%26aufirst%3DK.%2BN.%26aulast%3DLange%26aufirst%3DW.%26aulast%3DSchwenke%26aufirst%3DS.%26aulast%3DGast%26aufirst%3DG.%26aulast%3DHuchshorn%26aufirst%3DP.%26aulast%3DPalache%26aufirst%3DA.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DK.%26atitle%3DEffect%2520of%2520Immunomodulator%2520Adamantylamide%2520Dipeptide%2520on%2520Antibody%2520Response%2520to%2520Influenza%2520Subunit%2520Vaccines%2520and%2520Protection%2520against%2520Aerosol%2520Influenza%2520Infection%26jtitle%3DVaccine%26date%3D1990%26volume%3D8%26spage%3D159%26epage%3D163%26doi%3D10.1016%2F0264-410X%2890%2990140-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corral, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinstein, S.</span></span> <span> </span><span class="NLM_article-title">Adamantylamide Dipeptide as Effective Immunoadjuvant in Rabbits and Mice</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4603</span>– <span class="NLM_lpage">4609</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(01)00259-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0264-410X%2801%2900259-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11535307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFWrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=4603-4609&author=P.+D.+Beckerauthor=R.+S.+Corralauthor=C.+A.+Guzm%C3%A1nauthor=S.+Grinstein&title=Adamantylamide+Dipeptide+as+Effective+Immunoadjuvant+in+Rabbits+and+Mice&doi=10.1016%2FS0264-410X%2801%2900259-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice</span></div><div class="casAuthors">Becker, P. D.; Corral, R. S.; Guzman, C. A.; Grinstein, S.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4603-4609</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In the search for more potent and less toxic immunomodulators, adamantylamide dipeptide (AdDP) was synthesized by the covalent union of amantadine with the L-alanyl-D-isoglutamine residue of muramyldipeptide (MDP).  The present expts. demonstrate the ability of AdDP, co-administered with a protein immunogen, to raise or enhance a humoral response in immunized animals.  BALB/c mice were immunized either by the i.p. or oral route with ovalbumin (Ova) alone or combined with either AdDP or CpG oligonucleotide (ODN-CpG), a proved adjuvant.  A clear adjuvant dose-response relationship was obsd. on the increment of Ova-specific serum antibody titers when AdDP was used as adjuvant, irresp. of the administration route.  The IgG isotype anal. showed that AdDP promotes a consistent increment in IgG1 antibodies assocd. with a dominant Th2 response pattern.  When administered by the oral route, AdDP was at least as efficient as ODN-CpG as adjuvant.  Similar results were obtained in rabbits immunized by the oral route, suggesting that the adjuvanticity of AdDP is not restricted to the murine system.  In conclusion, AdDP was shown to be a powerful and non-toxic adjuvant at both systemic and mucosal levels, which makes it a promising tool for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr9D8vBjNJ_bVg90H21EOLACvtfcHk0ljLlxsoYeOszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFWrtrY%253D&md5=1c7e370a52a8a6617dbaae2992a96a4b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2801%2900259-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252801%252900259-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DP.%2BD.%26aulast%3DCorral%26aufirst%3DR.%2BS.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DC.%2BA.%26aulast%3DGrinstein%26aufirst%3DS.%26atitle%3DAdamantylamide%2520Dipeptide%2520as%2520Effective%2520Immunoadjuvant%2520in%2520Rabbits%2520and%2520Mice%26jtitle%3DVaccine%26date%3D2001%26volume%3D19%26spage%3D4603%26epage%3D4609%26doi%3D10.1016%2FS0264-410X%2801%2900259-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urleb, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Modulation of Tumour Necrosis Factor Production with Desmuramyldipeptide Analogues</span>. <i>Pfluegers Arch.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>440</i></span>,  <span class="NLM_fpage">R064</span>– <span class="NLM_lpage">R066</span>, <span class="refDoi"> DOI: 10.1007/s004240000008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1007%2Fs004240000008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=28008484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVyhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2000&pages=R064-R066&author=S.+Sim%C4%8Di%C4%8Dauthor=B.+Wraberauthor=M.+Sollnerauthor=U.+Urlebauthor=S.+Gobec&title=Modulation+of+Tumour+Necrosis+Factor+Production+with+Desmuramyldipeptide+Analogues&doi=10.1007%2Fs004240000008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of tumor necrosis factor production with desmuramyldipeptide analogs</span></div><div class="casAuthors">Simcic, Sasa; Wraber, Branka; Sollner, Marija; Urleb, Uros; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">5, Suppl.</span>),
    <span class="NLM_cas:pages">R64-R66</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Some synthetic analogs of the immunomodulatory agent muramyl dipeptide (MDP), i.e. phthalimido- (LK-511, LK-413, LK-512, LK-423, LK-508), adamantyl- (LK-415, LK-517), 7-oxoalkyl-(LK-409) desmuramylpeptides were assessed for the tumor necrosis factor (TNF) inducing activity and the ability to modulate TNF prodn. in in vitro phorbol 12-myristate 13-acetate (PMA) & ionomycin stimulated cultures of human peripheral blood mononuclear cells.  A kinetic study over a 40-h period indicated that desmuramyldipeptides were weak TNF inducers compared to romurtide, PMA & ionomycin or lipopolysaccharide.  By contrast, they showed the potential to up- or down-regulate the prodn. of TNF evoked by PMA & ionomycin, which was strongly dependent on the time of the stimulation.  After 4h of stimulation, the TNF secretion was augmented by LK-508, LK-409 and LK-511, after 18 h by LK-409 and LK-423, and after 40 h by LK-423, LK-511, LK-415 and LK-512.  However, LK-517 and LK-512 inhibited the secretion of TNF after the 18-h period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsTNqXhRzCX7Vg90H21EOLACvtfcHk0ljLlxsoYeOszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVyhsL8%253D&md5=9bc8d3346ce9276a5e7fd9b976ca3b22</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs004240000008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004240000008%26sid%3Dliteratum%253Aachs%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DWraber%26aufirst%3DB.%26aulast%3DSollner%26aufirst%3DM.%26aulast%3DUrleb%26aufirst%3DU.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DModulation%2520of%2520Tumour%2520Necrosis%2520Factor%2520Production%2520with%2520Desmuramyldipeptide%2520Analogues%26jtitle%3DPfluegers%2520Arch.%26date%3D2000%26volume%3D440%26spage%3DR064%26epage%3DR066%26doi%3D10.1007%2Fs004240000008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolenc, M. S.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Novel Desmuramyldipeptide Analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3762</span>– <span class="NLM_lpage">3777</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2011.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21669478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3762-3777&author=%C5%BD.+Jakopinauthor=E.+Corsiniauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+S.+Dolenc&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Novel+Desmuramyldipeptide+Analogs&doi=10.1016%2Fj.ejmech.2011.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel desmuramyldipeptide analogs</span></div><div class="casAuthors">Jakopin, Ziga; Corsini, Emanuela; Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3762-3777</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel desmuramyldipeptides have been designed and synthesized as part of the search for therapeutically useful muramyldipeptide (MDP) analogs.  Their immunomodulatory properties were initially assessed in vitro, evaluating their effect on lipopolysaccharide (LPS)-induced cytokine release in THP-1 cells.  Following the initial screening, selected compds. were further investigated for immunomodulatory properties using LPS and phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells.  The results confirmed the immunomodulatory properties of some of the synthesized desmuramyldipeptide analogs.  Taken together, the data confirmed the immunostimulatory effect of pyrido-fused [1,2]-benzisothiazole-contg. MDP deriv. I, while for indole-contg. MDP derivs. II and III, an immunosuppressive effect was obsd.  Further studies will be necessary to address their potential therapeutic use as immunomodulatory drugs, both as immunostimulants or antiinflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdf0ICGmE7rrVg90H21EOLACvtfcHk0ljLlxsoYeOszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI&md5=0e658d046b6551ad97d9e5887bb960c8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DCorsini%26aufirst%3DE.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DDolenc%26aufirst%3DM.%2BS.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Desmuramyldipeptide%2520Analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3762%26epage%3D3777%26doi%3D10.1016%2Fj.ejmech.2011.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">New Muramyl Dipeptide (MDP) Mimics without the Carbohydrate Moiety as Potential Adjuvant Candidates for a Therapeutic Hepatitis B Vaccine (HBV)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4292</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.bmcl.2011.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21683593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4292-4295&author=N.+Zhaoauthor=Y.+Maauthor=S.+Zhangauthor=X.+Fangauthor=Z.+Liangauthor=G.+Liu&title=New+Muramyl+Dipeptide+%28MDP%29+Mimics+without+the+Carbohydrate+Moiety+as+Potential+Adjuvant+Candidates+for+a+Therapeutic+Hepatitis+B+Vaccine+%28HBV%29&doi=10.1016%2Fj.bmcl.2011.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)</span></div><div class="casAuthors">Zhao, Nan; Ma, Yao; Zhang, Shengmei; Fang, Xin; Liang, Zhenglun; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4292-4295</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new muramyl dipeptide (MDP) mimics were designed and synthesized via a solid-phase synthetic route.  Their adjuvant activities were evaluated ex vivo for investigation of the synergism of the S28-39 peptide, which is an MHC class I binding epitope of recombinant hepatitis B surface antigen (HBsAg) for both humans and mice.  Several compds. without the carbohydrate moiety exerted better adjuvanticity than the MDP-C that has been reported by the authors previously.  A primary screening test revealed that compds. 6, 14 and 16 exhibited stronger adjuvanticity compared with other MDP mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0n6Vaul0AJ7Vg90H21EOLACvtfcHk0ljLlxsoYeOszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D&md5=110f9bdbbcd8c37da8dfc295e4128dfe</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DNew%2520Muramyl%2520Dipeptide%2520%2528MDP%2529%2520Mimics%2520without%2520the%2520Carbohydrate%2520Moiety%2520as%2520Potential%2520Adjuvant%2520Candidates%2520for%2520a%2520Therapeutic%2520Hepatitis%2520B%2520Vaccine%2520%2528HBV%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4292%26epage%3D4295%26doi%3D10.1016%2Fj.bmcl.2011.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Immunomodulatory Properties of Novel Nucleotide Oligomerization Domain 2 (Nod2) Agonistic Desmuramyldipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6478</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.1021/jm300503b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300503b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6478-6488&author=%C5%BD.+Jakopinauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Immunomodulatory+Properties+of+Novel+Nucleotide+Oligomerization+Domain+2+%28Nod2%29+Agonistic+Desmuramyldipeptides&doi=10.1021%2Fjm300503b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory Properties of Novel Nucleotide Oligomerization Domain 2 (Nod2) Agonistic Desmuramyldipeptides</span></div><div class="casAuthors">Jakopin, Ziga; Gobec, Martina; Mlinaric-Rascan, Irena; Sollner Dolenc, Marija</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6478-6488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a pressing need for the development of novel adjuvants for human use.  The minimal bioactive structure of bacterial peptidoglycan (PGN), muramyldipeptide (MDP), and its deriv. murabutide (MB) have long been known for their adjuvant activities.  For this reason, a series of novel desmuramyldipeptides have been designed and synthesized as part of our search for therapeutically useful MDP analogs.  Since nucleotide oligomerization domain 2 (Nod2) is a putative receptor for MDP, we used engineered HEK293 cells overexpressing Nod2 to screen and validate our compds. for their Nod2-agonist activity.  Their immunomodulatory properties were subsequently assessed in vitro by evaluating their effect on proinflammatory cytokine prodn. of phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells (PBMCs).  Herein, we present novel desmuramyldipeptides, the most active of them possessing immunoenhancing properties as a result of their potent Nod2-agonistic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwj-B62knTQ7Vg90H21EOLACvtfcHk0lht3JI5oOfFTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D&md5=7da25625df463ffa238394773501767e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm300503b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300503b%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DImmunomodulatory%2520Properties%2520of%2520Novel%2520Nucleotide%2520Oligomerization%2520Domain%25202%2520%2528Nod2%2529%2520Agonistic%2520Desmuramyldipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6478%26epage%3D6488%26doi%3D10.1021%2Fjm300503b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolenc, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Z.</span></span> <span> </span><span class="NLM_article-title">Structural Requirements of Acylated Gly-l-Ala-d-Glu Analogs for Activation of the Innate Immune Receptor NOD2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2016.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=27039337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=1-12&author=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+S.+Dolencauthor=Z.+Jakopin&title=Structural+Requirements+of+Acylated+Gly-l-Ala-d-Glu+Analogs+for+Activation+of+the+Innate+Immune+Receptor+NOD2&doi=10.1016%2Fj.ejmech.2016.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements of acylated Gly-L-Ala-D-Glu analogs for activation of the innate immune receptor NOD2</span></div><div class="casAuthors">Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The fragment of bacterial peptidoglycan muramyl dipeptide (MDP) has long been known for its adjuvant activity, however the underlying mechanism of this action has only recently been elucidated.  It is ascribed to its agonist action on the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2).  In spite of the pressing need for novel adjuvants for human use, this discovery is hampered, by not knowing the structural requirements underlying the immunostimulatory activity.  The authors have investigated how minor modifications of hit compd. acyl Gly-L-Ala-D-Glu deriv. I modulate the mol. recognition by NOD2.  A series of novel desmuramyldipeptides has been designed and synthesized leading to the identification of compd. 16, in which the sugar moiety is replaced by a 6-phenylindole moiety, that exhibits the strongest NOD2 activation to date sans the carbohydrate moiety.  The results have enabled a deeper understanding of the structural requirements of desmuramylpeptides for NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0x5MPpjFx7Vg90H21EOLACvtfcHk0lht3JI5oOfFTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D&md5=7a990ab9f29e7802bd24bcb051c60bd4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DDolenc%26aufirst%3DM.%2BS.%26aulast%3DJakopin%26aufirst%3DZ.%26atitle%3DStructural%2520Requirements%2520of%2520Acylated%2520Gly-l-Ala-d-Glu%2520Analogs%2520for%2520Activation%2520of%2520the%2520Innate%2520Immune%2520Receptor%2520NOD2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalamati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. H.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Immunological Evaluation of Novel Amphiphilic Desmuramyl Peptides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2017.09.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29028529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=26-36&author=F.+A.+Khanauthor=M.+Ulanovaauthor=B.+Baiauthor=D.+Yalamatiauthor=Z.+H.+Jiang&title=Design%2C+Synthesis+and+Immunological+Evaluation+of+Novel+Amphiphilic+Desmuramyl+Peptides&doi=10.1016%2Fj.ejmech.2017.09.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides</span></div><div class="casAuthors">Khan, Farooq-Ahmad; Ulanova, Marina; Bai, Bing; Yalamati, Damayanthi; Jiang, Zi-Hua</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) - an essential bacterial cell wall component - is recognized by our immune system as pathogen-assocd. mol. pattern (PAMP) which results in immune responses with adverse toxic effects.  In order to harness the beneficial properties from the pro-inflammatory characteristics of the bacterial cell wall motif, MDP was strategically re-designed while conserving the L-D configurations of the dipeptide moiety.  The muramic acid was replaced with a hydrophilic arene and lipophilic chain was introduced at peptide end to give the amphiphilic desmuramyl peptides (DMPs).  The novel DMPs were found to modulate the immune response by amplifying the LPS-induced surface glycoprotein (ICAM-1) expression in THP-1 cells without showing significant toxicity.  Furthermore, these compds. were able to trigger the secretion of higher levels of pro-inflammatory cytokine (TNF-α) than the well-studied NOD2 agonist, Murabutide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobuKf0Rtg3pbVg90H21EOLACvtfcHk0lht3JI5oOfFTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvP&md5=9f65538e0a5fe8c232102c253356e68a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.070%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DF.%2BA.%26aulast%3DUlanova%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DB.%26aulast%3DYalamati%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DZ.%2BH.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Immunological%2520Evaluation%2520of%2520Novel%2520Amphiphilic%2520Desmuramyl%2520Peptides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D26%26epage%3D36%26doi%3D10.1016%2Fj.ejmech.2017.09.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašič, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štimac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trontelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderluh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2707</span>– <span class="NLM_lpage">2724</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslWmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2707-2724&author=M.+Gobecauthor=T.+Toma%C5%A1i%C4%8Dauthor=A.+%C5%A0timacauthor=R.+Frkanecauthor=J.+Tronteljauthor=M.+Anderluhauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=%C5%BD.+Jakopin&title=Discovery+of+Nanomolar+Desmuramylpeptide+Agonists+of+the+Innate+Immune+Receptor+Nucleotide-Binding+Oligomerization+Domain-Containing+Protein+2+%28NOD2%29+Possessing+Immunostimulatory+Properties&doi=10.1021%2Facs.jmedchem.7b01052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of nanomolar desmuramylpeptide agonists of the innate immune receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) possessing immunostimulatory properties</span></div><div class="casAuthors">Gobec, Martina; Tomasic, Tihomir; Stimac, Adela; Frkanec, Ruza; Trontelj, Jurij; Anderluh, Marko; Mlinaric-Rascan, Irena; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2707-2724</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2).  There is a pressing need for novel adjuvants, and NOD2 agonists provide an untapped source of potential candidates.  Here, we report the design, synthesis, and characterization of a series of novel acyl tripeptides.  A pivotal structural element for mol. recognition by NOD2 has been identified, culminating in the discovery of compd. 9, the most potent desmuramylpeptide NOD2 agonist to date.  Compd. 9 augmented pro-inflammatory cytokine release from human peripheral blood mononuclear cells in synergy with lipopolysaccharide.  Furthermore, it was able to induce ovalbumin-specific IgG titers in a mouse model of adjuvancy.  These findings provide deeper insights into the structural requirements of desmuramylpeptides for NOD2-activation and highlight the potential use of NOD2 agonists as adjuvants for vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOxF_6cWHX7Vg90H21EOLACvtfcHk0lhz-2ozn8Norg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslWmsLY%253D&md5=6d449dadd56e82616ebfea6243d80f8e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01052%26sid%3Dliteratum%253Aachs%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DToma%25C5%25A1i%25C4%258D%26aufirst%3DT.%26aulast%3D%25C5%25A0timac%26aufirst%3DA.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTrontelj%26aufirst%3DJ.%26aulast%3DAnderluh%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DDiscovery%2520of%2520Nanomolar%2520Desmuramylpeptide%2520Agonists%2520of%2520the%2520Innate%2520Immune%2520Receptor%2520Nucleotide-Binding%2520Oligomerization%2520Domain-Containing%2520Protein%25202%2520%2528NOD2%2529%2520Possessing%2520Immunostimulatory%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2707%26epage%3D2724%26doi%3D10.1021%2Facs.jmedchem.7b01052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauro, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahnson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-Rich Repeat Domain of Nod2</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=264-270&author=M.+L.+Lauroauthor=E.+A.+D%E2%80%99Ambrosioauthor=B.+J.+Bahnsonauthor=C.+L.+Grimes&title=Molecular+Recognition+of+Muramyl+Dipeptide+Occurs+in+the+Leucine-Rich+Repeat+Domain+of+Nod2&doi=10.1021%2Facsinfecdis.6b00154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2</span></div><div class="casAuthors">Lauro, Mackenzie L.; D'Ambrosio, Elizabeth A.; Bahnson, Brian J.; Grimes, Catherine Leimkuhler</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">264-270</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic mutations in the innate immune receptor nucleotide-binding oligomerization domain-contg. 2 (Nod2) have demonstrated increased susceptibility to Crohn's disease, an inflammatory bowel disease that is hypothesized to be accompanied by changes in the gut microbiota.  Nod2 responds to the presence of bacteria, specifically a fragment of the bacterial cell wall, muramyl dipeptide (MDP).  The proposed site of this interaction is the leucine-rich repeat (LRR) domain.  Surface plasmon resonance and mol. modeling were used to investigate the interaction of the LRR domain with MDP.  A functional and pure LRR domain was obtained from Escherichia coli expression in high yield.  The LRR domain binds to MDP with high affinity, with a KD of 212 ± 24 nM.  Crit. portions of the receptor were detd. by mutagenesis of putative binding residues.  Fragment anal. of MDP revealed that both the peptide and carbohydrate portion contribute to the binding interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUCvojsr_fLVg90H21EOLACvtfcHk0lhz-2ozn8Norg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN&md5=75ab3d912d40a9e0f1ab611d57cae68e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00154%26sid%3Dliteratum%253Aachs%26aulast%3DLauro%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DE.%2BA.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26atitle%3DMolecular%2520Recognition%2520of%2520Muramyl%2520Dipeptide%2520Occurs%2520in%2520the%2520Leucine-Rich%2520Repeat%2520Domain%2520of%2520Nod2%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D264%26epage%3D270%26doi%3D10.1021%2Facsinfecdis.6b00154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maekawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of NOD2 and Its Implications in Human Disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11813</span>, <span class="refDoi"> DOI: 10.1038/ncomms11813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fncomms11813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=27283905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11813&author=S.+Maekawaauthor=U.+Ohtoauthor=T.+Shibataauthor=K.+Miyakeauthor=T.+Shimizu&title=Crystal+Structure+of+NOD2+and+Its+Implications+in+Human+Disease&doi=10.1038%2Fncomms11813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of NOD2 and its implications in human disease</span></div><div class="casAuthors">Maekawa, Sakiko; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11813</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg. protein 2 (NOD2), a member of the NOD-like receptors family, are crucial for innate immune responses.  Mutations of NOD2 have been assocd. with chronic inflammatory disorders such as Crohn's disease (CD), Blau syndrome (BS) and early-onset sarcoidosis (EOS), but little is known about its signalling mechanism and the role it plays in these diseases.  Here, we report the crystal structure of rabbit NOD2 in an ADP-bound state.  The structure reveals an inactive closed conformation in which the subdomains in the NOD domain are closely packed by ADP-mediated and inter-domain interactions.  Mapping of the BS- or EOS-assocd. gain-of-function mutations reveals that most of these mutations are located in the NOD subdomain interfaces, and are likely to disrupt the inner domain interactions, facilitating a conformational change to the active form.  Conversely, mutations assocd. with CD are distributed throughout the protein, some of which may affect oligomer formation and ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJqTm2zQOG7Vg90H21EOLACvtfcHk0lhz-2ozn8Norg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D&md5=ff4a78caf8d9e744e473b6767c9d8154</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms11813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11813%26sid%3Dliteratum%253Aachs%26aulast%3DMaekawa%26aufirst%3DS.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DCrystal%2520Structure%2520of%2520NOD2%2520and%2520Its%2520Implications%2520in%2520Human%2520Disease%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11813%26doi%3D10.1038%2Fncomms11813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The “Cyclopropyl Fragment” Is a Versatile Player That Frequently Appears in Preclinical/Clinical Drug Molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%80%9CCyclopropyl+Fragment%E2%80%9D+Is+a+Versatile+Player+That+Frequently+Appears+in+Preclinical%2FClinical+Drug+Molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0lijrb03lq0c4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%259CCyclopropyl%2520Fragment%25E2%2580%259D%2520Is%2520a%2520Versatile%2520Player%2520That%2520Frequently%2520Appears%2520in%2520Preclinical%252FClinical%2520Drug%2520Molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Modulation of the Immune Response by a Synthetic Adjuvant and Analogs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2472</span>– <span class="NLM_lpage">2475</span>, <span class="refDoi"> DOI: 10.1073/pnas.73.7.2472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.73.7.2472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1065901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE28XltVOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1976&pages=2472-2475&author=L.+Chedidauthor=F.+Audibertauthor=P.+Lefrancierauthor=J.+Choayauthor=E.+Lederer&title=Modulation+of+the+Immune+Response+by+a+Synthetic+Adjuvant+and+Analogs&doi=10.1073%2Fpnas.73.7.2472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the immune response by a synthetic adjuvant and analogs</span></div><div class="casAuthors">Chedid, L.; Audibert, F.; Lafrancier, P.; Choay, J.; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2472-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">N-Acetylmuramyl-L-alanyl-D-isoglutamine increases the humoral immune response of mice when given in aq. media instead of the usual water-in-oil emulsions.  Moreover, this compd. is adjuvant active even by the oral route.  In view of studying the relation between chem. structure and biol. activity, several synthetic analogs were tested.  The immune response could be modulated according to chem. modifications, and the synthetic analog with D- in place of L-alanine was shown to inhibit the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87LLelnt9aLVg90H21EOLACvtfcHk0lijrb03lq0c4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltVOgur4%253D&md5=fb68de365b38d84c8a3f06b1a29773b6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.73.7.2472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.73.7.2472%26sid%3Dliteratum%253Aachs%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DAudibert%26aufirst%3DF.%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DChoay%26aufirst%3DJ.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DModulation%2520of%2520the%2520Immune%2520Response%2520by%2520a%2520Synthetic%2520Adjuvant%2520and%2520Analogs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1976%26volume%3D73%26spage%3D2472%26epage%3D2475%26doi%3D10.1073%2Fpnas.73.7.2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byars, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, A. C.</span></span> <span> </span><span class="NLM_article-title">Adjuvant Formulation for Use in Vaccines to Elicit Both Cell-Mediated and Humoral Immunity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/0264-410X(87)90105-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2F0264-410X%2887%2990105-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3499713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL2sXmtVCqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1987&pages=223-228&author=N.+E.+Byarsauthor=A.+C.+Allison&title=Adjuvant+Formulation+for+Use+in+Vaccines+to+Elicit+Both+Cell-Mediated+and+Humoral+Immunity&doi=10.1016%2F0264-410X%2887%2990105-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity</span></div><div class="casAuthors">Byars, Noelene E.; Allison, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-8</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    </div><div class="casAbstract">Adjuvant formulations which elicit both humoral and cell-mediated immunity will be required for vaccines based on peptides, viral and bacterial subunits and genetically engineered antigens.  An adjuvant formulation which increases both cell-mediated and humoral immunity and is free of significant side effects encountered with other adjuvants or vehicles is described.  The components include the threonyl analog of muramyl dipeptide, Tween 80, Pluronic L121 and squalane.  This formulation was effective with several antigens, in several species, including rodents, cats and monkeys.  The formulation will be useful for both human and veterinary vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bIfnd8zh4bVg90H21EOLACvtfcHk0lijrb03lq0c4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtVCqu7s%253D&md5=1af249ccb54e3948b2de0daefca172e3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0264-410X%2887%2990105-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0264-410X%252887%252990105-8%26sid%3Dliteratum%253Aachs%26aulast%3DByars%26aufirst%3DN.%2BE.%26aulast%3DAllison%26aufirst%3DA.%2BC.%26atitle%3DAdjuvant%2520Formulation%2520for%2520Use%2520in%2520Vaccines%2520to%2520Elicit%2520Both%2520Cell-Mediated%2520and%2520Humoral%2520Immunity%26jtitle%3DVaccine%26date%3D1987%26volume%3D5%26spage%3D223%26epage%3D228%26doi%3D10.1016%2F0264-410X%2887%2990105-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Identification of a Synthetic Muramyl Peptide Derivative with Enhanced Nod2 Stimulatory Capacity</span>. <i>Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1177/1753425912471691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1177%2F1753425912471691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23339926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=493-503&author=S.+J.+Rubinoauthor=J.+G.+Magalhaesauthor=D.+Philpottauthor=G.+M.+Bahrauthor=D.+Blanotauthor=S.+E.+Girardin&title=Identification+of+a+Synthetic+Muramyl+Peptide+Derivative+with+Enhanced+Nod2+Stimulatory+Capacity&doi=10.1177%2F1753425912471691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity</span></div><div class="casAuthors">Rubino, Stephen J.; Magalhaes, Joao G.; Philpott, Dana; Bahr, George M.; Blanot, Didier; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">493-503, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Muramyl peptides (MPs) represent the building blocks of bacterial peptidoglycan, a crit. component of bacterial cell walls.  MPs are well characterized for their immunomodulatory properties, and numerous studies have delineated the role of MPs or synthetic MP analogs in host defense, adjuvanticity and inflammation.  More recently, Nod1 and Nod2 have been identified as the host sensors for specific MPs and in particular, Nod2 was shown to detect muramyl dipeptide (MDP), a MP found in both Gram-pos. and Gram-neg. bacterial cell walls.  Because mutations in Nod2 are assocd. with the etiol. of Crohn's disease, there is a need to identify synthetic MP analogs that could potentiate Nod2-dependent immunity.  Here, we analyzed the Nod2-activating property of 36 MP analogs that had been tested previously for their adjuvanticity and anti-infectious activity.  Using a luciferase-based screen, we demonstrate that addn. of a Me group to the second amino acid of MDP generates a MDP deriv. with enhanced Nod2-activating capacity.  We further validated these results in murine macrophages, human dendritic cells and in vivo.  These results offer a basis for the rational development of synthetic MPs that could be used in the treatment of inflammatory disorders that have been assocd. with Nod2 dysfunction, such as Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2n3YBmuCU7Vg90H21EOLACvtfcHk0ljBfCKMIh3fkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M&md5=5238da0a9a6bbf359078c44f9c84ae09</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1177%2F1753425912471691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912471691%26sid%3Dliteratum%253Aachs%26aulast%3DRubino%26aufirst%3DS.%2BJ.%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DPhilpott%26aufirst%3DD.%26aulast%3DBahr%26aufirst%3DG.%2BM.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DIdentification%2520of%2520a%2520Synthetic%2520Muramyl%2520Peptide%2520Derivative%2520with%2520Enhanced%2520Nod2%2520Stimulatory%2520Capacity%26jtitle%3DInnate%2520Immun.%26date%3D2013%26volume%3D19%26spage%3D493%26epage%3D503%26doi%3D10.1177%2F1753425912471691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waters, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrell, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. H.</span></span> <span> </span><span class="NLM_article-title">Uveitis Induction in the Rabbit by Muramyl Dipeptides</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1128/IAI.51.3.816-825.1986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FIAI.51.3.816-825.1986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3949381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL28XhvF2murk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1986&pages=816-825&author=R.+V.+Watersauthor=T.+G.+Terrellauthor=G.+H.+Jones&title=Uveitis+Induction+in+the+Rabbit+by+Muramyl+Dipeptides&doi=10.1128%2FIAI.51.3.816-825.1986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Uveitis induction in the rabbit by muramyl dipeptides</span></div><div class="casAuthors">Waters, Ruth V.; Terrell, Timothy G.; Jones, Gordon H.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">816-25</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Intraocular inflammation (uveitis) was produced in rabbits by i.v. or s.c. treatment with N-acetylmuramyl-L-alanyl-D-isoglutamine  [53678-77-6] and several of its synthetic analogs at doses of ≤0.2 mg/kg in saline.  A dose-dependent increase in permeability of the ocular blood-aq. barrier as measured by leakage of protein or fluoresceinated dextran from the serum into the eye was obsd. 2-14 h after glycopeptide treatment.  Peak response occurred at ∼3 h postdose.  The lowest dose found to produce maximal vascular leakage for the most active glycopeptide analogs was 1 mg/kg.  The adjuvant-inactive L-L-stereoisomer  [59331-38-3] of N-acetylmurmuramyl-L-alanyl-D-isoglutamine was inactive, even at doses as high as 10 mg/kg.  Analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine which were homologous in the lactyl side chain caused less uveitis.  Chronic biweekly i.v. treatment of rabbits for 1 mo with either N-acetyl-L-α-aminobutyryl-D-isoglutamine  [101910-88-7] or its lipophilic 6-O-stearoyl deriv.  [92627-93-5] at 1 mg/kg, but not with murabutide  [74817-61-1], resulted in leukocytic inflammatory lesions unique to the uveal tract of the eye.  The uveitis was potentially reversible and occurred with decreased severity as long as 2 mo after cessation of chronic treatment.  Pyrogenicity but not adjuvanticity correlated with ability of glycopeptides to induce vascular leakage.  Thus, several adjuvant-active muramyl dipeptide analogs with minimal ability to cause acute vascular leakage or chronic inflammation in the rabbit eye have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4_idkYeCqbVg90H21EOLACvtfcHk0ljBfCKMIh3fkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvF2murk%253D&md5=fa32cb76fe077c195a4279436f51307d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FIAI.51.3.816-825.1986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.51.3.816-825.1986%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DR.%2BV.%26aulast%3DTerrell%26aufirst%3DT.%2BG.%26aulast%3DJones%26aufirst%3DG.%2BH.%26atitle%3DUveitis%2520Induction%2520in%2520the%2520Rabbit%2520by%2520Muramyl%2520Dipeptides%26jtitle%3DInfect.%2520Immun.%26date%3D1986%26volume%3D51%26spage%3D816%26epage%3D825%26doi%3D10.1128%2FIAI.51.3.816-825.1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Enhancement of Nonspecific Immunity to Klebsiella Pneumoniae Infection by a Synthetic Immunoadjuvant (N-Acetylmuramyl-L-Alanyl-D-Isoglutamine) and Several Analogs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2089</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1073/pnas.74.5.2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.74.5.2089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=325566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE2sXksFWms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1977&pages=2089-2093&author=L.+Chedidauthor=M.+Parantauthor=F.+Parantauthor=P.+Lefrancherauthor=J.+Choayauthor=E.+Lederer&title=Enhancement+of+Nonspecific+Immunity+to+Klebsiella+Pneumoniae+Infection+by+a+Synthetic+Immunoadjuvant+%28N-Acetylmuramyl-L-Alanyl-D-Isoglutamine%29+and+Several+Analogs&doi=10.1073%2Fpnas.74.5.2089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs</span></div><div class="casAuthors">Chedid, L.; Parant, M.; Parant, F.; Lefrancier, P.; Choay, J.; Lederer, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2089-93</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">N-acetylmuramyl-L-alanyl-D-isoglutamine and 4 other synthetic adjuvants that are structural analogs of part of the mycobacterial peptidoglycan monomer are shown to enhance the nonspecific immunity of mice infected by K. pneumoniae.  These compds. are active by various routes, including oral administration; they are also effective when administered after challenge.  Of the 17 other analogs tested, none is able to increase significantly resistance to infection, although 7 of these mols. are adjuvant-active in saline.  Previously it was shown that in contrast to lipopolysaccharides, these synthetic adjuvants are devoid of immunogenicity, mitogenicity, and toxicity in normal or adrenalectomized mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2X-kzpASLF7Vg90H21EOLACvtfcHk0ljBfCKMIh3fkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXksFWms7c%253D&md5=cc35ec34c4e56f9fd0ab5d8c8a68bb64</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1073%2Fpnas.74.5.2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.74.5.2089%26sid%3Dliteratum%253Aachs%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DParant%26aufirst%3DM.%26aulast%3DParant%26aufirst%3DF.%26aulast%3DLefrancher%26aufirst%3DP.%26aulast%3DChoay%26aufirst%3DJ.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DEnhancement%2520of%2520Nonspecific%2520Immunity%2520to%2520Klebsiella%2520Pneumoniae%2520Infection%2520by%2520a%2520Synthetic%2520Immunoadjuvant%2520%2528N-Acetylmuramyl-L-Alanyl-D-Isoglutamine%2529%2520and%2520Several%2520Analogs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1977%26volume%3D74%26spage%3D2089%26epage%3D2093%26doi%3D10.1073%2Fpnas.74.5.2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roychowdhury, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Proinflammatory Properties of Muramyl Tripeptides Containing Lysine and Diaminopimelic Acid Moieties</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2088</span>– <span class="NLM_lpage">2097</span>, <span class="refDoi"> DOI: 10.1002/cbic.200500181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fcbic.200500181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=16222728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ehtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=2088-2097&author=A.+Roychowdhuryauthor=M.+A.+Wolfertauthor=G.+J.+Boons&title=Synthesis+and+Proinflammatory+Properties+of+Muramyl+Tripeptides+Containing+Lysine+and+Diaminopimelic+Acid+Moieties&doi=10.1002%2Fcbic.200500181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and proinflammatory properties of muramyl tripeptides containing lysine and diaminopimelic acid moieties</span></div><div class="casAuthors">Roychowdhury, Abhijit; Wolfert, Margreet A.; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2088-2097</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The unusual amino acid diaminopimelic acid (DAP) was prepd. by cross metathesis of appropriately protected vinyl glycine and allyl glycine derivs.  Catalytic hydrogenation of the cross-coupling product resulted in redn. of the double bond and the removal of protecting groups.  The resulting compds. were appropriately protected for the polymer-supported and soln.-phase synthesis of muramyl tripeptides I [R1 = R2 = NH2 (2) or OH (3)], which differ in the amidation of the α-carboxylic acids of the isoglutamine and DAP moieties.  Muramyl dipeptide (MDP), the DAP-contg. muramyl tripeptide 3, and the lysine-contg. muramyl tripeptides induced TNF-α gene expression without TNF-α protein prodn. in a human monocytic cell line.  The obsd. block in translation could be removed by co-incubation with LPS, resulting in an apparent synergistic effect.  Compd. 2 did not induce TNF-α gene expression, neither did it exhibit a synergistic effect with LPS; this indicates that amidation of the α-carboxylic acids of the isoglutamine and DAP moieties results in a loss of biol. activity.  It is proposed that amidation of α-carboxylic acids is a strategy that may be used by pathogens to avoid detection by the innate immune system.  Furthermore, the pattern recognition receptors Nod1 and Nod2 have been implicated in the possible induction of a synergistic effect of muramoyl peptides with LPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp28ne2N6kjEbVg90H21EOLACvtfcHk0liHOS-RQpxSLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ehtLvL&md5=d27c8075907ab22788a1c51a46b8ae69</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200500181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200500181%26sid%3Dliteratum%253Aachs%26aulast%3DRoychowdhury%26aufirst%3DA.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DBoons%26aufirst%3DG.%2BJ.%26atitle%3DSynthesis%2520and%2520Proinflammatory%2520Properties%2520of%2520Muramyl%2520Tripeptides%2520Containing%2520Lysine%2520and%2520Diaminopimelic%2520Acid%2520Moieties%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D2088%26epage%3D2097%26doi%3D10.1002%2Fcbic.200500181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervé, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansonetti, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengin-Lecreulx, D.</span></span> <span> </span><span class="NLM_article-title">Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">41702</span>– <span class="NLM_lpage">41708</span>, <span class="refDoi"> DOI: 10.1074/jbc.M307198200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M307198200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12871942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1ams7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=41702-41708&author=S.+E.+Girardinauthor=L.+H.+Travassosauthor=M.+Herv%C3%A9author=D.+Blanotauthor=I.+G.+Bonecaauthor=D.+J.+Philpottauthor=P.+J.+Sansonettiauthor=D.+Mengin-Lecreulx&title=Peptidoglycan+Molecular+Requirements+Allowing+Detection+by+Nod1+and+Nod2&doi=10.1074%2Fjbc.M307198200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2</span></div><div class="casAuthors">Girardin, Stephen E.; Travassos, Leonardo H.; Herve, Mireille; Blanot, Didier; Boneca, Ivo G.; Philpott, Dana J.; Sansonetti, Philippe J.; Mengin-Lecreulx, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">41702-41708</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod1 and Nod2 are mammalian proteins implicated in the intracellular detection of pathogen-assocd. mol. patterns.  Recently, naturally occurring peptidoglycan (PG) fragments were identified as the microbial motifs sensed by Nod1 and Nod2.  Whereas Nod2 detects GlcNAc-MurNAc dipeptide (GM-Di), Nod1 senses a unique diaminopimelate-contg. GlcNAc-MurNAc tripeptide muropeptide (GM-TriDAP) found mostly in Gram-neg. bacterial PGs.  Because Nod1 and Nod2 detect similar yet distinct muropeptides, we further analyzed the mol. sensing specificity of Nod1 and Nod2 toward PG fragments.  Using a wide array of natural or modified muramyl peptides, we show here that Nod1 and Nod2 have evolved divergent strategies to achieve PG sensing.  By defining the PG structural requirements for Nod1 and Nod2 sensing, this study reveals how PG processing and modifications, either by host or bacterial enzymes, may affect innate immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZk7F7GiPHp7Vg90H21EOLACvtfcHk0liHOS-RQpxSLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1ams7g%253D&md5=0a8a693bc5e596e860206a92a2705d72</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307198200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307198200%26sid%3Dliteratum%253Aachs%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DHerv%25C3%25A9%26aufirst%3DM.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSansonetti%26aufirst%3DP.%2BJ.%26aulast%3DMengin-Lecreulx%26aufirst%3DD.%26atitle%3DPeptidoglycan%2520Molecular%2520Requirements%2520Allowing%2520Detection%2520by%2520Nod1%2520and%2520Nod2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D41702%26epage%3D41708%26doi%3D10.1074%2Fjbc.M307198200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakalarski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mazière, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumperman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delamarre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span> <span> </span><span class="NLM_article-title">Endosomes Are Specialized Platforms for Bacterial Sensing and NOD2 Signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1038/nature13133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fnature13133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=24695226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=240-244&author=N.+Nakamuraauthor=J.+R.+Lillauthor=Q.+Phungauthor=Z.+Jiangauthor=C.+Bakalarskiauthor=A.+De+Mazi%C3%A8reauthor=J.+Klumpermanauthor=M.+Schlatterauthor=L.+Delamarreauthor=I.+Mellman&title=Endosomes+Are+Specialized+Platforms+for+Bacterial+Sensing+and+NOD2+Signalling&doi=10.1038%2Fnature13133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomes are specialized platforms for bacterial sensing and NOD2 signalling</span></div><div class="casAuthors">Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; de Maziere, Ann; Klumperman, Judith; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7499</span>),
    <span class="NLM_cas:pages">240-244</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The detection of microbial pathogens involves the recognition of conserved microbial components by host cell sensors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs).  TLRs are membrane receptors that survey the extracellular environment for microbial infections, whereas NLRs are cytosolic complexes that detect microbial products that reach the cytosol.  Upon detection, both sensor classes trigger innate inflammatory responses and allow the engagement of adaptive immunity.  Endo-lysosomes are the entry sites for a variety of pathogens, and therefore the sites at which the immune system first senses their presence.  Pathogens internalized by endocytosis are well known to activate TLRs 3 and 7-9 that are localized to endocytic compartments and detect ligands present in the endosomal lumen.  Internalized pathogens also activate sensors in the cytosol such as NOD1 and NOD2 (ref. 2), indicating that endosomes also provide for the translocation of bacterial components across the endosomal membrane.  Despite the fact that NOD2 is well understood to have a key role in regulating innate immune responses and that mutations at the NOD2 locus are a common risk factor in inflammatory bowel disease and possibly other chronic inflammatory states, little is known about how its ligands escape from endosomes.  Here we show that two endo-lysosomal peptide transporters, SLC15A3 and SLC15A4, are preferentially expressed by dendritic cells, esp. after TLR stimulation.  The transporters mediate the egress of bacterially derived components, such as the NOD2 cognate ligand muramyl dipeptide (MDP), and are selectively required for NOD2 responses to endosomally derived MDP.  Enhanced expression of the transporters also generates endosomal membrane tubules characteristic of dendritic cells, which further enhanced the NOD2-dependent response to MDP.  Finally, sensing required the recruitment of NOD2 and its effector kinase RIPK2 to the endosomal membrane, possibly by forming a complex with SLC15A3 or SLC15A4.  Thus, dendritic cell endosomes are specialized platforms for both the lumenal and cytosolic sensing of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoppdcGuBL0_bVg90H21EOLACvtfcHk0liHOS-RQpxSLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D&md5=dd38ce753d9529651acea52f83a753b1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnature13133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13133%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DPhung%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DBakalarski%26aufirst%3DC.%26aulast%3DDe%2BMazi%25C3%25A8re%26aufirst%3DA.%26aulast%3DKlumperman%26aufirst%3DJ.%26aulast%3DSchlatter%26aufirst%3DM.%26aulast%3DDelamarre%26aufirst%3DL.%26aulast%3DMellman%26aufirst%3DI.%26atitle%3DEndosomes%2520Are%2520Specialized%2520Platforms%2520for%2520Bacterial%2520Sensing%2520and%2520NOD2%2520Signalling%26jtitle%3DNature%26date%3D2014%26volume%3D509%26spage%3D240%26epage%3D244%26doi%3D10.1038%2Fnature13133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marina-García, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, G.</span></span> <span> </span><span class="NLM_article-title">Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">4321</span>– <span class="NLM_lpage">4327</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.0802197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19299732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=4321-4327&author=N.+Marina-Garc%C3%ADaauthor=L.+Franchiauthor=Y.-G.+Kimauthor=Y.+Huauthor=D.+E.+Smithauthor=G.-J.+Boonsauthor=G.+N%C3%BA%C3%B1ez&title=Clathrin-+and+Dynamin-Dependent+Endocytic+Pathway+Regulates+Muramyl+Dipeptide+Internalization+and+NOD2+Activation&doi=10.4049%2Fjimmunol.0802197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation</span></div><div class="casAuthors">Marina-Garcia, Noemi; Franchi, Luigi; Kim, Yun-Gi; Hu, Yonjun; Smith, David E.; Boons, Geert-Jan; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4321-4327</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP), the NOD2 agonist, induces NF-κB and MAPK activation leading to the prodn. of antimicrobial and proinflammatory mols.  MDP is internalized into acidified vesicles in macrophages.  However, the endocytic mechanism of MDP uptake that induces NOD2 signaling is unknown.  We now report the identification of an endocytosis pathway dependent on clathrin and dynamin that mediates MDP internalization and NOD2 activation.  Intracellular MDP uptake was inhibited by chlorpromazine, a drug that disrupts clathrin-dependent endocytosis, but not by compds. that block pinocytosis or cellular entry via scavenger or mannose receptors.  In contrast, MDP uptake and NOD2-dependent signaling were unimpaired in macrophages deficient in PepT1, a peptide transporter previously implicated in MDP internalization.  Both chlorpromazine and knockdown of clathrin expression by RNA interference attenuated MDP-induced NF-κB and MAPK activation.  Furthermore, MDP uptake and NOD2-dependent signaling were impaired by inhibition of dynamin, a GTPase required for budding of clathrin-coated vesicles from the plasma membrane.  Finally, bafilomycin A, a specific inhibitor of the vacuolar proton pump, blocked MDP accumulation in acidified vesicles and cytokine responses, suggesting that vacuolar maturation is important for MDP-induced NOD2 signaling.  These studies provide evidence for a clathrin- and dynamin-dependent endocytosis pathway that mediates MDP uptake and NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8_dCzxcnmtrVg90H21EOLACvtfcHk0lht-C9t1UXwpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D&md5=7df403b628d10949d61a470550e7ae02</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802197%26sid%3Dliteratum%253Aachs%26aulast%3DMarina-Garc%25C3%25ADa%26aufirst%3DN.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DY.-G.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DBoons%26aufirst%3DG.-J.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26atitle%3DClathrin-%2520and%2520Dynamin-Dependent%2520Endocytic%2520Pathway%2520Regulates%2520Muramyl%2520Dipeptide%2520Internalization%2520and%2520NOD2%2520Activation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D4321%26epage%3D4327%26doi%3D10.4049%2Fjimmunol.0802197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattoli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtal, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavricka, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">PH-Dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">23818</span>– <span class="NLM_lpage">23829</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.033670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M109.033670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19570976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=23818-23829&author=J.+Leeauthor=I.+Tattoliauthor=K.+A.+Wojtalauthor=S.+R.+Vavrickaauthor=D.+J.+Philpottauthor=S.+E.+Girardin&title=PH-Dependent+Internalization+of+Muramyl+Peptides+from+Early+Endosomes+Enables+Nod1+and+Nod2+Signaling&doi=10.1074%2Fjbc.M109.033670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling</span></div><div class="casAuthors">Lee, Jooeun; Tattoli, Ivan; Wojtal, Kacper A.; Vavricka, Stephan R.; Philpott, Dana J.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">23818-23829</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides.  The biol. effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear.  Using the human epithelial cell line HEK293T as a model system, the authors demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-β-cyclodextrin.  In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6.  Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5.  Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands.  In support for this, the authors identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-κB signaling.  Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder assocd. with mutations in Nod1 and Nod2.  Together, the authors' results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyr2dvGF25XrVg90H21EOLACvtfcHk0lht-C9t1UXwpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J&md5=ce9181846219003ee56b3c0e487d591c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033670%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTattoli%26aufirst%3DI.%26aulast%3DWojtal%26aufirst%3DK.%2BA.%26aulast%3DVavricka%26aufirst%3DS.%2BR.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DPH-Dependent%2520Internalization%2520of%2520Muramyl%2520Peptides%2520from%2520Early%2520Endosomes%2520Enables%2520Nod1%2520and%2520Nod2%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D23818%26epage%3D23829%26doi%3D10.1074%2Fjbc.M109.033670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vavricka, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musch, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phanvijhitsiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waypa, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneewind, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. B.</span></span> <span> </span><span class="NLM_article-title">HPepT1 Transports Muramyl Dipeptide, Activating NF-κB and Stimulating IL-8 Secretion in Human Colonic Caco2/Bbe Cells</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">1401</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2004.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1053%2Fj.gastro.2004.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15521010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1401-1409&author=S.+R.+Vavrickaauthor=M.+W.+Muschauthor=J.+E.+Changauthor=Y.+Nakagawaauthor=K.+Phanvijhitsiriauthor=T.+S.+Waypaauthor=D.+Merlinauthor=O.+Schneewindauthor=E.+B.+Chang&title=HPepT1+Transports+Muramyl+Dipeptide%2C+Activating+NF-%CE%BAB+and+Stimulating+IL-8+Secretion+in+Human+Colonic+Caco2%2FBbe+Cells&doi=10.1053%2Fj.gastro.2004.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">HPepT1 transports muramyl dipeptide, activating NF-.vkappa.1B and stimulating IL-8 secretion in human colonic Caco2/bbe cells</span></div><div class="casAuthors">Vavricka, Stephan R.; Musch, Mark W.; Chang, Jonathan E.; Nakagawa, Yasushi; Phanvijhitsiri, Kittiporn; Waypa, Tonya S.; Merlin, Didier; Schneewind, Olaf; Chang, Eugene B.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1401-1409</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Bacterial proteoglycan-derived muramyl dipeptide (MDP) activates the intracellular NOD2/CARD15 gene product.  How intestinal epithelial cells take up MDP is poorly understood.  We hypothesized that the intestinal apical di-/tripeptide transporter, hPepT1, transports MDP, thereby activating downstream pathways similar to nuclear factor κ B (NF-κB).  Time- and concn.-dependent 3H-MDP uptakes were studied in Caco2/bbe (C2) cell monolayers where hPepT1 expression was either over- or underexpressed, using an inducible adenovirus system or silencing RNA (siRNA), resp.  NF-κB activation and interleukin (IL)-8 and monocyte chemoattractant protein-1 (MCP-1) release were detd. by ELISA.  NOD2/CARD15 expression was inhibited by siRNA.  MDP in human duodenal, cecal, and stool samples was measured.  MDP, but not its isoforms, inhibited uptake of glycosylsarcosine in C2 cells, indicating stereoselective and competitive inhibition.  Approx. 90% of the MDP was cytosolic, showing uptake rather than binding.  The Km for MDP uptake was 4.3 mmol/L.  Cells overexpressing hPepT1 showed increased Gly-Sar and MDP uptake, whereas decreased uptake was obsd. after hPepT1 siRNA-inhibition.  MDP treatment activated NF-κB, resulting in IL-8 release, an effect blocked by siRNA-inhibited expression of NOD2/CARD15.  MDP content in cecal and stool samples (in normal subjects) was 20-87 μmol/L, but undetectable in duodenal fluid.  In colonic epithelial cells, MDP is taken up by hPepT1 and activates NF-κB and chemokine prodn.  Because hPepT1 expression in chronic colonic inflammation is increased, this may play an important role in promoting colonocyte participation in host defense and pathogen clearance through increased uptake of MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbKSWLRST-IrVg90H21EOLACvtfcHk0lht-C9t1UXwpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKisrzE&md5=76223a95416d7f9f866c828da4cbfdfd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2004.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2004.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DVavricka%26aufirst%3DS.%2BR.%26aulast%3DMusch%26aufirst%3DM.%2BW.%26aulast%3DChang%26aufirst%3DJ.%2BE.%26aulast%3DNakagawa%26aufirst%3DY.%26aulast%3DPhanvijhitsiri%26aufirst%3DK.%26aulast%3DWaypa%26aufirst%3DT.%2BS.%26aulast%3DMerlin%26aufirst%3DD.%26aulast%3DSchneewind%26aufirst%3DO.%26aulast%3DChang%26aufirst%3DE.%2BB.%26atitle%3DHPepT1%2520Transports%2520Muramyl%2520Dipeptide%252C%2520Activating%2520NF-%25CE%25BAB%2520and%2520Stimulating%2520IL-8%2520Secretion%2520in%2520Human%2520Colonic%2520Caco2%252FBbe%2520Cells%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1401%26epage%3D1409%26doi%3D10.1053%2Fj.gastro.2004.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smrdel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabnar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Černe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrenšek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovačič, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogataj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urleb, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrhar, A.</span></span> <span> </span><span class="NLM_article-title">Physicochemical and Preclinical Pharmacokinetic and Toxicological Evaluation of LK-423—a New Phthalimido-Desmuramyl-Dipeptide Derivative with Immunomodulating Activity</span>. <i>Drug Dev. Ind. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.3109/03639040902889814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3109%2F03639040902889814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19832629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1293-1304&author=P.+Smrdelauthor=I.+Grabnarauthor=I.+Locatelliauthor=M.+%C4%8Cerneauthor=S.+Andren%C5%A1ekauthor=N.+Kova%C4%8Di%C4%8Dauthor=A.+Kristlauthor=M.+Bogatajauthor=U.+Urlebauthor=A.+Mrhar&title=Physicochemical+and+Preclinical+Pharmacokinetic+and+Toxicological+Evaluation+of+LK-423%E2%80%94a+New+Phthalimido-Desmuramyl-Dipeptide+Derivative+with+Immunomodulating+Activity&doi=10.3109%2F03639040902889814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423 phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity</span></div><div class="casAuthors">Smrdel, Polona; Grabnar, Iztok; Locatelli, Igor; Cerne, Manica; Andrensek, Samo; Kovacic, Natasa; Kristl, Albin; Bogataj, Marija; Urleb, Uros; Mrhar, Ales</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1293-1304</span>CODEN:
                <span class="NLM_cas:coden">DDIPD8</span>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">LK-423 is a new phthalimido-desmuramyl-dipeptide deriv. with immunomodulating activity.  As optimized delivery to the site of action appears crucial for further preclin. development of LK-423, the aim of this study was to perform a physicochem. and preclin. pharmacokinetic and toxicol. evaluation.  The soly., partition coeff., permeability, and stability profile were detd.  Pharmacokinetics were evaluated in rats following i.v. and oral application of LK-423, and in dogs after i.v. administration and oral administration of microcapsules, designed for colon-specific delivery of LK-423 based on pH-, time-, and enzyme-controlled release mechanisms.  Addnl., the acute and subchronic toxicity was examd.  LK-423 is hydrophilic, sparingly to slightly sol., and poorly permeable.  Stability profile in aq. soln. is pH dependent.  A pharmacokinetic study following i.v. application to rats and dogs revealed that LK-423 is rapidly eliminated with a short terminal phase half-life, and high plasma clearance, as well as a limited distribution to the peripheral tissue.  Oral bioavailability of LK-423 is low, presumably due to low permeability.  Debris of insol. microcapsule coating in feces and obtained plasma concn. profiles confirm that LK-423 microcapsules are a promising approach for local treatment of inflammatory diseases of the large intestine.  Acute and a subchronic toxicity results indicate that LK-423 is a safe and nontoxic drug under the applied exptl. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLWRgVEBDtmbVg90H21EOLACvtfcHk0lhcSG3ySFbhaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrnL&md5=c73a505d4c1f75ae9ab8d51da65a14c4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3109%2F03639040902889814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03639040902889814%26sid%3Dliteratum%253Aachs%26aulast%3DSmrdel%26aufirst%3DP.%26aulast%3DGrabnar%26aufirst%3DI.%26aulast%3DLocatelli%26aufirst%3DI.%26aulast%3D%25C4%258Cerne%26aufirst%3DM.%26aulast%3DAndren%25C5%25A1ek%26aufirst%3DS.%26aulast%3DKova%25C4%258Di%25C4%258D%26aufirst%3DN.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DBogataj%26aufirst%3DM.%26aulast%3DUrleb%26aufirst%3DU.%26aulast%3DMrhar%26aufirst%3DA.%26atitle%3DPhysicochemical%2520and%2520Preclinical%2520Pharmacokinetic%2520and%2520Toxicological%2520Evaluation%2520of%2520LK-423%25E2%2580%2594a%2520New%2520Phthalimido-Desmuramyl-Dipeptide%2520Derivative%2520with%2520Immunomodulating%2520Activity%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2009%26volume%3D35%26spage%3D1293%26epage%3D1304%26doi%3D10.3109%2F03639040902889814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamawaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, Y.</span></span> <span> </span><span class="NLM_article-title">Adjuvant Activity of Synthetic 6-O-’mycoloyl’-N-Acetylmuramyl-L-Alanyl-D-Isoglutamine and Related Compounds</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1128/IAI.20.3.600-607.1978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2Fiai.20.3.600-607.1978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=97234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaE1cXltVGlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1978&pages=600-607&author=I.+Azumaauthor=K.+Sugimuraauthor=M.+Yamawakiauthor=M.+Uemiyaauthor=S.+Kusumotoauthor=S.+Okadaauthor=T.+Shibaauthor=Y.+Yamamura&title=Adjuvant+Activity+of+Synthetic+6-O-%E2%80%99mycoloyl%E2%80%99-N-Acetylmuramyl-L-Alanyl-D-Isoglutamine+and+Related+Compounds&doi=10.1128%2FIAI.20.3.600-607.1978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds</span></div><div class="casAuthors">Azuma, Ichiro; Sugimura, Kazuhisa; Yamawaki, Mikio; Uemiya, Masanao; Kusumoto, Shoichi; Okada, Satoshi; Shiba, Tetsuo; Yamamura, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">600-7</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Adjuvant and antitumor activities of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine were examd.  All the synthetic 6-O-corynomycoloyl-, 6-O-nocardomycoloyl-, and 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine were active as adjuvants for cell-mediated immune responses.  However, 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine was less active as an adjuvant on circulating antibody formation.  It was shown that pyrogenic activity of N-acetylmuramyldipeptide was reduced by 6-O-acylation with mycolic acid, but not with nocardomycolic or corynomycolic acids.  Tumor-suppression activity was obsd. by the synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine by using transplantable tumor in syngenic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY1SYthz4YMrVg90H21EOLACvtfcHk0lhcSG3ySFbhaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXltVGlt7w%253D&md5=818773f59eabe3932fccdc1bab99b05e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1128%2Fiai.20.3.600-607.1978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fiai.20.3.600-607.1978%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DI.%26aulast%3DSugimura%26aufirst%3DK.%26aulast%3DYamawaki%26aufirst%3DM.%26aulast%3DUemiya%26aufirst%3DM.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DShiba%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DY.%26atitle%3DAdjuvant%2520Activity%2520of%2520Synthetic%25206-O-%25E2%2580%2599mycoloyl%25E2%2580%2599-N-Acetylmuramyl-L-Alanyl-D-Isoglutamine%2520and%2520Related%2520Compounds%26jtitle%3DInfect.%2520Immun.%26date%3D1978%26volume%3D20%26spage%3D600%26epage%3D607%26doi%3D10.1128%2FIAI.20.3.600-607.1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamet, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span> <span> </span><span class="NLM_article-title">Apyrogenic, Adjuvant-Active N-Acetylmuramyl-Dipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1021/jm00343a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00343a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL38XkslU%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=87-90&author=P.+Lefrancierauthor=M.+Derrienauthor=X.+Jametauthor=J.+Choayauthor=E.+Ledererauthor=F.+Audibertauthor=M.+Parantauthor=F.+Parantauthor=L.+Chedid&title=Apyrogenic%2C+Adjuvant-Active+N-Acetylmuramyl-Dipeptides&doi=10.1021%2Fjm00343a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides</span></div><div class="casAuthors">Lefrancier, Pierre; Derrien, Marcel; Jamet, Xavier; Choay, Jean; Lederer, Edgar; Audibert, Francoise; Parant, Monique; Parant, Francine; Chedid, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-90</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Seven analogs I (R = alkyl) of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) were synthesized in which the D-isoglutaminyl residue was replaced by D-glutamine alkyl esters.  They are all adjuvant active; however, their i.v. injection does not induce a febrile response in rabbits at a dose of 10 mg/kg, in contrast to MDP in which the minimal pyrogenic dose is 25 μg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9wAiNEhILbVg90H21EOLACvtfcHk0lgINKrEZ1K7KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslU%253D&md5=6813ca9606d5a0e0e7822292aa305207</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm00343a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00343a018%26sid%3Dliteratum%253Aachs%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DDerrien%26aufirst%3DM.%26aulast%3DJamet%26aufirst%3DX.%26aulast%3DChoay%26aufirst%3DJ.%26aulast%3DLederer%26aufirst%3DE.%26aulast%3DAudibert%26aufirst%3DF.%26aulast%3DParant%26aufirst%3DM.%26aulast%3DParant%26aufirst%3DF.%26aulast%3DChedid%26aufirst%3DL.%26atitle%3DApyrogenic%252C%2520Adjuvant-Active%2520N-Acetylmuramyl-Dipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D87%26epage%3D90%26doi%3D10.1021%2Fjm00343a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Needham, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawden, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfield, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bone, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotherton, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krige, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legris, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testar, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, A. H.</span></span> <span> </span><span class="NLM_article-title">Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1124/jpet.111.183640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1124%2Fjpet.111.183640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21778281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=132-142&author=L.+A.+Needhamauthor=A.+H.+Davidsonauthor=L.+J.+Bawdenauthor=A.+Belfieldauthor=E.+A.+Boneauthor=D.+H.+Brothertonauthor=S.+Bryantauthor=M.+H.+Charltonauthor=V.+L.+Clarkauthor=S.+J.+Daviesauthor=A.+Donaldauthor=F.+A.+Dayauthor=D.+Krigeauthor=V.+Legrisauthor=J.+McDermottauthor=Y.+McGovernauthor=J.+Owenauthor=S.+R.+Patelauthor=S.+Pintatauthor=R.+J.+Testarauthor=G.+M.+A.+Wellsauthor=D.+Moffatauthor=A.+H.+Drummond&title=Drug+Targeting+to+Monocytes+and+Macrophages+Using+Esterase-Sensitive+Chemical+Motifs&doi=10.1124%2Fjpet.111.183640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs</span></div><div class="casAuthors">Needham, Lindsey A.; Davidson, Alan H.; Bawden, Lindsay J.; Belfield, Andrew; Bone, Elisabeth A.; Brotherton, Deborah H.; Bryant, Sam; Charlton, Michael H.; Clark, Vanessa L.; Davies, Stephen J.; Donald, Alastair; Day, Francesca A.; Krige, David; Legris, Valerie; McDermott, Joanne; McGovern, Yvonne; Owen, Jo; Patel, Sanjay R.; Pintat, Stephane; Testar, Richard J.; Wells, Graham M. A.; Moffat, David; Drummond, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The therapeutic and toxic effects of drugs are often generated through effects on distinct cell types in the body.  Selective delivery of drugs to specific cells or cell lineages would, therefore, have major advantages, in particular, the potential to significantly improve the therapeutic window of an agent.  Cells of the monocyte-macrophage lineage represent an important target for many therapeutic agents because of their central involvement in a wide range of diseases including inflammation, cancer, atherosclerosis, and diabetes.  We have developed a versatile chem. platform that is designed to enhance the potency and delivery of small-mol. drugs to intracellular mol. targets.  One facet of the technol. involves the selective delivery of drugs to cells of the monocyte-macrophage lineage, using the intracellular carboxylesterase, human carboxylesterase-1 (hCE-1), which is expressed predominantly in these cells.  Here, we demonstrate selective delivery of many types of intracellularly targeted small mols. to monocytes and macrophages by attaching a small esterase-sensitive chem. motif (ESM) that is selectively hydrolyzed within these cells to a charged, pharmacol. active drug.  ESM versions of histone deacetylase (HDAC) inhibitors, for example, are extremely potent anticytokine and antiarthritic agents with a wider therapeutic window than conventional HDAC inhibitors.  In human blood, effects on monocytes (hCE-1-pos.) are seen at concns. 1000-fold lower than those that affect other cell types (hCE-1-neg.).  Chem. conjugates of this type, by limiting effects on other cells, could find widespread applicability in the treatment of human diseases where monocyte-macrophages play a key role in disease pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5B4-j7rP0LVg90H21EOLACvtfcHk0lgINKrEZ1K7KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbnL&md5=c71ecc27d0f43ef10c0ee8778a36d4d3</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.183640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.183640%26sid%3Dliteratum%253Aachs%26aulast%3DNeedham%26aufirst%3DL.%2BA.%26aulast%3DDavidson%26aufirst%3DA.%2BH.%26aulast%3DBawden%26aufirst%3DL.%2BJ.%26aulast%3DBelfield%26aufirst%3DA.%26aulast%3DBone%26aufirst%3DE.%2BA.%26aulast%3DBrotherton%26aufirst%3DD.%2BH.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCharlton%26aufirst%3DM.%2BH.%26aulast%3DClark%26aufirst%3DV.%2BL.%26aulast%3DDavies%26aufirst%3DS.%2BJ.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DDay%26aufirst%3DF.%2BA.%26aulast%3DKrige%26aufirst%3DD.%26aulast%3DLegris%26aufirst%3DV.%26aulast%3DMcDermott%26aufirst%3DJ.%26aulast%3DMcGovern%26aufirst%3DY.%26aulast%3DOwen%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DPintat%26aufirst%3DS.%26aulast%3DTestar%26aufirst%3DR.%2BJ.%26aulast%3DWells%26aufirst%3DG.%2BM.%2BA.%26aulast%3DMoffat%26aufirst%3DD.%26aulast%3DDrummond%26aufirst%3DA.%2BH.%26atitle%3DDrug%2520Targeting%2520to%2520Monocytes%2520and%2520Macrophages%2520Using%2520Esterase-Sensitive%2520Chemical%2520Motifs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D132%26epage%3D142%26doi%3D10.1124%2Fjpet.111.183640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltiel, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fergus, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt-Leopold, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marston, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tecle, H.</span></span> <span> </span><span class="NLM_article-title">The Discovery of the Benzhydroxamate MEK Inhibitors CI-1040 and PD 0325901</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6501</span>– <span class="NLM_lpage">6504</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.bmcl.2008.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18952427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6501-6504&author=S.+D.+Barrettauthor=A.+J.+Bridgesauthor=D.+T.+Dudleyauthor=A.+R.+Saltielauthor=J.+H.+Fergusauthor=C.+M.+Flammeauthor=A.+M.+Delaneyauthor=M.+Kaufmanauthor=S.+Lepageauthor=W.+R.+Leopoldauthor=S.+A.+Przybranowskiauthor=J.+Sebolt-Leopoldauthor=K.+Van+Becelaereauthor=A.+M.+Dohertyauthor=R.+M.+Kennedyauthor=D.+Marstonauthor=W.+A.+Howardauthor=Y.+Smithauthor=J.+S.+Warmusauthor=H.+Tecle&title=The+Discovery+of+the+Benzhydroxamate+MEK+Inhibitors+CI-1040+and+PD+0325901&doi=10.1016%2Fj.bmcl.2008.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901</span></div><div class="casAuthors">Barrett, Stephen D.; Bridges, Alexander J.; Dudley, David T.; Saltiel, Alan R.; Fergus, James H.; Flamme, Cathlin M.; Delaney, Amy M.; Kaufman, Michael; LePage, Sophie; Leopold, Wilbur R.; Przybranowski, Sally A.; Sebolt-Leopold, Judith; Van Becelaere, Keri; Doherty, Annette M.; Kennedy, Robert M.; Marston, Dan; Howard, W. Allen, Jr.; Smith, Yvonne; Warmus, Joseph S.; Tecle, Haile</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6501-6504</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of benzhydroxamate esters derived from their precursor anthranilic acids have been prepd. and have been identified as potent MEK inhibitors.  CI-1040 (I) was the first MEK inhibitor to demonstrate in vivo activity in preclin. animal models and subsequently became the first MEK inhibitor to enter clin. trial.  CI-1040 suffered however from poor exposure due to its poor soly. and rapid clearance, and as a result, development of the compd. was terminated.  Optimization of the diphenylamine core and modification of the hydroxamate side chain for cell potency, soly., and exposure with oral delivery resulted in the discovery of the clin. candidate PD 0325901 (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpam9NxZxX93rVg90H21EOLACvtfcHk0liNY8PWkP8clg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI&md5=e64f7ae6a446c504528621e7d14d67ce</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DS.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26aulast%3DFergus%26aufirst%3DJ.%2BH.%26aulast%3DFlamme%26aufirst%3DC.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DLepage%26aufirst%3DS.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DPrzybranowski%26aufirst%3DS.%2BA.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DKennedy%26aufirst%3DR.%2BM.%26aulast%3DMarston%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DTecle%26aufirst%3DH.%26atitle%3DThe%2520Discovery%2520of%2520the%2520Benzhydroxamate%2520MEK%2520Inhibitors%2520CI-1040%2520and%2520PD%25200325901%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6501%26epage%3D6504%26doi%3D10.1016%2Fj.bmcl.2008.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, R.</span></span> <span> </span><span class="NLM_article-title">Prodrugs Design Based on Inter- and Intramolecular Chemical Processes</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fcbdd.12224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23998799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVajurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=643-668&author=R.+Karaman&title=Prodrugs+Design+Based+on+Inter-+and+Intramolecular+Chemical+Processes&doi=10.1111%2Fcbdd.12224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs Design Based on Inter- and Intramolecular Chemical Processes</span></div><div class="casAuthors">Karaman, Rafik</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">643-668</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This review provides the reader a concise overview of the majority of prodrug approaches with the emphasis on the modern approaches to prodrug design.  The chem. approach catalyzed by metabolic enzymes which is considered as widely used among all other approaches to minimize the undesirable drug physicochem. properties is discussed.  Part of this review will shed light on the use of MO methods such as DFT, semiempirical and ab initio for the design of novel prodrugs.  This novel prodrug approach implies prodrug design based on enzyme models that were utilized for mimicking enzyme catalysis.  The computational approach exploited for the prodrug design involves MO and mol. mechanics (DFT,ab initio, and MM2) calcns. and correlations between exptl. and calcd. values of intramol. processes that were exptl. studied to assign the factors detg. the reaction rates in certain processes for better understanding on how enzymes might exert their extraordinary catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWvKE8uQzlT7Vg90H21EOLACvtfcHk0liNY8PWkP8clg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVajurfL&md5=5d94c6ea1d0e7e71c646cd70dfccc2d0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12224%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DR.%26atitle%3DProdrugs%2520Design%2520Based%2520on%2520Inter-%2520and%2520Intramolecular%2520Chemical%2520Processes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D82%26spage%3D643%26epage%3D668%26doi%3D10.1111%2Fcbdd.12224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J. A.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Cleavage of Benzyl Ethers, Esters, and Carbamates in the Presence of Other Easily Reducible Groups</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1999</i></span> (<span class="NLM_issue">S1</span>),  <span class="NLM_fpage">1399</span>– <span class="NLM_lpage">1400</span>, <span class="refDoi"> DOI: 10.1055/s-1999-3664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1055%2Fs-1999-3664" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1999&publication_year=1999&pages=1399-1400&issue=S1&author=R.+S.+Colemanauthor=J.+A.+Shah&title=Chemoselective+Cleavage+of+Benzyl+Ethers%2C+Esters%2C+and+Carbamates+in+the+Presence+of+Other+Easily+Reducible+Groups&doi=10.1055%2Fs-1999-3664"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1055%2Fs-1999-3664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1999-3664%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BS.%26aulast%3DShah%26aufirst%3DJ.%2BA.%26atitle%3DChemoselective%2520Cleavage%2520of%2520Benzyl%2520Ethers%252C%2520Esters%252C%2520and%2520Carbamates%2520in%2520the%2520Presence%2520of%2520Other%2520Easily%2520Reducible%2520Groups%26jtitle%3DSynthesis%26date%3D1999%26volume%3D1999%26issue%3DS1%26spage%3D1399%26epage%3D1400%26doi%3D10.1055%2Fs-1999-3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppeck, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span> <span> </span><span class="NLM_article-title">A Convenient and Scaleable Procedure for Removing the Fmoc Group in Solution</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">5329</span>– <span class="NLM_lpage">5333</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)00853-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0040-4039%2800%2900853-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslWmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=5329-5333&author=J.+E.+Sheppeckauthor=H.+Karauthor=H.+Hong&title=A+Convenient+and+Scaleable+Procedure+for+Removing+the+Fmoc+Group+in+Solution&doi=10.1016%2FS0040-4039%2800%2900853-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient and scaleable procedure for removing the Fmoc group in solution</span></div><div class="casAuthors">Sheppeck, J. E.; Kar, H.; Hong, H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">5329-5333</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An improved and simple reagent system was developed to facilitate soln.-phase deprotection of Fmoc-protected amino acids.  Catalytic DBU in the presence of an aliph. or polymer-supported thiol rapidly removed the Fmoc group to provide the amine free base in excellent yields and purity on multi-gram scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRwEh4RdXYILVg90H21EOLACvtfcHk0lg2lWKnysVtAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslWmurc%253D&md5=7eda49e1d4c0b550b73bb3783dcae388</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2900853-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252900853-4%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DKar%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DH.%26atitle%3DA%2520Convenient%2520and%2520Scaleable%2520Procedure%2520for%2520Removing%2520the%2520Fmoc%2520Group%2520in%2520Solution%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D5329%26epage%3D5333%26doi%3D10.1016%2FS0040-4039%2800%2900853-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">A Novel Immunostimulator, N2-[α-O-Benzyl-N-(Acetylmuramyl) -L-Alanyl-D-Isoglutaminyl]-N6-Trans-(m-Nitrocinnamoyl)-L-Lysine, and Its Adjuvancy on the Hepatitis B Surface Antigen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5112</span>– <span class="NLM_lpage">5122</span>, <span class="refDoi"> DOI: 10.1021/jm0493313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0493313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVCltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5112-5122&author=H.-Z.+Yangauthor=S.+Xuauthor=X.-Y.+Liaoauthor=S.-D.+Zhangauthor=Z.-L.+Liangauthor=B.-H.+Liuauthor=J.-Y.+Baiauthor=C.+Jiangauthor=J.+Dingauthor=G.-F.+Chengauthor=G.+Liu&title=A+Novel+Immunostimulator%2C+N2-%5B%CE%B1-O-Benzyl-N-%28Acetylmuramyl%29+-L-Alanyl-D-Isoglutaminyl%5D-N6-Trans-%28m-Nitrocinnamoyl%29-L-Lysine%2C+and+Its+Adjuvancy+on+the+Hepatitis+B+Surface+Antigen&doi=10.1021%2Fjm0493313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Immunostimulator, N2-[α-O-Benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and Its Adjuvancy on the Hepatitis B Surface Antigen</span></div><div class="casAuthors">Yang, Hong-Zhen; Xu, Song; Liao, Xue-Yan; Zhang, Suo-De; Liang, Zheng-Lun; Liu, Bai-He; Bai, Jin-Ye; Jiang, Chao; Ding, Jian; Cheng, Gui-Fang; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5112-5122</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Muramyl dipeptide C (MDP-C), N2-[α-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, has been synthesized as a novel, nonspecific immunomodulator.  This study shows that MDP-C induces strong cytolytic activity by macrophages on P388 leukemia cells and cytotoxic activity by cytotoxic T lymphocytes (CTLs) on P815 mastocytoma cells.  The results also indicate that MDP-C is an effective stimulator for prodn. of interleukin-2 and interleukin-12 by murine bone morrow derived dendritic cells (BMDCs) and prodn. of interferon-γ by CTLs.  Addnl., MDP-C increases the expression levels of several surface mols., including CD11c, MHC class I, and intercellular adhesion mol.-1 in BMDCs.  Moreover, MDP-C remarkably enhances the immune system's responsiveness to hepatitis B surface antigen (HBsAg) in hepatitis B virus transgenic mice for both antibody prodn. and specific HBsAg T-cell responses ex vivo.  Thus, MDP-C is an apyrogenic, nonallergenic, and low-toxicity immunostimulator with great potential for diagnostic, immunotherapeutic, and prophylactic applications in diseases such as hepatitis B and cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQgp5am5lbGLVg90H21EOLACvtfcHk0lg2lWKnysVtAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVCltrg%253D&md5=664055ca9ac2df91e0ef0f2067801bb1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm0493313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493313%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.-Z.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DX.-Y.%26aulast%3DZhang%26aufirst%3DS.-D.%26aulast%3DLiang%26aufirst%3DZ.-L.%26aulast%3DLiu%26aufirst%3DB.-H.%26aulast%3DBai%26aufirst%3DJ.-Y.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.-F.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DA%2520Novel%2520Immunostimulator%252C%2520N2-%255B%25CE%25B1-O-Benzyl-N-%2528Acetylmuramyl%2529%2520-L-Alanyl-D-Isoglutaminyl%255D-N6-Trans-%2528m-Nitrocinnamoyl%2529-L-Lysine%252C%2520and%2520Its%2520Adjuvancy%2520on%2520the%2520Hepatitis%2520B%2520Surface%2520Antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5112%26epage%3D5122%26doi%3D10.1021%2Fjm0493313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Effenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek Knötigová, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zyka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čelechovská, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartheldyová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubatka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudelka, Š.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukáč, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalová, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šaman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Křupka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkocziova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosztyu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šebela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drož, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hučko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanásová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledvina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span> <span> </span><span class="NLM_article-title">Nonpyrogenic Molecular Adjuvants Based on NorAbu-Muramyldipeptide and NorAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7745</span>– <span class="NLM_lpage">7763</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00593</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00593" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7745-7763&author=R.+Effenbergauthor=P.+Tur%C3%A1nek+Kn%C3%B6tigov%C3%A1author=D.+Zykaauthor=H.+%C4%8Celechovsk%C3%A1author=J.+Ma%C5%A1ekauthor=E.+Bartheldyov%C3%A1author=F.+Hubatkaauthor=%C5%A0.+Koudelkaauthor=R.+Luk%C3%A1%C4%8Dauthor=A.+Kovalov%C3%A1author=D.+%C5%A0amanauthor=M.+K%C5%99upkaauthor=L.+Barkocziovaauthor=P.+Kosztyuauthor=M.+%C5%A0ebelaauthor=L.+Dro%C5%BEauthor=M.+Hu%C4%8Dkoauthor=M.+Kan%C3%A1sov%C3%A1author=A.+D.+Millerauthor=M.+Ra%C5%A1kaauthor=M.+Ledvinaauthor=J.+Tur%C3%A1nek&title=Nonpyrogenic+Molecular+Adjuvants+Based+on+NorAbu-Muramyldipeptide+and+NorAbu-Glucosaminyl+Muramyldipeptide%3A+Synthesis%2C+Molecular+Mechanisms+of+Action%2C+and+Biological+Activities+in+Vitro+and+in+Vivo&doi=10.1021%2Facs.jmedchem.7b00593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpyrogenic Molecular Adjuvants Based on norAbu-Muramyldipeptide and norAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo</span></div><div class="casAuthors">Effenberg, Roman; Turanek Knotigova, Pavlina; Zyka, Daniel; Celechovska, Hana; Masek, Josef; Bartheldyova, Eliska; Hubatka, Frantisek; Koudelka, Stepan; Lukac, Robert; Kovalova, Anna; Saman, David; Krupka, Michal; Barkocziova, Lucia; Kosztyu, Petr; Sebela, Marek; Droz, Ladislav; Hucko, Michal; Kanasova, Maria; Miller, Andrew D.; Raska, Milan; Ledvina, Miroslav; Turanek, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7745-7763</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acyl analogs of muramyldipeptide (MDP) (abbreviated N-L18 norAbuGMDP, N-B30 norAbuGMDP, norAbuMDP-Lys(L18), norAbuMDP-Lys(B30), norAbuGMDP-Lys(L18), norAbuGMDP-Lys(B30), B30 norAbuMDP, L18 norAbuMDP) are designed and synthesized comprising the normuramyl-L-α-aminobutanoyl (norAbu) structural moiety.  All new analogs show depressed pyrogenicity in both free (micellar) state and in liposomal formulations when tested in rabbits in vivo (s.c. and iv application).  New analogs are also shown to be selective activators of NOD2 and NLRP3 (inflammasome) in vitro but not NOD1.  Potencies of NOD2 and NLRP3 stimulation are found comparable with free MDP and other pos. controls.  Analogs are also demonstrated to be effective in stimulating cellular proliferation when the sera from mice are injected s.c. with individual liposome-loaded analogs, causing proliferation of bone marrow-derived GM-progenitors cells.  Importantly, vaccination nanoparticles prepd. from metallochelation liposomes, His-tagged antigen rOspA from Borrelia burgdorferi, and lipophilic analog norAbuMDP-Lys(B30) as adjuvant, are shown to provoke OspA-specific antibody responses with a strong Th1-bias (dominance of IgG2a response).  In contrast, the adjuvant effects of Alum or parent MDP show a strong Th2-bias (dominance of IgG1 response).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUp8pDHzdC7Vg90H21EOLACvtfcHk0lg2lWKnysVtAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF&md5=ca10207e03938dc2e1dd1400b79d38d8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00593%26sid%3Dliteratum%253Aachs%26aulast%3DEffenberg%26aufirst%3DR.%26aulast%3DTur%25C3%25A1nek%2BKn%25C3%25B6tigov%25C3%25A1%26aufirst%3DP.%26aulast%3DZyka%26aufirst%3DD.%26aulast%3D%25C4%258Celechovsk%25C3%25A1%26aufirst%3DH.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DBartheldyov%25C3%25A1%26aufirst%3DE.%26aulast%3DHubatka%26aufirst%3DF.%26aulast%3DKoudelka%26aufirst%3D%25C5%25A0.%26aulast%3DLuk%25C3%25A1%25C4%258D%26aufirst%3DR.%26aulast%3DKovalov%25C3%25A1%26aufirst%3DA.%26aulast%3D%25C5%25A0aman%26aufirst%3DD.%26aulast%3DK%25C5%2599upka%26aufirst%3DM.%26aulast%3DBarkocziova%26aufirst%3DL.%26aulast%3DKosztyu%26aufirst%3DP.%26aulast%3D%25C5%25A0ebela%26aufirst%3DM.%26aulast%3DDro%25C5%25BE%26aufirst%3DL.%26aulast%3DHu%25C4%258Dko%26aufirst%3DM.%26aulast%3DKan%25C3%25A1sov%25C3%25A1%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DRa%25C5%25A1ka%26aufirst%3DM.%26aulast%3DLedvina%26aufirst%3DM.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DNonpyrogenic%2520Molecular%2520Adjuvants%2520Based%2520on%2520NorAbu-Muramyldipeptide%2520and%2520NorAbu-Glucosaminyl%2520Muramyldipeptide%253A%2520Synthesis%252C%2520Molecular%2520Mechanisms%2520of%2520Action%252C%2520and%2520Biological%2520Activities%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7745%26epage%3D7763%26doi%3D10.1021%2Facs.jmedchem.7b00593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayyad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F. C.</span></span> <span> </span><span class="NLM_article-title">Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3836</span>– <span class="NLM_lpage">3844</span>, <span class="refDoi"> DOI: 10.1002/asia.202001003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Fasia.202001003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=32975372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFahtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=3836-3844&author=W.+C.+Chengauthor=T.+Y.+Youauthor=Z.+Z.+Teoauthor=A.+A.+Sayyadauthor=J.+Maharanaauthor=C.+W.+Guoauthor=P.+H.+Liangauthor=C.+S.+Linauthor=F.+C.+Meng&title=Further+Insights+on+Structural+Modifications+of+Muramyl+Dipeptides+to+Study+the+Human+NOD2+Stimulating+Activity&doi=10.1002%2Fasia.202001003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Further insights on structural modifications of muramyl dipeptides to study the human NOPD2 stimulating activity</span></div><div class="casAuthors">Cheng, Wei-Chieh; You, Ting-Yun; Teo, Zhen-Zhuo; Sayyad, Ashik A.; Maharana, Jitendra; Guo, Chih-Wei; Liang, Pi-Hui; Lin, Chung-Shun; Meng, Fan-Chun</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3836-3844</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of muramyl dipeptide (MDP) analogs with structural modifications at the C4 position of MurNAc and on the D-iso-glutamine (isoGln) residue of the peptide part were synthesized.  The C4-diversification of MurNAc was conveniently achieved by using CuAAC click strategy to conjugate an azido muramyl dipeptide precursor with structurally diverse alkynes.  D-Glutamic acid (Glu), replaced with isoGln, was applied for the structural diversity through esterification or amidation of the carboxylic acid.  In total, 26 MDP analogs were synthesized and bio-evaluated for the study of human NOD2 stimulation activity in the innate immune response.  Interestingly, MDP derivs. with an ester moiety are found to be more potent than ref. compd. MDP itself or MDP analogs contg. an amide moiety.  Among the varied lengths of the alkyl chain in ester derivs., the MDP analog bearing the D-glutamate dodecyl (C12) ester moiety showed the best NOD2 stimulation potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUmChGuw6K9bVg90H21EOLACvtfcHk0ljSzuIQuv4BxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFahtrzI&md5=71f50964c0946a0b5a1f2d81ba0a480b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fasia.202001003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.202001003%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DW.%2BC.%26aulast%3DYou%26aufirst%3DT.%2BY.%26aulast%3DTeo%26aufirst%3DZ.%2BZ.%26aulast%3DSayyad%26aufirst%3DA.%2BA.%26aulast%3DMaharana%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DC.%2BW.%26aulast%3DLiang%26aufirst%3DP.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BS.%26aulast%3DMeng%26aufirst%3DF.%2BC.%26atitle%3DFurther%2520Insights%2520on%2520Structural%2520Modifications%2520of%2520Muramyl%2520Dipeptides%2520to%2520Study%2520the%2520Human%2520NOD2%2520Stimulating%2520Activity%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2020%26volume%3D15%26spage%3D3836%26epage%3D3844%26doi%3D10.1002%2Fasia.202001003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piveteau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gealageas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roignant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolojanahary, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemdani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herledan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biela, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez-Poulain, R.</span></span> <span> </span><span class="NLM_article-title">Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9067</span>– <span class="NLM_lpage">9089</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01444</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1amurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9067-9089&author=P.+Hermantauthor=D.+Boscauthor=C.+Piveteauauthor=R.+Gealageasauthor=B.+Lamauthor=C.+Roncoauthor=M.+Roignantauthor=H.+Tolojanaharyauthor=L.+Jeanauthor=P.+Y.+Renardauthor=M.+Lemdaniauthor=M.+Bourotteauthor=A.+Herledanauthor=C.+Bedartauthor=A.+Bielaauthor=F.+Lerouxauthor=B.+Deprezauthor=R.+Deprez-Poulain&title=Controlling+Plasma+Stability+of+Hydroxamic+Acids%3A+A+MedChem+Toolbox&doi=10.1021%2Facs.jmedchem.7b01444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox</span></div><div class="casAuthors">Hermant, Paul; Bosc, Damien; Piveteau, Catherine; Gealageas, Ronan; Lam, BaoVy; Ronco, Cyril; Roignant, Matthieu; Tolojanahary, Hasina; Jean, Ludovic; Renard, Pierre-Yves; Lemdani, Mohamed; Bourotte, Marilyne; Herledan, Adrien; Bedart, Corentin; Biela, Alexandre; Leroux, Florence; Deprez, Benoit; Deprez-Poulain, Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9067-9089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas.  Some hydroxamic acids display a high plasma clearance resulting in poor in vivo activity, though they may be very potent compds. in vitro.  The authors designed a 57-member library of hydroxamic acids to explore the structure-plasma stability relationships in these series and to identify which enzyme(s) and which pharmacophores are crit. for plasma stability.  Arylesterases and carboxylesterases were identified as the main metabolic enzymes for hydroxamic acids.  Finally, the authors suggest structural features to be introduced or removed to improve stability.  This work thus provides the first medicinal chem. toolbox (exptl. procedures and structural guidance) to assess and control the plasma stability of hydroxamic acids and realize their full potential as in vivo pharmacol. probes and therapeutic agents.  This study is particularly relevant to preclin. development as it allows obtaining compds. equally stable in human and rodent models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp13iDBW5DnrVg90H21EOLACvtfcHk0ljSzuIQuv4BxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1amurbE&md5=a7314d840db2c12c7fb769d0b8d52236</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01444%26sid%3Dliteratum%253Aachs%26aulast%3DHermant%26aufirst%3DP.%26aulast%3DBosc%26aufirst%3DD.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DGealageas%26aufirst%3DR.%26aulast%3DLam%26aufirst%3DB.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DRoignant%26aufirst%3DM.%26aulast%3DTolojanahary%26aufirst%3DH.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.%2BY.%26aulast%3DLemdani%26aufirst%3DM.%26aulast%3DBourotte%26aufirst%3DM.%26aulast%3DHerledan%26aufirst%3DA.%26aulast%3DBedart%26aufirst%3DC.%26aulast%3DBiela%26aufirst%3DA.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DControlling%2520Plasma%2520Stability%2520of%2520Hydroxamic%2520Acids%253A%2520A%2520MedChem%2520Toolbox%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9067%26epage%3D9089%26doi%3D10.1021%2Facs.jmedchem.7b01444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durland-Busbice, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinz-Taheny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantzig, A. H.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1158%2F1078-0432.CCR-12-1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=23325581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1159-1168&author=S.+E.+Prattauthor=S.+Durland-Busbiceauthor=R.+L.+Shepardauthor=K.+Heinz-Tahenyauthor=P.+W.+Iversenauthor=A.+H.+Dantzig&title=Human+Carboxylesterase-2+Hydrolyzes+the+Prodrug+of+Gemcitabine+%28LY2334737%29+and+Confers+Prodrug+Sensitivity+to+Cancer+Cells&doi=10.1158%2F1078-0432.CCR-12-1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells</span></div><div class="casAuthors">Pratt, Susan E.; Durland-Busbice, Sara; Shepard, Robert L.; Heinz-Taheny, Kathleen; Iversen, Philip W.; Dantzig, Anne H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1159-1168</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The oral prodrug of gemcitabine LY2334737 is cleaved systemically to gemcitabine; the mechanism responsible for hydrolysis is unknown.  LY2334737 cytotoxicity was tested in the NCI-60 panel; mining of microarray expression data identified carboxylesterase (CES) as a top hydrolase candidate.  Studies examd. whether CES is responsible for hydrolysis and whether cellular CES expression confers prodrug sensitivity.  Exptl. Design: Human recombinant CES isoenzymes were assayed for LY2334737 hydrolysis.  Stable CES-overexpressing HCT-116 transfectants and a SK-OV-3 knockdown were prepd.  Cell lines were tested for drug sensitivity and CES expression by quant. real time-PCR (qRT-PCR), Western blotting, and immunohistochem. staining.  Bystander cytotoxicity studies were conducted with GFP-tagged PC-3 cells as the reporter cell line.  Therapeutic response of the HCT-116 transfectants was evaluated in xenografts.  Results: Of 3 human CES isoenzymes tested, only CES2 hydrolyzed LY2334737.  Five cell lines that express CES2 responded to LY2334737 treatment.  LY2334737 was less cytotoxic to a SK-OV-3 CES2 knockdown than parental cells.  The drug response of CES2-transfected HCT-116 cells correlated with CES2 expression level.  Bystander studies showed statistically greater PC-3-GFP growth inhibition by LY2334737 when cells were cocultured with CES2 and not mock transfectants.  Oral treatment of xenograft models with 3.2 mg/kg LY2334737 once a day for 21 days showed greater tumor growth inhibition of CES2 transfectant than the mock transfectant (P ≤ 0.001).  Conclusions: CES2 is responsible for the slow hydrolysis of LY2334737.  Because intact prodrug circulates at high plasma levels after oral LY2334737 administration, improved response rates may be obsd. by tailoring LY2334737 treatment to patients with CES2 tumor expression.  Clin Cancer Res; 19(5); 1159-68. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM5cExv8fNIbVg90H21EOLACvtfcHk0ljSzuIQuv4BxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D&md5=37b16874ce4de70dea8a5e57f8aa8a0b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1184%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DS.%2BE.%26aulast%3DDurland-Busbice%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DR.%2BL.%26aulast%3DHeinz-Taheny%26aufirst%3DK.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DDantzig%26aufirst%3DA.%2BH.%26atitle%3DHuman%2520Carboxylesterase-2%2520Hydrolyzes%2520the%2520Prodrug%2520of%2520Gemcitabine%2520%2528LY2334737%2529%2520and%2520Confers%2520Prodrug%2520Sensitivity%2520to%2520Cancer%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D1159%26epage%3D1168%26doi%3D10.1158%2F1078-0432.CCR-12-1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterases: A Comprehensive Review</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.apsb.2018.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30245959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=699-712&author=D.+Wangauthor=L.+Zouauthor=Q.+Jinauthor=J.+Houauthor=G.+Geauthor=L.+Yang&title=Human+Carboxylesterases%3A+A+Comprehensive+Review&doi=10.1016%2Fj.apsb.2018.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Human carboxylesterases: a comprehensive review</span></div><div class="casAuthors">Wang Dandan; Zou Liwei; Jin Qiang; Ge Guangbo; Yang Ling; Hou Jie</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">699-712</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase superfamily.  In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade.  These two enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants.  The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs.  This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators.  The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism.  It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdULHHuJhbyicZfW6udTcc2ebbEPHMnTiQ4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D&md5=4c0b70b0208577496c8e0270af5eda8e</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DHuman%2520Carboxylesterases%253A%2520A%2520Comprehensive%2520Review%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26spage%3D699%26epage%3D712%26doi%3D10.1016%2Fj.apsb.2018.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. H.</span></span> <span> </span><span class="NLM_article-title">Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">11618</span>– <span class="NLM_lpage">11628</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608644200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1074%2Fjbc.M608644200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17303577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFemtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=11618-11628&author=L.+Zhaoauthor=M.+J.+Kwonauthor=S.+Huangauthor=J.+Y.+Leeauthor=K.+Fukaseauthor=N.+Inoharaauthor=D.+H.+Hwang&title=Differential+Modulation+of+Nods+Signaling+Pathways+by+Fatty+Acids+in+Human+Colonic+Epithelial+HCT116+Cells&doi=10.1074%2Fjbc.M608644200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells</span></div><div class="casAuthors">Zhao, Ling; Kwon, Myung-Ja; Huang, Shurong; Lee, Joo Y.; Fukase, Koichi; Inohara, Naohiro; Hwang, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11618-11628</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg. proteins (Nods) are intracellular pattern recognition receptors recognizing conserved moieties of bacterial peptidoglycan through their leucine-rich repeats domain.  The agonists for Nods activate proinflammatory signaling pathways, including NF-κB pathways.  The results from our previous studies showed that the activation of TLR4 and TLR2, leucine-rich repeat-contg. pattern recognition receptors, were differentially modulated by satd. and n-3 polyunsatd. fatty acids in macrophages and dendritic cells.  Here, we show the differential modulation of NF-κB activation and interleukin-8 (IL-8) expression in colonic epithelial cells HCT116 by satd. and unsatd. fatty acids mediated through Nods proteins.  Lauric acid (C12:0) dose dependently activated NF-κB and induced IL-8 expression in HCT116 cells, which express both Nod1 and Nod2, but not detectable amts. of TLR2 and TLR4.  These effects of lauric acid were inhibited by dominant neg. forms of Nod1 or Nod2, but not by dominant neg. forms of TLR2, TLR4, and TLR5.  The effects of lauric acid were also attenuated by small RNA interference targeting Nod1 or Nod2.  In contrast, polyunsatd. fatty acids, esp. n-3 polyunsatd. fatty acids, inhibited the activation of NF-κB and IL-8 expression induced by lauric acid or known Nods ligands in HCT116.  Furthermore, lauric acid induced, but docosahexaenoic acid inhibited lauric acid- or Nod2 ligand MDP-induced, Nod2 oligomerization in HEK293T cells transfected with Nod2.  Together, these results provide new insights into the role of dietary fatty acids in modulating inflammation in colon epithelial cells.  The results suggest that Nods may be involved in inducing sterile inflammation, one of the key etiol. conditions in the development of many chronic inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgi02SieBwb7Vg90H21EOLACvtfcHk0ljFN9KsufNhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFemtbg%253D&md5=72fc6f77dab89a364060e6d48488399a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608644200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608644200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DKwon%26aufirst%3DM.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DHwang%26aufirst%3DD.%2BH.%26atitle%3DDifferential%2520Modulation%2520of%2520Nods%2520Signaling%2520Pathways%2520by%2520Fatty%2520Acids%2520in%2520Human%2520Colonic%2520Epithelial%2520HCT116%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D11618%26epage%3D11628%26doi%3D10.1074%2Fjbc.M608644200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalyuzhin, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemlyakov, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, B. B.</span></span> <span> </span><span class="NLM_article-title">Distinctive Immunomodulating Properties and Interactivity with Model Membranes and Cells of Two Homologous Muramyl Dipeptide Derivatives Differing by Their Lipophilicity</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1016/S0192-0561(96)00061-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0192-0561%2896%2900061-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=9089008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADyaK2s3ksVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1996&pages=651-659&author=O.+V.+Kalyuzhinauthor=A.+E.+Zemlyakovauthor=B.+B.+Fuchs&title=Distinctive+Immunomodulating+Properties+and+Interactivity+with+Model+Membranes+and+Cells+of+Two+Homologous+Muramyl+Dipeptide+Derivatives+Differing+by+Their+Lipophilicity&doi=10.1016%2FS0192-0561%2896%2900061-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Distinctive immunomodulating properties and interactivity with model membranes and cells of two homologous muramyl dipeptide derivatives differing by their lipophilicity</span></div><div class="casAuthors">Kalyuzhin O V; Zemlyakov A E; Fuchs B B</div><div class="citationInfo"><span class="NLM_cas:title">International journal of immunopharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">651-9</span>
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">We have studied and compared the immunomodulating activities of two muramyl dipeptide (MDP) derivatives: beta-heptylglycoside-MDP (C7H15MDP) and beta-hexadecylglycoside-MDP (C16H33MDP).  The amphiphilic derivative C7H15MDP has been found to be a more effective stimulator of T lymphocyte proliferation and allospecific cytotoxic T cell generation in a mixed lymphocyte culture, and a more effective activator of interleukin-1 (IL-1) and tumour necrosis factor (TNF) production by murine peritoneal macrophages, in comparison with MDP and C16H33MDP used in equimolar concentrations.  C7H15MDP also stimulated cytotoxicity of natural killer (NK) cells: On the contrary, its lipophilic homologue C16H33MDP did not show such activities in vitro except for its influence on IL-1 and TNF production.  We have found significant differences in the interaction of these two 14C-labelled MDP derivatives with model membranes and in the uptake of these preparations by erythroleukemia K562 cells.  We consider the hydrolipophilic balance of the above preparations to be the main cause of their different interactions with membranes and their uptake by cells and, as a result, their opposite immunomodulating activities in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU4x9c7LCMHYxhnOQkIHOxfW6udTcc2ebbEPHMnTiQ4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3ksVWquw%253D%253D&md5=53f39651259c0defb1cbc358fe59ebc8</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0192-0561%2896%2900061-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0192-0561%252896%252900061-6%26sid%3Dliteratum%253Aachs%26aulast%3DKalyuzhin%26aufirst%3DO.%2BV.%26aulast%3DZemlyakov%26aufirst%3DA.%2BE.%26aulast%3DFuchs%26aufirst%3DB.%2BB.%26atitle%3DDistinctive%2520Immunomodulating%2520Properties%2520and%2520Interactivity%2520with%2520Model%2520Membranes%2520and%2520Cells%2520of%2520Two%2520Homologous%2520Muramyl%2520Dipeptide%2520Derivatives%2520Differing%2520by%2520Their%2520Lipophilicity%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1996%26volume%3D18%26spage%3D651%26epage%3D659%26doi%3D10.1016%2FS0192-0561%2896%2900061-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzelj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbančič, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Structural Features and Functional Activities of Benzimidazoles as NOD2 Antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">112089</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ejmech.2020.112089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=32014680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2020&pages=112089&author=S.+Guzeljauthor=M.+Gobecauthor=D.+Urban%C4%8Di%C4%8Dauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=E.+Corsiniauthor=%C5%BD.+Jakopin&title=Structural+Features+and+Functional+Activities+of+Benzimidazoles+as+NOD2+Antagonists&doi=10.1016%2Fj.ejmech.2020.112089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features and functional activities of benzimidazoles as NOD2 antagonists</span></div><div class="casAuthors">Guzelj, Samo; Gobec, Martina; Urbancic, Dunja; Mlinaric-Rascan, Irena; Corsini, Emanuela; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112089pp.</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To gain insight into the structure-activity relationships of NOD2 antagonists, a series of novel analogs was designed and synthesized, and then screened for antagonist activity vs. NOD2, and counter-screened vs. NOD1.  N-(2,3-Dihydro-1H-indene-5-yl)-2-(2-(2-(phenylsulfonamido)ethyl)-1H-benzo [d]imidazole-l-yl)acetamide and N-(2,3-dihydro-1H-indene-5-yl)-2-(2-(2-(phenylsulfonamido)ethyl)-1H-benzo [d]imidazole-l-yl)acetamide were identified as potent and moderately selective NOD2 antagonists, and N-(2,3-dihydro-1H-indene-5-yl)-2-(2-(2-((5-(dimethylamino)naphthalene)-1-sulfonamido)ethyl)-1H-benzo[d]imidazole-1-yl)acetamide and N-(2,3-dihydro-1H-inden-5-yl)-2-(2-(3-(Nmethylphenylsulfonamido)propyl)-1H-benzo[d]imidazol-1-yl)acetamide as dual NOD1/NOD2 antagonists, with balanced activities against both targets in the low micromolar range.  These data enable in-depth exploration of their structure-activity relationships and provide deeper understanding of the structural features required for NOD2 antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPLN9pOAgrF7Vg90H21EOLACvtfcHk0ljoUErxFrqtaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFOgt74%253D&md5=d7ede6be50594c89517e68ba503023fe</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112089%26sid%3Dliteratum%253Aachs%26aulast%3DGuzelj%26aufirst%3DS.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DUrban%25C4%258Di%25C4%258D%26aufirst%3DD.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DCorsini%26aufirst%3DE.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DStructural%2520Features%2520and%2520Functional%2520Activities%2520of%2520Benzimidazoles%2520as%2520NOD2%2520Antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D190%26spage%3D112089%26doi%3D10.1016%2Fj.ejmech.2020.112089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schupp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuettenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, M.</span></span> <span> </span><span class="NLM_article-title">Stability of Alkyl Chain-Mediated Lipid Anchoring in Liposomal Membranes</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2213</span>, <span class="refDoi"> DOI: 10.3390/cells9102213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3390%2Fcells9102213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitFOhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=2213&author=L.+Gleueauthor=J.+Schuppauthor=N.+Zimmerauthor=E.+Beckerauthor=H.+Freyauthor=A.+Tuettenbergauthor=M.+Helm&title=Stability+of+Alkyl+Chain-Mediated+Lipid+Anchoring+in+Liposomal+Membranes&doi=10.3390%2Fcells9102213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Stability of alkyl chain-mediated lipid anchoring in liposomal membranes</span></div><div class="casAuthors">Gleue, Lukas; Schupp, Jonathan; Zimmer, Niklas; Becker, Eyleen; Frey, Holger; Tuettenberg, Andrea; Helm, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2213</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Lipid exchange among biol. membranes, lipoprotein particles, micelles, and liposomes is an important yet underrated phenomenon with repercussions throughout the life sciences.  The premature loss of lipid mols. from liposomal formulations severely impacts therapeutic applications of the latter and thus limits the type of lipids and lipid conjugates available for fine-tuning liposomal properties.  While cholesterol derivs., with their irregular lipophilic surface shape, are known to readily undergo lipid exchange and interconvert, e.g., with serum, the situation is unclear for lipids with regular, linear-shaped alkyl chains.  This study compares the propensity of fluorescence-labeled lipid conjugates of systematically varied lengths to migrate from liposomal particles consisting mainly of egg phosphatidyl choline 3 (EPC3) and cholesterol into biomembranes.  We show that dialkyl glyceryl lipids with chains of 18-20 methylene units are inherently stable in liposomal membranes.  In contrast, C16 lipids show some lipid exchange, albeit significantly less than comparable cholesterol conjugates.  Remarkably, the C18 chain length, which confers noticeable anchor stability, corresponds to the typical chain length in biol. membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol5WwGGG770bVg90H21EOLACvtfcHk0ljoUErxFrqtaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitFOhsbw%253D&md5=f30d4d45a2a25efedfd8a8a0226522c3</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3390%2Fcells9102213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells9102213%26sid%3Dliteratum%253Aachs%26aulast%3DGleue%26aufirst%3DL.%26aulast%3DSchupp%26aufirst%3DJ.%26aulast%3DZimmer%26aufirst%3DN.%26aulast%3DBecker%26aufirst%3DE.%26aulast%3DFrey%26aufirst%3DH.%26aulast%3DTuettenberg%26aufirst%3DA.%26aulast%3DHelm%26aufirst%3DM.%26atitle%3DStability%2520of%2520Alkyl%2520Chain-Mediated%2520Lipid%2520Anchoring%2520in%2520Liposomal%2520Membranes%26jtitle%3DCells%26date%3D2020%26volume%3D9%26spage%3D2213%26doi%3D10.3390%2Fcells9102213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Der Meer, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of Muramyl Dipeptide Stimulation of Cytokine Production by Blood Components</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2249.2009.03926.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fj.1365-2249.2009.03926.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19438594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=428-433&author=J.+H.+M.+Van%0ADer+Meerauthor=M.+G.+Neteaauthor=C.+A.+Dinarello&title=Modulation+of+Muramyl+Dipeptide+Stimulation+of+Cytokine+Production+by+Blood+Components&doi=10.1111%2Fj.1365-2249.2009.03926.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of muramyl dipeptide stimulation of cytokine production by blood components</span></div><div class="casAuthors">van der Meer, J. H. M.; Netea, M. G.; Dinarello, C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-433</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is the minimal active fragment of peptidoglycan of the cell wall of Gram-pos. bacteria, with potential beneficial effects as a vaccine adjuvant.  Peptidoglycans and MDP are recognized by the intracellular receptor NOD2 (nucleotide-binding oligomerization domain 2), leading to prodn. of proinflammatory cytokines.  In the present study, it is shown that, despite stimulatory effects on isolated human mononuclear cells, MDP does not stimulate prodn. of tumor necrosis factor-α, interleukin-1β or interleukin-6 in a whole-blood assay.  However, MDP retains synergistic effects on lipopolysaccharide-induced cytokines in whole blood.  Screening tests of NOD2 function based on whole-blood stimulation should therefore employ strategies based on the synergistic effects of MDP on Toll-like receptor-induced cytokine prodn.  Plasma was not responsible for the inhibition of MDP in whole blood.  The inhibition of MDP stimulation was dependent upon cellular components, with erythrocyte-derived Hb and neutrophils collaborating in the inhibition of MDP effects in whole blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUdpMc135fu7Vg90H21EOLACvtfcHk0ljoUErxFrqtaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D&md5=a6310bc3893e2094498393e42d080279</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2009.03926.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2009.03926.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BMeer%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DModulation%2520of%2520Muramyl%2520Dipeptide%2520Stimulation%2520of%2520Cytokine%2520Production%2520by%2520Blood%2520Components%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2009%26volume%3D156%26spage%3D428%26epage%3D433%26doi%3D10.1111%2Fj.1365-2249.2009.03926.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferwerda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naber, T. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan Kullberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adema, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Meer, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">6518</span>– <span class="NLM_lpage">6523</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.174.10.6518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.174.10.6518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15879155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvV2lsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=6518-6523&author=M.+G.+Neteaauthor=G.+Ferwerdaauthor=D.+J.+de+Jongauthor=T.+Jansenauthor=L.+Jacobsauthor=M.+Kramerauthor=T.+H.+J.+Naberauthor=J.+P.+H.+Drenthauthor=S.+E.+Girardinauthor=B.+Jan+Kullbergauthor=G.+J.+Ademaauthor=J.+W.+M.+Van+der+Meer&title=Nucleotide-Binding+Oligomerization+Domain-2+Modulates+Specific+TLR+Pathways+for+the+Induction+of+Cytokine+Release&doi=10.4049%2Fjimmunol.174.10.6518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release</span></div><div class="casAuthors">Netea, Mihai G.; Ferwerda, Gerben; De Jong, Dirk J.; Jansen, Trees; Jacobs, Liesbeth; Kramer, Matthijs; Naber, Ton H. J.; Drenth, Joost P. H.; Girardin, Stephen E.; Kullberg, Bart Jan; Adema, Gosse J.; Van der Meer, Jos W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6518-6523</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The recognition of peptidoglycan by cells of the innate immune system has been controversial; both TLR2 and nucleotide-binding oligomerization domain-2 (NOD2) have been implicated in this process.  In the present study we demonstrate that although NOD2 is required for recognition of peptidoglycan, this leads to strong synergistic effects on TLR2-mediated prodn. of both pro- and anti-inflammatory cytokines.  Defective IL-10 prodn. in patients with Crohn's disease bearing loss of function mutations of NOD2 may lead to overwhelming inflammation due to a subsequent Th1 bias.  In addn. to the potentiation of TLR2 effects, NOD2 is a modulator of signals transmitted through TLR4 and TLR3, but not through TLR5, TLR9, or TLR7.  Thus, interaction between NOD2 and specific TLR pathways may represent an important modulatory mechanism of innate immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkVzWqYuBjtLVg90H21EOLACvtfcHk0lg2KA8OCQFseQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvV2lsr8%253D&md5=bde0c40f99924444f5583d08273ed2ab</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.174.10.6518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.174.10.6518%26sid%3Dliteratum%253Aachs%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DFerwerda%26aufirst%3DG.%26aulast%3Dde%2BJong%26aufirst%3DD.%2BJ.%26aulast%3DJansen%26aufirst%3DT.%26aulast%3DJacobs%26aufirst%3DL.%26aulast%3DKramer%26aufirst%3DM.%26aulast%3DNaber%26aufirst%3DT.%2BH.%2BJ.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%2BH.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DJan%2BKullberg%26aufirst%3DB.%26aulast%3DAdema%26aufirst%3DG.%2BJ.%26aulast%3DVan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DNucleotide-Binding%2520Oligomerization%2520Domain-2%2520Modulates%2520Specific%2520TLR%2520Pathways%2520for%2520the%2520Induction%2520of%2520Cytokine%2520Release%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D6518%26epage%3D6523%26doi%3D10.4049%2Fjimmunol.174.10.6518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Aulock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, C.</span></span> <span> </span><span class="NLM_article-title">MDP and Other Muropeptides - Direct and Synergistic Effects on the Immune System</span>. <i>J. Endotoxin Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1179/096805106X89044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1179%2F096805106X89044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=16690010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=69-85&author=S.+Traubauthor=S.+von+Aulockauthor=T.+Hartungauthor=C.+Hermann&title=MDP+and+Other+Muropeptides+-+Direct+and+Synergistic+Effects+on+the+Immune+System&doi=10.1179%2F096805106X89044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">MDP and other muropeptides - direct and synergistic effects on the immune system</span></div><div class="casAuthors">Traub, Stephanie; von Aulock, Sonja; Hartung, Thomas; Hermann, Corinna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endotoxin Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-85</span>CODEN:
                <span class="NLM_cas:coden">JENREB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0519</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  Muropeptides are breakdown products of peptidoglycan (PGN) of Gram-neg. and Gram-pos. bacteria.  They are released during bacterial growth and division, as part of the host response by lysozyme and amidases, or upon antibiotic treatment.  After phagocytosis of bacteria or bacterial breakdown products by host immune cells, the muropeptides trigger intracellular signaling cascades, leading to altered gene expression and activation of the immune response.  Numerous muropeptides and derivs. have been synthesized chem. to characterize their immunostimulatory effects and adjuvant activity.  Muramyl dipeptide, a natural partial structure of PGN, is the minimal structure with adjuvant activity.  This review discusses the structure and occurrence of muropeptides and gives a broad overview of their inflammatory and adjuvant activity and the possible involvement of receptors in these responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEKqY15UjK3LVg90H21EOLACvtfcHk0lg2KA8OCQFseQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D&md5=b10e36602d50c3022a76e7bf47b3d3e6</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1179%2F096805106X89044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F096805106X89044%26sid%3Dliteratum%253Aachs%26aulast%3DTraub%26aufirst%3DS.%26aulast%3Dvon%2BAulock%26aufirst%3DS.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHermann%26aufirst%3DC.%26atitle%3DMDP%2520and%2520Other%2520Muropeptides%2520-%2520Direct%2520and%2520Synergistic%2520Effects%2520on%2520the%2520Immune%2520System%26jtitle%3DJ.%2520Endotoxin%2520Res.%26date%3D2006%26volume%3D12%26spage%3D69%26epage%3D85%26doi%3D10.1179%2F096805106X89044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, H.</span></span> <span> </span><span class="NLM_article-title">Muramyldipeptide and Diaminopimelic Acid-Containing Desmuramylpeptides in Combination with Chemically Synthesized Toll-like Receptor Agonists Synergistically Induced Production of Interleukin-8 in a NOD2- and NOD1-Dependent Manner, Respectively, in Human</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2004.00433.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fj.1462-5822.2004.00433.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15617523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotlWrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=53-61&author=A.+Ueharaauthor=S.+Yangauthor=Y.+Fujimotoauthor=K.+Fukaseauthor=S.+Kusumotoauthor=K.+Shibataauthor=S.+Sugawaraauthor=H.+Takada&title=Muramyldipeptide+and+Diaminopimelic+Acid-Containing+Desmuramylpeptides+in+Combination+with+Chemically+Synthesized+Toll-like+Receptor+Agonists+Synergistically+Induced+Production+of+Interleukin-8+in+a+NOD2-+and+NOD1-Dependent+Manner%2C+Respectively%2C+in+Human&doi=10.1111%2Fj.1462-5822.2004.00433.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture</span></div><div class="casAuthors">Uehara, A.; Yang, S.; Fujimoto, Y.; Fukase, K.; Kusumoto, S.; Shibata, K.; Sugawara, S.; Takada, H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Two types of synthetic peptidoglycan fragments, diaminopimelic acid (DAP)-contg. desmuramylpeptides (DMP) and muramyldipeptide (MDP), induced secretion of interleukin (IL)-8 in a dose-dependent manner in human monocytic THP-1 cells, although high concns. of compds. are required as compared with chem. synthesized Toll-like receptor (TLR) agonists mimicking bacterial components: TLR2 agonistic lipopeptide (Pam3CSSNA), TLR4 agonistic lipid A (LA-15-PP) and TLR9 agonistic bacterial CpG DNA.  The authors found marked synergistic IL-8 secretion induced by MDP or DAP-contg. DMP in combination with synthetic TLR agonists in THP-1 cells.  Suppression of the mRNA expression of nucleotide-binding oligomerization domain (NOD)1 and NOD2 by RNA interference specifically inhibited the synergistic IL-8 secretion induced by DMP and MDP with these TLR agonists resp.  In accordance with the above results, enhanced IL-8 mRNA expression and the activation of nuclear factor (NF)-κB induced by MDP or DMP in combination with synthetic TLR agonists were markedly suppressed in NOD2- and NOD1-silenced cells resp.  These findings indicated that NOD2 and NOD1 are specifically responsible for the synergistic effects of MDP and DMP with TLR agonists, and suggested that in host innate immune responses to invading bacteria, combinatory dual signaling through extracellular TLRs and intracellular NODs might lead to the synergistic activation of host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUbud42ZGZvrVg90H21EOLACvtfcHk0lg2KA8OCQFseQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotlWrsA%253D%253D&md5=c89bceb1dc9f08b145d9e8d8f5fe879a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2004.00433.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2004.00433.x%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DFujimoto%26aufirst%3DY.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26atitle%3DMuramyldipeptide%2520and%2520Diaminopimelic%2520Acid-Containing%2520Desmuramylpeptides%2520in%2520Combination%2520with%2520Chemically%2520Synthesized%2520Toll-like%2520Receptor%2520Agonists%2520Synergistically%2520Induced%2520Production%2520of%2520Interleukin-8%2520in%2520a%2520NOD2-%2520and%2520NOD1-Dependent%2520Manner%252C%2520Respectively%252C%2520in%2520Human%26jtitle%3DCell.%2520Microbiol.%26date%3D2005%26volume%3D7%26spage%3D53%26epage%3D61%26doi%3D10.1111%2Fj.1462-5822.2004.00433.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitting, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengin-Lecreulx, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caroff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaillon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adib-Conquy, M.</span></span> <span> </span><span class="NLM_article-title">Synergistic Stimulation of Human Monocytes and Dendritic Cells by Toll-like Receptor 4 and NOD1- and NOD2- Activating Agonists</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2459</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1002/eji.200526286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1002%2Feji.200526286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=16021602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Gmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=2459-2470&author=J.+H.+Fritzauthor=S.+E.+Girardinauthor=C.+Fittingauthor=C.+Wertsauthor=D.+Mengin-Lecreulxauthor=M.+Caroffauthor=J.+M.+Cavaillonauthor=D.+J.+Philpottauthor=M.+Adib-Conquy&title=Synergistic+Stimulation+of+Human+Monocytes+and+Dendritic+Cells+by+Toll-like+Receptor+4+and+NOD1-+and+NOD2-+Activating+Agonists&doi=10.1002%2Feji.200526286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists</span></div><div class="casAuthors">Fritz, Jorg H.; Girardin, Stephen E.; Fitting, Catherine; Werts, Catherine; Mengin-Lecreulx, Dominique; Caroff, Martine; Cavaillon, Jean-Marc; Philpott, Dana J.; Adib-Conquy, Minou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2459-2470</span>CODEN:
                <span class="NLM_cas:coden">EJIMAF</span>;
        ISSN:<span class="NLM_cas:issn">0014-2980</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Muropeptides are degrdn. products of bacterial peptidoglycan (PG) sensed by nucleotide-binding oligomerization domain 1 (NOD1) and NOD2, members of a recently discovered family of pattern recognition mols. (PRM).  One of these muropeptides, muramyl dipeptide (MDP) mediates cell signaling by NOD2, exerts adjuvant activity and synergizes with lipopolysaccharide (LPS) to induce pro-inflammatory responses in vitro and in vivo.  In contrast, few and contradictory results exist about the stimulatory capacity of NOD1 agonists.  Thus, the ability of NOD1 (MurNAc-L-Ala-γ-D-Glu-meso-diaminopimelic acid, MtriDAP) and NOD2 (MurNAc-L-Ala-D-isoGln, MDP; MurNAc-L-Ala-γ-D-Glu-L-Lys, MtriLYS) agonists to activate primary human myeloid cells was examd.  The authors show that both CD14+ monocytes and CD1a+ immature dendritic cells (DC) express NOD1 and NOD2 mRNA.  Stimulation of primary human monocytes and DC with highly purified muropeptides (MtriDAP, MDP and MtriLYS) induces release of pro-inflammatory cytokines.  The authors reveal here that NOD1 as well as NOD2 agonists act cooperatively with LPS to stimulate the release of both pro- and anti-inflammatory cytokines in these myeloid cell subsets.  Finally, the authors report that NOD1 as well as NOD2 agonists synergize with sub-active doses of LPS to induce DC maturation, demonstrating that NOD agonists act cooperatively with mols. sensed by Toll-like receptor 4 to instruct the onset of adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3O1mLZxSadrVg90H21EOLACvtfcHk0liMyI2bI71ylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Gmur4%253D&md5=b32a674d49e8c4ae127b2f3bb3cf82cc</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Feji.200526286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200526286%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DFitting%26aufirst%3DC.%26aulast%3DWerts%26aufirst%3DC.%26aulast%3DMengin-Lecreulx%26aufirst%3DD.%26aulast%3DCaroff%26aufirst%3DM.%26aulast%3DCavaillon%26aufirst%3DJ.%2BM.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DAdib-Conquy%26aufirst%3DM.%26atitle%3DSynergistic%2520Stimulation%2520of%2520Human%2520Monocytes%2520and%2520Dendritic%2520Cells%2520by%2520Toll-like%2520Receptor%25204%2520and%2520NOD1-%2520and%2520NOD2-%2520Activating%2520Agonists%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2005%26volume%3D35%26spage%3D2459%26epage%3D2470%26doi%3D10.1002%2Feji.200526286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. W.</span></span> <span> </span><span class="NLM_article-title">Dual Roles of NOD2 in TLR4-Mediated Signal Transduction and -Induced Inflammatory Gene Expression in Macrophages</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2010.01567.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1111%2Fj.1462-5822.2010.01567.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21199260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Gisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=717-730&author=W.+H.+Tsaiauthor=D.+Y.+Huangauthor=Y.+H.+Yuauthor=C.+Y.+Chenauthor=W.+W.+Lin&title=Dual+Roles+of+NOD2+in+TLR4-Mediated+Signal+Transduction+and+-Induced+Inflammatory+Gene+Expression+in+Macrophages&doi=10.1111%2Fj.1462-5822.2010.01567.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages</span></div><div class="casAuthors">Tsai, Wen-Hsiang; Huang, Duen-Yi; Yu, Yang-Hao; Chen, Chih-Yi; Lin, Wan-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">717-730</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NOD2 of the NLRs and TLR4 of the TLRs are major pattern-recognition receptors, which sense different microbial pathogens and have important roles in innate immunity.  Herein, we investigated the roles of NOD2 in TLR4-mediated signalling and gene regulation in RAW264.7 macrophages.  We found that MDP (a NOD2 ligand) increased LPS-induced expressions of TNF-α, IL-1β, IL-6, INOS and COX-2.  MDP did not affect LPS-induced activation of MAPKs or IKK, while it potentiated LPS-induced NF-κB activation.  Meanwhile TLR4 activation increased NOD2 mRNA expression, and upregulated NOD2 upon MDP treatment is a pos. regulator of TLR4-mediated signalling.  Intriguingly we found that NOD2 silencing led to increases in LPS-induced signal transduction and inflammatory responses, and a decrease in LPS-elicited homologous tolerance.  We thus propose that NOD2 in the absence of MDP treatment might also play a neg. regulatory role in the action of TLR4.  Further, we demonstrated that both CARD and LRR domains of the NOD2 protein were responsible for the neg. regulatory action on TLR4.  In summary, it is the first time to demonstrate that NOD2 have dual effects on TLR4 signalling and exert a novel ligand-independent action.  Elucidating mol. mechanisms by which NOD2 exerts its ligand-independent action on TLR4 requires further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2DLBiJ6PHMLVg90H21EOLACvtfcHk0liMyI2bI71ylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Gisrk%253D&md5=0100e88602d0dd9510f1fa58944a7ea7</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2010.01567.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2010.01567.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DW.%2BH.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DYu%26aufirst%3DY.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DW.%2BW.%26atitle%3DDual%2520Roles%2520of%2520NOD2%2520in%2520TLR4-Mediated%2520Signal%2520Transduction%2520and%2520-Induced%2520Inflammatory%2520Gene%2520Expression%2520in%2520Macrophages%26jtitle%3DCell.%2520Microbiol.%26date%3D2011%26volume%3D13%26spage%3D717%26epage%3D730%26doi%3D10.1111%2Fj.1462-5822.2010.01567.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo
Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapoval, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medvedev, A. E.</span></span> <span> </span><span class="NLM_article-title">Activation of Cytokine-Producing and Antitumor Activities of Natural Killer Cells and Macrophages by Engagement of Toll-like and NOD-like Receptors</span>. <i>Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1177/1753425910372000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1177%2F1753425910372000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=20682587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGisrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=375-387&author=F.+Qiuauthor=A.+Maniarauthor=M.+Quevedo%0ADiazauthor=A.+I.+Chapovalauthor=A.+E.+Medvedev&title=Activation+of+Cytokine-Producing+and+Antitumor+Activities+of+Natural+Killer+Cells+and+Macrophages+by+Engagement+of+Toll-like+and+NOD-like+Receptors&doi=10.1177%2F1753425910372000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors</span></div><div class="casAuthors">Qiu, Fu; Maniar, Amudhan; Diaz, Marco Quevedo; Chapoval, Andrei I.; Medvedev, Andrei E.</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Macrophages and natural killer (NK) cells are important antitumor effectors by virtue of their ability to produce cytokines, chemokines and interferons (IFNs) and to mediate tumor cytotoxicity.  Little is known about the impact of Toll-like receptor (TLR) and nucleotide binding and oligomerization domain (NOD)-like receptor (NLR) pathways on NK cell functions, and the role of TLRs and NLRs in macrophage activation is incompletely understood.  In this study, we examd. the capacities of expressed TLRs and NLRs to elicit cytokine prodn. in human NK cells and THP1 macrophages, and to activate NK cytotoxicity against the squamous cell carcinoma of head and neck cell line Tu167 and erythroleukemia K562 cells.  We found that NK cells express high levels of NOD2, NLRP3, TLR3, TLR7, and TLR9, while NOD1 was expressed at low levels.  All tested NLR and TLR agonists potentiated NK cytotoxicity against Tu167 cells, whereas only poly (I:C) increased NK cytotoxicity against K562 cells.  Poly (I:C) and Escherichia coli RNA markedly up-regulated TNF-α and IFN-γ expression in the NK92 cell line and human CD56+CD3- primary NK cells.  High levels of NOD2, TLR7 and TLR9 proteins were obsd. in human THP1 cells, followed by TLR3, NOD1, and NLRP3.  Stimulation of NLRP3 with E. coli RNA led to the highest induction of TNF-α, IL-6, IL-12p40, RANTES and IFN-β, whereas TLR7, TLR3, TLR9, NOD1 and NOD2 agonists had lower effects.  Our data reveal involvement of TLRs and NLRs in potentiation of antitumor cytotoxicity and cytokine-producing activities of human NK cells and macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnYmtQp05Z_rVg90H21EOLACvtfcHk0liMyI2bI71ylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGisrvE&md5=27c3fc7a79e0261bc1140f9eebb92bc4</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1177%2F1753425910372000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425910372000%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DManiar%26aufirst%3DA.%26aulast%3DQuevedo%2BDiaz%26aufirst%3DM.%26aulast%3DChapoval%26aufirst%3DA.%2BI.%26aulast%3DMedvedev%26aufirst%3DA.%2BE.%26atitle%3DActivation%2520of%2520Cytokine-Producing%2520and%2520Antitumor%2520Activities%2520of%2520Natural%2520Killer%2520Cells%2520and%2520Macrophages%2520by%2520Engagement%2520of%2520Toll-like%2520and%2520NOD-like%2520Receptors%26jtitle%3DInnate%2520Immun.%26date%3D2011%26volume%3D17%26spage%3D375%26epage%3D387%26doi%3D10.1177%2F1753425910372000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Athié-Morales, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, C. M.</span></span> <span> </span><span class="NLM_article-title">Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">4082</span>– <span class="NLM_lpage">4089</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.180.6.4082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.180.6.4082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18322218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisl2jtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=4082-4089&author=V.+Athi%C3%A9-Moralesauthor=G.+M.+O%E2%80%99Connorauthor=C.+M.+Gardiner&title=Activation+of+Human+NK+Cells+by+the+Bacterial+Pathogen-Associated+Molecular+Pattern+Muramyl+Dipeptide&doi=10.4049%2Fjimmunol.180.6.4082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide</span></div><div class="casAuthors">Athie-Morales, Veronica; O'Connor, Geraldine M.; Gardiner, Clair M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4082-4089</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is a bacterial pathogen assocd. mol. pattern derived from both Gram-pos. and -neg. bacteria.  It is a specific ligand for nuclear oligomerization domain 2, a pattern recognition receptor best characterized for its role in immunosurveillance in the gut.  In this study, the authors demonstrate that human peripheral blood NK cells express nuclear oligomerization domain 2 and respond to MDP.  NK cells naturally internalize MDP leading to direct cell activation, including signaling through NF-κB: characterized by p50/p65 heterodimers at early stimulations times and sustained activation of p50 homodimers.  Moreover, MDP synergizes with IFN-α and IL-12 to activate NK cells and stimulate IFN-γ secretion, suggesting a role for accessory cells in induction of an optimal NK cell response.  Although IL-12 costimulation leads to a greater IFN-γ response by NK cells, higher levels of CD69 in response to MDP are induced in the presence of IFN-α, suggesting that different pathogen-induced cytokine profiles will affect down-stream NK cell responses.  In contrast, MDP alone or in combination with either IFN-α or IL-12 only poorly increases NK cell cytotoxicity.  In summary, this report identifies MDP as a bacterial pathogen assocd. mol. pattern that activates human NK cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLgbPkn2nW2bVg90H21EOLACvtfcHk0ljjZeZOXkUW9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisl2jtro%253D&md5=1d0902a4786820232d37b70b608469fb</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.180.6.4082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.180.6.4082%26sid%3Dliteratum%253Aachs%26aulast%3DAthi%25C3%25A9-Morales%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DG.%2BM.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26atitle%3DActivation%2520of%2520Human%2520NK%2520Cells%2520by%2520the%2520Bacterial%2520Pathogen-Associated%2520Molecular%2520Pattern%2520Muramyl%2520Dipeptide%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D4082%26epage%3D4089%26doi%3D10.4049%2Fjimmunol.180.6.4082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, S. W.</span></span> <span> </span><span class="NLM_article-title">Interactions between Human Monocytes and Tumour Cells. Monocytes Can Either Enhance or Inhibit the Growth and Survival of K562 Cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1038/bjc.1992.296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fbjc.1992.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1520583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADyaK38zpt1OjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1992&pages=463-469&author=B.+Daviesauthor=S.+W.+Edwards&title=Interactions+between+Human+Monocytes+and+Tumour+Cells.+Monocytes+Can+Either+Enhance+or+Inhibit+the+Growth+and+Survival+of+K562+Cells&doi=10.1038%2Fbjc.1992.296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells</span></div><div class="casAuthors">Davies B; Edwards S W</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-9</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Human bloodstream monocytes can kill cultured tumour cells (K562), as assessed by specific release of 51Cr from the targets and by inhibition of 3H-thymidine incorporation.  Confluent monolayers of monocytes were required for maximal cytotoxicity, and the density of the K562 cells was also an important factor.  For example, when K562 cells were seeded at high cell densities, they were killed during incubation with monocytes, but when seeded at low cell densities their growth and survival was enhanced during culture with monocytes.  The factor(s) which promoted the survival and division of low density K562 cultures was endogenously secreted from monocytes as it was present in monocyte-conditioned medium, whereas the cytotoxic factor(s) were only expressed during co-culture of monocytes with K562 cells.  Conditioned medium from HL 60, U-937, HeLa and K562 could also enhance the growth and survival of low density K562 cultures, and a similar effect was also observed upon the addition of catalase and superoxide dismutase to such cultures.  Thus, the monocyte:target ratio is important in determining whether monocytes exhibit cytotoxic or growth-promoting effects and hence tumour-derived or monocyte-derived reactive oxidant species may play a role in tumour cell cycle regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ438yWUhto_v_I8Jvzw4xCfW6udTcc2eYwOXqr7IPB9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zpt1OjsA%253D%253D&md5=749c7906e26fdb2366b10e50e9b49aec</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1992.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1992.296%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DEdwards%26aufirst%3DS.%2BW.%26atitle%3DInteractions%2520between%2520Human%2520Monocytes%2520and%2520Tumour%2520Cells.%2520Monocytes%2520Can%2520Either%2520Enhance%2520or%2520Inhibit%2520the%2520Growth%2520and%2520Survival%2520of%2520K562%2520Cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1992%26volume%3D66%26spage%3D463%26epage%3D469%26doi%3D10.1038%2Fbjc.1992.296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Berestein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidler, I. J.</span></span> <span> </span><span class="NLM_article-title">Potentiation of Direct Antitumor Cytotoxicity and Production of Tumor Cytolytic Factors in Human Blood Monocytes by Human Recombinant Interferon-Gamma and Muramyl Dipeptide Derivatives</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1007/BF00199855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1007%2FBF00199855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3081250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL28XhvVClsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1986&pages=93-99&author=S.+Soneauthor=G.+Lopez-Beresteinauthor=I.+J.+Fidler&title=Potentiation+of+Direct+Antitumor+Cytotoxicity+and+Production+of+Tumor+Cytolytic+Factors+in+Human+Blood+Monocytes+by+Human+Recombinant+Interferon-Gamma+and+Muramyl+Dipeptide+Derivatives&doi=10.1007%2FBF00199855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives</span></div><div class="casAuthors">Sone, Saburo; Lopez-Berestein, Gabriel; Fidler, Isaiah J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-9</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    </div><div class="casAbstract">The authors investigated whether human peripheral blood monocytes isolated by centrifugal elutriation from healthy donors could be activated to become tumoricidal and release tumor cytolytic factor (TCF) subsequent to incubation with recombinant human interferon-γ (r-IFN-γ) or a deriv. of muramyl dipeptide (nor-MDP), or both.  Blood monocytes incubated in endotoxin-free medium contg. up to 1000 units/mL of r-IFN-γ or in medium contg. <1 μg/mL of nor-MDP were not activated to lyse radiolabeled allogeneic human tumor cells.  In contrast, the incubation of monocytes with various dose combinations of r-IFN-γ and nor-MDP generated significant direct cytotoxic activity as well as prodn. of TCF.  Preincubation of the r-IFN-γ and nor-MDP mixt. with polymyxin B did not inhibit the synergism, thus ruling out the possibility that the process was due to endotoxin contamination.  TCF harvested from monocyte culture supernatants was cytolytic against 5 allogeneic tumor targets, but not against a nontumorigenic cell line.  Thus, r-IFN-γ can prime human blood monocytes to allow their activation by synthetic nor-MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqy0FUWvb3sbVg90H21EOLACvtfcHk0ljjZeZOXkUW9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVClsr8%253D&md5=477d315b64583fe8fc89596a5e48fddf</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2FBF00199855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00199855%26sid%3Dliteratum%253Aachs%26aulast%3DSone%26aufirst%3DS.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DFidler%26aufirst%3DI.%2BJ.%26atitle%3DPotentiation%2520of%2520Direct%2520Antitumor%2520Cytotoxicity%2520and%2520Production%2520of%2520Tumor%2520Cytolytic%2520Factors%2520in%2520Human%2520Blood%2520Monocytes%2520by%2520Human%2520Recombinant%2520Interferon-Gamma%2520and%2520Muramyl%2520Dipeptide%2520Derivatives%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D1986%26volume%3D21%26spage%3D93%26epage%3D99%26doi%3D10.1007%2FBF00199855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandarian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunga, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Saenz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetti, M.</span></span> <span> </span><span class="NLM_article-title">A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>, <span class="NLM_elocation-id">e56191</span> <span class="refDoi"> DOI: 10.3791/56191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3791%2F56191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&author=F.+Kandarianauthor=G.+M.+Sungaauthor=D.+Arango-Saenzauthor=M.+Rossetti&title=A+Flow+Cytometry-Based+Cytotoxicity+Assay+for+the+Assessment+of+Human+NK+Cell+Activity&doi=10.3791%2F56191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.3791%2F56191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F56191%26sid%3Dliteratum%253Aachs%26aulast%3DKandarian%26aufirst%3DF.%26aulast%3DSunga%26aufirst%3DG.%2BM.%26aulast%3DArango-Saenz%26aufirst%3DD.%26aulast%3DRossetti%26aufirst%3DM.%26atitle%3DA%2520Flow%2520Cytometry-Based%2520Cytotoxicity%2520Assay%2520for%2520the%2520Assessment%2520of%2520Human%2520NK%2520Cell%2520Activity%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2017%26volume%3D126%26doi%3D10.3791%2F56191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay-McLean, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coenraads, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuy, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, N. F.</span></span> <span> </span><span class="NLM_article-title">Expression of Ligands for Activating Natural Killer Cell Receptors on Cell Lines Commonly Used to Assess Natural Killer Cell Function</span>. <i>BMC Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">8</span>, <span class="refDoi"> DOI: 10.1186/s12865-018-0272-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1186%2Fs12865-018-0272-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30696399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=8&author=A.+Tremblay-McLeanauthor=S.+Coenraadsauthor=Z.+Kianiauthor=F.+P.+Dupuyauthor=N.+F.+Bernard&title=Expression+of+Ligands+for+Activating+Natural+Killer+Cell+Receptors+on+Cell+Lines+Commonly+Used+to+Assess+Natural+Killer+Cell+Function&doi=10.1186%2Fs12865-018-0272-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function</span></div><div class="casAuthors">Tremblay-McLean Alexandra; Coenraads Sita; Kiani Zahra; Dupuy Franck P; Bernard Nicole F; Tremblay-McLean Alexandra; Kiani Zahra; Bernard Nicole F; Bernard Nicole F; Bernard Nicole F</div><div class="citationInfo"><span class="NLM_cas:title">BMC immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Natural killer cell responses to virally-infected or transformed cells depend on the integration of signals received through inhibitory and activating natural killer cell receptors.  Human Leukocyte Antigen null cells are used in vitro to stimulate natural killer cell activation through missing-self mechanisms.  On the other hand, CEM.NKr.CCR5 cells are used to stimulate natural killer cells in an antibody dependent manner since they are resistant to direct killing by natural killer cells.  Both K562 and 721.221 cell lines lack surface major histocompatibility compatibility complex class Ia ligands for inhibitory natural killer cell receptors.  Previous work comparing natural killer cell stimulation by K562 and 721.221 found that they stimulated different frequencies of natural killer cell functional subsets.  We hypothesized that natural killer cell function following K562, 721.221 or CEM.NKr.CCR5 stimulation reflected differences in the expression of ligands for activating natural killer cell receptors.  RESULTS:  K562 expressed a higher intensity of ligands for Natural Killer G2D and the Natural Cytotoxicity Receptors, which are implicated in triggering natural killer cell cytotoxicity. 721.221 cells expressed a greater number of ligands for activating natural killer cell receptors. 721.221 expressed cluster of differentiation 48, 80 and 86 with a higher mean fluorescence intensity than did K562.  The only ligands for activating receptor that were detected on CEM.NKr.CCR5 cells at a high intensity were cluster of differentiation 48, and intercellular adhesion molecule-2.  CONCLUSIONS:  The ligands expressed by K562 engage natural killer cell receptors that induce cytolysis.  This is consistent with the elevated contribution that the cluster of differentiation 107a function makes to total K562 induced natural killer cell functionality compared to 721.221 cells.  The ligands expressed on 721.221 cells can engage a larger number of activating natural killer cell receptors, which may explain their ability to activate a larger frequency of these cells to become functional and secrete cytokines.  The few ligands for activating natural killer cell receptors expressed by CEM.NKr.CCR5 may reduce their ability to activate natural killer cells in an antibody independent manner explaining their relative resistance to direct natural killer cell cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ87iNUlz2Cuxe4jJGKT5N0fW6udTcc2eYSHmf6b_SJ_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmslahsQ%253D%253D&md5=b33a908f8db06ab0efe73b3a320b78f5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1186%2Fs12865-018-0272-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12865-018-0272-x%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay-McLean%26aufirst%3DA.%26aulast%3DCoenraads%26aufirst%3DS.%26aulast%3DKiani%26aufirst%3DZ.%26aulast%3DDupuy%26aufirst%3DF.%2BP.%26aulast%3DBernard%26aufirst%3DN.%2BF.%26atitle%3DExpression%2520of%2520Ligands%2520for%2520Activating%2520Natural%2520Killer%2520Cell%2520Receptors%2520on%2520Cell%2520Lines%2520Commonly%2520Used%2520to%2520Assess%2520Natural%2520Killer%2520Cell%2520Function%26jtitle%3DBMC%2520Immunol.%26date%3D2019%26volume%3D20%26spage%3D8%26doi%3D10.1186%2Fs12865-018-0272-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempsey, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacane, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panara, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bongrazio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, J. W.</span></span> <span> </span><span class="NLM_article-title">Activation of Human Natural Killer Cells by Lipopolysaccharide and Generation of Interleukin-1alpha, Beta, Tumour Necrosis Factor and Interleukin-6. Effect of IL-1 Receptor Antagonist</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1833315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3MXmtlSisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1991&pages=450-456&author=P.+Contiauthor=R.+A.+Dempseyauthor=M.+Realeauthor=R.+C.+Barbacaneauthor=M.+R.+Panaraauthor=M.+Bongrazioauthor=J.+W.+Mier&title=Activation+of+Human+Natural+Killer+Cells+by+Lipopolysaccharide+and+Generation+of+Interleukin-1alpha%2C+Beta%2C+Tumour+Necrosis+Factor+and+Interleukin-6.+Effect+of+IL-1+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1alpha, beta, tumor necrosis factor and interleukin-6.  Effect of IL-1 receptor antagonist</span></div><div class="casAuthors">Conti, P.; Dempsey, R. A.; Reale, M.; Barbacane, R. C.; Panara, M. R.; Bongrazio, M.; Mier, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-6</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    </div><div class="casAbstract">The presence in the body of an antigen species of a bacterial lipopolysaccharide (LPS) has a pleiotropic effect on the immune system activating macrophages, lymphocytes, and natural killer (NK) cells.  Recently it was reported that human macrophages not only secrete interleukin-1 (IL-1) but also its inhibitor, called IL-1 receptor antagonist (IL-1ra), structurally similar to IL-1β, but with no IL-1-like activity and which binds to the IL-1 receptor.  The authors show that LPS stimulates NK cell activity and IL-1ra potentiates the stimulatory effect of human recombinant interleukin-2 (hrIL-2) on NK cell activity.  In addn., hrIL-1ra inhibits DNA synthesis in lymphocyte cultures stimulated with phytohemagglutinin (PHA) (20 μg/mL), presumably via IL-1 inhibition.  LPS is a potent stimulator of monokines: IL-6, tumor necrosis factor-α (TNF-α), and IL-1β, as detd. by RIA method, and interferon-γ (IFN-γ), IL-2, TNF-α, and IL-1α, as detd. by ELISA method, in peripheral blood mononuclear cells (PBMC).  PBMC were used as effector cells since LPS requires the presence of accessory cells to activate lymphocytes and bind to the HLA-DR mol. on accessory cells.  The effect of LPS on PBMC cytotoxicity was compared with an endotoxin-free ext. of Escherichia coli, OM-8990, which did not provoke cytokine prodn. nor did it cause enhancement of NK cell activity.  Human recombinant IL-1ra potentiates the stimulatory effect of IL-2 on NK cell activity, similar to hrIL-1β.  Since IL-1ra is a part of the IL-1 family, it may work in a similar fashion to IL-1, which also potentiates IL-2 to enhance NK cell activity but has been shown not to be directly important in tumor cell killing.  In addn., hrIL-1ra can amplify the effect of IL-2 on NK activity, possibly by inhibiting the cyclooxygenase products, which are immunosuppressive and are generated in antigen-stimulated PBMC cultures.  The generation of IFN-γ by PBMC after treatment with LPS strongly suggests that the enhancement of NK cell activity may be indirectly due to IFN prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra0QyCYWopEbVg90H21EOLACvtfcHk0lglt2YFEKih5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtlSisLg%253D&md5=b4ebcae4f8e3be5438ce098ee31061fd</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DP.%26aulast%3DDempsey%26aufirst%3DR.%2BA.%26aulast%3DReale%26aufirst%3DM.%26aulast%3DBarbacane%26aufirst%3DR.%2BC.%26aulast%3DPanara%26aufirst%3DM.%2BR.%26aulast%3DBongrazio%26aufirst%3DM.%26aulast%3DMier%26aufirst%3DJ.%2BW.%26atitle%3DActivation%2520of%2520Human%2520Natural%2520Killer%2520Cells%2520by%2520Lipopolysaccharide%2520and%2520Generation%2520of%2520Interleukin-1alpha%252C%2520Beta%252C%2520Tumour%2520Necrosis%2520Factor%2520and%2520Interleukin-6.%2520Effect%2520of%2520IL-1%2520Receptor%2520Antagonist%26jtitle%3DImmunology%26date%3D1991%26volume%3D73%26spage%3D450%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodziejczyk, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wysocka-Skrzela, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myśliwski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosnowska, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antitumor Activity of Conjugates of Muramyldipeptide, Normuramyldipeptide, and Desmuramylpeptides with Acridine/Acridone Derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3606</span>– <span class="NLM_lpage">3615</span>, <span class="refDoi"> DOI: 10.1021/jm001115g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001115g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntF2hsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3606-3615&author=K.+Dzierzbickaauthor=A.+M.+Kolodziejczykauthor=B.+Wysocka-Skrzelaauthor=A.+My%C5%9Bliwskiauthor=D.+Sosnowska&title=Synthesis+and+Antitumor+Activity+of+Conjugates+of+Muramyldipeptide%2C+Normuramyldipeptide%2C+and+Desmuramylpeptides+with+Acridine%2FAcridone+Derivatives&doi=10.1021%2Fjm001115g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antitumor Activity of Conjugates of Muramyldipeptide, Normuramyldipeptide, and Desmuramylpeptides with Acridine/Acridone Derivatives</span></div><div class="casAuthors">Dzierzbicka, Krystyna; Kolodziejczyk, Aleksander M.; Wysocka-Skrzela, Barbara; Mysliwski, Andrzej; Sosnowska, Danuta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3606-3615</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of muramyldipeptides I (R = acridine or acridone derivs.; Xaa = L-Ala, L-Val; Y = CH2Ph, Me), normuramyldipeptides II (R1 = H, Me; Xaa = L-Ala, L-Val, L-Pro; R2 = acridine or acridone derivs.) and desmuramyldipeptides analogs III·2HCl (R3 = acridine or acridone derivs.) and IV·2HCl contg. acridine derivs. V (Alk = alkylene) or acridone derivs. VI are described.  In I, the hydroxyl group at C6 of the sugar moiety formed esters with acridine/acridone N-substituted ω-aminoalkanocarboxylic acids, whereas II, III and IV have an amide bond formed between the carboxylic group of isoglutamine and the amine function of the resp. acridine/acridone derivs.  The preliminary screening data indicate that I, III and IV exhibit small cytotoxic activity; several compds. of type II exhibit potent in vitro cytotoxic activity against a panel of human cell lines and have been selected by the National Cancer Institute (NCI) Evaluation Committee for further testing.  I (R = V, Alk = CH2CH2; Xaa = L-Ala, Y = CH2Ph) shows an immunostimulating effect on the cytotoxic activity of the NK cells obtained from the spleen of healthy and Ab melanoma bearing animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRe-Ggxl4FYLVg90H21EOLACvtfcHk0lglt2YFEKih5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntF2hsr8%253D&md5=5879c5469a8bf2a58bc70f871cf49eb9</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm001115g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001115g%26sid%3Dliteratum%253Aachs%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DKolodziejczyk%26aufirst%3DA.%2BM.%26aulast%3DWysocka-Skrzela%26aufirst%3DB.%26aulast%3DMy%25C5%259Bliwski%26aufirst%3DA.%26aulast%3DSosnowska%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Antitumor%2520Activity%2520of%2520Conjugates%2520of%2520Muramyldipeptide%252C%2520Normuramyldipeptide%252C%2520and%2520Desmuramylpeptides%2520with%2520Acridine%252FAcridone%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3606%26epage%3D3615%26doi%3D10.1021%2Fjm001115g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span> <span> </span><span class="NLM_article-title">Induction of Maturation in Cultured Human Monocytic Leukemia Cells by a Phorbol Diester</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1530</span>– <span class="NLM_lpage">1536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=6949641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL38Xks1OmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1982&pages=1530-1536&author=S.+Tsuchiyaauthor=Y.+Gotaauthor=H.+Okumuraauthor=S.+Nakaeauthor=T.+Konnoauthor=K.+Tadaauthor=Y.+Kobayashi&title=Induction+of+Maturation+in+Cultured+Human+Monocytic+Leukemia+Cells+by+a+Phorbol+Diester"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester</span></div><div class="casAuthors">Tsuchiya, Shigeru; Kobayashi, Yasuko; Goto, Yoichi; Okumura, Hidesada; Nakae, Shingi; Konno, Tasuke; Tada, Keiya</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1530-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Suspension cultures of a human monocytic leukemia cell line, THP-1, were treated with 0.16-160 nM 12-O-tetradecanoylphorbol 13-acetate (TPA)(I)  [16561-29-8].  In an original cell line, THP-1-O, cultured again from -80° cryopreservation, >80% of the cells adhered to the glass substrate with marked morphol. change within 3 h of TPA treatment.  Adherent cells became flat and ameboid in shape, and many microvilli and flaps of the cell surface disappeared.  Well-developed Golgi app., rough endoplasmic reticula, and a large amt. of free ribosomes were seen in the cytoplasm.  On the other hand, in THP-1-R cells cultured continuously without cryopreservation for 26 mo, ∼80% of the cells adhered to the substrate 48 h after TPA treatment.  Round and ovoid shapes were kept in THP-1-R cells treated with TPA.  Surface Fc receptors for IgG were present on >90% of THP-1-O and THP-1-R cells and were little affected by treatment with TPA.  Sixty to 70% of the TPA-treated THP-1-O and THP-1-R cells were able to phagocytize yeasts and IgG-coated sheep erythrocytes.  Less than 20% of the untreated THP-1 cells were able to phagocytize yeasts and IgG-coated sheep erythrocytes.  In histochem. staining, α-naphthyl butyrate esterase  [9013-79-0] was enhanced after treatment with TPA.  lysozyme  [16561-29-8] Activity in culture supernatants was not affected by TPA treatment.  When exposed to latex beads and TPA, increased 14CO2 prodn. from 1-14C-glucose in THP-1-O cells was obsd.  Thus, after treatment with TPA, human monocytic leukemia cells may be converted into mature cells with functions of macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokMwBQGw8vorVg90H21EOLACvtfcHk0litB6BO_wWKzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xks1OmsLw%253D&md5=32acb53dd3d1f64484e00a6d2ec5c29c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DGota%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DH.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DTada%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26atitle%3DInduction%2520of%2520Maturation%2520in%2520Cultured%2520Human%2520Monocytic%2520Leukemia%2520Cells%2520by%2520a%2520Phorbol%2520Diester%26jtitle%3DCancer%2520Res.%26date%3D1982%26volume%3D42%26spage%3D1530%26epage%3D1536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pache, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodabakhshi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaseichuk, O.</span></span> <span> </span><span class="NLM_article-title">Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1523</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-09234-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2Fs41467-019-09234-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30944313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252Fhtl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1523&author=Y.+Zhouauthor=B.+Zhouauthor=L.+Pacheauthor=M.+Changauthor=C.+Bennerauthor=S.+K.+Chandaauthor=A.+H.+Khodabakhshiauthor=O.+Tanaseichuk&title=Metascape+Provides+a+Biologist-Oriented+Resource+for+the+Analysis+of+Systems-Level+Datasets&doi=10.1038%2Fs41467-019-09234-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</span></div><div class="casAuthors">Zhou Yingyao; Zhou Bin; Khodabakhshi Alireza Hadj; Tanaseichuk Olga; Pache Lars; Chanda Sumit K; Chang Max; Benner Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1523</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A critical component in the interpretation of systems-level studies is the inference of enriched biological pathways and protein complexes contained within OMICs datasets.  Successful analysis requires the integration of a broad set of current biological databases and the application of a robust analytical pipeline to produce readily interpretable results.  Metascape is a web-based portal designed to provide a comprehensive gene list annotation and analysis resource for experimental biologists.  In terms of design features, Metascape combines functional enrichment, interactome analysis, gene annotation, and membership search to leverage over 40 independent knowledgebases within one integrated portal.  Additionally, it facilitates comparative analyses of datasets across multiple independent and orthogonal experiments.  Metascape provides a significantly simplified user experience through a one-click Express Analysis interface to generate interpretable outputs.  Taken together, Metascape is an effective and efficient tool for experimental biologists to comprehensively analyze and interpret OMICs-based studies in the big data era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUXgctuHZqc4HWj6b1v8uTfW6udTcc2eaO9NEjH7N1q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252Fhtl2rtg%253D%253D&md5=cb130c08668f9c8221f464a84039164d</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-09234-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-09234-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DPache%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DBenner%26aufirst%3DC.%26aulast%3DChanda%26aufirst%3DS.%2BK.%26aulast%3DKhodabakhshi%26aufirst%3DA.%2BH.%26aulast%3DTanaseichuk%26aufirst%3DO.%26atitle%3DMetascape%2520Provides%2520a%2520Biologist-Oriented%2520Resource%2520for%2520the%2520Analysis%2520of%2520Systems-Level%2520Datasets%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D1523%26doi%3D10.1038%2Fs41467-019-09234-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salyer, A. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S. A.</span></span> <span> </span><span class="NLM_article-title">Transcriptomal Signatures of Vaccine Adjuvants and Accessory Immunostimulation of Sentinel Cells by Toll-like Receptor 2/6 Agonists</span>. <i>Hum. Vaccines Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1686</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.1080/21645515.2018.1480284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F21645515.2018.1480284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=29852079" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1686-1696&author=A.+C.+D.+Salyerauthor=S.+A.+David&title=Transcriptomal+Signatures+of+Vaccine+Adjuvants+and+Accessory+Immunostimulation+of+Sentinel+Cells+by+Toll-like+Receptor+2%2F6+Agonists&doi=10.1080%2F21645515.2018.1480284"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1080%2F21645515.2018.1480284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21645515.2018.1480284%26sid%3Dliteratum%253Aachs%26aulast%3DSalyer%26aufirst%3DA.%2BC.%2BD.%26aulast%3DDavid%26aufirst%3DS.%2BA.%26atitle%3DTranscriptomal%2520Signatures%2520of%2520Vaccine%2520Adjuvants%2520and%2520Accessory%2520Immunostimulation%2520of%2520Sentinel%2520Cells%2520by%2520Toll-like%2520Receptor%25202%252F6%2520Agonists%26jtitle%3DHum.%2520Vaccines%2520Immunother.%26date%3D2018%26volume%3D14%26spage%3D1686%26epage%3D1696%26doi%3D10.1080%2F21645515.2018.1480284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokol, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-032713-120145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev-immunol-032713-120145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=24655300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVemtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=659-702&author=J.+W.+Griffithauthor=C.+L.+Sokolauthor=A.+D.+Luster&title=Chemokines+and+Chemokine+Receptors%3A+Positioning+Cells+for+Host+Defense+and+Immunity&doi=10.1146%2Fannurev-immunol-032713-120145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines and chemokine receptors: positioning cells for host defense and immunity</span></div><div class="casAuthors">Griffith, Jason W.; Sokol, Caroline L.; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">659-702</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Chemokines are chemotactic cytokines that control the migratory patterns and positioning of all immune cells.  Although chemokines were initially appreciated as important mediators of acute inflammation, we now know that this complex system of approx. 50 endogenous chemokine ligands and 20 G protein-coupled seven-transmembrane signaling receptors is also crit. for the generation of primary and secondary adaptive cellular and humoral immune responses.  Recent studies demonstrate important roles for the chemokine system in the priming of naive T cells, in cell fate decisions such as effector and memory cell differentiation, and in regulatory T cell function.  In this review, we focus on recent advances in understanding how the chemokine system orchestrates immune cell migration and positioning at the organismic level in homeostasis, in acute inflammation, and during the generation and regulation of adoptive primary and secondary immune responses in the lymphoid system and peripheral nonlymphoid tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-1gG2fqwlE7Vg90H21EOLACvtfcHk0litB6BO_wWKzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVemtLo%253D&md5=ef858cb14d464ca55622f931fac475f9</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032713-120145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032713-120145%26sid%3Dliteratum%253Aachs%26aulast%3DGriffith%26aufirst%3DJ.%2BW.%26aulast%3DSokol%26aufirst%3DC.%2BL.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DChemokines%2520and%2520Chemokine%2520Receptors%253A%2520Positioning%2520Cells%2520for%2520Host%2520Defense%2520and%2520Immunity%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D32%26spage%3D659%26epage%3D702%26doi%3D10.1146%2Fannurev-immunol-032713-120145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvanantham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comeau, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croft, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nucleotide Oligomerization Domain-Containing Proteins Instruct T Cell Helper Type 2 Immunity through Stromal Activation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">14896</span>– <span class="NLM_lpage">14901</span>, <span class="refDoi"> DOI: 10.1073/pnas.1015063108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1073%2Fpnas.1015063108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21856952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFyktb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=14896-14901&author=J.+G.+Magalhaesauthor=S.+J.+Rubinoauthor=L.+H.+Travassosauthor=L.+Le+Bourhisauthor=W.+Duanauthor=G.+Sellgeauthor=K.+Geddesauthor=C.+Reardonauthor=M.+Lechmannauthor=L.+A.+Carneiroauthor=T.+Selvananthamauthor=J.+H.+Fritzauthor=B.+C.+Taylorauthor=D.+Artisauthor=T.+W.+Makauthor=M.+R.+Comeauauthor=M.+Croftauthor=S.+E.+Girardinauthor=D.+J.+Philpott&title=Nucleotide+Oligomerization+Domain-Containing+Proteins+Instruct+T+Cell+Helper+Type+2+Immunity+through+Stromal+Activation&doi=10.1073%2Fpnas.1015063108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation</span></div><div class="casAuthors">Magalhaes, Joao G.; Rubino, Stephen J.; Travassos, Leonardo H.; Le Bourhis, Lionel; Duan, Wei; Sellge, Gernot; Geddes, Kaoru; Reardon, Colin; Lechmann, Matthias; Carneiro, Leticia A.; Selvanantham, Thirumahal; Fritz, Jorg H.; Taylor, Betsy C.; Artis, David; Mak, Tak Wah; Comeau, Michael R.; Croft, Michael; Girardin, Stephen E.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">14896-14901, S14896/1-S14896/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although a no. of studies have examd. the development of T-helper cell type 2 (Th2) immunity in different settings, the mechanisms underlying the initiation of this arm of adaptive immunity are not well understood.  We exploited the fact that immunization with antigen plus either nucleotide-binding oligomerization domain-contg. proteins 1 (Nod1) or 2 (Nod2) agonists drives Th2 induction to understand how these pattern-recognition receptors mediate the development of systemic Th2 immune responses.  Here, we show in bone-marrow chimeric mice that Nod1 and Nod2 expression within the stromal compartment is necessary for priming of effector CD4+ Th2 responses and specific IgG1 antibodies.  In contrast, sensing of these ligands by dendritic cells was not sufficient to induce Th2 immunity, although these cells contribute to the response.  Moreover, we detd. that CD11c+ cells were the crit. antigen-presenting cells, whereas basophils and B cells did not affect the capacity of Nod ligands to induce CD4+ Th2 effector function.  Finally, we found that full Th2 induction upon Nod1 and Nod2 activation was dependent on both thymic stromal lymphopoietin prodn. by the stromal cells and the up-regulation of the costimulatory mol., OX40 ligand, on dendritic cells.  This study provides in vivo evidence of how systemic Th2 immunity is induced in the context of Nod stimulation.  Such understanding will influence the rational design of therapeutics that could reprogram the immune system during an active Th1-mediated disease, such as Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5oZUZGqE2mrVg90H21EOLACvtfcHk0liM7JrTf3Yrgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFyktb7P&md5=36f71771b5f06951de0f3f9938db70c3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015063108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015063108%26sid%3Dliteratum%253Aachs%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DRubino%26aufirst%3DS.%2BJ.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DSellge%26aufirst%3DG.%26aulast%3DGeddes%26aufirst%3DK.%26aulast%3DReardon%26aufirst%3DC.%26aulast%3DLechmann%26aufirst%3DM.%26aulast%3DCarneiro%26aufirst%3DL.%2BA.%26aulast%3DSelvanantham%26aufirst%3DT.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DTaylor%26aufirst%3DB.%2BC.%26aulast%3DArtis%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DComeau%26aufirst%3DM.%2BR.%26aulast%3DCroft%26aufirst%3DM.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNucleotide%2520Oligomerization%2520Domain-Containing%2520Proteins%2520Instruct%2520T%2520Cell%2520Helper%2520Type%25202%2520Immunity%2520through%2520Stromal%2520Activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D14896%26epage%3D14901%26doi%3D10.1073%2Fpnas.1015063108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoggins, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, C. M.</span></span> <span> </span><span class="NLM_article-title">Interferon-Stimulated Genes and Their Antiviral Effector Functions</span>. <i>Curr. Opin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1016/j.coviro.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.coviro.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=22328912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=519-525&author=J.+W.+Schogginsauthor=C.+M.+Rice&title=Interferon-Stimulated+Genes+and+Their+Antiviral+Effector+Functions&doi=10.1016%2Fj.coviro.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-stimulated genes and their antiviral effector functions</span></div><div class="casAuthors">Schoggins, John W.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">519-525</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Many viruses trigger the type I interferon (IFN) system, leading to the transcription of hundreds of interferon-stimulated genes (ISGs).  The products of these ISGs exert numerous antiviral effector functions, many of which are still not fully described.  Recent efforts have been aimed at identifying which ISGs are antiviral and further characterizing their mechanisms of action.  IFN effectors vary widely in their magnitude of inhibitory activity and display combinatorial antiviral properties.  Collectively, ISGs can target almost any step in a virus life cycle.  Some of the most potent antiviral effectors reinforce the system by further inducing IFN or ISGs.  Other genes enhance or facilitate viral replication, suggesting that some viruses may have evolved to co-opt IFN effectors for a survival advantage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfASL1CEkHzrVg90H21EOLACvtfcHk0liM7JrTf3Yrgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htrfP&md5=da3904fc16d3d47401de41246d7aaf8d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSchoggins%26aufirst%3DJ.%2BW.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DInterferon-Stimulated%2520Genes%2520and%2520Their%2520Antiviral%2520Effector%2520Functions%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2011%26volume%3D1%26spage%3D519%26epage%3D525%26doi%3D10.1016%2Fj.coviro.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proietti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pucchio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sestili, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vincenzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venditti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capone, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seif, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maeyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tough, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardelli, F.</span></span> <span> </span><span class="NLM_article-title">Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.169.1.375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.169.1.375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12077267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=375-383&author=E.+Proiettiauthor=L.+Bracciauthor=S.+Puzelliauthor=T.+Di+Pucchioauthor=P.+Sestiliauthor=E.+De+Vincenziauthor=M.+Vendittiauthor=I.+Caponeauthor=I.+Seifauthor=E.+De+Maeyerauthor=D.+Toughauthor=I.+Donatelliauthor=F.+Belardelli&title=Type+I+IFN+as+a+Natural+Adjuvant+for+a+Protective+Immune+Response%3A+Lessons+from+the+Influenza+Vaccine+Model&doi=10.4049%2Fjimmunol.169.1.375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model</span></div><div class="casAuthors">Proietti, Enrico; Bracci, Laura; Puzelli, Simona; Di Pucchio, Tiziana; Sestili, Paola; De Vincenzi, Enrico; Venditti, Massimo; Capone, Imerio; Seif, Isabelle; De Maeyer, Edward; Tough, David; Donatelli, Isabella; Belardelli, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">375-383</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The identification of natural adjuvants capable of selectively promoting an efficient immune response against infectious agents would represent an important advance in immunol., with direct implications for vaccine development, whose progress is generally hampered by the difficulties in defining powerful synthetic adjuvants suitable for clin. use.  Here, we demonstrate that endogenous type I IFN is necessary for the Th1 type of immune response induced by typical adjuvants in mice and that IFN itself is an unexpectedly powerful adjuvant when administered with the human influenza vaccine, for inducing IgG2a and IgA prodn. and conferring protection from virus challenge.  The finding that these cytokines, currently used in patients, are necessary for full expression of adjuvant activity and are sufficient for the generation of a protective immune response opens new perspectives in understanding the basis of immunity and in vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv70AN_-b_5LVg90H21EOLACvtfcHk0liM7JrTf3Yrgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKisL4%253D&md5=a7d590f7cf763f874f0ba8c1848884f8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.169.1.375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.169.1.375%26sid%3Dliteratum%253Aachs%26aulast%3DProietti%26aufirst%3DE.%26aulast%3DBracci%26aufirst%3DL.%26aulast%3DPuzelli%26aufirst%3DS.%26aulast%3DDi%2BPucchio%26aufirst%3DT.%26aulast%3DSestili%26aufirst%3DP.%26aulast%3DDe%2BVincenzi%26aufirst%3DE.%26aulast%3DVenditti%26aufirst%3DM.%26aulast%3DCapone%26aufirst%3DI.%26aulast%3DSeif%26aufirst%3DI.%26aulast%3DDe%2BMaeyer%26aufirst%3DE.%26aulast%3DTough%26aufirst%3DD.%26aulast%3DDonatelli%26aufirst%3DI.%26aulast%3DBelardelli%26aufirst%3DF.%26atitle%3DType%2520I%2520IFN%2520as%2520a%2520Natural%2520Adjuvant%2520for%2520a%2520Protective%2520Immune%2520Response%253A%2520Lessons%2520from%2520the%2520Influenza%2520Vaccine%2520Model%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D375%26epage%3D383%26doi%3D10.4049%2Fjimmunol.169.1.375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Sorsa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proietti, E.</span></span> <span> </span><span class="NLM_article-title">Type I Interferons as Vaccine Adjuvants against Infectious Diseases and Cancer</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1586/14760584.7.3.373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1586%2F14760584.7.3.373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18393607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlahtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=373-381&author=L.+Bracciauthor=V.+La+Sorsaauthor=F.+Belardelliauthor=E.+Proietti&title=Type+I+Interferons+as+Vaccine+Adjuvants+against+Infectious+Diseases+and+Cancer&doi=10.1586%2F14760584.7.3.373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Type I interferons as vaccine adjuvants against infectious diseases and cancer</span></div><div class="casAuthors">Bracci, Laura; La Sorsa, Valentina; Belardelli, Filippo; Proietti, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Presently, new attention is given to type I interferons (IFNs) as essential factors linking innate and adaptive immunity.  Several studies provided evidence about the importance of IFN-α in the differentiation of the Th1 subset, in the generation and activity of cytotoxic T lymphocytes, in the enhancement of a primary antibody response and in the activation of dendritic cells.  Owing to their immunomodulatory properties, type I IFNs can represent good candidates to be used as adjuvants for vaccination.  In the present review, we summarize recent studies in humans and in animal models, suggesting a possible application of type I IFNs as adjuvants for the development of more effective vaccines against infectious diseases and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Pb5qN0fE6bVg90H21EOLACvtfcHk0liyt0-zxyEaxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlahtbw%253D&md5=efb274ef8c40a7a0a5e30ec0c75f3f86</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1586%2F14760584.7.3.373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14760584.7.3.373%26sid%3Dliteratum%253Aachs%26aulast%3DBracci%26aufirst%3DL.%26aulast%3DLa%2BSorsa%26aufirst%3DV.%26aulast%3DBelardelli%26aufirst%3DF.%26aulast%3DProietti%26aufirst%3DE.%26atitle%3DType%2520I%2520Interferons%2520as%2520Vaccine%2520Adjuvants%2520against%2520Infectious%2520Diseases%2520and%2520Cancer%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2008%26volume%3D7%26spage%3D373%26epage%3D381%26doi%3D10.1586%2F14760584.7.3.373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span> <span> </span><span class="NLM_article-title">Type I Interferon Related Genes Are Common Genes on the Early Stage after Vaccination by Meta-Analysis of Microarray Data</span>. <i>Hum. Vaccines Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1080/21645515.2015.1008884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F21645515.2015.1008884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25839220" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=739-745&author=J.+Zhangauthor=J.+Shaoauthor=X.+Wuauthor=Q.+Maoauthor=Y.+Wangauthor=F.+Gaoauthor=W.+Kongauthor=Z.+Liang&title=Type+I+Interferon+Related+Genes+Are+Common+Genes+on+the+Early+Stage+after+Vaccination+by+Meta-Analysis+of+Microarray+Data&doi=10.1080%2F21645515.2015.1008884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1080%2F21645515.2015.1008884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21645515.2015.1008884%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DZ.%26atitle%3DType%2520I%2520Interferon%2520Related%2520Genes%2520Are%2520Common%2520Genes%2520on%2520the%2520Early%2520Stage%2520after%2520Vaccination%2520by%2520Meta-Analysis%2520of%2520Microarray%2520Data%26jtitle%3DHum.%2520Vaccines%2520Immunother.%26date%3D2015%26volume%3D11%26spage%3D739%26epage%3D745%26doi%3D10.1080%2F21645515.2015.1008884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khabar, K. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, H. A.</span></span> <span> </span><span class="NLM_article-title">Post-Transcriptional Control of the Interferon System</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">769</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2007.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.biochi.2007.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17408842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFKrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2007&pages=761-769&author=K.+S.+A.+Khabarauthor=H.+A.+Young&title=Post-Transcriptional+Control+of+the+Interferon+System&doi=10.1016%2Fj.biochi.2007.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Post-transcriptional control of the interferon system</span></div><div class="casAuthors">Khabar, Khalid S. A.; Young, Howard A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">761-769</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The interferon (IFN) system is a well-controlled network of signaling, transcriptional, and post-transcriptional processes that orchestrate host defense against microbes.  The IFN response comprises a multi-array of IFN-stimulated gene products that mediate a variety of biol. processes designed to control infection and regulate specific immune responses.  In this review, the authors focus on post-transcriptional mechanisms of gene regulation that occur during the course of IFN induction and during the response of cells to IFN.  Post-transcriptional mechanisms involve different levels of regulation such as mRNA stability, alternative splicing, and translation.  Such controls offer a fine tuning mechanism for efficient and rapid response and as a neg. feedback control in IFN biosynthesis and response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgIlYEt4emhLVg90H21EOLACvtfcHk0liyt0-zxyEaxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFKrtbs%253D&md5=49acb0a7279de3ba235829ec7f582327</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2007.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2007.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DKhabar%26aufirst%3DK.%2BS.%2BA.%26aulast%3DYoung%26aufirst%3DH.%2BA.%26atitle%3DPost-Transcriptional%2520Control%2520of%2520the%2520Interferon%2520System%26jtitle%3DBiochimie%26date%3D2007%26volume%3D89%26spage%3D761%26epage%3D769%26doi%3D10.1016%2Fj.biochi.2007.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, R. M.</span></span> <span> </span><span class="NLM_article-title">Dendritic Cells and the Control of Immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>392</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/32588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1038%2F32588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=9521319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1998&pages=245-252&author=J.+Banchereauauthor=R.+M.+Steinman&title=Dendritic+Cells+and+the+Control+of+Immunity&doi=10.1038%2F32588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells and the control of immunity</span></div><div class="casAuthors">Banchereau, Jacques; Steinman, Ralph M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">392</span>
        (<span class="NLM_cas:issue">6673</span>),
    <span class="NLM_cas:pages">245-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 103 refs.  B and T lymphocytes are the mediators of immunity, but their function is under the control of dendritic cells.  Dendritic cells in the periphery capture and process antigens, express lymphocyte co-stimulatory mols., migrate to lymphoid organs, and secrete cytokines to initiate immune responses.  They not only activate lymphocytes, they also tolerize T cells to antigens that are innate to the body (self-antigens), thereby minimizing autoimmune reactions.  Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow mol. and cell biol. anal.  With knowledge comes the realization that these cells are a powerful tool for manipulating the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cFu9pwhnSrVg90H21EOLACvtfcHk0liyt0-zxyEaxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFWrsr8%253D&md5=af17ace619fc543c7260cb04146d4c30</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2F32588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F32588%26sid%3Dliteratum%253Aachs%26aulast%3DBanchereau%26aufirst%3DJ.%26aulast%3DSteinman%26aufirst%3DR.%2BM.%26atitle%3DDendritic%2520Cells%2520and%2520the%2520Control%2520of%2520Immunity%26jtitle%3DNature%26date%3D1998%26volume%3D392%26spage%3D245%26epage%3D252%26doi%3D10.1038%2F32588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Todate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Muramyl Dipeptide-Lys Stimulates the Function of Human Dendritic Cells</span>. <i>J. Leukoc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1189/jlb.70.5.723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1189%2Fjlb.70.5.723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11698491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=723-729&author=A.+Todateauthor=T.+Sudaauthor=H.+Kuwataauthor=K.+Chidaauthor=H.+Nakamura&title=Muramyl+Dipeptide-Lys+Stimulates+the+Function+of+Human+Dendritic+Cells&doi=10.1189%2Fjlb.70.5.723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl dipeptide-Lys stimulates the function of human dendritic cells</span></div><div class="casAuthors">Todate, Akihito; Suda, Takafumi; Kuwata, Hiroshi; Chida, Kingo; Nakamura, Hirotoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">723-729</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP)-Lys (L18), a synthetic MDP analog derived from bacterial cell walls, has been reported to be a potent immunoadjuvant that enhances protective immunity against pathogens and tumors by stimulating immune-competent cells, such as monocytes and macrophages.  However, it is not known whether MDP-Lys modulates the function of dendritic cells (DCs), which are the most potent antigen-presenting cells and play a crucial role in initiating T cell-mediated immunity.  Therefore, we examd. the effects of MDP-Lys on the expression of surface mols., cytokine prodn., and antigen-presenting function of human DCs generated from peripheral blood cells in the presence of interleukin (IL)-4 and granulocyte-macrophage colony-stimulating factor.  We found that MDP-Lys markedly up-regulated the expression of CD80, CD83, CD86, and CD40, but not human leukocyte antigen-DR, and stimulated the prodn. of tumor necrosis factor-α, IL-6, IL-8, IL-10, and IL-12 (p40) by human DCs in a dose-dependent manner.  Furthermore, MDP-Lys-treated DCs showed enhanced antigen-presenting function compared with untreated DCs, as assessed by an allogeneic mixed lymphocyte reaction.  These results suggested that the immunoadjuvant activity of MDP-Lys in vivo is mediated, in part, by its stimulation of DC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVi5NO0qPVQLVg90H21EOLACvtfcHk0lgWz8Nw8hWtnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D&md5=0123eaf8d8f353ed56e2dd604b90afc4</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1189%2Fjlb.70.5.723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.70.5.723%26sid%3Dliteratum%253Aachs%26aulast%3DTodate%26aufirst%3DA.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DH.%26aulast%3DChida%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DMuramyl%2520Dipeptide-Lys%2520Stimulates%2520the%2520Function%2520of%2520Human%2520Dendritic%2520Cells%26jtitle%3DJ.%2520Leukoc.%2520Biol.%26date%3D2001%26volume%3D70%26spage%3D723%26epage%3D729%26doi%3D10.1189%2Fjlb.70.5.723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewulf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr, G. M.</span></span> <span> </span><span class="NLM_article-title">Enhanced Maturation and Functional Capacity of Monocyte-Derived Immature Dendritic Cells by the Synthetic Immunomodulator Murabutide</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2567.2001.01269.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1046%2Fj.1365-2567.2001.01269.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11529939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1els78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2001&pages=479-487&author=V.+Vidalauthor=J.+Dewulfauthor=G.+M.+Bahr&title=Enhanced+Maturation+and+Functional+Capacity+of+Monocyte-Derived+Immature+Dendritic+Cells+by+the+Synthetic+Immunomodulator+Murabutide&doi=10.1046%2Fj.1365-2567.2001.01269.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide</span></div><div class="casAuthors">Vidal, Vincent; Dewulf, Joelle; Bahr, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">479-487</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Murabutide is a safe synthetic immunomodulator derived from muramyl dipeptide, the smallest bioactive unit of bacterial peptidoglycan.  Although it is well known that muramyl peptides modulate the functions of monocytes/macrophages, their activity on dendritic cells is poorly documented.  We thus investigated the effects of Murabutide on immunophenotype, endocytosis, T-cell stimulatory capacity, and cytokine secretion of human monocyte-derived immature dendritic cells (iDCs).  We found that Murabutide triggers immunophenotypic changes as upon treatment, iDCs up-regulate the surface expression of the major histocompatibility complex type II mol. human leukocyte antigen-DR, the co-stimulatory mols. CD80, CD86 and CD40 and the differentiation marker CD83, and down-regulate the expression of the mannose receptor.  These phenotypic changes are also mirrored by changes in their biol. activity.  Subsequent to treatment with the synthetic immunomodulator, DC have a decreased endocytic capacity but exhibit enhanced stimulatory capacity for both allogeneic and autologous T cells.  In addn., Murabutide-stimulated iDCs have a greater cytostatic activity toward the tumor cell line THP-1.  Furthermore, in the presence of Murabutide, DCs transiently increased the release of macrophage inhibitory protein-1β, tumor necrosis factor-α and interleukin-10, whereas the enhanced prodn. of macrophage-colony stimulating factor was sustained over the 3-day period analyzed.  In addn., Murabutide triggers the phosphorylation of the three classes of mitogen-activated protein kinases in iDCs.  Our results demonstrate that Murabutide triggers the maturation and activation of monocyte-derived iDCs.  As this immunomodulator is approved for administration in humans, it could be a useful adjunct to boost the efficacy of DC-based vaccines designed against tumors or virus-infected cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRYQqkI-ucAbVg90H21EOLACvtfcHk0lgWz8Nw8hWtnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1els78%253D&md5=4af31647b9cfee735ada109fca7cd27a</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2567.2001.01269.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2567.2001.01269.x%26sid%3Dliteratum%253Aachs%26aulast%3DVidal%26aufirst%3DV.%26aulast%3DDewulf%26aufirst%3DJ.%26aulast%3DBahr%26aufirst%3DG.%2BM.%26atitle%3DEnhanced%2520Maturation%2520and%2520Functional%2520Capacity%2520of%2520Monocyte-Derived%2520Immature%2520Dendritic%2520Cells%2520by%2520the%2520Synthetic%2520Immunomodulator%2520Murabutide%26jtitle%3DImmunology%26date%3D2001%26volume%3D103%26spage%3D479%26epage%3D487%26doi%3D10.1046%2Fj.1365-2567.2001.01269.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohteki, T.</span></span> <span> </span><span class="NLM_article-title">Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.4049%2Fjimmunol.0900726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=20008287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=736-745&author=J.+Asanoauthor=H.+Tadaauthor=N.+Onaiauthor=T.+Satoauthor=Y.+Horieauthor=Y.+Fujimotoauthor=K.+Fukaseauthor=A.+Suzukiauthor=T.+W.+Makauthor=T.+Ohteki&title=Nucleotide+Oligomerization+Binding+Domain-Like+Receptor+Signaling+Enhances+Dendritic+Cell-Mediated+Cross-Priming+In+Vivo&doi=10.4049%2Fjimmunol.0900726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo</span></div><div class="casAuthors">Asano, Jumpei; Tada, Hiroyuki; Onai, Nobuyuki; Sato, Taku; Horie, Yasuo; Fujimoto, Yukari; Fukase, Koichi; Suzuki, Akira; Mak, Tak W.; Ohteki, Toshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">736-745</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Nucleotide oligomerization binding domain (Nod)-like receptors are crit. cytosolic sensors for the recognition of bacterial peptidoglycan.  However, their role in the induction of dendritic cell (DC)-mediated cross-priming remains unclear.  In this study, the authors demonstrate that injecting ligands for Nod1 and Nod2 along with Ag into wild-type mice significantly enhanced the cross-priming of Ag-specific CD8+ T cells by CD8α+ DCs, as assessed from the expansion of IFN-γ+ CD8+ T cells, CTL activity against Ag-pulsed targets, and the rejection of transplanted tumors expressing the cognate Ag.  The enhancement of CD8α+ DC-mediated cross-priming was likely due to the upregulation of Ag cross-presentation and of costimulatory mols.  The authors' findings collectively indicate that Nod1/2 signaling is crit. for the optimal induction of DC cross-priming in vivo, which may offer an alternative therapeutic pathway in cancer and hosts refractory to TLR signals or paralyzed by viral evasion strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6nN-YGjYJ3bVg90H21EOLACvtfcHk0lgWz8Nw8hWtnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslCmtg%253D%253D&md5=ca81c1e78255fd64b892f89963e8029b</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900726%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DJ.%26aulast%3DTada%26aufirst%3DH.%26aulast%3DOnai%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DHorie%26aufirst%3DY.%26aulast%3DFujimoto%26aufirst%3DY.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DOhteki%26aufirst%3DT.%26atitle%3DNucleotide%2520Oligomerization%2520Binding%2520Domain-Like%2520Receptor%2520Signaling%2520Enhances%2520Dendritic%2520Cell-Mediated%2520Cross-Priming%2520In%2520Vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26spage%3D736%26epage%3D745%26doi%3D10.4049%2Fjimmunol.0900726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corridoni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steevels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thézénas, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prota, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gileadi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ternette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerundolo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, A.</span></span> <span> </span><span class="NLM_article-title">NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">958</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2019.00958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3389%2Ffimmu.2019.00958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=31114588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsl2nsb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=958&author=D.+Corridoniauthor=S.+Shiraishiauthor=T.+Chapmanauthor=T.+Steevelsauthor=D.+Muraroauthor=M.-L.+Th%C3%A9z%C3%A9nasauthor=G.+Protaauthor=J.-L.+Chenauthor=U.+Gileadiauthor=N.+Ternetteauthor=V.+Cerundoloauthor=A.+Simmons&title=NOD2+and+TLR2+Signal+via+TBK1+and+PI31+to+Direct+Cross-Presentation+and+CD8+T+Cell+Responses&doi=10.3389%2Ffimmu.2019.00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 and TLR2 signal via TBK1 and PI31 to direct cross-presentation and CD8 T cell responses</span></div><div class="casAuthors">Corridoni, Daniele; Shiraishi, Seiji; Chapman, Thomas; Steevels, Tessa; Muraro, Daniele; Thezenas, Marie-Laetitia; Prota, Gennaro; Chen, Ji-Li; Gileadi, Uzi; Ternette, Nicola; Cerundolo, Vincenzo; Simmons, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">958</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">NOD2 and TLR2 recognize components of bacterial cell wall peptidoglycan and direct defense against enteric pathogens.  CD8+ T cells are important for immunity to such pathogens but how NOD2 and TLR2 induce antigen specific CD8+ T cell responses is unknown.  Here, we define how these pattern recognition receptors (PRRs) signal in primary dendritic cells (DCs) to influence MHC class I antigen presentation.  We show NOD2 and TLR2 phosphorylate PI31 via TBK1 following activation in DCs.  PI31 interacts with TBK1 and Sec16A at endoplasmic reticulum exit sites (ERES), which pos. regulates MHC class I peptide loading and immunoproteasome stability.  Following NOD2 and TLR2 stimulation, depletion of PI31 or inhibition of TBK1 activity in vivo impairs DC cross-presentation and CD8+ T cell activation.  DCs from Crohn's patients expressing NOD2 polymorphisms show dysregulated cross-presentation and CD8+ T cell responses.  Our findings reveal unidentified mechanisms that underlie CD8+ T cell responses to bacteria in health and in Crohn's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob81TlNX1Fc7Vg90H21EOLACvtfcHk0lhsvUxR80Y_XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsl2nsb3L&md5=56d42d96d773d59be298874d62d6017f</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2019.00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2019.00958%26sid%3Dliteratum%253Aachs%26aulast%3DCorridoni%26aufirst%3DD.%26aulast%3DShiraishi%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%26aulast%3DSteevels%26aufirst%3DT.%26aulast%3DMuraro%26aufirst%3DD.%26aulast%3DTh%25C3%25A9z%25C3%25A9nas%26aufirst%3DM.-L.%26aulast%3DProta%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.-L.%26aulast%3DGileadi%26aufirst%3DU.%26aulast%3DTernette%26aufirst%3DN.%26aulast%3DCerundolo%26aufirst%3DV.%26aulast%3DSimmons%26aufirst%3DA.%26atitle%3DNOD2%2520and%2520TLR2%2520Signal%2520via%2520TBK1%2520and%2520PI31%2520to%2520Direct%2520Cross-Presentation%2520and%2520CD8%2520T%2520Cell%2520Responses%26jtitle%3DFront.%2520Immunol.%26date%3D2019%26volume%3D10%26spage%3D958%26doi%3D10.3389%2Ffimmu.2019.00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eirikis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, U.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of Lymphocyte Activation Marker Expression and Cytokine Secretion Profile in Stimulated Human Peripheral Blood Mononuclear Cell Cultures: An in Vitro Model to Monitor Cellular Immune Function</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/j.jim.2004.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.jim.2004.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15541283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFCisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2004&pages=127-142&author=M.+Reddyauthor=E.+Eirikisauthor=C.+Davisauthor=H.+M.+Davisauthor=U.+Prabhakar&title=Comparative+Analysis+of+Lymphocyte+Activation+Marker+Expression+and+Cytokine+Secretion+Profile+in+Stimulated+Human+Peripheral+Blood+Mononuclear+Cell+Cultures%3A+An+in+Vitro+Model+to+Monitor+Cellular+Immune+Function&doi=10.1016%2Fj.jim.2004.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function</span></div><div class="casAuthors">Reddy, Manjula; Eirikis, Edward; Davis, Cuc; Davis, Hugh M.; Prabhakar, Uma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-142</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of lymphocytes is a complex, yet finely regulated cascade of events that results in the expression of cytokine receptors, prodn. and secretion of cytokines and expression of several cell surface mols. that eventually lead to divergent immune responses.  Assessing the qual. and quant. nature of lymphocyte function following immunotherapy provides valuable information about the immune responses mediated by a therapeutic agent.  To facilitate evaluation of the immunomodulatory activity of therapeutic agents, we have established a platform of in vitro immunoassays with normal human peripheral blood mononuclear cells (PBMCs) treated with several polyclonal activators that are known to exhibit different modes of action.  We evaluated the kinetics of cell surface marker expression and cytokine release from PBMCs stimulated in parallel with various activating agents over a time course.  These stimulating agents induced early (CD69 and CD71) and late (CD25 and HLA-DR) activation markers to varying antigen densities, indicated different cytokine profiles, and showed differential inhibition with dexamethasone (DEX), an inhibitor of early signaling events.  Based on the assocn. or correlation of the kinetics of activation marker expression and secreted cytokines, the results of our study indicate the appropriate time points for the simultaneous measurement of both these activation products.  This study defines the kinetics for both measures of T cell activation and provides a comprehensive review with various polyclonal activators that can serve as a ref. for monitoring lymphocyte function in clin. study samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV9WHA6sVSG7Vg90H21EOLACvtfcHk0lhsvUxR80Y_XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFCisbw%253D&md5=b9dcc72e6e7252c29f69fad606d8f039</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.jim.2004.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jim.2004.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%26aulast%3DEirikis%26aufirst%3DE.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DH.%2BM.%26aulast%3DPrabhakar%26aufirst%3DU.%26atitle%3DComparative%2520Analysis%2520of%2520Lymphocyte%2520Activation%2520Marker%2520Expression%2520and%2520Cytokine%2520Secretion%2520Profile%2520in%2520Stimulated%2520Human%2520Peripheral%2520Blood%2520Mononuclear%2520Cell%2520Cultures%253A%2520An%2520in%2520Vitro%2520Model%2520to%2520Monitor%2520Cellular%2520Immune%2520Function%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D2004%26volume%3D293%26spage%3D127%26epage%3D142%26doi%3D10.1016%2Fj.jim.2004.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Létourneau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantaleo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyman, O.</span></span> <span> </span><span class="NLM_article-title">IL-2- and CD25-Dependent Immunoregulatory Mechanisms in the Homeostasis of T-Cell Subsets</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">758</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2009.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.jaci.2009.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19348914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2isLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=758-762&author=S.+L%C3%A9tourneauauthor=C.+Kriegauthor=G.+Pantaleoauthor=O.+Boyman&title=IL-2-+and+CD25-Dependent+Immunoregulatory+Mechanisms+in+the+Homeostasis+of+T-Cell+Subsets&doi=10.1016%2Fj.jaci.2009.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets</span></div><div class="casAuthors">Letourneau, Sven; Krieg, Carsten; Pantaleo, Giuseppe; Boyman, Onur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">758-762</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  IL-2 plays a pivotal role in regulating the adaptive immune system by controlling the survival and proliferation of regulatory T (Treg) cells, which are required for the maintenance of immune tolerance.  Moreover, IL-2 is implicated in the differentiation and homeostasis of effector T-cell subsets, including TH1, TH2, TH17, and memory CD8+ T cells.  The IL-2 receptor is composed of 3 distinct subunits, namely the α (CD25), β (CD122), and γ (γc) chains.  Of crucial importance for the delivery of IL-2 signals to Treg cells is the expression of CD25, which, along with CD122 and γc, confers high affinity binding to IL-2.  Notably, recent findings suggest a novel role for CD25, whereby CD25 mols. on Treg cells and possibly other cells are capable of influencing T-cell homeostasis by means of IL-2 deprivation.  This review explores these findings and integrates them into our current understanding of T-cell homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8izAMuuIItrVg90H21EOLACvtfcHk0lhsvUxR80Y_XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2isLk%253D&md5=1db3f85daa51c87a3bde459c949b8e0f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2009.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2009.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A9tourneau%26aufirst%3DS.%26aulast%3DKrieg%26aufirst%3DC.%26aulast%3DPantaleo%26aufirst%3DG.%26aulast%3DBoyman%26aufirst%3DO.%26atitle%3DIL-2-%2520and%2520CD25-Dependent%2520Immunoregulatory%2520Mechanisms%2520in%2520the%2520Homeostasis%2520of%2520T-Cell%2520Subsets%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2009%26volume%3D123%26spage%3D758%26epage%3D762%26doi%3D10.1016%2Fj.jaci.2009.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Heel, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Playford, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span> <span> </span><span class="NLM_article-title">NOD2 Activity Modulates the Phenotype of LPS-Stimulated Dendritic Cells to Promote the Development of T-Helper Type 2-like Lymphocytes - Possible Implications for NOD2-Associated Crohn’s Disease</span>. <i>J. Crohn’s Colitis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.crohns.2007.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.crohns.2007.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=21172192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fls1yrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=106-115&author=M.+Butlerauthor=R.+Chaudharyauthor=D.+A.+van+Heelauthor=R.+J.+Playfordauthor=S.+Ghosh&title=NOD2+Activity+Modulates+the+Phenotype+of+LPS-Stimulated+Dendritic+Cells+to+Promote+the+Development+of+T-Helper+Type+2-like+Lymphocytes+-+Possible+Implications+for+NOD2-Associated+Crohn%E2%80%99s+Disease&doi=10.1016%2Fj.crohns.2007.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease</span></div><div class="casAuthors">Butler Matt; Chaudhary Rakesh; van Heel David A; Playford Raymond J; Ghosh Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Crohn's & colitis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-15</span>
        ISSN:<span class="NLM_cas:issn">1873-9946</span>.
    </div><div class="casAbstract">Sensing of commensal microorganisms via Toll-like receptors (TLR) in the gut is essential for maintaining intestinal homeostasis in healthy individuals.  Conversely, Crohn's disease is characterised by an inappropriate T helper-type 1 (Th1)-mediated immune response towards these same microorganisms.  NOD2 is expressed by dendritic cells (DC) and mediates responses to bacterial muramyl-dipeptides (MDP).  Mutations in NOD2 (CARD15) have recently been associated with susceptibility to Crohn's disease although the underlying mechanisms have yet to be established.  We investigated the functional outcome of NOD2 and TLR4-mediated activation in monocyte-derived DC from wild-type NOD2 healthy controls and NOD2 frame-shift mutation-carrying Crohn's disease patients.  In wild-type DC, MDP acted synergistically with LPS to amplify inflammatory cytokine production, enhance co-stimulatory molecule expression, and produce DC that promoted the proliferation of naive, allogeneic, CD4(+) T lymphocytes with a Th2-like cytokine profile.  By contrast, DC carrying homozygous NOD2 mutations were unable to react to MDP, responded to LPS only, and promoted the development of Th1 cells.  These results suggest activation of the NOD2 pathway in DC modulates their response to TLR agonists and regulates their ability to induce polarised Th1 responses.  As a consequence, Crohn's disease patients with defective NOD2 may be predisposed to the generation of strongly polarised Th1 responses against common commensal microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ35j2NBeL_ZNK0qsdY6Nc1fW6udTcc2eanlcWcnixNdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fls1yrug%253D%253D&md5=7d02fcf2b45699c6e3e68e10da11a12c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.crohns.2007.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.crohns.2007.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%26aulast%3DChaudhary%26aufirst%3DR.%26aulast%3Dvan%2BHeel%26aufirst%3DD.%2BA.%26aulast%3DPlayford%26aufirst%3DR.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26atitle%3DNOD2%2520Activity%2520Modulates%2520the%2520Phenotype%2520of%2520LPS-Stimulated%2520Dendritic%2520Cells%2520to%2520Promote%2520the%2520Development%2520of%2520T-Helper%2520Type%25202-like%2520Lymphocytes%2520-%2520Possible%2520Implications%2520for%2520NOD2-Associated%2520Crohn%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Crohn%25E2%2580%2599s%2520Colitis%26date%3D2007%26volume%3D1%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.crohns.2007.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Numata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsukawa, A.</span></span> <span> </span><span class="NLM_article-title">Innate Immune Response in Th1- and Th2-Dominant Mouse Strains</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1097/01.shk.0000142249.08135.e9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1097%2F01.shk.0000142249.08135.e9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=15489639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSlurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=460-466&author=H.+Watanabeauthor=K.+Numataauthor=T.+Itoauthor=K.+Takagiauthor=A.+Matsukawa&title=Innate+Immune+Response+in+Th1-+and+Th2-Dominant+Mouse+Strains&doi=10.1097%2F01.shk.0000142249.08135.e9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immune response in Th1- and Th2-dominant mouse strains</span></div><div class="casAuthors">Watanabe, Hiroyuki; Numata, Kousuke; Ito, Takaaki; Takagi, Katsumasa; Matsukawa, Akihiro</div><div class="citationInfo"><span class="NLM_cas:title">Shock</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-466</span>CODEN:
                <span class="NLM_cas:coden">SAGUAI</span>;
        ISSN:<span class="NLM_cas:issn">1073-2322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">C57BL/6 and BALB/c mice are prototypical Th1- and Th2-type mouse strains, resp.  In the present study, we attempted to characterize the innate immune response of macrophages from these mouse strains.  Macrophages from C57BL/6 mice produced higher levels of tumor necrosis factor-α (TNF-α) and interleukin (IL)-12 than those from BALB/c mice after stimulation with macrophage-activating lipopeptide-2 (MALP-2, a synthetic TLR-2 ligand) or lipopolysaccharide (LPS, a TLR-4 ligand).  The augmented IL-12 prodn. by C57BL/6 macrophages increased interferon-γ and, in contrast, decreased IL-13 prodn. by CD4+ T cells.  On stimulation with MALP-2 or LPS, C57BL/6 macrophages produced lysosomal enzyme and nitric oxide, effector mols. for bacterial killing, whereas BALB/c macrophages did not.  Bactericidal activity of BALB/c macrophages was impaired relative to C57BL/6 macrophages when cells were infected with live bacteria in vitro.  In a murine model of septic peritonitis induced by cecal ligation and puncture (CLP), BALB/c mice failed to facilitate bacterial clearance relative to C57BL/6 mice despite an augmented peritoneal leukocyte infiltration that was assocd. with increased peritoneal levels of cytokines/chemokines.  BALB/c mice exhibited increased plasma and hepatic levels of cytokines/chemokines, resulting in an exaggerated systemic inflammation as detd. by acute-phase proteins.  Finally, BALB/c mice were vulnerable to CLP-induced lethality relative to C57BL/6 mice.  Altogether, innate immune response of macrophages is different between these mouse strains, which may affect the development of Th1 and Th2 adaptive immunity in these strains.  Reduced systemic inflammatory response in C57BL/6 mice that may result from an eminent local response appears to be beneficial during sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJulbLeviK4LVg90H21EOLACvtfcHk0lj4spQy-bgdmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSlurbN&md5=92e0bd6db93ab6c03549cbc1a52f92d8</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1097%2F01.shk.0000142249.08135.e9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.shk.0000142249.08135.e9%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DNumata%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DMatsukawa%26aufirst%3DA.%26atitle%3DInnate%2520Immune%2520Response%2520in%2520Th1-%2520and%2520Th2-Dominant%2520Mouse%2520Strains%26jtitle%3DShock%26date%3D2004%26volume%3D22%26spage%3D460%26epage%3D466%26doi%3D10.1097%2F01.shk.0000142249.08135.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nörder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinstein, S.</span></span> <span> </span><span class="NLM_article-title">Immune Modulator Adamantylamide Dipeptide Stimulates Efficient Major Histocompatibility Complex Class I-Restricted Responses in Mice</span>. <i>Clin. Vaccine Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1128/CVI.00316-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1128%2FCVI.00316-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17344349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=538-543&author=P.+D.+Beckerauthor=M.+N%C3%B6rderauthor=C.+A.+Guzm%C3%A1nauthor=S.+Grinstein&title=Immune+Modulator+Adamantylamide+Dipeptide+Stimulates+Efficient+Major+Histocompatibility+Complex+Class+I-Restricted+Responses+in+Mice&doi=10.1128%2FCVI.00316-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice</span></div><div class="casAuthors">Becker, Pablo D.; Noerder, Miriam; Guzman, Carlos A.; Grinstein, Saul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Vaccine Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">CVILA6</span>;
        ISSN:<span class="NLM_cas:issn">1556-6811</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Adamantylamide L-alanyl-D-isoglutamine (AdDP) is a synthetic adjuvant which belongs to the family of the desmuramyl peptides.  AdDP exerts its adjuvant properties when it is administered either by the parenteral or by the mucosal route, leading to the elicitation of strong humoral responses at both the systemic and the mucosal levels.  However, very little is known about the effect of AdDP on cellular immunity.  Here we demonstrate that AdDP is able to stimulate cellular responses, which are characterized by the release of gamma interferon by CD8+ T cells when they are restimulted with a major histocompatibilty complex class I-restricted peptide and strong in vivo lymphocyte-mediated cytotoxic activity.  The capacity of AdDP to stimulate the elicitation of both cellular and humoral adaptive responses makes this adjuvant a promising tool for the development of mucosal vaccine formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRNVT7JnXhLbVg90H21EOLACvtfcHk0lj4spQy-bgdmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslSmsL8%253D&md5=2865e0b5d5185c8f0e69e7d2620a463b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1128%2FCVI.00316-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCVI.00316-06%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DP.%2BD.%26aulast%3DN%25C3%25B6rder%26aufirst%3DM.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DC.%2BA.%26aulast%3DGrinstein%26aufirst%3DS.%26atitle%3DImmune%2520Modulator%2520Adamantylamide%2520Dipeptide%2520Stimulates%2520Efficient%2520Major%2520Histocompatibility%2520Complex%2520Class%2520I-Restricted%2520Responses%2520in%2520Mice%26jtitle%3DClin.%2520Vaccine%2520Immunol.%26date%3D2007%26volume%3D14%26spage%3D538%26epage%3D543%26doi%3D10.1128%2FCVI.00316-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meshcheryakova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andronova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, V.</span></span> <span> </span><span class="NLM_article-title">Evidence for Correlation between the Intensities of Adjuvant Effects and NOD2 Activation by Monomeric, Dimeric and Lipophylic Derivatives of N-Acetylglucosaminyl-N-Acetylmuramyl Peptides</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4515</span>– <span class="NLM_lpage">4520</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2007.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.vaccine.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=17481783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2mu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=4515-4520&author=E.+Meshcheryakovaauthor=E.+Makarovauthor=D.+Philpottauthor=T.+Andronovaauthor=V.+Ivanov&title=Evidence+for+Correlation+between+the+Intensities+of+Adjuvant+Effects+and+NOD2+Activation+by+Monomeric%2C+Dimeric+and+Lipophylic+Derivatives+of+N-Acetylglucosaminyl-N-Acetylmuramyl+Peptides&doi=10.1016%2Fj.vaccine.2007.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for correlation between the intensities of adjuvant effects and NOD2 activation by monomeric, dimeric and lipophylic derivatives of N-acetylglucosaminyl-N-acetylmuramyl peptides</span></div><div class="casAuthors">Meshcheryakova, Elena; Makarov, Evgenii; Philpott, Dana; Andronova, Tat'yana; Ivanov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4515-4520</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Adjuvanticity of a series of peptidoglycan fragments-known as muramyl peptides-and their lipophylic derivs. was examd. and compared with the ability of these compds. to activate NF-kB pathway through NOD2.  The adjuvant activity of di, tetrasaccharide peptides and stearoyl contg. derivs. has at least two peaks in dose-response curves and the greater of them correlates with resp. dose-response data for NF-kB stimulation through NOD2.  Introduction of stearoyl moiety, with the aim of improving muramyl peptide interaction with the cell membrane and subsequent intracellular delivery, influenced the corresponding activities in vitro, but did not correlate with improved effects in vivo expts.  IgG subtypes tests indicate that muramyl peptides preferentially stimulate IgG1 prodn., whereas the tetrasaccharide contg. muramyl peptide addnl. induces prodn. of IgG2b subclasses.  On the whole, comparison of the adjuvanticity in vivo and the NOD2 activation in vitro revealed a clear correlation between the two responses.  These findings confirm the view that NOD2 pathway activation should account, at least in part, for the adjuvant effects of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdvS1EOgNnmbVg90H21EOLACvtfcHk0ljewbYezXCreQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2mu7c%253D&md5=78576c3948d6f0d5fe529afdcc99c96d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMeshcheryakova%26aufirst%3DE.%26aulast%3DMakarov%26aufirst%3DE.%26aulast%3DPhilpott%26aufirst%3DD.%26aulast%3DAndronova%26aufirst%3DT.%26aulast%3DIvanov%26aufirst%3DV.%26atitle%3DEvidence%2520for%2520Correlation%2520between%2520the%2520Intensities%2520of%2520Adjuvant%2520Effects%2520and%2520NOD2%2520Activation%2520by%2520Monomeric%252C%2520Dimeric%2520and%2520Lipophylic%2520Derivatives%2520of%2520N-Acetylglucosaminyl-N-Acetylmuramyl%2520Peptides%26jtitle%3DVaccine%26date%3D2007%26volume%3D25%26spage%3D4515%26epage%3D4520%26doi%3D10.1016%2Fj.vaccine.2007.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, D. V.</span></span> <span> </span><span class="NLM_article-title">Well-Defined and Potent Liposomal Hepatitis B Vaccines Adjuvanted with Lipophilic MDP Derivatives</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2008.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.nano.2008.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=19523433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1eqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=334-344&author=V.+Jainauthor=S.+P.+Vyasauthor=D.+V.+Kohli&title=Well-Defined+and+Potent+Liposomal+Hepatitis+B+Vaccines+Adjuvanted+with+Lipophilic+MDP+Derivatives&doi=10.1016%2Fj.nano.2008.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives</span></div><div class="casAuthors">Jain, Vikas; Vyas, Suresh P.; Kohli, Dharmveer V.</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-344</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The characterization of immunol. cascades of the innate immune system activated by invariant mol. structures termed as pathogen-assocd. mol. patterns recognized by pattern recognition receptors of macrophages and dendritic cells, have allowed the elucidation of the mechanisms underlying the immunomodulatory properties of adjuvants.  Thus, adjuvant-active lipophilic analogs of N-acetyl muramyl dipeptide (MDP) were incorporated in liposomal hepatitis B surface antigen (HBsAg) formulations.  The immunoreactivity of the formulations was evaluated by measuring anti-HBs, IgG, and isotype antibody titer and compared with alumadsorbed HBsAg formulation.  The formulations were also evaluated for cell-mediated immune response by HBsAg-specific proliferation of splenocytes and simultaneous estn. of cytokines (interleukin-4 [IL-4], interferon-γ [IFN-γ]).  Results indicate that the serum IgG and anti-HBs titer obtained after i.m. administration of liposomal muramyl tripeptide-phosphatidylethanolamine (MTP-PE) and liposomal N-acetylmuramyl-L-alanyl-D-isoglutamine-glycerol dipalmitate (MDP-GDP) antigenic formulations were significantly higher.  The incorporation of MTP-PE on the liposomal HBsAg increased the stimulation index (SI) four to five times as compared to plain HBsAg soln., and it also induced significantly higher Th1 cellular immune response with a predominant IFN-γ level.  So it is the novel effective and potentially safe approach in which liposomes act as delivery vehicles for hepatitis B viral antigen to antigen-presenting cells and is ornamented with a biol. response modifier that could activate these target cells to enhance the antigen presentation to T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKF7cV_b7UYLVg90H21EOLACvtfcHk0ljewbYezXCreQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1eqsQ%253D%253D&md5=ece8c37c546f9fb3279fa4ef57d0f40a</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2008.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2008.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DV.%26aulast%3DVyas%26aufirst%3DS.%2BP.%26aulast%3DKohli%26aufirst%3DD.%2BV.%26atitle%3DWell-Defined%2520and%2520Potent%2520Liposomal%2520Hepatitis%2520B%2520Vaccines%2520Adjuvanted%2520with%2520Lipophilic%2520MDP%2520Derivatives%26jtitle%3DNanomedicine%26date%3D2009%26volume%3D5%26spage%3D334%26epage%3D344%26doi%3D10.1016%2Fj.nano.2008.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwendener, R. A.</span></span> <span> </span><span class="NLM_article-title">Liposomes as Vaccine Delivery Systems: A Review of the Recent Advances</span>. <i>Ther. Adv. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1177/2051013614541440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1177%2F2051013614541440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=25364509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFWitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=159-182&author=R.+A.+Schwendener&title=Liposomes+as+Vaccine+Delivery+Systems%3A+A+Review+of+the+Recent+Advances&doi=10.1177%2F2051013614541440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Liposomes as vaccine delivery systems: a review of the recent advances</span></div><div class="casAuthors">Schwendener, Reto A.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Vaccines</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">159-182</span>CODEN:
                <span class="NLM_cas:coden">TAVHAV</span>;
        ISSN:<span class="NLM_cas:issn">2051-0144</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Liposomes and liposome-derived nanovesicles such as archaeosomes and virosomes have become important carrier systems in vaccine development and the interest for liposome-based vaccines has markedly increased.  A key advantage of liposomes, archaeosomes and virosomes in general, and liposome-based vaccine delivery systems in particular, is their versatility and plasticity.  Liposome compn. and prepn. can be chosen to achieve desired features such as selection of lipid, charge, size, size distribution, entrapment and location of antigens or adjuvants.  Depending on the chem. properties, water-sol. antigens (proteins, peptides, nucleic acids, carbohydrates, haptens) are entrapped within the aq. inner space of liposomes, whereas lipophilic compds. (lipopeptides, antigens, adjuvants, linker mols.) are intercalated into the lipid bilayer and antigens or adjuvants can be attached to the liposome surface either by adsorption or stable chem. linking.  Coformulations contg. different types of antigens or adjuvants can be combined with the parameters mentioned to tailor liposomal vaccines for individual applications.  Special emphasis is given in this review to cationic adjuvant liposome vaccine formulations.  Examples of vaccines made with CAF01, an adjuvant composed of the synthetic immune-stimulating mycobacterial cordfactor glycolipid trehalose dibehenate as immunomodulator and the cationic membrane forming mol. di-Me dioctadecylammonium are presented.  Other vaccines such as cationic liposome-DNA complexes (CLDCs) and other adjuvants like muramyl dipeptide, monophosphoryl lipid A and listeriolysin O are mentioned as well.  The field of liposomes and liposome-based vaccines is vast.  Therefore, this review concs. on recent and relevant studies emphasizing current reports dealing with the most studied antigens and adjuvants, and pertinent examples of vaccines.  Studies on liposome-based veterinary vaccines and exptl. therapeutic cancer vaccines are also summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWNgLJ_ogUJLVg90H21EOLACvtfcHk0ljewbYezXCreQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFWitrw%253D&md5=a80234bd900bbeacdaa20a44f24c38fd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1177%2F2051013614541440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2051013614541440%26sid%3Dliteratum%253Aachs%26aulast%3DSchwendener%26aufirst%3DR.%2BA.%26atitle%3DLiposomes%2520as%2520Vaccine%2520Delivery%2520Systems%253A%2520A%2520Review%2520of%2520the%2520Recent%2520Advances%26jtitle%3DTher.%2520Adv.%2520Vaccines%26date%3D2014%26volume%3D2%26spage%3D159%26epage%3D182%26doi%3D10.1177%2F2051013614541440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finkelman, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katona, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schooley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosmann, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, W. E.</span></span> <span> </span><span class="NLM_article-title">Lymphokine Control of in Vivo Immunoglobulin Isotype Selection</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1146/annurev.iy.08.040190.001511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1146%2Fannurev.iy.08.040190.001511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1693082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFGksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=303-330&author=F.+D.+Finkelmanauthor=J.+Holmesauthor=I.+M.+Katonaauthor=J.+F.+Urbanauthor=M.+P.+Beckmannauthor=L.+S.+Parkauthor=K.+A.+Schooleyauthor=R.+L.+Coffmanauthor=T.+R.+Mosmannauthor=W.+E.+Paul&title=Lymphokine+Control+of+in+Vivo+Immunoglobulin+Isotype+Selection&doi=10.1146%2Fannurev.iy.08.040190.001511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphokine control of in vivo immunoglobulin isotype selection</span></div><div class="casAuthors">Finkelman, Fred D.; Holmes, Joanne; Katona, Ildy M.; Urban, Joseph F., Jr.; Beckmann, M. Patricia; Park, Linda S.; Schooley, Kenneth A.; Coffman, Robert L.; Mosmann, Timothy R.; Paul, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">303-33</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    </div><div class="casAbstract">A review with 76 refs. of the role of interleukins and interferons in the regulation of Ig isotype selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGootFYwwR1SYbVg90H21EOLACvtfcHk0ljewbYezXCreQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFGksLs%253D&md5=8b650c349b802f9f3720d529669b7f78</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1146%2Fannurev.iy.08.040190.001511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.iy.08.040190.001511%26sid%3Dliteratum%253Aachs%26aulast%3DFinkelman%26aufirst%3DF.%2BD.%26aulast%3DHolmes%26aufirst%3DJ.%26aulast%3DKatona%26aufirst%3DI.%2BM.%26aulast%3DUrban%26aufirst%3DJ.%2BF.%26aulast%3DBeckmann%26aufirst%3DM.%2BP.%26aulast%3DPark%26aufirst%3DL.%2BS.%26aulast%3DSchooley%26aufirst%3DK.%2BA.%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26aulast%3DMosmann%26aufirst%3DT.%2BR.%26aulast%3DPaul%26aufirst%3DW.%2BE.%26atitle%3DLymphokine%2520Control%2520of%2520in%2520Vivo%2520Immunoglobulin%2520Isotype%2520Selection%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1990%26volume%3D8%26spage%3D303%26epage%3D330%26doi%3D10.1146%2Fannurev.iy.08.040190.001511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Comparative Study of Structurally Related Peptidoglycan Monomer and Muramyl Dipeptide on Humoral IgG Immune Response to Ovalbumin in Mouse</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2010.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.intimp.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=20403461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=751-759&author=L.+Habjanecauthor=B.+Halassyauthor=J.+Toma%C5%A1i%C4%87&title=Comparative+Study+of+Structurally+Related+Peptidoglycan+Monomer+and+Muramyl+Dipeptide+on+Humoral+IgG+Immune+Response+to+Ovalbumin+in+Mouse&doi=10.1016%2Fj.intimp.2010.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse</span></div><div class="casAuthors">Habjanec, Lidija; Halassy, Beata; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">751-759</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structurally related peptidoglycan monomer (PGM) and muramyl dipeptide (MDP) differ in several aspects of biol. activity but have in common immunostimulating properties.  Comparative study of the effects of these adjuvants on humoral IgG immune response specific for protein antigen ovalbumin (OVA) was carried out in two inbred mouse strains, CBA and NIH/OlaHsd, and their ability to modulate the bias of immune response towards Th1/Th2 was evaluated.  MDP had better adjuvant activity at some points than PGM, whereas both adjuvants stimulated Th2-biased immune response specific for OVA.  In comparison to Complete Freund's adjuvant (CFA), as a golden std. of adjuvant action, both PGM and MDP exhibited considerably lower activity.  Addn. of PGM to Incomplete Freund's adjuvant (IFA) on humoral immune response was studied also, and the effect of such adjuvant formulation was compared to the effect of CFA.  While CFA induced the switch towards Th1-biased immune response, the addn. of PGM into IFA did have no impact on modulating the immune response towards more pronounced Th2-type of immune response, defined by IFA itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEa9MV5PnV7bVg90H21EOLACvtfcHk0lgP_qf2nJNbkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D&md5=0279f7b455963f0048e0d182805bd5f1</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DComparative%2520Study%2520of%2520Structurally%2520Related%2520Peptidoglycan%2520Monomer%2520and%2520Muramyl%2520Dipeptide%2520on%2520Humoral%2520IgG%2520Immune%2520Response%2520to%2520Ovalbumin%2520in%2520Mouse%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2010%26volume%3D10%26spage%3D751%26epage%3D759%26doi%3D10.1016%2Fj.intimp.2010.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, J. M.</span></span> <span> </span><span class="NLM_article-title">Activation of Alveolar Macrophage Tumoricidal Activity and Eradication of Experimental Metastases by Freeze-Dried Liposomes Containing a New Lipophilic Muramyl Dipeptide Derivative</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=3838084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaL2MXhtF2mtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=128-134&author=N.+C.+Phillipsauthor=M.+L.+Morasauthor=L.+Chedidauthor=P.+Lefrancierauthor=J.+M.+Bernard&title=Activation+of+Alveolar+Macrophage+Tumoricidal+Activity+and+Eradication+of+Experimental+Metastases+by+Freeze-Dried+Liposomes+Containing+a+New+Lipophilic+Muramyl+Dipeptide+Derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative</span></div><div class="casAuthors">Phillips, Nigel C.; Moras, Maria L.; Chedid, Louis; Lefrancier, Pierre; Bernard, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-34</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The ability of a member of a new class of lipophilic muramyl dipeptide (MDP)  [53678-77-6] deriv., muramyl dipeptide-glyceryldipalmitate (MDP-GDP)  [95238-29-2], to induce alveolar macrophage cytotoxic activity in vitro towards B16 melanoma cells when incorporated into 2 types of liposome was studied.  MDP-GDP incorporated into conventionally prepd. liposomes formulated from distearoylphosphatidylcholine  [4539-70-2] and phosphatidylserine (7:3 molar ratio) was 10-fold more effective than liposomes contg. MDP, and 7000-fold more effective than free MDP in inducing macrophage cytotoxic activity.  MDP-GDP incorporated into freeze-dried liposomes was 50,000- to 100,000-fold more effective than free MDP in inducing such activity.  Freeze-dried liposomes contg. MDP-GDP were efficiently localized in the lungs of normal mice, and induced cytotoxic activity in the alveolar macrophages.  Such liposomes were able to significantly reduce the pulmonary metastatic burden of mice carrying the B16 melanoma.  These data provide evidence that this class of lipophilic MDP deriv., when incorporated into freeze-dried liposomes, is a potent inducer of macrophage cytotoxic activity in vitro and in situ, and has antitumor activity in vivo.  In addn., the use of a freeze-drying procedure allows the prepn. and long-term storage of reproducible liposome formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTM_-uSCzLwLVg90H21EOLACvtfcHk0lgP_qf2nJNbkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtF2mtL8%253D&md5=dfbc7f2f99c9e06635cbc3a23cdc858a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DN.%2BC.%26aulast%3DMoras%26aufirst%3DM.%2BL.%26aulast%3DChedid%26aufirst%3DL.%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DBernard%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520Alveolar%2520Macrophage%2520Tumoricidal%2520Activity%2520and%2520Eradication%2520of%2520Experimental%2520Metastases%2520by%2520Freeze-Dried%2520Liposomes%2520Containing%2520a%2520New%2520Lipophilic%2520Muramyl%2520Dipeptide%2520Derivative%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribić, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manček-Keber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinnaeve, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehér, K.</span></span> <span> </span><span class="NLM_article-title">Targeted Delivery of Adamantylated Peptidoglycan Immunomodulators in Lipid Nanocarriers: NMR Shows That Cargo Fragments Are Available on the Surface</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">4132</span>– <span class="NLM_lpage">4145</span>, <span class="refDoi"> DOI: 10.1021/acs.jpcb.0c00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jpcb.0c00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntVKksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2020&pages=4132-4145&author=R.+Ribi%C4%87author=M.+Man%C4%8Dek-Keberauthor=F.+Chainauthor=D.+Sinnaeveauthor=J.+C.+Martinsauthor=R.+Jeralaauthor=S.+Tomi%C4%87author=K.+Feh%C3%A9r&title=Targeted+Delivery+of+Adamantylated+Peptidoglycan+Immunomodulators+in+Lipid+Nanocarriers%3A+NMR+Shows+That+Cargo+Fragments+Are+Available+on+the+Surface&doi=10.1021%2Facs.jpcb.0c00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Delivery of Adamantylated Peptidoglycan Immunomodulators in Lipid Nanocarriers: NMR Shows That Cargo Fragments Are Available on the Surface</span></div><div class="casAuthors">Ribic, Rosana; Mancek-Keber, Mateja; Chain, Fernando; Sinnaeve, Davy; Martins, Jose C.; Jerala, Roman; Tomic, Srdjanka; Feher, Krisztina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4132-4145</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an in-depth investigation of the membrane interactions of peptidoglycan (PGN)-based immune adjuvants designed for lipid-based delivery systems using NMR spectroscopy.  The derivs. contain a cargo peptidoglycan (PGN) dipeptide fragment and an adamantyl group, which serves as an anchor to the lipid bilayer.  Furthermore, derivs. with a mannose group that can actively target cell surface receptors on immune cells are also studied.  We showed that the targeting mannose group and the cargo PGN fragment are both available on the lipid bilayer surface, thereby enabling interactions with cognate receptors.  We found that the nonmannosylated compds. are incorporated stronger into the lipid assemblies than the mannosylated ones, but the latter compds. penetrate deeper in the bilayer.  This might be explained by stronger electrostatic interactions available for zwitterionic nonmannosylated derivs. as opposed to the compds. in which the charged N-terminus is capped by mannose groups.  The higher incorporation efficiency of the nonmannosylated compds. correlated with a larger relative enhancement in immune stimulation activities upon lipid incorporation compared to that of the derivs. with the mannose group.  The chirality of the adamantyl group also influenced the incorporation efficiency, which in turn correlated with membrane-assocd. conformations that affect possible intermol. interactions with lipid mols.  These findings will help in improving the development of PGN-based immune adjuvants suitable for delivery in lipid nanoparticles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDrKFb-vglLVg90H21EOLACvtfcHk0lj5aShlZDcUog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntVKksrg%253D&md5=f136e4dd03eb00ee5d0c9d57dc70ec08</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jpcb.0c00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jpcb.0c00029%26sid%3Dliteratum%253Aachs%26aulast%3DRibi%25C4%2587%26aufirst%3DR.%26aulast%3DMan%25C4%258Dek-Keber%26aufirst%3DM.%26aulast%3DChain%26aufirst%3DF.%26aulast%3DSinnaeve%26aufirst%3DD.%26aulast%3DMartins%26aufirst%3DJ.%2BC.%26aulast%3DJerala%26aufirst%3DR.%26aulast%3DTomi%25C4%2587%26aufirst%3DS.%26aulast%3DFeh%25C3%25A9r%26aufirst%3DK.%26atitle%3DTargeted%2520Delivery%2520of%2520Adamantylated%2520Peptidoglycan%2520Immunomodulators%2520in%2520Lipid%2520Nanocarriers%253A%2520NMR%2520Shows%2520That%2520Cargo%2520Fragments%2520Are%2520Available%2520on%2520the%2520Surface%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2020%26volume%3D124%26spage%3D4132%26epage%3D4145%26doi%3D10.1021%2Facs.jpcb.0c00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brgles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurašin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikirić, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Entrapment of Ovalbumin into Liposomes - Factors Affecting Entrapment Efficiency, Liposome Size, and Zeta Potential</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1080/08982100802312762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F08982100802312762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=18770073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOrurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=235-248&author=M.+Brglesauthor=D.+Jura%C5%A1inauthor=M.+D.+Sikiri%C4%87author=R.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Entrapment+of+Ovalbumin+into+Liposomes+-+Factors+Affecting+Entrapment+Efficiency%2C+Liposome+Size%2C+and+Zeta+Potential&doi=10.1080%2F08982100802312762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Entrapment of Ovalbumin into Liposomes-Factors Affecting Entrapment Efficiency, Liposome Size, and Zeta Potential</span></div><div class="casAuthors">Brgles, Marija; Jurasin, Darija; Sikiric, Maja Dutour; Frkanec, Ruza; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Various amts. of Ovalbumin (OVA) were encapsulated into pos. and neg. charged multilamellar liposomes, with the aim to investigate the entrapment efficiency in different buffers and to study their effects on the liposome size and zeta potential.  Results showed that the entrapment efficiency of OVA in anionic liposomes was the same in 10 mM Phosphate Buffer (PB) as in Phosphate-Buffered Saline (PBS; PB + 0.15 M NaCl).  Also, liposome size was approx. 1200 nm for all anionic liposomes incorporating OVA.  The entrapment efficiency of OVA in cationic liposomes was highly dependent on ionic strength.  The size of cationic liposomes was approx. 1200 nm in PBS, regardless of protein content, but increased with the amt. of the incorporated protein in PB.  Aggregation of cationic liposomes in PB was obsd. when the mass of the protein was 2.5 mg or greater.  The zeta potential of anionic liposomes was neg. and of cationic liposomes pos. in the whole range of protein mass tested.  These results show how different compns. of lipid and aq. phases can be used to vary the entrapment efficiency, liposome size, and zeta potential-the factors that are of great importance for the use of liposomes as drug carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhYnJ-NAzl77Vg90H21EOLACvtfcHk0lj5aShlZDcUog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOrurjN&md5=2ccc236c578fa6060330541e518501a3</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1080%2F08982100802312762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08982100802312762%26sid%3Dliteratum%253Aachs%26aulast%3DBrgles%26aufirst%3DM.%26aulast%3DJura%25C5%25A1in%26aufirst%3DD.%26aulast%3DSikiri%25C4%2587%26aufirst%3DM.%2BD.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEntrapment%2520of%2520Ovalbumin%2520into%2520Liposomes%2520-%2520Factors%2520Affecting%2520Entrapment%2520Efficiency%252C%2520Liposome%2520Size%252C%2520and%2520Zeta%2520Potential%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2008%26volume%3D18%26spage%3D235%26epage%3D248%26doi%3D10.1080%2F08982100802312762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tandrup Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foged, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith Korsholm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rades, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, D.</span></span> <span> </span><span class="NLM_article-title">Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics8010007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.3390%2Fpharmaceutics8010007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=7&author=S.+Tandrup+Schmidtauthor=C.+Fogedauthor=K.+Smith+Korsholmauthor=T.+Radesauthor=D.+Christensen&title=Liposome-Based+Adjuvants+for+Subunit+Vaccines%3A+Formulation+Strategies+for+Subunit+Antigens+and+Immunostimulators&doi=10.3390%2Fpharmaceutics8010007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics8010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics8010007%26sid%3Dliteratum%253Aachs%26aulast%3DTandrup%2BSchmidt%26aufirst%3DS.%26aulast%3DFoged%26aufirst%3DC.%26aulast%3DSmith%2BKorsholm%26aufirst%3DK.%26aulast%3DRades%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DD.%26atitle%3DLiposome-Based%2520Adjuvants%2520for%2520Subunit%2520Vaccines%253A%2520Formulation%2520Strategies%2520for%2520Subunit%2520Antigens%2520and%2520Immunostimulators%26jtitle%3DPharmaceutics%26date%3D2016%26volume%3D8%26spage%3D7%26doi%3D10.3390%2Fpharmaceutics8010007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Targeting Strategies of Liposomal Subunit Vaccine Delivery Systems to Improve Vaccine Efficacy</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1080/1061186X.2018.1547734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1080%2F1061186X.2018.1547734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30589361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1WhurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=780-789&author=R.+Yuauthor=Y.+Maiauthor=Y.+Zhaoauthor=Y.+Houauthor=Y.+Liuauthor=J.+Yang&title=Targeting+Strategies+of+Liposomal+Subunit+Vaccine+Delivery+Systems+to+Improve+Vaccine+Efficacy&doi=10.1080%2F1061186X.2018.1547734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy</span></div><div class="casAuthors">Yu, Rui; Mai, Yaping; Zhao, Yue; Hou, Yanhui; Liu, Yanhua; Yang, Jianhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Liposomes are versatile delivery systems and immunol. adjuvants that not only can load various antigens, such as proteins, peptides, nucleic acids and carbohydrates, but also can combine them with immunostimulators.  Liposomes have great potential in the development of new types of vaccines, and much effort has been devoted to enhancing vaccine efficacy in recent years.  Different types of immune cells such as macrophages and dendritic cells play an important role in the immune response and in preventing or treating cancer, allergy or many other infectious diseases.  Targeting liposome-based delivery systems to certain immune cells and organs is one of the most effective measures in such treatments.  Extensive research has shown that liposomes combined with immunostimulators or modified with pattern recognition receptor ligands can target various immune cells and the lymphatic system, thus not only inducing and promoting the desired immune response but also decreasing adverse effects throughout the body and avoiding targeting irrelevant cell types or tissues.  Therefore, in this review, we outline some targeting strategies that can be adopted in the design of liposomal vaccines to improve vaccine efficacy, and we summarise the related liposome-based vaccine applications in several diseases.  These applications have great potential to treat or prevent some infectious and intractable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdOLUHq18--bVg90H21EOLACvtfcHk0lj5aShlZDcUog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1WhurzL&md5=7f95c644c04cde3803d105dfb3b360e5</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1080%2F1061186X.2018.1547734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1061186X.2018.1547734%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DR.%26aulast%3DMai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DTargeting%2520Strategies%2520of%2520Liposomal%2520Subunit%2520Vaccine%2520Delivery%2520Systems%2520to%2520Improve%2520Vaccine%2520Efficacy%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2019%26volume%3D27%26spage%3D780%26epage%3D789%26doi%3D10.1080%2F1061186X.2018.1547734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Opanasopit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashida, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Liver Metastasis by Targeting of Immunomodulators Using Mannosylated Liposome Carriers</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1016/S0168-3659(02)00006-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0168-3659%2802%2900006-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=11943405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=283-294&author=P.+Opanasopitauthor=M.+Sakaiauthor=M.+Nishikawaauthor=S.+Kawakamiauthor=F.+Yamashitaauthor=M.+Hashida&title=Inhibition+of+Liver+Metastasis+by+Targeting+of+Immunomodulators+Using+Mannosylated+Liposome+Carriers&doi=10.1016%2FS0168-3659%2802%2900006-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers</span></div><div class="casAuthors">Opanasopit, Praneet; Sakai, Megumi; Nishikawa, Makiya; Kawakami, Shigeru; Yamashita, Fumiyoshi; Hashida, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Mannosylated liposomes were prepd. by incorporating cholesten-5-yloxy-N-(4-((1-imino-2-β-d-thiomannosylethyl)amino)butyl)formamide (Man-C4-Chol) into small unilamellar liposomes consisting of cholesterol and distearoyl phosphatidylcholine (DSPC).  The biodistribution of liposomes labeled with [3H]cholesteryl hexadecyl ether was examd. in mice.  The rate and extent of the hepatic uptake of those [3H]liposomes increased proportionally on increasing the mixing ratio of Man-C4-Chol.  Their hepatic uptake was reduced by increasing the administered dose due to the limited no. of mannose receptors.  The liver uptake of [3H]Man-liposomes was preferentially mediated by liver non-parenchymal cells (NPC) and significantly inhibited by co-injection with an excess of Man-BSA, indicating the involvement of a mannose receptor-mediated mechanism in the hepatic uptake of Man-liposomes.  Muramyl dipeptide (MDP), an immunomodulator, was also incorporated into the liposomes and its inhibitory effect in an exptl. liver metastasis model was examd.  In contrast to free MDP treatment, which showed little effect on the inhibition of metastasis, liposomal MDP significantly reduced the no. of metastatic colonies in the liver.  Active targeting of MDP to liver NPC by Man-liposomes resulted in more effective inhibition than delivery of MDP by liposomes without mannose.  Treatment with MDP/Man-liposomes further increased the survival of the tumor-bearing mice.  These results suggest that Man-liposomes are effective carriers for targeted delivery of bioactive compds. to liver NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkOYKO9WhFo7Vg90H21EOLACvtfcHk0lhp8BUT8A4Iew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFyrsbg%253D&md5=3255950f255754266c2a5fc1d749b34d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2802%2900006-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252802%252900006-8%26sid%3Dliteratum%253Aachs%26aulast%3DOpanasopit%26aufirst%3DP.%26aulast%3DSakai%26aufirst%3DM.%26aulast%3DNishikawa%26aufirst%3DM.%26aulast%3DKawakami%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DF.%26aulast%3DHashida%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520Liver%2520Metastasis%2520by%2520Targeting%2520of%2520Immunomodulators%2520Using%2520Mannosylated%2520Liposome%2520Carriers%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2002%26volume%3D80%26spage%3D283%26epage%3D294%26doi%3D10.1016%2FS0168-3659%2802%2900006-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanasarn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloat, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span> <span> </span><span class="NLM_article-title">Negatively Charged Liposomes Show Potent Adjuvant Activity When Simply Admixed with Protein Antigens</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1021/mp200016d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200016d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1174-1185&author=N.+Yanasarnauthor=B.+R.+Sloatauthor=Z.+Cui&title=Negatively+Charged+Liposomes+Show+Potent+Adjuvant+Activity+When+Simply+Admixed+with+Protein+Antigens&doi=10.1021%2Fmp200016d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Negatively Charged Liposomes Show Potent Adjuvant Activity When Simply Admixed with Protein Antigens</span></div><div class="casAuthors">Yanasarn, Nijaporn; Sloat, Brian R.; Cui, Zhengrong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1174-1185</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liposomes have been investigated extensively as a vaccine delivery system.  Herein the adjuvant activities of liposomes with different net surface charges (neutral, pos., or neg.) were evaluated when admixed with protein antigens, ovalbumin (OVA, pI = 4.7), Bacillus anthracis protective antigen protein (PA, pI = 5.6), or cationized OVA (cOVA).  Mice immunized s.c. with OVA admixed with different liposomes generated different antibody responses.  Interestingly, OVA admixed with net neg. charged liposomes prepd. with DOPA was as immunogenic as OVA admixed with pos. charged liposomes prepd. with DOTAP.  Immunization of mice with the anthrax PA protein admixed with the net neg. charged DOPA liposomes also induced a strong and functional anti-PA antibody response.  When the cationized OVA was used as a model antigen, liposomes with net neutral, neg., or pos. charges showed comparable adjuvant activities.  Immunization of mice with the OVA admixed with DOPA liposomes also induced OVA-specific CD8+ cytotoxic T lymphocyte responses and significantly delayed the growth of OVA-expressing B16-OVA tumors in mice.  However, not all net neg. charged liposomes showed a strong adjuvant activity.  The adjuvant activity of the neg. charged liposomes may be related to the liposome's ability (i) to up-regulate the expression of mols. related to the activation and maturation of antigen-presenting cells and (ii) to slightly facilitate the uptake of the antigens by antigen-presenting cells.  Simply admixing certain neg. charged liposomes with certain protein antigens of interest may represent a novel platform for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolppNDqLIroLVg90H21EOLACvtfcHk0lhp8BUT8A4Iew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGis7s%253D&md5=b61d68897a849b3c9784b058abdb2284</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fmp200016d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200016d%26sid%3Dliteratum%253Aachs%26aulast%3DYanasarn%26aufirst%3DN.%26aulast%3DSloat%26aufirst%3DB.%2BR.%26aulast%3DCui%26aufirst%3DZ.%26atitle%3DNegatively%2520Charged%2520Liposomes%2520Show%2520Potent%2520Adjuvant%2520Activity%2520When%2520Simply%2520Admixed%2520with%2520Protein%2520Antigens%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2011%26volume%3D8%26spage%3D1174%26epage%3D1185%26doi%3D10.1021%2Fmp200016d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Štimac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendelja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikirić, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span> <span> </span><span class="NLM_article-title">Mannosylated Liposomes with Built-in Peptidoglycan Based Immunomodulators for Subunit Vaccine Formulations</span>. <i>Croat. Chem. Acta</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.5562/cca3309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.5562%2Fcca3309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=645-656&author=A.+%C5%A0timacauthor=K.+Bendeljaauthor=M.+D.+Sikiri%C4%87author=L.+Frkanecauthor=R.+Frkanec&title=Mannosylated+Liposomes+with+Built-in+Peptidoglycan+Based+Immunomodulators+for+Subunit+Vaccine+Formulations&doi=10.5562%2Fcca3309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.5562%2Fcca3309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5562%252Fcca3309%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0timac%26aufirst%3DA.%26aulast%3DBendelja%26aufirst%3DK.%26aulast%3DSikiri%25C4%2587%26aufirst%3DM.%2BD.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DFrkanec%26aufirst%3DR.%26atitle%3DMannosylated%2520Liposomes%2520with%2520Built-in%2520Peptidoglycan%2520Based%2520Immunomodulators%2520for%2520Subunit%2520Vaccine%2520Formulations%26jtitle%3DCroat.%2520Chem.%2520Acta%26date%3D2017%26volume%3D90%26spage%3D645%26epage%3D656%26doi%3D10.5562%2Fcca3309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lozzio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozzio, B.</span></span> <span> </span><span class="NLM_article-title">Human Chronic Myelogenous Leukemia Cell-Line with Positive Philadelphia Chromosome</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1182/blood.V45.3.321.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1182%2Fblood.V45.3.321.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=163658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A280%3ADyaE2M7gvFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1975&pages=321-334&author=C.+Lozzioauthor=B.+Lozzio&title=Human+Chronic+Myelogenous+Leukemia+Cell-Line+with+Positive+Philadelphia+Chromosome&doi=10.1182%2Fblood.V45.3.321.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome</span></div><div class="casAuthors">Lozzio C B; Lozzio B B</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-34</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">A cell-line derived from a patient with chronic myelogenous leukemia (CML) is described.  The new cell-line, which has over 175 serial passanges in a 3 1/2-yr period, has the following characteristics: (1) CML cells started to proliferate actively since they were first incubated in culture media.  A threefold increase in the total number of cells was observed during the first seven passages; the cell population increased by a factor of 10 to 20 every 7 days from passage 8 through 85; from 20 to 40 times from passage 86 through 150, and more than 40 times after 150 passages. (2) The majority of the nononucleated cells are undifferentiated blasts. (3) The karyotype of all the cells examined show the Philadelphia (Ph1) chromosome and a long acrocentric marker plus aneuploidy.  The Giemsa-banding studies identified the Ph1 chromosome as a terminal deletion of the long arm of chromosome 22:del(22)(q12) and the long acrocentric marker as an unbalanced reciprocal translocation of one chromosome 17 and the long arm of one chromosome 15. (4) The CML cells do not produce immunoglobulins, are free of mycoplasma, Epstein-Barr virus, and herpes-like virus particles. (5) CML cells have no alkaline phosphatase and myeloperoxidase activities and did not engulf inert particles. (6) Cultured CML cells provide a constant source of a specific antigen.  This CML cell-line represents a unique source of CML cells with meaningful indicators of malignancy for clinical and experimental studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSn4RF_5flkqEg6wdEZmT2rfW6udTcc2eYUIca4KpGpE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2M7gvFyjug%253D%253D&md5=d396e38802cebb103ab1c7b9adbe35af</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1182%2Fblood.V45.3.321.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V45.3.321.321%26sid%3Dliteratum%253Aachs%26aulast%3DLozzio%26aufirst%3DC.%26aulast%3DLozzio%26aufirst%3DB.%26atitle%3DHuman%2520Chronic%2520Myelogenous%2520Leukemia%2520Cell-Line%2520with%2520Positive%2520Philadelphia%2520Chromosome%26jtitle%3DBlood%26date%3D1975%26volume%3D45%26spage%3D321%26epage%3D334%26doi%3D10.1182%2Fblood.V45.3.321.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacchini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfarano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Circosta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottardi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faldella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rege-Cambrin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thunberg, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligaris-Cappio, F.</span></span> <span> </span><span class="NLM_article-title">MEC1 and MEC2: Two New Cell Lines Derived from B-Chronic Lymphocytic Leukaemia in Prolymphocytoid Transformation</span>. <i>Leuk. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/S0145-2126(98)00154-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0145-2126%2898%2900154-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10071128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADyaK1MXhslSls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=127-136&author=A.+Stacchiniauthor=M.+Aragnoauthor=A.+Vallarioauthor=A.+Alfaranoauthor=P.+Circostaauthor=D.+Gottardiauthor=A.+Faldellaauthor=G.+Rege-Cambrinauthor=U.+Thunbergauthor=K.+Nilssonauthor=F.+Caligaris-Cappio&title=MEC1+and+MEC2%3A+Two+New+Cell+Lines+Derived+from+B-Chronic+Lymphocytic+Leukaemia+in+Prolymphocytoid+Transformation&doi=10.1016%2FS0145-2126%2898%2900154-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukemia in prolymphocytoid transformation</span></div><div class="casAuthors">Stacchini, Alessandra; Aragno, Michela; Vallario, Antonella; Alfarano, Alda; Circosta, Paola; Gottardi, Daniela; Faldella, Alessandra; Rege-Cambrin, Giovanna; Thunberg, Ulf; Nilsson, Kenneth; Caligaris-Cappio, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The authors report the establishment and characterization of two cell lines, MEC1 and MEC2, that grew spontaneously on two subsequent occasions from the peripheral blood (PB) of a patient with B-chronic lymphocytic leukemia (B-CLL) in prolymphocytoid transformation.  The patient was EBV-seropos., his leukemic cells were EBNA neg., but the spontaneously grown cell lines are EBNA-2 pos.  In liq. culture MEC1 cells grow adherent to the vessel wall and as tiny clumps; MEC2 cells do not adhere and form large clumps.  The doubling time of MEC1 is 40h and of MEC2 is 31h.  Both cell lines express the same light (κ) and heavy chains (μ, δ) as the fresh parental B-CLL cells at the same high intensity, share the expression of mature B cell markers (CD19, CD20, CD21, CD22), differ in the expression of CD23 and FMC7, are CD11a +, CD18 +, CD44 +, CD49d +, CD54 + and express at high levels both CD80 and CD86.  CD5 is neg. on MEC1 cells (as on the vast majority of parental cells) and it has been lost by MEC2 cells after several months of culture.  The cells have a complex karyotype.  The tumor origin of MEC1 and MEC2 has been demonstrated by Southern blot anal. of the IgH loci and by Ig gene DNA sequencing.  They use the VH4 Ig family and have not undergone somatic mutations (94.8% homol. with germline Ig gene 4-59).  Cytofluorog. anal. and RT-PCR reveal that MEC1 and MEC2 overexpress Bcl-2 together with Bax, express large amts. of Bcl-xL and trace amts. of Bcl-xS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhWMnYUms6JrVg90H21EOLACvtfcHk0lhpls6FW2BDrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslSls78%253D&md5=d35e4d9891598ad2d609c93b2a9965cd</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2FS0145-2126%2898%2900154-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0145-2126%252898%252900154-4%26sid%3Dliteratum%253Aachs%26aulast%3DStacchini%26aufirst%3DA.%26aulast%3DAragno%26aufirst%3DM.%26aulast%3DVallario%26aufirst%3DA.%26aulast%3DAlfarano%26aufirst%3DA.%26aulast%3DCircosta%26aufirst%3DP.%26aulast%3DGottardi%26aufirst%3DD.%26aulast%3DFaldella%26aufirst%3DA.%26aulast%3DRege-Cambrin%26aufirst%3DG.%26aulast%3DThunberg%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DK.%26aulast%3DCaligaris-Cappio%26aufirst%3DF.%26atitle%3DMEC1%2520and%2520MEC2%253A%2520Two%2520New%2520Cell%2520Lines%2520Derived%2520from%2520B-Chronic%2520Lymphocytic%2520Leukaemia%2520in%2520Prolymphocytoid%2520Transformation%26jtitle%3DLeuk.%2520Res.%26date%3D1999%26volume%3D23%26spage%3D127%26epage%3D136%26doi%3D10.1016%2FS0145-2126%2898%2900154-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span> <span> </span><span class="NLM_article-title">IDEP: An Integrated Web Application for Differential Expression and Pathway Analysis of RNA-Seq Data</span>. <i>BMC Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">534</span>, <span class="refDoi"> DOI: 10.1186/s12859-018-2486-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1186%2Fs12859-018-2486-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=30567491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1Sks73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=534&author=S.+X.+Geauthor=E.+W.+Sonauthor=R.+Yao&title=IDEP%3A+An+Integrated+Web+Application+for+Differential+Expression+and+Pathway+Analysis+of+RNA-Seq+Data&doi=10.1186%2Fs12859-018-2486-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">IDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data</span></div><div class="casAuthors">Ge, Steven Xijin; Son, Eun Wo; Yao, Runan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Bioinformatics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">534</span>CODEN:
                <span class="NLM_cas:coden">BBMIC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2105</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">RNA-seq is widely used for transcriptomic profiling, but the bioinformatics anal. of resultant data can be time-consuming and challenging, esp. for biologists.  We aim to streamline the bioinformatic analyses of gene-level data by developing a user-friendly, interactive web application for exploratory data anal., differential expression, and pathway anal.  IDEP (integrated Differential Expression and Pathway anal.) seamlessly connects 63 R/Bioconductor packages, 2 web services, and comprehensive annotation and pathway databases for 220 plant and animal species.  The workflow can be reproduced by downloading customized R code and related pathway files.  As an example, we analyzed an RNA-Seq dataset of lung fibroblasts with Hoxa1 knockdown and revealed the possible roles of SP1 and E2F1 and their target genes, including microRNAs, in blocking G1/S transition.  In another example, our anal. shows that in mouse B cells without functional p53, ionizing radiation activates the MYC pathway and its downstream genes involved in cell proliferation, ribosome biogenesis, and non-coding RNA metab.  In wildtype B cells, radiation induces p53-mediated apoptosis and DNA repair while suppressing the target genes of MYC and E2F1, and leads to growth and cell cycle arrest. iDEP helps unveil the multifaceted functions of p53 and the possible involvement of several microRNAs such as miR-92a, miR-504, and miR-30a.  In both examples, we validated known mol. pathways and generated novel, testable hypotheses.  Combining comprehensive analytic functionalities with massive annotation databases, iDEP enables biologists to easily translate transcriptomic and proteomic data into actionable insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMv97MM-Va7Vg90H21EOLACvtfcHk0lhpls6FW2BDrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1Sks73P&md5=6b592701c5c3a4896d2ecebb91854df8</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1186%2Fs12859-018-2486-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12859-018-2486-6%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DS.%2BX.%26aulast%3DSon%26aufirst%3DE.%2BW.%26aulast%3DYao%26aufirst%3DR.%26atitle%3DIDEP%253A%2520An%2520Integrated%2520Web%2520Application%2520for%2520Differential%2520Expression%2520and%2520Pathway%2520Analysis%2520of%2520RNA-Seq%2520Data%26jtitle%3DBMC%2520Bioinf.%26date%3D2018%26volume%3D19%26spage%3D534%26doi%3D10.1186%2Fs12859-018-2486-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Štimac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvitaš, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vugrek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span> <span> </span><span class="NLM_article-title">Design and Syntheses of Mono and Multivalent Mannosyl-Lipoconjugates for Targeted Liposomal Drug Delivery</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2016.06.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2Fj.ijpharm.2016.06.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=27363934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOitLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2016&pages=44-56&author=A.+%C5%A0timacauthor=J.+T.+Cvita%C5%A1author=L.+Frkanecauthor=O.+Vugrekauthor=R.+Frkanec&title=Design+and+Syntheses+of+Mono+and+Multivalent+Mannosyl-Lipoconjugates+for+Targeted+Liposomal+Drug+Delivery&doi=10.1016%2Fj.ijpharm.2016.06.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design and syntheses of mono and multivalent mannosyl-lipoconjugates for targeted liposomal drug delivery</span></div><div class="casAuthors">Stimac, Adela; Cvitas, Jelena Trmcic; Frkanec, Leo; Vugrek, Oliver; Frkanec, Ruza</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-56</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multivalent mannosyl-lipoconjugates may be of interest for glycosylation of liposomes and targeted drug delivery because the mannose specifically binds to C-type lectin receptors on the particular cells.  In this paper syntheses of two types of novel O-mannosides are presented.  Conjugates 1 and 2 with a COOH- and NH2-functionalized spacer and the connection to a lysine and FmocNH-PEG-COOH, are described.  The coupling reactions of prepd. intermediates 6 and 4 with a PEGylated-DSPE or palmitic acid, resp., are presented.  Compds. 5, mono-, 8, di- and 12, tetravalent mannosyl-lipoconjugates, were synthesized.  The synthesized compds. were incorporated into liposomes and liposomal prepns. featuring exposed mannose units were characterized.  Carbohydrate liposomal quartz crystal microbalance based assay has been established for studying carbohydrate-lectin binding.  It was demonstrated that liposomes with incorporated mannosyl-lipoconjugates were effectively recognized by Con A and have great potential to be used for targeted liposomal drug delivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbWSukjX7-LVg90H21EOLACvtfcHk0lhpls6FW2BDrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOitLbL&md5=a4ad7918ca70761b6fc7cb0b6dc76407</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2016.06.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2016.06.123%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0timac%26aufirst%3DA.%26aulast%3DCvita%25C5%25A1%26aufirst%3DJ.%2BT.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DVugrek%26aufirst%3DO.%26aulast%3DFrkanec%26aufirst%3DR.%26atitle%3DDesign%2520and%2520Syntheses%2520of%2520Mono%2520and%2520Multivalent%2520Mannosyl-Lipoconjugates%2520for%2520Targeted%2520Liposomal%2520Drug%2520Delivery%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2016%26volume%3D511%26spage%3D44%26epage%3D56%26doi%3D10.1016%2Fj.ijpharm.2016.06.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travaš, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstanović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Špoljar, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljevaković, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Entrapment of Peptidoglycans and Adamantyltripeptides into Liposomes: An HPLC Assay for Determination of Encapsulation Efficiency</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1081/LPR-120026452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1081%2FLPR-120026452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=14670233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=279-294&author=R.+Frkanecauthor=D.+Trava%C5%A1author=M.+Krstanovi%C4%87author=B.+H.+%C5%A0poljarauthor=D.+Ljevakovi%C4%87author=B.+Vrane%C5%A1i%C4%87author=L.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Entrapment+of+Peptidoglycans+and+Adamantyltripeptides+into+Liposomes%3A+An+HPLC+Assay+for+Determination+of+Encapsulation+Efficiency&doi=10.1081%2FLPR-120026452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency</span></div><div class="casAuthors">Frkanec, Ruza; Travas, Dijana; Krstanovic, Marina; Spoljar, Beata Halassy; Ljevakovic, Durdica; Vranesic, Branka; Frkanec, Leo; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">279-294</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The encapsulation of different immunomodulating peptides, the peptidoglycan monomer, its semisynthetic derivs. (Adamant-1-yl)-acetyl-peptidoglycan monomer and Boc-Tyr-peptidoglycan monomer, resp., and of 2 diastereoisomers of adamantyltripeptides into the large neg. charged multilamellar liposomes was investigated.  The reproducible quant. method using HPLC was established for the detn. of the entrapped compds.  It was shown that the tested compds. could be efficiently incorporated into liposomes using either the film or modified film method.  The results confirmed that the peptidoglycans with lipophilic substituents and particularly the adamantyltripeptides were incorporated into liposomes with higher efficiency than the peptidoglycan monomer using either of the described methods.  Liposome prepns. were stable at 4°C up to 7 days as shown by minimal leaking of the entrapped material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1hI__p75OorVg90H21EOLACvtfcHk0lgYaccMHLkQDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D&md5=d7c820181996614dad55faa819effe09</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1081%2FLPR-120026452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FLPR-120026452%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTrava%25C5%25A1%26aufirst%3DD.%26aulast%3DKrstanovi%25C4%2587%26aufirst%3DM.%26aulast%3D%25C5%25A0poljar%26aufirst%3DB.%2BH.%26aulast%3DLjevakovi%25C4%2587%26aufirst%3DD.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEntrapment%2520of%2520Peptidoglycans%2520and%2520Adamantyltripeptides%2520into%2520Liposomes%253A%2520An%2520HPLC%2520Assay%2520for%2520Determination%2520of%2520Encapsulation%2520Efficiency%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2003%26volume%3D13%26spage%3D279%26epage%3D294%26doi%3D10.1081%2FLPR-120026452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noethig-Laslo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirosavljević, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">A Spin Labelling Study of Immunomodulating Peptidoglycan Monomer and Adamantyltripeptides Entrapped into Liposomes</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1611</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/S0005-2736(03)00054-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=10.1016%2FS0005-2736%2803%2900054-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=12659960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1611&publication_year=2003&pages=187-196&author=R.+Frkanecauthor=V.+Noethig-Lasloauthor=B.+Vrane%C5%A1i%C4%87author=K.+Mirosavljevi%C4%87author=J.+Toma%C5%A1i%C4%87&title=A+Spin+Labelling+Study+of+Immunomodulating+Peptidoglycan+Monomer+and+Adamantyltripeptides+Entrapped+into+Liposomes&doi=10.1016%2FS0005-2736%2803%2900054-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes</span></div><div class="casAuthors">Frkanec, Ruza; Noethig-Laslo, Vesna; Vranesic, Branka; Mirosavljevic, Krunoslav; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1611</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">187-196</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The interaction of immunostimulating compds., the peptidoglycan monomer (PGM) and structurally related adamantyltripeptides (AdTP1 and AdTP2), resp., with phospholipids in liposomal bilayers were investigated by ESR spectroscopy.  The fatty acids bearing the nitroxide spin label at different positions along the acyl chain were used to investigate the interaction of tested compds. with neg. charged multilamellar liposomes.  ESR spectra were studied at 290 and 310 K.  The entrapment of the adamantyltripeptides affected the motional properties of all spin labeled lipids, while the entrapment of PGM had no effect.  Spin labeled PGM was prepd. and the novel compd. bearing the spin label attached via the amino group of diaminopimelic acid was chromatog. purified and chem. characterized.  The rotational correlation time of the spin labeled mol. dissolved in buffer at pH 7.4 was studied as a function of temp.  The conformational change was obsd. above 300 K.  The same effect was obsd. with the spin labeled PGM incorporated into liposomes.  Such effect was not obsd. when the spin labeled PGM was studied at alk. pH, probably due to the hydrolysis of PGM mol.  The study of possible interaction with liposomal membrane is relevant to the use of tested compds. incorporated into liposomes, as adjuvants in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKdV2HeMqDUbVg90H21EOLACvtfcHk0lgYaccMHLkQDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D&md5=d85964e73e290fbc42df57e31045d890</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2FS0005-2736%2803%2900054-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2736%252803%252900054-3%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DNoethig-Laslo%26aufirst%3DV.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DMirosavljevi%25C4%2587%26aufirst%3DK.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DA%2520Spin%2520Labelling%2520Study%2520of%2520Immunomodulating%2520Peptidoglycan%2520Monomer%2520and%2520Adamantyltripeptides%2520Entrapped%2520into%2520Liposomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2003%26volume%3D1611%26spage%3D187%26epage%3D196%26doi%3D10.1016%2FS0005-2736%2803%2900054-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgYaccMHLkQDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i85"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00644">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22203"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00644?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00644</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">(Molecular formula strings <a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_001.csv">CSV</a>)</p></li><li><p class="inline">Synthesis and analytical data of intermediate compounds <b>4</b>, <b>5</b>, <b>7</b>–<b>17</b>, <b>22</b>, <b>33</b>–<b>40</b>, <b>47</b>–<b>55</b>, <b>65</b>–<b>67</b>, and <b>69</b>–<b>71</b>, supporting schemes and figures, experimental procedure for chiral HPLC resolution of compound <b>29</b>, <sup>1</sup>H–<sup>1</sup>H NOESY determination of cyclopropane stereoconfiguration in compounds <b>27</b>, <b>28</b>, <b>29a</b>, and <b>29b</b>, and <sup>1</sup>H and <sup>13</sup>C NMR spectra of representative tested compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_001.csv">jm1c00644_si_001.csv (3.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00644/suppl_file/jm1c00644_si_002.pdf">jm1c00644_si_002.pdf (2.84 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00644&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00644%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00644" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a99b258423cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
